{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "1cy2twph3l2",
   "metadata": {},
   "source": "# Open Medic — Données de prescription de l'Assurance Maladie\n\n**Source :** CNAM / Ameli open data | **Couverture :** 2014–2024 | **Format :** CSV Latin-1 ; séparateur `;`\n\nAnalyse du fichier Open Medic 2024 (~1,9 million de lignes) sous huit angles complémentaires,\nde la concentration des prescriptions aux inégalités démographiques.\n\n| # | Question | Dimensions clés |\n|---|----------|----------------|\n| Q1 | La prescription est-elle concentrée sur quelques médicaments ? | `CIP13`, `BOITES` |\n| Q2 | Comment les dépenses se répartissent-elles par classe thérapeutique ? | `l_ATC1`, `BOITES`, `REM` |\n| Q3 | La prescription révèle-t-elle des inégalités démographiques ? | `age`, `sexe`, `l_ATC1` |\n| Q4 | Pénétration des génériques et économies potentielles | `TOP_GEN`, `GEN_NUM`, `l_ATC1` |\n| Q5 | Profil prescripteur par spécialité médicale | `PSP_SPE`, `l_ATC1` |\n| Q6 | Disparités régionales de prescription | `BEN_REG`, `ATC2` |\n| Q7 | Polymédication et budget des seniors (60 ans et plus) | `age`, `l_ATC1`, `REM` |\n| Q8 | Volume et montants remboursés par molécule (substance chimique) | `l_ATC5`, `BOITES`, `REM` |"
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "s92cvwk6rlg",
   "metadata": {},
   "outputs": [],
   "source": [
    "import httpx\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "import re\n",
    "from pathlib import Path\n",
    "\n",
    "RAW_DIR = Path(\"../../data/raw/open_medic\")\n",
    "RAW_DIR.mkdir(parents=True, exist_ok=True)\n",
    "YEAR = 2024\n",
    "\n",
    "def find_col(df, patterns):\n",
    "    \"\"\"Return first column whose name contains one of the patterns (case-insensitive).\"\"\"\n",
    "    for pat in patterns:\n",
    "        for c in df.columns:\n",
    "            if pat.lower() in c.lower():\n",
    "                return c\n",
    "    return None\n",
    "\n",
    "def open_medic_url(year: int) -> str:\n",
    "    return f\"https://open-data-assurance-maladie.ameli.fr/medicaments/download.php?Dir_Rep=Open_MEDIC_Base_Complete&Annee={year}\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "dggdrwsejrd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Already exists: 479 MB\n"
     ]
    }
   ],
   "source": [
    "# Téléchargement de l'année la plus récente (ignoré si le fichier existe déjà)\n",
    "dest = RAW_DIR / f\"open_medic_{YEAR}.csv\"\n",
    "\n",
    "if not dest.exists():\n",
    "    url = open_medic_url(YEAR)\n",
    "    print(f\"Downloading Open Medic {YEAR}...\")\n",
    "    print(f\"URL: {url}\")\n",
    "    with httpx.stream(\"GET\", url, follow_redirects=True, timeout=600) as resp:\n",
    "        resp.raise_for_status()\n",
    "        total = int(resp.headers.get(\"content-length\", 0))\n",
    "        downloaded = 0\n",
    "        with open(dest, \"wb\") as f:\n",
    "            for chunk in resp.iter_bytes(65536):\n",
    "                f.write(chunk)\n",
    "                downloaded += len(chunk)\n",
    "                if total:\n",
    "                    print(f\"\\r  {downloaded/1e6:.0f}/{total/1e6:.0f} MB ({100*downloaded/total:.0f}%)\", end=\"\")\n",
    "    print(f\"\\nDone: {dest.stat().st_size/1e6:.0f} MB\")\n",
    "else:\n",
    "    print(f\"Already exists: {dest.stat().st_size/1e6:.0f} MB\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "i5019cidw8l",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Open Medic 2024 — 1,916,885 lignes × 21 colonnes\n",
      "Total boîtes : 2368M  |  Total remboursé : 0.3 Md€\n",
      "\n",
      "Colonnes identifiées :\n",
      "  CIP13                         : ✓  CIP13\n",
      "  Boîtes                        : ✓  BOITES\n",
      "  Montant remboursé             : ✓  REM\n",
      "  Âge patient                   : ✓  age\n",
      "  Sexe patient                  : ✓  sexe\n",
      "  Spécialité prescripteur       : ✓  PSP_SPE\n",
      "  ATC1 (libellé)                : ✓  l_ATC1\n",
      "  ATC2 (code brut)              : ✓  ATC2\n",
      "  Région bénéficiaire           : ✓  BEN_REG\n",
      "  TOP_GEN                       : ✓  TOP_GEN\n",
      "  GEN_NUM                       : ✓  GEN_NUM\n"
     ]
    }
   ],
   "source": [
    "dest = RAW_DIR / f\"open_medic_{YEAR}.csv\"\n",
    "assert dest.exists(), (\n",
    "    f\"Fichier introuvable : {dest}\\n\"\n",
    "    \"→ Exécuter d'abord la cellule de téléchargement ci-dessus.\"\n",
    ")\n",
    "\n",
    "df = pd.read_csv(dest, sep=\";\", encoding=\"latin-1\", low_memory=False)\n",
    "df.columns = df.columns.str.strip()\n",
    "\n",
    "# Colonnes clés (noms variables selon les millésimes)\n",
    "CIP_COL       = find_col(df, ['CIP13'])\n",
    "BOX_COL       = find_col(df, ['boite', 'BOITE', 'BOITES'])\n",
    "REM_COL       = find_col(df, ['REM'])\n",
    "BSE_COL       = find_col(df, ['BSE'])\n",
    "AGE_COL       = find_col(df, ['AGE', 'age'])\n",
    "SEX_COL       = find_col(df, ['sexe', 'SEX'])\n",
    "PSP_SPE_COL   = find_col(df, ['PSP_SPE'])\n",
    "ATC1_COL      = find_col(df, ['L_ATC1', 'ATC1'])\n",
    "ATC2_CODE_COL = find_col(df, ['ATC2'])   # code brut J01, C10… (avant L_ATC2)\n",
    "REG_COL       = find_col(df, ['BEN_REG'])\n",
    "GEN_COL       = find_col(df, ['TOP_GEN'])\n",
    "GENNUM_COL    = find_col(df, ['GEN_NUM'])\n",
    "\n",
    "# Conversion numérique (format français : virgule décimale)\n",
    "for col in [BOX_COL, REM_COL, BSE_COL]:\n",
    "    if col and df[col].dtype == object:\n",
    "        df[col] = pd.to_numeric(\n",
    "            df[col].astype(str).str.replace(',', '.').str.replace(' ', ''),\n",
    "            errors='coerce'\n",
    "        )\n",
    "\n",
    "print(f\"Open Medic {YEAR} — {len(df):,} lignes × {len(df.columns)} colonnes\")\n",
    "print(f\"Total boîtes : {df[BOX_COL].sum()/1e6:.0f}M  |  Total remboursé : {df[REM_COL].sum()/1e9:.1f} Md€\\n\")\n",
    "print(\"Colonnes identifiées :\")\n",
    "for label, col in [\n",
    "    (\"CIP13\",                   CIP_COL),\n",
    "    (\"Boîtes\",                  BOX_COL),\n",
    "    (\"Montant remboursé\",       REM_COL),\n",
    "    (\"Âge patient\",             AGE_COL),\n",
    "    (\"Sexe patient\",            SEX_COL),\n",
    "    (\"Spécialité prescripteur\", PSP_SPE_COL),\n",
    "    (\"ATC1 (libellé)\",          ATC1_COL),\n",
    "    (\"ATC2 (code brut)\",        ATC2_CODE_COL),\n",
    "    (\"Région bénéficiaire\",     REG_COL),\n",
    "    (\"TOP_GEN\",                 GEN_COL),\n",
    "    (\"GEN_NUM\",                 GENNUM_COL),\n",
    "]:\n",
    "    status = f\"✓  {col}\" if col else \"✗  non trouvée\"\n",
    "    print(f\"  {label:<30}: {status}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "kbi0o7p4wi",
   "metadata": {},
   "source": [
    "---\n",
    "## Dictionnaire des variables — `2024_descriptif-variables_open-medic.xls`\n",
    "\n",
    "Contenu complet du fichier de description officiel CNAM, feuille par feuille.\n",
    "Utile comme référence lors de la rédaction d'articles."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "dlghi0vsune",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Fichier : 2024_descriptif-variables_open-medic.xls\n",
      "Feuilles (13) : ['Variables', 'ATC1', 'ATC2', 'ATC3', 'ATC4', 'ATC5', 'CIP13', 'TOP_GEN', 'GEN_NUM', 'AGE', 'SEXE', 'BEN_REG', 'PSP_SPE']\n",
      "\n",
      "================================================================================\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : Variables\n",
      "================================================================================\n",
      "\n",
      "  Variable | Libellé | \n",
      "  Médicament |  | \n",
      "  ATC1 | Goupe Principal Anatomique | Classification ATC Hiérarchique des Médicaments\n",
      "  ATC2 | Sous-Groupe Thérapeutique  | \n",
      "  ATC3 | Sous-Groupe Pharmacologique | \n",
      "  ATC4 | Sous-Groupe Chimique | \n",
      "  ATC5 | Sous-Groupe Substance Chimique | \n",
      "  CIP13 | Code Identification Spécialité Pharmaceutqiue | \n",
      "  TOP_GEN | Top Générique | \n",
      "  GEN_NUM | Groupe Générique | \n",
      "  Bénéficiaire |  | \n",
      "  AGE | Age au moment des soins | \n",
      "  SEXE | Sexe | \n",
      "  BEN_REG | Région de Résidence du Bénéficiaire | \n",
      "  Prescripteur |  | \n",
      "  PSP_SPE | Prescripteur | \n",
      "  Indicateurs |  | \n",
      "  REM | Montant Remboursé | \n",
      "  BSE | Base de Remboursement | \n",
      "  BOITES | Nombre de boîtes délivrées | \n",
      "  NBC | Nombre de consommants (disponible uniquement dans les bases type NB_) | \n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : ATC1\n",
      "================================================================================\n",
      "\n",
      "  ATC1 | Libellé ATC1\n",
      "  A | SYSTEME DIGESTIF ET METABOLISME\n",
      "  B | SANG ET ORGANES HEMATOPOIETQUES\n",
      "  C | SYSTEME CARDIO-VASCULAIRE\n",
      "  D | DERMATOLOGIE\n",
      "  G | SYSTEME GENITO-URINAIRE ET HORMONES SEXUELLES\n",
      "  H | HORMONES SYSTEMIQUES, A L EXCLUSION DES HORMONES SEXUELLES ET DES INSULINES\n",
      "  J | ANTI-INFECTIEUX (USAGE SYSTEMIQUE)\n",
      "  L | ANTINEOPLASIQUES ET AGENTS IMMUNOMODULANTS\n",
      "  M | SYSTEME MUSCULO-SQUELETTIQUE\n",
      "  N | SYSTEME NERVEUX\n",
      "  P | ANTIPARASITAIRES, INSECTICIDES ET REPULSIFS\n",
      "  R | SYSTEME RESPIRATOIRE\n",
      "  S | ORGANES SENSORIELS\n",
      "  V | DIVERS\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : ATC2\n",
      "================================================================================\n",
      "\n",
      "  ATC2 | Libellé ATC2\n",
      "  A01 | PREPARATIONS STOMATOLOGIQUES\n",
      "  A02 | MEDICAMENTS POUR LES TROUBLES DE L'ACIDITE\n",
      "  A03 | MEDICAMENTS POUR LES TROUBLES FONCTIONNELS GASTROINTESTINAUX\n",
      "  A04 | ANTIEMETIQUES ET ANTINAUSEEUX\n",
      "  A05 | THERAPEUTIQUE HEPATIQUE ET BILIAIRE\n",
      "  A06 | LAXATIFS\n",
      "  A07 | ANTIDIARRHEIQUES, ANTIINFLAMMATOIRES ET ANTIINFECTIEUX INTESTINAUX\n",
      "  A09 | MEDICAMENTS DE LA DIGESTION, ENZYMES INCLUSES\n",
      "  A10 | MEDICAMENTS DU DIABETE\n",
      "  A11 | VITAMINES\n",
      "  A12 | SUPPLEMENTS MINERAUX\n",
      "  A16 | AUTRES MEDICAMENTS DES VOIES DIGESTIVES ET DU METABOLISME\n",
      "  B01 | ANTITHROMBOTIQUES\n",
      "  B02 | ANTIHEMMORRAGIQUES\n",
      "  B03 | PREPARATIONS ANTIANEMIQUES\n",
      "  B05 | SUBSTITUTS DU SANG ET SOLUTIONS DE PERFUSION\n",
      "  B06 | AUTRES MEDICAMENTS UTILISES EN HEMATOLOGIE\n",
      "  C01 | MEDICAMENTS EN CARDIOLOGIE\n",
      "  C02 | ANTIHYPERTENSEURS\n",
      "  C03 | DIURETIQUES\n",
      "  C04 | VASODILATATEURS PERIPHERIQUES\n",
      "  C05 | VASCULOPROTECTEURS\n",
      "  C07 | BETABLOQUANTS\n",
      "  C08 | INHIBITEURS CALCIQUES\n",
      "  C09 | MEDICAMENTS AGISSANT SUR LE SYSTEME RENINE-ANGIOTENSINE\n",
      "  C10 | AGENTS MODIFIANT LES LIPIDES\n",
      "  D01 | ANTIFONGIQUES A USAGE DERMATOLOGIQUE\n",
      "  D02 | EMOLLIENTS ET PROTECTEURS\n",
      "  D03 | PREPARATIONS POUR LE TRAITEMENT DES PLAIES ET ULCERES\n",
      "  D05 | MEDICAMENTS CONTRE LE PSORIASIS\n",
      "  D06 | ANTIBIOTIQUES ET CHIMIOTHERAPIE A USAGE DERMATOLOGIQUE\n",
      "  D07 | CORTICOIDES, PREPARATIONS DERMATOLOGIQUES\n",
      "  D08 | ANTISEPTIQUES ET DESINFECTANTS\n",
      "  D10 | PREPARATIONS ANTIACNEIQUES\n",
      "  D11 | AUTRES PREPARATIONS DERMATOLOGIQUES\n",
      "  G01 | ANTIINFECTIEUX ET ANTISEPTIQUES A USAGE GYNECOLOGIQUE\n",
      "  G02 | AUTRES MEDICAMENTS GYNECOLOGIQUES\n",
      "  G03 | HORMONES SEXUELLES ET MODULATEURS DE LA FONCTION GENITALE\n",
      "  G04 | MEDICAMENTS UROLOGIQUES\n",
      "  H01 | HORMONES HYPOPHYSAIRES,HYPOTHALAMIQUES ET ANALOGUES\n",
      "  H02 | CORTICOIDES A USAGE SYSTEMIQUE\n",
      "  H03 | MEDICAMENTS DE LA THYROIDE\n",
      "  H04 | HORMONES PANCREATIQUES\n",
      "  H05 | MEDICAMENTS DE L'EQUILIBRE CALCIQUE\n",
      "  J01 | ANTIBACTERIENS A USAGE SYSTEMIQUE\n",
      "  J02 | ANTIMYCOSIQUES A USAGE SYSTEMIQUE\n",
      "  J04 | ANTIMYCOBACTERIENS\n",
      "  J05 | ANTIVIRAUX A USAGE SYSTEMIQUE\n",
      "  J06 | IMMUNSERUMS ET IMMUNOGLOBULINES\n",
      "  J07 | VACCINS\n",
      "  L01 | ANTINEOPLASIQUES\n",
      "  L02 | THERAPEUTIQUE ENDOCRINE\n",
      "  L03 | IMMUNOSTIMULANTS\n",
      "  L04 | IMMUNOSUPPRESSEURS\n",
      "  M01 | ANTIINFLAMMATOIRES ET ANTIRHUMATISMAUX\n",
      "  M02 | TOPIQUES POUR DOULEURS ARTICULAIRES OU MUSCULAIRES\n",
      "  M03 | MYORELAXANTS\n",
      "  M04 | ANTIGOUTTEUX\n",
      "  M05 | MEDICAMENTS POUR LE TRAITEMENT DES DESORDRES OSSEUX\n",
      "  M09 | AUTRES MEDICAMENTS DES DESORDRES MUSCULOSQUELETTIQUES\n",
      "  N01 | ANESTHESIQUES\n",
      "  N02 | ANALGESIQUES\n",
      "  N03 | ANTIEPILEPTIQUES\n",
      "  N04 | ANTIPARKINSONIENS\n",
      "  N05 | PSYCHOLEPTIQUES\n",
      "  N06 | PSYCHOANALEPTIQUES\n",
      "  N07 | AUTRES MEDICAMENTS DU SYSTEME NERVEUX\n",
      "  P01 | ANTIPROTOZOAIRES\n",
      "  P02 | ANTHELMINTHIQUES\n",
      "  P03 | PYRETHRINES\n",
      "  R01 | PREPARATIONS NASALES\n",
      "  R03 | MEDICAMENTS POUR LES SYNDROMES OBSTRUCTIFS DES VOIES AERIENNES\n",
      "  R05 | MEDICAMENTS DU RHUME ET DE LA TOUX\n",
      "  R06 | ANTIHISTAMINIQUES A USAGE SYSTEMIQUE\n",
      "  R07 | AUTRES MEDICAMENTS DE L'APPAREIL RESPIRATOIRE\n",
      "  S01 | MEDICAMENTS OPHTALMOLOGIQUES\n",
      "  S02 | MEDICAMENTS OTOLOGIQUES\n",
      "  V01 | ALLERGENES\n",
      "  V03 | TOUS AUTRES MEDICAMENTS\n",
      "  V04 | MEDICAMENTS POUR DIAGNOSTIC\n",
      "  V08 | PRODUITS DE CONTRASTE\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : ATC3\n",
      "================================================================================\n",
      "\n",
      "  ATC3 | Libellé ATC3\n",
      "  A01A | PREPARATIONS STOMATOLOGIQUES\n",
      "  A02A | ANTIACIDES\n",
      "  A02B | MEDICAMENTS POUR L'ULCÈRE PEPTIQUE ET LE REFLUX GASTRO-OESOPHAGIEN (RGO)\n",
      "  A03A | MEDICAMENTS POUR LES TROUBLES FONCTIONNELS INTESTINAUX\n",
      "  A03B | BELLADONE ET DERIVES\n",
      "  A03E | ANTISPASMODIQUES ET ANTICHOLINERGIQUES EN ASSOCIATION AVEC D'AUTRES MEDICAMENTS\n",
      "  A03F | STIMULANTS DE LA MOTRICITE INTESTINALE\n",
      "  A04A | ANTIEMETIQUES ET ANTINAUSEEUX\n",
      "  A05A | THERAPEUTIQUE BILIAIRE\n",
      "  A05B | THERAPEUTIQUE HEPATIQUE, LIPOTROPIQUES\n",
      "  A06A | LAXATIFS\n",
      "  A07A | ANTIINFECTIEUX INTESTINAUX\n",
      "  A07B | ADSORBANTS INTESTINAUX\n",
      "  A07D | RALENTISSEURS DE LA MOTRICITE INTESTINALE\n",
      "  A07E | ANTIINFLAMMATOIRES INTESTINAUX\n",
      "  A07X | AUTRES ANTIDIARRHEIQUES\n",
      "  A09A | MEDICAMENTS DE LA DIGESTION, ENZYMES INCLUSES\n",
      "  A10A | INSULINES ET ANALOGUES\n",
      "  A10B | MEDICAMENTS HYPOGLYCEMIANTS, INSULINES EXCLUSES\n",
      "  A11C | VITAMINES A ET D, ASSOCIATIONS DES DEUX INCLUSES\n",
      "  A11D | VITAMINE B1 NON ASSOCIEE ET EN ASSOCIATION AVEC VITAMINES B6 ET B12\n",
      "  A11H | AUTRES PREPARATIONS VITAMINIQUES NON ASSOCIEES\n",
      "  A12A | CALCIUM\n",
      "  A12B | POTASSIUM\n",
      "  A12C | AUTRES SUPPLEMENTS MINERAUX\n",
      "  A16A | AUTRES MEDICAMENTS DES VOIES DIGESTIVES ET DU METABOLISME\n",
      "  B01A | ANTITHROMBOTIQUES\n",
      "  B02A | ANTIFIBRINOLYTIQUES\n",
      "  B02B | VITAMINE K ET AUTRES HEMOSTATIQUES\n",
      "  B03A | PREPARATIONS MARTIALES\n",
      "  B03B | VITAMINE B12 ET ACIDE FOLIQUE\n",
      "  B03X | AUTRES PREPARATIONS ANTIANEMIQUES\n",
      "  B05B | SOLUTIONS INTRAVEINEUSES\n",
      "  B05X | ADDITIFS POUR SOLUTIONS INTRAVEINEUSES\n",
      "  B06A | AUTRES MEDICAMENTS UTILISES EN HEMATOLOGIE\n",
      "  C01A | GLUCOSIDES CARDIOTONIQUES\n",
      "  C01B | ANTIARYTHMIQUES, CLASSE I ET III\n",
      "  C01C | STIMULANTS CARDIAQUES, GLUCOSIDES CARDIOTONIQUES EXCLUS\n",
      "  C01D | VASODILATATEURS EN CARDIOLOGIE\n",
      "  C01E | AUTRES MEDICAMENTS EN CARDIOLOGIE\n",
      "  C02A | ADRENOLYTIQUES A ACTION CENTRALE\n",
      "  C02C | ADRENOLYTIQUES À ACTION PERIPHERIQUE\n",
      "  C02D | MEDICAMENTS AGISSANT SUR LE MUSCLE LISSE ARTERIOLAIRE\n",
      "  C02L | ANTIHYPERTENSEURS ET DIURETIQUES EN ASSOCIATION\n",
      "  C03A | DIURETIQUES \"LOW-CEILING\", THIAZIDIQUES\n",
      "  C03B | DIURETIQUES \"LOW-CEILING\", THIAZIDIQUES EXCLUS\n",
      "  C03C | DIURETIQUES DE L'ANSE\n",
      "  C03D | DIURETIQUES EPARGNEURS POTASSIQUES\n",
      "  C03E | DIURETIQUES ET EPARGNEURS POTASSIQUES EN ASSOCIATION\n",
      "  C03X | AUTRES DIURETIQUES\n",
      "  C04A | VASODILATATEURS PERIPHERIQUES\n",
      "  C05B | THERAPEUTIQUE ANTIVARIQUEUSE\n",
      "  C07A | BETABLOQUANTS\n",
      "  C07B | BETABLOQUANTS ET THIAZIDIQUES\n",
      "  C07D | BETABLOQUANTS, THIAZIDIQUES ET AUTRES DIURETIQUES\n",
      "  C07F | BETABLOQUANTS ET AUTRES ANTIHYPERTENSEURS\n",
      "  C08C | INHIBITEURS CALCIQUES SELECTIFS A EFFETS VASCULAIRES\n",
      "  C08D | INHIBITEURS CALCIQUES SELECTIFS A EFFETS CARDIAQUES DIRECTS\n",
      "  C08G | INHIBITEURS CALCIQUES ET DIURETIQUES\n",
      "  C09A | INHIBITEURS DE L'ENZYME DE CONVERSION (IEC) NON ASSOCIES\n",
      "  C09B | INHIBITEURS DE L'ENZYME DE CONVERSION (IEC) EN ASSOCIATION\n",
      "  C09C | ANTAGONISTES DE L'ANGIOTENSINE II, NON ASSOCIES\n",
      "  C09D | ANTAGONISTES DE L'ANGIOTENSINE II EN ASSOCIATION\n",
      "  C10A | AGENTS MODIFIANT LES LIPIDES NON ASSOCIES\n",
      "  C10B | AGENTS MODIFIANT LES LIPIDES EN ASSOCIATION\n",
      "  D01A | ANTIFONGIQUES A USAGE TOPIQUE\n",
      "  D01B | ANTIFONGIQUES A USAGE SYSTEMIQUE\n",
      "  D02A | EMOLLIENTS ET PROTECTEURS\n",
      "  D03A | CICATRISANTS\n",
      "  D05A | MEDICAMENTS CONTRE LE PSORIASIS A USAGE TOPIQUE\n",
      "  D05B | MEDICAMENTS CONTRE LE PSORIASIS A USAGE SYSTEMIQUE\n",
      "  D06A | ANTIBIOTIQUES A USAGE TOPIQUE\n",
      "  D06B | CHIMIOTHERAPIE A USAGE TOPIQUE\n",
      "  D07A | CORTICOIDES NON ASSOCIES\n",
      "  D07X | CORTICOIDES, AUTRES ASSOCIATIONS\n",
      "  D08A | ANTISEPTIQUES ET DESINFECTANTS\n",
      "  D10A | PREPARATIONS ANTIACNEIQUES A USAGE TOPIQUE\n",
      "  D10B | PREPARATIONS ANTIACNEIQUES A USAGE SYSTEMIQUE\n",
      "  D11A | AUTRES PREPARATIONS DERMATOLOGIQUES\n",
      "  G01A | ANTIINFECTIEUX ET ANTISEPTIQUES, ASSOCIATIONS AUX CORTICOIDES EXCLUES\n",
      "  G02A | OCYTOCIQUES\n",
      "  G02B | CONTRACEPTIFS A USAGE TOPIQUE\n",
      "  G02C | AUTRES MEDICAMENTS GYNECOLOGIQUES\n",
      "  G03A | CONTRACEPTIFS HORMONAUX A USAGE SYSTEMIQUE\n",
      "  G03B | ANDROGENES\n",
      "  G03C | ESTROGENES\n",
      "  G03D | PROGESTATIFS\n",
      "  G03F | PROGESTATIFS ET ESTROGENES EN ASSOCIATION\n",
      "  G03G | GONADOTROPHINES ET AUTRES STIMULANTS DE L'OVULATION\n",
      "  G03H | ANTIANDROGENES\n",
      "  G03X | AUTRES HORMONES SEXUELLES ET MODULATEURS DE LA FONCTION GENITALE\n",
      "  G04B | AUTRES MEDICAMENTS UROLOGIQUES, ANTISPASMODIQUES INCLUS\n",
      "  G04C | MEDICAMENTS UTILISES DANS L'HYPERTROPHIE BENIGNE DE LA PROSTATE\n",
      "  H01A | HORMONES DE L'ANTE HYPOPHYSE ET ANALOGUES\n",
      "  H01B | HORMONES DE LA POST HYPOPHYSE\n",
      "  H01C | HORMONES HYPOTHALAMIQUES\n",
      "  H02A | CORTICOIDES A USAGE SYSTEMIQUE NON ASSOCIES\n",
      "  H02C | ANTIHORMONES SURRENALIENNES\n",
      "  H03A | PREPARATIONS THYROIDIENNES\n",
      "  H03B | ANTITHYROIDIENS\n",
      "  H04A | HORMONES GLYCOGENOLYTIQUES\n",
      "  H05A | HORMONES PARATHYROIDIENNES ET ANALOGUES\n",
      "  H05B | AGENTS ANTIPARATHYROÏDIENS\n",
      "  J01A | TETRACYCLINES\n",
      "  J01C | BETALACTAMINES : PENICILLINES\n",
      "  J01D | AUTRES BETALACTAMINES\n",
      "  J01E | SULFAMIDES ET TRIMETHOPRIME\n",
      "  J01F | MACROLIDES, LINCOSAMIDES ET STREPTOGRAMINES\n",
      "  J01G | AMINOSIDES ANTIBACTERIENS\n",
      "  J01M | QUINOLONES ANTIBACTERIENNES\n",
      "  J01R | ASSOCIATIONS D'ANTIBACTERIENS\n",
      "  J01X | AUTRES ANTIBACTERIENS\n",
      "  J02A | ANTIMYCOSIQUES A USAGE SYSTEMIQUE\n",
      "  J04A | ANTITUBERCULEUX\n",
      "  J04B | ANTILEPREUX\n",
      "  J05A | ANTIVIRAUX A ACTION DIRECTE\n",
      "  J06B | IMMUNOGLOBULINES\n",
      "  J07A | VACCINS BACTERIENS\n",
      "  J07B | VACCINS VIRAUX\n",
      "  J07C | VACCINS BACTERIENS ET VIRAUX ASSOCIES\n",
      "  L01A | AGENTS ALKYLANTS\n",
      "  L01B | ANTIMETABOLITES\n",
      "  L01C | ALCALOIDES VEGETAUX ET AUTRES MEDICAMENTS D'ORIGINE NATURELLE\n",
      "  L01E | INHIBITEURS DE PROTEINE KINASE\n",
      "  L01X | AUTRES ANTINEOPLASIQUES\n",
      "  L02A | HORMONES ET APPARENTES\n",
      "  L02B | ANTIHORMONES ET APPARENTES\n",
      "  L03A | IMMUNOSTIMULANTS\n",
      "  L04A | IMMUNOSUPPRESSEURS\n",
      "  M01A | ANTIINFLAMMATOIRES, ANTIRHUMATISMAUX, NON STEROIDIENS\n",
      "  M01C | ANTIRHUMATISMAUX SPECIFIQUES\n",
      "  M02A | TOPIQUES POUR DOULEURS ARTICULAIRE ET MUSCULAIRE\n",
      "  M03B | MYORELAXANTS A ACTION CENTRALE\n",
      "  M03C | MYORELAXANTS A ACTION DIRECTE\n",
      "  M04A | ANTIGOUTTEUX\n",
      "  M05B | MEDICAMENTS AGISSANT SUR LA STRUCTURE OSSEUSE ET LA MINERALISATION\n",
      "  M09A | AUTRES MEDICAMENTS DES DESORDRES MUSCULO-SQUELETTIQUES\n",
      "  N01B | ANESTHESIQUES LOCAUX\n",
      "  N02A | OPIOIDES\n",
      "  N02B | AUTRES ANALGESIQUES ET ANTIPYRETIQUES\n",
      "  N02C | ANTIMIGRAINEUX\n",
      "  N03A | ANTIEPILEPTIQUES\n",
      "  N04A | ANTICHOLINERGIQUES\n",
      "  N04B | DOPAMINERGIQUES\n",
      "  N05A | ANTIPSYCHOTIQUES\n",
      "  N05B | ANXIOLYTIQUES\n",
      "  N05C | HYPNOTIQUES ET SEDATIFS\n",
      "  N06A | ANTIDEPRESSEURS\n",
      "  N06B | PSYCHOSTIMULANTS, AGENTS UTILISES DANS LE TDAH ET NOOTROPES\n",
      "  N07A | PARASYMPATHOMIMETIQUES\n",
      "  N07B | MEDICAMENTS UTILISES DANS LES PHENOMÈNES DE DEPENDANCE\n",
      "  N07C | ANTIVERTIGINEUX\n",
      "  N07X | AUTRES MEDICAMENTS DU SYSTEME NERVEUX\n",
      "  P01A | MEDICAMENTS CONTRE L'AMIBIASE ET AUTRES PROTOZOOSES\n",
      "  P01B | ANTIPALUDIQUES\n",
      "  P01C | ANTILEISHMANIENS ET TRYPANOCIDES\n",
      "  P02B | ANTITREMATODES\n",
      "  P02C | ANTINEMATODES\n",
      "  P02D | ANTICESTODES\n",
      "  P03A | ANTIPARASITAIRES EXTERNES, SCABICIDES INCLUS\n",
      "  R01A | DECONGESTIONNANTS ET AUTRES PREPARATIONS A USAGE TOPIQUE\n",
      "  R03A | ADRENERGIQUES POUR INHALATION\n",
      "  R03B | AUTRES MEDICAMENTS POUR LES SYNDROMES OBSTRUCTIFS DES VOIES AERIENNES PAR INHALATION\n",
      "  R03C | ADRENERGIQUES A USAGE SYSTEMIQUE\n",
      "  R03D | AUTRES MEDICAMENTS POUR LES SYNDROMES OBSTRUCTIFS DES VOIES AERIENNES À USAGE SYSTEMIQUE\n",
      "  R05C | EXPECTORANTS, SAUF ASSOCIATIONS AUX ANTITUSSIFS\n",
      "  R05D | ANTITUSSIFS, SAUF ASSOCIATIONS AUX EXPECTORANTS\n",
      "  R06A | ANTIHISTAMINIQUES A USAGE SYSTEMIQUE\n",
      "  R07A | AUTRES MEDICAMENTS DE L'APPAREIL RESPIRATOIRE\n",
      "  S01A | ANTIINFECTIEUX\n",
      "  S01B | ANTIINFLAMMATOIRES\n",
      "  S01C | ANTIINFLAMMATOIRES ET ANTIINFECTIEUX EN ASSOCIATION\n",
      "  S01E | ANTIGLAUCOMATEUX ET MYOTIQUES\n",
      "  S01F | MYDRIATIQUES ET CYCLOPLEGIQUES\n",
      "  S01G | DECONGESTIONNANTS ET ANTIALLERGIQUES\n",
      "  S01K | ADJUVANTS EN CHIRURGIE OPHTALMIQUE\n",
      "  S01L | MEDICAMENTS CONTRE LES TROUBLES OCULOVASCULAIRES\n",
      "  S01X | AUTRES MEDICAMENTS OPHTALMOLOGIQUES\n",
      "  S02A | ANTIINFECTIEUX\n",
      "  S02C | CORTICOIDES ET ANTIINFECTIEUX EN ASSOCIATION\n",
      "  S02D | AUTRES MEDICAMENTS OTOLOGIQUES\n",
      "  V01A | ALLERGENES\n",
      "  V03A | TOUS AUTRES MEDICAMENTS\n",
      "  V04C | AUTRES MEDICAMENTS POUR DIAGNOSTIC\n",
      "  V08A | PRODUITS DE CONTRASTE IODES\n",
      "  V08B | PRODUITS DE CONTRASTE NON IODES\n",
      "  V08C | PRODUITS DE CONTRASTE POUR IMAGERIE PAR RESONANCE MAGNETIQUE\n",
      "  V08D | PRODUITS POUR ECHOGRAPHIE\n",
      "  C05A | MEDICAMENTS POUR LE TRAITEMENT DES HEMORROIDES ET DES FISSURES ANALES A USAGE TOPIQUE\n",
      "  L01D | ANTIBIOTIQUES CYTOTOXIQUES ET APPARENTES\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : ATC4\n",
      "================================================================================\n",
      "\n",
      "  ATC4 | Libellé ATC4 |  | \n",
      "  A01AA | MEDICAMENTS PROPHYLACTIQUES ANTICARIES |  | \n",
      "  A01AB | ANTIINFECTIEUX POUR TRAITEMENT ORAL LOCAL |  | \n",
      "  A01AD | AUTRES MEDICAMENTS POUR TRAITEMENT ORAL LOCAL |  | \n",
      "  A02AB | ANTIACIDES A BASE D'ALUMINIUM |  | \n",
      "  A02AD | ASSOCIATIONS ET COMPLEXES A BASE D'ALUMINIUM, DE CALCIUM ET DE MAGNESIUM |  | \n",
      "  A02AX | ANTIACIDES : AUTRES ASSOCIATIONS |  | \n",
      "  A02BA | ANTAGONISTES DES RECEPTEURS H2 |  | \n",
      "  A02BC | INHIBITEURS DE LA POMPE A PROTONS |  | \n",
      "  A02BD | ASSOCIATIONS POUR L'ERADICATION D'HELICOBACTER PYLORI |  | \n",
      "  A02BX | AUTRES MEDICAMENTS POUR L'ULCÈRE PEPTIQUE ET LE REFLUX GASTROOESOPHAGIEN (RGO) |  | \n",
      "  A03AA | ANTICHOLINERGIQUES DE SYNTHESE : ESTERS AVEC GROUPEMENT AMINE TERTIAIRE |  | \n",
      "  A03AX | AUTRES MEDICAMENTS POUR LES TROUBLES FONCTIONNELS INTESTINAUX |  | \n",
      "  A03BB | ALCALOIDES HEMISYNTHETIQUES DE LA BELLADONE : AMMONIUMS QUATERNAIRES |  | \n",
      "  A03ED | ANTISPASMODIQUES EN ASSOCIATION AVEC D'AUTRES MEDICAMENTS |  | \n",
      "  A03FA | STIMULANTS DE LA MOTRICITE INTESTINALE |  | \n",
      "  A04AA | ANTAGONISTES DE LA SEROTONINE (5HT3) |  | \n",
      "  A04AD | AUTRES ANTIEMETIQUES |  | \n",
      "  A05AA | ACIDES BILIAIRES |  | \n",
      "  A05BA | THERAPEUTIQUE HEPATIQUE |  | \n",
      "  A06AA | LAXATIFS LUBRIFIANTS |  | \n",
      "  A06AB | LAXATIFS STIMULANTS |  | \n",
      "  A06AC | LAXATIFS DE LEST |  | \n",
      "  A06AD | LAXATIFS OSMOTIQUES |  | \n",
      "  A06AG | LAVEMENTS |  | \n",
      "  A06AH | ANTAGONISTES DE RECEPTEURS |  | \n",
      "  A06AX | AUTRES LAXATIFS |  | \n",
      "  A07AA | ANTIBIOTIQUES |  | \n",
      "  A07BC | AUTRES ADSORBANTS INTESTINAUX |  | \n",
      "  A07DA | RALENTISSEURS DE LA MOTRICITE INTESTINALE |  | \n",
      "  A07EA | CORTICOIDES A ACTION LOCALE |  | \n",
      "  A07EC | ACIDE AMINOSALICYLIQUE ET ANALOGUES |  | \n",
      "  A07XA | AUTRES ANTIDIARRHEIQUES |  | \n",
      "  A09AA | PREPARATIONS ENZYMATIQUES |  | \n",
      "  A10AB | INSULINES ET ANALOGUES D’ACTION RAPIDE POUR INJECTION |  | \n",
      "  A10AC | INSULINES ET ANALOGUES D'ACTION INTERMEDIAIRE POUR INJECTION |  | \n",
      "  A10AD | INSULINES ET ANALOGUES D’ACTION INTERMEDIAIRE ET À DEBUT D’ACTION RAPIDE POUR INJECTION |  | \n",
      "  A10AE | INSULINES ET ANALOGUES D’ACTION LENTE POUR INJECTION |  | \n",
      "  A10BA | BIGUANIDES |  | \n",
      "  A10BB | SULFAMIDES, DERIVES DE L'UREE |  | \n",
      "  A10BD | ASSOCIATION DE MEDICAMENTS HYPOGLYCEMIANTS ORAUX |  | \n",
      "  A10BF | INHIBITEURS DE L'ALPHA GLUCOSIDASE |  | \n",
      "  A10BH | INHIBITEURS DE LA DIPEPTIDYL PEPTIDASE 4 (DPP-4) |  | \n",
      "  A10BJ | ANALOGUES DES RECEPTEURS GLUACON-LIKE PEPTIDE-1 |  | \n",
      "  A10BK | INHIBITEURS DU SODIUM-GLUCOSE CO-TRANSPORTEUR 2 | * | \n",
      "  A10BX | AUTRES MEDICAMENTS HYPOGLYCEMIANTS, INSULINES EXCLUSES |  | \n",
      "  A11CA | VITAMINE A NON ASSOCIEE |  | \n",
      "  A11CC | VITAMINE D ET ANALOGUES |  | \n",
      "  A11DA | VITAMINE B1, NON ASSOCIEE |  | \n",
      "  A11HA | AUTRES PREPARATIONS VITAMINIQUES NON ASSOCIEES |  | \n",
      "  A12AA | CALCIUM |  | \n",
      "  A12AX | CALCIUM EN ASSOCIATION AVEC D'AUTRES SUBSTANCES |  | \n",
      "  A12BA | DERIVES POTASSIQUES |  | \n",
      "  A12CC | MAGNESIUM |  | \n",
      "  A12CX | AUTRES ELEMENTS MINERAUX |  | \n",
      "  A16AA | ACIDES AMINES ET DERIVES |  | \n",
      "  A16AB | ENZYMES |  | \n",
      "  A16AX | DIVERS MEDICAMENTS DES VOIES DIGESTIVES ET DU METABOLISME |  | \n",
      "  B01AA | ANTIVITAMINES K |  | \n",
      "  B01AB | GROUPE DE L'HEPARINE |  | \n",
      "  B01AC | INHIBITEURS DE L'AGREGATION PLAQUETTAIRE, HEPARINE EXCLUE |  | \n",
      "  B01AE | INHIBITEURS DIRECTS DE LA THROMBINE |  | \n",
      "  B01AF | INHIBITEURES DIRECTS DU FACTEUR Xa |  | \n",
      "  B01AX | AUTRES ANTITHROMBOTIQUES |  | \n",
      "  B02AA | ACIDES AMINES |  | \n",
      "  B02BA | VITAMINE K |  | \n",
      "  B02BX | AUTRES HEMOSTATIQUES SYSTEMIQUES |  | \n",
      "  B03AA | FER BIVALENT, PREPARATIONS ORALES |  | \n",
      "  B03AB | FER TRIVALENT, PREPARATIONS ORALES |  | \n",
      "  B03BA | VITAMINE B12 (CYANOCOBALAMINE ET DERIVES) |  | \n",
      "  B03BB | ACIDE FOLIQUE ET DERIVES |  | \n",
      "  B03XA | AUTRES PREPARATIONS ANTIANEMIQUES |  | \n",
      "  B05BA | SOLUTIONS POUR NUTRITION PARENTERALE |  | \n",
      "  B05BB | SOLUTIONS MODIFIANT LE BILAN ELECTROLYTIQUE |  | \n",
      "  B05X | ADDITIFS POUR SOLUTIONS INTRAVENEUSES |  | \n",
      "  B05XA | SOLUTIONS D'ELECTROLYTES |  | \n",
      "  B05XC | VITAMINES |  | \n",
      "  B05XX | AUTRES ADDITIFS POUR SOLUTIONS INTRAVEINEUSES |  | \n",
      "  B06AC | AUTRES MÉDICAMENTS UTILISÉS DANS L ANGIO-ŒDÈME HÉRÉDITAIRE |  | \n",
      "  C01AA | GLUCOSIDES DE LA DIGITALE |  | \n",
      "  C01BA | ANTIARYTHMIQUES, CLASSE IA |  | \n",
      "  C01BB | ANTIARYTHMIQUES, CLASSE IB |  | \n",
      "  C01BC | ANTIARYTHMIQUES, CLASSE IC |  | \n",
      "  C01BD | ANTIARYTHMIQUES, CLASSE III |  | \n",
      "  C01BG | AUTRES ANTIARYTHMIQUES DE CLASSE I |  | \n",
      "  C01CA | ADRENERGIQUES ET DOPAMINERGIQUES |  | \n",
      "  C01DA | DERIVES NITRES |  | \n",
      "  C01DX | AUTRES VASODILATATEURS EN CARDIOLOGIE |  | \n",
      "  C01EB | AUTRES MEDICAMENTS EN CARDIOLOGIE |  | \n",
      "  C02AB | MEthyldopa |  | \n",
      "  C02AC | AGONISTES DES RECEPTEURS A L'IMIDAZOLINE |  | \n",
      "  C02CA | ALPHA-BLOQUANTS |  | \n",
      "  C02DC | DERIVES DE LA PYRIMIDINE |  | \n",
      "  C02LA | ALCALOIDES DU RAUWOLFIA ET DIURETIQUES EN ASSOCIATION |  | \n",
      "  C03AA | THIAZIDIQUES NON ASSOCIES |  | \n",
      "  C03BA | SULFAMIDES NON ASSOCIES |  | \n",
      "  C03BX | AUTRES DIURETIQUES \"LOW-CEILING\" |  | \n",
      "  C03CA | SULFAMIDES NON ASSOCIES |  | \n",
      "  C03DA | ANTAGONISTES DE L'ALDOSTERONE |  | \n",
      "  C03DB | AUTRES DIURETIQUES EPARGNEURS POTASSIQUES |  | \n",
      "  C03EA | DIURETIQUES \"LOW-CEILING\" ET EPARGNEURS POTASSIQUES |  | \n",
      "  C03EB | DIURETIQUES DE L'ANSE ET EPARGNEURS POTASSIQUES |  | \n",
      "  C03XA | ANTAGONISTES DE LA VASOPRESSINE |  | \n",
      "  C04AX | AUTRES VASODILATATEURS PERIPHERIQUES |  | \n",
      "  C05BA | HEPARINES OU HEPARINOIDES A USAGE TOPIQUE |  | \n",
      "  C07AA | BETABLOQUANTS, NON SELECTIFS |  | \n",
      "  C07AB | BETABLOQUANTS, SELECTIFS |  | \n",
      "  C07AG | ALPHA ET BETA BLOQUANTS |  | \n",
      "  C07BB | BETABLOQUANTS SELECTIFS ET THIAZIDIQUES |  | \n",
      "  C07DA | BETABLOQUANTS NON SELECTIFS, THIAZIDIQUES ET AUTRES DIURETIQUES |  | \n",
      "  C07FB | BETABLOQUANTS SELECTIFS ET AUTRES ANTIHYPERTENSEURS |  | \n",
      "  C08CA | DERIVES DE LA DIHYDROPYRIDINE |  | \n",
      "  C08DA | DERIVES DE LA PHENYLALKYLAMINE |  | \n",
      "  C08DB | DERIVES DE LA BENZOTHIAZEPINE |  | \n",
      "  C08GA | INHIBITEUR CALCIQUE ET DIURETIQUE |  | \n",
      "  C09AA | INHIBITEURS DE L'ENZYME DE CONVERSION (IEC) NON ASSOCIES |  | \n",
      "  C09BA | INHIBITEURS DE L'ENZYME DE CONVERSION (IEC) ET DIURETIQUES |  | \n",
      "  C09BB | INHIBITEURS DE L'ENZYME DE CONVERSION (IEC) ET INHIBITEURS CALCIQUES |  | \n",
      "  C09BX | INHIBITEURS DE L'ENZYME DE CONVERSION, AUTRES ASSOCIATIONS |  | *\n",
      "  C09CA | ANTAGONISTES DE L'ANGIOTENSINE II NON ASSOCIES |  | \n",
      "  C09DA | ANTAGONISTES DE L'ANGIOTENSINE II ET DIURETIQUES |  | \n",
      "  C09DB | ANTAGONISTES DE L’ANGIOTENSINE II ET INHIBITEURS CALCIQUES |  | \n",
      "  C09DX | ANTAGONISTES DE L ANGIOTENSINE II, AUTRES ASSOCIATIONS |  | \n",
      "  C10AA | INHIBITEURS DE L'HMG-COA REDUCTASE |  | *\n",
      "  C10AB | FIBRATES |  | \n",
      "  C10AC | SEQUESTRANTS D'ACIDES BILIAIRES |  | \n",
      "  C10AX | AUTRES AGENTS MODIFIANT LES LIPIDES |  | \n",
      "  C10BA | INHIBITEURS DE L’HMG -COA REDUCTASE EN ASSOCIATION AVEC D’AUTRES AGENTS MODIFIANT LES LIPIDES |  | \n",
      "  C10BX | INHIBITEURS DE L’HMG -COA REDUCTASE, AUTRES ASSOCIATIONS |  | \n",
      "  D01AC | DERIVES IMIDAZOLES ET TRIAZOLES |  | \n",
      "  D01AE | AUTRES ANTIFONGIQUES A USAGE TOPIQUE |  | \n",
      "  D01BA | ANTIFONGIQUES A USAGE SYSTEMIQUE |  | \n",
      "  D02AB | MEDICAMENTS A BASE DE ZINC |  | \n",
      "  D02AC | PARAFFINE ET PRODUITS GRAS |  | \n",
      "  D02AX | AUTRES EMOLLIENTS ET PROTECTEURS |  | \n",
      "  D03AX | AUTRES CICATRISANTS |  | \n",
      "  D05AD | PSORALENES A USAGE TOPIQUE |  | \n",
      "  D05AX | AUTRES MEDICAMENTS CONTRE LE PSORIASIS A USAGE TOPIQUE |  | \n",
      "  D05BA | PSORALENES A USAGE SYSTEMIQUE |  | \n",
      "  D05BB | RETINOIDES POUR LE TRAITEMENT DU PSORIASIS |  | \n",
      "  D06AX | AUTRES ANTIBIOTIQUES A USAGE TOPIQUE |  | \n",
      "  D06BA | SULFAMIDES |  | \n",
      "  D06BB | ANTIVIRAUX |  | \n",
      "  D06BX | AUTRES CHIMIOTHERAPIES |  | \n",
      "  D07AB | CORTICOIDES D'ACTIVITE MODEREE (GROUPE II) |  | \n",
      "  D07AC | CORTICOIDES D'ACTIVITE FORTE (GROUPE III) |  | \n",
      "  D07AD | COSTICOSTEROIDES D'ACTIVITE TRES FORTE (GROUPE IV) |  | \n",
      "  D07XC | CORTICOIDES D'ACTIVITE FORTE, AUTRES ASSOCIATIONS |  | \n",
      "  D08AC | BIGUANIDES ET AMIDINES |  | \n",
      "  D08AG | DERIVES IODES |  | \n",
      "  D08AX | AUTRES ANTISEPTIQUES ET DESINFECTANTS |  | \n",
      "  D10AD | RETINOIDES ANTIACNEIQUES A USAGE TOPIQUE |  | \n",
      "  D10AE | PEROXYDES |  | \n",
      "  D10AF | ANTIINFECTIEUX POUR LE TRAITEMENT DE L'ACNE |  | \n",
      "  D10AX | AUTRES PREPARATIONS ANTIACNEIQUES A USAGE TOPIQUE |  | \n",
      "  D10BA | RETINOIDES POUR LE TRAITEMENT DE L'ACNE |  | \n",
      "  D10BX | AUTRES PREPARATIONS ANTIACNEIQUES A USAGE SYSTEMIQUE |  | \n",
      "  D11AH | MEDICAMENTS UTILISES DANS LA DERMATITE, EXCLUS CORTICOSTEROIDES |  | \n",
      "  G01AA | ANTIBIOTIQUES |  | \n",
      "  G01AF | DERIVES IMIDAZOLES |  | \n",
      "  G02AB | ALCALOIDES DE L'ERGOT |  | \n",
      "  G02BA | CONTRACEPTIFS INTRAUTERINS |  | \n",
      "  G02CB | INHIBITEURS DE LA PROLACTINE |  | \n",
      "  G03AA | PROGESTATIFS ET ESTROGENES EN ASSOCIATION FIXE |  | \n",
      "  G03AB | PROGESTATIFS ET ESTROGENES POUR ADMINISTRATION SEQUENTIELLE |  | \n",
      "  G03AC | PROGESTATIFS |  | \n",
      "  G03AD | CONTRACEPTION D'URGENCE |  | \n",
      "  G03BA | DERIVES DU 3 OXOANDROSTENE |  | \n",
      "  G03BB | DERIVES DE LA 5 ANDROSTAN-3-ONE |  | \n",
      "  G03CA | ESTROGENES NATURELS ET HEMISYNTHETIQUES NON ASSOCIES |  | \n",
      "  G03DA | DERIVES PREGNENE 4 |  | \n",
      "  G03DB | DERIVES PREGNADIENE |  | \n",
      "  G03FA | PROGESTATIFS ET ESTROGENES EN ASSOCIATION |  | \n",
      "  G03FB | PROGESTATIFS ET ESTROGENES POUR ADMINISTRATION SEQUENTIELLE |  | \n",
      "  G03GA | GONADOTROPHINES |  | \n",
      "  G03GB | STIMULANTS SYNTHETIQUES DE L'OVULATION |  | \n",
      "  G03HA | ANTIANDROGENES NON ASSOCIES |  | \n",
      "  G03HB | ANTIANDROGENES ET ESTROGENES |  | \n",
      "  G03XA | ANTIGONADOTROPHINES ET ANALOGUES |  | \n",
      "  G03XC | MODULATEURS SELECTIFS DES RECEPTEURS AUX ESTROGÈNES |  | \n",
      "  G04BD | ANTISPASMODIQUES URINAIRES |  | \n",
      "  G04BE | MEDICAMENTS UTILISES DANS LES TROUBLES DE L'ERECTION |  | \n",
      "  G04CA | ALPHA-BLOQUANTS |  | \n",
      "  G04CB | INHIBITEURS DE L'ALPHA-5-TESTOSTERONE REDUCTASE |  | \n",
      "  G04CX | AUTRES MEDICAMENTS UTILISES DANS L'HYPERTROPHIE BENIGNE DE LA PROSTATE |  | \n",
      "  H01AA | ACTH |  | \n",
      "  H01AC | SOMATROPINE ET AGONISTES DE LA SOMATROPINE |  | \n",
      "  H01AX | Autres hormones de l'ante hypophyse et analogues |  | \n",
      "  H01BA | VASOPRESSINE ET ANALOGUES |  | \n",
      "  H01CA | HORMONES ENTRAINANT LA LIBERATION DE GONADOTROPHINES |  | \n",
      "  H01CB | ANTIHORMONE DE CROISSANCE |  | \n",
      "  H01CC | HORMONES ENTRAINANT LA LIBERATION D'ANTAGONISTES DES GONADOTROPHINES |  | \n",
      "  H02AA | MINERALOCORTICOIDES |  | \n",
      "  H02AB | GLUCOCORTICOIDES |  | \n",
      "  H02CA | INHIBITEURS DE CORTICOIDES |  | \n",
      "  H03AA | HORMONES THYROIDIENNES |  | \n",
      "  H03BA | THIOURACILES |  | \n",
      "  H03BB | DERIVES IMIDAZOLES SOUFRES |  | \n",
      "  H04AA | HORMONES GLYCOGENOLYTIQUES |  | \n",
      "  H05AA | HORMONES PARATHYROIDIENNES ET ANALOGUES |  | \n",
      "  H05BX | AUTRES AGENTS ANTIPARATHYROÏDIENS |  | \n",
      "  J01AA | TETRACYCLINES |  | \n",
      "  J01CA | PENICILLINES A LARGE SPECTRE |  | \n",
      "  J01CE | PENICILLINES SENSIBLES AUX BETALACTAMASES |  | \n",
      "  J01CF | PENICILLINES RESISTANTES AUX BETALACTAMASES |  | \n",
      "  J01CR | ASSOCIATIONS DE PENICILLINES, INHIBITEURS DE BETALACTAMASES INCLUS |  | \n",
      "  J01DB | CEPHALOSPORINES DE PREMIERE GENERATION |  | \n",
      "  J01DC | CEPHALOSPORINES DE DEUXIEME GENERATION |  | \n",
      "  J01DD | CEPHALOSPORINES DE TROISIEME GENERATION |  | \n",
      "  J01DE | CEPHALOSPORINES DE QUATRIEME GENERATION |  | \n",
      "  J01DF | MONOBACTAMS |  | \n",
      "  J01DH | CARBAPENEMS |  | \n",
      "  J01EA | TRIMETHOPRIME ET DERIVES |  | \n",
      "  J01EC | SULFAMIDES D'ACTION INTERMEDIAIRE |  | \n",
      "  J01EE | ASSOCIATIONS DE SULFAMIDES ET DE TRIMETHOPRIME, DERIVES INCLUS |  | \n",
      "  J01FA | MACROLIDES |  | \n",
      "  J01FF | LINCOSAMIDES |  | \n",
      "  J01FG | STEPTOGRAMINES (SYNERGISTINES) |  | \n",
      "  J01GB | AUTRES AMINOSIDES |  | \n",
      "  J01MA | FLUOROQUINOLONES |  | \n",
      "  J01RA | ASSOCIATIONS D'ANTIBACTERIENS |  | \n",
      "  J01XB | POLYMYXINES |  | \n",
      "  J01XC | ANTIBACTERIENS STEROIDIENS |  | \n",
      "  J01XE | DERIVES DU NITROFURANE |  | \n",
      "  J01XX | AUTRES ANTIBACTERIENS |  | \n",
      "  J02AA | ANTIBIOTIQUES |  | \n",
      "  J02AC | DERIVES TRIAZOLES |  | \n",
      "  J02AX | AUTRES ANTIMYCOSIQUES A USAGE SYSTEMIQUE |  | \n",
      "  J04AB | ANTIBIOTIQUES |  | \n",
      "  J04AC | HYDRAZIDES |  | \n",
      "  J04AK | AUTRES ANTITUBERCULEUX |  | \n",
      "  J04AM | ASSOCIATIONS D'ANTITUBERCULEUX |  | \n",
      "  J04BA | ANTILEPREUX |  | \n",
      "  J05AB | NUCLEOSIDES ET NUCLEOTIDES, INHIBITEURS DE LA TRANSCRIPTASE EXCLUS |  | \n",
      "  J05AE | INHIBITEURS DE PROTEASE |  | \n",
      "  J05AF | INHIBITEURS DE LA TRANSCRIPTASE REVERSE NUCLEOSIDES ET NUCLEOTIDES |  | \n",
      "  J05AG | INHIBITEURS DE LA TRANSCRIPTASE REVERSE NON NUCLEOSIDES |  | \n",
      "  J05AH | INHIBITEURS DE LA NEURAMINIDASE |  | \n",
      "  J05AJ | INHIBITEUR D INTÉGRASE |  | \n",
      "  J05AP | ANTIVIRAUX POUR LE TRAITEMENT DES INFECTIONS HCV |  | \n",
      "  J05AR | ANTIVIRAUX POUR LE TRAITEMENT DES INFECTIONS HIV EN ASSOCIATION |  | \n",
      "  J05AX | AUTRES ANTIVIRAUX |  | \n",
      "  J06BB | IMMUNOGLOBULINES SPECIFIQUES |  | \n",
      "  J07AG | VACCINS ANTIHAEMOPHILUS INFLUENZAE B |  | \n",
      "  J07AH | VACCINS ANTIMENINGOCOCCIQUES |  | \n",
      "  J07AL | VACCINS ANTIPNEUMOCOCCIQUES |  | \n",
      "  J07AN | VACCINS ANTITUBERCULEUX |  | \n",
      "  J07BB | VACCINS ANTIGRIPPAUX |  | *\n",
      "  J07BC | VACCINS CONTRE LES HEPATITES |  | \n",
      "  J07BD | VACCINS CONTRE LA ROUGEOLE |  | \n",
      "  J07BF | VACCINS CONTRE LA POLIOMYELITE |  | \n",
      "  J07BH | VACCINS CONTRE LES DIARRHEES A ROTAVIRUS |  | \n",
      "  J07BK | VACCINS CONTRE LA VARICELLE-ZONA |  | \n",
      "  J07BM | VACCINS CONTRE LE PAPILLOMAVIRUS |  | \n",
      "  J07CA | VACCINS BACTERIENS ET VIRAUX ASSOCIES |  | \n",
      "  L01AA | MOUTARDES A L'AZOTE |  | \n",
      "  L01AB | ALKYLSULFONATES |  | \n",
      "  L01AX | AUTRES AGENTS ALKYLANTS |  | \n",
      "  L01BA | ANALOGUES DE L'ACIDE FOLIQUE |  | \n",
      "  L01BB | ANALOGUES DE LA PURINE |  | \n",
      "  L01BC | ANALOGUES DE LA PYRIMIDINE |  | \n",
      "  L01CA | VINCAALCALOIDES ET ANALOGUES |  | \n",
      "  L01CB | DERIVES DE LA PODOPHYLLOTOXINE |  | \n",
      "  L01CE | INHIBITEURS DE LA TOPO-ISOMÉRASE 1 (TOP1) |  | \n",
      "  L01EA | INHIBITEURS DE TYROSINE KINASE BCR-ABL |  | \n",
      "  L01EB | INHIBITEURS DE TYROSINE KINASE EGFR |  | \n",
      "  L01EC | INHIBITEURS DE SÉRINE-THRÉONINE KINASE B-RAF (BRAF) |  | \n",
      "  L01ED | INHIBITEURS DE KINASE DU LYMPHOME ANAPLASIQUE (ALK) |  | \n",
      "  L01EE | INHIBITEURS MEK (MITOGEN-ACTIVATED PROTEIN KINASE) |  | \n",
      "  L01EF | INHIBITEURS DE KINASE CYCLINE-DÉPENDANTE (CDK) |  | \n",
      "  L01EG | INHIBITEURS DE KINASE MTOR |  | \n",
      "  L01EH | INHIBITEURS DE TYROSINE KINASE HER2 |  | \n",
      "  L01EJ | INHIBITEURS DE JANUS KINASE (JAK) |  | \n",
      "  L01EK | INHIBITEURS DE TYROSINE KINASE VEGFR |  | *\n",
      "  L01EL | INHIBITEURS DE TYROSINE KINASE DE BRUTON (BTK) |  | \n",
      "  L01EM | INHIBITEURS DE TYROSINE DE LA PHOSPHATIDYLINOSITOL-3 KINASE (PI3K) |  | \n",
      "  L01EN | INHIBITEURS DE TYROSINE KINASE DU RECEPTEUR DU FACTEUR DE CROISSANCE DES FIBROBLASTES (FGFR) |  | \n",
      "  L01EX | AUTRES INHIBITEURS DE PROTÉINE KINASE |  | \n",
      "  L01XB | METHYLHYDRAZINES |  | \n",
      "  L01XD | SENSIBILISATEURS UTILISES DANS LA THERAPIE PHOTODYNAMIQUE/RADIOTHERAPIE |  | \n",
      "  L01XF | RÉTINOÏDES POUR LE TRAITEMENT DU CANCER |  | \n",
      "  L01XG | INHIBITEURS DU PROTEASOME |  | \n",
      "  L01XJ | INHIBITEURS DE LA VOIE HEDGEHOG |  | \n",
      "  L01XK | INHIBITEURS DE POLY (ADP-RIBOSE) POLYMÉRASE (PARP) |  | \n",
      "  L01XX | AUTRES ANTINEOPLASIQUES |  | \n",
      "  L02AB | PROGESTATIFS |  | \n",
      "  L02AE | ANALOGUES DE L'HORMONE ENTRAINANT LA LIBERATION DE GONADOTROPHINES |  | \n",
      "  L02BA | ANTI-ESTROGENES |  | \n",
      "  L02BB | ANTIANDROGENES |  | \n",
      "  L02BG | INHIBITEURS ENZYMATIQUES |  | \n",
      "  L02BX | AUTRES HORMONES ANTAGONISTES ET AGENTS APPARENTES |  | \n",
      "  L03AA | FACTEURS DE CROISSANCE |  | \n",
      "  L03AB | INTERFERONS |  | \n",
      "  L03AX | AUTRES IMMUNOSTIMULANTS |  | \n",
      "  L04AA | IMMUNOSUPPRESSEURS SELECTIFS |  | \n",
      "  L04AB | INHIBITEURS DU FACTEUR NECROSANT DES TUMEURS ALFA (TNF-a) |  | \n",
      "  L04AC | INHIBITEURS DE L’INTERLEUKINE |  | \n",
      "  L04AD | INHIBITEURS DE LA CALCINEURINE |  | \n",
      "  L04AX | AUTRES IMMUNOSUPPRESSEURS |  | \n",
      "  M01AB | DERIVES DE L'ACIDE ACETIQUE ET APPARENTES |  | \n",
      "  M01AC | OXICAMS |  | \n",
      "  M01AE | DERIVES DE L'ACIDE PROPIONIQUE |  | \n",
      "  M01AG | FENAMATES |  | \n",
      "  M01AH | COXIBS |  | \n",
      "  M01AX | AUTRES ANTIINFLAMMATOIRES ANTIRHUMATISMAUX NON STEROIDIENS |  | \n",
      "  M01CC | PENICILLAMINE ET ANALOGUES |  | \n",
      "  M02AA | ANTIINFLAMMATOIRES NON STEROIDIENS A USAGE TOPIQUE |  | \n",
      "  M03BX | AUTRES MEDICAMENTS A ACTION CENTRALE |  | \n",
      "  M03CA | DANTROLENE ET DERIVES |  | \n",
      "  M04AA | INHIBITEURS DE LA SYNTHESE DE L'ACIDE URIQUE |  | \n",
      "  M04AB | URICOSURIQUES |  | \n",
      "  M04AC | MEDICAMENTS SANS EFFET SUR LE METABOLISME DE L'ACIDE URIQUE |  | \n",
      "  M05BA | DIPHOSPHONATES |  | \n",
      "  M05BB | DIPHOSPHONATES EN ASSOCIATION |  | \n",
      "  M05BX | AUTRES MEDICAMENTS AGISSANT SUR LA STRUCTURE OSSEUSE ET LA MINERALISATION |  | \n",
      "  M09AA | QUININE ET DERIVES |  | \n",
      "  M09AX | AUTRES MEDICAMENTS DES DESORDRES MUSCULO-SQUELETTIQUES |  | \n",
      "  N01BA | ESTERS DE L'ACIDE AMINOBENZOIQUE |  | \n",
      "  N01BB | AMIDES |  | \n",
      "  N02AA | ALCALOIDES NATURELS DE L'OPIUM |  | \n",
      "  N02AB | DERIVES DE LA PHENYLPIPERIDINE |  | \n",
      "  N02AC | DERIVES DE LA DIPHENYLPROPYLAMINE |  | \n",
      "  N02AE | DERIVES DE L'ORIPAVINE |  | \n",
      "  N02AJ | OPIACES EN ASSOCIATION AVEC ANALGESIQUES NON-OPIOIDES |  | \n",
      "  N02AX | AUTRES OPIOIDES |  | \n",
      "  N02BA | ACIDE SALICYLIQUE ET DERIVES |  | \n",
      "  N02BE | ANILIDES |  | \n",
      "  N02BF | GABAPENTINOIDES |  | \n",
      "  N02BG | AUTRES ANALGESIQUES ET ANTIPYRETIQUES |  | \n",
      "  N02CA | ALCALOIDES DE L'ERGOT |  | \n",
      "  N02CC | AGONISTES SELECTIFS DES RECEPTEURS 5HT1 |  | \n",
      "  N02CX | AUTRES ANTIMIGRAINEUX |  | \n",
      "  N03AA | BARBITURIQUES ET DERIVES |  | \n",
      "  N03AB | DERIVES DE L'HYDANTOINE |  | \n",
      "  N03AD | DERIVES DU SUCCINIMIDE |  | \n",
      "  N03AE | DERIVES DE LA BENZODIAZEPINE |  | \n",
      "  N03AF | DERIVES DU CARBOXAMIDE |  | \n",
      "  N03AG | DERIVES D'ACIDE GRAS |  | \n",
      "  N03AX | AUTRES ANTIEPILEPTIQUES |  | \n",
      "  N04AA | AMINES TERTIAIRES |  | \n",
      "  N04BA | DOPA ET DERIVES |  | \n",
      "  N04BB | DERIVES DE L'ADAMANTANE |  | \n",
      "  N04BC | AGONISTES DOPAMINERGIQUES |  | \n",
      "  N04BD | INHIBITEURS DE LA MONOAMINE OXYDASE TYPE B |  | \n",
      "  N04BX | AUTRES DOPAMINERGIQUES |  | \n",
      "  N05AA | PHENOTHIAZINES A CHAINE ALIPHATIQUE |  | \n",
      "  N05AC | PHENOTHIAZINES DE STRUCTURE PIPERIDINIQUE |  | \n",
      "  N05AD | DERIVES DE LA BUTYROPHENONE |  | \n",
      "  N05AF | DERIVES DU THIOXANTHENE |  | \n",
      "  N05AG | DERIVES DE LA DIPHENYLBUTYLPIPERIDINE |  | \n",
      "  N05AH | DIAZEPINES, OXAZEPINES ET THIAZEPINES |  | \n",
      "  N05AL | BENZAMIDES |  | \n",
      "  N05AN | LITHIUM |  | \n",
      "  N05AX | AUTRES ANTIPSYCHOTIQUES |  | \n",
      "  N05BA | DERIVES DE LA BENZODIAZEPINE |  | \n",
      "  N05BB | DERIVES DU DIPHENYLMETHANE |  | \n",
      "  N05BE | DERIVES DE L'AZASPIRODECANEDIONE |  | \n",
      "  N05BX | AUTRES ANXIOLYTIQUES |  | \n",
      "  N05CD | DERIVES DE LA BENZODIAZEPINE |  | \n",
      "  N05CF | SUBSTANCES APPARENTEES AUX BENZODIAZEPINES |  | \n",
      "  N05CH | AGONISTES DES RECEPTEURS DE LA MELATONINE |  | \n",
      "  N06AA | INHIBITEURS NON SELECTIFS DE LA RECAPTURE DE LA MONOAMINE |  | \n",
      "  N06AB | INHIBITEURS SELECTIFS DE LA RECAPTURE DE LA SEROTONINE |  | \n",
      "  N06AG | INHIBITEURS DE LA MONAMINE OXYDASE TYPE A |  | \n",
      "  N06AX | AUTRES ANTIDEPRESSEURS |  | \n",
      "  N06BA | SYMPATHOMIMETIQUES D'ACTION CENTRALE |  | \n",
      "  N06BC | DERIVES DE LA XANTHINE |  | \n",
      "  N06BX | AUTRES PSYCHOSTIMULANTS ET NOOTROPES |  | \n",
      "  N07AA | ANTICHOLINESTERASIQUES |  | \n",
      "  N07BA | MEDICAMENTS UTILISES DANS LA DEPENDANCE À LA NICOTINE |  | \n",
      "  N07BB | MEDICAMENTS UTILISES DANS LA DEPENDANCE ALCOOLIQUE |  | \n",
      "  N07BC | MEDICAMENTS UTILISES DANS LA DEPENDANCE AUX OPIOÏDES |  | \n",
      "  N07CA | ANTIVERTIGINEUX |  | \n",
      "  N07XX | AUTRES MEDICAMENTS DU SYSTEME NERVEUX |  | \n",
      "  P01AB | DERIVES DU NITROIMIDAZOLE |  | \n",
      "  P01AX | AUTRES MEDICAMENTS CONTRE L'AMIBIASE ET AUTRES PROTOZOOSES |  | \n",
      "  P01BA | AMINOQUINOLEINES |  | \n",
      "  P01BB | BIGUANIDES |  | \n",
      "  P01BC | METHANOLQUINOLEINES |  | \n",
      "  P01BD | DIAMINOPYRIMIDINES |  | \n",
      "  P01BF | ARTEMISININE ET DERVIVES, EN ASSOCIATION |  | \n",
      "  P01CB | MEDICAMENTS A BASE D'ANTIMOINE |  | \n",
      "  P01CX | AUTRES ANTILEISHMANIENS ET TRYPANOCIDES |  | \n",
      "  P02BA | DERIVES DE LA QUINOLEINE ET APPARENTES |  | \n",
      "  P02CA | DERIVES DU BENZIMIDAZOLE |  | \n",
      "  P02CC | DERIVES DE LA TETRAHYDROPYRIMIDINE |  | \n",
      "  P02CF | AVERMECTINES |  | \n",
      "  P02DA | DERIVES DE L'ACIDE SALICYLIQUE |  | \n",
      "  P03AC | PYRETHRINES, DERIVES DE SYNTHESE INCLUS |  | \n",
      "  P03AX | AUTRES ANTIPARASITAIRES EXTERNES, SCABICIDES INCLUS |  | \n",
      "  R01AA | SYMPATHOMIMETIQUES NON ASSOCIES |  | \n",
      "  R01AC | ANTIALLERGIQUES, CORTICOIDES EXCLUS |  | \n",
      "  R01AD | CORTICOIDES |  | \n",
      "  R01AX | AUTRES PREPARATIONS NASALES |  | \n",
      "  R03AC | AGONISTES SELECTIFS BETA 2 ADRENERGIQUES |  | \n",
      "  R03AK | ADRENERGIQUES ET AUTRES MEDICAMENTS POUR LES SYNDROMES OBSTRUCTIFS DES VOIES AERIENNES |  | \n",
      "  R03AL | ADRENERGIQUES EN ASSOCIATION AVEC ANTICHOLINERGIQUES |  | \n",
      "  R03BA | GLUCOCORTICOIDES |  | \n",
      "  R03BB | ANTICHOLINERGIQUES |  | \n",
      "  R03CC | AGONISTES SELECTIFS BETA 2 ADRENERGIQUES |  | \n",
      "  R03DA | XANTHINES |  | \n",
      "  R03DC | ANTAGONISTES DES RECEPTEURS AUX LEUCOTRIÈNES |  | \n",
      "  R03DX | AUTRES MEDICAMENTS POUR LES SYNDROMES OBSTRUCTIFS DES VOIES AERIENNES À USAGE SYSTEMIQUE |  | \n",
      "  R05CB | MUCOLYTIQUES |  | \n",
      "  R05DA | ALCALOIDES DE L'OPIUM ET DERIVES |  | \n",
      "  R05DB | AUTRES ANTITUSSIFS |  | \n",
      "  R06AD | DERIVES DE LA PHENOTHIAZINE |  | \n",
      "  R06AE | DERIVES DE LA PIPERAZINE |  | \n",
      "  R06AX | AUTRES ANTIHISTAMINIQUES A USAGE SYSTEMIQUE |  | \n",
      "  R07AX | AUTRES MEDICAMENTS DU SYSTEME RESPIRATOIRE |  | \n",
      "  S01AA | ANTIBIOTIQUES |  | \n",
      "  S01AD | ANTIVIRAUX |  | \n",
      "  S01AE | FLUOROQUINOLONES |  | \n",
      "  S01AX | AUTRES ANTIINFECTIEUX |  | \n",
      "  S01BA | CORTICOIDES NON ASSOCIES |  | \n",
      "  S01BC | ANTIINFLAMMATOIRES NON STEROIDIENS |  | \n",
      "  S01CA | CORTICOIDES ET ANTIINFECTIEUX EN ASSOCIATION |  | \n",
      "  S01CC | ANTIINFLAMMATOIRES NON STEROIDIENS ET ANTIINFECTIEUX EN ASSOCIATION |  | \n",
      "  S01EA | SYMPATHOMIMETIQUES ANTIGLAUCOMATEUX |  | \n",
      "  S01EB | PARASYMPATHOMIMETIQUES |  | \n",
      "  S01EC | INHIBITEURS DE L'ANHYDRASE CARBONIQUE |  | \n",
      "  S01ED | BETABLOQUANTS |  | \n",
      "  S01EE | Analogues de la prostaglandine |  | \n",
      "  S01FA | ANTICHOLINERGIQUES |  | \n",
      "  S01FB | SYMPATHOMIMETIQUES, ANTIGLAUCOMATEUX EXCLUS |  | \n",
      "  S01GX | AUTRES ANTIALLERGIQUES |  | \n",
      "  S01KA | MEDICAMENTS VISCOELASTIQUES |  | \n",
      "  S01LA | MEDICAMENTS CONTRE LA NEOVASCULARISATION |  | \n",
      "  S01XA | AUTRES MEDICAMENTS OPHTALMOLOGIQUES |  | \n",
      "  S02AA | ANTIINFECTIEUX |  | \n",
      "  S02CA | CORTICOIDES ET ANTIINFECTIEUX EN ASSOCIATION |  | \n",
      "  S02DA | ANALGESIQUES ET ANESTHESIQUES |  | \n",
      "  V01AA | EXTRAITS D'ALLERGENES |  | \n",
      "  V03AB | ANTIDOTES |  | \n",
      "  V03AC | CHELATEURS DU FER |  | \n",
      "  V03AE | MEDICAMENTS DE L'HYPERKALIEMIE ET DE L'HYPERPHOSPHATEMIE |  | \n",
      "  V03AF | MEDICAMENTS DETOXIFIANTS DANS UN TRAITEMENT CYTOSTATIQUE |  | \n",
      "  V03AX | AUTRES MEDICAMENTS |  | \n",
      "  V04CD | TESTS POUR LA FONCTION HYPOPHYSAIRE |  | \n",
      "  V04CF | DIAGNOSTIC DE LA TUBERCULOSE |  | \n",
      "  V04CM | TESTS POUR LES TROUBLES DE LA FERTILITE |  | \n",
      "  V04CX | AUTRES MEDICAMENTS POUR DIAGNOSTIC |  | \n",
      "  V08AA | PRODUITS DE CONTRASTE DE HAUTE OSMOLARITE, HYDROSOLUBLES, |  | \n",
      "  V08AB | PRODUITS DE CONTRASTE DE BASSE OSMOLARITE, HYDROSOLUBLES, A TROPISME RENAL |  | \n",
      "  V08BA | PRODUITS DE CONTRASTE BARYTES |  | \n",
      "  V08CA | PRODUITS DE CONTRASTE PARAMAGNETIQUES |  | \n",
      "  V08DA | PRODUITS POUR ECHOGRAPHIE |  | \n",
      "  A01AA | MEDICAMENTS PROPHYLACTIQUES ANTICARIES |  | \n",
      "  A02AH | ANTIACIDES AVEC BICARBONATE DE SODIUM |  | \n",
      "  A05AX | AUTRES MEDICAMENTS POUR LA THERAPEUTIQUE BILIAIRE |  | \n",
      "  C05AX | AUTRES MEDICAMENTS POUR LE TRAITEMENT DES HEMORROIDES ET DES FISSURES ANALES A USAGE TOPIQUE |  | \n",
      "  J06BD | ANTICORPS MONONUCLONAUX ANTIVIRAUX |  | \n",
      "  J07BX | AUTRES VACCINS VIRAUX |  | \n",
      "  L01DC | AUTRES ANTIBIOTIQUES CYTOTOXIQUES |  | \n",
      "  L01ED | INHIBITEURS DE KINASE DU LYMPHOME ANAPLASIQUE (ALK)) |  | \n",
      "  L01EM | INHIBITEURS DE PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) |  | \n",
      "  L01EN | NON DETERMINE |  | \n",
      "  L01XG | INHIBITEURS DE PROTÉASOME |  | \n",
      "  L04AE | MODULTAURES DES RECEPTEURS DE LA SPHINGOSINE-1 PHOSPHATE (S1P) |  | \n",
      "  L04AF | INHIBITEURS DELA JANUS KINASE (JAK) |  | \n",
      "  L04AG | ANTICORPS MONOCLONAUX |  | \n",
      "  L04AH | INHIBITEURS DE LA KINASE CIBLE DE LA RAPAMYCINE (chez les mammifères) (mTOR) |  | \n",
      "  L04AJ | INHIBITEURS DU COMPLEMENT |  | \n",
      "  L04AK | INHIBITEURS DE LA DIHYDROOROTATE DESHYDROGENASE |  | \n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : ATC5\n",
      "================================================================================\n",
      "\n",
      "  ATC5 | Libellé ATC5\n",
      "  A01AA01 | SODIUM FLUORURE\n",
      "  A01AA02 | SODIUM MONOFLUOROPHOSPHATE\n",
      "  A01AA51 | SODIUM FLUORURE EN ASSOCIATION\n",
      "  A01AB03 | CHLORHEXIDINE\n",
      "  A01AB09 | MICONAZOLE\n",
      "  A01AB11 | DIVERS STOMATO LOCAL (ANTIINFECTIEUX OU ANTISEPTIQUES)\n",
      "  A01AD11 | DIVERS STOMATO LOCAL (SAUF ANTIINFECTIEUX OU ANTISEPTIQUES)\n",
      "  A02AB01 | ALUMINIUM HYDROXYDE\n",
      "  A02AB03 | ALUMINIUM PHOSPHATE\n",
      "  A02AD01 | ASSOCIATIONS DE SELS\n",
      "  A02AX | ANTIACIDES : AUTRES ASSOCIATIONS\n",
      "  A02BA01 | CIMETIDINE\n",
      "  A02BA02 | RANITIDINE\n",
      "  A02BA03 | FAMOTIDINE\n",
      "  A02BC01 | OMEPRAZOLE\n",
      "  A02BC02 | PANTOPRAZOLE\n",
      "  A02BC03 | LANSOPRAZOLE\n",
      "  A02BC04 | RABEPRAZOLE\n",
      "  A02BC05 | ESOMEPRAZOLE\n",
      "  A02BD08 | BISMUTH POTASSIQUE, TETRACYCLINE ET METRONIDAZOLE\n",
      "  A02BX13 | ALGINIQUE ACIDE EN ASSOCIATION AVEC ANTIACIDES\n",
      "  A03AA04 | MEBEVERINE\n",
      "  A03AA05 | TRIMEBUTINE\n",
      "  A03AX04 | PINAVERIUM\n",
      "  A03AX12 | PHLOROGLUCINOL\n",
      "  A03AX58 | ALVERINE EN ASSOCIATION\n",
      "  A03BB01 | BUTYLSCOPOLAMINE\n",
      "  A03ED | ANTISPASMODIQUES EN ASSOCIATION AVEC D'AUTRES MEDICAMENTS\n",
      "  A03FA01 | METOCLOPRAMIDE\n",
      "  A03FA03 | DOMPERIDONE\n",
      "  A03FA05 | ALIZAPRIDE\n",
      "  A04AA01 | ONDANSETRON\n",
      "  A04AA02 | GRANISETRON\n",
      "  A04AA55 | PALONOSETRON EN ASSOCIATION\n",
      "  A04AD01 | SCOPOLAMINE\n",
      "  A04AD05 | METOPIMAZINE\n",
      "  A04AD12 | APREPITANT\n",
      "  A05AA02 | URSODESOXYCHOLIQUE ACIDE\n",
      "  A05BA | THERAPEUTIQUE HEPATIQUE\n",
      "  A05BA01 | ARGININE GLUTAMATE\n",
      "  A06AA51 | HUILE DE PARAFFINE EN ASSOCIATION\n",
      "  A06AB58 | PICOSULFATE DE SODIUM, ASSOCIATIONS\n",
      "  A06AC01 | ISPAGHUL (GRAINE DE PSYLLIUM)\n",
      "  A06AC03 | STERCULIA\n",
      "  A06AD10 | SELS MINERAUX EN ASSOCIATION\n",
      "  A06AD11 | LACTULOSE\n",
      "  A06AD12 | LACTITOL\n",
      "  A06AD15 | MACROGOL\n",
      "  A06AD65 | MACROGOL EN ASSOCIATION\n",
      "  A06AG20 | ASSOCIATIONS\n",
      "  A06AH01 | METHYLNALTREXONE BROMURE\n",
      "  A06AH03 | HALOXEGOL\n",
      "  A06AX02 | MEDICAMENTS PRODUISANT DE L'ANHYDRIDE CARBONIQUE\n",
      "  A07AA02 | NYSTATINE\n",
      "  A07BC05 | DIOSMECTITE\n",
      "  A07BC54 | ATTAPULGITE EN ASSOCIATION\n",
      "  A07DA03 | LOPERAMIDE\n",
      "  A07EA02 | HYDROCORTISONE\n",
      "  A07EA04 | BETAMETHASONE\n",
      "  A07EA06 | BUDESONIDE\n",
      "  A07EC | ACIDE AMINOSALICYLIQUE ET ANALOGUES\n",
      "  A07EC01 | SULFASALAZINE\n",
      "  A07EC02 | MESALAZINE\n",
      "  A07EC03 | OLSALAZINE\n",
      "  A07XA04 | RACECADOTRIL\n",
      "  A09AA02 | MULTIENZYMES (LIPASE, PROTEASE...)\n",
      "  A10AB01 | INSULINE HUMAINE\n",
      "  A10AB04 | INSULINE LISPRO\n",
      "  A10AB05 | INSULINE ASPART\n",
      "  A10AB06 | INSULINE GLULISINE\n",
      "  A10AC01 | INSULINE HUMAINE\n",
      "  A10AD01 | INSULINE HUMAINE\n",
      "  A10AD04 | INSULINE LISPRO\n",
      "  A10AD05 | INSULINE ASPART\n",
      "  A10AE04 | INSULINE GLARGINE\n",
      "  A10AE05 | INSULINE DETEMIR\n",
      "  A10AE06 | INSULINE DEGLUDEC\n",
      "  A10AE56 | INSULINE DEGLUDEC ET LIRAGLUTIDE\n",
      "  A10BA02 | METFORMINE\n",
      "  A10BB01 | GLIBENCLAMIDE\n",
      "  A10BB07 | GLIPIZIDE\n",
      "  A10BB09 | GLICLAZIDE\n",
      "  A10BB12 | GLIMEPIRIDE\n",
      "  A10BD07 | METFORMINE ET SITAGLIPTINE\n",
      "  A10BD08 | METFORMINE ET VILDAGLIPTINE\n",
      "  A10BD10 | METFORMINE ET SAXAGLIPTINE\n",
      "  A10BD15 | METFORMINE + DAPAGLIFLOZINE\n",
      "  A10BD20 | METFORMINE + EMPAGLIFLOZINE\n",
      "  A10BF01 | ACARBOSE\n",
      "  A10BH01 | SITAGLIPTINE\n",
      "  A10BH02 | VILDAGLIPTINE\n",
      "  A10BH03 | SAXAGLIPTINE\n",
      "  A10BJ01 | EXENATIDE\n",
      "  A10BJ02 | LIRAGLUTIDE\n",
      "  A10BJ05 | DULAGLUTIDE\n",
      "  A10BJ06 | SEMAGLUTIDE\n",
      "  A10BK01 | DAPAGLIFLOZINE\n",
      "  A10BK03 | EMPAGLIFLOZINE\n",
      "  A10BX02 | REPAGLINIDE\n",
      "  A11CA01 | RETINOL (VIT A)\n",
      "  A11CC01 | ERGOCALCIFEROL\n",
      "  A11CC03 | ALFACALCIDOL\n",
      "  A11CC04 | CALCITRIOL\n",
      "  A11CC05 | COLECALCIFEROL\n",
      "  A11CC06 | CALCIFEDIOL\n",
      "  A11DA01 | THIAMINE (VIT B1)\n",
      "  A11HA02 | PYRIDOXINE (VIT B6)\n",
      "  A11HA03 | TOCOPHEROL (VIT E)\n",
      "  A12AA | CALCIUM\n",
      "  A12AA03 | CALCIUM GLUCONATE\n",
      "  A12AA04 | CALCIUM CARBONATE\n",
      "  A12AX | CALCIUM EN ASSOCIATION AVEC VITAMINE D ET/OU AUTRES MEDICAMENTS\n",
      "  A12BA01 | POTASSIUM CHLORURE\n",
      "  A12BA03 | POTASSIUM BITARTRATE\n",
      "  A12BA05 | POTASSIUM GLUCONATE\n",
      "  A12BA51 | POTASSIUM CHLORURE EN ASSOCIATION\n",
      "  A12CC08 | MAGNESIUM PIDOLATE\n",
      "  A12CX | AUTRES ELEMENTS MINERAUX\n",
      "  A16AA01 | LEVOCARNITINE\n",
      "  A16AA07 | METRELEPTINE\n",
      "  A16AB09 | IDURSULFASE\n",
      "  A16AB13 | ASFOTASE ALPHA\n",
      "  A16AX | DIVERS MEDICAMENTS DU TRACTUS ALIMENTAIRE ET DU METABOLISME\n",
      "  A16AX02 | ANETHOLE TRITHIONE\n",
      "  A16AX08 | TEDUGLUTIDE\n",
      "  A16AX12 | TRIENTINE\n",
      "  A16AX14 | MIGALASTAT\n",
      "  A16AX16 | GIVOSIRAN\n",
      "  B01AA03 | WARFARINE\n",
      "  B01AA07 | ACENOCOUMAROL\n",
      "  B01AA12 | FLUINDIONE\n",
      "  B01AB01 | HEPARINE\n",
      "  B01AB04 | DALTEPARINE\n",
      "  B01AB05 | ENOXAPARINE\n",
      "  B01AB06 | NADROPARINE\n",
      "  B01AB10 | TINZAPARINE\n",
      "  B01AC04 | CLOPIDOGREL\n",
      "  B01AC05 | TICLOPIDINE\n",
      "  B01AC06 | ACETYLSALICYLIQUE ACIDE\n",
      "  B01AC22 | PRASUGREL\n",
      "  B01AC24 | TICAGRELOR\n",
      "  B01AC30 | ASSOCIATIONS\n",
      "  B01AE07 | DABIGATRAN\n",
      "  B01AF01 | RIVAROXABAN\n",
      "  B01AF02 | APIXABAN\n",
      "  B01AX05 | FONDAPARINUX\n",
      "  B02AA02 | TRANEXAMIQUE ACIDE\n",
      "  B02BA01 | PHYTOMENADIONE\n",
      "  B02BX04 | ROMIPLOSTIME\n",
      "  B02BX05 | ELTROMBOPAG\n",
      "  B02BX06 | EMICIZUMAB\n",
      "  B02BX09 | FOSTAMATINIB\n",
      "  B03AA02 | FUMARATE FERREUX\n",
      "  B03AA06 | SUCCINATE FERREUX\n",
      "  B03AA07 | SULFATE FERREUX\n",
      "  B03AA10 | ASCORBATE FERREUX\n",
      "  B03AB03 | EDETATE DE FER SODIQUE\n",
      "  B03BA01 | CYANOCOBALAMINE\n",
      "  B03BA03 | HYDROXOCOBALAMINE\n",
      "  B03BB01 | FOLIQUE ACIDE\n",
      "  B03XA01 | ERYTHROPOIETINE\n",
      "  B03XA02 | DARBEPOETINE ALFA\n",
      "  B03XA03 | METHOXY POLYETHYLENE GLYCOL-EPOETINE BETA\n",
      "  B03XA06 | LUSPATERCEPT\n",
      "  B05BA03 | HYDRATES DE CARBONE\n",
      "  B05BA10 | ASSOCIATIONS\n",
      "  B05BB01 | ELECTROLYTES\n",
      "  B05BB02 | ELECTROLYTES AVEC HYDRATES DE CARBONE\n",
      "  B05X | ELECTROLYTES\n",
      "  B05XA02 | SODIUM BICARBONATE\n",
      "  B05XA03 | SODIUM CHLORURE\n",
      "  B05XA05 | SILICATE DE MAGNESIUM\n",
      "  B05XC | VITAMINES\n",
      "  B05XX | AUTRES ADDITIFS POUR SOLUTION INTRAVEINEUSE\n",
      "  B06AC05 | LANADELUMAB\n",
      "  B06AC06 | BEROTRALSTAT\n",
      "  C01AA05 | DIGOXINE\n",
      "  C01BA03 | DISOPYRAMIDE\n",
      "  C01BA13 | HYDROQUINIDINE\n",
      "  C01BB02 | MEXILETINE\n",
      "  C01BC03 | PROPAFENONE\n",
      "  C01BC04 | FLECAINIDE\n",
      "  C01BD01 | AMIODARONE\n",
      "  C01BG07 | CIBENZOLINE\n",
      "  C01CA17 | MIDODRINE\n",
      "  C01CA24 | EPINEPHRINE\n",
      "  C01DA02 | NITROGLYCERINE\n",
      "  C01DA08 | ISOSORBIDE DINITRATE\n",
      "  C01DX12 | MOLSIDOMINE\n",
      "  C01DX16 | NICORANDIL\n",
      "  C01EB17 | IVABRADINE\n",
      "  C02AB02 | METHYLDOPA (RACEMIQUE)\n",
      "  C02AC01 | CLONIDINE\n",
      "  C02AC05 | MOXONIDINE\n",
      "  C02AC06 | RILMENIDINE\n",
      "  C02CA01 | PRAZOSINE\n",
      "  C02CA04 | DOXAZOSINE\n",
      "  C02CA06 | URAPIDIL\n",
      "  C02DC01 | MINOXIDIL\n",
      "  C02LA01 | RESERPINE ET DIURETIQUES\n",
      "  C03AA03 | HYDROCHLOROTHIAZIDE\n",
      "  C03BA11 | INDAPAMIDE\n",
      "  C03BX03 | CICLETANINE\n",
      "  C03CA01 | FUROSEMIDE\n",
      "  C03CA02 | BUMETANIDE\n",
      "  C03CA03 | PIRETANIDE\n",
      "  C03DA01 | SPIRONOLACTONE\n",
      "  C03DA04 | EPLERENONE\n",
      "  C03DB01 | AMILORIDE\n",
      "  C03EA01 | HYDROCHLOROTHIAZIDE ET EPARGNEURS POTASSIQUES\n",
      "  C03EA04 | ALTIZIDE ET EPARGNEURS POTASSIQUES\n",
      "  C03EB01 | FUROSEMIDE ET EPARGNEURS POTASSIQUES\n",
      "  C03XA | ANTAGONISTE DE VASOPRESSINE\n",
      "  C03XA01 | TOLVAPTAN\n",
      "  C04AX21 | NAFTIDROFURYL\n",
      "  C05BA04 | PENTOSANE POLYSULFATE SODIQUE\n",
      "  C07AA03 | PINDOLOL\n",
      "  C07AA05 | PROPRANOLOL\n",
      "  C07AA06 | TIMOLOL\n",
      "  C07AA07 | SOTALOL\n",
      "  C07AA12 | NADOLOL\n",
      "  C07AA16 | TERTATOLOL\n",
      "  C07AB02 | METOPROLOL\n",
      "  C07AB03 | ATENOLOL\n",
      "  C07AB04 | ACEBUTOLOL\n",
      "  C07AB05 | BETAXOLOL\n",
      "  C07AB07 | BISOPROLOL\n",
      "  C07AB08 | CELIPROLOL\n",
      "  C07AB12 | NEBIVOLOL\n",
      "  C07AG01 | LABETALOL\n",
      "  C07AG02 | CARVEDILOL\n",
      "  C07BB03 | ATENOLOL ET THIAZIDIQUES\n",
      "  C07BB07 | BISOPROLOL ET THIAZIDIQUES\n",
      "  C07BB12 | NEBIVOLOL ET THIAZIDIQUES\n",
      "  C07DA06 | TIMOLOL, THIAZIDIQUES ET AUTRES DIURETIQUES\n",
      "  C07FB02 | METOPROLOL ET AUTRES ANTIHYPERTENSEURS\n",
      "  C07FB03 | ATENOLOL ET AUTRES ANTIHYPERTENSEURS\n",
      "  C08CA01 | AMLODIPINE\n",
      "  C08CA02 | FELODIPINE\n",
      "  C08CA03 | ISRADIPINE\n",
      "  C08CA04 | NICARDIPINE\n",
      "  C08CA05 | NIFEDIPINE\n",
      "  C08CA06 | NIMODIPINE\n",
      "  C08CA08 | NITRENDIPINE\n",
      "  C08CA11 | MANIDIPINE\n",
      "  C08CA13 | LERCANIDIPINE\n",
      "  C08DA01 | VERAPAMIL\n",
      "  C08DB01 | DILTIAZEM\n",
      "  C08GA02 | AMLODIPINE ET DIURETIQUES\n",
      "  C09AA01 | CAPTOPRIL\n",
      "  C09AA02 | ENALAPRIL\n",
      "  C09AA03 | LISINOPRIL\n",
      "  C09AA04 | PERINDOPRIL\n",
      "  C09AA05 | RAMIPRIL\n",
      "  C09AA06 | QUINAPRIL\n",
      "  C09AA07 | BENAZEPRIL\n",
      "  C09AA09 | FOSINOPRIL\n",
      "  C09AA10 | TRANDOLAPRIL\n",
      "  C09AA15 | ZOFENOPRIL\n",
      "  C09BA01 | CAPTOPRIL ET DIURETIQUES\n",
      "  C09BA02 | ENALAPRIL ET DIURETIQUES\n",
      "  C09BA03 | LISINOPRIL ET DIURETIQUES\n",
      "  C09BA04 | PERINDOPRIL ET DIURETIQUES\n",
      "  C09BA05 | RAMIPRIL ET DIURETIQUES\n",
      "  C09BA06 | QUINAPRIL ET DIURETIQUES\n",
      "  C09BA07 | BENAZEPRIL ET DIURETIQUES\n",
      "  C09BA09 | FOSINOPRIL ET DIURETIQUES\n",
      "  C09BB02 | ENALAPRIL ET LERCANIDIPINE\n",
      "  C09BB04 | PERINDOPRIL ET AMLODIPINE\n",
      "  C09BB07 | RAMIPRIL + AMLODIPINE\n",
      "  C09BB10 | TRANDOLAPRIL ET VERAPAMIL\n",
      "  C09BX02 | PERINDOPRIL ET BISOPROLOL\n",
      "  C09CA01 | LOSARTAN\n",
      "  C09CA03 | VALSARTAN\n",
      "  C09CA04 | IRBESARTAN\n",
      "  C09CA06 | CANDESARTAN\n",
      "  C09CA07 | TELMISARTAN\n",
      "  C09DA01 | LOSARTAN ET DIURETIQUES\n",
      "  C09DA03 | VALSARTAN ET DIURETIQUES\n",
      "  C09DA04 | IRBESARTAN ET DIURETIQUES\n",
      "  C09DA06 | CANDESARTAN ET DIURETIQUES\n",
      "  C09DA07 | TELMISARTAN ET DIURETIQUES\n",
      "  C09DB01 | VALSARTAN ET AMLODIPINE\n",
      "  C09DB04 | TELMISARTAN ET AMLODIPINE\n",
      "  C09DB05 | IRBESARTAN + AMLODIPINE\n",
      "  C09DX04 | VALSARTAN + SACUBITRIL\n",
      "  C10AA01 | SIMVASTATINE\n",
      "  C10AA03 | PRAVASTATINE\n",
      "  C10AA04 | FLUVASTATINE\n",
      "  C10AA05 | ATORVASTATINE\n",
      "  C10AA07 | ROSUVASTATINE\n",
      "  C10AB02 | BEZAFIBRATE\n",
      "  C10AB04 | GEMFIBROZIL\n",
      "  C10AB05 | FENOFIBRATE\n",
      "  C10AB08 | CIPROFIBRATE\n",
      "  C10AC01 | COLESTYRAMINE\n",
      "  C10AX09 | EZETIMIBE\n",
      "  C10AX12 | LOMITAPIDE\n",
      "  C10AX13 | EVOLOCUMAB\n",
      "  C10AX14 | ALIROCUMAB\n",
      "  C10BA02 | SIMVASTATINE ET EZETIMIBE\n",
      "  C10BA05 | ATORVASTATINE ET EZETIMIBE\n",
      "  C10BA06 | ROSUVASTATINE + EZETIMIBE\n",
      "  C10BX03 | ATORVASTATINE ET AMLODIPINE\n",
      "  D01AC02 | MICONAZOLE\n",
      "  D01AC03 | ECONAZOLE\n",
      "  D01AC05 | ISOCONAZOLE\n",
      "  D01AC07 | TIOCONAZOLE\n",
      "  D01AC08 | KETOCONAZOLE\n",
      "  D01AC10 | BIFONAZOLE\n",
      "  D01AC11 | OXICONAZOLE\n",
      "  D01AC12 | FENTICONAZOLE\n",
      "  D01AC13 | OMOCONAZOLE\n",
      "  D01AC14 | SERTACONAZOLE\n",
      "  D01AC60 | BIFONAZOLE EN ASSOCIATION\n",
      "  D01AE14 | CICLOPIROX\n",
      "  D01AE15 | TERBINAFINE\n",
      "  D01AE16 | AMOROLFINE\n",
      "  D01BA01 | GRISEOFULVINE\n",
      "  D01BA02 | TERBINAFINE\n",
      "  D02AB | MEDICAMENTS A BASE D'OXYDE DE ZINC\n",
      "  D02AC | PARAFFINE ET PRODUITS GRAS\n",
      "  D02AX | AUTRES EMOLLIENTS ET PROTECTEURS\n",
      "  D03AX | AUTRES CICATRISANTS\n",
      "  D05AD02 | METHOXSALENE\n",
      "  D05AX02 | CALCIPOTRIOL\n",
      "  D05AX03 | CALCITRIOL\n",
      "  D05AX52 | CALCIPOTRIOL EN ASSOCIATION\n",
      "  D05BA02 | METHOXSALENE\n",
      "  D05BB02 | ACITRETINE\n",
      "  D06AX01 | FUSIDIQUE ACIDE\n",
      "  D06AX09 | MUPIROCINE\n",
      "  D06BA01 | SULFADIAZINE ARGENTIQUE\n",
      "  D06BB04 | PODOPHYLLOTOXINE\n",
      "  D06BB10 | IMIQUIMOD\n",
      "  D06BX01 | METRONIDAZOLE\n",
      "  D07AB02 | HYDROCORTISONE BUTYRATE\n",
      "  D07AB08 | DESONIDE\n",
      "  D07AC01 | BETAMETHASONE\n",
      "  D07AC06 | DIFLUCORTOLONE\n",
      "  D07AC16 | HYDROCORTISONE ACEPONATE\n",
      "  D07AC17 | FLUTICASONE\n",
      "  D07AC19 | DIFLUPREDNATE\n",
      "  D07AD01 | CLOBETASOL\n",
      "  D07XC01 | BETAMETHASONE\n",
      "  D08AC02 | CHLORHEXIDINE\n",
      "  D08AC04 | HEXAMIDINE\n",
      "  D08AC52 | CHLORHEXIDINE EN ASSOCIATION\n",
      "  D08AG02 | POVIDONE IODEE\n",
      "  D08AX07 | SODIUM HYPOCHLORITE\n",
      "  D10AD01 | TRETINOINE\n",
      "  D10AD02 | RETINOL (VIT A)\n",
      "  D10AD03 | ADAPALENE\n",
      "  D10AE01 | BENZOYLE PEROXYDE\n",
      "  D10AF02 | ERYTHROMYCINE\n",
      "  D10AX | AUTRES PREPARATIONS ANTIACNEIQUES A USAGE TOPIQUE\n",
      "  D10BA01 | ISOTRETINOINE\n",
      "  D10BX | AUTRES PREPARATIONS ANTIACNEIQUES A USAGE SYSTEMIQUE\n",
      "  D11AH01 | TACROLIMUS\n",
      "  D11AH04 | ALITRETINOINE\n",
      "  D11AH05 | DUPILUMAB\n",
      "  D11AH07 | TRALOKINUMAB\n",
      "  D11AH08 | ABROCITINIB\n",
      "  G01AA51 | NYSTATINE EN ASSOCIATION\n",
      "  G01AF01 | METRONIDAZOLE\n",
      "  G01AF05 | ECONAZOLE\n",
      "  G01AF07 | ISOCONAZOLE\n",
      "  G01AF08 | TIOCONAZOLE\n",
      "  G01AF12 | FENTICONAZOLE\n",
      "  G01AF19 | SERTACONAZOLE\n",
      "  G02AB01 | METHYLERGOMETRINE\n",
      "  G02BA03 | DIU EN PLASTIQUE AVEC DES PROGESTATIFS\n",
      "  G02CB03 | CABERGOLINE\n",
      "  G02CB04 | QUINAGOLIDE\n",
      "  G03AA07 | LEVONORGESTREL ET ESTROGENE\n",
      "  G03AB03 | LEVONORGESTREL ET ESTROGENE\n",
      "  G03AC03 | LEVONORGESTREL\n",
      "  G03AC06 | MEDROXYPROGESTERONE\n",
      "  G03AC08 | ETONOGESTREL\n",
      "  G03AC09 | DESOGESTREL\n",
      "  G03AD01 | LEVONORGESTREL\n",
      "  G03AD02 | ULIPRISTAL\n",
      "  G03BA03 | TESTOSTERONE\n",
      "  G03BB02 | ANDROSTANOLONE\n",
      "  G03CA03 | ESTRADIOL\n",
      "  G03CA04 | ESTRIOL\n",
      "  G03CA09 | PROMESTRIENE\n",
      "  G03DA03 | HYDROXYPROGESTERONE\n",
      "  G03DA04 | PROGESTERONE\n",
      "  G03DB01 | DYDROGESTERONE\n",
      "  G03DB03 | MEDROGESTONE\n",
      "  G03DB04 | NOMEGESTROL\n",
      "  G03DB06 | CHLORMADINONE\n",
      "  G03DB08 | DIENOGEST\n",
      "  G03FA01 | NORETHISTERONE ET ESTROGENE\n",
      "  G03FA04 | PROGESTERONE ET ESTROGENE\n",
      "  G03FA11 | LEVONORGESTREL ET ESTROGENE\n",
      "  G03FA12 | MEDROXYPROGESTERONE ET ESTROGENE\n",
      "  G03FA14 | DYDROGESTERONE ET ESTROGENE\n",
      "  G03FB05 | NORETHISTERONE ET ESTROGENE\n",
      "  G03FB06 | MEDROXYPROGESTERONE ET ESTROGENE\n",
      "  G03FB08 | DYDROGESTERONE ET ESTROGENE\n",
      "  G03FB09 | LEVONORGESTREL ET ESTROGENE\n",
      "  G03GA02 | GONADOTROPHINE MENOPAUSIQUE HUMAINE\n",
      "  G03GA04 | UROFOLLITROPHINE\n",
      "  G03GA05 | FOLLITROPINE ALFA\n",
      "  G03GA06 | FOLLITROPINE BETA\n",
      "  G03GA07 | LUTROPINE ALFA\n",
      "  G03GA08 | CHORIOGONADOTROPINE ALFA\n",
      "  G03GA09 | CORIFOLLITROPINE ALFA\n",
      "  G03GA10 | FOLLITROPINE\n",
      "  G03GA30 | ASSOCIATIONS\n",
      "  G03GB02 | CLOMIFENE\n",
      "  G03HA01 | CYPROTERONE\n",
      "  G03HB01 | CYPROTERONE ET ESTROGENE\n",
      "  G03XA01 | DANAZOL\n",
      "  G03XC01 | RALOXIFENE\n",
      "  G04BD02 | FLAVOXATE\n",
      "  G04BD04 | OXYBUTYNINE\n",
      "  G04BD08 | SOLIFENACINE\n",
      "  G04BD09 | TROSPIUM\n",
      "  G04BD11 | FESOTERODINE\n",
      "  G04BE01 | ALPROSTADIL\n",
      "  G04CA01 | ALFUZOSINE\n",
      "  G04CA02 | TAMSULOSINE\n",
      "  G04CA03 | TERAZOSINE\n",
      "  G04CA04 | SILODOSINE\n",
      "  G04CA52 | TAMSULOSINE ET DUTASTERIDE\n",
      "  G04CB01 | FINASTERIDE\n",
      "  G04CB02 | DUTASTERIDE\n",
      "  G04CX01 | PYGEUM AFRICANUM\n",
      "  G04CX02 | SERENOA REPENS\n",
      "  H01AA02 | TETRACOSACTIDE\n",
      "  H01AC01 | SOMATROPINE\n",
      "  H01AC03 | MECASERMINE\n",
      "  H01AX01 | PEGVISOMANT\n",
      "  H01BA02 | DESMOPRESSINE\n",
      "  H01CA01 | GONADORELINE\n",
      "  H01CA02 | NAFARELINE\n",
      "  H01CB02 | OCTREOTIDE\n",
      "  H01CB03 | LANREOTIDE\n",
      "  H01CB05 | PASIREOTIDE\n",
      "  H01CC01 | GANIRELIX\n",
      "  H01CC02 | CETRORELIX\n",
      "  H02AA02 | FLUDROCORTISONE\n",
      "  H02AB01 | BETAMETHASONE\n",
      "  H02AB02 | DEXAMETHASONE\n",
      "  H02AB04 | METHYLPREDNISOLONE\n",
      "  H02AB06 | PREDNISOLONE\n",
      "  H02AB07 | PREDNISONE\n",
      "  H02AB08 | TRIAMCINOLONE\n",
      "  H02AB09 | HYDROCORTISONE\n",
      "  H02CA03 | KETOCONAZOLE\n",
      "  H03AA01 | LEVOTHYROXINE SODIQUE\n",
      "  H03AA02 | LIOTHYRONINE SODIQUE\n",
      "  H03AA03 | ASSOCIATIONS DE LEVOTHYROXINE ET LIOTHYRONINE\n",
      "  H03BA02 | PROPYLTHIOURACILE\n",
      "  H03BA03 | BENZYLTHIOURACILE\n",
      "  H03BB01 | CARBIMAZOLE\n",
      "  H03BB02 | THIAMAZOLE\n",
      "  H04AA01 | GLUCAGON\n",
      "  H05AA02 | TERIPARATIDE\n",
      "  H05BX01 | CINACALCET\n",
      "  J01AA02 | DOXYCYCLINE\n",
      "  J01AA04 | LYMECYCLINE\n",
      "  J01AA07 | TETRACYCLINE\n",
      "  J01AA08 | MINOCYCLINE\n",
      "  J01CA04 | AMOXICILLINE\n",
      "  J01CA08 | PIVMECILLINAM\n",
      "  J01CE02 | PHENOXYMETHYLPENICILLINE\n",
      "  J01CE08 | BENZATHINE BENZYLPENICILLINE\n",
      "  J01CF02 | CLOXACILLINE\n",
      "  J01CF04 | OXACILLINE\n",
      "  J01CR01 | AMPICILLINE ET INHIBITEUR D'ENZYME\n",
      "  J01CR02 | AMOXICILLINE ET INHIBITEUR D'ENZYME\n",
      "  J01CR05 | PIPERACILLINE ET INHIBITEUR D'ENZYME\n",
      "  J01DB01 | CEFALEXINE\n",
      "  J01DB05 | CEFADROXIL\n",
      "  J01DC02 | CEFUROXIME\n",
      "  J01DC04 | CEFACLOR\n",
      "  J01DD02 | CEFTAZIDIME\n",
      "  J01DD04 | CEFTRIAXONE\n",
      "  J01DD08 | CEFIXIME\n",
      "  J01DD13 | CEFPODOXIME\n",
      "  J01DE01 | CEFEPIME\n",
      "  J01DF01 | AZTREONAM\n",
      "  J01DH02 | MEROPENEM\n",
      "  J01DH51 | IMIPENEM ET INHIBITEUR ENZYME (CILASTATINE SODIQUE)\n",
      "  J01EA01 | TRIMETHOPRIME\n",
      "  J01EC02 | SULFADIAZINE\n",
      "  J01EE01 | SULFAMETHOXAZOLE ET TRIMETHOPRIME\n",
      "  J01FA01 | ERYTHROMYCINE\n",
      "  J01FA02 | SPIRAMYCINE\n",
      "  J01FA06 | ROXITHROMYCINE\n",
      "  J01FA07 | JOSAMYCINE\n",
      "  J01FA09 | CLARITHROMYCINE\n",
      "  J01FA10 | AZITHROMYCINE\n",
      "  J01FF01 | CLINDAMYCINE\n",
      "  J01FG01 | PRISTINAMYCINE\n",
      "  J01GB01 | TOBRAMYCINE\n",
      "  J01GB03 | GENTAMICINE\n",
      "  J01GB06 | AMIKACINE\n",
      "  J01MA01 | OFLOXACINE\n",
      "  J01MA02 | CIPROFLOXACINE\n",
      "  J01MA12 | LEVOFLOXACINE\n",
      "  J01MA14 | MOXIFLOXACINE\n",
      "  J01RA04 | SPIRAMYCINE EN ASSOCIATION AVEC AUTRES ANTIBACTERIENS\n",
      "  J01XB01 | COLISTINE\n",
      "  J01XC01 | FUSIDIQUE ACIDE\n",
      "  J01XE01 | NITROFURANTOINE\n",
      "  J01XX01 | FOSFOMYCINE\n",
      "  J02AA01 | AMPHOTERICINE B\n",
      "  J02AC01 | FLUCONAZOLE\n",
      "  J02AC02 | ITRACONAZOLE\n",
      "  J02AC03 | VORICONAZOLE\n",
      "  J02AX01 | FLUCYTOSINE\n",
      "  J04AB02 | RIFAMPICINE\n",
      "  J04AB04 | RIFABUTINE\n",
      "  J04AC01 | ISONIAZIDE\n",
      "  J04AK01 | PYRAZINAMIDE\n",
      "  J04AK02 | ETHAMBUTOL\n",
      "  J04AM02 | RIFAMPICINE ET ISONIAZIDE\n",
      "  J04AM05 | RIFAMPICINE, PYRAZINAMIDE ET ISONIAZIDE\n",
      "  J04BA02 | DAPSONE\n",
      "  J05AB01 | ACICLOVIR\n",
      "  J05AB09 | FAMCICLOVIR\n",
      "  J05AB11 | VALACICLOVIR\n",
      "  J05AB14 | VALGANCICLOVIR\n",
      "  J05AE03 | RITONAVIR\n",
      "  J05AE07 | FOSAMPRENAVIR\n",
      "  J05AE08 | ATAZANAVIR\n",
      "  J05AE09 | TIPRANAVIR\n",
      "  J05AE10 | DARUNAVIR\n",
      "  J05AE30 | NIRMATRELVIR + RITONAVIR\n",
      "  J05AF01 | ZIDOVUDINE\n",
      "  J05AF05 | LAMIVUDINE\n",
      "  J05AF06 | ABACAVIR\n",
      "  J05AF07 | TENOFOVIR DISOPROXIL\n",
      "  J05AF08 | ADEFOVIR DIPIVOXIL\n",
      "  J05AF09 | EMTRICITABINE\n",
      "  J05AF10 | ENTECAVIR\n",
      "  J05AG01 | NEVIRAPINE\n",
      "  J05AG03 | EFAVIRENZ\n",
      "  J05AG04 | ETRAVIRINE\n",
      "  J05AG05 | RILPIVIRINE\n",
      "  J05AG06 | DORAVIRINE\n",
      "  J05AH02 | OSELTAMIVIR\n",
      "  J05AJ01 | RALTEGRAVIR\n",
      "  J05AJ03 | DOLUTEGRAVIR\n",
      "  J05AJ04 | CABOTEGRAVIR\n",
      "  J05AP08 | SOFOSBUVIR\n",
      "  J05AP51 | SOFOSBUVIR + LEDIPASVIR\n",
      "  J05AP55 | SOFOSBUVIR + VELPATASVIR\n",
      "  J05AP56 | SOFOSBUVIR + VELPATASVIR + VOXILAPREVIR\n",
      "  J05AP57 | GLECAPREVIR + PIBRENTASVIR\n",
      "  J05AR01 | ZIDOVUDINE ET LAMIVUDINE\n",
      "  J05AR02 | LAMIVUDINE ET ABACAVIR\n",
      "  J05AR03 | TENOFOVIR DISOPROXIL ET EMTRICITABINE\n",
      "  J05AR04 | ZIDOVUDINE, LAMIVUDINE ET ABACAVIR\n",
      "  J05AR06 | EMTRICITABINE, TENOFOVIR DISOPROXIL ET EFAVIRENZ\n",
      "  J05AR08 | EMTRICITABINE, TENOFOVIR DISOPROXIL ET RILPIVIRINE\n",
      "  J05AR09 | EMTRICITABINE, TENOFOVIR DISOPROXIL, ELVITEGRAVIR ET COBICISTAT\n",
      "  J05AR10 | LOPINAVIR ET RITONAVIR\n",
      "  J05AR13 | LAMIVUDINE, ABACAVIR ET DOLUTEGRAVIR\n",
      "  J05AR18 | EMTRICITABINE, TENOFOVIR ALAFENAMIDE, ELVITEGRAVIR ET COBICISTAT\n",
      "  J05AR19 | EMTRICITABINE + TENOFOVIR ALAFENAMIDE + RILPIVIRINE\n",
      "  J05AR20 | EMTRICITABINE + TENOFOVIR ALAFENAMIDE + BICTEGRAVIR\n",
      "  J05AR21 | DOLUTEGRAVIR + RILPIVIRINE\n",
      "  J05AR24 | LAMIVUDINE + TENOFOVIR DISOPROXIL + DORAVIRINE\n",
      "  J05AR25 | LAMIVUDINE + DOLUTEGRAVIR\n",
      "  J05AX07 | ENFUVIRTIDE\n",
      "  J05AX09 | MARAVIROC\n",
      "  J05AX18 | LETERMOVIR\n",
      "  J05AX29 | FOSTEMSAVIR\n",
      "  J06BB01 | IMMUNOGLOBULINE ANTI-D (rh)\n",
      "  J06BB02 | IMMUNOGLOBULINE ANTITETANIQUE\n",
      "  J07AG01 | HAEMOPHILUS INFLUENZAE B, ANTIGENE PURIFIE CONJUGUE\n",
      "  J07AH07 | MENINGOCOQUE C, ANTIGENES POLYSACCHARIDIQUES CONJUGUES\n",
      "  J07AH08 | ANTIGENES POLYSACCHARIDIQUES TRETRAVALENTS CONJUGUES DE MENINGOCOQUE\n",
      "  J07AH09 | MENINGOCOQUE B, VACCIN MULTICOMPOSANTS\n",
      "  J07AL01 | PNEUMOCOCCUS, ANTIGENE POLYSACCHARIDIQUE PURIFIE\n",
      "  J07AL02 | PNEUMOCOCCUS, ANTIGENE POLYSACCHARIDIQUE PURIFIE CONJUGUE\n",
      "  J07AN01 | TUBERCULOSE, BACTERIE VIVANTE ATTENUEE\n",
      "  J07BB02 | GRIPPE, VIRUS FRACTIONNE INACTIVE OU ANTIGENE PURIFIE\n",
      "  J07BC01 | HEPATITE B, ANTIGENE PURIFIE\n",
      "  J07BC02 | HEPATITE A, VIRUS ENTIER INACTIVE\n",
      "  J07BD52 | ROUGEOLE EN ASSOCIATION AVEC OREILLONS ET RUBEOLE, VIRUS VIVANTS ATTENUES\n",
      "  J07BF03 | VIRUS ENTIER TRIVALENT INACTIVE DE POLIOMYELITE\n",
      "  J07BH01 | ROTAVIRUS VIVANT ATTENUE\n",
      "  J07BH02 | ROTAVIRUS PENTAVALENT VIVANT ATTENUE\n",
      "  J07BK01 | VARICELLE, VIRUS VIVANT ATTENUE\n",
      "  J07BK02 | VIRUS VARICELLE-ZONA VIVANT, ATTENUE\n",
      "  J07BM01 | PAPILLOMAVIRUS (TYPES HUMAINS 6, 11, 16, 18)\n",
      "  J07BM02 | PAPILLOMAVIRUS (TYPES HUMAINS 16, 18)\n",
      "  J07BM03 | PAPILLOMAVIRUS TYPES HUMAINS 6, 11, 16, 18, 31, 33, 45, 52, 58\n",
      "  J07CA01 | DIPHTERIE-POLYOMIELITE-TETANOS\n",
      "  J07CA02 | DIPHTERIE-COQUELUCHE-POLIOMYELITE-TETANOS\n",
      "  J07CA06 | DIPHTERIE-HAEMOPHILUS INFLUENZAE B-COQUELUCHE-POLIOMYELITE-TETANOS\n",
      "  J07CA09 | DIPHTERIE-HAEMOPHILUS INFLUENZAE B-COQUELUCHE-POLIOMYELITE-TETANOS-HEPATITE B\n",
      "  L01AA01 | CYCLOPHOSPHAMIDE\n",
      "  L01AA02 | CHLORAMBUCIL\n",
      "  L01AA03 | MELPHALAN\n",
      "  L01AB01 | BUSULFAN\n",
      "  L01AX02 | PIPOBROMAN\n",
      "  L01BA01 | METHOTREXATE\n",
      "  L01BB02 | MERCAPTOPURINE\n",
      "  L01BB04 | CLADRIBINE\n",
      "  L01BB05 | FLUDARABINE\n",
      "  L01BC01 | CYTARABINE\n",
      "  L01BC02 | FLUOROURACILE\n",
      "  L01BC06 | CAPECITABINE\n",
      "  L01BC07 | AZACITIDINE\n",
      "  L01BC59 | TRIFLURIDINE EN ASSOCIATION\n",
      "  L01CA04 | VINORELBINE\n",
      "  L01CB01 | ETOPOSIDE\n",
      "  L01CE01 | TOPOTECAN\n",
      "  L01EA01 | IMATINIB\n",
      "  L01EA02 | DASATINIB\n",
      "  L01EA03 | NILOTINIB\n",
      "  L01EA04 | BOSUTINIB\n",
      "  L01EA05 | PONATINIB\n",
      "  L01EB01 | GEFITINIB\n",
      "  L01EB02 | ERLOTINIB\n",
      "  L01EB03 | AFATINIB\n",
      "  L01EB04 | OSIMERTINIB\n",
      "  L01EC01 | VEMURAFENIB\n",
      "  L01EC02 | DABRAFENIB\n",
      "  L01EC03 | ENCORAFENIB\n",
      "  L01ED01 | CRIZOTINIB\n",
      "  L01ED02 | CERITINIB\n",
      "  L01ED03 | ALECTINIB\n",
      "  L01ED04 | BRIGATINIB\n",
      "  L01ED05 | LORLATINIB\n",
      "  L01EE01 | TRAMETINIB\n",
      "  L01EE02 | COBIMETINIB\n",
      "  L01EE03 | BINIMETINIB\n",
      "  L01EF01 | PALBOCICLIB\n",
      "  L01EF02 | RIBOCICLIB\n",
      "  L01EF03 | ABEMACICLIB\n",
      "  L01EG02 | EVEROLIMUS\n",
      "  L01EH01 | LAPATINIB\n",
      "  L01EJ01 | RUXOLITINIB\n",
      "  L01EJ02 | FEDRATINIB\n",
      "  L01EK01 | AXITINIB\n",
      "  L01EL01 | IBRUTINIB\n",
      "  L01EM01 | IDELALISIB\n",
      "  L01EN02 | PEMIGATINIB\n",
      "  L01EX01 | SUNITINIB\n",
      "  L01EX02 | SORAFENIB\n",
      "  L01EX03 | PAZOPANIB\n",
      "  L01EX04 | VANDETANIB\n",
      "  L01EX05 | REGORAFENIB\n",
      "  L01EX07 | CABOZANTINIB\n",
      "  L01EX08 | LENVATINIB\n",
      "  L01EX09 | NINTEDANIB\n",
      "  L01EX10 | MIDOSTAURINE\n",
      "  L01EX13 | GILTERITINIB\n",
      "  L01XB01 | PROCARBAZINE\n",
      "  L01XD03 | METHYLE AMINOLEVULINATE\n",
      "  L01XF03 | BEXAROTENE\n",
      "  L01XG03 | IXAZOMIB\n",
      "  L01XJ01 | VISMODEGIB\n",
      "  L01XJ02 | SONIDEGIB\n",
      "  L01XK01 | OLAPARIB\n",
      "  L01XK02 | NIRAPARIB\n",
      "  L01XK03 | RUCAPARIB\n",
      "  L01XK04 | TALAZOPARIB\n",
      "  L01XX05 | HYDROXYCARBAMIDE\n",
      "  L01XX11 | ESTRAMUSTINE\n",
      "  L01XX35 | ANAGRELIDE\n",
      "  L01XX52 | VENETOCLAX\n",
      "  L02AB01 | MEGESTROL\n",
      "  L02AB02 | MEDROXYPROGESTERONE\n",
      "  L02AE02 | LEUPRORELINE\n",
      "  L02AE03 | GOSERELINE\n",
      "  L02AE04 | TRIPTORELINE\n",
      "  L02BA01 | TAMOXIFENE\n",
      "  L02BA02 | TOREMIFENE\n",
      "  L02BA03 | FULVESTRANT\n",
      "  L02BB02 | NILUTAMIDE\n",
      "  L02BB03 | BICALUTAMIDE\n",
      "  L02BB04 | ENZALUTAMIDE\n",
      "  L02BB05 | APALUTAMIDE\n",
      "  L02BB06 | DAROLUTAMIDE\n",
      "  L02BG03 | ANASTROZOLE\n",
      "  L02BG04 | LETROZOLE\n",
      "  L02BG06 | EXEMESTANE\n",
      "  L02BX02 | DEGARELIX\n",
      "  L02BX03 | ABIRATERONE\n",
      "  L03AA02 | FILGRASTIM\n",
      "  L03AA10 | LENOGRASTIM\n",
      "  L03AA13 | PEGFILGRASTIM\n",
      "  L03AA14 | LIPEGFILGRASTIM\n",
      "  L03AB07 | INTERFERON BETA-1A\n",
      "  L03AB08 | INTERFERON BETA-1B\n",
      "  L03AB11 | PEGINTERFERON ALFA-2A\n",
      "  L03AB13 | PEGINTERFERON BETA-1A\n",
      "  L03AX13 | GLATIRAMERE ACETATE\n",
      "  L04AA06 | MYCOPHENOLIQUE ACIDE\n",
      "  L04AA10 | SIROLIMUS\n",
      "  L04AA13 | LEFLUNOMIDE\n",
      "  L04AA18 | EVEROLIMUS\n",
      "  L04AA24 | ABATACEPT\n",
      "  L04AA26 | BELIMUMAB\n",
      "  L04AA27 | FINGOLIMOD\n",
      "  L04AA29 | TOFACITINIB\n",
      "  L04AA31 | TERIFLUNOMIDE\n",
      "  L04AA32 | APREMILAST\n",
      "  L04AA33 | VEDOLIZUMAB\n",
      "  L04AA37 | BARICITINIB\n",
      "  L04AA40 | CLADRIBINE\n",
      "  L04AA44 | UPADACITINIB\n",
      "  L04AA45 | FILGOTINIB\n",
      "  L04AA50 | PONESIMOD\n",
      "  L04AA52 | OFATUMUMAB\n",
      "  L04AB01 | ETANERCEPT\n",
      "  L04AB02 | INFLIXIMAB\n",
      "  L04AB04 | ADALIMUMAB\n",
      "  L04AB05 | CERTOLIZUMAB PEGOL\n",
      "  L04AB06 | GOLIMUMAB\n",
      "  L04AC03 | ANAKINRA\n",
      "  L04AC05 | USTEKINUMAB\n",
      "  L04AC07 | TOCILIZUMAB\n",
      "  L04AC08 | CANAKINUMAB\n",
      "  L04AC10 | SECUKINUMAB\n",
      "  L04AC12 | BRODALUMAB\n",
      "  L04AC13 | IXEKIZUMAB\n",
      "  L04AC14 | SARILUMAB\n",
      "  L04AC16 | GUSELKUMAB\n",
      "  L04AC17 | TILDRAKIZUMAB\n",
      "  L04AC18 | RISANKIZUMAB\n",
      "  L04AC21 | BIMEKIZUMAB\n",
      "  L04AD01 | CICLOSPORINE\n",
      "  L04AD02 | TACROLIMUS\n",
      "  L04AX01 | AZATHIOPRINE\n",
      "  L04AX03 | METHOTREXATE\n",
      "  L04AX05 | PIRFENIDONE\n",
      "  L04AX07 | DIMETHYL FUMARATE\n",
      "  M01AB01 | INDOMETACINE\n",
      "  M01AB02 | SULINDAC\n",
      "  M01AB05 | DICLOFENAC\n",
      "  M01AB08 | ETODOLAC\n",
      "  M01AB16 | ACECLOFENAC\n",
      "  M01AB55 | DICLOFENAC EN ASSOCIATION\n",
      "  M01AC01 | PIROXICAM\n",
      "  M01AC02 | TENOXICAM\n",
      "  M01AC06 | MELOXICAM\n",
      "  M01AE01 | IBUPROFENE\n",
      "  M01AE02 | NAPROXENE\n",
      "  M01AE03 | KETOPROFENE\n",
      "  M01AE09 | FLURBIPROFENE\n",
      "  M01AE11 | TIAPROFENIQUE ACIDE\n",
      "  M01AG01 | MEFENAMIQUE ACIDE\n",
      "  M01AH01 | CELECOXIB\n",
      "  M01AH05 | ETORICOXIB\n",
      "  M01AX01 | NABUMETONE\n",
      "  M01AX02 | NIFLUMIQUE ACIDE\n",
      "  M01AX22 | MORNIFLUMATE\n",
      "  M01CC01 | PENICILLAMINE\n",
      "  M02AA07 | PIROXICAM\n",
      "  M02AA13 | IBUPROFENE\n",
      "  M02AA15 | DICLOFENAC\n",
      "  M02AA17 | NIFLUMIQUE ACIDE\n",
      "  M03BX01 | BACLOFENE\n",
      "  M03CA01 | DANTROLENE\n",
      "  M04AA01 | ALLOPURINOL\n",
      "  M04AA03 | FEBUXOSTAT\n",
      "  M04AB01 | PROBENECIDE\n",
      "  M04AC01 | COLCHICINE\n",
      "  M05BA02 | CLODRONIQUE ACIDE\n",
      "  M05BA04 | ALENDRONIQUE ACIDE\n",
      "  M05BA07 | RISEDRONIQUE ACIDE\n",
      "  M05BA08 | ZOLEDRONIQUE ACIDE\n",
      "  M05BB03 | ALENDRONIQUE ACIDE ET COLECALCIFEROL\n",
      "  M05BB04 | RISEDRONIQUE ACIDE, CALCIUM ET COLECALCIFEROL, EN SEQUENTIEL\n",
      "  M05BX04 | DENOSUMAB\n",
      "  M05BX05 | BUROSUMAB\n",
      "  M09AA72 | QUININE + PSYCHOLEPTIQUES\n",
      "  M09AX | AUTRES MEDICAMENTS DES DESORDRES MUSCULO-SQUELETTIQUES\n",
      "  M09AX10 | RISDIPLAM\n",
      "  N01BA02 | PROCAINE\n",
      "  N01BB02 | LIDOCAINE\n",
      "  N01BB52 | LIDOCAINE EN ASSOCIATION\n",
      "  N02AA01 | MORPHINE\n",
      "  N02AA03 | HYDROMORPHONE\n",
      "  N02AA05 | OXYCODONE\n",
      "  N02AA08 | DIHYDROCODEINE\n",
      "  N02AA55 | OXYCODONE + NALOXONE\n",
      "  N02AB03 | FENTANYL\n",
      "  N02AC | DERIVES DE LA DIPHENYLPROPYLAMINE\n",
      "  N02AE01 | BUPRENORPHINE\n",
      "  N02AJ06 | CODEINE + PARACETAMOL\n",
      "  N02AJ08 | CODEINE + IBUPROFENE\n",
      "  N02AJ13 | TRAMADOL + PARACETAMOL\n",
      "  N02AX02 | TRAMADOL\n",
      "  N02BA01 | ACETYLSALICYLIQUE ACIDE\n",
      "  N02BA71 | ACETYLSALICYLIQUE ACIDE EN ASSOCIATION AVEC DES PSYCHOLEPTIQUES\n",
      "  N02BE01 | PARACETAMOL\n",
      "  N02BE51 | PARACETAMOL EN ASSOCIATION SAUF PSYCHOLEPTIQUES\n",
      "  N02BE71 | PARACETAMOL EN ASSOCIATION AVEC DES PSYCHOLEPTIQUES\n",
      "  N02BF01 | GABAPENTINE\n",
      "  N02BF02 | PREGABALINE\n",
      "  N02BG06 | NEFOPAM\n",
      "  N02CA01 | DIHYDROERGOTAMINE\n",
      "  N02CA52 | ERGOTAMINE EN ASSOCIATION SAUF AUX PSYCHOLEPTIQUES\n",
      "  N02CC01 | SUMATRIPTAN\n",
      "  N02CC02 | NARATRIPTAN\n",
      "  N02CC03 | ZOLMITRIPTAN\n",
      "  N02CC04 | RIZATRIPTAN\n",
      "  N02CC05 | ALMOTRIPTAN\n",
      "  N02CC06 | ELETRIPTAN\n",
      "  N02CC07 | FROVATRIPTAN\n",
      "  N02CX01 | PIZOTIFENE\n",
      "  N02CX06 | OXETORONE\n",
      "  N03AA02 | PHENOBARBITAL\n",
      "  N03AA03 | PRIMIDONE\n",
      "  N03AB02 | PHENYTOINE\n",
      "  N03AD01 | ETHOSUXIMIDE\n",
      "  N03AE01 | CLONAZEPAM\n",
      "  N03AF01 | CARBAMAZEPINE\n",
      "  N03AF02 | OXCARBAZEPINE\n",
      "  N03AF03 | RUFINAMIDE\n",
      "  N03AF04 | ESLICARBAZEPINE\n",
      "  N03AG01 | VALPROIQUE ACIDE\n",
      "  N03AG02 | VALPROMIDE\n",
      "  N03AG04 | VIGABATRIN\n",
      "  N03AG06 | TIAGABINE\n",
      "  N03AX09 | LAMOTRIGINE\n",
      "  N03AX11 | TOPIRAMATE\n",
      "  N03AX14 | LEVETIRACETAM\n",
      "  N03AX15 | ZONISAMIDE\n",
      "  N03AX17 | STIRIPENTOL\n",
      "  N03AX18 | LACOSAMIDE\n",
      "  N03AX22 | PERAMPANEL\n",
      "  N03AX23 | BRIVARACETAM\n",
      "  N03AX24 | CANNABIDIOL\n",
      "  N03AX25 | CENOBAMATE\n",
      "  N04AA01 | TRIHEXYPHENIDYL\n",
      "  N04AA02 | BIPERIDENE\n",
      "  N04AA12 | TROPATEPINE\n",
      "  N04BA02 | LEVODOPA ET INHIBITEUR DE LA DECARBOXYLASE\n",
      "  N04BA03 | LEVODOPA, INHIBITEUR DE LA DECARBOXYLASE ET INHIBITEUR DE LA COMT\n",
      "  N04BB01 | AMANTADINE\n",
      "  N04BC01 | BROMOCRIPTINE\n",
      "  N04BC04 | ROPINIROLE\n",
      "  N04BC05 | PRAMIPEXOLE\n",
      "  N04BC07 | APOMORPHINE\n",
      "  N04BC08 | PIRIBEDIL\n",
      "  N04BC09 | ROTIGOTINE\n",
      "  N04BD01 | SELEGILINE\n",
      "  N04BD02 | RASAGILINE\n",
      "  N04BX01 | TOLCAPONE\n",
      "  N04BX02 | ENTACAPONE\n",
      "  N05AA01 | CHLORPROMAZINE\n",
      "  N05AA02 | LEVOMEPROMAZINE\n",
      "  N05AA06 | CYAMEMAZINE\n",
      "  N05AC01 | PERICIAZINE\n",
      "  N05AC04 | PIPOTIAZINE\n",
      "  N05AD01 | HALOPERIDOL\n",
      "  N05AD05 | PIPAMPERONE\n",
      "  N05AF01 | FLUPENTIXOL\n",
      "  N05AF05 | ZUCLOPENTHIXOL\n",
      "  N05AG02 | PIMOZIDE\n",
      "  N05AH01 | LOXAPINE\n",
      "  N05AH02 | CLOZAPINE\n",
      "  N05AH03 | OLANZAPINE\n",
      "  N05AH04 | QUETIAPINE\n",
      "  N05AL01 | SULPIRIDE\n",
      "  N05AL03 | TIAPRIDE\n",
      "  N05AL05 | AMISULPRIDE\n",
      "  N05AN01 | LITHIUM\n",
      "  N05AX08 | RISPERIDONE\n",
      "  N05AX12 | ARIPIPRAZOLE\n",
      "  N05AX13 | PALIPERIDONE\n",
      "  N05BA01 | DIAZEPAM\n",
      "  N05BA04 | OXAZEPAM\n",
      "  N05BA05 | CLORAZEPATE POTASSIQUE\n",
      "  N05BA06 | LORAZEPAM\n",
      "  N05BA08 | BROMAZEPAM\n",
      "  N05BA09 | CLOBAZAM\n",
      "  N05BA11 | PRAZEPAM\n",
      "  N05BA12 | ALPRAZOLAM\n",
      "  N05BA16 | NORDAZEPAM\n",
      "  N05BA18 | ETHYLE LOFLAZEPATE\n",
      "  N05BA21 | CLOTIAZEPAM\n",
      "  N05BB01 | HYDROXYZINE\n",
      "  N05BE01 | BUSPIRONE\n",
      "  N05BX03 | ETIFOXINE\n",
      "  N05CD04 | ESTAZOLAM\n",
      "  N05CD06 | LORMETAZEPAM\n",
      "  N05CD08 | MIDAZOLAM\n",
      "  N05CD11 | LOPRAZOLAM\n",
      "  N05CF01 | ZOPICLONE\n",
      "  N05CF02 | ZOLPIDEM\n",
      "  N05CH01 | MELATONINE\n",
      "  N06AA02 | IMIPRAMINE\n",
      "  N06AA04 | CLOMIPRAMINE\n",
      "  N06AA06 | TRIMIPRAMINE\n",
      "  N06AA09 | AMITRIPTYLINE\n",
      "  N06AA12 | DOXEPINE\n",
      "  N06AA16 | DOSULEPINE\n",
      "  N06AA17 | AMOXAPINE\n",
      "  N06AA21 | MAPROTILINE\n",
      "  N06AB03 | FLUOXETINE\n",
      "  N06AB04 | CITALOPRAM\n",
      "  N06AB05 | PAROXETINE\n",
      "  N06AB06 | SERTRALINE\n",
      "  N06AB08 | FLUVOXAMINE\n",
      "  N06AB10 | ESCITALOPRAM\n",
      "  N06AG02 | MOCLOBEMIDE\n",
      "  N06AX01 | OXITRIPTAN\n",
      "  N06AX03 | MIANSERINE\n",
      "  N06AX11 | MIRTAZAPINE\n",
      "  N06AX14 | TIANEPTINE\n",
      "  N06AX16 | VENLAFAXINE\n",
      "  N06AX17 | MILNACIPRAN\n",
      "  N06AX21 | DULOXETINE\n",
      "  N06AX22 | AGOMELATINE\n",
      "  N06AX26 | VORTIOXETINE\n",
      "  N06BA04 | METHYLPHENIDATE\n",
      "  N06BA07 | MODAFINIL\n",
      "  N06BA14 | SOLRIAMFETOL\n",
      "  N06BC01 | CAFEINE\n",
      "  N06BX03 | PIRACETAM\n",
      "  N07AA01 | NEOSTIGMINE\n",
      "  N07AA02 | PYRIDOSTIGMINE\n",
      "  N07AA30 | AMBENONIUM\n",
      "  N07BA01 | NICOTINE\n",
      "  N07BA03 | VARENICLINE\n",
      "  N07BB | MEDICAMENTS UTILISES DANS LA DEPENDANCE ALCOOLIQUE\n",
      "  N07BB01 | DISULFIRAM\n",
      "  N07BB03 | ACAMPROSATE\n",
      "  N07BB04 | NALTREXONE\n",
      "  N07BB05 | NALMEFENE\n",
      "  N07BC01 | BUPRENORPHINE\n",
      "  N07BC02 | METHADONE\n",
      "  N07BC51 | BUPRENORPHINE EN ASSOCIATION\n",
      "  N07CA01 | BETAHISTINE\n",
      "  N07CA03 | FLUNARIZINE\n",
      "  N07CA04 | ACETYLLEUCINE\n",
      "  N07XX02 | RILUZOLE\n",
      "  N07XX05 | AMIFAMPRIDINE\n",
      "  N07XX06 | TETRABENAZINE\n",
      "  N07XX07 | FAMPRIDINE\n",
      "  N07XX08 | TAFAMIDIS\n",
      "  N07XX11 | PITOLISANT\n",
      "  N07XX12 | PATISIRAN\n",
      "  N07XX15 | INOTERSEN\n",
      "  P01AB01 | METRONIDAZOLE\n",
      "  P01AB02 | TINIDAZOLE\n",
      "  P01AB07 | SECNIDAZOLE\n",
      "  P01AX06 | ATOVAQUONE\n",
      "  P01BA01 | CHLOROQUINE\n",
      "  P01BB51 | PROGUANIL EN ASSOCIATION\n",
      "  P01BC02 | MEFLOQUINE\n",
      "  P01BD01 | PYRIMETHAMINE\n",
      "  P01BF01 | ARTEMETHER ET LUMEFANTRINE\n",
      "  P01BF05 | ARTENIMOL ET PIPERAQUINE\n",
      "  P01CB01 | ANTIMONIATE DE MEGLUMINE\n",
      "  P01CX01 | PENTAMIDINE ISETHIONATE\n",
      "  P02BA01 | PRAZIQUANTEL\n",
      "  P02CA03 | ALBENDAZOLE\n",
      "  P02CA05 | FLUBENDAZOLE\n",
      "  P02CC01 | PYRANTEL\n",
      "  P02CF01 | IVERMECTINE\n",
      "  P02DA01 | NICLOSAMIDE\n",
      "  P03AC04 | PERMETHRINE\n",
      "  P03AC51 | PYRETHRUM EN ASSOCIATION\n",
      "  P03AX01 | BENZOATE DE BENZYLE\n",
      "  R01AA05 | OXYMETAZOLINE\n",
      "  R01AC03 | AZELASTINE\n",
      "  R01AD01 | BECLOMETASONE\n",
      "  R01AD05 | BUDESONIDE\n",
      "  R01AD07 | TIXOCORTOL\n",
      "  R01AD09 | MOMETASONE\n",
      "  R01AD11 | TRIAMCINOLONE\n",
      "  R01AD12 | FLUTICASONE FUROATE\n",
      "  R01AD58 | DECONGESTIONNANTS ET AUTRES PREPARATIONS NASALES, CORTICOSTEROIDES EN ASSOCIATION\n",
      "  R01AX03 | IPRATROPIUM BROMURE\n",
      "  R01AX06 | MUPIROCINE\n",
      "  R03AC02 | SALBUTAMOL\n",
      "  R03AC03 | TERBUTALINE\n",
      "  R03AC12 | SALMETEROL\n",
      "  R03AC13 | FORMOTEROL\n",
      "  R03AC18 | INDACATEROL\n",
      "  R03AC19 | OLODATEROL\n",
      "  R03AK06 | SALMETEROL ET FLUTICASONE\n",
      "  R03AK07 | FORMOTEROL ET BUDESONIDE\n",
      "  R03AK08 | FORMOTEROL ET BECLOMETASONE\n",
      "  R03AK10 | VILANTEROL ET FLUTICASONE FUROATE\n",
      "  R03AK11 | FORMOTEROL ET FLUTICASONE\n",
      "  R03AK14 | INDACATEROL + MOMETASONE\n",
      "  R03AL01 | FENOTEROL ET BROMURE D'IPRATROPIUM\n",
      "  R03AL03 | VILANTEROL, UMECLIDINIUM BROMURE\n",
      "  R03AL04 | INDACATEROL ET BROMURE DE GLYCOPYRRONIUM\n",
      "  R03AL08 | VILANTEROL + UMECLIDINIUM + FLUTICASONE\n",
      "  R03AL09 | FORMOTEROL + GLYCOPYRRONIUM BROMURE + BECLOMETASONE\n",
      "  R03AL11 | FORMOTEROL + GLYCOPYRRONIUM BROMURE + BUDESONIDE\n",
      "  R03AL12 | INDACATEROL + GLYCOPYRRONIUM BROMURE + MOMETASONE\n",
      "  R03BA01 | BECLOMETASONE\n",
      "  R03BA02 | BUDESONIDE\n",
      "  R03BA05 | FLUTICASONE\n",
      "  R03BA07 | MOMETASONE\n",
      "  R03BA08 | CICLESONIDE\n",
      "  R03BB01 | IPRATROPIUM BROMURE\n",
      "  R03BB04 | TIOTROPIUM BROMURE\n",
      "  R03BB06 | GLYCOPYRRONIUM BROMURE\n",
      "  R03BB07 | UMECLIDINIUM BROMURE\n",
      "  R03BB54 | TIOTROPIUM BROMURE EN ASSOCIATION\n",
      "  R03CC02 | SALBUTAMOL\n",
      "  R03CC03 | TERBUTALINE\n",
      "  R03CC12 | BAMBUTEROL\n",
      "  R03DA04 | THEOPHYLLINE\n",
      "  R03DC03 | MONTELUKAST\n",
      "  R03DX05 | OMALIZUMAB\n",
      "  R03DX09 | MEPOLIZUMAB\n",
      "  R03DX10 | BENRALIZUMAB\n",
      "  R05CB | MUCOLYTIQUES\n",
      "  R05CB01 | ACETYLCYSTEINE\n",
      "  R05CB13 | DORNASE ALFA\n",
      "  R05DA04 | CODEINE\n",
      "  R05DA08 | PHOLCODINE\n",
      "  R05DA09 | DEXTROMETHORPHANE\n",
      "  R05DA20 | ASSOCIATIONS ANTITUSSIVES\n",
      "  R05DB09 | OXELADINE\n",
      "  R06AD01 | ALIMEMAZINE\n",
      "  R06AD07 | MEQUITAZINE\n",
      "  R06AD08 | OXOMEMAZINE\n",
      "  R06AE05 | MECLOZINE\n",
      "  R06AE07 | CETIRIZINE\n",
      "  R06AE09 | LEVOCETIRIZINE\n",
      "  R06AX13 | LORATADINE\n",
      "  R06AX17 | KETOTIFENE\n",
      "  R06AX22 | EBASTINE\n",
      "  R06AX25 | MIZOLASTINE\n",
      "  R06AX26 | FEXOFENADINE\n",
      "  R06AX27 | DESLORATADINE\n",
      "  R06AX28 | RUPATADINE\n",
      "  R06AX29 | BILASTINE\n",
      "  R07AX02 | IVACAFTOR\n",
      "  R07AX30 | IVACAFTOR + LUMACAFTOR\n",
      "  R07AX31 | IVACAFTOR + TEZACAFTOR\n",
      "  R07AX32 | IVACAFTOR + TEZACAFTOR + ELEXACAFTOR\n",
      "  S01AA12 | TOBRAMYCINE\n",
      "  S01AA13 | FUSIDIQUE ACIDE\n",
      "  S01AA16 | RIFAMYCINE\n",
      "  S01AA26 | AZITHROMYCINE\n",
      "  S01AA30 | ASSOCIATIONS DE DIFFERENTS ANTIBIOTIQUES EN OPHTALMOLOGIE\n",
      "  S01AD02 | TRIFLURIDINE\n",
      "  S01AD03 | ACICLOVIR\n",
      "  S01AD09 | GANCICLOVIR\n",
      "  S01AE01 | OFLOXACINE\n",
      "  S01AE02 | NORFLOXACINE\n",
      "  S01AE03 | CIPROFLOXACINE\n",
      "  S01AX | AUTRES ANTIINFECTIEUX\n",
      "  S01AX07 | SODIUM BORATE\n",
      "  S01AX16 | PICLOXYDINE\n",
      "  S01BA01 | DEXAMETHASONE\n",
      "  S01BA07 | FLUOROMETHOLONE\n",
      "  S01BA15 | FLUOCINOLONE\n",
      "  S01BC01 | INDOMETACINE\n",
      "  S01BC03 | DICLOFENAC\n",
      "  S01BC04 | FLURBIPROFENE\n",
      "  S01BC05 | KETOROLAC\n",
      "  S01BC11 | BROMFENAC SODIUM SESQUIHYDRATE\n",
      "  S01CA01 | DEXAMETHASONE ET ANTIINFECTIEUX\n",
      "  S01CC02 | INDOMETACINE + ANTI-INFECTIEUX\n",
      "  S01EA03 | APRACLONIDINE\n",
      "  S01EA05 | BRIMONIDINE\n",
      "  S01EB01 | PILOCARPINE\n",
      "  S01EC01 | ACETAZOLAMIDE\n",
      "  S01EC03 | DORZOLAMIDE\n",
      "  S01EC04 | BRINZOLAMIDE\n",
      "  S01EC54 | BRINZOLAMIDE EN ASSOCIATION\n",
      "  S01ED01 | TIMOLOL\n",
      "  S01ED02 | BETAXOLOL\n",
      "  S01ED03 | LEVOBUNOLOL\n",
      "  S01ED05 | CARTEOLOL\n",
      "  S01ED51 | TIMOLOL EN ASSOCIATION\n",
      "  S01EE01 | LATANOPROST\n",
      "  S01EE03 | BIMATOPROST\n",
      "  S01EE04 | TRAVOPROST\n",
      "  S01FA01 | ATROPINE\n",
      "  S01FA06 | TROPICAMIDE\n",
      "  S01FB01 | PHENYLEPHRINE\n",
      "  S01GX01 | CROMOGLICIQUE ACIDE\n",
      "  S01GX02 | LEVOCABASTINE\n",
      "  S01GX03 | SPAGLUMIQUE ACIDE\n",
      "  S01GX07 | AZELASTINE\n",
      "  S01GX08 | KETOTIFENE\n",
      "  S01GX09 | OLOPATADINE\n",
      "  S01GX10 | EPINASTINE\n",
      "  S01KA02 | HYPROMELLOSE\n",
      "  S01LA01 | VERTEPORFIN\n",
      "  S01LA04 | RANIBIZUMAB\n",
      "  S01LA05 | AFLIBERCEPT\n",
      "  S01XA02 | RETINOL\n",
      "  S01XA18 | CICLOSPORINE\n",
      "  S01XA20 | LARMES ARTIFICIELLES ET DIVERSES AUTRES PREPARATIONS\n",
      "  S01XA21 | MERCAPTAMINE\n",
      "  S02AA12 | RIFAMYCINE\n",
      "  S02AA15 | CIPROFLOXACINE\n",
      "  S02AA16 | OFLOXACINE\n",
      "  S02CA05 | FLUOCINOLONE ET ANTIINFECTIEUX\n",
      "  S02CA06 | DEXAMETHASONE ET ANTIINFECTIEUX\n",
      "  S02CA07 | FLUDROCORTISONE ET ANTIINFECTIEUX\n",
      "  S02DA30 | ASSOCIATIONS (ANALGESIQUES ET ANESTHESIQUES)\n",
      "  V01AA02 | POLLEN D'HERBE\n",
      "  V01AA03 | POUSSIERES DE MAISON ET ACARIENS\n",
      "  V01AA05 | POLLEN D'ARBRE\n",
      "  V03AB | ANTIDOTES = DMSA (SUCCIMER)\n",
      "  V03AB15 | NALOXONE\n",
      "  V03AC01 | DEFEROXAMINE\n",
      "  V03AC03 | DEFERASIROX\n",
      "  V03AE01 | SULFONATE DE POLYSTYRENE\n",
      "  V03AE02 | SEVELAMER\n",
      "  V03AE03 | LANTHANUM CARBONATE\n",
      "  V03AE05 | OXYHYDROXYDE SUCRO-FERRIQUE\n",
      "  V03AF03 | CALCIUM FOLINATE\n",
      "  V03AF04 | CALCIUM LEVOFOLINATE\n",
      "  V03AX | AUTRES MEDICAMENTS\n",
      "  V04CD01 | METYRAPONE\n",
      "  V04CF01 | TUBERCULINE\n",
      "  V04CM01 | GONADORELINE\n",
      "  V04CX | AUTRES MEDICAMENTS POUR DIAGNOSTIC\n",
      "  V04CX05 | UREE CARBONE C13\n",
      "  V04CX06 | HEXYLAMINOLEVULINATE\n",
      "  V08AA01 | DIATRIZOIQUE ACIDE\n",
      "  V08AA05 | IOXITALAMIQUE ACIDE\n",
      "  V08AB02 | IOHEXOL\n",
      "  V08AB04 | IOPAMIDOL\n",
      "  V08AB05 | IOPROMIDE\n",
      "  V08AB07 | IOVERSOL\n",
      "  V08AB09 | IODIXANOL\n",
      "  V08AB10 | IOMEPROL\n",
      "  V08AB11 | IOBITRIDOL\n",
      "  V08BA02 | SULFATE DE BARIUM SANS AGENTS DE MISE EN SUSPENSION\n",
      "  V08CA02 | GADOTERIQUE ACIDE\n",
      "  V08CA04 | GADOTERIDOL\n",
      "  V08CA08 | GADOBENIQUE ACIDE\n",
      "  V08CA09 | GADOBUTROL\n",
      "  V08DA05 | SOUFRE HEXAFLUORURE\n",
      "  A02AH | ANTIACIDES + BICARBONATE DE SODIUM\n",
      "  A05AX04 | MARALIXIBAT CHLORURE\n",
      "  A05AX05 | ODEVIXIBAT\n",
      "  A06AH05 | NALDEMEDINE\n",
      "  A07AA11 | RIFAXIMINE\n",
      "  A10BK02 | CANAGLIFLOZINE\n",
      "  A16AX18 | LUMASIRAN\n",
      "  B03XA05 | ROXADUSTAT\n",
      "  C01EB24 | MAVACAMTEN\n",
      "  C05AX03 | AUTRES PREPARATIONS EN ASSOCIATION\n",
      "  C10AX18 | VOLANESORSEN\n",
      "  D11AH09 | RUXOLITINIB\n",
      "  G03GA01 | GONADOTROPHINE CHORIONIQUE\n",
      "  H01AC08 | SOMATROGONE\n",
      "  H02CA02 | OSILODROSTAT\n",
      "  J05AX31 | LENACAPAVIR\n",
      "  J06BD08 | NIRSEVIMAB\n",
      "  J07BX05 | VACCINS CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL\n",
      "  L01DC01 | BLEOMYCINE\n",
      "  L01EA06 | ASCIMINIB\n",
      "  L01EE04 | SELUMETINIB\n",
      "  L01EH03 | TUCATINIB\n",
      "  L01EL02 | ACALABRUTINIB\n",
      "  L01EL03 | ZANUBRUTINIB\n",
      "  L01EN04 | FUTIBATINIB\n",
      "  L01EX18 | AVAPRITINIB\n",
      "  L01EX19 | RIPRETINIB\n",
      "  L01XX66 | SELINEXOR\n",
      "  L02BX04 | RELUGOLIX\n",
      "  L03AX03 | VACCIN BCG\n",
      "  L04AC19 | SATRALIZUMAB\n",
      "  L04AE01 | FINGOLIMOD\n",
      "  L04AE04 | PONESIMOD\n",
      "  L04AF01 | TOFACITINIB\n",
      "  L04AF02 | BARICITINIB\n",
      "  L04AF03 | UPADACITINIB\n",
      "  L04AF04 | FILGOTINIB\n",
      "  L04AF07 | DEUCRAVACITINIB\n",
      "  L04AF08 | RITLECITINIB\n",
      "  L04AG04 | BELIMUMAB\n",
      "  L04AG05 | VEDOLIZUMAB\n",
      "  L04AG12 | OFATUMUMAB\n",
      "  L04AH01 | SIROLIMUS\n",
      "  L04AJ03 | PEGCETACOPLAN\n",
      "  L04AJ05 | AVACOPAN\n",
      "  L04AK01 | LEFLUNOMIDE\n",
      "  L04AK02 | TERIFLUNOMIDE\n",
      "  L04AX09 | DIROXIMEL FUMARATE\n",
      "  M05BX07 | VOSORITIDE\n",
      "  N03AX26 | FENFLURAMINE\n",
      "  N04BA07 | FOSLEVODOPA + INHIBITEUR DE DECARBOXYLASE\n",
      "  N05CF04 | ESZOPICLONE\n",
      "  N06BX13 | IDEBENONE\n",
      "  N07XX18 | VUTRISIRAN\n",
      "  R01AD59 | MOMETASONE EN ASSOCIATION\n",
      "  R03DX11 | TEZEPELUMAB\n",
      "  S01LA06 | BROLUCIZUMAB\n",
      "  S01LA09 | FARICIMAB\n",
      "  V01AA07 | INSECTES\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : CIP13\n",
      "================================================================================\n",
      "\n",
      "  CIP13 | Libellé CIP13\n",
      "  3400921604696 | YELLOX 0,9MG/ML COLLY FL5ML 1\n",
      "  3400921609080 | AVONEX 0,03MG/0,5ML SOL INJ STYLO 4\n",
      "  3400921610550 | POLYGYNAX VIRGO CAPSULE VAGINALE 6\n",
      "  3400921610840 | NICORANDIL SDZ 20MG CPR 30\n",
      "  3400921611731 | NICORANDIL SDZ 10MG CPR 30\n",
      "  3400921612790 | LHRH FERRING 0,1 MG SOL INJ AMP 1\n",
      "  3400921617535 | VALSARTAN/HCTZ CRT 80/12,5MG CPR 30\n",
      "  3400921618075 | VALSARTAN/HCTZ CRT 80/12,5MG CPR 90\n",
      "  3400921619195 | VALSARTAN/HCTZ CRT 160/12,5MG CPR 30\n",
      "  3400921619546 | VALSARTAN/HCTZ CRT 160/12,5MG CPR 90\n",
      "  3400921620726 | VALSARTAN/HCTZ CRT 160/25MG CPR 30\n",
      "  3400921621266 | VALSARTAN/HCTZ CRT 160/25MG CPR 90\n",
      "  3400921625929 | LEVETIRACETAM TVC 250MG CPR 60\n",
      "  3400921626001 | LEVETIRACETAM TVC 500MG CPR 60\n",
      "  3400921626179 | LEVETIRACETAM TVC 1000MG CPR 60\n",
      "  3400921636116 | LETROZOLE CRT 2,5MG CPR 30\n",
      "  3400921643497 | LOSARTAN HCTZ VTS 100/12,5MG CPR 28\n",
      "  3400921644098 | LOSARTAN HCTZ VTS 100/12,5MG CPR 90\n",
      "  3400921653663 | DOXAZOSINE SUBSTIPHARM LP 4MG CPR 28\n",
      "  3400921655674 | DOXAZOSINE ARW LP 8MG CPR CA 28\n",
      "  3400921656794 | DOXAZOSINE SUBSTIPHARM LP 8MG CPR 28\n",
      "  3400921658286 | CLARELUX 500MCG/G MOUSS FL 1\n",
      "  3400921661477 | ELFASETTE VIA 75MCG CPR 28\n",
      "  3400921661538 | ELFASETTE VIA 75MCG CPR 84\n",
      "  3400921673074 | ALLOPURINOL ZTV 100MG CPR 28\n",
      "  3400921675894 | ALLOPURINOL ZTV 200MG CPR 28\n",
      "  3400921676266 | ALLOPURINOL ZTV 300MG CPR 28\n",
      "  3400921676327 | ENBREL 10 MG PDR ET SOL INJ PEDIAT 4\n",
      "  3400921677447 | ALLOPURINOL CRT 100MG CPR 28\n",
      "  3400921678918 | ALLOPURINOL CRT 200 MG CPR 28\n",
      "  3400921680058 | ALLOPURINOL CRT 300 MG CPR 28\n",
      "  3400921686951 | ATENOLOL ZEN 50MG CPR 30\n",
      "  3400921687262 | ATENOLOL ZEN 50MG CPR 90\n",
      "  3400921687491 | ALFUZOSINE CRT LP 10MG CPR 30\n",
      "  3400921687552 | TASIGNA 200MG GELULE 28\n",
      "  3400921687613 | TASIGNA 200MG GELULE 112\n",
      "  3400921687781 | OMNITROPE 15 MG SOL INJ 1\n",
      "  3400921687842 | OMNITROPE 15 MG SOL INJ 5\n",
      "  3400921687903 | OMNITROPE 15 MG SOL INJ 10\n",
      "  3400921689914 | EBASTINE TVC 10MG CPR ORODISP 30\n",
      "  3400921691924 | RIZATRIPTAN EG 5MG CPR 12\n",
      "  3400921692525 | RIZATRIPTAN EG 10MG CPR 12\n",
      "  3400921693065 | RIZATRIPTAN EG 10MG CPR ORODISP 6\n",
      "  3400921693126 | RIZATRIPTAN EG 10MG CPR ORODISP 12\n",
      "  3400921694994 | ATENOLOL ZEN 100MG CPR 30\n",
      "  3400921695137 | ATENOLOL ZEN 100MG CPR 90\n",
      "  3400921702903 | MENVEO PDR ET SOL INJ 1\n",
      "  3400921709476 | OVITRELLE 0,25 MG INJ STY 0,5ML 1\n",
      "  3400921717631 | RISEDRONATE ARW 35MG CPR 4\n",
      "  3400921717921 | RISEDRONATE ARW 35MG CPR 12\n",
      "  3400921718812 | CANDESARTAN ARW 4MG CPR 30\n",
      "  3400921719123 | CANDESARTAN ARW 4MG CPR 90\n",
      "  3400921719642 | CANDESARTAN ARW 8MG CPR 30\n",
      "  3400921719932 | CANDESARTAN ARW 8MG CPR 90\n",
      "  3400921720471 | CANDESARTAN ARW 16MG CPR 30\n",
      "  3400921720822 | CANDESARTAN ARW 16MG CPR 90\n",
      "  3400921721362 | CANDESARTAN ARW 32MG CPR 30\n",
      "  3400921722314 | LATANOPROST BGA 0,005% COLLYRE 1\n",
      "  3400921723953 | CANDESARTAN/HCTZ ACT 8/12,5 MG CPR 30\n",
      "  3400921724325 | CANDESARTAN/HCTZ ACT 8/12,5 MG CPR 90\n",
      "  3400921724783 | CANDESARTAN/HCTZ ACT 16/12,5 MG CPR 30\n",
      "  3400921725094 | CANDESARTAN/HCTZ ACT 16/12,5 MG CPR 90\n",
      "  3400921725384 | XGEVA 120 MG SOL INJ 1\n",
      "  3400921729177 | CANDESARTAN/HYDROCHLOROTHIAZIDE ARROW 16 MG/12,5 M\n",
      "  3400921738681 | CANDESARTAN BGA 32MG CPR 30\n",
      "  3400921740233 | ATORVASTATINE BGR 10 MG CPR 30\n",
      "  3400921740813 | ATORVASTATINE BGR 10 MG CPR 90\n",
      "  3400921741292 | ATORVASTATINE BGR 20 MG CPR 30\n",
      "  3400921741704 | ATORVASTATINE BGR 20 MG CPR 90\n",
      "  3400921742183 | ATORVASTATINE BGR 40 MG CPR 30\n",
      "  3400921742763 | ATORVASTATINE BGR 40 MG CPR 90\n",
      "  3400921743364 | ATORVASTATINE BGR 80 MG CPR 30\n",
      "  3400921743883 | ATORVASTATINE BGR 80 MG CPR 90\n",
      "  3400921748857 | DESLORATADINE ZEN 5MG CPR 15\n",
      "  3400921749229 | DESLORATADINE ZEN 5MG CPR 30\n",
      "  3400921750058 | OCTREOTIDE ARW 0,5 MG SOL INJ 6\n",
      "  3400921750577 | OCTREOTIDE ARW 0,1 MG SOL INJ 6\n",
      "  3400921751239 | OCTREOTIDE ARW 0,05 MG SOL INJ 6\n",
      "  3400921751987 | EURARTESIM 320MG/40MG CPR 12\n",
      "  3400921752649 | ZOMETA 4 MG PERF FL 1\n",
      "  3400921753820 | DESLORATADINE TVS 5 MG CPR 15\n",
      "  3400921754131 | DESLORATADINE TVS 5 MG CPR 30\n",
      "  3400921756203 | DESLORATADINE GNR 5MG CPR 15\n",
      "  3400921756661 | DESLORATADINE GNR 5MG CPR 30\n",
      "  3400921758733 | CLOPIDOGREL SUN 75MG CPR 30\n",
      "  3400921760453 | DESLORATADINE GNR 0,5MG/ML BUV 150ML 1\n",
      "  3400921761405 | DESLORATADINE EG 0,5MG/ML BUV 150ML 1\n",
      "  3400921762693 | DESLORATADINE ZEN 0,5MG/ML BUV 150ML 1\n",
      "  3400921763645 | DESLORATADINE ARW 0,5MG/ML BUV 150ML 1\n",
      "  3400921763706 | RISEDRONATE SDZ 75MG CPR 2\n",
      "  3400921763935 | RISEDRONATE SDZ 75MG CPR 6\n",
      "  3400921764246 | OXOMEMAZINE ZTL 0,33MG/ML SOL BUV 1\n",
      "  3400921765717 | BENAZEPRIL ARW 5MG CPR 30\n",
      "  3400921766196 | BENAZEPRIL ARW 5MG CPR 90\n",
      "  3400921767728 | BENAZEPRIL ARW 10MG CPR 30\n",
      "  3400921768268 | BENAZEPRIL ARW 10MG CPR 90\n",
      "  3400921769678 | BENAZEPRIL HCTZ ARW 10/12,5MG CPR 30\n",
      "  3400921770278 | BENAZEPRIL HCTZ ARW 10/12,5MG CPR 90\n",
      "  3400921776133 | LEVOFLOXACINE ARL 500MG CPR 5\n",
      "  3400921777024 | RILUZOLE SDZ 50MG CPR 56\n",
      "  3400921782165 | IRBESARTAN HCTZ MYP 150/12,5MG CPR 30\n",
      "  3400921782455 | IRBESARTAN HCTZ MYP 150/12,5MG CPR 90\n",
      "  3400921782745 | IRBESARTAN HCTZ MYP 300/12,5MG CPR 30\n",
      "  3400921783056 | IRBESARTAN HCTZ MYP 300/12,5MG CPR 90\n",
      "  3400921783285 | IRBESARTAN HCTZ MYP 300/25MG CPR 30\n",
      "  3400921783575 | IRBESARTAN HCTZ MYP 300/25MG CPR 90\n",
      "  3400921783926 | IRBESARTAN HCTZ CRT 150/12,5MG CPR 30\n",
      "  3400921784237 | IRBESARTAN HCTZ CRT 150/12,5MG CPR 90\n",
      "  3400921784695 | IRBESARTAN HCTZ CRT 300/12,5MG CPR 30\n",
      "  3400921784985 | IRBESARTAN HCTZ CRT 300/12,5MG CPR 90\n",
      "  3400921785296 | IRBESARTAN HCTZ CRT 300/25MG CPR 30\n",
      "  3400921785586 | IRBESARTAN HCTZ CRT 300/25MG CPR 90\n",
      "  3400921787719 | SMOFKABIVEN E EMULS INJ POC 493ML 6\n",
      "  3400921789089 | MONTELUKAST ALT 10MG CPR 28\n",
      "  3400921790030 | ZOLMITRIPTAN EG 2,5MG CPR 6\n",
      "  3400921790269 | ZOLMITRIPTAN EG 2,5MG CPR 12\n",
      "  3400921790559 | LANSOPRAZOLE BGR 30 MG 1 BOITE DE 28, GELULES GAST\n",
      "  3400921790788 | ZOLMITRIPTAN EG 2,5MG CPR ORODISP 6\n",
      "  3400921790900 | ZOLMITRIPTAN EG 2,5MG CPR ORODISP 12\n",
      "  3400921792102 | EXEMESTANE ZEN 25MG CPR 30\n",
      "  3400921795004 | MONTELUKAST ARW 10MG CPR 28\n",
      "  3400921796063 | NICOTINELL FRU EXO 2MG GOM 96\n",
      "  3400921796124 | NICOTINELL FRU EXO 2MG GOM 204\n",
      "  3400921804201 | PYLERA 140/125/125 MG GELULE 120\n",
      "  3400921809633 | DORZOLAMIDE TIMOLOL ZEN COLLYRE 5ML 1\n",
      "  3400921810813 | LOSARTAN HCTZ KRK 100/12,5MG CPR 30\n",
      "  3400921811353 | LOSARTAN HCTZ KRK 100/12,5MG CPR 90\n",
      "  3400921811704 | AZITHROMYCINE TVC 250MG CPR 6\n",
      "  3400921815085 | NARATRIPTAN ZEN 2,5MG CPR 6\n",
      "  3400921815146 | NARATRIPTAN ZEN 2,5MG CPR 12\n",
      "  3400921815894 | LATANOPROST BGA 0,005% COLLYRE 3\n",
      "  3400921818048 | IRBESARTAN HCTZ ACT 300/12,5MG CPR 30\n",
      "  3400921818796 | IRBESARTAN HCTZ ACT 300/12,5MG CPR 90\n",
      "  3400921824131 | PRAVASTATINE SDZ 20 MG CPR 90\n",
      "  3400921824360 | PRAVASTATINE SDZ 40 MG CPR 90\n",
      "  3400921824599 | VYNDAQEL 20MG CAPS 30\n",
      "  3400921836547 | RABEPRAZOLE ZEN 10MG CPR 14\n",
      "  3400921836776 | RABEPRAZOLE ZEN 10MG CPR 28\n",
      "  3400921837896 | RABEPRAZOLE ZEN 20MG CPR 14\n",
      "  3400921838329 | RABEPRAZOLE ZEN 20MG CPR 28\n",
      "  3400921843750 | MIRTAZAPINE ARG 15MG CPR 30\n",
      "  3400921845761 | PRAVASTATINE MYL 10MG CPR 28\n",
      "  3400921846133 | PRAVASTATINE VIATRIS 20MG CPR 28\n",
      "  3400921846423 | PRAVASTATINE VIATRIS 20MG CPR 84\n",
      "  3400921846652 | PRAVASTATINE MYL 40MG CPR 28\n",
      "  3400921846881 | PRAVASTATINE MYL 40MG CPR 84\n",
      "  3400921847543 | RABEPRAZOLE ARG 10MG CPR 14\n",
      "  3400921848083 | RABEPRAZOLE ARG 10MG CPR 28\n",
      "  3400921849844 | RABEPRAZOLE ARG 20MG CPR 14\n",
      "  3400921850215 | RABEPRAZOLE ARG 20MG CPR 28\n",
      "  3400921852165 | RABEPRAZOLE ZYD 10MG CPR 14\n",
      "  3400921852516 | RABEPRAZOLE ZYD 10MG CPR 28\n",
      "  3400921854466 | RABEPRAZOLE ZYD 20MG CPR 14\n",
      "  3400921854817 | RABEPRAZOLE ZYD 20MG CPR 28\n",
      "  3400921856538 | BREAKYL 200MCG FILM ORODISP 28\n",
      "  3400921856996 | BREAKYL 400MCG FILM ORODISP 28\n",
      "  3400921858259 | ATORVASTATINE ACC 10MG CPR 30\n",
      "  3400921858778 | ATORVASTATINE ACC 20MG CPR 30\n",
      "  3400921859379 | ATORVASTATINE ACC 40MG CPR 30\n",
      "  3400921860559 | ATORVASTATINE ACC 80MG CPR 30\n",
      "  3400921861099 | MONTELUKAST TVC 4MG GLE SACH 28\n",
      "  3400921865462 | IRBESARTAN VIATRIS 75MG CPR PELL 30\n",
      "  3400921866063 | IRBESARTAN VIATRIS 75MG CPR PELL 90\n",
      "  3400921866643 | IRBESARTAN VIATRIS 150MG CPR 30\n",
      "  3400921867244 | IRBESARTAN VIATRIS 150MG CPR 90\n",
      "  3400921867992 | IRBESARTAN VIATRIS 300MG CPR 30\n",
      "  3400921868654 | IRBESARTAN VIATRIS 300MG CPR 90\n",
      "  3400921871845 | LOSARTAN HCTZ ARL 50/12,5MG CPR 30\n",
      "  3400921872217 | LOSARTAN HCTZ ARL 50/12,5MG CPR 90\n",
      "  3400921872965 | LOSARTAN HCTZ ARL 100/12,5MG CPR 30\n",
      "  3400921873337 | LOSARTAN HCTZ ARL 100/12,5MG CPR 90\n",
      "  3400921873856 | LOSARTAN HCTZ ARL 100/25 MG CPR 30\n",
      "  3400921874396 | LOSARTAN HCTZ ARL 100/25 MG CPR 90\n",
      "  3400921879599 | MORPHINE CHL REN 1000 MG INJ 1\n",
      "  3400921897579 | DOXYCYCLINE SDZ 100MG CPR 30\n",
      "  3400921898989 | VIRAMUNE 400MG CPR LP 30\n",
      "  3400921906257 | CHOLURSO 250MG CPR 60\n",
      "  3400921906608 | CHOLURSO 500MG CPR 60\n",
      "  3400921907209 | PRAVASTATINE EG 20MG CPR 28\n",
      "  3400921907377 | PRAVASTATINE EG 20MG CPR 84\n",
      "  3400921907667 | PRAVASTATINE EG 40MG CPR 28\n",
      "  3400921907728 | PRAVASTATINE EG 40MG CPR 84\n",
      "  3400921911978 | TELMISARTAN VIATRIS 40MG CPR 30\n",
      "  3400921912289 | TELMISARTAN VIATRIS 40MG CPR 90\n",
      "  3400921913521 | TELMISARTAN VIATRIS 80MG CPR 30\n",
      "  3400921913989 | TELMISARTAN VIATRIS 80MG CPR 90\n",
      "  3400921919783 | PRAVASTATINE BGA 10MG CPR 28\n",
      "  3400921920154 | PRAVASTATINE BGA 20MG CPR 28\n",
      "  3400921920383 | PRAVASTATINE BGA 20MG CPR 84\n",
      "  3400921920505 | PRAVASTATINE BGA 40MG CPR 28\n",
      "  3400921920734 | PRAVASTATINE BGA 40MG CPR 84\n",
      "  3400921921045 | PRAVASTATINE EVO 10MG CPR 28\n",
      "  3400921921564 | PRAVASTATINE EVO 20MG CPR 28\n",
      "  3400921921793 | PRAVASTATINE EVO 20MG CPR 84\n",
      "  3400921921915 | PRAVASTATINE EVO 40MG CPR 28\n",
      "  3400921922226 | PRAVASTATINE EVO 40MG CPR 84\n",
      "  3400921922516 | XARELTO 15 MG CPR 14\n",
      "  3400921922684 | XARELTO 15 MG CPR 28\n",
      "  3400921922745 | XARELTO 15 MG CPR 42\n",
      "  3400921922974 | XARELTO 20 MG CPR 14\n",
      "  3400921923056 | XARELTO 20 MG CPR 28\n",
      "  3400921924527 | TELMISARTAN EG 40MG CPR 30\n",
      "  3400921924695 | TELMISARTAN EG 40MG CPR 90\n",
      "  3400921924756 | TELMISARTAN EG 80MG CPR 30\n",
      "  3400921924817 | TELMISARTAN EG 80MG CPR 90\n",
      "  3400921925647 | LEVETIRACETAM SDZ 250MG CPR 60\n",
      "  3400921926767 | LEVETIRACETAM SDZ 500MG CPR 60\n",
      "  3400921927719 | LEVETIRACETAM SDZ 1000MG CPR 60\n",
      "  3400921931211 | DELURSAN 500MG CPR PEL 60\n",
      "  3400921937534 | LATANOPROST SDZ 0,005% COLLYRE 1\n",
      "  3400921938074 | LOSARTAN HCTZ ZYD 100/25MG CPR 30\n",
      "  3400921938364 | LOSARTAN HCTZ ZYD 100/25MG CPR 90\n",
      "  3400921938593 | LOSARTAN HCTZ ZYD 50/12,5MG CPR 30\n",
      "  3400921938715 | LOSARTAN HCTZ ZYD 50/12,5MG CPR 90\n",
      "  3400921939255 | LEVETIRACETAM SDZ 100MG/ML SOL BUV 1\n",
      "  3400921939545 | FAMPYRA 10MG LP CPR 28\n",
      "  3400921939606 | FAMPYRA 10MG LP CPR 56\n",
      "  3400921940206 | RISEDRONATE ALT 35MG CPR 4\n",
      "  3400921940435 | RISEDRONATE ALT 35MG CPR 12\n",
      "  3400921941784 | PARACETAMOL TVC 500MG GELULE 16\n",
      "  3400921942156 | PARACETAMOL CRT 500MG GELULE 16\n",
      "  3400921943856 | LOSARTAN HCTZ EG 100/12,5MG CPR 30\n",
      "  3400921944167 | LOSARTAN HCTZ EG 100/12,5MG CPR 90\n",
      "  3400921946697 | INTELENCE 200 MG CPR 60\n",
      "  3400921947298 | EDURANT 25MG CPR 30\n",
      "  3400921947359 | EVIPLERA 200/25/245MG CPR 30\n",
      "  3400921947588 | VOTUBIA 2,5 MG CPR 30\n",
      "  3400921947649 | VOTUBIA 5 MG CPR 30\n",
      "  3400921947700 | VOTUBIA 10 MG CPR 30\n",
      "  3400921957754 | BICALUTAMIDE ZYD 50MG CPR 30\n",
      "  3400921959246 | TERBINAFINE ARG 250MG CPR 28\n",
      "  3400921959536 | DORZOLAMIDE TIMOLOL EG COLLYRE 5ML 1\n",
      "  3400921961256 | PRAVASTATINE EG 10MG CPR 28\n",
      "  3400921965919 | LAMOTRIGINE ARL 25MG CPR DISP 30\n",
      "  3400921966688 | LAMOTRIGINE ARL 50MG CPR DISP 30\n",
      "  3400921967289 | LAMOTRIGINE ARL 100MG CPR DISP 30\n",
      "  3400921967920 | LAMOTRIGINE ARL 200MG CPR DISP 30\n",
      "  3400921968170 | BISOPROLOL HCTZ CRT 10/6,25MG CPR 30\n",
      "  3400921968521 | BISOPROLOL HCTZ CRT 10/6,25MG CPR 90\n",
      "  3400921968699 | BISOPROLOL HCTZ CRT 5/6,25MG CPR 30\n",
      "  3400921968989 | BISOPROLOL HCTZ CRT 5/6,25MG CPR 90\n",
      "  3400921969122 | BISOPROLOL HCTZ CRT 2,5/6,25 CPR 30\n",
      "  3400921969412 | BISOPROLOL HCTZ CRT 2,5/6,25 CPR 90\n",
      "  3400921972542 | RIZATRIPTAN VIATRIS 10MG CPR ORODISP 6\n",
      "  3400921972603 | RIZATRIPTAN VIATRIS 10MG CPR ORODISP 12\n",
      "  3400921974492 | ZOLMITRIPTAN VIATR 2,5MG CPR ORODISP 6\n",
      "  3400921974782 | ZOLMITRIPTAN VIATR 2,5MG CPR ORODISP 12\n",
      "  3400921975673 | LOSARTAN HCTZ ARW 100/12,5MG CPR 30\n",
      "  3400921977516 | LOSARTAN HCTZ BGA 100/12,5MG CPR 30\n",
      "  3400921977806 | LOSARTAN HCTZ BGA 100/12,5MG CPR 90\n",
      "  3400921982596 | ZOLMITRIPTAN VTS 2,5MG CPR 6\n",
      "  3400921982657 | ZOLMITRIPTAN VTS 2,5MG CPR 12\n",
      "  3400921997507 | ANASTROZOLE ZYD 1MG CPR 90\n",
      "  3400921998627 | LANSOPRAZOLE MYP 15 MG GELULE 30\n",
      "  3400922000510 | LANSOPRAZOLE MYP 30 MG GELULE 28\n",
      "  3400922007892 | KOMBOGLYZE 2,5 MG/1000 MG CPR 60\n",
      "  3400922008844 | RILUZOLE VIATRIS 50MG CPR 56\n",
      "  3400922015767 | CANDESARTAN EG 4MG CPR 30\n",
      "  3400922016078 | CANDESARTAN EG 4MG CPR 90\n",
      "  3400922016887 | CANDESARTAN EG 8MG CPR 30\n",
      "  3400922017198 | CANDESARTAN EG 8MG CPR 90\n",
      "  3400922018720 | CANDESARTAN EG 16MG CPR 30\n",
      "  3400922019031 | CANDESARTAN EG 16MG CPR 90\n",
      "  3400922020389 | CANDESARTAN EG 32MG CPR 30\n",
      "  3400922028026 | STRUCTOCAL VIT D3 1000MG/880UI CPR 30\n",
      "  3400922028484 | PHOCYTAN 0,66MMOL/ML AMP 10ML 10\n",
      "  3400922032108 | GABAPENTINE SDZ 600MG CPR 90\n",
      "  3400922032337 | GABAPENTINE SDZ 800MG CPR 90\n",
      "  3400922032856 | BETAHISTINE ACC 8 MG CPR 30\n",
      "  3400922033167 | CITALOPRAM BGR 20 MG CPR 28\n",
      "  3400922033747 | ESOMEPRAZOLE ZYD 20MG GELULE 7\n",
      "  3400922033808 | ESOMEPRAZOLE ZYD 20MG GELULE 14\n",
      "  3400922033976 | ESOMEPRAZOLE ZYD 20MG GELULE 28\n",
      "  3400922034287 | ESOMEPRAZOLE ZYD 40MG GELULE 14\n",
      "  3400922034348 | ESOMEPRAZOLE ZYD 40MG GELULE 28\n",
      "  3400922035987 | ESOMEPRAZOLE CRT 20MG GELULE 14\n",
      "  3400922036069 | ESOMEPRAZOLE CRT 20MG GELULE 28\n",
      "  3400922036298 | ESOMEPRAZOLE CRT 40MG GELULE 14\n",
      "  3400922036359 | ESOMEPRAZOLE CRT 40MG GELULE 28\n",
      "  3400922060941 | MONTELUKAST SUN 10MG CPR 28\n",
      "  3400922061313 | MONTELUKAST SUN 5MG CPR CROQ 28\n",
      "  3400922062723 | GLIMEPIRIDE EVO 1MG CPR 30\n",
      "  3400922063034 | GLIMEPIRIDE EVO 1MG CPR 90\n",
      "  3400922063492 | GLIMEPIRIDE EVO 2MG CPR 30\n",
      "  3400922063782 | GLIMEPIRIDE EVO 2MG CPR 90\n",
      "  3400922064093 | GLIMEPIRIDE EVO 3MG CPR 30\n",
      "  3400922064444 | GLIMEPIRIDE EVO 3MG CPR 90\n",
      "  3400922065274 | GLIMEPIRIDE EVO 4MG CPR 30\n",
      "  3400922065625 | GLIMEPIRIDE EVO 4MG CPR 90\n",
      "  3400922066806 | CAPRELSA 100 MG CPR 30\n",
      "  3400922066974 | CAPRELSA 300 MG CPR 30\n",
      "  3400922069067 | TAMIFLU 6 MG/ML PDR POUR SUSP BUV 1\n",
      "  3400922069128 | INOVELON 40MG/ML SUSP BUVABLE 1\n",
      "  3400922079004 | OLANZAPINE ARW 5MG CPR 28\n",
      "  3400922080062 | OLANZAPINE ARW 7,5MG CPR 28\n",
      "  3400922080871 | OLANZAPINE ARW 10MG CPR 28\n",
      "  3400922083544 | MOXIFLOXACINE SDZ 400MG CPR 5\n",
      "  3400922083605 | MOXIFLOXACINE SDZ 400MG CPR 7\n",
      "  3400922084664 | LEFLUNOMIDE VIATRIS 10MG CPR 30\n",
      "  3400922084893 | LEFLUNOMIDE VIATRIS 10MG CPR 30\n",
      "  3400922084954 | LEFLUNOMIDE VIATRIS 20MG CPR 30\n",
      "  3400922085265 | LEFLUNOMIDE VIATRIS 20MG CPR 30\n",
      "  3400922085845 | MIRTAZAPINE ZYD 15MG CPR 30\n",
      "  3400922086385 | MILNACIPRAN BGA 50MG GELULE 56\n",
      "  3400922086736 | ACETYLLEUCINE TVC 500MG CPR 30\n",
      "  3400922086965 | METFORMINE EG 850MG CPR 30\n",
      "  3400922087337 | CEFUROXIME BGR 250 MG CPR 8\n",
      "  3400922087566 | ZELBORAF 240MG CPR 56\n",
      "  3400922090009 | CANDESARTAN/HCTZ ZEN 8/12,5 CPR 30\n",
      "  3400922090467 | CANDESARTAN/HCTZ ZEN 8/12,5 CPR 90\n",
      "  3400922090818 | CANDESARTAN/HCTZ ZEN 16/12,5 CPR 30\n",
      "  3400922091129 | CANDESARTAN/HCTZ ZEN 16/12,5 CPR 90\n",
      "  3400922092829 | BUDESONIDE VTS 0,5MG/2ML SUSP INH 20\n",
      "  3400922092997 | BUDESONIDE VTS 1MG/2ML SUSP INH 20\n",
      "  3400922094489 | DESLORATADINE ACT 5MG CPR 30\n",
      "  3400922094779 | VALSARTAN ZYD 40 MG CPR 30\n",
      "  3400922094830 | VALSARTAN ZYD 40 MG CPR 90\n",
      "  3400922095080 | VALSARTAN ZYD 80 MG CPR 30\n",
      "  3400922095141 | VALSARTAN ZYD 80 MG CPR 90\n",
      "  3400922095202 | VALSARTAN ZYD 160MG CPR 30\n",
      "  3400922095370 | VALSARTAN ZYD 160MG CPR 90\n",
      "  3400922095950 | TRAMADOL/PARACETAMOL VTS CPR 20\n",
      "  3400922096032 | TRAMADOL/PARACETAMOL BGA CPR 20\n",
      "  3400922096261 | TRAMADOL/PARACETAMOL SDZ CPR 20\n",
      "  3400922096322 | TRAMADOL/PARACETAMOL ZEN CPR 20\n",
      "  3400922097152 | DESLORATADINE EG 5MG CPR 15\n",
      "  3400922097381 | DESLORATADINE EG 5MG CPR 30\n",
      "  3400922099224 | DESLORATADINE SUN 5MG CPR 15\n",
      "  3400922099682 | DESLORATADINE SUN 5MG CPR 30\n",
      "  3400922099972 | OLANZAPINE EVO 5MG CPR DISP 28\n",
      "  3400922100494 | OLANZAPINE EVO 10MG CPR DISP 28\n",
      "  3400922104638 | CANDESARTAN/HCTZ EGL 8/12,5 CPR 30\n",
      "  3400922104928 | CANDESARTAN/HCTZ EGL 8/12,5 CPR 90\n",
      "  3400922105239 | CANDESARTAN/HCTZ EGL 16/12,5 CPR 30\n",
      "  3400922105529 | CANDESARTAN/HCTZ EGL 16/12,5 CPR 90\n",
      "  3400922108421 | BUCCOLAM 2,5 MG SOL BUCCALE 4\n",
      "  3400922108599 | BUCCOLAM 5 MG SOL BUCCALE 4\n",
      "  3400922108650 | BUCCOLAM 7,5 MG SOL BUCCALE 4\n",
      "  3400922108711 | BUCCOLAM 10 MG SOL BUCCALE 4\n",
      "  3400922110721 | RALOXIFENE SDZ 60MG CPR 28\n",
      "  3400922110950 | RALOXIFENE SDZ 60MG CPR 84\n",
      "  3400922115344 | CANDESARTAN ARW 4MG CPR 30\n",
      "  3400922116693 | CANDESARTAN ARROW 8 MG 1 BOITE DE 30, COMPRIMES SE\n",
      "  3400922117126 | CANDESARTAN ARROW 8 MG 1 BOITE DE 90, COMPRIMES SE\n",
      "  3400922117706 | CANDESARTAN ARROW 16 MG 1 BOITE DE 30, COMPRIMES S\n",
      "  3400922118246 | CANDESARTAN ARROW 16 MG 1 BOITE DE 90, COMPRIMES S\n",
      "  3400922125459 | LATANOPROST VTSG 0,005% COLLYRE 1\n",
      "  3400922125510 | LATANOPROST VTSG 0,005% COLLYRE 3\n",
      "  3400922132204 | TAMSULOSINE SDZ LP 0,4MG CPR 30\n",
      "  3400922132952 | TAMSULOSINE TVC LP 0,4MG CPR 30\n",
      "  3400922134215 | LEVOCETIRIZINE ZEN 5MG CPR 28\n",
      "  3400922134673 | ATORVASTATINE ARW 10MG CPR 30\n",
      "  3400922135045 | ATORVASTATINE ARW 10MG CPR 90\n",
      "  3400922135335 | ATORVASTATINE ARW 20MG CPR 30\n",
      "  3400922135793 | ATORVASTATINE ARW 20MG CPR 90\n",
      "  3400922136165 | LETROZOLE EVO 2,5MG CPR 30\n",
      "  3400922136745 | ATORVASTATINE ARW 40MG CPR 30\n",
      "  3400922137056 | ATORVASTATINE ARW 40MG CPR 90\n",
      "  3400922137285 | ROPINIROLE EG LP 2MG CPR 28\n",
      "  3400922137926 | ROPINIROLE ZEN LP 2MG CPR 28\n",
      "  3400922138466 | ROPINIROLE ZEN LP 4MG CPR 28\n",
      "  3400922139128 | ROPINIROLE ZEN LP 8MG CPR 28\n",
      "  3400922139876 | VALSARTAN/HCTZ EVO 80/12,5MG CPR 30\n",
      "  3400922140247 | VALSARTAN/HCTZ EVO 80/12,5MG CPR 90\n",
      "  3400922141428 | VALSARTAN/HCTZ EVO 160/25MG CPR 30\n",
      "  3400922141886 | VALSARTAN/HCTZ EVO 160/25MG CPR 90\n",
      "  3400922142609 | KETOPROFENE EG LP 100MG CPR 20\n",
      "  3400922142838 | KETOPROFENE TVC LP 100MG CPR 20\n",
      "  3400922143149 | KETOPROFENE ARW LP 100MG CPR 20\n",
      "  3400922143378 | KETOPROFENE BGA LP 100MG CPR 20\n",
      "  3400922144320 | OLANZAPINE CRT 7,5 MG CPR 28\n",
      "  3400922144498 | OLANZAPINE CRT 5 MG CPR 28\n",
      "  3400922144559 | OLANZAPINE CRT 10 MG CPR 28\n",
      "  3400922145389 | ATORVASTATINE ARW 80MG CPR 30\n",
      "  3400922145679 | ATORVASTATINE ARW 80MG CPR 90\n",
      "  3400922152134 | METFORMINE EG 500MG CPR 90\n",
      "  3400922152363 | METFORMINE EG 850MG CPR 90\n",
      "  3400922153025 | LATANOPROST VIATRIS 0,005% COLLYRE 1\n",
      "  3400922153193 | LATANOPROST VIATRIS 0,005% COLLYRE 3\n",
      "  3400922159287 | RAMIPRIL/HCTZ ARW 5/12,5 MG CPR 30\n",
      "  3400922159577 | RAMIPRIL/HCTZ ARW 5/12,5 MG CPR 90\n",
      "  3400922160009 | RAMIPRIL/HCTZ EG 5/12,5MG CPR 30\n",
      "  3400922161297 | IRBESARTAN ZEN 75 MG CPR PELL 30\n",
      "  3400922161358 | IRBESARTAN ZEN 75 MG CPR PELL 90\n",
      "  3400922161419 | IRBESARTAN ZEN 150 MG CPR PELL 30\n",
      "  3400922161587 | IRBESARTAN ZEN 150 MG CPR PELL 90\n",
      "  3400922161648 | IRBESARTAN ZEN 300 MG CPR PELL 30\n",
      "  3400922161709 | IRBESARTAN ZEN 300 MG CPR PELL 90\n",
      "  3400922161938 | IRBESARTAN TVC 75MG CPR PELL 30\n",
      "  3400922162300 | IRBESARTAN TVC 75MG CPR PELL 90\n",
      "  3400922162997 | IRBESARTAN TVC 150MG CPR PELL 30\n",
      "  3400922163079 | IRBESARTAN BGA 75MG CPR PELL 30\n",
      "  3400922163949 | IRBESARTAN BGA 75MG CPR PELL 90\n",
      "  3400922164199 | IRBESARTAN TVC 150MG CPR PELL 90\n",
      "  3400922164489 | IRBESARTAN TVC 300MG CPR PELL 30\n",
      "  3400922165141 | IRBESARTAN TVC 300MG CPR PELL 90\n",
      "  3400922165660 | IRBESARTAN BGA 150MG CPR PELL 30\n",
      "  3400922166261 | IRBESARTAN BGA 150MG CPR PELL 90\n",
      "  3400922167152 | IRBESARTAN BGA 300MG CPR PELL 30\n",
      "  3400922167381 | IRBESARTAN HCTZ TVC 150/12,5MG CPR 30\n",
      "  3400922167961 | IRBESARTAN BGA 300MG CPR PELL 90\n",
      "  3400922168043 | IRBESARTAN HCTZ TVC 150/12,5MG CPR 90\n",
      "  3400922168562 | IRBESARTAN HCTZ TVC 300/12,5MG CPR 30\n",
      "  3400922168852 | IRBESARTAN HCTZ TVC 300/12,5MG CPR 90\n",
      "  3400922169163 | IRBESARTAN HCTZ TVC 300/25MG CPR 30\n",
      "  3400922169453 | IRBESARTAN HCTZ TVC 300/25MG CPR 90\n",
      "  3400922178967 | OPTILOVA 20/100 MCG CPR 28\n",
      "  3400922179049 | OPTILOVA 20/100 MCG CPR 84\n",
      "  3400922179339 | LEVOCETIRIZINE KRKA 5MG CPR 14\n",
      "  3400922179629 | LEVOCETIRIZINE KRKA 5MG CPR 28\n",
      "  3400922182988 | RALOXIFENE EG 60MG CPR 28\n",
      "  3400922183121 | RALOXIFENE EG 60MG CPR 84\n",
      "  3400922183350 | ZOLMITRIPTAN SDZ 2,5MG CPR 6\n",
      "  3400922183411 | ZOLMITRIPTAN SDZ 2,5MG CPR 12\n",
      "  3400922183589 | ATORVASTATINE ALM 10MG CPR 90\n",
      "  3400922183640 | ATORVASTATINE ALM 20MG CPR 90\n",
      "  3400922183701 | ATORVASTATINE ALM 40MG CPR 90\n",
      "  3400922190563 | ATORVASTATINE ZYF 10MG CPR 90\n",
      "  3400922190624 | ATORVASTATINE ZYF 20MG CPR 90\n",
      "  3400922190792 | REBIF 22 MCG SOL INJ STYLO 0,5ML 12\n",
      "  3400922190853 | ATORVASTATINE ZYF 40MG CPR 90\n",
      "  3400922190914 | REBIF 44 MCG SOL INJ STYLO 0,5ML 12\n",
      "  3400922191164 | REBIF 8.8/22 MCG SOL INJ STYLO 12\n",
      "  3400922191225 | ATORVASTATINE ZYF 80MG CPR 90\n",
      "  3400922191393 | IRBESARTAN HCTZ ZEN 150/12,5MG CPR P 30\n",
      "  3400922191454 | IRBESARTAN HCTZ ZEN 150/12,5MG CPR P 90\n",
      "  3400922191515 | IRBESARTAN HCTZ ZEN 300/12,5MG CPR P 30\n",
      "  3400922191683 | IRBESARTAN HCTZ ZEN 300/12,5MG CPR P 90\n",
      "  3400922191744 | IRBESARTAN HCTZ ZEN 300/25MG CPR 30\n",
      "  3400922191805 | IRBESARTAN HCTZ ZEN 300/25MG CPR 90\n",
      "  3400922197319 | ESOMEPRAZOLE HCS 20MG GELULE 7\n",
      "  3400922197487 | ESOMEPRAZOLE HCS 20MG GELULE 14\n",
      "  3400922197548 | ESOMEPRAZOLE HCS 20MG GELULE 28\n",
      "  3400922197609 | ESOMEPRAZOLE HCS 40MG GELULE 14\n",
      "  3400922197777 | ESOMEPRAZOLE HCS 40MG GELULE 28\n",
      "  3400922198088 | FENTANYL BGR 12MICROG/H DISP TRANSD 5\n",
      "  3400922198149 | VIMPAT 10MG/ML SIR FL 200ML 1\n",
      "  3400922198729 | ZOLMITRIPTAN SDZ 2,5MG CPR ORODISP 6\n",
      "  3400922198897 | ZOLMITRIPTAN SDZ 2,5MG CPR ORODISP 12\n",
      "  3400922200712 | CANDESARTAN HCS 4MG CPR 30\n",
      "  3400922201252 | CANDESARTAN HCS 4MG CPR 90\n",
      "  3400922203492 | CANDESARTAN HCS 8MG CPR 30\n",
      "  3400922203904 | CANDESARTAN HCS 8MG CPR 90\n",
      "  3400922206226 | CANDESARTAN HCS 16MG CPR 30\n",
      "  3400922206745 | CANDESARTAN HCS 16MG CPR 90\n",
      "  3400922208695 | CANDESARTAN HCS 32MG CPR 30\n",
      "  3400922214610 | MONOKETO 0,25MG/ML COLLYRE UNIDOSE 60\n",
      "  3400922227337 | REPAGLINIDE ACC 0,5MG CPR 90\n",
      "  3400922227917 | REPAGLINIDE ACC 1MG CPR 90\n",
      "  3400922228518 | REPAGLINIDE ACC 2MG CPR 90\n",
      "  3400922232188 | ACARBOSE ARL 50MG CPR 90\n",
      "  3400922233888 | ACARBOSE ARL 100MG CPR 90\n",
      "  3400922235660 | SIGNIFOR 0,6 MG SOL INJ AMP 60\n",
      "  3400922253930 | NIMENRIX PDR ET SOL INJ SER 2A 1\n",
      "  3400922257204 | ELUDRILPERIO 0,2% SOL BDB FL 200ML 1\n",
      "  3400922258034 | BISOPROLOL ZTL 2,5MG CPR 30\n",
      "  3400922258324 | BUDESONIDE EVO 0,5MG/2ML SUSP INH 20\n",
      "  3400922258492 | BUDESONIDE EVO 1MG/2ML SUSP INH 20\n",
      "  3400922262345 | BISOPROLOL ZTL 5MG CPR 30\n",
      "  3400922262635 | BISOPROLOL ZTL 10MG CPR 30\n",
      "  3400922262864 | BISOPROLOL ZTL 10MG CPR 90\n",
      "  3400922263526 | BRICANYL TURBUHALER 500MCG/DOSE PDR 1\n",
      "  3400922264127 | LAMIVUDINE /ZIDO VTS 150/300MG CPR 60\n",
      "  3400922266718 | LOPERAMIDE EVO 2MG GELULE 20\n",
      "  3400922269900 | LORATADINE SDZ 10MG CPR 15\n",
      "  3400922274751 | ACIDE URSODESOX ARW 250MG CPR 20\n",
      "  3400922275123 | LEVETIRACETAM ALT 500MG CPR 60\n",
      "  3400922276762 | ENTACAPONE VTS 200MG CPR 60\n",
      "  3400922276823 | ENTACAPONE VTS 200MG CPR 100\n",
      "  3400922278254 | GLIMEPIRIDE ARG 1MG CPR 30\n",
      "  3400922278544 | GLIMEPIRIDE ARG 1MG CPR 90\n",
      "  3400922279206 | GLIMEPIRIDE ARG 2MG CPR 30\n",
      "  3400922279664 | GLIMEPIRIDE ARG 2MG CPR 90\n",
      "  3400922280493 | GLIMEPIRIDE ARG 3MG CPR 30\n",
      "  3400922280783 | GLIMEPIRIDE ARG 3MG CPR 90\n",
      "  3400922281674 | GLIMEPIRIDE ARG 4MG CPR 30\n",
      "  3400922282046 | GLIMEPIRIDE ARG 4MG CPR 90\n",
      "  3400922284286 | ATORVASTATINE VIATRIS 10MG CPR 30\n",
      "  3400922284576 | ATORVASTATINE VIATRIS 20MG CPR 30\n",
      "  3400922284927 | ATORVASTATINE VTS 40MG CPR 30\n",
      "  3400922285238 | ATORVASTATINE VTS 80MG CPR 30\n",
      "  3400922285818 | ILUVIEN 190MCG IMP INTRAVITREEN 1\n",
      "  3400922296753 | BISOPROLOL AHL 2,5MG CPR 30\n",
      "  3400922297125 | BISOPROLOL AHL 2,5MG CPR 90\n",
      "  3400922298306 | BISOPROLOL AHL 5MG CPR 30\n",
      "  3400922298825 | BISOPROLOL AHL 5MG CPR 90\n",
      "  3400922300177 | BISOPROLOL AHL 10MG CPR 30\n",
      "  3400922300696 | BISOPROLOL AHL 10MG CPR 90\n",
      "  3400922301938 | FENTANYL VTS 12 MICROG/H DISP TRANSD 5\n",
      "  3400922302300 | FENTANYL VIAT 25MICROG/H DISP TRANSD 5\n",
      "  3400922302768 | FENTANYL VTS 50MICROG/H DISP TRANSD 5\n",
      "  3400922303079 | FENTANYL VTS 75MICROG/H DISP TRANSD 5\n",
      "  3400922303420 | FENTANYL VTS 100MICROG/H DISP TRANSD 5\n",
      "  3400922312583 | CANDESARTAN CRT 4 MG CPR 30\n",
      "  3400922313016 | CANDESARTAN CRT 4 MG CPR 90\n",
      "  3400922313993 | CANDESARTAN CRT 8 MG CPR 30\n",
      "  3400922314594 | CANDESARTAN CRT 8 MG CPR 90\n",
      "  3400922315317 | CANDESARTAN CRT16 MG CPR 30\n",
      "  3400922315836 | CANDESARTAN CRT16 MG CPR 90\n",
      "  3400922316208 | LATANOPROST/TIM ARW CY 2,5ML 1\n",
      "  3400922316376 | LATANOPROST/TIM ARW CY 2,5ML 3\n",
      "  3400922316437 | LATANOPROST/TIM TVC CY 2,5ML 1\n",
      "  3400922316666 | LATANOPROST/TIM TVC CY 2,5ML 3\n",
      "  3400922316727 | LATANOPROST/TIM EG CY 2,5ML 1\n",
      "  3400922316895 | LATANOPROST/TIM EG CY 2,5ML 3\n",
      "  3400922321288 | CIPROFLOXACINE ACC 500MG CPR 12\n",
      "  3400922324241 | METOPROLOL ACC 100MG CPR 30\n",
      "  3400922324821 | METOPROLOL ACC 100MG CPR 90\n",
      "  3400922325941 | LEVETIRACETAM SUN 500MG CPR 60\n",
      "  3400922328034 | CEFIXIME VTS 200MG CPR 8\n",
      "  3400922328553 | CANDESARTAN ZYD 8MG CPR 90\n",
      "  3400922329154 | BISOPROLOL ARL 10MG CPR 30\n",
      "  3400922329444 | BISOPROLOL ARL 10MG CPR 90\n",
      "  3400922333984 | ACIDE URSODESOX VTS 250MG CPR 20\n",
      "  3400922334295 | ACIDE URSODESOX TVC 250MG CPR 20\n",
      "  3400922334585 | ACIDE URSODESOX BGA 250MG CPR 20\n",
      "  3400922339788 | CANDESARTAN/HCTZ CRT 8/12,5 MG CPR 30\n",
      "  3400922340210 | CANDESARTAN/HCTZ CRT 8/12,5 MG CPR 90\n",
      "  3400922344690 | BISOPROLOL HCTZ VTS 2,5/6,25MG CPR 30\n",
      "  3400922344751 | BISOPROLOL HCTZ VTS 2,5/6,25MG CPR 90\n",
      "  3400922345871 | BISOPROLOL HCTZ VTS 5/6,25MG CPR 30\n",
      "  3400922345932 | BISOPROLOL HCTZ VTS 5/6,25MG CPR 90\n",
      "  3400922347134 | BISOPROLOL HCTZ VTS 10/6,25MG CPR 30\n",
      "  3400922347363 | BISOPROLOL HCTZ VTS 10/6,25MG CPR 90\n",
      "  3400922351445 | CANDESARTAN/HCTZ CRT 16/12,5 MG CPR 30\n",
      "  3400922352046 | CANDESARTAN/HCTZ CRT 16/12,5 MG CPR 90\n",
      "  3400922357829 | ROPINIROLE EG LP 4MG CPR 28\n",
      "  3400922358598 | ROPINIROLE EG LP 8MG CPR 28\n",
      "  3400922361901 | FOSRENOL 750MG SACHET 90\n",
      "  3400922362090 | FOSRENOL 1000MG SACHET 90\n",
      "  3400922364513 | VALSARTAN VIATRIS 40MG CPR 30\n",
      "  3400922364742 | VALSARTAN VIATRIS 40MG CPR 90\n",
      "  3400922365404 | VALSARTAN VIATRIS 80MG CPR 30\n",
      "  3400922366005 | OXCARBAZEPINE SDZ 150MG CPR 50\n",
      "  3400922366524 | VALSARTAN VIATRIS 80MG CPR 90\n",
      "  3400922367293 | VALSARTAN VIATRIS 160MG CPR 30\n",
      "  3400922367415 | VALSARTAN VIATRIS 160MG CPR 90\n",
      "  3400922368016 | OXCARBAZEPINE SDZ 300MG CPR 50\n",
      "  3400922368993 | OXCARBAZEPINE SDZ 600MG CPR 50\n",
      "  3400922371085 | ATORVASTATINE VTSG 10MG CPR 28\n",
      "  3400922371436 | ATORVASTATINE VTSG 20MG CPR 28\n",
      "  3400922371955 | ATORVASTATINE VTSG 40MG CPR 28\n",
      "  3400922372556 | ATORVASTATINE VTSG 80 MG CPR 28\n",
      "  3400922376288 | LATANOPROST VTSG 0,005% COLLYRE 3\n",
      "  3400922376639 | LAMIVUDINE VTS 150MG CPR 60\n",
      "  3400922377001 | LAMIVUDINE VTS 300MG CPR 30\n",
      "  3400922377759 | MONTELUKAST ARL 4MG CPR CROQ 28\n",
      "  3400922379302 | MONTELUKAST ARL 5MG CPR CROQ 28\n",
      "  3400922381480 | LEVETIRACETAM ACC 250 MG CPR 60\n",
      "  3400922381602 | LEVETIRACETAM ACC 500 MG CPR 60\n",
      "  3400922382142 | LEVETIRACETAM ACC 1 000 MG CPR 60\n",
      "  3400922384962 | RIZATRIPTAN ARL 10MG CPR ORODISP 12\n",
      "  3400922385563 | HELICIDINE 10% SIROP FL 125ML 1\n",
      "  3400922385624 | HELICIDINE 10% S/S SIR FP 250ML 1\n",
      "  3400922394909 | ESCITALOPRAM SDZ 5MG CPR 28\n",
      "  3400922397450 | ESCITALOPRAM SDZ 10MG CPR 28\n",
      "  3400922399003 | ESCITALOPRAM SDZ 15MG CPR 28\n",
      "  3400922399980 | ESCITALOPRAM SDZ 20MG CPR 28\n",
      "  3400922400792 | OXOMEMAZINE SDZ 0,33MG/ML SIROP 1\n",
      "  3400922400853 | OXOMEMAZINE SDZ 0,33MG/ML SOL BUV 1\n",
      "  3400922402406 | PANTOPRAZOLE EVO 20MG CPR 28\n",
      "  3400922403526 | PANTOPRAZOLE EVO 40MG CPR 14\n",
      "  3400922403816 | PANTOPRAZOLE EVO 40MG CPR 28\n",
      "  3400922406947 | VALSARTAN CRT 40MG CPR 30\n",
      "  3400922407029 | VALSARTAN CRT 40MG CPR 90\n",
      "  3400922407197 | VALSARTAN CRT 80MG CPR 30\n",
      "  3400922407258 | VALSARTAN CRT 80MG CPR 90\n",
      "  3400922407487 | VALSARTAN CRT 160MG CPR 30\n",
      "  3400922407548 | VALSARTAN CRT 160MG CPR 90\n",
      "  3400922408897 | AC ZOLEDRONIQUE SDZ 4MG/100ML SOL IN 1\n",
      "  3400922409498 | MONTELUKAST ALM 10MG CPR 28\n",
      "  3400922412689 | OPRYMEA 0,18MG CPR 30\n",
      "  3400922413051 | OPRYMEA 0,7MG CPR 30\n",
      "  3400922414461 | DASSELTA 5MG CPR 30\n",
      "  3400922414690 | ZALASTA 5MG CPR 28\n",
      "  3400922414751 | ZALASTA 7,5MG CPR 28\n",
      "  3400922414980 | ZALASTA 10MG CPR 28\n",
      "  3400922415291 | ZALASTA 5MG CPR DISP 28\n",
      "  3400922415413 | ZALASTA 10MG CPR DISP 28\n",
      "  3400922415703 | CLOPIDOGREL KRK 75MG CPR 30\n",
      "  3400922419206 | MONTELUKAST EVO 10MG CPR 28\n",
      "  3400922425009 | RILUZOLE ZEN 50MG CPR 56\n",
      "  3400922433332 | IRBESARTAN HCTZ ARG 150/12,5MG CPR 30\n",
      "  3400922433790 | IRBESARTAN HCTZ ARG 150/12,5MG CPR 90\n",
      "  3400922434223 | IRBESARTAN HCTZ ARG 300/12,5MG CPR 30\n",
      "  3400922436524 | IRBESARTAN HCTZ ARG 300/25MG CPR 30\n",
      "  3400922436814 | IRBESARTAN HCTZ ARG 300/25MG CPR 90\n",
      "  3400922438764 | TIMOLOL SDZ 0,25% COLLYRE FL 5ML 1\n",
      "  3400922438825 | TIMOLOL SDZ 0,50% COLLYRE FL 5ML 1\n",
      "  3400922439655 | NEVIRAPINE VIATRIS 200MG CPR 60\n",
      "  3400922439716 | CILOXADEX SUSP AURIC FL 5ML 1\n",
      "  3400922443447 | IRBESARTAN BGR 75MG CPR PELL 30\n",
      "  3400922443966 | IRBESARTAN BGR 75MG CPR PELL 90\n",
      "  3400922444277 | IRBESARTAN BGR 150 MG CPR PELL 30\n",
      "  3400922444796 | IRBESARTAN BGR 150 MG CPR PELL 90\n",
      "  3400922445229 | IRBESARTAN BGR 300 MG CPR PELL 30\n",
      "  3400922445809 | IRBESARTAN BGR 300 MG CPR PELL 90\n",
      "  3400922446400 | RAMIPRIL/HCTZ ZEN 5/12,5MG CPR 30\n",
      "  3400922448701 | VALSARTAN KRK 40MG CPR 30\n",
      "  3400922448879 | VALSARTAN KRK 40MG CPR 90\n",
      "  3400922448930 | VALSARTAN KRK 80MG CPR 30\n",
      "  3400922449012 | VALSARTAN KRK 80MG CPR 90\n",
      "  3400922453842 | ZOLMITRIPTAN CRT 2,5MG CPR ORODISP 12\n",
      "  3400922457116 | CLOPIDOGREL ZF 75MG CPR 30\n",
      "  3400922457406 | XALUPRINE 20 MG/ML SUSP ORALE 1\n",
      "  3400922459127 | IFIRMACOMBI 150/12,5 MG CPR 30\n",
      "  3400922459356 | IFIRMACOMBI 150/12,5 MG CPR 90\n",
      "  3400922459585 | AVAXIM 80U PED SUSP INJ SER AIG S 1\n",
      "  3400922460765 | IFIRMACOMBI 300/12,5 MG CPR 30\n",
      "  3400922460994 | IFIRMACOMBI 300/12,5 MG CPR 90\n",
      "  3400922461076 | IFIRMACOMBI 300/25 MG CPR 30\n",
      "  3400922461366 | IFIRMACOMBI 300/25 MG CPR 90\n",
      "  3400922462257 | JAKAVI 5 MG CPR 60\n",
      "  3400922463438 | RABEPRAZOLE CRT 10MG CPR 28\n",
      "  3400922465678 | RABEPRAZOLE CRT 20MG CPR 28\n",
      "  3400922472362 | AC ZOLEDRONIQUE SDZ 5 MG SOL INJ 1\n",
      "  3400922473192 | ATOVAQ/PROGUAN EG 250/100MG CPR 12\n",
      "  3400922474144 | ANTIGONE 75MCG CPR 28\n",
      "  3400922474373 | ANTIGONE 75MCG CPR 84\n",
      "  3400922480237 | VENLAFAXINE SUN LP 75MG GEL 30\n",
      "  3400922481128 | VENLAFAXINE SUN LP 37,5MG GELULE 30\n",
      "  3400922487441 | IRBESARTAN HCTZ ZYD 300/25MG CPR 30\n",
      "  3400922487670 | IRBESARTAN HCTZ ZYD 300/25MG CPR 90\n",
      "  3400922489452 | RABEPRAZOLE ARW 10MG CPR 28\n",
      "  3400922490403 | RABEPRAZOLE ARW 20MG CPR 28\n",
      "  3400922491752 | RABEPRAZOLE SUN 20MG CPR 28\n",
      "  3400922495194 | CELECOXIB TVC 100MG GELULE 30\n",
      "  3400922497556 | CELECOXIB TVC 200MG GELULE 30\n",
      "  3400926602901 | VALSARTAN/HCTZ VTS 80/12,5MG CPR 30\n",
      "  3400926603380 | VALSARTAN/HCTZ VTS 80/12,5MG CPR 90\n",
      "  3400926604103 | VALSARTAN/HCTZ VTS 160/12,5MG CPR 30\n",
      "  3400926604622 | VALSARTAN/HCTZ VTS 160/12,5MG CPR 90\n",
      "  3400926605452 | VALSARTAN/HCTZ VTS 160/25MG CPR 30\n",
      "  3400926605803 | VALSARTAN/HCTZ VTS 160/25MG CPR 90\n",
      "  3400926606114 | KALYDECO 150 MG CPR 56\n",
      "  3400926615048 | CICLOPIROX OLAMINE BGA 1% CREME 1\n",
      "  3400926615109 | CICLOPIROX OLAMINE TVC 1% CREME 1\n",
      "  3400926615277 | MYCOSKIN 1% CREME 1\n",
      "  3400926617578 | AMLODIPINE RATIO 5MG GELULE 30\n",
      "  3400926617929 | AMLODIPINE RATIO 5MG GELULE 90\n",
      "  3400926618230 | AMLODIPINE EVP 10MG GELULE 30\n",
      "  3400926618520 | AMLODIPINE EVP 10MG GELULE 90\n",
      "  3400926618698 | KETOPROFENE VIATRIS LP 100MG CPR 20\n",
      "  3400926619121 | MONOOX 1,5MG COLLY UNIDOS 20\n",
      "  3400926620240 | MONTELUKAST ZEN 4MG GRANULES 28\n",
      "  3400926621070 | MONTELUKAST ZTL 5MG CPR CROQ 28\n",
      "  3400926622602 | MONTELUKAST ZTL 10MG CPR 28\n",
      "  3400926628925 | BRICANYL LP 5MG CPR 60\n",
      "  3400926629007 | KETOPROFENE SUN LP 100MG CPR 20\n",
      "  3400926629526 | KETOPROFENE SDZ LP 100 MG CPR 20\n",
      "  3400926629984 | CANDESARTAN TVC 4MG CPR 30\n",
      "  3400926630065 | CANDESARTAN TVC 4MG CPR 90\n",
      "  3400926630126 | CANDESARTAN TVC 8MG CPR 30\n",
      "  3400926630294 | CANDESARTAN TVC 8MG CPR 90\n",
      "  3400926630355 | CANDESARTAN TVC 16MG CPR 30\n",
      "  3400926630416 | CANDESARTAN TVC 16MG CPR 90\n",
      "  3400926630584 | CANDESARTAN TVC 32MG CPR 30\n",
      "  3400926632076 | LOSARTAN KRK 50MG CPR 30\n",
      "  3400926632366 | LOSARTAN KRK 50MG CPR 90\n",
      "  3400926632717 | LOSARTAN KRK 100MG CPR 90\n",
      "  3400926632885 | FORMODUAL NEXT 100/6 MCG/DOSE INH 1\n",
      "  3400926633257 | ATORVASTATINE HCS 10MG CPR 30\n",
      "  3400926633608 | ATORVASTATINE HCS 10MG CPR 90\n",
      "  3400926634377 | ATORVASTATINE HCS 20MG CPR 30\n",
      "  3400926634896 | ATORVASTATINE HCS 20MG CPR 90\n",
      "  3400926635558 | ATORVASTATINE HCS 40MG CPR 30\n",
      "  3400926635909 | ATORVASTATINE HCS 40MG CPR 90\n",
      "  3400926636210 | INNOVAIR NEXTHALER 100/6 MCG INH 120 1\n",
      "  3400926643881 | CLOPIDOGREL BGR 75 MG CPR 30\n",
      "  3400926644024 | REPAGLINIDE KRKA 0,5 MG CPR 90\n",
      "  3400926644192 | REPAGLINIDE KRKA 0,5 MG CPR 270\n",
      "  3400926644253 | REPAGLINIDE KRKA 1MG CPR 90\n",
      "  3400926644314 | REPAGLINIDE KRKA 1MG CPR 270\n",
      "  3400926644482 | REPAGLINIDE KRKA 2 MG CPR 90\n",
      "  3400926644543 | REPAGLINIDE KRKA 2 MG CPR 270\n",
      "  3400926648046 | INLYTA 1MG CPR 56\n",
      "  3400926648275 | INLYTA 5MG CPR 56\n",
      "  3400926648794 | FLUTIFORM 50/5MICROG SUSP INHAL 1\n",
      "  3400926648855 | FLUTIFORM 125/5MICROG SUSP INHAL 1\n",
      "  3400926649807 | FORXIGA 10MG CPR 28\n",
      "  3400926649975 | FORXIGA 10MG CPR 30\n",
      "  3400926656430 | PRAVASTATINE ARW 10MG CPR 28\n",
      "  3400926657901 | PRAVASTATINE ARW 20MG CPR 28\n",
      "  3400926658441 | PRAVASTATINE ARW 20MG CPR 84\n",
      "  3400926659332 | PRAVASTATINE ARW 40MG CPR 28\n",
      "  3400926659912 | PRAVASTATINE ARW 40MG CPR 84\n",
      "  3400926661281 | RABEPRAZOLE VIATRIS 10MG CPR 14\n",
      "  3400926661632 | RABEPRAZOLE VIATRIS 10MG CPR 28\n",
      "  3400926663414 | RABEPRAZOLE VIATRIS 20MG CPR 14\n",
      "  3400926663872 | RABEPRAZOLE VIATRIS 20MG CPR 28\n",
      "  3400926665654 | RABEPRAZOLE EVO 10MG CPR 14\n",
      "  3400926666026 | RABEPRAZOLE EVO 10MG CPR 28\n",
      "  3400926667894 | RABEPRAZOLE EVO 20MG CPR 14\n",
      "  3400926668327 | RABEPRAZOLE EVO 20MG CPR 28\n",
      "  3400926669966 | CEFPODOXIME ARL 100 MG CPR 10\n",
      "  3400926674359 | GLYCER/VASEL/PARAF PFS CREME 1\n",
      "  3400926675530 | OMNIPAQUE 300MG SOL INJ FP 100ML NEM 1\n",
      "  3400926675769 | OMNIPAQUE 300MG SOL INJ FP 100ML MED 1\n",
      "  3400926675820 | OMNIPAQUE 300MG SOL INJ FP 150ML MEM 1\n",
      "  3400926675998 | OMNIPAQUE 300MG SOL INJ FP 150ML MED 1\n",
      "  3400926676599 | OMNIPAQUE 350MG SOL IN 100ML 1\n",
      "  3400926676650 | OMNIPAQUE 350MG SOL INJ 100ML 1\n",
      "  3400926676711 | OMNIPAQUE 350MG SOL INJ FP 150ML MEM 1\n",
      "  3400926676889 | OMNIPAQUE 350MG SOL INJ FP 150ML MED 1\n",
      "  3400926677312 | VISIPAQUE 270MG/ML INJ FP MEM 100ML 1\n",
      "  3400926677602 | VISIPAQUE 270MG/ML INJ FP MED 150ML 1\n",
      "  3400926677770 | VISIPAQUE 320MG/ML INJ FP MEM 100ML 1\n",
      "  3400926677831 | VISIPAQUE 320MG/ML INJ FP MED 100ML 1\n",
      "  3400926678081 | VISIPAQUE 320MG/ML INJ FP MEM 150ML 1\n",
      "  3400926678142 | VISIPAQUE 320MG/ML INJ FP MED 150ML 1\n",
      "  3400926679552 | NICORANDIL VTS 10MG CPR 30\n",
      "  3400926681852 | NICORANDIL VTS 20MG CPR 30\n",
      "  3400926683115 | STEOVESS 70MG CPR EFF 4\n",
      "  3400926683283 | STEOVESS 70MG CPR EFF 12\n",
      "  3400926686475 | VALSARTAN ARL 40MG CPR 30\n",
      "  3400926687137 | VALSARTAN ARL 40MG CPR 30\n",
      "  3400926687717 | VALSARTAN ARL 80MG CPR 30\n",
      "  3400926688318 | VALSARTAN ARL 80MG CPR 90\n",
      "  3400926688837 | VALSARTAN ARL 160MG CPR 30\n",
      "  3400926689667 | VALSARTAN ARL 160MG CPR 90\n",
      "  3400926690038 | CANDESARTAN EVO 4MG CPR 30\n",
      "  3400926690267 | CANDESARTAN EVO 4MG CPR 90\n",
      "  3400926690328 | CANDESARTAN EVO 8MG CPR 30\n",
      "  3400926690496 | CANDESARTAN EVO 8MG CPR 90\n",
      "  3400926690557 | CANDESARTAN EVO 16MG CPR 30\n",
      "  3400926690618 | CANDESARTAN EVO 16MG CPR 90\n",
      "  3400926690908 | TRAMADOL EVO 50MG GELULE 30\n",
      "  3400926691158 | CANDESARTAN EVO 32MG CPR 30\n",
      "  3400926692100 | MELAXOSE PATE ORALE POT 1\n",
      "  3400926704209 | STALEVO 175MG/43,75MG/200MG CPR 100\n",
      "  3400926704728 | TOVIAZ LP 4 MG CPR 30\n",
      "  3400926704896 | TOVIAZ LP 8 MG CPR 30\n",
      "  3400926704957 | PREZISTA 100 MG/ML SUSP BUV 1\n",
      "  3400926708689 | RIZATRIPTAN ARW 10MG CPR 12\n",
      "  3400926712471 | PERINDOPRIL ARL 2 MG CPR 30\n",
      "  3400926713423 | PERINDOPRIL ARL 4 MG CPR 30\n",
      "  3400926714253 | PERINDOPRIL ARL 8 MG CPR 30\n",
      "  3400926717506 | OXYBUTYNINE ACC 5MG CPR 60\n",
      "  3400926721466 | TRAMADOL/PARACETAMOL KRK CPR 20\n",
      "  3400926722357 | STABLON 12,5MG CPR 28\n",
      "  3400926722418 | STABLON 12,5MG CPR 28\n",
      "  3400926736484 | DESOGESTREL BGA 75MCG CPR 28\n",
      "  3400926736545 | DESOGESTREL BGA 75MCG CPR 84\n",
      "  3400926738266 | MONOPROST 0,005% COLLYRE UNIDOSE 30\n",
      "  3400926742638 | GABAPENTINE ARG 600MG CPR 90\n",
      "  3400926744298 | ATOVAQ/PROGUAN VTS 250/100MG CPR 12\n",
      "  3400926752392 | TIANEPTINE BGA 12,5MG CPR 28\n",
      "  3400926752514 | OPTIDRIL 30/150 MCG CPR 28\n",
      "  3400926752682 | OPTIDRIL 30/150 MCG CPR 84\n",
      "  3400926754983 | SEEBRI BREEZ 44 MCG GELULE INH 30\n",
      "  3400926762568 | XALKORI 200 MG GELULE 60\n",
      "  3400926762797 | XALKORI 250 MG GELULE 60\n",
      "  3400926765750 | PANTOPRAZOLE ZYF 20MG CPR 28\n",
      "  3400926766351 | PANTOPRAZOLE ZYF 40MG CPR 7\n",
      "  3400926766580 | PANTOPRAZOLE ZYF 40MG CPR 14\n",
      "  3400926766870 | PANTOPRAZOLE ZYF 40MG CPR 28\n",
      "  3400926774974 | METOJECT 15 MG/0,3ML SOL INJ SER 1\n",
      "  3400926775346 | IFIRMASTA 75MG CPR PELL 30\n",
      "  3400926775407 | IFIRMASTA 75MG CPR PELL 90\n",
      "  3400926775575 | IFIRMASTA 150MG CPR PELL 30\n",
      "  3400926775636 | IFIRMASTA 150MG CPR PELL 90\n",
      "  3400926775865 | IFIRMASTA 300MG CPR PELL 30\n",
      "  3400926775926 | IFIRMASTA 300MG CPR PELL 90\n",
      "  3400926776008 | FYCOMPA 2 MG CPR 7\n",
      "  3400926776237 | FYCOMPA 4 MG CPR 28\n",
      "  3400926776527 | FYCOMPA 6 MG CPR 28\n",
      "  3400926776756 | FYCOMPA 8 MG CPR 28\n",
      "  3400926776985 | FYCOMPA 10 MG CPR 28\n",
      "  3400926777128 | FYCOMPA 12 MG CPR 28\n",
      "  3400926779078 | VALSARTAN/HCTZ ARG 80/12,5MG CR 30\n",
      "  3400926779658 | VALSARTAN/HCTZ ARG 80/12,5MG CR 90\n",
      "  3400926780029 | VALSARTAN/HCTZ ARG 160/12,5MG CPR 30\n",
      "  3400926780548 | VALSARTAN/HCTZ ARG 160/12,5MG CPR 90\n",
      "  3400926781088 | VALSARTAN/HCTZ ARG 160/25MG CPR 30\n",
      "  3400926781668 | VALSARTAN/HCTZ ARG 160/25MG CPR 90\n",
      "  3400926782498 | GLYCER/VASEL/PARAF BGA CREME 1\n",
      "  3400926783501 | EYLEA 4 MG SOL INJ SER 1\n",
      "  3400926783679 | EYLEA 4 MG SOL INJ 1\n",
      "  3400926784102 | ELIQUIS 5MG CPR 60\n",
      "  3400926787172 | CICLOPIROX OLAMINE SDZ 1% CREME 1\n",
      "  3400926788414 | AFINITOR 2,5 MG CPR 30\n",
      "  3400926788704 | PREZISTA 800MG CPR 30\n",
      "  3400926788872 | VIREAD 123 MG CPR 30\n",
      "  3400926788933 | VIREAD 163 MG CPR 30\n",
      "  3400926789015 | VIREAD 204 MG CPR 30\n",
      "  3400926789183 | VIREAD 33 MG/G GRANULES ORAL FL 1\n",
      "  3400926791483 | REPAGLINIDE EVO 0,5 MG CPR 90\n",
      "  3400926791834 | REPAGLINIDE EVO 2 MG CPR 90\n",
      "  3400926792374 | REPAGLINIDE EVO 1 MG CPR 90\n",
      "  3400926797348 | TRAMADOL/PARACETAMOL VNP CPR 20\n",
      "  3400926803063 | LEVETIRACETAM ARW SOL BUV150ML+S1ML 1\n",
      "  3400926803124 | LEVETIRACETAM ARW SOL BUV150ML+S3ML 1\n",
      "  3400926803292 | LEVETIRACETAM ARW SOL BUV300ML+S10ML 1\n",
      "  3400926803933 | LEVETIRACETAM ARL 250MG CPR 60\n",
      "  3400926804305 | LEVETIRACETAM ARL 500MG CPR 60\n",
      "  3400926805364 | LEVETIRACETAM ARL 1000MG CPR 60\n",
      "  3400926807894 | LEVETIRACETAM ARL 500MG CPR 30\n",
      "  3400926808266 | DESOPOP 75MCG CPR 84\n",
      "  3400926808907 | PERINDOPRIL INDA BGA 2,5/0,625MG CPR 30\n",
      "  3400926809157 | PERINDOPRIL INDA BGA 2,5/0,625MG CPR 90\n",
      "  3400926809737 | PERINDOPRIL INDAP BGA 5MG/1,25MG CPR 30\n",
      "  3400926810047 | PERINDOPRIL INDAP BGA 5MG/1,25MG CPR 90\n",
      "  3400926812577 | PROPRANOLOL ACC 40MG CPR 50\n",
      "  3400926813529 | RABEPRAZOLE ARW 10MG CP 28\n",
      "  3400926814700 | RABEPRAZOLE ALM 20MG CPR 28\n",
      "  3400926818890 | ALMOTRIPTAN VTS 12,5MG CPR 6\n",
      "  3400926819033 | ALMOTRIPTAN VTS 12,5MG CPR 12\n",
      "  3400926822163 | RABEPRAZOLE EGL 10MG CPR 14\n",
      "  3400926822453 | RABEPRAZOLE EGL 10MG CPR 28\n",
      "  3400926823283 | RABEPRAZOLE EGL 20MG CPR 14\n",
      "  3400926823405 | RABEPRAZOLE EGL 20MG CPR 28\n",
      "  3400926825874 | DESLORATADINE VIATRIS 5 MG CPR 15\n",
      "  3400926826017 | DESLORATADINE VIATRIS 5 MG CPR 30\n",
      "  3400926826765 | LATANOPROST/TIM ZEN CY 2,5ML 1\n",
      "  3400926826826 | LATANOPROST/TIM ZEN CY 2,5ML 3\n",
      "  3400926827137 | OLANZAPINE ACC 5MG CPR 28\n",
      "  3400926827427 | OLANZAPINE ACC 7,5MG CPR 28\n",
      "  3400926827885 | DICLOFENAC SDZ 1% GEL FL100ML 1\n",
      "  3400926827946 | OLANZAPINE ACC 10MG CPR 28\n",
      "  3400926830038 | MODAFINIL EG 100MG CPR 30\n",
      "  3400926830618 | IRBESARTAN HCTZ BGA 150/12,5 MG CPR 30\n",
      "  3400926831097 | IRBESARTAN HCTZ BGA 150/12,5 MG CPR 90\n",
      "  3400926831387 | IRBESARTAN HCTZ BGA 300/12,5 MG CPR 30\n",
      "  3400926831738 | IRBESARTAN HCTZ BGA 300/12,5 MG CPR 90\n",
      "  3400926832278 | IRBESARTAN HCTZ BGA 300/25MG CPR 30\n",
      "  3400926832797 | IRBESARTAN HCTZ BGA 300/25MG CPR 90\n",
      "  3400926838072 | TRAMADOL/PARACETAMOL TVC CPR 20\n",
      "  3400926844165 | DILTIAZEM BGR LP 200MG GELULE 90\n",
      "  3400926844516 | DILTIAZEM BGR LP 300MG GELULE 90\n",
      "  3400926844745 | FYCOMPA 2 MG CPR 28\n",
      "  3400926851897 | LEVETIRACETAM VIATRIS SOL BUV 300ML 1\n",
      "  3400926853389 | TRESIBA 100U/ML SOL INJ CART 5\n",
      "  3400926857004 | MONTELUKAST ACC 4MG CPR CROQ 28\n",
      "  3400926857813 | TRESIBA 200U/ML SOL INJ STYLO 2\n",
      "  3400926857981 | TRESIBA 200U/ML SOL INJ STYLO 3\n",
      "  3400926860073 | MONTELUKAST ACC 5MG CPR CROQ 28\n",
      "  3400926861025 | DESLORATADINE ZYD 5MG CPR 15\n",
      "  3400926861193 | DESLORATADINE ZYD 5MG CPR 30\n",
      "  3400926863036 | BEXSERO SUSP INJ 1\n",
      "  3400926879815 | ZYCLARA 3,75% CREME 28\n",
      "  3400926881764 | ESCITALOPRAM SUN 15MG CPR PEL 28\n",
      "  3400926882884 | ESCITALOPRAM SUN 15MG CPR 28\n",
      "  3400926884376 | ORENCIA 125 MG SOL INJ 4\n",
      "  3400926885038 | PARACETAMOL TVS 500MG CPR EFF 16\n",
      "  3400926885328 | PARACETAMOL TVS 1000MG CPR EFF 8\n",
      "  3400926886158 | PARACETAMOL GNR 500MG CPR EFF 16\n",
      "  3400926886448 | PARACETAMOL GNR 1G CPR EFF 8\n",
      "  3400926887100 | TERBUTALINE VTS 5MG/2ML SOL INHAL 20\n",
      "  3400926887339 | TERBUTALINE VTS 5MG/2ML SOL INHAL 50\n",
      "  3400926887797 | LOSARTAN HCTZ KRK 50/12,5MG CPR 30\n",
      "  3400926887919 | LOSARTAN HCTZ KRK 50/12,5MG CPR 90\n",
      "  3400926888169 | LOSARTAN HCTZ KRK 100/25MG CPR 30\n",
      "  3400926888398 | LOSARTAN HCTZ KRK 100/25MG CPR 90\n",
      "  3400926888688 | METOJECT 7,5 MG/0,15ML SOL INJ SER 1\n",
      "  3400926889050 | METOJECT 10 MG/0,2ML SOL INJ SER 1\n",
      "  3400926889401 | METOJECT 20 MG/0,4ML SOL INJ SER 1\n",
      "  3400926889920 | METOJECT 25 MG/0,5ML SOL INJ SER 1\n",
      "  3400926890988 | DILTIAZEM BGR LP 300MG GELULE 30\n",
      "  3400926891060 | DILTIAZEM BGR LP 200MG GELULE 30\n",
      "  3400926893071 | NICOTINE EG FRUIT 2 MG GOMME 108\n",
      "  3400926896492 | NICOTINE EG FRUIT 4 MG GOMME 108\n",
      "  3400926899745 | NICOTINE EG 2MG GOMME MENT SS SUCRE 108\n",
      "  3400926903169 | NICOTINE EG 4MG GOMME MENT SS SUCRE 108\n",
      "  3400926904340 | PERINDOPRIL INDAP TVC 5MG/1,25MG CPR 30\n",
      "  3400926904630 | PERINDOPRIL INDAP TVC 5MG/1,25MG CPR 90\n",
      "  3400926904869 | PERINDOPRIL INDA TVC 2,5/0,625MG CPR 30\n",
      "  3400926905170 | PERINDOPRIL INDA TVC 2,5/0,625MG CPR 90\n",
      "  3400926907990 | XENETIX 300 INJ FV 20ML 1\n",
      "  3400926908362 | XENETIX 350 SOL INJ FL 20ML 1\n",
      "  3400926909543 | GLICLAZIDE TVC LM 60MG CPR 30\n",
      "  3400926910082 | GLICLAZIDE TVC LM 60MG CPR 90\n",
      "  3400926910891 | GLICLAZIDE TVC LM 60MG CPR 30\n",
      "  3400926911324 | GLICLAZIDE TVC LM 60MG CPR 90\n",
      "  3400926911904 | GLICLAZIDE ARW LM 60MG CPR 30\n",
      "  3400926912383 | GLICLAZIDE ARW LM 60MG CPR 90\n",
      "  3400926913045 | GLICLAZIDE ARW LM 60MG CPR 30\n",
      "  3400926913564 | GLICLAZIDE ARW LM 60MG CPR 90\n",
      "  3400926914226 | GLICLAZIDE MYP LM 60MG CPR 30\n",
      "  3400926914684 | GLICLAZIDE MYP LM 60MG CPR 90\n",
      "  3400926915285 | GLICLAZIDE MYP LM 60MG CPR 30\n",
      "  3400926915636 | GLICLAZIDE MYP LM 60MG CPR 90\n",
      "  3400926921149 | HALDOL 2MG/ML SOL BUV FL 30ML 1\n",
      "  3400926929473 | DILTIAZEM TVS LP 200MG GELULE 28\n",
      "  3400926929992 | DILTIAZEM TVS LP 200MG GELULE 84\n",
      "  3400926931193 | DILTIAZEM TVS LP 300MG GELULE 84\n",
      "  3400926933265 | REPAGLINIDE ARL 0,5MG CPR 90\n",
      "  3400926933906 | REPAGLINIDE ARL 1 MG CPR 90\n",
      "  3400926934446 | REPAGLINIDE ARL 2 MG CPR 90\n",
      "  3400926936457 | PERINDOPRIL INDAP BGA 10/2,5MG CPR 30\n",
      "  3400926936808 | PERINDOPRIL INDAP BGA 10/2,5MG CPR 90\n",
      "  3400926939939 | ASPIRINE PROTECT 100MG CPR 30\n",
      "  3400926941130 | DESLORATADINE ALM 5MG CPR 15\n",
      "  3400926941420 | DESLORATADINE ALM 5MG CPR 30\n",
      "  3400926941598 | AMOX/AC CLAV ZYD 1G/125MG AD SACH 8\n",
      "  3400926941710 | AMOX/AC CLAV ZYD 1G/125MG AD SACH 12\n",
      "  3400926942489 | TRAMADOL/PARACETAMOL EGL CPR 20\n",
      "  3400926943141 | TRAMADOL PARACETAMOL SUN CPR 20\n",
      "  3400926943202 | FROVATRIPTAN MYL 2,5 MG CPR 2\n",
      "  3400926943370 | FROVATRIPTAN MYL 2,5 MG CPR 6\n",
      "  3400926943431 | FROVATRIPTAN MYL 2,5 MG CPR 12\n",
      "  3400926943660 | DILTIAZEM ZTL LP 200MG GELULE 28\n",
      "  3400926943950 | DILTIAZEM ZTL LP 200MG GELULE 84\n",
      "  3400926944261 | DILTIAZEM ZTL LP 300MG GELULE 28\n",
      "  3400926944551 | DILTIAZEM ZTL LP 300MG GELULE 84\n",
      "  3400926944902 | CABERGOLINE SDZ 0,5MG CPR 8\n",
      "  3400926947163 | RAMIPRIL/HCTZ BGA 5/12,5MG CPR 30\n",
      "  3400926947743 | RAMIPRIL/HCTZ BGA 5/12,5MG CPR 90\n",
      "  3400926949006 | RAMIPRIL/HCTZ VTS 5/12,5MG CPR 30\n",
      "  3400926950583 | RAMIPRIL/HCTZ SDZ 5/12,5MG CPR 30\n",
      "  3400926951184 | RAMIPRIL/HCTZ SDZ 5/12,5MG CPR 90\n",
      "  3400926951306 | OMEPRAZOLE SUN 10MG GELULE 14\n",
      "  3400926951535 | OMEPRAZOLE SUN 10MG GELULE 28\n",
      "  3400926952365 | RAMIPRIL/HCTZ TVC 5/12,5MG CPR 30\n",
      "  3400926953775 | OMEPRAZOLE SUN 20MG GELULE 7\n",
      "  3400926954086 | OMEPRAZOLE SUN 20MG GELULE 14\n",
      "  3400926954376 | OMEPRAZOLE SUN 20MG GELULE 28\n",
      "  3400926955786 | LANSOPRAZOLE ZYF 30MG GELULE 7\n",
      "  3400926955847 | LANSOPRAZOLE ZYF 30MG GELULE 14\n",
      "  3400926955908 | LANSOPRAZOLE ZYF 30MG GELULE 28\n",
      "  3400926957278 | LANSOPRAZOLE ZYF 15MG GELULE 15\n",
      "  3400926957568 | LANSOPRAZOLE ZYF 15MG GELULE 30\n",
      "  3400926958978 | TELMISARTAN ZEN 40MG CPR 30\n",
      "  3400926959340 | TELMISARTAN ZEN 40MG CPR 90\n",
      "  3400926961121 | TRAMADOL/PARACETAMOL ARW CPR 20\n",
      "  3400926963422 | TRAMADOL/PARACETAMOL CRT CPR 20\n",
      "  3400926965204 | QUETIAPINE ARW LP 300MG CPR 30\n",
      "  3400926965433 | QUETIAPINE ARW LP 300MG CPR 60\n",
      "  3400926965723 | QUETIAPINE ARW LP 400MG CPR 30\n",
      "  3400926965952 | QUETIAPINE ARW LP 400MG CPR 60\n",
      "  3400926967505 | CAPECITABINE TVC 500 MG CPR 120\n",
      "  3400926971175 | ACARBOSE EG 50MG CPR 90\n",
      "  3400926971465 | ACARBOSE EG 100MG CPR 90\n",
      "  3400926972356 | ATORVASTATINE SUN 10MG CPR 30\n",
      "  3400926972875 | ATORVASTATINE SUN 10MG CPR 90\n",
      "  3400926973476 | ATORVASTATINE SUN 20MG CPR 30\n",
      "  3400926974077 | ATORVASTATINE SUN 20MG CPR 90\n",
      "  3400926974657 | ATORVASTATINE SUN 40MG CPR 30\n",
      "  3400926975197 | ATORVASTATINE SUN 40MG CPR 90\n",
      "  3400926975609 | ATORVASTATINE SUN 80MG CPR 30\n",
      "  3400926976439 | BETAXOLOL TEVA SANTE 20MG CPR 30\n",
      "  3400926976729 | BETAXOLOL TEVA SANTE 20MG CPR 90\n",
      "  3400926977849 | VICTAN 2MG CPR 30\n",
      "  3400926980511 | PEGASYS 90 MICROG SOL INJ SER 1\n",
      "  3400926980801 | TRAMADOL/PARACETAMOL ARL CPR 20\n",
      "  3400926982751 | ACARBOSE SDZ 50MG CPR 90\n",
      "  3400926983062 | ACARBOSE SDZ 100MG CPR 90\n",
      "  3400926983291 | DICLOFENAC SDZ 1% GEL TB 50G 1\n",
      "  3400926983413 | DICLOFENAC SDZ 1% GEL TB 100G 1\n",
      "  3400926983642 | CAPECITABINE ZEN 500MG CPR 120\n",
      "  3400926983871 | CAPECITABINE ZEN 150 MG CPR 60\n",
      "  3400926984182 | RISEDRONATE BGR 75MG CPR 2\n",
      "  3400926984304 | RISEDRONATE BGR 75MG CPR 6\n",
      "  3400926987084 | ESCITALOPRAM BGA 5MG CPR 14\n",
      "  3400926987145 | ESCITALOPRAM BGA 5MG CPR 28\n",
      "  3400926987206 | ESCITALOPRAM BGA 10MG CPR 28\n",
      "  3400926987374 | ESCITALOPRAM BGA 15MG CPR 28\n",
      "  3400926987435 | ESCITALOPRAM BGA 20 MG CPR 28\n",
      "  3400926990626 | CANDESARTAN/HCTZ ZYD 8/12,5 CPR 30\n",
      "  3400926990916 | CANDESARTAN/HCTZ ZYD 8/12,5 CPR 90\n",
      "  3400926991746 | CANDESARTAN/HCTZ ZYD 16/12,5 CPR 30\n",
      "  3400926991975 | CANDESARTAN/HCTZ ZYD 16/12,5 CPR 90\n",
      "  3400926992576 | ISENTRESS 100MG CPR 60\n",
      "  3400926992927 | TELMISARTAN ZEN 80MG CPR 30\n",
      "  3400926993467 | TELMISARTAN ZEN 80MG CPR 90\n",
      "  3400926993528 | BOSULIF 100 MG CPR 28\n",
      "  3400926993757 | BOSULIF 500 MG CPR 28\n",
      "  3400926994129 | IOMERON 400 SOL INJ FL 100ML SMC 1\n",
      "  3400926994297 | IOMERON 400 SOL INJ FL 150ML SMC 1\n",
      "  3400926994358 | EXTAVIA 0,25MG/ML PDR INJ 1,2/2,25ML 15\n",
      "  3400926994938 | IOMERON 350 SOL INJ FL 100ML SMC 1\n",
      "  3400926995010 | IOMERON 350 SOL INJ FL 150ML SMC 1\n",
      "  3400926995249 | IZINOVA SOL BUV FL 176ML 2\n",
      "  3400926997250 | MONTELUKAST AHL 10MG CPR 28\n",
      "  3400927303173 | ATORVASTATINE EVO 80MG CPR 30\n",
      "  3400927321214 | TRAMADOL/PARACETAMOL EVO CPR 20\n",
      "  3400927321504 | TRAMADOL/PARACETAMOL BGR CPR 20\n",
      "  3400927323973 | DORZOLAMIDE TIMOLOL ACT COLLYRE 5ML 1\n",
      "  3400927325816 | JAKAVI 5 MG CPR 56\n",
      "  3400927326066 | JAKAVI 15 MG CPR 56\n",
      "  3400927326295 | JAKAVI 20 MG CPR 56\n",
      "  3400927328428 | BETAXOLOL EG 20MG CPR 30\n",
      "  3400927328596 | BETAXOLOL EG 20MG CPR 90\n",
      "  3400927329029 | TELMISARTAN/HCTZ CRT 40MG/12,5MG CPR 30\n",
      "  3400927329487 | TELMISARTAN/HCTZ CRT 40MG/12,5MG CPR 90\n",
      "  3400927331619 | CHAMPIX 1 MG CPR 28\n",
      "  3400927331787 | CHAMPIX 1 MG CPR 56\n",
      "  3400927332098 | CHAMPIX 0,5 MG ET 1 MG CPR 25\n",
      "  3400927333279 | TELMISARTAN/HCTZ CRT 80MG/12,5MG CPR 90\n",
      "  3400927334399 | TELMISARTAN/HCTZ CRT 80MG/12,5MG CPR 30\n",
      "  3400927335570 | TELMISARTAN/HCTZ CRT 80MG/25MG CPR 30\n",
      "  3400927336003 | TELMISARTAN/HCTZ CRT 80MG/25MG CPR 90\n",
      "  3400927341373 | TELMISARTAN/HCTZ TVS 40MG/12,5MG CPR 30\n",
      "  3400927341892 | TELMISARTAN/HCTZ TVS 40MG/12,5MG CPR 90\n",
      "  3400927344046 | TELMISARTAN/HCTZ TVS 80MG/12,5MG CPR 30\n",
      "  3400927344565 | TELMISARTAN/HCTZ TVS 80MG/12,5MG CPR 90\n",
      "  3400927346866 | TELMISARTAN/HCTZ TVS 80MG/25MG CPR 30\n",
      "  3400927347238 | TELMISARTAN/HCTZ TVS 80MG/25MG CPR 90\n",
      "  3400927349010 | EUCREAS 50 MG/1000 MG CPR 60\n",
      "  3400927350368 | HEXYON SUSP INJ SER 1\n",
      "  3400927352898 | LANSOPRAZOLE VIATRIS 15MG CPR OROD 14\n",
      "  3400927352959 | LANSOPRAZOLE VIATRIS 15MG CPR OROD 28\n",
      "  3400927356513 | MOXIFLOXACINE EG 400MG CPR 5\n",
      "  3400927356681 | MOXIFLOXACINE EG 400MG CPR 7\n",
      "  3400927357404 | ESOMEPRAZOLE ACF 20MG CPR 14\n",
      "  3400927357572 | ESOMEPRAZOLE ACF 20MG CPR 28\n",
      "  3400927359583 | ESOMEPRAZOLE ARL 40MG CPR 28\n",
      "  3400927366338 | ESOMEPRAZOLE VTS 20 MG GELULE 28\n",
      "  3400927366796 | ESOMEPRAZOLE VTS 40 MG GELULE 28\n",
      "  3400927367168 | VENLAFAXINE VTS LP 75MG GELULE 30\n",
      "  3400927368110 | PANTOPRAZOLE VIATRIS 20MG CPR 28\n",
      "  3400927368868 | GLICLAZIDE KRKA LM 30MG CPR 30\n",
      "  3400927368929 | GLICLAZIDE KRKA LM 30MG CPR 60\n",
      "  3400927369001 | SETOFILM 4MG FILM DISP 2\n",
      "  3400927369179 | SETOFILM 4MG FILM DISP 4\n",
      "  3400927369230 | SETOFILM 8MG FILM DISP 2\n",
      "  3400927369469 | SETOFILM 8MG FILM DISP 4\n",
      "  3400927369520 | CLOXACILLINE SDZ 500 MG GELULE 16\n",
      "  3400927369810 | CLOXACILLINE EG 500 MG GELULE 16\n",
      "  3400927369988 | CLOXACILLINE VTS 500MG GELULE 16\n",
      "  3400927370069 | CLOXACILLINE ZEN 500 MG, GELULE 16\n",
      "  3400927370120 | CLOXACILLINE BGA 500 MG GELULE 16\n",
      "  3400927370359 | GLICLAZIDE KRKA LM 60MG CPR 30\n",
      "  3400927370588 | GLICLAZIDE KRKA LM 60MG CPR 90\n",
      "  3400927370649 | GLICLAZIDE KRKA LM 60MG CPR 30\n",
      "  3400927370878 | GLICLAZIDE KRKA LM 60MG CPR 90\n",
      "  3400927371189 | LEPONEX 25MG CPR 7\n",
      "  3400927371240 | LEPONEX 25MG CPR 14\n",
      "  3400927371301 | LEPONEX 25MG CPR 28\n",
      "  3400927371769 | XENETIX 300 SOL INJ POC 150ML DISP 1\n",
      "  3400927371998 | LEPONEX 100MG CPR 14\n",
      "  3400927372070 | LEPONEX 100MG CPR 28\n",
      "  3400927372421 | XENETIX 350 SOL INJ POC150ML 10\n",
      "  3400927372889 | TELMISARTAN/HCTZ EG 40MG/12,5MG CPR 30\n",
      "  3400927373251 | TELMISARTAN/HCTZ EG 40MG/12,5MG CPR 90\n",
      "  3400927374951 | TELMISARTAN/HCTZ EG 80MG/12,5MG CPR 30\n",
      "  3400927375491 | TELMISARTAN/HCTZ EG 80MG/12,5MG CPR 90\n",
      "  3400927377044 | TELMISARTAN/HCTZ EG 80MG/25MG CPR 30\n",
      "  3400927377563 | TELMISARTAN/HCTZ EG 80MG/25MG CPR 90\n",
      "  3400927378973 | BETAXOLOL VTS 20MG CPR 30\n",
      "  3400927379116 | BETAXOLOL VTS 20MG CPR 90\n",
      "  3400927379574 | BETAXOLOL BGA 20MG CPR 30\n",
      "  3400927379864 | BETAXOLOL BGA 20MG CPR 90\n",
      "  3400927380525 | BETAXOLOL SDZ 20MG CPR 30\n",
      "  3400927380754 | BETAXOLOL SDZ 20MG CPR 90\n",
      "  3400927381935 | TERBUTALINE SDZ 5MG/2ML SOL INHAL 50\n",
      "  3400927383946 | IRBESARTAN ACC 75MG CPR PELL 30\n",
      "  3400927384028 | IRBESARTAN ACC 75MG CPR PELL 90\n",
      "  3400927384196 | IRBESARTAN ACC 150MG CPR PELL 30\n",
      "  3400927384257 | IRBESARTAN ACC 150MG CPR PELL 90\n",
      "  3400927384318 | IRBESARTAN ACC 300MG CPR PELL 30\n",
      "  3400927384486 | IRBESARTAN ACC 300MG CPR PELL 90\n",
      "  3400927386329 | TELMISARTAN ACT 40MG CPR 30\n",
      "  3400927387159 | TELMISARTAN ACT 80MG CPR 30\n",
      "  3400927387449 | TELMISARTAN ACT 80MG CPR 90\n",
      "  3400927389801 | CAPECITABINE ACC 150 MG CPR 60\n",
      "  3400927390579 | CAPECITABINE ACC 500 MG CPR 120\n",
      "  3400927390920 | MENOPUR 600 UI PDR ET SOL INJ 1\n",
      "  3400927396083 | CLOPIDOGREL ARW 75MG CPR 30\n",
      "  3400927397264 | CLOPIDOGREL ARW 75MG CPR 30\n",
      "  3400927398216 | ESCITALOPRAM BBK 5 MG CPR 28\n",
      "  3400927399794 | ESCITALOPRAM BBK 10 MG CPR 28\n",
      "  3400927400209 | TANGANIL 500MG CPR 30\n",
      "  3400927400896 | ESCITALOPRAM BBK 15 MG CPR 28\n",
      "  3400927401497 | CANDESARTAN/HCTZ TVS 8/12,5 CPR 30\n",
      "  3400927401619 | CANDESARTAN/HCTZ TVS 8/12,5 CPR 90\n",
      "  3400927402098 | ESCITALOPRAM BBK 20 MG CPR 28\n",
      "  3400927402159 | CANDESARTAN/HCTZ TVS 16/12,5 CPR 30\n",
      "  3400927402210 | CANDESARTAN/HCTZ TVS 16/12,5 CPR 90\n",
      "  3400927403279 | RAMIPRIL KRKA 1,25MG CPR 30\n",
      "  3400927403620 | RAMIPRIL KRKA 1,25MG CPR 90\n",
      "  3400927404221 | RAMIPRIL KRKA 2,5MG CPR 30\n",
      "  3400927404511 | RAMIPRIL KRKA 2,5MG CPR 90\n",
      "  3400927405051 | RAMIPRIL KRKA 5MG CPR 30\n",
      "  3400927405341 | RAMIPRIL KRKA 5MG CPR 90\n",
      "  3400927405921 | RAMIPRIL KRKA 10MG CPR 30\n",
      "  3400927406232 | RAMIPRIL KRKA 10MG CPR 90\n",
      "  3400927406461 | VASTEN 20 MG CPR 28\n",
      "  3400927406522 | VASTEN 20 MG CPR 84\n",
      "  3400927406690 | VASTEN 40 MG CPR 28\n",
      "  3400927406751 | VASTEN 40 MG CPR 84\n",
      "  3400927406812 | OPTIMIZETTE 75 MCG CPR 28\n",
      "  3400927406980 | OPTIMIZETTE 75 MCG CPR 84\n",
      "  3400927407123 | RISEDRONATE VIATRIS 75MG CPR 2\n",
      "  3400927407352 | RISEDRONATE VIATRIS 75MG CPR 6\n",
      "  3400927407871 | ESCITALOPRAM SUN 10MG CPR 28\n",
      "  3400927408472 | ESCITALOPRAM SUN 20MG CPR 28\n",
      "  3400927409653 | EFAVIRENZ VTS 600MG CPR 30\n",
      "  3400927410253 | CANDESARTAN/HCTZ VTS 16/12,5 CPR 30\n",
      "  3400927410772 | CANDESARTAN/HCTZ VTS 16/12,5 CPR 90\n",
      "  3400927413445 | CANDESARTAN/HCTZ VTS 8/12,5 CPR 30\n",
      "  3400927414046 | CANDESARTAN/HCTZ VTS 8/12,5 CPR 90\n",
      "  3400927417757 | ESOMEPRAZOLE SDZ 20 MG GELULE 7\n",
      "  3400927417818 | ESOMEPRAZOLE SDZ 20 MG GELULE 14\n",
      "  3400927417986 | ESOMEPRAZOLE SDZ 20 MG GELULE 28\n",
      "  3400927418068 | ESOMEPRAZOLE SDZ 40MG GELULE 14\n",
      "  3400927418129 | ESOMEPRAZOLE SDZ 40MG GELULE 28\n",
      "  3400927418358 | LANSOPRAZOLE VIATRIS 30MG CPR OROD 14\n",
      "  3400927418419 | LANSOPRAZOLE VIATRIS 30MG CPR OROD 28\n",
      "  3400927418938 | DICLOFENAC VIATRIS 1% GEL FL100ML 1\n",
      "  3400927419249 | NUTROPINAQ 10 MG (30 UI) SOL INJ 3\n",
      "  3400927419478 | JAYDESS 13,5 MG DISP INTRA UTERIN 1\n",
      "  3400927419829 | ICLUSIG 45 MG CPR 30\n",
      "  3400927421020 | DICLOFENAC ARG 1% GEL TUBE 50G 1\n",
      "  3400927421259 | DICLOFENAC CRT 1% GEL FL 50G 1\n",
      "  3400927422959 | RIZATRIPTAN SDZ 10MG CPR ORODISP 6\n",
      "  3400927423031 | RIZATRIPTAN SDZ 10MG CPR ORODISP 12\n",
      "  3400927424151 | RIZATRIPTAN BGA 10MG CPR ORODISP 6\n",
      "  3400927424212 | RIZATRIPTAN BGA 10MG CPR ORODISP 12\n",
      "  3400927426391 | EFAVIRENZ TVC 600 MG CPR 30\n",
      "  3400927426452 | STRIBILD 150/150/200/245MG CPR 30\n",
      "  3400927427343 | ESCITALOPRAM EVO 5MG CPR 28\n",
      "  3400927427862 | ESCITALOPRAM EVO 15MG CPR 28\n",
      "  3400927428005 | ESCITALOPRAM EVO 10MG CPR 28\n",
      "  3400927428234 | ESCITALOPRAM EVO 20MG CPR 28\n",
      "  3400927428692 | ALEVETABS 220MG CPR 24\n",
      "  3400927432484 | XTANDI 40 MG CAPS MOLLE 112\n",
      "  3400927436048 | FOSTIMONKIT 225 UI/ML PDR ET SOL INJ 5\n",
      "  3400927436277 | FOSTIMONKIT 300 UI/ML PDR ET SOL INJ 5\n",
      "  3400927440298 | IRBESARTAN ARW 75 MG CPR 30\n",
      "  3400927440359 | IRBESARTAN ARW 75 MG CPR 90\n",
      "  3400927440588 | IRBESARTAN ARW 150 MG CPR 30\n",
      "  3400927440649 | IRBESARTAN ARW 150 MG CPR 90\n",
      "  3400927440878 | IRBESARTAN ARW 300MG CPR 30\n",
      "  3400927440939 | IRBESARTAN ARW 300MG CPR 90\n",
      "  3400927441189 | IRBESARTAN HCTZ ARW 150/12,5MG CPR 30\n",
      "  3400927441240 | IRBESARTAN HCTZ ARW 150/12,5MG CPR 90\n",
      "  3400927441530 | IRBESARTAN HCTZ ARW 300/12,5MG CPR 30\n",
      "  3400927441769 | IRBESARTAN HCTZ ARW 300/12,5MG CPR 90\n",
      "  3400927442070 | IRBESARTAN HCTZ ARW 300/25MG CPR 30\n",
      "  3400927442131 | IRBESARTAN HCTZ ARW 300/25MG CPR 90\n",
      "  3400927442599 | FLUARIXTETRA SUSP INJ SER VACCI 1\n",
      "  3400927442650 | FLUARIXTETRA SUSP INJ SER 1\n",
      "  3400927443190 | CAPECITABINE VIATRIS 150MG CPR 60\n",
      "  3400927443480 | SELINCRO 18MG CPR 14\n",
      "  3400927447914 | LEVETIRACETAM EG 250MG CPR 60\n",
      "  3400927448393 | LEVETIRACETAM EG 500MG CPR 60\n",
      "  3400927449574 | LEVETIRACETAM EG 1000MG CPR 60\n",
      "  3400927449864 | CAPECITABINE VIATRIS 500MG CPR 120\n",
      "  3400927450464 | TELMISARTAN/HCTZ GNR 40MG/12,5MG CPR 30\n",
      "  3400927450983 | TELMISARTAN/HCTZ GNR 40MG/12,5MG CPR 90\n",
      "  3400927451355 | TELMISARTAN/HCTZ GNR 80MG/12,5MG CPR 30\n",
      "  3400927451874 | TELMISARTAN/HCTZ GNR 80MG/12,5MG CPR 90\n",
      "  3400927452246 | TELMISARTAN/HCTZ GNR 80MG/25MG CPR 30\n",
      "  3400927452826 | TELMISARTAN/HCTZ GNR 80MG/25MG CPR 90\n",
      "  3400927455667 | TOPIRAMATE ACC 100 MG CPR 28\n",
      "  3400927456497 | TOPIRAMATE ACC 50 MG CPR 28\n",
      "  3400927458569 | ROPINIROLE BGA LP 2MG CPR 28\n",
      "  3400927459160 | ROPINIROLE BGA LP 4MG CPR 28\n",
      "  3400927459689 | ROPINIROLE BGA LP 8MG CPR 28\n",
      "  3400927460579 | TELMISARTAN/HCTZ BGA 40MG/12,5MG CPR 30\n",
      "  3400927461002 | TELMISARTAN/HCTZ BGA 40MG/12,5MG CPR 90\n",
      "  3400927463181 | TELMISARTAN/HCTZ BGA 80MG/12,5MG CPR 30\n",
      "  3400927463532 | TELMISARTAN/HCTZ BGA 80MG/12,5MG CPR 90\n",
      "  3400927465772 | TELMISARTAN/HCTZ BGA 80MG/25MG CPR 30\n",
      "  3400927466205 | TELMISARTAN/HCTZ BGA 80MG/25MG CPR 90\n",
      "  3400927468674 | TELMISARTAN/HCTZ VIA 40MG/12,5MG CPR 30\n",
      "  3400927469107 | TELMISARTAN/HCTZ VIA 40MG/12,5MG CPR 90\n",
      "  3400927471346 | TELMISARTAN/HCTZ VTS 80MG/12,5MG CPR 30\n",
      "  3400927471865 | TELMISARTAN/HCTZ VTS 80MG/12,5MG CPR 90\n",
      "  3400927473937 | TELMISARTAN/HCTZ VTS 80MG/25MG CPR 30\n",
      "  3400927474309 | TELMISARTAN/HCTZ VTS 80MG/25MG CPR 90\n",
      "  3400927476778 | ERIVEDGE 150MG GELULE 28\n",
      "  3400927479441 | VORICONAZOLE SDZ 50MG CPR 56\n",
      "  3400927480041 | CAPECITABINE EG 150MG CPR 60\n",
      "  3400927480331 | CAPECITABINE EG 500MG CPR 120\n",
      "  3400927480799 | DILTIAZEM TVS LP 300MG GELULE 28\n",
      "  3400927480850 | LATANOPROST/TIM VTS COLLYRE 2,5ML 1\n",
      "  3400927480911 | LATANOPROST/TIM VTS COLLYRE 2,5ML 3\n",
      "  3400927481390 | ESOMEPRAZOLE TVC 20MG GELULE 7\n",
      "  3400927481451 | ESOMEPRAZOLE TVC 20MG GELULE 14\n",
      "  3400927481512 | ESOMEPRAZOLE TVC 20MG GELULE 28\n",
      "  3400927481680 | ESOMEPRAZOLE TVC 40MG GELULE 14\n",
      "  3400927481741 | ESOMEPRAZOLE TVC 40MG GELULE 28\n",
      "  3400927481970 | GABAPENTINE PFZ 100MG GELULE 90\n",
      "  3400927482052 | GABAPENTINE PFZ 300MG GELULE 90\n",
      "  3400927482113 | GABAPENTINE PFZ 400MG GELULE 90\n",
      "  3400927482342 | GABAPENTINE PFZ 600MG CPR 90\n",
      "  3400927482571 | GABAPENTINE PFZ 800MG CPR 90\n",
      "  3400927489846 | ATOVAQ/PROGUAN ZEN 250/100MG CPR 12\n",
      "  3400927490095 | ATOVAQ/PROGUAN BGA 250/100MG CPR 12\n",
      "  3400927494987 | RISPERIDONE VTS 0,5MG CPR DISP 28\n",
      "  3400927495359 | RISPERIDONE VTS 1MG CPR DISP 28\n",
      "  3400927495700 | RISPERIDONE VIATRIS 2MG CPR DISP 28\n",
      "  3400927496189 | RISPERIDONE VIATRIS 3MG CPR DISP 28\n",
      "  3400927496530 | RISPERIDONE VIATRIS 4MG CPR DISP 28\n",
      "  3400927497070 | RALOXIFENE CRT 60MG CPR 28\n",
      "  3400927497360 | RALOXIFENE CRT 60MG CPR 84\n",
      "  3400927497889 | TECFIDERA 120MG GELULE 14\n",
      "  3400927497940 | TECFIDERA 240MG GELULE 56\n",
      "  3400927498190 | LEVETIRACETAM ZYD 250MG CPR 60\n",
      "  3400927498541 | LEVETIRACETAM ZYD 500MG CPR 60\n",
      "  3400927499432 | LEVETIRACETAM ZYD 1 000MG CPR 60\n",
      "  3400927499890 | AUBAGIO 14MG CPR 28\n",
      "  3400927500473 | ATOVAQ/PROGUAN TEVA 250/100MG CPR 12\n",
      "  3400927501425 | LAMIVUDINE SDZ 150MG CPR 60\n",
      "  3400927501944 | LAMIVUDINE SDZ 300MG CPR 30\n",
      "  3400927503726 | QUETIAPINE ARW LP 50 MG CPR 30\n",
      "  3400927505676 | MOMETASONE SDZ 50 MICROG SUSP NASALE 1\n",
      "  3400927510939 | TELMISARTAN/HCTZ SDZ 40MG/12,5MG CPR 30\n",
      "  3400927511301 | TELMISARTAN/HCTZ SDZ 40MG/12,5MG CPR 90\n",
      "  3400927513541 | TRAMADOL/PARACETAMOL ZYD CPR 20\n",
      "  3400927517044 | FYREMADEL 0,25 MG SOL INJ 1\n",
      "  3400927517105 | FYREMADEL 0,25 MG SOL INJ 5\n",
      "  3400927517273 | PRAVASTATINE ZEN 20MG CPR 28\n",
      "  3400927517334 | PRAVASTATINE ZEN 20MG CPR 84\n",
      "  3400927517563 | PRAVASTATINE ZEN 20MG CPR 28\n",
      "  3400927517624 | PRAVASTATINE ZEN 20MG CPR 84\n",
      "  3400927517792 | PRAVASTATINE ZEN 40MG CPR 28\n",
      "  3400927517853 | PRAVASTATINE ZEN 40MG CPR 84\n",
      "  3400927517914 | PRAVASTATINE ZEN 40MG CPR 28\n",
      "  3400927518164 | PRAVASTATINE ZEN 40MG CPR 84\n",
      "  3400927518805 | FLUVASTATINE ACC LP 80MG CPR 30\n",
      "  3400927519284 | FLUVASTATINE ACC LP 80MG CPR 90\n",
      "  3400927520006 | STIVARGA 40 MG CPR 84\n",
      "  3400927521126 | TELMISARTAN/HCTZ SDZ 80MG/12,5MG CPR 30\n",
      "  3400927521584 | TELMISARTAN/HCTZ SDZ 80MG/12,5MG CPR 90\n",
      "  3400927523717 | TELMISARTAN/HCTZ SDZ 80MG/25MG CPR 30\n",
      "  3400927524196 | TELMISARTAN/HCTZ SDZ 80MG/25MG CPR 90\n",
      "  3400927534362 | TELMISARTAN/HCTZ ACT 40MG/12,5MG CPR 30\n",
      "  3400927534713 | TELMISARTAN/HCTZ ACT 40MG/12,5MG CPR 90\n",
      "  3400927536953 | TELMISARTAN/HCTZ ACT 80MG/12,5MG CPR 30\n",
      "  3400927537493 | TELMISARTAN/HCTZ ACT 80MG/12,5MG CPR 90\n",
      "  3400927539626 | TELMISARTAN/HCTZ ACT 80MG/25MG CPR 30\n",
      "  3400927540165 | TELMISARTAN/HCTZ ACT 80MG/25MG CPR 90\n",
      "  3400927542466 | NEVIRAPINE ARL 200MG CPR 60\n",
      "  3400927543876 | VITAROS 300 MCG CREME UNIDOSE 4\n",
      "  3400927545368 | EFAVIRENZ SDZ 600MG CPR 30\n",
      "  3400927547379 | INLYTA 3MG CPR 56\n",
      "  3400927547669 | INLYTA 7MG CPR 56\n",
      "  3400927549670 | TAFINLAR 50 MG GELULE 120\n",
      "  3400927549731 | TAFINLAR 75 MG GELULE 120\n",
      "  3400927550102 | CANDESARTAN ARL 4MG CPR 90\n",
      "  3400927550621 | CANDESARTAN ARL 8MG CPR 90\n",
      "  3400927551161 | CANDESARTAN ARL 16MG CPR 90\n",
      "  3400927552342 | FROVATRIPTAN TEVA 2,5 MG CPR 12\n",
      "  3400927552403 | OMNITROPE 5 MG SOL INJ CS 1\n",
      "  3400927552571 | OMNITROPE 5 MG SOL INJ CS 5\n",
      "  3400927552632 | OMNITROPE 5 MG SOL INJ CS 10\n",
      "  3400927552861 | OMNITROPE 10 MG SOL INJ CS 1\n",
      "  3400927552922 | OMNITROPE 10 MG SOL INJ CS 5\n",
      "  3400927553004 | OMNITROPE 10 MG SOL INJ CS 10\n",
      "  3400927556883 | ESCITALOPRAM EG 5MG CPR 14\n",
      "  3400927556944 | ESCITALOPRAM EG 5MG CPR 28\n",
      "  3400927557835 | ESCITALOPRAM EG 10MG CPR 28\n",
      "  3400927558726 | ESCITALOPRAM EG 15MG CPR 28\n",
      "  3400927559266 | ESCITALOPRAM EG 20MG CPR 28\n",
      "  3400927559495 | TELMISARTAN/HCTZ ZEN 40MG/12,5MG CPR 30\n",
      "  3400927559556 | TELMISARTAN/HCTZ ZEN 40MG/12,5MG CPR 90\n",
      "  3400927559617 | TELMISARTAN/HCTZ ZEN 80MG/12,5MG CPR 30\n",
      "  3400927559785 | TELMISARTAN/HCTZ ZEN 80MG/12,5MG CPR 90\n",
      "  3400927559846 | TELMISARTAN/HCTZ ZEN 80MG/25MG CPR 30\n",
      "  3400927559907 | TELMISARTAN/HCTZ ZEN 80MG/25MG CPR 90\n",
      "  3400927560446 | FENTANYL TVS 12MICROG/H DISP TRANSD 5\n",
      "  3400927560675 | FENTANYL TVS 25MICROG/H DISP TRANSD 5\n",
      "  3400927560965 | FENTANYL TVS 50MICROG/H DISP TRANSD 5\n",
      "  3400927561108 | FENTANYL TVS 75MICROG/H DISP TRANSD 5\n",
      "  3400927561337 | FENTANYL TVS 100MICROG/H DISP TRANSD 5\n",
      "  3400927561627 | GANFORT 0,3/5MG/ML COLLYRE UNIDOSE 30\n",
      "  3400927562396 | CODOLIPRANE 500MG/30MG CPR 16\n",
      "  3400927563119 | DYMISTA 137MCG/50MCG SUSP NASALE 1\n",
      "  3400927564239 | METFORMINE ZEN 500MG CPR 30\n",
      "  3400927564529 | METFORMINE ZEN 500MG CPR 90\n",
      "  3400927564758 | EPIPEN 150 MCG SOL INJ STYLO 2\n",
      "  3400927564987 | EPIPEN 300 MCG SOL INJ STYLO 2\n",
      "  3400927565649 | GIOTRIF 20MG CPR 28\n",
      "  3400927565700 | GIOTRIF 30MG CPR 28\n",
      "  3400927565878 | GIOTRIF 40MG CPR 28\n",
      "  3400927566011 | TEGLUTIK 5MG / ML SUSP BUV 1\n",
      "  3400927566479 | ULTIBRO BREEZ.85MCG/43MCG GELULE 30\n",
      "  3400927567070 | LORMETAZEPAM ACT 1MG CPR SEC 14\n",
      "  3400927567131 | LORMETAZEPAM ACT 2MG CPR SEC 14\n",
      "  3400927567711 | OMEPRAZOLE ZTL 10MG GELULE 28\n",
      "  3400927568022 | OMEPRAZOLE ZTL 20MG GELULE 7\n",
      "  3400927568190 | OMEPRAZOLE ZTL 20MG GELULE 14\n",
      "  3400927568251 | OMEPRAZOLE ZTL 20MG GELULE 28\n",
      "  3400927568312 | SIMPONI 100 MG INJ STYLO 1\n",
      "  3400927568480 | SIMPONI 100 MG INJ SRG 1\n",
      "  3400927569432 | COLOBREATHE 1 662 500 UI PDR INH 56\n",
      "  3400927570032 | TROSPIPHARM 20 MG CPR 30\n",
      "  3400927570902 | FLECAINIDE TVC LP 50MG GELULE 30\n",
      "  3400927571091 | FLECAINIDE TVC LP 100MG GELULE 30\n",
      "  3400927571152 | FLECAINIDE TVC LP 150MG GELULE 30\n",
      "  3400927571213 | FLECAINIDE TVC LP 200MG GELULE 30\n",
      "  3400927575174 | VALSARTAN/HCTZ EVO 160/12,5MG CPR 30\n",
      "  3400927575693 | VALSARTAN/HCTZ EVO 160/12,5MG CPR 90\n",
      "  3400927576645 | AC ZOLEDRONIQUE BGA 5 MG INJ 1\n",
      "  3400927576706 | CAPECITABINE ARW 500MG CPR 120\n",
      "  3400927576874 | CAPECITABINE ARW 150MG CPR 60\n",
      "  3400927578885 | FOSINOPRIL ARL 20MG CPR 30\n",
      "  3400927580666 | VALACICLOVIR ARW 500MG CPR 10\n",
      "  3400927580956 | VALACICLOVIR ARW 500MG CPR 42\n",
      "  3400927581328 | VALACICLOVIR ARW 500MG CPR 112\n",
      "  3400927584459 | ATORVASTATINE VIATRIS 10MG CPR 30\n",
      "  3400927584510 | ATORVASTATINE VIATRIS 10MG CPR 90\n",
      "  3400927584749 | ATORVASTATINE VIATRIS 20MG CPR 30\n",
      "  3400927584800 | ATORVASTATINE VIATRIS 20MG CPR 90\n",
      "  3400927585050 | ATORVASTATINE VTS 40MG CPR 30\n",
      "  3400927585111 | ATORVASTATINE VTS 40MG CPR 90\n",
      "  3400927585340 | ATORVASTATINE VTS 80MG CPR 30\n",
      "  3400927585401 | ATORVASTATINE VTS 80MG CPR 90\n",
      "  3400927586231 | GLICLAZIDE BGA LM 60MG CPR 30\n",
      "  3400927586750 | GLICLAZIDE BGA LM 60MG CPR 90\n",
      "  3400927587290 | FLECAINIDE BGA LP 50 MG GELULE 30\n",
      "  3400927587351 | FLECAINIDE BGA LP 100 MG GELULE 30\n",
      "  3400927587412 | FLECAINIDE BGA LP 150 MG GELULE 30\n",
      "  3400927587580 | FLECAINIDE BGA LP 200 MG GELULE 30\n",
      "  3400927587641 | FLECAINIDE ZEN LP 50MG GELULE 30\n",
      "  3400927587702 | FLECAINIDE ZEN LP 100MG GELULE 30\n",
      "  3400927587870 | FLECAINIDE ZEN LP 150MG GELULE 30\n",
      "  3400927587931 | FLECAINIDE ZEN LP 200MG GELULE 30\n",
      "  3400927588990 | LONQUEX 6 MG SOL INJ 1\n",
      "  3400927589713 | DESLORATADINE SDZ 5 MG CPR 15\n",
      "  3400927589881 | DESLORATADINE SDZ 5 MG CPR 30\n",
      "  3400927590313 | AMOXICILLINE ZYF 500 MG GELULE 12\n",
      "  3400927593093 | LATANOPROST/TIM BGA COLLYRE 2,5ML 1\n",
      "  3400927593154 | LATANOPROST/TIM BGA COLLYRE 2,5ML 3\n",
      "  3400927593215 | DICLOFENAC ZEN 1% GEL TB 100G 1\n",
      "  3400927597527 | NATRIXAM 1,5MG/5MG CPR LM 30\n",
      "  3400927597756 | NATRIXAM 1,5MG/5MG CPR LM 90\n",
      "  3400927598357 | NATRIXAM 1,5MG/10MG CPR LM 30\n",
      "  3400927598586 | NATRIXAM 1,5MG/10MG CPR LM 90\n",
      "  3400927602931 | ALMOTRIPTAN SDZ 12,5MG CPR 12\n",
      "  3400927603303 | RIAMET 20MG/120MG CPR 24\n",
      "  3400927603471 | ECOBEC 250MICROG SOL INHAL S/P 1\n",
      "  3400927603822 | OLANZAPINE VTS 5MG CPR DISP 28\n",
      "  3400927604362 | OLANZAPINE VTS 10MG CPR DISP 28\n",
      "  3400927605772 | CELECOXIB ZEN 100 MG GELULE 30\n",
      "  3400927607035 | TRAMADOL/PARACETAMOL ARW CPR EFF 20\n",
      "  3400927607264 | OMEPRAZOLE ZYF 10MG GELULE 14\n",
      "  3400927607325 | OMEPRAZOLE ZYF 10MG GELULE 28\n",
      "  3400927607493 | OMEPRAZOLE ZYF 20MG GELULE 7\n",
      "  3400927607554 | OMEPRAZOLE ZYF 20MG GELULE 14\n",
      "  3400927607615 | OMEPRAZOLE ZYF 20MG GELULE 28\n",
      "  3400927607783 | ACAMPROSATE BGA 333MG CPR 60\n",
      "  3400927607905 | ACAMPROSATE BGA 333MG CPR 180\n",
      "  3400927609565 | CELECOXIB ZEN 200MG GELULE 30\n",
      "  3400927610226 | MUPIROCINE BGA 2 % POMMADE 1\n",
      "  3400927610394 | AC ZOLEDRONIQUE VTS 5 MG SOL INJ 1\n",
      "  3400927610806 | NEVIRAPINE SDZ 200MG CPR 60\n",
      "  3400927610974 | LIDOCAINE/PRILOCAINE BGA 5% PANS 1\n",
      "  3400927611575 | ACARBOSE VIATRIS 50MG CPR 90\n",
      "  3400927611926 | ACARBOSE VIATRIS 100MG CPR 90\n",
      "  3400927619960 | RELVAR ELLIPTA 92/22 MICROG PDR INH 30\n",
      "  3400927620102 | RELVAR ELLIPTA 184/22 MICROG PDR INH 30\n",
      "  3400927622281 | OPRYMEA LP 0,26MG CPR 30\n",
      "  3400927622403 | OPRYMEA LP 0,52MG CPR 30\n",
      "  3400927622632 | OPRYMEA LP 1,05MG CPR 30\n",
      "  3400927622922 | OPRYMEA LP 2,1MG CPR 30\n",
      "  3400927623004 | LEVONORGESTREL VIATRIS 1,5MG CPR 1\n",
      "  3400927626074 | LOJUXTA 10MG GELULE 28\n",
      "  3400927626425 | MODAFINIL ARW 100MG CPR 30\n",
      "  3400927626654 | CAPECITABINE BGA 150 MG CPR 60\n",
      "  3400927626715 | CAPECITABINE BGA 150 MG CPR 60\n",
      "  3400927626883 | CAPECITABINE BGA 500 MG CPR 120\n",
      "  3400927626944 | CAPECITABINE BGA 500 MG CPR 120\n",
      "  3400927629037 | TELMISARTAN ZYD 40MG CPR 30\n",
      "  3400927629327 | TELMISARTAN ZYD 40MG CPR 90\n",
      "  3400927629617 | TELMISARTAN ZYD 80MG CPR 30\n",
      "  3400927629846 | TELMISARTAN ZYD 80MG CPR 90\n",
      "  3400927636240 | ULTRAVIST 300 SOL INJ SER 150ML 1\n",
      "  3400927637131 | ULTRAVIST 370 SOL INJ SER 150ML NEC 1\n",
      "  3400927642623 | CAPECITABINE SDZ 150MG CPR 60\n",
      "  3400927642791 | CAPECITABINE SDZ 500MG CPR 120\n",
      "  3400927642913 | REVOLADE 75 MG CPR 28\n",
      "  3400927643514 | VOTUBIA 2 MG CPR DISP 30\n",
      "  3400927643682 | VOTUBIA 3 MG CPR DISP 30\n",
      "  3400927643743 | VOTUBIA 5 MG CPR DISP 30\n",
      "  3400927646584 | AZITHROMYCINE BGA 250MG CPR 6\n",
      "  3400927651267 | RAMIPRIL SUN 1,25MG CPR 30\n",
      "  3400927651328 | RAMIPRIL SUN 1,25MG CPR 90\n",
      "  3400927652677 | RAMIPRIL SUN 2,5MG CPR 30\n",
      "  3400927652738 | RAMIPRIL SUN 2,5MG CPR 90\n",
      "  3400927653568 | RAMIPRIL SUN 5MG CPR 30\n",
      "  3400927653629 | RAMIPRIL SUN 5MG CPR 90\n",
      "  3400927654398 | RAMIPRIL SUN 10MG CPR 30\n",
      "  3400927654459 | RAMIPRIL SUN 10MG CPR 90\n",
      "  3400927656989 | RECIVIT 133MICROG CPR SUBLING 30\n",
      "  3400927657702 | RECIVIT 267MICROG CPR SUBLING 30\n",
      "  3400927658532 | RECIVIT 400MICROG CPR SUBLING 30\n",
      "  3400927665516 | LIDOCAINE/PRILOCAINE ZEN 5% PANS 1\n",
      "  3400927671029 | TRAMADOL/PARACETAMOL NIX CPR 20\n",
      "  3400927671197 | LUCENTIS 1,65 MG SOL INJ SER 1\n",
      "  3400927673559 | IRBESARTAN HCTZ EVP 150/12,5MG CPR 30\n",
      "  3400927673849 | IRBESARTAN HCTZ EVP 150/12,5MG CPR 90\n",
      "  3400927674150 | IRBESARTAN HCTZ EVP 300/12,5MG CPR 30\n",
      "  3400927674440 | IRBESARTAN HCTZ EVP 300/12,5MG CPR 90\n",
      "  3400927674730 | IRBESARTAN HCTZ EVP 300/25MG CPR 30\n",
      "  3400927675102 | IRBESARTAN HCTZ EVP 300/25MG CPR 90\n",
      "  3400927687976 | BISOPROLOL KRK 2,5MG CPR 30\n",
      "  3400927689000 | BISOPROLOL KRK 5MG CPR 30\n",
      "  3400927690129 | BISOPROLOL KRK 10MG CPR 30\n",
      "  3400927690648 | BISOPROLOL KRK 10MG CPR 90\n",
      "  3400927693199 | DUPHALAC 10 G/15ML SOL BUV SACHET GF 20\n",
      "  3400927696091 | DICLOFENAC CRT 1% GEL FL 100G 1\n",
      "  3400927697104 | FLECAINIDE ARL 100MG CPR 30\n",
      "  3400927701917 | EBASTINE VIATRIS 10MG CPR ORODISP 30\n",
      "  3400927702686 | EBASTINE ZEN 10 MG CPR ORODISP 30\n",
      "  3400927703287 | EBASTINE BGA 10MG CPR ORODISP 30\n",
      "  3400927704697 | EBASTINE ARW 10 MG CPR ORODISP 30\n",
      "  3400927705120 | CEFTRIAXONE SDZ 1G/10ML PDR INJ IV 1\n",
      "  3400927705298 | CEFTRIAXONE SDZ 1G/3,5ML PDR INJ IM 1\n",
      "  3400927706998 | IOMERON 350 FV 150ML TR NEMOTO 1\n",
      "  3400927707070 | SOVALDI 400 MG CPR 28\n",
      "  3400927707360 | IOMERON 400 FV 150ML TR NEMOTO 1\n",
      "  3400927708022 | BRINTELLIX 5MG CPR 28\n",
      "  3400927708190 | BRINTELLIX 10MG CPR 28\n",
      "  3400927708251 | BRINTELLIX 15MG CPR 28\n",
      "  3400927708312 | BRINTELLIX 20MG CPR 28\n",
      "  3400927708541 | CORBILTA 75 MG/ 18,75 MG/ 200 MG CPR 100\n",
      "  3400927710780 | RALOXIFENE ARW 60MG CPR 28\n",
      "  3400927711091 | RALOXIFENE ARW 60MG CPR 84\n",
      "  3400927711503 | IRBESARTAN EVO 75 MG CPR PELL 30\n",
      "  3400927711961 | IRBESARTAN EVO 75 MG CPR PELL 90\n",
      "  3400927712272 | IRBESARTAN EVO 150 MG CPR PELL 30\n",
      "  3400927712623 | IRBESARTAN EVO 150 MG CPR PELL 90\n",
      "  3400927712913 | IRBESARTAN EVO 300 MG CPR PELL 30\n",
      "  3400927713392 | IRBESARTAN EVO 300 MG CPR PELL 90\n",
      "  3400927713972 | BROMAZEPAM ARW 1,5MG CPR 120\n",
      "  3400927714283 | LEVONOR/ETHINYL SDZ 100/20MICROG CPR 21\n",
      "  3400927714344 | LEVONOR/ETHINYL SDZ 100/20MICROG CPR 63\n",
      "  3400927714573 | NOVORAPID PUMPCART 160U SOL INJ CART 5\n",
      "  3400927714634 | TIVICAY 50MG CPR 30\n",
      "  3400927716065 | ESCITALOPRAM ARW 5MG CPR 28\n",
      "  3400927716645 | ESCITALOPRAM ARW 10MG CPR 28\n",
      "  3400927717246 | ESCITALOPRAM ARW 15MG CPR 28\n",
      "  3400927717994 | ESCITALOPRAM ARW 20MG CPR 28\n",
      "  3400927721847 | ABILIFY MAINTENA LP 300 MG SOL INJ 1\n",
      "  3400927721908 | ABILIFY MAINTENA LP 400 MG SOL INJ 1\n",
      "  3400927722097 | REVESTIVE 5MG PDR ET SOL INJ 28\n",
      "  3400927723278 | STRIVERDI RESPIMAT 2,5MCG SOL INH 1\n",
      "  3400927723629 | BISOPROLOL QVR 1,25MG CPR 30\n",
      "  3400927723858 | BISOPROLOL QVR 1,25MG CPR 90\n",
      "  3400927724749 | BISOPROLOL QVR 2,5MG CPR 30\n",
      "  3400927725869 | BISOPROLOL QVR 3,75MG CPR 30\n",
      "  3400927726989 | BISOPROLOL QVR 5MG CPR 30\n",
      "  3400927727122 | BISOPROLOL QVR 5MG CPR 90\n",
      "  3400927727931 | BISOPROLOL QVR 7,5MG CPR 30\n",
      "  3400927728822 | BISOPROLOL QVR 10MG CPR 30\n",
      "  3400927729652 | GLICLAZIDE EGG LM 30 MG CPR 30\n",
      "  3400927729881 | GLICLAZIDE EGG LM 30 MG CPR 60\n",
      "  3400927730023 | GLICLAZIDE EGG LM 30 MG CPR 180\n",
      "  3400927731082 | ELETRIPTAN QUIVER 20 MG CPR PEL 6\n",
      "  3400927731204 | ELETRIPTAN QVR 40MG CPR PEL 6\n",
      "  3400927731433 | ELETRIPTAN QVR 40MG CPR PEL 10\n",
      "  3400927732034 | KINERET 100 MG SOL INJ SER 7\n",
      "  3400927733734 | ESCITALOPRAM ZTL 5MG CPR 28\n",
      "  3400927734106 | ESCITALOPRAM ZTL 10MG CPR 28\n",
      "  3400927734564 | ESCITALOPRAM ZTL 15MG CPR 28\n",
      "  3400927734854 | ESCITALOPRAM ZTL 20MG CPR 28\n",
      "  3400927735684 | DILTIAZEM GNR LP 200 MG GELULE 30\n",
      "  3400927737008 | DILTIAZEM GNR LP 300 MG GELULE 30\n",
      "  3400927737756 | DILTIAZEM GNR LP 300 MG GELULE 90\n",
      "  3400927738067 | CELECOXIB HCS 200MG GELULE 30\n",
      "  3400927738357 | CELECOXIB HCS 100MG GELULE 30\n",
      "  3400927738586 | ESCITALOPRAM TVC 5MG CPR 14\n",
      "  3400927738647 | ESCITALOPRAM TVC 5MG CPR 28\n",
      "  3400927738708 | ESCITALOPRAM TVC 10MG CPR 28\n",
      "  3400927738876 | ESCITALOPRAM TVC 15MG CPR 28\n",
      "  3400927738937 | ESCITALOPRAM TEVA 20 MG CPR 28\n",
      "  3400927739309 | CLOPIDOGREL TVC 75 MG CPR 30\n",
      "  3400927740428 | ESCITALOPRAM ZYD 5MG CPR 14\n",
      "  3400927740596 | ESCITALOPRAM ZYD 5MG CPR 28\n",
      "  3400927740657 | ESCITALOPRAM ZYD 10MG CPR 28\n",
      "  3400927741548 | ESCITALOPRAM ZYD 15MG CPR 28\n",
      "  3400927748752 | OXYCODONE EG LP 5 MG CPR 28\n",
      "  3400927749872 | ESCITALOPRAM ZYD 20MG CPR 28\n",
      "  3400927749933 | AMOX/AC CLAV CRT 1 G/125 MG AD SACH 8\n",
      "  3400927750014 | AMOX/AC CLAV CRT 1 G/125 MG AD SACH 12\n",
      "  3400927750182 | AMOX/AC CLAV SUN 1G/125MG AD SACH 8\n",
      "  3400927750243 | AMOX/AC CLAV SUN 1G/125MG AD SACH 12\n",
      "  3400927750304 | AMOX/AC CLAV ALM 1 G/125 MG AD SACH 8\n",
      "  3400927750472 | AMOX/AC CLAV ALM 1 G/125 MG AD SACH 12\n",
      "  3400927750533 | AMOX/AC CLAV TVC 1G/125 MG PDR ORALE 8\n",
      "  3400927750762 | AMOX/AC CLAV TVC 1G/125 MG PDR ORALE 12\n",
      "  3400927751653 | OXYCODONE EG LP 10MG CPR 28\n",
      "  3400927753725 | OXYCODONE EG LP 15MG CPR 28\n",
      "  3400927755095 | OXYCODONE EG LP 20MG CPR 28\n",
      "  3400927756337 | OXYCODONE EG LP 30MG CPR 28\n",
      "  3400927757976 | OXYCODONE EG LP 40MG CPR 28\n",
      "  3400927759239 | OXYCODONE EG LP 60MG CPR 28\n",
      "  3400927760587 | OXYCODONE EG LP 80MG CPR 28\n",
      "  3400927761300 | AC ZOLEDRONIQUE BGA 4MG INJ FL 100ML 1\n",
      "  3400927761768 | AC ZOLEDRONIQUE MYL 4MG SOL INJ 1\n",
      "  3400927783760 | OXYCODONE BGA LP 5 MG CPR 28\n",
      "  3400927785023 | OXYCODONE BGA LP 10 MG CPR 28\n",
      "  3400927786372 | OXYCODONE BGA LP 15 MG CPR 28\n",
      "  3400927787782 | OXYCODONE BGA LP 20 MG CPR 28\n",
      "  3400927789045 | OXYCODONE BGA LP 30 MG CPR 28\n",
      "  3400927790454 | OXYCODONE BGA LP 40 MG CPR 28\n",
      "  3400927791635 | OXYCODONE BGA LP 60 MG CPR 28\n",
      "  3400927793066 | OXYCODONE BGA LP 80 MG CPR 28\n",
      "  3400927793875 | PERINDOPRIL CRT 2,5 MG CPR 30\n",
      "  3400927794247 | PERINDOPRIL CRT 5 MG CPR 30\n",
      "  3400927797149 | ULTRAVIST 300 SOL INJ FV100ML MED 1\n",
      "  3400927797668 | DILTIAZEM VIATRIS LP 200MG GELULE 30\n",
      "  3400927797958 | DILTIAZEM VIATRIS LP 200MG GELULE 90\n",
      "  3400927798269 | DILTIAZEM VIATRIS LP 300MG GELULE 30\n",
      "  3400927798559 | DILTIAZEM VIATRIS LP 300MG GELULE 90\n",
      "  3400927799211 | ULTRAVIST 37 G SOL INJ MED 1\n",
      "  3400927799389 | ULTRAVIST 55.5 G SOL INJ MED 1\n",
      "  3400927800023 | AC ZOLEDRONIQUE VTS 4MG SOL INJ 1\n",
      "  3400927801662 | BETAHISTINE ZYF 8MG CPR 90\n",
      "  3400927801891 | BETAHISTINE ZYF 24MG CPR 60\n",
      "  3400927802492 | LEVETIRACETAM CRT 250MG CPR 60\n",
      "  3400927803215 | LEVETIRACETAM CRT 500MG CPR 60\n",
      "  3400927805455 | LEVETIRACETAM CRT 1000MG CPR 60\n",
      "  3400927808296 | ESCITALOPRAM KRK 20MG CPR 28\n",
      "  3400927808708 | ESCITALOPRAM KRK 15MG CPR 28\n",
      "  3400927809187 | ESCITALOPRAM KRK 10MG CPR 28\n",
      "  3400927809538 | ESCITALOPRAM KRK 5MG CPR 28\n",
      "  3400927810596 | LEVONORGESTREL EG 1,5MG CPR 1\n",
      "  3400927810947 | CELECOXIB SDZ 100MG GELULE 30\n",
      "  3400927811609 | CELECOXIB SDZ 200MG GELULE 30\n",
      "  3400927812378 | EBASTINE VIATRIS 10MG CPR 30\n",
      "  3400927812897 | EBASTINE ZEN 10 MG CPR 30\n",
      "  3400927813030 | EBASTINE BGA 10MG CPR 15\n",
      "  3400927813320 | EBASTINE BGA 10MG CPR 30\n",
      "  3400927814150 | EBASTINE ARW 10 MG CPR 30\n",
      "  3400927817861 | OMEPRAZOLE ZTL 10MG GELULE 14\n",
      "  3400927817922 | OMEPRAZOLE ZTL 10MG GELULE 28\n",
      "  3400927818004 | OMEPRAZOLE ZTL 20MG GELULE 14\n",
      "  3400927818172 | OMEPRAZOLE ZTL 20MG GELULE 28\n",
      "  3400927818752 | DOPACEPTIN 100 MG SOL INJ 5\n",
      "  3400927821592 | ESOMEPRAZOLE EGL 20MG CPR 7\n",
      "  3400927821653 | ESOMEPRAZOLE EGL 20MG CPR 14\n",
      "  3400927821714 | ESOMEPRAZOLE EGL 20MG CPR 28\n",
      "  3400927822483 | ESOMEPRAZOLE EGL 40MG CPR 14\n",
      "  3400927822544 | ESOMEPRAZOLE EGL 40MG CPR 28\n",
      "  3400927823374 | ESOMEPRAZOLE EVO 20MG CPR 14\n",
      "  3400927823435 | ESOMEPRAZOLE EVO 20MG CPR 28\n",
      "  3400927824326 | ESOMEPRAZOLE EVO 40MG CPR 14\n",
      "  3400927824494 | ESOMEPRAZOLE EVO 40MG CPR 28\n",
      "  3400927824845 | ROACTEMRA 162 MG SOL INJ SER 4\n",
      "  3400927827747 | ESCITALOPRAM CRT 5MG CPR 28\n",
      "  3400927830068 | ESCITALOPRAM CRT 10MG CPR 28\n",
      "  3400927831997 | ESCITALOPRAM CRT 15MG CPR 28\n",
      "  3400927832710 | ESCITALOPRAM CRT 20MG CPR 28\n",
      "  3400927835841 | GLYCER/VASEL/PARAF VIATRIS CREME 1\n",
      "  3400927836503 | MONTELUKAST ARW 4MG GRANULES 28\n",
      "  3400927838163 | LOLISTREL GE 100MCG/20MCG CPR 21\n",
      "  3400927838224 | LOLISTREL GE 100MCG/20MCG CPR 63\n",
      "  3400927838453 | LEVONOR/ETHINYL EG 100/20MICROG CPR 63\n",
      "  3400927838514 | GLYCER/VASEL/PARAF SDZ CREME 1\n",
      "  3400927838682 | GLYCER/VASEL/PARAF ARW CREME 1\n",
      "  3400927838743 | DEXATOPIA CREME TUBE 250G 1\n",
      "  3400927839405 | PERINDOPRIL BGA 2,5MG CPR 30\n",
      "  3400927839863 | PERINDOPRIL BGA 2,5MG CPR 90\n",
      "  3400927840463 | PERINDOPRIL BGA 5MG CPR 30\n",
      "  3400927840753 | PERINDOPRIL BGA 5MG CPR 90\n",
      "  3400927841293 | PERINDOPRIL BGA 10MG CPR 30\n",
      "  3400927841583 | PERINDOPRIL BGA 10MG CPR 90\n",
      "  3400927841934 | ACIDE FOLIQUE VIATRIS 5MG CPR 20\n",
      "  3400927842016 | ACIDE FOLIQUE VIATRIS 5MG CPR 20\n",
      "  3400927842535 | CELECOXIB EG 100MG GELULE 30\n",
      "  3400927842825 | CELECOXIB EG 200MG GELULE 30\n",
      "  3400927846847 | OMEPRAZOLE ZTL 20MG GELULE 7\n",
      "  3400927847158 | ESCITALOPRAM ALM 5MG CPR 28\n",
      "  3400927847509 | ESCITALOPRAM ALM 15MG CPR 28\n",
      "  3400927847738 | ESCITALOPRAM ALM 10MG CPR 28\n",
      "  3400927848049 | ESCITALOPRAM ALM 20MG CPR 28\n",
      "  3400927848339 | AZITHROMYCINE KRK 250MG CPR 6\n",
      "  3400927851179 | ESCITALOPRAM ZEN 5 MG CPR 14\n",
      "  3400927851469 | ESCITALOPRAM ZEN 5 MG CPR 28\n",
      "  3400927851810 | ESCITALOPRAM ZEN 10 MG CPR 28\n",
      "  3400927852299 | ESCITALOPRAM ZEN 15 MG CPR 28\n",
      "  3400927855023 | MOXIFLOXACINE VIATRIS 400 MG CPR 5\n",
      "  3400927855191 | MOXIFLOXACINE VIATRIS 400 MG CPR 7\n",
      "  3400927855252 | MOXIFLOXACINE VIATRIS 400 MG CPR 5\n",
      "  3400927855313 | MOXIFLOXACINE VIATRIS 400 MG CPR 7\n",
      "  3400927856372 | VALGANCICLOVIR TVS 450MG CPR 60\n",
      "  3400927856723 | EZETIMIBE RBX 10MG CPR 28\n",
      "  3400927857034 | EZETIMIBE RBX 10MG CPR 90\n",
      "  3400927858444 | CELECOXIB ARW 100MG GELULE 30\n",
      "  3400927859274 | CELECOXIB ARW 200MG GELULE 30\n",
      "  3400927861055 | CELECOXIB VTS 100MG GELULE 30\n",
      "  3400927861284 | CELECOXIB VTSG 200MG GELULE 30\n",
      "  3400927870859 | LANSOPRAZOLE BGA 15MG CPR OROD 14\n",
      "  3400927870910 | LANSOPRAZOLE BGA 15MG CPR OROD 28\n",
      "  3400927871221 | LANSOPRAZOLE BGA 30 MG CPR OROD 14\n",
      "  3400927871399 | LANSOPRAZOLE BGA 30 MG CPR OROD 28\n",
      "  3400927871689 | ESOMEPRAZOLE ALT 20 MG CPR 28\n",
      "  3400927873690 | ESOMEPRAZOLE ALT 40 MG CPR 28\n",
      "  3400927875472 | DUORESP SPIROMAX 160/4,5 MCG INHAL 1\n",
      "  3400927875533 | DUORESP SPIROMAX 320/9 MCG INHAL 1\n",
      "  3400927875991 | BIMATOPROST SDZ 0,9 MG COLLYRE SOL 1\n",
      "  3400927880216 | TRAVOPROST TVC 40 MCG/ML COLLYRE 1\n",
      "  3400927883637 | HEMANGIOL 3,75 MG/ML SOL BUV 1\n",
      "  3400927886768 | XIGDUO 5MG/1000MG CPR 60\n",
      "  3400927886829 | XIGDUO 5MG/1000MG CPR 60\n",
      "  3400927886997 | TRAVOPROST BGR 40 MCG/ML COLLYRE 1\n",
      "  3400927887079 | TRAVOPROST EG 40 MCG/ML COLLYRE 1\n",
      "  3400927887598 | XELEVIA 50 MG CPR 30\n",
      "  3400927887659 | XELEVIA 100 MG CPR 30\n",
      "  3400927887710 | JANUVIA 50 MG CPR 30\n",
      "  3400927887888 | JANUVIA 100 MG CPR 30\n",
      "  3400927888601 | OXYCODONE VIATRIS LP 80MG CPR 28\n",
      "  3400927889080 | OXYCODONE VIATRIS LP 5MG CPR 28\n",
      "  3400927889370 | OXYCODONE MYL LP 10MG CPR 28\n",
      "  3400927889721 | OXYCODONE VIATRIS LP 20MG CPR 28\n",
      "  3400927890031 | OXYCODONE VIATRIS LP 40MG CPR 28\n",
      "  3400927891380 | CELECOXIB MYP 100MG GELULE 30\n",
      "  3400927891960 | CELECOXIB MYP 200MG GELULE 30\n",
      "  3400927892851 | JARDIANCE 10 MG CPR 30\n",
      "  3400927892912 | JARDIANCE 25 MG CPR 30\n",
      "  3400927893223 | CROMOGLICATE VTS 2% COLLYRE FL 5ML 1\n",
      "  3400927893391 | CROMOGLICATE VTS 2% COLLYRE FL 10ML 1\n",
      "  3400927894633 | HYDROXYZINE ZEN 25MG CPR 30\n",
      "  3400927895234 | HYDROXYZINE ZEN 25MG CPR 30\n",
      "  3400927895814 | HYDROXYZINE VIATRIS 25MG CPR 30\n",
      "  3400927896354 | HYDROXYZINE VIATRIS 25MG CPR 30\n",
      "  3400927896873 | HYDROXYZINE SDZ 25MG CPR 30\n",
      "  3400927897306 | HYDROXYZINE SDZ 25MG CPR 30\n",
      "  3400927898075 | HYDROXYZINE BGA 25MG CPR 30\n",
      "  3400927898655 | HYDROXYZINE BGA 25MG CPR 30\n",
      "  3400927899195 | HYDROXYZINE ARW 25MG CPR 30\n",
      "  3400927899607 | HYDROXYZINE ARW 25MG CPR 30\n",
      "  3400927902659 | RAMIPRIL ARG 2.5 MG CPR 90\n",
      "  3400927903021 | OVALEAP 300 UI SOL INJ CART 1\n",
      "  3400927903199 | OVALEAP 450UI SOL INJ CART 1\n",
      "  3400927903250 | OVALEAP 900UI SOL INJ CART 1\n",
      "  3400927908163 | GADOVIST 1MMOL/ML SOL INJ FL 2ML 1\n",
      "  3400927909924 | ALGINATE BICAR SODIUM VIATRIS SACHET 24\n",
      "  3400927910524 | DESLORATADINE EVO 5MG CPR 15\n",
      "  3400927910982 | DESLORATADINE EVO 5MG CPR 30\n",
      "  3400927913655 | CREON 5000U GLE GASTRO FL20G 1\n",
      "  3400927913716 | IPRATROPIUM SDZ 0,5MG/2ML AD INHAL 10\n",
      "  3400927914485 | IPRATROPIUM SDZ 0,25MG/1ML ENF INHAL 30\n",
      "  3400927916267 | EZETIMIBE VTS 10MG CPR 28\n",
      "  3400927916786 | EZETIMIBE VTS 10MG CPR 30\n",
      "  3400927916908 | EZETIMIBE VTS 10MG CPR 90\n",
      "  3400927918100 | EZETIMIBE VTS 10MG CPR 28\n",
      "  3400927918797 | ALMOTRIPTAN BGA 12,5MG CPR 6\n",
      "  3400927918858 | ALMOTRIPTAN BGA 12,5MG CPR 12\n",
      "  3400927919800 | ALENDRONIQUE ACIDE ARL 70MG CPR 4\n",
      "  3400927920059 | ALENDRONIQUE ACIDE ARL 70MG CPR 12\n",
      "  3400927920639 | OMEPRAZOLE ARW 20MG GELULE 28\n",
      "  3400927922640 | NICOPASS CITRON 2MG SS GOMME 96\n",
      "  3400927923760 | NICOPASS CITRON 4MG GOMME SS SUCRE 96\n",
      "  3400927924880 | NICOPASS MENTHE 2MG GOMME SS SUCRE 96\n",
      "  3400927925832 | NICOPASS MENTHE 4MG GOMME SS SUCRE 96\n",
      "  3400927926372 | ESCITALOPRAM ZEN 20 MG CPR 28\n",
      "  3400927926433 | MOXIFLOXACINE KRK 400 MG CPR 5\n",
      "  3400927926662 | MOXIFLOXACINE KRK 400 MG CPR 7\n",
      "  3400927927034 | ALGINATE BICAR SODIUM SDZ SACHET 24\n",
      "  3400927927492 | ALGINATE BICAR SODIUM ZEN SUSP BUV 24\n",
      "  3400927928383 | AMOXICILLINE ZTL 500MG/5ML PDR ORALE 1\n",
      "  3400927928505 | AMOXICILLINE ZTL 250MG/5ML PDR ORALE 1\n",
      "  3400927928734 | AMOXICILLINE ZTL 125MG/5ML PDR BUV 1\n",
      "  3400927928963 | AMOXICILLINE ZTL 1G CPR DISP 6\n",
      "  3400927929045 | AMOXICILLINE ZTL 1G CPR DISP 14\n",
      "  3400927929335 | AMOXICILLINE ZTL 500MG GELULE 12\n",
      "  3400927929625 | SIMBRINZA COLLYRE 5ML 1\n",
      "  3400927929854 | LANSOPRAZOLE SDZ 15MG CPR OROD 14\n",
      "  3400927929915 | LANSOPRAZOLE SDZ 15MG CPR OROD 28\n",
      "  3400927930683 | LANSOPRAZOLE SDZ 30MG CPR OROD 28\n",
      "  3400927931116 | LANSOPRAZOLE ZEN 15MG CPR OROD 14\n",
      "  3400927931284 | LANSOPRAZOLE ZEN 15MG CPR OROD 28\n",
      "  3400927931864 | LANSOPRAZOLE ZEN 30MG CPR OROD 14\n",
      "  3400927931925 | LANSOPRAZOLE ZEN 30MG CPR OROD 28\n",
      "  3400927932526 | LANSOPRAZOLE EG 15MG CPR OROD 14\n",
      "  3400927932694 | LANSOPRAZOLE EG 15MG CPR OROD 28\n",
      "  3400927933127 | LANSOPRAZOLE EG 30MG CPR OROD 14\n",
      "  3400927933295 | LANSOPRAZOLE EG 30MG CPR OROD 28\n",
      "  3400927937729 | AMOXICILLINE ARL 500MG GELULE 12\n",
      "  3400927938030 | PREGABALINE PFZ 25 MG GELULE 56\n",
      "  3400927938269 | PREGABALINE PFZ 25 MG GELULE 84\n",
      "  3400927938320 | PREGABALINE PFZ 50 MG GELULE 84\n",
      "  3400927938498 | PREGABALINE PFZ 75 MG GELULE 56\n",
      "  3400927938559 | PREGABALINE PFZ 100 MG GELULE 84\n",
      "  3400927938610 | PREGABALINE PFZ 150 MG GELULE 56\n",
      "  3400927938788 | PREGABALINE PFZ 200 MG GELULE 84\n",
      "  3400927938849 | PREGABALINE PFZ 300 MG GELULE 56\n",
      "  3400927939099 | BEMFOLA 75 UI SOL INJ STYLO 1\n",
      "  3400927939150 | BEMFOLA 150 UI SOL INJ STYLO 1\n",
      "  3400927939211 | BEMFOLA 225 UI SOL INJ STYLO 1\n",
      "  3400927939389 | BEMFOLA 300 UI SOL INJ STYLO 1\n",
      "  3400927939440 | BEMFOLA 450UI SOL INJ STYLO 1\n",
      "  3400927939501 | MOMETASONE TVC 50 MICROG SUSP NASALE 1\n",
      "  3400927939730 | AMOROLFINE BGR 5% VERNIS MED 20SP 1\n",
      "  3400927940040 | AMOROLFINE ARW 5% VERNIS MED 20SP 1\n",
      "  3400927942921 | PERINDOPRIL TVC 2,5MG CPR 30\n",
      "  3400927943232 | PERINDOPRIL TVC 2,5MG CPR 90\n",
      "  3400927943461 | PERINDOPRIL TVC 5 MG CPR 30\n",
      "  3400927943751 | PERINDOPRIL TVC 5 MG CPR 90\n",
      "  3400927943812 | PERINDOPRIL TVC 10 MG CPR 30\n",
      "  3400927944123 | PERINDOPRIL TVC 10 MG CPR 90\n",
      "  3400927944352 | MEKINIST 0,5 MG CPR 30\n",
      "  3400927944703 | MEKINIST 2 MG CPR 30\n",
      "  3400927946073 | DAIVOBET 50 MICROG/0,5MG/G GEL CART 1\n",
      "  3400927946363 | ISENTRESS 100MG GRANULES SUSP BUV 60\n",
      "  3400927946424 | TIMOFEROL 50 MG CPR 30\n",
      "  3400927946653 | TIMOFEROL 50 MG CPR 90\n",
      "  3400927946943 | DOTAREM 0,5 MMOL/ML INJ SER 15ML+NEC 1\n",
      "  3400927947025 | DOTAREM 0,5 MMOL/ML INJ SER 20ML+NEC 1\n",
      "  3400927948954 | TRIUMEQ 50MG/600MG/300MG CPR 30\n",
      "  3400927949036 | PLEGRIDY 63/94 MCG SOL INJ SER 2\n",
      "  3400927949265 | PLEGRIDY 63/94 MCG SOL INJ STYLO 2\n",
      "  3400927949326 | PLEGRIDY 125 MCG SOL INJ SER 2\n",
      "  3400927949555 | PLEGRIDY 125 MCG SOL INJ STYLO 2\n",
      "  3400927949784 | SEVELAMER CARBONATE TVC 800MG CPR 180\n",
      "  3400927949845 | IMBRUVICA 140 MG GELULE 90\n",
      "  3400927949906 | IMBRUVICA 140 MG GELULE 120\n",
      "  3400927952166 | CELECOXIB ZYD 100MG GELULE 30\n",
      "  3400927952456 | CELECOXIB ZYD 200 MG GELULE 30\n",
      "  3400927954177 | VORICONAZOLE VTS 50MG CPR 28\n",
      "  3400927954528 | VORICONAZOLE VTS 50MG CPR 56\n",
      "  3400927955709 | VORICONAZOLE VTS 200MG CPR 28\n",
      "  3400927956010 | VORICONAZOLE VTS 200MG CPR 56\n",
      "  3400927956478 | DULCILARMES 1,5% COLLYRE UNIDOSE 60\n",
      "  3400927959660 | ZYDELIG 100 MG CPR 60\n",
      "  3400927959721 | ZYDELIG 150 MG CPR 60\n",
      "  3400927960321 | XENETIX 300 SOL INJ POC 100ML INJ 1\n",
      "  3400927960499 | XENETIX 300 SOL INJ POC 150ML INJ 1\n",
      "  3400927966064 | OMEPRAZOLE ALT 20MG GELULE 28\n",
      "  3400927966705 | XENETIX 350 SOL INJ POC 100ML INJ 1\n",
      "  3400927966873 | XENETIX 350 SOL INJ POC150ML INJ 1\n",
      "  3400927967184 | METFORMINE ARL 500MG CPR 30\n",
      "  3400927968136 | METFORMINE ARL 500MG CPR 90\n",
      "  3400927969317 | EPLERENONE TVC 25 MG CPR 30\n",
      "  3400927969775 | EPLERENONE TVC 25 MG CPR 90\n",
      "  3400927970207 | METFORMINE ARL 850 MG CPR 30\n",
      "  3400927971785 | METFORMINE ARL 850 MG CPR 90\n",
      "  3400927973109 | EPLERENONE TVC 50 MG CPR 30\n",
      "  3400927973628 | EPLERENONE TVC 50 MG CPR 90\n",
      "  3400927974397 | METFORMINE ARL 1000MG CPR 30\n",
      "  3400927974977 | METFORMINE ARL 1000MG CPR 90\n",
      "  3400927975288 | ESOMEPRAZOLE EVP 20MG GELULE 14\n",
      "  3400927975349 | ESOMEPRAZOLE EVP 20MG GELULE 28\n",
      "  3400927975578 | ESOMEPRAZOLE EVP 40MG GELULE 14\n",
      "  3400927975639 | ESOMEPRAZOLE EVP 40MG GELULE 28\n",
      "  3400927976469 | AMISULPRIDE VIATRIS 100MG CPR 30\n",
      "  3400927977411 | AMISULPRIDE VIATRIS 200MG CPR 60\n",
      "  3400927977879 | AMISULPRIDE VIATRIS 400MG CPR 30\n",
      "  3400927982491 | MILEVONI 0.15/0,03MG CPR 63\n",
      "  3400927982613 | LEVONOR/ETHINYL EG 0.15/0,03MG CPR 63\n",
      "  3400927983153 | LYMECYCLINE ARW 408MG GELULE 28\n",
      "  3400927983672 | CLOPIDOGREL ACC 75MG CPR 30\n",
      "  3400927984334 | LEPTAX 250 MG CPR 60\n",
      "  3400927984853 | LEPTAX 500 MG CPR 60\n",
      "  3400927985393 | LEPTAX 750 MG CPR 60\n",
      "  3400927989995 | AMOROLFINE CRT 5% VERNIS MED 20SP 1\n",
      "  3400927990656 | EBASTINE SDZ 10 MG CPR ORODISP 30\n",
      "  3400927996979 | LEVIDCEN 250MG GRANULES SAC 60\n",
      "  3400927997570 | LEVIDCEN 500MG GRANULES SAC 60\n",
      "  3400927998232 | LEVIDCEN 750MG GRANULES SAC 60\n",
      "  3400927998980 | LEVIDCEN 1000 MG GRANULES SAC 60\n",
      "  3400927999703 | LIPOROSA 10MG/10MG GELULE 30\n",
      "  3400928000125 | LIPOROSA 10MG/10MG GELULE 90\n",
      "  3400928000415 | LIPOROSA 20MG/10MG GELULE 30\n",
      "  3400928000873 | LIPOROSA 20MG/10MG GELULE 90\n",
      "  3400928000934 | CANDESARTAN/HCTZ EVO 8/12,5 MG CPR 30\n",
      "  3400928001016 | CANDESARTAN/HCTZ EVO 8/12,5 MG CPR 90\n",
      "  3400928001184 | CANDESARTAN/HCTZ EVO 16/12,5 MG CPR 30\n",
      "  3400928001245 | CANDESARTAN/HCTZ EVO 16/12,5 MG CPR 90\n",
      "  3400928001306 | METHYLPHENIDATE VIATRIS LP 18MG CPR 28\n",
      "  3400928001535 | METHYLPHENIDATE VIATRIS LP 36MG CPR 28\n",
      "  3400928001825 | METHYLPHENIDATE VIATRIS LP 54MG CPR 28\n",
      "  3400928004895 | LIPTRUZET 10 MG/10 MG CPR 30\n",
      "  3400928004956 | LIPTRUZET 10 MG/10 MG CPR 90\n",
      "  3400928005038 | PAROXETINE SUN 20MG CPR 14\n",
      "  3400928005328 | LIPTRUZET 10 MG/20 MG CPR 30\n",
      "  3400928005496 | LIPTRUZET 10 MG/20 MG CPR 90\n",
      "  3400928005557 | LIPTRUZET 10 MG/40 MG CPR 30\n",
      "  3400928005618 | LIPTRUZET 10 MG/40 MG CPR 90\n",
      "  3400928005786 | LIPTRUZET 10 MG/80 MG CPR 30\n",
      "  3400928005847 | LIPTRUZET 10 MG/80 MG CPR 90\n",
      "  3400928008510 | LEVOD/C/E BGA 50/12.5/200MG CPR 100\n",
      "  3400928009050 | LEVOD/C/E BGA 75/18,75/200MG CPR 100\n",
      "  3400928009579 | LEVOD/C/E BGA 100/25/200MG CPR 100\n",
      "  3400928010179 | LEVOD/C/E BGA 125/31,25/200MG CPR 100\n",
      "  3400928010759 | LEVOD/C/E BGA 150/37,5/200MG CPR 100\n",
      "  3400928011299 | LEVOD/C/E BGA 175/43,75/200MG CPR 100\n",
      "  3400928011701 | LEVOD/C/E BGA 200/50/200MG CPR 100\n",
      "  3400928012012 | BYDUREON 2 MG LP PDR INJ STYLO 4\n",
      "  3400928019516 | ROPINIROLE ARW LP 2MG CPR 28\n",
      "  3400928020116 | ROPINIROLE ARW LP 4MG CPR 28\n",
      "  3400928020635 | ROPINIROLE ARW LP 8MG CPR 28\n",
      "  3400928021236 | DILTIAZEM ARW LP 200MG GELULE 30\n",
      "  3400928021694 | DILTIAZEM ARW LP 200MG GELULE 90\n",
      "  3400928021816 | DILTIAZEM ARW LP 300MG GELULE 30\n",
      "  3400928022127 | DILTIAZEM ARW LP 300MG GELULE 90\n",
      "  3400928022417 | ALMOTRIPTAN TVC 12,5MG CPR 6\n",
      "  3400928022585 | ALMOTRIPTAN TVC 12,5MG CPR 12\n",
      "  3400928022707 | VELPHORO 500 MG CPR CROQUER 90\n",
      "  3400928023476 | LEVONOR/ETHINYL BGA 0.15/0,03MG CPR 63\n",
      "  3400928023995 | CELECOXIB CRT 200 MG GELULE 30\n",
      "  3400928024886 | PARACETAMOL EVO 500 MG GELULE 16\n",
      "  3400928025777 | TARDYFERON 50 MG CPR 30\n",
      "  3400928028389 | FORMOTEROL VTS 12 MICROG PDR INH GEL 30\n",
      "  3400928028440 | FORMOTEROL VTS 12 MICROG PDR INH GEL 60\n",
      "  3400928030399 | FORMOTEROL ZEN 12 MICROG PDR INH GEL 30\n",
      "  3400928030450 | FORMOTEROL ZEN 12 MICROG PDR INH GEL 60\n",
      "  3400928099709 | VYNDAMAX 61MG CAPS 30\n",
      "  3400928099716 | VYNDAQEL 61 MG CAPSULE MOLLE 90\n",
      "  3400928099723 | TUBERSOL (DERIVE PROTEINIQUE PURIFIE DE TUBERCULIN\n",
      "  3400928099754 | FROVATRIPTAN TEVA 2,5 MG CPR 6\n",
      "  3400928099761 | VAXIGRIPTETRA HS SUSP INJ SER 1\n",
      "  3400928099792 | SOLUMEDROL 40MG/1ML PDR ET SOL INJ 1\n",
      "  3400928099815 | MINIRIN 2,5MCG/DOS NAS FL5ML 1\n",
      "  3400928099839 | VALIUM 10MG CPR 30\n",
      "  3400928099846 | INFLUSPLIT TETRA INJ S0,5ML SA 10\n",
      "  3400928099860 | FLUZONE HD INJ SRG0,7ML S/A 10\n",
      "  3400928099877 | VAXIGRIPTETRA SUSP INJ SER 0.5ML A/A 10\n",
      "  3400928099907 | VISUDYNE 15 MG PDR INJ 1\n",
      "  3400928099914 | MINURIN 0,1 MG/ML SOL PULV NAS FL5ML 1\n",
      "  3400928099938 | MYCOBUTIN 150 MG GELULE 30\n",
      "  3400928099945 | SOLUMEDROL 125MG PDR ET SOL INJ 1\n",
      "  3400928099952 | MYSOLINE 250MG CPR 60\n",
      "  3400928099976 | PREDNISOLONE TVC 5MG CPR 30\n",
      "  3400928099983 | PREDNISOLONE ACC 5MG CPR 28\n",
      "  3400928099990 | PREDNISOLONE APO 5MG CPR 30\n",
      "  3400930000649 | A313 50 000 UI CAPSULE 30\n",
      "  3400930000854 | HUMALOG 200 UI/ML KWIKPEN SOL INJ 5\n",
      "  3400930000885 | HARVONI 90MG/400MG CPR 28\n",
      "  3400930000915 | JANUMET 50MG/1000MG CPR 60\n",
      "  3400930000922 | VELMETIA 50MG/1000MG CPR 60\n",
      "  3400930001196 | ENVARSUS LP 0,75MG CPR 30\n",
      "  3400930001226 | ENVARSUS LP 1MG CPR 30\n",
      "  3400930001264 | ENVARSUS LP 4MG CPR 30\n",
      "  3400930001332 | CELECOXIB BGA 100MG GELULE 30\n",
      "  3400930001370 | CELECOXIB BGA 200MG GELULE 30\n",
      "  3400930001417 | SIGNIFOR 20 MG PDR SOLV SUSP INJ 1\n",
      "  3400930001424 | SIGNIFOR 40 MG PDR SOLV SUSP INJ 1\n",
      "  3400930001431 | SIGNIFOR 60 MG PDR SOLV SUSP INJ 1\n",
      "  3400930001479 | A313 POMMADE 1\n",
      "  3400930002209 | FUROSEMIDE ZEN 500MG CPR 30\n",
      "  3400930002230 | TOPISCAB 5% CREME TB 30G 1\n",
      "  3400930002278 | TOPALGIC 50MG GELULE 30\n",
      "  3400930002285 | CONTRAMAL 50MG GELULE 30\n",
      "  3400930002353 | CITALOPRAM MYL 20MG CPR 28\n",
      "  3400930002377 | SEVELAMER CARBONATE BGA 800 MG CPR 180\n",
      "  3400930002384 | SEVELAMER CARBONATE MYP 800MG CPR 180\n",
      "  3400930002452 | JAKAVI 10 MG CPR 56\n",
      "  3400930002926 | RABEPRAZOLE ALT 10MG CPR 28\n",
      "  3400930003060 | RABEPRAZOLE ALT 20MG CPR 28\n",
      "  3400930003220 | LEVOD/C/E EG 50/12.5/200MG CPR 100\n",
      "  3400930003305 | LEVOD/C/E EG 100/25/200MG CPR 100\n",
      "  3400930003381 | LEVOD/C/E EG 150/37,5/200MG CPR 100\n",
      "  3400930003459 | LEVOD/C/E EG 175/43,75/200MG CPR 100\n",
      "  3400930003534 | LEVOD/C/E EG 200/50/200MG CPR 100\n",
      "  3400930003626 | LEVOD/C/E EG 75/18,75/200MG CPR 100\n",
      "  3400930003657 | LEVOD/C/E EG 125/31,25/200MG CPR 100\n",
      "  3400930003671 | ZOPICLONE VIATRIS 7,5MG CPR 14\n",
      "  3400930003732 | TRULICITY 0,75 MG SOL INJ STYLO 4\n",
      "  3400930003763 | TRULICITY 1,5 MG SOL INJ STYLO 4\n",
      "  3400930003985 | LIDOCAINE/PRILOCAINE TVC 5% CREME 1\n",
      "  3400930004036 | LEVETIRACETAM KRK 250 MG CPR 60\n",
      "  3400930004104 | LEVETIRACETAM KRK 500 MG CPR 60\n",
      "  3400930004227 | LEVETIRACETAM KRK 1 000 MG CPR 60\n",
      "  3400930004241 | SODIUM CHL LAV 0,9% SOL INJ PP 50ML 1\n",
      "  3400930004258 | SODIUM CHL LAV 0,9% SOL INJ PP 100ML 1\n",
      "  3400930004265 | SODIUM CHL LAV 0,9% SOL INJ PP 250ML 1\n",
      "  3400930004272 | SODIUM CHL LAV 0,9% SOL INJ PP 500ML 1\n",
      "  3400930004289 | SODIUM CHL LAV 0,9% SOL INJ PP 1L 1\n",
      "  3400930004296 | LOSARTAN BGA 50MG CPR 90\n",
      "  3400930004319 | IMETH 2,5MG CPR 24\n",
      "  3400930004371 | CLARITHROMYCINE EG LM 500MG CPR 5\n",
      "  3400930004500 | DOTAREM 0,5MMOL/ML INJ SER 15ML+ N.A 1\n",
      "  3400930004517 | DOTAREM 0,5MMOL/ML INJ SER 20ML+ N.A 1\n",
      "  3400930004548 | CHOLECALCIFEROL ARW 2,5MG/2ML SOL BU 1\n",
      "  3400930004555 | CHOLECALCIFEROL SDZ 2,5MG/2ML SOL BU 1\n",
      "  3400930004562 | CHOLECALCIFEROL BGA 2,5MG/2ML SOL BU 1\n",
      "  3400930004579 | CHOLECALCIFEROL VTS 2,5MG/2ML SOL BU 1\n",
      "  3400930004593 | ANORO ELLIPTA 55MCG/22MCG PDR INH 30\n",
      "  3400930004609 | MOVENTIG 12.5 MG CPR 30\n",
      "  3400930004647 | INCRUSE ELT 55 MCG PDR INH UNIDOSE 30\n",
      "  3400930004678 | MOVENTIG 25MG CPR 30\n",
      "  3400930005248 | CETIRIZINE BGA 10 MG CPR 15\n",
      "  3400930005286 | ALMOTRIPTAN ZYD 12,5MG CPR 6\n",
      "  3400930005293 | ALMOTRIPTAN ZYD 12,5MG CPR 12\n",
      "  3400930005460 | ZANEXTRA 20MG/20MG CPR 30\n",
      "  3400930005521 | ZANEXTRA 20MG/20MG CPR 90\n",
      "  3400930005576 | LERCAPRESS 20MG/20MG CPR 30\n",
      "  3400930005637 | LERCAPRESS 20MG/20MG CPR 90\n",
      "  3400930005682 | EPLERENONE EG 25 MG CPR 30\n",
      "  3400930005712 | EPLERENONE EG 50 MG CPR 30\n",
      "  3400930005873 | EPLERENONE VTSG 25MG CPR 30\n",
      "  3400930005897 | EPLERENONE VTSG 25MG CPR 90\n",
      "  3400930005941 | EPLERENONE VTSG 50MG CPR 30\n",
      "  3400930005965 | EPLERENONE VTSG 50MG CPR 90\n",
      "  3400930005989 | EPLERENONE EG 25 MG CPR 90\n",
      "  3400930006009 | EPLERENONE EG 50 MG CPR 90\n",
      "  3400930006023 | OFEV 100MG CAPS 60\n",
      "  3400930006047 | OFEV 150MG CAPS 60\n",
      "  3400930006238 | HYDROXYZINE CRT 25MG CPR 30\n",
      "  3400930006283 | HYDROXYZINE CRT 25MG CPR 30\n",
      "  3400930006344 | HYDROXYZINE EG 25MG CPR 30\n",
      "  3400930006405 | HYDROXYZINE EG 25MG CPR 30\n",
      "  3400930006467 | HYDROXYZINE TVC 25MG CPR 30\n",
      "  3400930006528 | HYDROXYZINE TVC 25MG CPR 30\n",
      "  3400930007303 | AMOROLFINE EG 5% VERNIS MED III 1\n",
      "  3400930007327 | METYRAPONE HRA PHARMA 250MG CAPS 50\n",
      "  3400930007631 | KETOCONAZOLE HRA 200MG CPR 60\n",
      "  3400930007716 | VALSARTAN ARL 40MG CPR 90\n",
      "  3400930007723 | VALSARTAN ARL 80MG CPR 90\n",
      "  3400930007730 | VALSARTAN ARL 160MG CPR 90\n",
      "  3400930007990 | PARACETAMOL VIATRIS 500 MG GELULE 16\n",
      "  3400930008102 | BROMAZEPAM ARW 6MG CPR 30\n",
      "  3400930008218 | NICORANDIL EG 10MG CPR 30\n",
      "  3400930008232 | NICORANDIL EG 20MG CPR 30\n",
      "  3400930008256 | TRAVOPROST SDZ 40 MCG/ML COLLYRE 1\n",
      "  3400930008386 | AMIODARONE BGA 200MG CPR 30\n",
      "  3400930008713 | VALGANCICLOVIR SDZ 450MG CPR 60\n",
      "  3400930008720 | VALGANCICLOVIR VTS 450MG CPR 60\n",
      "  3400930008737 | PANTOPRAZOLE ACC 40 MG PDR INJ 1\n",
      "  3400930008775 | NATULAN 50MG GELULE 50\n",
      "  3400930008829 | AMOXICILLINE BGR 1 G CPR DISP 6\n",
      "  3400930008843 | AMOXICILLINE BGR 1 G CPR DISP 14\n",
      "  3400930008867 | AMOROLFINE ZEN 5% VERNIS MED III 1\n",
      "  3400930008881 | OTEZLA 10MG/ 20MG/ 30MG CPR 27\n",
      "  3400930008898 | OTEZLA 30 MG CPR 56\n",
      "  3400930008966 | VALGANCICLOVIR ARW 450MG CPR 60\n",
      "  3400930009291 | ADOPORT 2MG GELULE 50\n",
      "  3400930009543 | QUETIAPINE KRK LP 300 MG CPR 30\n",
      "  3400930009567 | QUETIAPINE KRK LP 300 MG CPR 60\n",
      "  3400930009734 | AMOROLFINE TVC 5% VERNIS MED III 1\n",
      "  3400930009772 | EPLERENONE ARW 25MG CPR 30\n",
      "  3400930009949 | EPLERENONE ARW 25MG CPR 90\n",
      "  3400930010129 | EPLERENONE ARW 50MG CPR 30\n",
      "  3400930010242 | QUETIAPINE VTS LP 50MG CPR 10\n",
      "  3400930010266 | QUETIAPINE VTS LP 50MG CPR 30\n",
      "  3400930010310 | QUETIAPINE VTS LP 300MG CPR 30\n",
      "  3400930010334 | QUETIAPINE VTS LP 300MG CPR 60\n",
      "  3400930010365 | QUETIAPINE VTS LP 400MG CPR 30\n",
      "  3400930010389 | QUETIAPINE VTS LP 400MG CPR 60\n",
      "  3400930010419 | ACCOFIL 30 MUI/0,5 ML SOL INJ SER 1\n",
      "  3400930010433 | ACCOFIL 30 MUI/0,5 ML SOL INJ SER 5\n",
      "  3400930010457 | ACCOFIL 48 MUI/0,5 ML SOL INJ SER 1\n",
      "  3400930010488 | ACCOFIL 48 MUI/0,5 ML SOL INJ SER 5\n",
      "  3400930010594 | COSENTYX 150 MG PDR INJ 1\n",
      "  3400930010600 | COSENTYX 150 MG INJ SERINGUE 1\n",
      "  3400930010617 | COSENTYX 150 MG INJ SERINGUE 2\n",
      "  3400930010624 | COSENTYX 150 MG INJ STYLO 1\n",
      "  3400930010631 | COSENTYX 150 MG INJ STYLO 2\n",
      "  3400930010662 | AMOXICILLINE MYP 1G CPR DISP 6\n",
      "  3400930010693 | BACTRIM AD CPR 20\n",
      "  3400930010716 | AMOXICILLINE MYP 1G CPR DISP 14\n",
      "  3400930010822 | GLICLAZIDE EG LM 60MG CPR 30\n",
      "  3400930010853 | GLICLAZIDE EG LM 60MG CPR 90\n",
      "  3400930010990 | GLICLAZIDE ZEN LM 60MG CPR 30\n",
      "  3400930011003 | GLICLAZIDE ZEN LM 60MG CPR 90\n",
      "  3400930011041 | VALGANCICLOVIR EG 450 MG CPR 60\n",
      "  3400930011096 | FORMOTEROL BGA 12 MICROG PDR INH GEL 30\n",
      "  3400930011102 | FORMOTEROL BGA 12 MICROG PDR INH GEL 60\n",
      "  3400930011515 | ESOMEPRAZOLE RBX 20MG CPR 14\n",
      "  3400930011539 | ESOMEPRAZOLE RBX 20MG CPR 28\n",
      "  3400930011638 | ESOMEPRAZOLE RBX 40MG CPR 14\n",
      "  3400930011669 | ESOMEPRAZOLE RBX 40MG CPR 28\n",
      "  3400930011867 | PROHANCE 4748,1MG SOL INJ SER + NEC 1\n",
      "  3400930011881 | PROHANCE 4748,1MG SOL INJ SER + NIA 1\n",
      "  3400930011942 | NEFOPAM MSO 20 MG SOL INJ 5\n",
      "  3400930011997 | GLYCER/VASEL/PARAF EG CREME 1\n",
      "  3400930012000 | GLYCER/VASEL/PARAF ZEN CREME 1\n",
      "  3400930012024 | GLYCER/VASEL/PARAF CRT CREME 1\n",
      "  3400930012048 | PRAMIPEXOLE SDZ 0,26MG CPR LP 30\n",
      "  3400930012109 | RETACRIT 2000 UI/0,6ML INJ SER + D 6\n",
      "  3400930012116 | RETACRIT 3000 UI SOL INJ SER + D 6\n",
      "  3400930012123 | RETACRIT 4000UI SOL INJ SER + D 6\n",
      "  3400930012130 | RETACRIT 5000 UI SOL INJ SER + D 6\n",
      "  3400930012147 | RETACRIT 6000 UI SOL INJ SER + D 6\n",
      "  3400930012154 | RETACRIT 8000 UI SOL INJ SER + D 6\n",
      "  3400930012178 | RETACRIT 10 000UI SOL INJ SER D 6\n",
      "  3400930012192 | RETACRIT 20 000UI INJ SER + D 1\n",
      "  3400930012208 | RETACRIT 30 000UI SOL INJ SER + D 1\n",
      "  3400930012215 | RETACRIT 40 000UI SOL INJ SER + D 1\n",
      "  3400930012260 | EUROBIOL 12 500 U GELULE 100\n",
      "  3400930012284 | EUROBIOL 40 000 U GELULE 50\n",
      "  3400930012307 | ADIAZINE 500MG CPR 20\n",
      "  3400930012314 | PRAMIPEXOLE SDZ 0,52MG CPR LP 30\n",
      "  3400930012338 | PRAMIPEXOLE SDZ 1,05MG CPR LP 30\n",
      "  3400930012376 | PRAMIPEXOLE SDZ 2,1MG CPR LP 30\n",
      "  3400930012437 | EPLERENONE VTS 25MG CPR 30\n",
      "  3400930012482 | EPLERENONE VTS 50MG CPR 30\n",
      "  3400930012635 | FUROSEMIDE ZYD 20MG CPR 30\n",
      "  3400930012659 | FUROSEMIDE ZYD 40MG CPR 30\n",
      "  3400930013434 | JINARC 15 MG CPR 7\n",
      "  3400930013458 | JINARC 30 MG CPR 7\n",
      "  3400930013632 | AMOROLFINE SDZ 5% VERNIS MED 2,5ML 1\n",
      "  3400930013649 | THYROFIX 25 MICROG CPR 30\n",
      "  3400930013687 | THYROFIX 25 MICROG CPR 100\n",
      "  3400930013748 | SUPPLIVEN SOL INJ AMP 10ML 20\n",
      "  3400930013755 | THYROFIX 50 MICROG CPR 30\n",
      "  3400930013786 | THYROFIX 50 MICROG CPR 100\n",
      "  3400930013793 | THYROFIX 75 MICROG CPR 30\n",
      "  3400930013823 | THYROFIX 75 MICROG CPR 100\n",
      "  3400930013847 | THYROFIX 100 MICROG CPR 30\n",
      "  3400930013878 | THYROFIX 100 MICROG CPR 100\n",
      "  3400930013953 | RESITUNE 75 MG CPR 30\n",
      "  3400930013984 | RESITUNE 75 MG CPR 90\n",
      "  3400930014035 | RESITUNE 100MG CPR 30\n",
      "  3400930014066 | RESITUNE 100MG CPR 90\n",
      "  3400930014103 | TRAMADOL VTS LP 100MG CPR 30\n",
      "  3400930014202 | TIANEPTINE VIATRIS 12,5MG CPR 28\n",
      "  3400930015193 | CLOXACILLINE ARW 500MG GELULE 16\n",
      "  3400930015223 | BRINZOLAMIDE SDZ 50 MG COLLY FL 5ML 1\n",
      "  3400930016060 | JINARC 15 MG / 45 MG CPR 112\n",
      "  3400930016091 | JINARC 30 MG / 60 MG CPR 56\n",
      "  3400930016114 | JINARC 30 MG / 90 MG CPR 56\n",
      "  3400930016169 | ABASAGLAR 300 U SOL INJ CART 5\n",
      "  3400930016213 | ABASAGLAR 300 U SOL INJ STYLO 5\n",
      "  3400930016237 | CHLORHEX/BENZ/ALC BENZ BGA SOL 250ML 1\n",
      "  3400930016312 | IMETH 7,5 MG/0,3 ML SOL INJ 4\n",
      "  3400930016343 | IMETH 10 MG/0,4 ML SOL INJ 4\n",
      "  3400930016367 | IMETH 12,5 MG/0,5 ML SOL INJ 4\n",
      "  3400930016381 | IMETH 15 MG/0,6 ML SOL INJ 4\n",
      "  3400930016404 | IMETH 17,5 MG/0,7 ML SOL INJ 4\n",
      "  3400930016428 | IMETH 20 MG/0,8 ML SOL INJ 4\n",
      "  3400930016442 | IMETH 22,5 MG/0,9 ML SOL INJ 4\n",
      "  3400930016466 | IMETH 25 MG/ML SOL INJ 4\n",
      "  3400930016671 | TOUJEO 300 UI/ML STYLO 1.5ML 3\n",
      "  3400930016688 | TOUJEO 300 UI/ML STYLO 1.5ML 5\n",
      "  3400930016732 | OLANZAPINE BGA 5MG CPR 30\n",
      "  3400930016749 | OLANZAPINE BGA 10 MG CPR 30\n",
      "  3400930016930 | RACECADOTRIL BGR 100MG GELULE 20\n",
      "  3400930017258 | ARIPIPRAZOLE TVC 10MG CPR 28\n",
      "  3400930017357 | ARIPIPRAZOLE TVC 5MG CPR 28\n",
      "  3400930017456 | ARIPIPRAZOLE TVC 15MG CPR 28\n",
      "  3400930017531 | LEVONOR/ETHINYL BGA 100/20MICROG CPR 21\n",
      "  3400930017548 | LEVONOR/ETHINYL BGA 100/20MICROG CPR 63\n",
      "  3400930017586 | MESTINON 180MG CPR LP 50\n",
      "  3400930017609 | MENJUGATE 10 MCG SUSP INJ SER 1\n",
      "  3400930017630 | IPRATROPIUM CRT 0,5MG/2ML AD INHAL 10\n",
      "  3400930017852 | LEVETIRACETAM EVO 500 MG CPR 60\n",
      "  3400930018064 | SYNJARDY 5MG/1000MG CPR 60\n",
      "  3400930018071 | SYNJARDY 12.5MG/1000MG CPR 60\n",
      "  3400930018118 | PREGABALINE MYL 25MG GELULE 56\n",
      "  3400930018125 | PREGABALINE MYL 25MG GELULE 84\n",
      "  3400930018149 | PREGABALINE MYL 50MG GELULE 84\n",
      "  3400930018163 | PREGABALINE MYL 75MG GELULE 56\n",
      "  3400930018187 | PREGABALINE MYL 100MG GELULE 84\n",
      "  3400930018200 | PREGABALINE MYL 150MG GELULE 56\n",
      "  3400930018224 | PREGABALINE MYL 200MG GELULE 84\n",
      "  3400930018248 | PREGABALINE MYL 300MG GELULE 56\n",
      "  3400930018514 | XULTOPHY 300 U + 10,8 MG SOL INJ 5\n",
      "  3400930018552 | DULOXETINE MYL 30 MG GELULE 28\n",
      "  3400930018590 | DULOXETINE MYL 60MG GELULE 28\n",
      "  3400930018613 | ZOPICLONE BGA 7,5MG CPR 14\n",
      "  3400930018712 | EPLERENONE VTS 25MG CPR 90\n",
      "  3400930018804 | EPLERENONE VTS 50MG CPR 90\n",
      "  3400930018941 | LENVIMA 4MG GELULE 30\n",
      "  3400930018958 | LENVIMA 10MG GELULE 30\n",
      "  3400930018972 | ABILIFY MAINTENA LP 400 MG INJ SER 1\n",
      "  3400930019207 | ORENCIA 125 MG SOL INJ STYLO 4\n",
      "  3400930019252 | PREGABALINE SDG 25 MG GELULE 56\n",
      "  3400930019269 | PREGABALINE SDG 25 MG GELULE 84\n",
      "  3400930019276 | PREGABALINE SDG 50 MG GELULE 84\n",
      "  3400930019283 | PREGABALINE SDG 75 MG GELULE 56\n",
      "  3400930019290 | PREGABALINE SDG 100 MG GELULE 84\n",
      "  3400930019306 | PREGABALINE SDG 150 MG GELULE 56\n",
      "  3400930019313 | PREGABALINE SDG 200 MG GELULE 84\n",
      "  3400930019320 | PREGABALINE SDG 300 MG GELULE 56\n",
      "  3400930019344 | EPLERENONE ZEN 25MG CPR 30\n",
      "  3400930019467 | EPLERENONE ZEN 50MG CPR 30\n",
      "  3400930019726 | EPORATIO 20 000 UI/1ML INJ SER + A 1\n",
      "  3400930019764 | EPORATIO 30 000 UI/1ML INJ SER + A 1\n",
      "  3400930019795 | ETORICOXIB ZYF 30 MG CPR 28\n",
      "  3400930019825 | ATORVASTATINE BGR 10 MG CPR 90\n",
      "  3400930019849 | ATORVASTATINE BGR 40 MG CPR 90\n",
      "  3400930020005 | LEPTOPROL 5MG IMPLANT INJ SC 1\n",
      "  3400930020012 | ASCABIOL 10% EMULSION FL 125ML 1\n",
      "  3400930020029 | ICLUSIG 15 MG CPR 30\n",
      "  3400930020197 | METOJECT 7,5 MG/0,15ML SOL INJ STYL 1\n",
      "  3400930020227 | ETORICOXIB ZYF 60 MG CPR 28\n",
      "  3400930020258 | METOJECT 10 MG/0,2ML SOL INJ STY 1\n",
      "  3400930020296 | METOJECT 12,5 MG/0,25ML SOL INJ STY 1\n",
      "  3400930020326 | METOJECT 15 MG/0,3ML SOL INJ STYL 1\n",
      "  3400930020364 | METOJECT 17,5 MG/0,35ML SOL INJ STYL 1\n",
      "  3400930020395 | METOJECT 20 MG/0,4ML SOL INJ STYL 1\n",
      "  3400930020432 | METOJECT 22,5 MG/0,45ML SOL INJ STYL 1\n",
      "  3400930020463 | METOJECT 25 MG/0,5ML SOL INJ STYL 1\n",
      "  3400930020494 | METOJECT 27.5 MG/0,3ML SOL INJ STYL 1\n",
      "  3400930020524 | METOJECT 30 MG/0,6ML SOL INJ STYL 1\n",
      "  3400930020555 | RASAGILINE RTP 1MG CPR 30\n",
      "  3400930020609 | DULOXETINE BGA 30MG GELULE 28\n",
      "  3400930020647 | DULOXETINE BGA 60MG GELULE 28\n",
      "  3400930020784 | PARACETAMOL VIATRIS 500MG CPR 16\n",
      "  3400930021095 | FERTISTARTKIT 75 UI PDR ET SOL INJ 5\n",
      "  3400930021101 | FERTISTARTKIT 75 UI PDR ET SOL INJ 10\n",
      "  3400930021118 | FERTISTARTKIT 150 UI PDR ET SOL INJ 1\n",
      "  3400930021125 | FERTISTARTKIT 150 UI PDR ET SOL INJ 5\n",
      "  3400930021132 | FERTISTARTKIT 150 UI PDR ET SOL INJ 10\n",
      "  3400930021149 | DESLORATADINE BGA 5MG CPR 30\n",
      "  3400930021286 | ALMOTRIPTAN ARW 12,5MG CPR 6\n",
      "  3400930021309 | ALMOTRIPTAN ARW 12,5MG CPR 12\n",
      "  3400930021354 | ALMOTRIPTAN EG 12,5MG CPR 6\n",
      "  3400930021378 | ALMOTRIPTAN EG 12,5MG CPR 12\n",
      "  3400930021477 | SANDOSTATINE LP 10 MG INJ SER + KIT 1\n",
      "  3400930021484 | SANDOSTATINE LP 20 MG INJ SER + KIT 1\n",
      "  3400930021545 | SANDOSTATINE LP 30 MG INJ SER + KIT 1\n",
      "  3400930021583 | PARACETAMOL VTS 500MG CPR EFF 16\n",
      "  3400930021613 | PARACETAMOL VTS 1000MG CPR EFF 8\n",
      "  3400930021668 | PARACETAMOL CRT 1G CPR EFF 8\n",
      "  3400930021880 | EPLERENONE ZEN 25MG CPR 90\n",
      "  3400930021910 | EPLERENONE ZEN 50MG CPR 90\n",
      "  3400930021989 | ALDOMET 250MG CPR 30\n",
      "  3400930022030 | VENLAFAXINE BGA LP 37,5MG GELULE 30\n",
      "  3400930022047 | VENLAFAXINE BGA LP 75MG GELULE 30\n",
      "  3400930022290 | ALEPSAL 50MG CPR 30\n",
      "  3400930022320 | MONTELUKAST EVO 5MG CPR CROQ 28\n",
      "  3400930022443 | MONTELUKAST ARW 5 MG CPR CROQ 28\n",
      "  3400930022535 | ROSUVASTATINE ZEN 5MG CPR 30\n",
      "  3400930022542 | ROSUVASTATINE ZEN 5MG CPR 90\n",
      "  3400930022559 | ROSUVASTATINE ZEN 10MG CPR 30\n",
      "  3400930022566 | ROSUVASTATINE ZEN 10MG CPR 90\n",
      "  3400930022573 | ROSUVASTATINE ZEN 20MG CPR 30\n",
      "  3400930022597 | ROSUVASTATINE ZEN 20MG CPR 90\n",
      "  3400930022627 | PREGABALINE TVS 25 MG GELULE 56\n",
      "  3400930022634 | PREGABALINE TVS 25 MG GELULE 84\n",
      "  3400930022689 | PREGABALINE TVS 50MG GELULE 84\n",
      "  3400930022733 | PREGABALINE TVS 75MG GELULE 56\n",
      "  3400930022771 | PREGABALINE TVS 100MG GELULE 84\n",
      "  3400930022818 | PREGABALINE TVS 150MG GELULE 56\n",
      "  3400930022849 | PREGABALINE TVS 200MG GELULE 84\n",
      "  3400930022863 | PREGABALINE TVS 300 MG GELULE 56\n",
      "  3400930023341 | LEVOTHYROX 200MICROG CPR EXC 30\n",
      "  3400930023433 | SEVELAMER CARBONATE SDZ 800 MG CPR 180\n",
      "  3400930023563 | SODIUM CHL VIAFLO 0,9% INJ POC 500ML 1\n",
      "  3400930023631 | ARIPIPRAZOLE SDZ 5MG CPR 28\n",
      "  3400930023648 | ARIPIPRAZOLE SDZ 10MG CPR 28\n",
      "  3400930023655 | ARIPIPRAZOLE SDZ 15MG CPR 28\n",
      "  3400930023778 | PREGABALINE ZEN 25 MG GELULE 56\n",
      "  3400930023785 | PREGABALINE ZEN 25 MG GELULE 84\n",
      "  3400930023792 | PREGABALINE ZEN 50 MG GELULE 84\n",
      "  3400930023808 | PREGABALINE ZEN 75 MG GELULE 56\n",
      "  3400930023815 | PREGABALINE ZEN 100 MG GELULE 84\n",
      "  3400930023839 | PREGABALINE ZEN 150 MG GELULE 56\n",
      "  3400930023846 | PREGABALINE ZEN 200 MG GELULE 84\n",
      "  3400930023853 | PREGABALINE ZEN 300 MG GELULE 56\n",
      "  3400930023884 | ARIPIPRAZOLE ZEN 5 MG CPR 28\n",
      "  3400930023891 | ARIPIPRAZOLE ZEN 10 MG CPR 28\n",
      "  3400930023907 | ARIPIPRAZOLE ZEN 15 MG CPR 28\n",
      "  3400930024157 | EPLERENONE CRT 25MG CPR 30\n",
      "  3400930024164 | NICOPATCHLIB 7 MG/24H DISP TRANSD 7\n",
      "  3400930024218 | NICOPATCHLIB 7 MG/24H DISP TRANSD 28\n",
      "  3400930024249 | NICOPATCHLIB 14MG/24H DISP TRANSDER 7\n",
      "  3400930024263 | NICOPATCHLIB 14MG/24H DISP TRANSDER 28\n",
      "  3400930024270 | NICOPATCHLIB 21MG/24H DISP TRANSDER 7\n",
      "  3400930024300 | NICOPATCHLIB 21MG/24H DISP TRANSDER 28\n",
      "  3400930024317 | EPLERENONE CRT 50MG CPR 30\n",
      "  3400930024522 | PROGESTERONE VIATRIS 100 MG CAPSULE 90\n",
      "  3400930024614 | GLICLAZIDE SUN 60MG CPR 30\n",
      "  3400930024638 | GLICLAZIDE SUN 60MG CPR 90\n",
      "  3400930025512 | EPLERENONE ZYD 25MG CPR 30\n",
      "  3400930025536 | EPLERENONE ZYD 25MG CPR 90\n",
      "  3400930025666 | EPLERENONE ZYD 50MG CPR 30\n",
      "  3400930025680 | EPLERENONE ZYD 50MG CPR 90\n",
      "  3400930025819 | EZETIMIBE/SIMVAST VTS 10MG/20MG CPR 30\n",
      "  3400930025826 | EZETIMIBE/SIMVAST VTS 10MG/20MG CPR 90\n",
      "  3400930025901 | EZETIMIBE/SIMVAST VTS 10MG/40MG CPR 30\n",
      "  3400930025918 | EZETIMIBE/SIMVAST VTS 10MG/40MG CPR 90\n",
      "  3400930026076 | ARIPIPRAZOLE BGR 5 MG CPR 28\n",
      "  3400930026106 | ARIPIPRAZOLE BGR 10 MG CPR 28\n",
      "  3400930026120 | ARIPIPRAZOLE BGR 15 MG CPR 28\n",
      "  3400930026151 | ARIPIPRAZOLE BGR 10 MG CPR ORODISP 28\n",
      "  3400930026175 | ARIPIPRAZOLE BGR 15 MG CPR ORODISP 28\n",
      "  3400930026250 | DORZOLAMIDE TIMOLOL CRT COLLYRE 5ML 1\n",
      "  3400930026366 | IMATINIB EG 100 MG CPR 60\n",
      "  3400930026571 | DULOXETINE VIATRIS 30 MG GELULE 28\n",
      "  3400930026793 | DULOXETINE VIATRIS 60MG GELULE 28\n",
      "  3400930026878 | IMATINIB EG 400 MG CPR 30\n",
      "  3400930026946 | ALGINATE BICAR SODIUM BGR SACHET 24\n",
      "  3400930026991 | ARIPIPRAZOLE TVC 10 MG CPR ORODISP 28\n",
      "  3400930027103 | ARIPIPRAZOLE TVC 15 MG CPR ORODISP 28\n",
      "  3400930027240 | EMERADE 150 MCG SOL INJ STYLO 2\n",
      "  3400930027271 | EMERADE 300 MCG SOL INJ STYLO 2\n",
      "  3400930027288 | ESOMEPRAZOLE BGA 20 MG GELULE 28\n",
      "  3400930027301 | ESOMEPRAZOLE BGA 40MG GELULE 28\n",
      "  3400930027356 | PREGABALINE SUN 25 MG GELULE 56\n",
      "  3400930027363 | PREGABALINE SUN 25 MG GELULE 84\n",
      "  3400930027547 | PREGABALINE SUN 50 MG GELULE 84\n",
      "  3400930027691 | PREGABALINE SUN 75 MG GELULE 56\n",
      "  3400930027851 | PREGABALINE SUN 100 MG GELULE 84\n",
      "  3400930027981 | PREGABALINE SUN 150 MG GELULE 56\n",
      "  3400930028117 | PREGABALINE SUN 200 MG GELULE 84\n",
      "  3400930028254 | PREGABALINE SUN 300 MG GELULE 56\n",
      "  3400930028322 | QUETIAPINE SDZ LP 50 MG CPR 30\n",
      "  3400930028377 | QUETIAPINE SDZ LP 300MG CPR 30\n",
      "  3400930028391 | QUETIAPINE SDZ LP 300MG CPR 60\n",
      "  3400930028407 | QUETIAPINE SDZ LP 400 MG CPR 30\n",
      "  3400930028414 | QUETIAPINE SDZ LP 400 MG CPR 60\n",
      "  3400930028438 | QUETIAPINE EG LP 50MG CPR 30\n",
      "  3400930028490 | QUETIAPINE EG LP 300 MG CPR 30\n",
      "  3400930028513 | QUETIAPINE EG LP 300 MG CPR 60\n",
      "  3400930028520 | QUETIAPINE EG LP 400 MG CPR 30\n",
      "  3400930028537 | QUETIAPINE EG LP 400 MG CPR 60\n",
      "  3400930028575 | REPATHA 140 MG SOL INJ SER 1\n",
      "  3400930028582 | REPATHA 140 MG SOL INJ STYLO 1\n",
      "  3400930028643 | ALMOTRIPTAN ZEN 12,5MG CPR 6\n",
      "  3400930028667 | ALMOTRIPTAN ZEN 12,5MG CPR 12\n",
      "  3400930028902 | PREGABALINE EG 25 MG GELULE 56\n",
      "  3400930028919 | PREGABALINE EG 25 MG GELULE 84\n",
      "  3400930028940 | PREGABALINE EG 50 MG GELULE 84\n",
      "  3400930028971 | PREGABALINE EG 75 MG GELULE 56\n",
      "  3400930029015 | PREGABALINE EG 150 MG GELULE 56\n",
      "  3400930029190 | FLUARIXTETRA SUSP INJ SER VACCIN 1\n",
      "  3400930029220 | FLUARIXTETRA SUSP INJ SER VACCIN 1\n",
      "  3400930029336 | ALOPLASTINE PATE 90G 1\n",
      "  3400930029435 | ELETRIPTAN VTS 40MG CPR 6\n",
      "  3400930029442 | ELETRIPTAN VTS 40MG CPR 10\n",
      "  3400930029480 | ACECLOFENAC BGA 100MG CPR 30\n",
      "  3400930029541 | ELETRIPTAN BGR 20MG CPR 6\n",
      "  3400930029589 | ELETRIPTAN BGR 40MG CPR 6\n",
      "  3400930029596 | ELETRIPTAN BGR 40MG CPR 10\n",
      "  3400930029749 | LEVOFLOXACINE KRK 500MG CPR 5\n",
      "  3400930030028 | PREGABALINE ALT 75 MG GELULE 56\n",
      "  3400930030035 | PREGABALINE ALT 150 MG GELULE 56\n",
      "  3400930030202 | ETORICOXIB VIATRIS 30 MG CPR 28\n",
      "  3400930030523 | ETORICOXIB VIATRIS 60 MG CPR 28\n",
      "  3400930030622 | DULOXETINE ALT 30MG GELULE 28\n",
      "  3400930030721 | ODOMZO 200 MG GELULE 30\n",
      "  3400930031162 | STRENSIQ 80MG SOL INJ 12\n",
      "  3400930031353 | CITALOPRAM BGR 20 MG CPR 28\n",
      "  3400930031421 | ARIPIPRAZOLE EG 5MG CPR 28\n",
      "  3400930031483 | ARIPIPRAZOLE EG 10MG CPR 28\n",
      "  3400930031568 | ARIPIPRAZOLE EG 15MG CPR 28\n",
      "  3400930031650 | ONDANSETRON EG 8MG CPR DISP 2\n",
      "  3400930031667 | ONDANSETRON EG 8MG CPR DISP 4\n",
      "  3400930031698 | DULOXETINE ZEN 30 MG GELULE 7\n",
      "  3400930031704 | DULOXETINE ZEN 30 MG GELULE 28\n",
      "  3400930031711 | DULOXETINE ZEN 60 MG GELULE 28\n",
      "  3400930031742 | ARIPIPRAZOLE EG 10 MG CPR ORODISP 28\n",
      "  3400930031810 | ARIPIPRAZOLE EG 15 MG CPR ORODISP 28\n",
      "  3400930031896 | PREGABALINE EVO 25 MG GELULE 56\n",
      "  3400930031902 | PREGABALINE EVO 25 MG GELULE 84\n",
      "  3400930031971 | PREGABALINE EVO 50 MG GELULE 84\n",
      "  3400930032190 | PREGABALINE EVO 75 MG GELULE 56\n",
      "  3400930032244 | PREGABALINE EVO 100 MG GELULE 84\n",
      "  3400930032343 | PREGABALINE EVO 150 MG GELULE 56\n",
      "  3400930032381 | PREGABALINE EVO 200 MG GELULE 84\n",
      "  3400930032534 | PREGABALINE EVO 300 MG GELULE 56\n",
      "  3400930032664 | PREGABALINE BGA 25 MG GELULE 56\n",
      "  3400930032671 | PREGABALINE BGA 25 MG GELULE 84\n",
      "  3400930032749 | PREGABALINE BGA 50 MG GELULE 84\n",
      "  3400930032886 | BRINZOLAMIDE VTS 10MG/ML COLL FL 5ML 1\n",
      "  3400930032916 | PREGABALINE BGA 75 MG GELULE 56\n",
      "  3400930032954 | PREGABALINE BGA 100 MG GELULE 84\n",
      "  3400930033074 | PREGABALINE BGA 150 MG GELULE 56\n",
      "  3400930033111 | PREGABALINE BGA 200 MG GELULE 84\n",
      "  3400930033234 | PREGABALINE BGA 300 MG GELULE 56\n",
      "  3400930033265 | NORVIR 100MG PDR SUSP BUV 30\n",
      "  3400930033289 | AMIKACINE VIATRIS 250 MG PDR INJ 20\n",
      "  3400930033302 | AMIKACINE VIATRIS 500 MG PDR INJ 20\n",
      "  3400930033326 | LEVONOR/ETHINYL CRT 100/20MICROG CPR 63\n",
      "  3400930033371 | EPLERENONE BGA 25 MG CPR 30\n",
      "  3400930033395 | EPLERENONE BGA 25 MG CPR 90\n",
      "  3400930033630 | EPLERENONE BGA 50 MG CPR 30\n",
      "  3400930033661 | EPLERENONE BGA 50 MG CPR 90\n",
      "  3400930034040 | ARIPIPRAZOLE KRKA 5MG CPR 28\n",
      "  3400930034125 | ARIPIPRAZOLE KRK 10MG CPR 28\n",
      "  3400930034217 | ARIPIPRAZOLE KRK 15MG CPR 28\n",
      "  3400930034378 | PRALUENT 75MG SOL INJ STYLO 2\n",
      "  3400930034392 | PRALUENT 150MG SOL INJ STYLO 2\n",
      "  3400930034521 | DULOXETINE TVS 30 MG GELULE 28\n",
      "  3400930034576 | DULOXETINE TVS 60MG GELULE 28\n",
      "  3400930035221 | NUTRYELT SOL INJ AMP 10ML 10\n",
      "  3400930035238 | CALCIUM GLUCON LAV 10% INJ AP 10ML 10\n",
      "  3400930035269 | ATORVASTATINE ARG 10 MG CPR 30\n",
      "  3400930035290 | ATORVASTATINE ARG 10 MG CPR 90\n",
      "  3400930035320 | ATORVASTATINE ARG 10 MG CPR 30\n",
      "  3400930035375 | ATORVASTATINE ARG 20 MG CPR 30\n",
      "  3400930035405 | ATORVASTATINE ARG 20 MG CPR 90\n",
      "  3400930035436 | ATORVASTATINE ARG 20 MG CPR 30\n",
      "  3400930035474 | ATORVASTATINE ARG 40 MG CPR 30\n",
      "  3400930035504 | ATORVASTATINE ARG 40 MG CPR 90\n",
      "  3400930035528 | ATORVASTATINE ARG 40 MG CPR 30\n",
      "  3400930035559 | ATORVASTATINE ARG 80 MG CPR 30\n",
      "  3400930035580 | ATORVASTATINE ARG 80 MG CPR 90\n",
      "  3400930035603 | ATORVASTATINE ARG 80 MG CPR 30\n",
      "  3400930035757 | LEVOCETIRIZINE CRT 5 MG CPR 28\n",
      "  3400930036228 | PARACETAMOL BGA 1G CPR 8\n",
      "  3400930036716 | MIRTAZAPINE CRT 15MG CPR 30\n",
      "  3400930036945 | REPAGLINIDE ARL 0,5MG CPR 270\n",
      "  3400930036952 | REPAGLINIDE ARL 1 MG CPR 270\n",
      "  3400930036969 | REPAGLINIDE ARL 2 MG CPR 270\n",
      "  3400930037553 | COTELLIC 20 MG CPR 63\n",
      "  3400930037577 | ARIPIPRAZOLE ACC 5 MG CPR 28\n",
      "  3400930037614 | ARIPIPRAZOLE ACC 10 MG CPR 28\n",
      "  3400930037652 | ARIPIPRAZOLE ACC 15 MG CPR 28\n",
      "  3400930037737 | GENVOYA 150/150/200/10MG CPR 30\n",
      "  3400930037799 | ROSUVASTATINE ALT 5MG CPR 30\n",
      "  3400930037812 | ROSUVASTATINE ALT 5MG CPR 90\n",
      "  3400930037843 | ROSUVASTATINE ALT 10MG CPR 30\n",
      "  3400930037867 | ROSUVASTATINE ALT 10MG CPR 90\n",
      "  3400930037904 | ENTRESTO 24 MG/26 MG CPR 28\n",
      "  3400930037911 | ENTRESTO 49MG/ 51MG CPR 56\n",
      "  3400930037928 | ENTRESTO 97MG/ 103MG CPR 56\n",
      "  3400930037997 | FUROSEMIDE BGA 20 MG CPR 30\n",
      "  3400930038017 | FUROSEMIDE BGA 40 MG CPR 30\n",
      "  3400930038055 | VITAMINE K1 CHP 10 MG/1ML SOL 5\n",
      "  3400930038291 | JEXT 0,15 MG SOL INJ STYLO 2\n",
      "  3400930038307 | JEXT 300 MCG SOL INJ STYLO 2\n",
      "  3400930038345 | DUALKOPT COLLYRE 1\n",
      "  3400930038352 | NUCALA 100 MG PDR SOL INJ 1\n",
      "  3400930038390 | NEBIVOLOL VTS 5 MG CPR 30\n",
      "  3400930038420 | NEBIVOLOL VTS 5 MG CPR 90\n",
      "  3400930038536 | PROPRANOLOL BGA 40MG CPR 50\n",
      "  3400930038628 | AKYNZEO 300 MG/0,50 MG GELULES 1\n",
      "  3400930038864 | QUETIAPINE ACC LP 50 MG CPR 30\n",
      "  3400930038918 | EMERADE 500 MCG SOL INJ STYLO 2\n",
      "  3400930039106 | LEVOD/C/E ARW 50/12.5/200MG CPR 100\n",
      "  3400930039175 | LEVOD/C/E ARW 75/18,75/200MG CPR 100\n",
      "  3400930039243 | LEVOD/C/E ARW 100/25/200MG CPR 100\n",
      "  3400930039304 | LEVOD/C/E ARW 125/31,25/200 MG CPR 100\n",
      "  3400930039366 | LEVOD/C/E ARW 150/37,5/200MG CPR 100\n",
      "  3400930039434 | LEVOD/C/E ARW 175/43,75/200 MG CPR 100\n",
      "  3400930039519 | LEVOD/C/E ARW 200/50/200MG CPR 100\n",
      "  3400930039939 | FORMODUAL NEXT 200/6 MICROG PDR INH 1\n",
      "  3400930039946 | INNOVAIR NEXT 200/6 MICROG PDR INH 1\n",
      "  3400930040027 | FORMODUAL 200/6 MICROG SOL INH 1\n",
      "  3400930040034 | INNOVAIR 200/6 MICROG SOL INH 120 D 1\n",
      "  3400930040072 | ABASAGLAR 300 U SOL INJ STYLO(1-80U) 5\n",
      "  3400930040096 | PREGABALINE ACC 25 MG GELULE 56\n",
      "  3400930040119 | PREGABALINE ACC 25 MG GELULE 84\n",
      "  3400930040133 | PREGABALINE ACC 50 MG GELULE 84\n",
      "  3400930040140 | PREGABALINE ACC 75 MG GELULE 56\n",
      "  3400930040171 | PREGABALINE ACC 100 MG GELULE 84\n",
      "  3400930040188 | PREGABALINE ACC 150 MG GELULE 56\n",
      "  3400930040218 | PREGABALINE ACC 200 MG GELULE 84\n",
      "  3400930040249 | PREGABALINE ACC 300 MG GELULE 56\n",
      "  3400930040294 | PREGABALINE ARL 25 MG GELULE 56\n",
      "  3400930040300 | PREGABALINE ARL 25 MG GELULE 84\n",
      "  3400930040386 | PREGABALINE ARL 50 MG GELULE 84\n",
      "  3400930040416 | PREGABALINE ARL 75 MG GELULE 56\n",
      "  3400930040461 | PREGABALINE ARL 100 MG GELULE 84\n",
      "  3400930040492 | PREGABALINE ARL 150 MG GELULE 56\n",
      "  3400930040546 | PREGABALINE ARL 200 MG GELULE 84\n",
      "  3400930040584 | PREGABALINE ARL 300 MG GELULE 56\n",
      "  3400930040669 | PARACETAMOL VIATRIS 1G CPR 8\n",
      "  3400930040768 | SOLIFENACINE VTS 5MG CPR 30\n",
      "  3400930040775 | SOLIFENACINE VTS 5MG CPR 30\n",
      "  3400930040805 | SOLIFENACINE VTS 10MG CPR 30\n",
      "  3400930040812 | SOLIFENACINE VTS 10MG CPR 30\n",
      "  3400930040881 | VALGANCICLOVIR ZEN 450MG CPR 60\n",
      "  3400930040928 | COLCHIMAX CPR 15\n",
      "  3400930040935 | COLCHICINE OPOCALCIUM 1MG CPR 15\n",
      "  3400930041000 | KALYDECO 75 MG GLE SACHET 56\n",
      "  3400930041017 | ORKAMBI 200/125 MG CPR 112\n",
      "  3400930041079 | MEROPENEM ARW 1 G INJ FL 10\n",
      "  3400930041093 | PERINDOPRIL INDAP ZYF 2/0,625 MG CPR 30\n",
      "  3400930041123 | PERINDOPRIL INDAP ZYF 4/1,25 MG CPR 30\n",
      "  3400930041130 | PERINDOPRIL INDAP ZYF 8/2,5 MG CPR 30\n",
      "  3400930041321 | SPIOLTO RESPIMAT 2,5MCG SOL PR INHAL 1\n",
      "  3400930041352 | PREGABALINE HCS 25 MG GELULE 56\n",
      "  3400930041369 | PREGABALINE HCS 25 MG GELULE 84\n",
      "  3400930041406 | PREGABALINE HCS 50 MG GELULE 84\n",
      "  3400930041420 | PREGABALINE HCS 75 MG GELULE 56\n",
      "  3400930041475 | PREGABALINE HCS 100 MG GELULE 84\n",
      "  3400930041499 | PREGABALINE HCS 150 MG GELULE 56\n",
      "  3400930041550 | PREGABALINE HCS 200 MG GELULE 84\n",
      "  3400930041604 | PREGABALINE HCS 300 MG GELULE 56\n",
      "  3400930041888 | ALLOPURINOL BGA 100MG CPR 28\n",
      "  3400930041963 | ALLOPURINOL BGA 200MG CPR 28\n",
      "  3400930042205 | EMEND PDR SUSP BUV 1\n",
      "  3400930042380 | DULOXETINE ACC 30MG GELULE 28\n",
      "  3400930042441 | DULOXETINE ACC 60MG GELULE 28\n",
      "  3400930042489 | HUMIRA 40 MG SOL INJ SERG + TAMP 2\n",
      "  3400930042564 | ATAZANAVIR TVC 150MG GELULE 60\n",
      "  3400930042601 | ATAZANAVIR TVC 200MG GELULE 60\n",
      "  3400930042625 | ATAZANAVIR TVC 300MG GELULE 30\n",
      "  3400930042687 | HUMIRA 40 MG SOL INJ STYLO + TAMP 2\n",
      "  3400930042717 | ATORVASTATINE VTSG 10MG CPR 90\n",
      "  3400930042724 | ATORVASTATINE VTSG 20MG CPR 90\n",
      "  3400930042731 | ATORVASTATINE VTSG 40MG CPR 90\n",
      "  3400930042748 | ATORVASTATINE VTSG 80 MG CPR 90\n",
      "  3400930043110 | BRINZOLAMIDE BGA 10MG/ML COLL FL 5ML 1\n",
      "  3400930043226 | PARACETAMOL BGA 500MG CPR FL 16\n",
      "  3400930043257 | VALGANCICLOVIR CRT 450MG CPR 60\n",
      "  3400930043264 | FULVESTRANT SDZ 250 MG SOL INJ 1\n",
      "  3400930043288 | WAKIX 4.5MG CPR 30\n",
      "  3400930043295 | WAKIX 18MG CPR 30\n",
      "  3400930043301 | BRINZOLAMIDE EG 10MG/ML COLL FL 5ML 1\n",
      "  3400930043431 | ARIPIPRAZOLE SDZ 10 MG CPR ORODISP 28\n",
      "  3400930043462 | ANAFRANIL 25MG SOL INJ 5\n",
      "  3400930043523 | ANAFRANIL 25MG CPR 50\n",
      "  3400930043578 | ARIPIPRAZOLE SDZ 15 MG CPR ORODISP 28\n",
      "  3400930043738 | MIANSERINE VIATRIS 10MG CPR 30\n",
      "  3400930043745 | MIANSERINE VIATRIS 30MG CPR 30\n",
      "  3400930044186 | DUTASTERIDE ACC 0,5MG CAPSULE 30\n",
      "  3400930044384 | PNEUMOVAX SOL INJ SER 1\n",
      "  3400930044421 | RISPERIDONE BGA 1 MG CPR 60\n",
      "  3400930044445 | RISPERIDONE BGA 2MG CPR 60\n",
      "  3400930044452 | RISPERIDONE BGA 4MG CPR 30\n",
      "  3400930044544 | VORICONAZOLE ACC 200MG CPR 28\n",
      "  3400930044599 | BENEPALI 50 MG SOL INJ SER 4\n",
      "  3400930044605 | BENEPALI 50 MG SOL INJ STYLO 4\n",
      "  3400930044629 | PERINDOPRIL INDAP ZYF 2/0,625 MG CPR 90\n",
      "  3400930044650 | PERINDOPRIL INDAP ZYF 4/1,25 MG CPR 90\n",
      "  3400930044674 | PERINDOPRIL INDAP ZYF 8/2,5 MG CPR 90\n",
      "  3400930045138 | DUTASTERIDE EVOLUGEN 0,5MG CAPSULE 30\n",
      "  3400930045329 | PARACETAMOL ACC 500MG CPR 16\n",
      "  3400930045343 | ACARIZAX 12 SQ-HDM LYOPHILISAT ORAL 30\n",
      "  3400930045350 | TRAMADOL/PARACETAMOL BGA CPR 20\n",
      "  3400930045404 | QUETIAPINE BGA LP 50MG CPR 10\n",
      "  3400930045411 | QUETIAPINE BGA LP 50MG CPR 30\n",
      "  3400930045589 | QUETIAPINE BGA LP 300MG CPR 30\n",
      "  3400930045602 | QUETIAPINE BGA LP 300MG CPR 60\n",
      "  3400930045626 | QUETIAPINE BGA LP 400MG CPR 30\n",
      "  3400930045640 | QUETIAPINE BGA LP 400MG CPR 60\n",
      "  3400930045657 | QUETIAPINE SUN LP 50MG CPR 30\n",
      "  3400930045671 | QUETIAPINE SUN LP 300MG CPR 30\n",
      "  3400930045688 | QUETIAPINE SUN LP 300MG CPR 60\n",
      "  3400930045695 | QUETIAPINE SUN LP 400MG CPR 30\n",
      "  3400930045701 | QUETIAPINE SUN LP 400MG CPR 60\n",
      "  3400930045725 | BISOPROLOL CRT 1,25 MG CPR 30\n",
      "  3400930045848 | BISOPROLOL CRT 2,5 MG CPR 30\n",
      "  3400930045862 | BISOPROLOL CRT 2,5 MG CPR 90\n",
      "  3400930045947 | BISOPROLOL CRT 3,75 MG CPR 30\n",
      "  3400930046050 | BISOPROLOL CRT 5 MG CPR 30\n",
      "  3400930046135 | ANDROTARDYL 250MG SOL INJ 1\n",
      "  3400930046173 | BISOPROLOL CRT 7,5 MG CPR 30\n",
      "  3400930046258 | BISOPROLOL CRT 10 MG CPR 30\n",
      "  3400930046326 | BRINZOLAMIDE CRT 10MG/ML COLL FL 5ML 1\n",
      "  3400930046333 | QUETIAPINE ZEN LP 50 MG CPR 10\n",
      "  3400930046340 | QUETIAPINE ZEN LP 50 MG CPR 30\n",
      "  3400930046517 | QUETIAPINE ZEN LP 300 MG CPR 30\n",
      "  3400930046531 | QUETIAPINE ZEN LP 300 MG CPR 60\n",
      "  3400930046555 | QUETIAPINE ZEN LP 400 MG CPR 30\n",
      "  3400930046579 | QUETIAPINE ZEN LP 400 MG CPR 60\n",
      "  3400930046760 | GLICLAZIDE MYP LM 60MG CPR 30\n",
      "  3400930047002 | CINACALCET TEVA 30 MG CPR 28\n",
      "  3400930047248 | CINACALCET TEVA 60 MG CPR 28\n",
      "  3400930047354 | CINACALCET TEVA 90 MG CPR 28\n",
      "  3400930047477 | GLICLAZIDE SDZ LM 60MG CPR 30\n",
      "  3400930047507 | GLICLAZIDE SDZ LM 60MG CPR 90\n",
      "  3400930047613 | ICLUSIG 30 MG CPR 30\n",
      "  3400930047644 | TAGRISSO 40 MG CPR 30\n",
      "  3400930047651 | TAGRISSO 80 MG CPR 30\n",
      "  3400930047934 | SOLIFENACINE TVC 5MG CPR 30\n",
      "  3400930048078 | SOLIFENACINE TVC 10MG CPR 30\n",
      "  3400930048252 | RASAGILINE KRKA 1 MG CPR 30\n",
      "  3400930048306 | IMATINIB SDZ 100MG CPR 60\n",
      "  3400930048351 | IMATINIB SDZ 400MG CPR 30\n",
      "  3400930049808 | ATORVASTATINE EGL 10MG CPR 30\n",
      "  3400930049853 | ATORVASTATINE EGL 10MG CPR 90\n",
      "  3400930049976 | ATORVASTATINE EGL 20 MG CPR 30\n",
      "  3400930050019 | ATORVASTATINE EGL 20 MG CPR 90\n",
      "  3400930050132 | ATORVASTATINE EGL 40 MG CPR 30\n",
      "  3400930050187 | ATORVASTATINE EGL 40 MG CPR 90\n",
      "  3400930050309 | ATORVASTATINE EGL 80 MG CPR 30\n",
      "  3400930050347 | ATORVASTATINE EGL 80 MG CPR 90\n",
      "  3400930050354 | PREDNISONE BGA 5 MG CPR 30\n",
      "  3400930050415 | RASAGILINE ZYD 1MG CPR 30\n",
      "  3400930050514 | AMLODIPINE BGA 10MG GELULE 30\n",
      "  3400930050538 | LERCANIDIPINE BGA 10MG CPR 90\n",
      "  3400930052068 | ROSUVASTATINE TVC 5MG CPR 30\n",
      "  3400930052440 | ROSUVASTATINE TVC 10MG CPR 30\n",
      "  3400930052860 | ROSUVASTATINE TVC 20MG CPR 30\n",
      "  3400930053065 | ROSUVASTATINE EG 5MG CPR 30\n",
      "  3400930053102 | ROSUVASTATINE EG 5MG CPR 90\n",
      "  3400930053225 | ROSUVASTATINE EG 10MG CPR 30\n",
      "  3400930053263 | ROSUVASTATINE EG 10MG CPR 90\n",
      "  3400930053287 | ANTIBIO SYNALAR SOL AURICULAIRE 1\n",
      "  3400930053393 | ROSUVASTATINE EG 20MG CPR 30\n",
      "  3400930053447 | ROSUVASTATINE EG 20MG CPR 90\n",
      "  3400930053621 | BRIVIACT 10 MG, COMPRIME PELLICULE 14\n",
      "  3400930053645 | BRIVIACT 25 MG CPR 56\n",
      "  3400930053652 | BRIVIACT 50 MG, COMPRIME PELLICULE 56\n",
      "  3400930053669 | BRIVIACT 75 MG, COMPRIME PELLICULE 56\n",
      "  3400930053676 | BRIVIACT 100 MG CPR 56\n",
      "  3400930053683 | BRIVIACT 10 MG/ML, SOLUTION BUVABLE 1\n",
      "  3400930053744 | ROSUVASTATINE ACC 5MG CPR 30\n",
      "  3400930053775 | ROSUVASTATINE ACC 5MG CPR 90\n",
      "  3400930053812 | ROSUVASTATINE ACC 10MG CPR 30\n",
      "  3400930053843 | ROSUVASTATINE ACC 10MG CPR 90\n",
      "  3400930053898 | ROSUVASTATINE ACC 20MG CPR 30\n",
      "  3400930053935 | ROSUVASTATINE ACC 20MG CPR 90\n",
      "  3400930054093 | ROSUVASTATINE CRT 5MG CPR 30\n",
      "  3400930054154 | ROSUVASTATINE CRT 5MG CPR 90\n",
      "  3400930054253 | ROSUVASTATINE CRT 10MG CPR 30\n",
      "  3400930054314 | ROSUVASTATINE CRT 10MG CPR 90\n",
      "  3400930054390 | ROSUVASTATINE CRT 20MG CPR 30\n",
      "  3400930054451 | ROSUVASTATINE CRT 20MG CPR 90\n",
      "  3400930054642 | ROSUVASTATINE BGA 5MG CPR 30\n",
      "  3400930054673 | ROSUVASTATINE BGA 5MG CPR 90\n",
      "  3400930054703 | ROSUVASTATINE BGA 10MG CPR 30\n",
      "  3400930054734 | ROSUVASTATINE BGA 10MG CPR 90\n",
      "  3400930054765 | ROSUVASTATINE BGA 20MG CPR 30\n",
      "  3400930054796 | ROSUVASTATINE BGA 20MG CPR 90\n",
      "  3400930055595 | DESOGESTREL SDZ 75 MCG CPR 28\n",
      "  3400930055601 | DESOGESTREL SDZ 75 MCG CPR 84\n",
      "  3400930055953 | BETAMETHASONE BGA 0,05 % CR TB 30 G 1\n",
      "  3400930056196 | GARDASIL 9 SUSP INJ FL 1\n",
      "  3400930056202 | GARDASIL 9 SUSP INJ SER + 2 AIG 1\n",
      "  3400930056509 | ENALAPRIL/LER BCR 20MG/10MG CPR 30\n",
      "  3400930056561 | ENALAPRIL/LER BCR 20MG/10MG CPR 90\n",
      "  3400930056608 | ENALAPRIL/LER BCR 20MG/20MG CPR 30\n",
      "  3400930056653 | ENALAPRIL/LER BCR 20MG/20MG CPR 90\n",
      "  3400930056707 | VORICONAZOLE BGA 50MG CPR 28\n",
      "  3400930056738 | VORICONAZOLE BGA 50MG CPR 56\n",
      "  3400930056783 | VORICONAZOLE BGA 200 MG CPR 14\n",
      "  3400930056806 | VORICONAZOLE BGA 200 MG CPR 28\n",
      "  3400930056844 | VORICONAZOLE BGA 200 MG CPR 56\n",
      "  3400930056882 | PREGABALINE CRT 25 MG GELULE 56\n",
      "  3400930056899 | PREGABALINE CRT 25 MG GELULE 84\n",
      "  3400930056943 | PREGABALINE CRT 50 MG GELULE 84\n",
      "  3400930057018 | IMATINIB HCS 100MG CPR 60\n",
      "  3400930057063 | IMATINIB HCS 400MG CPR 30\n",
      "  3400930057117 | IMATINIB TVC 100MG CPR 60\n",
      "  3400930057124 | IMATINIB TVC 400MG CPR 30\n",
      "  3400930057148 | DOMPERIDONE ZYD 10MG CPR 20\n",
      "  3400930057377 | CINACALCET MYL 30MG CPR 28\n",
      "  3400930057391 | CINACALCET MYL 60MG CPR 28\n",
      "  3400930057414 | CINACALCET MYL 90MG CPR 28\n",
      "  3400930057728 | DELPRIM 300 MG CPR 3\n",
      "  3400930057742 | QUETIAPINE KRK LP 50MG CPR 30\n",
      "  3400930057773 | LONSURF 15MG/6,14MG CPR 20\n",
      "  3400930057797 | LONSURF 15MG/6,14MG CPR 60\n",
      "  3400930057803 | LONSURF 20MG/8,19MG CPR 20\n",
      "  3400930057827 | LONSURF 20MG/8,19MG CPR 60\n",
      "  3400930057834 | CODOLIPRANE 500MG/30MG GELU 16\n",
      "  3400930057926 | EPLERENONE SDZ 25 MG CPR 30\n",
      "  3400930057988 | EPLERENONE SDZ 25 MG CPR 90\n",
      "  3400930058268 | EPLERENONE SDZ 50 MG CPR 30\n",
      "  3400930058336 | EPLERENONE SDZ 50 MG CPR 90\n",
      "  3400930058350 | CINACALCET ZEN 30 MG CPR 28\n",
      "  3400930058398 | CINACALCET ZEN 60 MG CPR 28\n",
      "  3400930058428 | DOMPERIDONE ARW 10MG CPR 20\n",
      "  3400930058459 | CINACALCET ZEN 90 MG CPR 28\n",
      "  3400930058497 | ZONISAMIDE SDZ 25 MG GELULE 14\n",
      "  3400930058510 | ZONISAMIDE SDZ 50 MG GELULE 14\n",
      "  3400930058589 | ZONISAMIDE SDZ 100 MG GELULE 56\n",
      "  3400930058725 | AMLODIPINE/VALSAR MYL 5MG/80MG CPR 30\n",
      "  3400930058732 | AMLODIPINE/VALSAR MYL 5MG/160MG CPR 30\n",
      "  3400930058749 | AMLODIPINE/VALSAR MYL 10MG/160MG CPR 30\n",
      "  3400930058756 | AMLODIPINE/VALSAR MYL 5MG/80MG CPR 90\n",
      "  3400930058763 | AMLODIPINE/VALSAR MYL 5MG/160MG CPR 90\n",
      "  3400930058787 | AMLODIPINE/VALSAR MYL 10MG/160MG CPR 90\n",
      "  3400930058794 | ZONISAMIDE MYL 25 MG GELULE 14\n",
      "  3400930058824 | ZONISAMIDE MYL 50 MG GELULE 14\n",
      "  3400930058886 | ZONISAMIDE MYL 100 MG GELULE 56\n",
      "  3400930058930 | ROSUVASTATINE SDZ 5MG CPR 30\n",
      "  3400930058978 | ROSUVASTATINE SDZ 5MG CPR 90\n",
      "  3400930058992 | ROSUVASTATINE SDZ 10MG CPR 30\n",
      "  3400930059036 | ROSUVASTATINE SDZ 10MG CPR 90\n",
      "  3400930059050 | ROSUVASTATINE SDZ 20MG CPR 30\n",
      "  3400930059104 | ROSUVASTATINE SDZ 20MG CPR 90\n",
      "  3400930059166 | VORICONAZOLE TVC 50 MG CPR 56\n",
      "  3400930059197 | VORICONAZOLE TVC 200 MG CPR 56\n",
      "  3400930059517 | DOMPERIDONE VIATRIS 10 MG CPR 20\n",
      "  3400930059531 | DIAZEPAM ARW 10 MG CPR 30\n",
      "  3400930059548 | DOMPERIDONE EG 10MG CPR 20\n",
      "  3400930059555 | ROZEX 0,75% EMULSION 50G 1\n",
      "  3400930059562 | ROZEX 0,75% CREME 50G 1\n",
      "  3400930059586 | LEVOCETIRIZINE ZEN 5MG CPR 14\n",
      "  3400930059609 | LEVOCETIRIZINE ZEN 5MG CPR 28\n",
      "  3400930059630 | IMATINIB ACC 100 MG CPR 60\n",
      "  3400930059654 | IMATINIB ACC 400 MG CPR 30\n",
      "  3400930059685 | ARIPIPRAZOLE MYP 5 MG CPR 28\n",
      "  3400930059692 | ARIPIPRAZOLE MYP 10MG CPR 28\n",
      "  3400930059708 | ARIPIPRAZOLE MYP 15MG CPR 28\n",
      "  3400930059760 | EZETIMIBE TVC 10MG CPR 30\n",
      "  3400930059791 | EZETIMIBE TVC 10MG CPR 90\n",
      "  3400930059814 | TREVICTA 175 MG SUSP INJ SER 1\n",
      "  3400930059821 | TREVICTA 263 MG SUSP INJ SER 1\n",
      "  3400930059838 | TREVICTA 350 MG SUSP INJ SER 1\n",
      "  3400930059845 | TREVICTA 525 MG SUSP INJ SER 1\n",
      "  3400930059876 | SYMBICORT RAPIHALER 200/6 MICROG 1\n",
      "  3400930059968 | ABACAVIR/LAM EG 600 MG/300 MG CPR 30\n",
      "  3400930060025 | LOPINAVIR/RITONAVIR MYL 100/25MG CPR 60\n",
      "  3400930060049 | LOPINAVIR/RITONAVIR MYL 200/50MG CPR 120\n",
      "  3400930060056 | IMIPENEM CIL ARW 500/500MG PDR INJ 1\n",
      "  3400930060063 | RASAGILINE MYL 1MG CPR 30\n",
      "  3400930060070 | DOMPERIDONE ALM 10MG CPR 20\n",
      "  3400930060087 | DOMPERIDONE BGA 10 MG CPR 20\n",
      "  3400930060094 | DOMPERIDONE BGA 10 MG CPR 20\n",
      "  3400930060117 | MOXIFLOXACINE BGA 400 MG CPR 5\n",
      "  3400930060124 | MOXIFLOXACINE BGA 400 MG CPR 7\n",
      "  3400930060148 | BRINZOLAMIDE ARW 50MG COLL FL 5ML 1\n",
      "  3400930060179 | OMEPRAZOLE VIATRIS 10MG GELULE 14\n",
      "  3400930060193 | OMEPRAZOLE VIATRIS 10MG GELULE 28\n",
      "  3400930060216 | OMEPRAZOLE VIATRIS 20MG GELULE 7\n",
      "  3400930060223 | OMEPRAZOLE VIATRIS 20MG GELULE 14\n",
      "  3400930060247 | OMEPRAZOLE VIATRIS 20MG GELULE 28\n",
      "  3400930060308 | PREGABALINE CRT 75 MG GELULE 56\n",
      "  3400930060346 | PREGABALINE CRT 150 MG GELULE 56\n",
      "  3400930060391 | PREGABALINE CRT 300 MG GELULE 56\n",
      "  3400930060520 | PRAVASTATINE CRP 20MG CPR 28\n",
      "  3400930060568 | PRAVASTATINE CRP 20MG CPR 84\n",
      "  3400930060629 | PRAVASTATINE CRP 40 MG CPR 28\n",
      "  3400930060650 | PRAVASTATINE CRP 40 MG CPR 84\n",
      "  3400930060698 | OMEPRAZOLE EVP 10MG GELULE 14\n",
      "  3400930060704 | OMEPRAZOLE EVP 10MG GELULE 28\n",
      "  3400930060711 | OMEPRAZOLE EVP 20MG GELULE 7\n",
      "  3400930060728 | OMEPRAZOLE EVP 20MG GELULE 14\n",
      "  3400930060735 | OMEPRAZOLE EVP 20MG GELULE 28\n",
      "  3400930060759 | TALTZ 80 MG SOL INJ STYLO 1\n",
      "  3400930060797 | TALTZ 80 MG SOL INJ SER 1\n",
      "  3400930060827 | GALAFOLD 123 MG GELULE 14\n",
      "  3400930060988 | METFORMINE ARL 500MG CPR 90\n",
      "  3400930060995 | METFORMINE ARL 850 MG CPR 90\n",
      "  3400930061060 | REVOLADE 25 MG PDR SUSP BUV 30\n",
      "  3400930061077 | TRIMEBUTINE BGA 200 MG CPR 30\n",
      "  3400930061107 | OXYBUTYNINE BGA 5MG CPR 60\n",
      "  3400930061121 | FUROSEMIDE VIATRIS 20MG CPR 30\n",
      "  3400930061138 | FUROSEMIDE VIATRIS 40MG CPR 30\n",
      "  3400930061411 | METFORMINE ARL 1000MG CPR 90\n",
      "  3400930061558 | ODEFSEY 200MG/25MG/25MG CPR 30\n",
      "  3400930061718 | EXJADE 90 MG CPR 30\n",
      "  3400930061749 | EXJADE 180 MG CPR 30\n",
      "  3400930061763 | EXJADE 360 MG CPR 30\n",
      "  3400930061770 | EXJADE 360 MG CPR 90\n",
      "  3400930061787 | MIRTAZAPINE VIATRIS 15MG CPR 30\n",
      "  3400930062166 | ALPRAZOLAM BGA 0,50MG CPR 30\n",
      "  3400930062852 | ARGININE VEYRON 1G/5ML SOL BUV AMP 20\n",
      "  3400930062890 | IMATINIB BGR 100MG CPR 60\n",
      "  3400930062968 | IMATINIB BGR 400MG CPR 30\n",
      "  3400930063026 | DOMPERIDONE SDZ 10MG CPR 20\n",
      "  3400930063071 | ONDANSETRON BGA 8MG CPR DISP 2\n",
      "  3400930063088 | ONDANSETRON BGA 8MG CPR DISP 4\n",
      "  3400930063163 | ARGININE VEYRON 0,918G/5ML SOL BUV 1\n",
      "  3400930063170 | IMATINIB ZEN 100 MG CPR 60\n",
      "  3400930063248 | IMATINIB ZEN 400 MG CPR 30\n",
      "  3400930063675 | ATENOLOL /NIFEDIPINE VTS GELULE 30\n",
      "  3400930063712 | ATENOLOL /NIFEDIPINE VTS GELULE 90\n",
      "  3400930063828 | ATENOLOL /NIFEDIPINE BGA GELULE 30\n",
      "  3400930063859 | ATENOLOL /NIFEDIPINE BGA GELULE 90\n",
      "  3400930063910 | MONTELUKAST BGR 5 MG CPR CROQ 28\n",
      "  3400930064030 | MONTELUKAST BGR10MG CPR 28\n",
      "  3400930064177 | MONTELUKAST ZEN 5MG CPR CROQ 28\n",
      "  3400930064290 | MONTELUKAST ZEN 10MG CPR 28\n",
      "  3400930064375 | ALGINATE BICAR SODIUM ARW SACHET 24\n",
      "  3400930064467 | QUETIAPINE AHL LP 300 MG CPR 30\n",
      "  3400930064481 | QUETIAPINE AHL LP 300 MG CPR 60\n",
      "  3400930064504 | QUETIAPINE AHL LP 400 MG CPR 30\n",
      "  3400930064528 | QUETIAPINE AHL LP 400 MG CPR 60\n",
      "  3400930064535 | FERTIFOL 0,4 MG CPR 90\n",
      "  3400930064641 | SERTRALINE BGA 50MG GELULE 28\n",
      "  3400930064665 | GABAPENTINE BGA 100MG GELULE 90\n",
      "  3400930064672 | GABAPENTINE BGA 300MG GELULE 90\n",
      "  3400930065068 | CLOPIDOGREL BGR 75 MG CPR 30\n",
      "  3400930065259 | IBUPROFENE ZEN 200MG CPR PELL 30\n",
      "  3400930065297 | IBUPROFENE ZEN 400MG CPR PELL 20\n",
      "  3400930065303 | IBUPROFENE ZEN 400MG CPR PELL 30\n",
      "  3400930065518 | DUTASTERIDE BGA 0,5MG CAPSULE 30\n",
      "  3400930065556 | LEVOTHYROX 25MICROG CPR EXC 30\n",
      "  3400930065570 | LEVOTHYROX 25MICROG CPR EXC 90\n",
      "  3400930065662 | LEVOTHYROX 50MICROG CPR EXC 30\n",
      "  3400930065686 | LEVOTHYROX 50MICROG CPR EXC 90\n",
      "  3400930065785 | LEVOTHYROX 75 MICROG CPR EXC 30\n",
      "  3400930065891 | LEVOTHYROX 100MICROG CPR EXC 30\n",
      "  3400930066010 | LEVOTHYROX 125 MICROG CPR SEC EXC 30\n",
      "  3400930066188 | LEVOTHYROX 150MICROG CPR EXC 30\n",
      "  3400930066249 | LEVOTHYROX 175MICROG CPR EXC 30\n",
      "  3400930066379 | LANSOPRAZOLE ARW 15 MG CPR OROD 14\n",
      "  3400930066386 | LANSOPRAZOLE ARW 15 MG CPR OROD 28\n",
      "  3400930066409 | LANSOPRAZOLE ARW 30 MG CPR OROD 14\n",
      "  3400930066423 | LANSOPRAZOLE ARW 30 MG CPR OROD 28\n",
      "  3400930066461 | ATORVASTATINE EVP 10MG CPR 30\n",
      "  3400930066478 | ATORVASTATINE EVP 10MG CPR 90\n",
      "  3400930066485 | ATORVASTATINE EVP 20MG CPR 30\n",
      "  3400930066492 | ATORVASTATINE EVP 20MG CPR 90\n",
      "  3400930066508 | ATORVASTATINE EVP 40MG CPR 30\n",
      "  3400930066515 | ATORVASTATINE EVP 40MG CPR 90\n",
      "  3400930066522 | ATORVASTATINE EVP 80MG CPR 30\n",
      "  3400930066539 | ATORVASTATINE EVP 80MG CPR 90\n",
      "  3400930066546 | MODOPAR 62,5 (50MG/12,5MG) GELULE 60\n",
      "  3400930066560 | MODOPAR 125 (100MG/25MG) GELULE 60\n",
      "  3400930066607 | MODOPAR 250 (200MG/50MG) GELULE 60\n",
      "  3400930066638 | MODOPAR LP 125 (100MG/25MG) GELULE 60\n",
      "  3400930066669 | MODOPAR 125 (100MG/25MG) CPR 60\n",
      "  3400930066690 | LEELOO CONTINU 100/20 MCG CPR 28\n",
      "  3400930066713 | LEELOO CONTINU 100/20 MCG CPR 84\n",
      "  3400930066737 | LEVONOR/ETHINYL BGACONT 100/20MCG CP 84\n",
      "  3400930066874 | ARTANE 2MG CPR 50\n",
      "  3400930066935 | ARTANE 5MG CPR 20\n",
      "  3400930067024 | BECLOMETASONE TVC 400MCG INH UNIDOSE 20\n",
      "  3400930067116 | BECLOMETASONE TVC 800MCG INH UNIDOSE 20\n",
      "  3400930067314 | EPCLUSA 400 MG/100MG CPR 28\n",
      "  3400930067390 | ACEBUTOLOL BGA 200 MG CPR 30\n",
      "  3400930067444 | FRAKIDEX COLLYRE FL C-GTT 5ML 1\n",
      "  3400930067550 | COSIMPREL 5 MG/ 10 MG CPR 30\n",
      "  3400930067567 | COSIMPREL 5 MG/ 10 MG CPR 90\n",
      "  3400930067574 | COSIMPREL 10 MG/5 MG CPR 30\n",
      "  3400930067581 | COSIMPREL 10 MG/5 MG CPR 90\n",
      "  3400930067598 | COSIMPREL 10 MG/10 MG CPR 30\n",
      "  3400930067604 | COSIMPREL 10 MG/10 MG CPR 90\n",
      "  3400930067611 | COSIMPREL 5 MG/ 5 MG CPR 30\n",
      "  3400930067628 | COSIMPREL 5 MG/ 5 MG CPR 90\n",
      "  3400930067680 | EZETIMIBE ZYD 10MG CPR 28\n",
      "  3400930067710 | EZETIMIBE ZYD 10MG CPR 90\n",
      "  3400930067727 | VAXIGRIPTETRA SUSP INJ SER 0.5ML A/A 1\n",
      "  3400930067758 | VAXIGRIPTETRA SUSP INJ SER 0.5ML A/A 1\n",
      "  3400930067833 | RASAGILINE BGA 1MG CPR 30\n",
      "  3400930067840 | NOVATREX 2,5MG CPR 12\n",
      "  3400930067857 | TIAPRIDE VIATRIS 100 MG CPR 20\n",
      "  3400930067963 | IMATINIB VTS 100MG CPR 60\n",
      "  3400930067970 | IMATINIB VTS 400MG CPR 30\n",
      "  3400930068144 | ROSUVASTATINE ZDF 5MG CPR 30\n",
      "  3400930068236 | ROSUVASTATINE ZDF 20MG CPR 30\n",
      "  3400930068274 | ROSUVASTATINE ZDF 10MG CPR 30\n",
      "  3400930068519 | OXYCODONE ARW 5MG GELULE 14\n",
      "  3400930068571 | OXYCODONE ARW 10MG GELULE 14\n",
      "  3400930068649 | OXYCODONE ARW 20MG GELULE 14\n",
      "  3400930068724 | DOMPERIDONE TVC 10MG CPR 20\n",
      "  3400930068786 | DOMPERIDONE ZEN 10MG CPR 20\n",
      "  3400930068823 | OXYCODONE SDZ 5MG GELULE 14\n",
      "  3400930068892 | OXYCODONE SDZ 10MG GELULE 14\n",
      "  3400930068960 | OXYCODONE SDZ 20MG GELULE 14\n",
      "  3400930069097 | AMOXICILLINE CRT 500MG GELULE 12\n",
      "  3400930069110 | BISOPROLOL EG 5MG CPR 30\n",
      "  3400930069134 | BISOPROLOL EG 5MG CPR 90\n",
      "  3400930069226 | BISOPROLOL EG 7,5MG CPR 30\n",
      "  3400930069301 | TENOFOVIR DISO EG 245 MG CPR 30\n",
      "  3400930069325 | TENOFOVIR DISO BGA 245 MG CPR 30\n",
      "  3400930069417 | EMTRICITABIN TENOF BGA 200/245MG CPR 30\n",
      "  3400930069424 | EMTRICITABIN TENOF EG 200/245MG CPR 30\n",
      "  3400930069455 | GLICLAZIDE EVO LM 60MG CPR 30\n",
      "  3400930069479 | GLICLAZIDE EVO LM 60MG CPR 90\n",
      "  3400930069561 | GLICLAZIDE CRT LM 60MG CPR 30\n",
      "  3400930069585 | GLICLAZIDE CRT LM 60MG CPR 90\n",
      "  3400930069608 | ASCOFER 33MG GELULE 30\n",
      "  3400930070062 | VALGANCICLOVIR ACC 450MG CPR 60\n",
      "  3400930070567 | LANSOPRAZOLE ARW 30 MG CPR OROD 14\n",
      "  3400930070574 | LANSOPRAZOLE ARW 30 MG CPR OROD 28\n",
      "  3400930070598 | LANSOPRAZOLE ARW 15 MG CPR OROD 14\n",
      "  3400930070604 | LANSOPRAZOLE ARW 15 MG CPR OROD 28\n",
      "  3400930071007 | CARVEDILOL ARW 6,25 MG CPR 28\n",
      "  3400930071106 | CARVEDILOL ARW 12,5 MG CPR 28\n",
      "  3400930071199 | CARVEDILOL ARW 25 MG CPR 28\n",
      "  3400930071533 | TAMSULOSINE ZEN LP 0,4MG CPR 30\n",
      "  3400930071700 | HEXVIX 85 MG PDR INTRAVESICALE SRG 1\n",
      "  3400930071724 | DULOXETINE VIATRIS 30 MG GELULE 28\n",
      "  3400930071731 | DULOXETINE VIATRIS 60MG GELULE 28\n",
      "  3400930071762 | MIKICORT 9 MG GRANULES SACHET 30\n",
      "  3400930071854 | METFORMINE VIATRIS 500MG CPR 30\n",
      "  3400930071878 | METFORMINE MYP 850MG CPR 30\n",
      "  3400930071892 | METFORMINE VIATRIS 1 000 MG CPR 30\n",
      "  3400930071922 | DOPACEPTIN 30 MG SOL INJ CART 5\n",
      "  3400930072394 | ROSUVASTATINE ARW 5MG CPR 30\n",
      "  3400930072431 | ROSUVASTATINE ARW 5MG CPR 90\n",
      "  3400930072561 | ROSUVASTATINE ARW 10MG CPR 30\n",
      "  3400930072608 | ROSUVASTATINE ARW 10MG CPR 90\n",
      "  3400930072745 | ROSUVASTATINE ARW 20MG CPR 30\n",
      "  3400930072783 | ROSUVASTATINE ARW 20MG CPR 90\n",
      "  3400930072899 | DULOXETINE BGA 30MG GELULE 28\n",
      "  3400930072905 | DULOXETINE BGA 60MG GELULE 28\n",
      "  3400930072943 | TAMSULOSINE BGA LP 0,4MG GELULE 30\n",
      "  3400930073308 | TENOFOVIR DISO ZEN 245 MG CPR 30\n",
      "  3400930073513 | FRAXIPARINE 3800UI AXA/0,4ML SOL INJ 10\n",
      "  3400930073520 | CABOMETYX 20 MG CPR 30\n",
      "  3400930073537 | CABOMETYX 40 MG CPR 30\n",
      "  3400930073544 | CABOMETYX 60 MG CPR 30\n",
      "  3400930073728 | BIMATOPROST EG 0,9 MG COLLYRE SOL 1\n",
      "  3400930073766 | BIMATOPROST VTS 0,9 MG COLLYRE SOL 1\n",
      "  3400930073803 | ROSUVASTATINE ALM 5MG CPR 30\n",
      "  3400930073810 | ROSUVASTATINE ALM 5MG CPR 90\n",
      "  3400930073841 | ROSUVASTATINE ALM 10MG CPR 30\n",
      "  3400930073865 | ROSUVASTATINE ALM 10MG CPR 90\n",
      "  3400930073896 | ROSUVASTATINE ALM 20MG CPR 30\n",
      "  3400930073902 | ROSUVASTATINE ALM 20MG CPR 90\n",
      "  3400930073957 | EZETIMIBE ALT 10MG CPR 28\n",
      "  3400930073964 | EZETIMIBE ALT 10MG CPR 30\n",
      "  3400930073988 | EZETIMIBE ALT 10MG CPR 90\n",
      "  3400930074282 | IMATINIB ARWL 100 MG CPR 60\n",
      "  3400930074404 | IMATINIB ARWL 400 MG CPR 30\n",
      "  3400930074589 | AMOXICILLINE EG 1G CP DISP 6\n",
      "  3400930074596 | AMOXICILLINE EG 1G CP DISP 14\n",
      "  3400930074695 | COPAXONE 40 MG SOL INJ SER 12\n",
      "  3400930074848 | ESCITALOPRAM MYL 10 MG CPR 28\n",
      "  3400930074879 | ESCITALOPRAM VIATRIS 15MG CPR 28\n",
      "  3400930074893 | ESCITALOPRAM VIATRIS 20MG CPR 28\n",
      "  3400930074985 | ENSTILAR 50 MCG/0.5MG/G MOUSSE CUT 1\n",
      "  3400930074992 | ENSTILAR 50 MCG/0.5MG/G MOUSSE CUT 2\n",
      "  3400930075005 | NORDIMET 7,5 MG SOL INJ STYLO 4\n",
      "  3400930075012 | NORDIMET 10 MG SOL INJ STYLO 4\n",
      "  3400930075029 | NORDIMET 12,5 MG SOL INJ STYLO 4\n",
      "  3400930075036 | NORDIMET 15 MG SOL INJ STYLO 4\n",
      "  3400930075043 | NORDIMET 17,5 MG SOL INJ STYLO 4\n",
      "  3400930075067 | NORDIMET 20 MG SOL INJ STYLO 4\n",
      "  3400930075074 | NORDIMET 22,5 MG SOL INJ STYLO 4\n",
      "  3400930075081 | NORDIMET 25 MG SOL INJ STYLO 4\n",
      "  3400930075104 | DOTAREM 0,5 MMOL/ML INJ SER 15ML+MED 1\n",
      "  3400930075128 | DOTAREM 0,5MMOL/ML INJ SER 20ML+ MED 1\n",
      "  3400930075142 | NASONEX 50 MCG/DOSE SUSP NASALE 140 1\n",
      "  3400930075210 | SIMVASTATINE BGA 20MG CPR 28\n",
      "  3400930075272 | IBRANCE 75 MG GELULE 21\n",
      "  3400930075296 | IBRANCE 100MG GELULE 21\n",
      "  3400930075302 | IBRANCE 125 MG GELULE 21\n",
      "  3400930075333 | MUPIROCINE VTS 2 % POMMADE 1\n",
      "  3400930075357 | MUPIROCINE ARW 2 % POMMADE 1\n",
      "  3400930075364 | MUPIROCINE SDZ 2 % POMMADE 1\n",
      "  3400930076163 | MUPIROCINE PFA 2 % POMMADE 1\n",
      "  3400930076194 | MUPIROCINE EG 2 % POMMADE 1\n",
      "  3400930076279 | ZYTIGA 500 MG CPR 60\n",
      "  3400930076286 | CIMZIA 200 MG SOL INJ STYLO 1ML 2\n",
      "  3400930076385 | LEVETIRACETAM ZEN 250MG CPR 60\n",
      "  3400930076439 | LEVETIRACETAM ZEN 500MG CPR 60\n",
      "  3400930076507 | LEVETIRACETAM ZEN 1 000 MG CPR 60\n",
      "  3400930076545 | PERINUTRIFLEX OMEGA E PERF 1250ML 5\n",
      "  3400930076576 | AMOXICILLINE EGL 500MG GELULE 12\n",
      "  3400930076880 | EMTRICITABIN TENOF ZEN 200/245MG CPR 30\n",
      "  3400930076941 | MURTIPA 10MG CPR 30\n",
      "  3400930076972 | ABACAVIR/LAM BGA 600 MG/300 MG CPR 30\n",
      "  3400930077214 | RUPATADINE BGA 10 MG CPR 30\n",
      "  3400930077252 | RUPATADINE EG 10 MG CPR 15\n",
      "  3400930077276 | RUPATADINE EG 10 MG CPR 30\n",
      "  3400930077320 | RUPATADINE VTS10 MG CPR 15\n",
      "  3400930077344 | RUPATADINE VTS10 MG CPR 30\n",
      "  3400930077429 | MEDNUTRIFLEX OMEGA E PERF 1250ML 5\n",
      "  3400930077436 | MEDNUTRIFLEX OMEGA E PERF 1875ML 5\n",
      "  3400930077450 | REANUTRIFLEX OMEGA E PERF 625ML 5\n",
      "  3400930077467 | REANUTRIFLEX OMEGA E PERF 1250ML 5\n",
      "  3400930077474 | REANUTRIFLEX OMEGA E PERF 1875ML 5\n",
      "  3400930077665 | RUPATADINE ARW 10MG CPR 30\n",
      "  3400930077696 | NINLARO 2,3MG GELULE 3\n",
      "  3400930077719 | NINLARO 3MG GELULE 3\n",
      "  3400930077726 | NINLARO 4 MG GELULE 3\n",
      "  3400930077856 | VENCLYXTO 10 MG CPR 14\n",
      "  3400930077887 | VENCLYXTO 50 MG CPR 7\n",
      "  3400930077894 | VENCLYXTO 100 MG CPR 7\n",
      "  3400930077900 | VENCLYXTO 100 MG CPR 14\n",
      "  3400930077917 | VENCLYXTO 100 MG CPR 112\n",
      "  3400930077948 | DUTASTERIDE SDZ 0,5MG CAPSULE 30\n",
      "  3400930078167 | AMLODIPINE/VALSART TVC 5MG/80MG CPR 30\n",
      "  3400930078198 | AMLODIPINE/VALSART TVC 5MG/80MG CPR 90\n",
      "  3400930078259 | AMLODIPINE/VALSART TVC 5MG/160MG CPR 30\n",
      "  3400930078273 | AMLODIPINE/VALSART TVC 5MG/160MG CPR 90\n",
      "  3400930078488 | AMLODIPINE/VALSAR TVC 10MG/160MG CPR 30\n",
      "  3400930078501 | AMLODIPINE/VALSAR TVC 10MG/160MG CPR 90\n",
      "  3400930078655 | REVINTY ELLIPTA 92/22MICROG INH U 30\n",
      "  3400930078679 | REVINTY ELLIPTA 184/22MICROG INH U 30\n",
      "  3400930078853 | XARELTO 15 MG + 20 MG CPR PELL 49\n",
      "  3400930078884 | IVABRADINE ZEN 5 MG CPR 56\n",
      "  3400930078914 | IVABRADINE ZEN 7.5 MG CPR 56\n",
      "  3400930078921 | VENLAFAXINE VIATRIS LP 37,5MG GELULE 30\n",
      "  3400930078976 | IRBESARTAN BGA 150MG CPR PELL 30\n",
      "  3400930079003 | IRBESARTAN BGA 300MG CPR PELL 30\n",
      "  3400930079034 | EMTRICITABIN TENOF MYL 200/245MG CPR 30\n",
      "  3400930079041 | TENOFOVIR DISO MYL 245 MG CPR 30\n",
      "  3400930079188 | IVABRADINE VTS 5 MG CPR 56\n",
      "  3400930079331 | IVABRADINE VTS 7.5 MG CPR 56\n",
      "  3400930079416 | ARIPIPRAZOLE ZYD 5 MG CPR 28\n",
      "  3400930079454 | ARIPIPRAZOLE ZYD 10MG CPR 28\n",
      "  3400930079485 | ARIPIPRAZOLE ZYD 15 MG CPR 28\n",
      "  3400930079522 | CETIRIZINE TVS 10MG CPR 15\n",
      "  3400930079676 | MONTELUKAST ARL 10MG CPR 28\n",
      "  3400930079799 | VAXELIS SUSP INJ SER 1\n",
      "  3400930079843 | IMODIUM 0,2MG/ML ENF SOL BUV 100 ML 1\n",
      "  3400930080061 | LEVETIRACETAM BGA 250 MG CPR 60\n",
      "  3400930080078 | LEVETIRACETAM BGA 500 MG CPR 60\n",
      "  3400930080085 | ATORVASTATINE VIATRIS 10MG CPR 30\n",
      "  3400930080092 | ATORVASTATINE VIATRIS 10MG CPR 90\n",
      "  3400930080108 | ATORVASTATINE VIATRIS 20MG CPR 30\n",
      "  3400930080115 | ATORVASTATINE VIATRIS 20MG CPR 90\n",
      "  3400930080122 | ATORVASTATINE VTS 40MG CPR 30\n",
      "  3400930080139 | ATORVASTATINE VTS 40MG CPR 90\n",
      "  3400930080146 | ATORVASTATINE VTS 80MG CPR 30\n",
      "  3400930080153 | ATORVASTATINE VTS 80MG CPR 90\n",
      "  3400930080177 | VORICONAZOLE SDZ 200MG CPR 28\n",
      "  3400930080184 | VORICONAZOLE SDZ 200MG CPR 56\n",
      "  3400930080238 | DICLOFENAC ARW 1% GEL FL 100 ML 1\n",
      "  3400930080412 | BISOPROLOL QVL 2,5 MG CPR 30\n",
      "  3400930080436 | BISOPROLOL QVL 2,5 MG CPR 90\n",
      "  3400930080528 | BISOPROLOL QUIVER LAB 3,75 MG, CPR 30\n",
      "  3400930080559 | BISOPROLOL QUIVER LAB 3,75 MG, CPR 90\n",
      "  3400930080610 | BISOPROLOL QVL 5MG CPR 30\n",
      "  3400930080689 | BISOPROLOL QVL 7,5 MG, COMPRI 30\n",
      "  3400930080702 | BISOPROLOL QVL 7,5 MG, COMPRI 90\n",
      "  3400930080757 | BISOPROLOL QVL 10MG CPR 30\n",
      "  3400930080788 | BISOPROLOL QVL 10MG CPR 90\n",
      "  3400930080832 | GASTROGRAFINE 76% SOL BUV/RECTALE 1\n",
      "  3400930081051 | TRINORDIOL CPR 21\n",
      "  3400930081068 | TRINORDIOL CPR 63\n",
      "  3400930081372 | ATARAX 25MG CPR 30\n",
      "  3400930081433 | ATARAX 0,2G/100ML SIROP FL 200ML 1\n",
      "  3400930081457 | XIMEPEG PDR ORALE SACHET 8\n",
      "  3400930081518 | DICLOFENAC ARG 1% GEL TB 100G 1\n",
      "  3400930081525 | CYSTADROPS 3,8 MG/ML, COLLYRE FL 5ML 1\n",
      "  3400930081549 | BECLOMETASONE CHI 400MCG INH UNIDOSE 20\n",
      "  3400930081570 | BECLOMETASONE CHI 800MCG INH UNIDOSE 20\n",
      "  3400930081594 | DULCILARMES 1,5% COLLYRE FL 1\n",
      "  3400930081679 | ETORICOXIB KRK 30 MG CPR 28\n",
      "  3400930081778 | ETORICOXIB KRK 60 MG CPR 28\n",
      "  3400930081808 | HYDROXYZINE VIATRIS 25MG CPR 30\n",
      "  3400930081815 | OXOMEMAZINE CRT 0,33MG/ML SS SOL BUV 1\n",
      "  3400930081822 | HYDROXYZINE BGA 25MG CPR 30\n",
      "  3400930081921 | TRAVOPROST CRT 40 MCG/ML COLLYRE 1\n",
      "  3400930082102 | DUTASTERIDE ARW 0,5 MG CAPSULE 30\n",
      "  3400930082157 | AMOXICILLINE ALM 1G CPR DISP 6\n",
      "  3400930082188 | AMOXICILLINE ALM 1G CPR DISP 14\n",
      "  3400930082232 | PROGESTERONE SDZ 100MG CAPSULE 90\n",
      "  3400930082270 | METOPROLOL ARL 50MG CPR 30\n",
      "  3400930082362 | METOPROLOL ARL 100MG CPR 30\n",
      "  3400930082416 | METOPROLOL ARL 100MG CPR 90\n",
      "  3400930082454 | GABAPENTINE TVS 600MG CPR 90\n",
      "  3400930082508 | GABAPENTINE TVS 800MG CPR 90\n",
      "  3400930082539 | ROPINIROLE MYP LP 2MG CPR 28\n",
      "  3400930082621 | ROPINIROLE MYP LP 4MG CPR 28\n",
      "  3400930082690 | ROPINIROLE MYP LP 8MG CPR 28\n",
      "  3400930082799 | LAVENTAIR 55MCG/22MCG PDR INH UNIDO 30\n",
      "  3400930082812 | LAMIVUDINE /ZIDO ARW 150/300MG CPR 60\n",
      "  3400930082867 | URAPIDIL STRAGEN LP 30MG GELULE 30\n",
      "  3400930082911 | URAPIDIL STRAGEN LP 60MG GELULE 30\n",
      "  3400930083048 | ALECENSA 150MG GELULE 224\n",
      "  3400930083062 | SPASMAG 1,2 G SOL INJ IV 10\n",
      "  3400930083161 | FIASP 300U SOL INJ STYLO 5\n",
      "  3400930083178 | FIASP 1000U SOL INJ FL 1\n",
      "  3400930083185 | FIASP 300U SOL INJ CART 5\n",
      "  3400930083420 | ABAMIPHARM 600/300MG CPR 30\n",
      "  3400930083437 | ABACAVIR/LAM SDZ 600 MG/300 MG CPR 30\n",
      "  3400930083451 | ABACAVIR/LAM MYL 600 MG/300 MG CPR 30\n",
      "  3400930083468 | MONOPROST 0,005% COLLYRE SOLUTION 1\n",
      "  3400930083529 | ROSUVASTATINE TVC 5MG CPR 90\n",
      "  3400930083536 | ROSUVASTATINE TVC 10MG CPR 90\n",
      "  3400930083543 | ROSUVASTATINE TVC 20MG CPR 90\n",
      "  3400930083567 | DUTASTERIDE CRT 0,5MG CAPSULE 30\n",
      "  3400930083611 | ARIPIPRAZOLE CRT 5 MG CPR 28\n",
      "  3400930083758 | ARIPIPRAZOLE CRT 10 MG CPR 28\n",
      "  3400930083796 | ARIPIPRAZOLE CRT 15 MG CPR 28\n",
      "  3400930084151 | ACTONEL 35 MG CPR GASTRO 4\n",
      "  3400930084168 | ACTONEL 35 MG CPR GASTRO 12\n",
      "  3400930084199 | VALGANCICLOVIR BGA 450 MG CPR 60\n",
      "  3400930084564 | ATURGYL 50 MG/100 ML SOL NASALE 1\n",
      "  3400930084588 | TRAVOPROST ZEN 40 MCG/ML COLLYRE 1\n",
      "  3400930084779 | IVABRADINE TVS 5 MG CPR 56\n",
      "  3400930084823 | IVABRADINE TVS 7,5 MG CPR 56\n",
      "  3400930084939 | DARUNAVIR MYL 400MG CPR 60\n",
      "  3400930084953 | DARUNAVIR MYL 600MG CPR 60\n",
      "  3400930084977 | DARUNAVIR MYL 800MG CPR 30\n",
      "  3400930085011 | TENOFOVIR DISO SDZ 245 MG CPR 30\n",
      "  3400930085028 | COSIDIME 20MG/5MG/ML COLLYRE 1\n",
      "  3400930085035 | COSIDIME 20MG/5MG/ML COLLYRE 3\n",
      "  3400930085127 | CEFUROXIME CRT 250 MG CPR 8\n",
      "  3400930085141 | PREGABALINE ZTK 25 MG GELULE 56\n",
      "  3400930085158 | PREGABALINE ZTK 25 MG GELULE 84\n",
      "  3400930085172 | PREGABALINE ZTK 50 MG GELULE 84\n",
      "  3400930085189 | PREGABALINE ZTK 75 MG GELULE 56\n",
      "  3400930085196 | PREGABALINE ZTK 100 MG GELULE 84\n",
      "  3400930085202 | PREGABALINE ZTK 150 MG GELULE 56\n",
      "  3400930085219 | PREGABALINE ZTK 200 MG GELULE 84\n",
      "  3400930085233 | PREGABALINE ZTK 300 MG GELULE 56\n",
      "  3400930085288 | LEVUNIQUE 1,5MG CPR 1\n",
      "  3400930085295 | LEVONORGESTREL ZEN 1,5MG CPR 1\n",
      "  3400930085332 | LAMIVUDINE ARW 150MG CPR 60\n",
      "  3400930085370 | LAMIVUDINE ARW 300MG CPR 30\n",
      "  3400930085417 | EZETIMIBE BGA 10MG CPR 30\n",
      "  3400930085431 | EZETIMIBE BGA 10MG CPR 90\n",
      "  3400930085448 | TIVICAY 10MG CPR 30\n",
      "  3400930085462 | TIVICAY 25MG CPR 30\n",
      "  3400930085493 | SEVELAMER CARB MYL 2,4G PDR ORALE 90\n",
      "  3400930085523 | SEVELAMER CARB SDZ 2,4G PDR ORALE 90\n",
      "  3400930085967 | EZETIMIBE ACC 10MG CPR 28\n",
      "  3400930086483 | EPLERENONE ACC 25MG CPR 30\n",
      "  3400930086490 | EPLERENONE ACC 25MG CPR 90\n",
      "  3400930086582 | EPLERENONE ACC 50MG CPR 30\n",
      "  3400930086599 | EPLERENONE ACC 50MG CPR 90\n",
      "  3400930086940 | ROSUVASTATINE VTS 5MG CPR 30\n",
      "  3400930086957 | ROSUVASTATINE VTS 5MG CPR 90\n",
      "  3400930086988 | ROSUVASTATINE VTS 5MG CPR 30\n",
      "  3400930087039 | ROSUVASTATINE VTS 10MG CPR 30\n",
      "  3400930087046 | ROSUVASTATINE VTS 10MG CPR 90\n",
      "  3400930087077 | ROSUVASTATINE VTS 10MG CPR 30\n",
      "  3400930087114 | ROSUVASTATINE VTS 20MG CPR 30\n",
      "  3400930087121 | ROSUVASTATINE VTS 20MG CPR 90\n",
      "  3400930087183 | PREGABALINE SDZ 25 MG GELULE 56\n",
      "  3400930087190 | PREGABALINE SDZ 25 MG GELULE 84\n",
      "  3400930087206 | PREGABALINE SDZ 50 MG GELULE 84\n",
      "  3400930087213 | PREGABALINE SDZ 75 MG GELULE 56\n",
      "  3400930087220 | PREGABALINE SDZ 100 MG GELULE 84\n",
      "  3400930087244 | PREGABALINE SDZ 200 MG GELULE 84\n",
      "  3400930087251 | PREGABALINE SDZ 300 MG GELULE 56\n",
      "  3400930087268 | PREGABALINE SDZ 150 MG GELULE 56\n",
      "  3400930087299 | ZYMAD 50000UI SOL BUV AMP 1\n",
      "  3400930087367 | OLUMIANT 2MG CPR 28\n",
      "  3400930087398 | OLUMIANT 4MG CPR 28\n",
      "  3400930087688 | CALCIDOSE VIT D3 500MG/800UI PDR 30\n",
      "  3400930087787 | CICLOPIROX OLAMI GRD 1,5% SHAMPOOING 1\n",
      "  3400930087824 | ONDANSETRON ZEN 8MG CPR DISP 2\n",
      "  3400930087831 | ONDANSETRON ZEN 8MG CPR DISP 4\n",
      "  3400930087916 | SOLIFENACINE BGA 5MG CPR 30\n",
      "  3400930087954 | SOLIFENACINE BGA 10MG CPR 30\n",
      "  3400930087992 | IVABRADINE EG 5 MG CPR 56\n",
      "  3400930088074 | IVABRADINE EG 7.5 MG CPR 56\n",
      "  3400930088111 | XELJANZ 5 MG CPR 56\n",
      "  3400930088272 | MEROPENEM ARL 1 G INJ FL 10\n",
      "  3400930088302 | DARUNAVIR BGA 600MG CPR 60\n",
      "  3400930088326 | DARUNAVIR BGA 800MG CPR 30\n",
      "  3400930088333 | RAMIPRIL ARG 5MG CPR 90\n",
      "  3400930088364 | RAMIPRIL ARG 10MG CPR 90\n",
      "  3400930088661 | AMLODIPINE/VALSART ZEN 5MG/80MG CP 30\n",
      "  3400930088678 | AMLODIPINE/VALSART ZEN 5MG/80MG CP 90\n",
      "  3400930088685 | AMLODIPINE/VALSART ZEN 5MG/160MG CP 30\n",
      "  3400930088692 | AMLODIPINE/VALSART ZEN 5MG/160MG CP 90\n",
      "  3400930088715 | AMLODIPINE/VALSART ZEN 10MG/160MG CP 30\n",
      "  3400930088722 | AMLODIPINE/VALSART ZEN 10MG/160MG CP 90\n",
      "  3400930088746 | OROCAL VIT D3 500MG/1000UI CPR 30\n",
      "  3400930088784 | PARACETAMOL BGA 500MG GELULE 16\n",
      "  3400930088821 | BIMATOPROST VTS 0.3MG COLLYRE FL 1\n",
      "  3400930088890 | SERTRALINE ARL 25MG GELULE 7\n",
      "  3400930088951 | SERTRALINE ARL 50MG GELULE 28\n",
      "  3400930089026 | NEVIRAPINE CRT 400MG CPR LP 30\n",
      "  3400930089170 | ELETRIPTAN ZYD 40 MG CPR 10\n",
      "  3400930089217 | PERGOVERIS 300/150UI 0.48ML INJ STYL 1\n",
      "  3400930089224 | PERGOVERIS (450UI+225UI)/0.72ML INJ 1\n",
      "  3400930089231 | PERGOVERIS (900/450UI)/ 1.44ML INJ 1\n",
      "  3400930089279 | IVABRADINE KRK 5 MG CPR 56\n",
      "  3400930089347 | IVABRADINE KRK 7,5 MG CPR 56\n",
      "  3400930089446 | RASAGILINE CRT 1MG CPR 30\n",
      "  3400930089514 | ILARIS 150 MG SOL INJ 1\n",
      "  3400930089958 | ABACAVIR SDZ 300MG CPR 60\n",
      "  3400930089965 | PREGABALINE ZYD 75 MG GELULE 56\n",
      "  3400930089972 | PREGABALINE ZYD 150 MG GELULE 56\n",
      "  3400930089989 | PREGABALINE ZYD 300 MG GELULE 56\n",
      "  3400930090015 | CETIRIZINE ARL 10MG CPR 15\n",
      "  3400930090114 | PRAVASTATINE CRT 10MG CPR SECABLE 28\n",
      "  3400930090213 | SEVELAMER CARB ARW 2,4G PDR ORALE 90\n",
      "  3400930090220 | LEVONORGESTREL CRT 1,5MG CPR 1\n",
      "  3400930090268 | NEBIVOLOL ALM 5MG CPR 30\n",
      "  3400930090299 | NEBIVOLOL ALM 5MG CPR 90\n",
      "  3400930090404 | IPRATROPIUM EG 0,5MG/2ML AD INHAL 10\n",
      "  3400930090794 | IPRATROPIUM ZEN 0,5MG/2ML AD INHAL 10\n",
      "  3400930090855 | IPRATROPIUM ZEN 0,25MG/1ML ENF INHAL 30\n",
      "  3400930090961 | OMNIPAQUE 350MG SOL INJ FP 150ML ULR 1\n",
      "  3400930090978 | OMNIPAQUE 350MG INJ FP TUB 100ML 1\n",
      "  3400930091074 | DUTASTERIDE ZTL 0,5MG CAPSULE 30\n",
      "  3400930091241 | DUTASTERIDE TEVA 0,5MG CAPSULE 30\n",
      "  3400930091678 | VENLAFAXINE ARG LP 150MG GELULE 30\n",
      "  3400930091845 | CLARISCAN 0,5MMOL/ML INJ SER 15ML 1\n",
      "  3400930091869 | CLARISCAN 0,5MMOL/ML INJ SER 20ML 1\n",
      "  3400930091906 | CLARISCAN 0,5 MMOL/ML SOL INJ FL10ML 1\n",
      "  3400930091920 | CLARISCAN 0,5 MMOL/ML SOL INJ FL15ML 1\n",
      "  3400930091944 | CLARISCAN 0,5 MMOL/ML INJ FL 20ML 1\n",
      "  3400930092330 | PRAMIPEXOLE ARL 0,18MG CPR 30\n",
      "  3400930092385 | PRAMIPEXOLE ARL 0,18MG CPR 100\n",
      "  3400930092460 | PRAMIPEXOLE ARL 0,7MG CPR 30\n",
      "  3400930092613 | DIPHANTE 100MG CPR 100\n",
      "  3400930092675 | BENEPALI 25 MG SOL INJ SER 4\n",
      "  3400930092903 | ATENOLOL BGA 50 MG CPR 30\n",
      "  3400930092934 | EBILFUMIN 30MG GELULE 10\n",
      "  3400930092965 | EBILFUMIN 45 MG GELULE 10\n",
      "  3400930092972 | EBILFUMIN 75 MG GELULE 10\n",
      "  3400930092989 | VALGANCICLOVIR VTS 450MG CPR 60\n",
      "  3400930093016 | ESOMEPRAZOLE ALM 20MG CPR 28\n",
      "  3400930093061 | ESOMEPRAZOLE ALM 40MG CPR 28\n",
      "  3400930093177 | ABACAVIR/LAM TVC 600 MG/300 MG CPR 30\n",
      "  3400930093207 | GIBITER EASY 160/4,5 MCG INH 120D 1\n",
      "  3400930093245 | GIBITER EASYHALER 320/9MCG INH 60D 1\n",
      "  3400930093337 | TENOFOVIR DISO TEVA 245 MG CPR 30\n",
      "  3400930093405 | VIZITRAV 40 MCG/ML COLLYRE 1\n",
      "  3400930093535 | DESOGESTREL CRT 75 MCG CPR 84\n",
      "  3400930093863 | EMTRICITABIN TENOF TVC 200/245MG CPR 30\n",
      "  3400930094754 | KYLEENA 19,5 MG DISP INTRA UTERIN 1\n",
      "  3400930094846 | TRAMADOL VIATRIS 50MG GELULE 30\n",
      "  3400930094853 | ALFUZOSINE VTS LP 10MG CPR 30\n",
      "  3400930094891 | ELETRIPTAN ZEN 20MG CPR 6\n",
      "  3400930094976 | ELETRIPTAN ZEN 40MG CPR 6\n",
      "  3400930094983 | ELETRIPTAN ZEN 40MG CPR 10\n",
      "  3400930095027 | DULOXETINE EVO 30 MG GELULE 28\n",
      "  3400930095133 | DULOXETINE EVO 60 MG GELULE 28\n",
      "  3400930095225 | ETORICOXIB ARW 30 MG CPR 28\n",
      "  3400930095294 | ETORICOXIB ARW 60 MG CPR 28\n",
      "  3400930095324 | EZETIMIBE/SIMVAST EVO 10MG/20MG CPR 30\n",
      "  3400930095355 | EZETIMIBE/SIMVAST EVO 10MG/20MG CPR 90\n",
      "  3400930095379 | EZETIMIBE/SIMVAST EVO 10MG/40MG CPR 30\n",
      "  3400930095393 | EZETIMIBE/SIMVAST EVO 10MG/40MG CPR 90\n",
      "  3400930095416 | EZETIMIBE/SIMVAST CRT 10MG/20MG CPR 30\n",
      "  3400930095430 | EZETIMIBE/SIMVAST CRT 10MG/20MG CPR 90\n",
      "  3400930095454 | EZETIMIBE/SIMVAST CRT 10MG/40MG CPR 30\n",
      "  3400930095478 | EZETIMIBE/SIMVAST CRT 10MG/40MG CPR 90\n",
      "  3400930095492 | EZETIMIBE/SIMVAST BGA 10MG/20MG CPR 30\n",
      "  3400930095515 | EZETIMIBE/SIMVAST BGA 10MG/20MG CPR 90\n",
      "  3400930095539 | EZETIMIBE/SIMVAST BGA 10MG/40MG CPR 30\n",
      "  3400930095553 | EZETIMIBE/SIMVAST BGA 10MG/40MG CPR 90\n",
      "  3400930095577 | CHOLECALCIFEROL TVC 2,5MG/2ML SOL BU 1\n",
      "  3400930095706 | SINETRAV 40 MCG/ML COLLYRE 1\n",
      "  3400930095744 | ALEND AC / D3 TVS 70 MG/2800 UI CPR 4\n",
      "  3400930095751 | ALEND AC / D3 TVS 70 MG/2800 UI CPR 12\n",
      "  3400930095775 | ALEND AC /D3 TVS 70MG/5600UI CPR 4\n",
      "  3400930095782 | ALEND AC /D3 TVS 70MG/5600UI CPR 12\n",
      "  3400930095874 | REPAGLINIDE EG 2MG CPR 270\n",
      "  3400930096086 | EZETIMIBE CRT 10MG CPR 28\n",
      "  3400930096147 | EFAVIR/EMTR/TENO TVC 600/200/245 CPR 30\n",
      "  3400930096253 | TENOFOVIR DISO ARW 204 MG CPR 30\n",
      "  3400930096284 | TENOFOVIR DISO ARW 245 MG CPR 30\n",
      "  3400930096321 | DUTASTERIDE KRK 0,5MG CAPSULE 30\n",
      "  3400930096376 | TRUMENBA SUSP INJ SERG 1\n",
      "  3400930096635 | NIQUITIN MENTHE G 2MG GOMME SS SUCRE 100\n",
      "  3400930096796 | NIQUITIN MENTHE G 4MG GOMME SS SUCRE 100\n",
      "  3400930096819 | BRIMONIDINE/TIM EG 2MG/5MG/ML COLLYR 1\n",
      "  3400930097274 | FUSIDATE DE SODIUM VTS 250MG CPR PEL 10\n",
      "  3400930097441 | EZETIMIBE/SIMVAST SDZ 10MG/20MG CPR 30\n",
      "  3400930097465 | EZETIMIBE/SIMVAST SDZ 10MG/20MG CPR 90\n",
      "  3400930097502 | EZETIMIBE/SIMVAST SDZ 10MG/40MG CPR 30\n",
      "  3400930097526 | EZETIMIBE/SIMVAST SDZ 10MG/40MG CPR 90\n",
      "  3400930097533 | CYAMEMAZINE VIATRIS 25MG CPR 30\n",
      "  3400930097557 | CYAMEMAZINE BGA 25MG CPR 30\n",
      "  3400930097762 | EZETIMIBE SDZ 10MG CPR 30\n",
      "  3400930097816 | EZETIMIBE SDZ 10MG CPR 90\n",
      "  3400930098028 | ALEND AC / D3 ARW 70 MG/2800 UI CPR 4\n",
      "  3400930098042 | ALEND AC / D3 ARW 70 MG/2800 UI CPR 12\n",
      "  3400930098073 | ENOXAPARINE CRU 10000UI/1ML INJ SER 10\n",
      "  3400930098127 | ENOXAPARINE CRU 8000UI/0.8ML SER 10\n",
      "  3400930098141 | ENOXAPARINE CRU 8000UI/0.8ML SER 10\n",
      "  3400930098196 | ENOXAPARINE CRU 6000UI/0.6ML SER 2\n",
      "  3400930098219 | ENOXAPARINE CRU 6000UI/0.6ML SER 6\n",
      "  3400930098264 | ENOXAPARINE CRU 4000UI/0.4ML SER 2\n",
      "  3400930098271 | ENOXAPARINE CRU 4000UI/0.4ML SER 6\n",
      "  3400930098325 | ENOXAPARINE CRU 2000UI/0,2ML SER 2\n",
      "  3400930098332 | ENOXAPARINE CRU 2000UI/0,2ML SER 6\n",
      "  3400930098387 | ACECLOFENAC EG LABO 100MG CPR 30\n",
      "  3400930098479 | SOLIFENACINE BSI 5MG CPR 30\n",
      "  3400930098516 | SOLIFENACINE BSI 10MG CPR 30\n",
      "  3400930098639 | ELMIRON 100MG GELULE 90\n",
      "  3400930098660 | DUTASTERIDE ARL 0,5 MG CAPSULE 30\n",
      "  3400930098721 | DUTASTERIDE EG 0,5MG CAPSULE 30\n",
      "  3400930098783 | ALEND AC /D3 ARW 70 MG/ 5600 UI CPR 4\n",
      "  3400930098806 | ALEND AC /D3 ARW 70 MG/ 5600 UI CPR 12\n",
      "  3400930098875 | DUTASTERIDE MYG 0,5MG CAPSULE 30\n",
      "  3400930098943 | ERELZI 25 MG SOL INJ SER 4\n",
      "  3400930098950 | ERELZI 50 MG SOL INJ SER 4\n",
      "  3400930098967 | ERELZI 50MG SOL INJ STYLO 4\n",
      "  3400930099070 | ALEND AC / D3 PHT 70 MG/2800 UI CPR 4\n",
      "  3400930099094 | ALEND AC / D3 PHT 70 MG/2800 UI CPR 12\n",
      "  3400930099230 | ALEND AC /D3 PHT 70 MG/ 5600 UI CPR 4\n",
      "  3400930099254 | ALEND AC /D3 PHT 70 MG/ 5600 UI CPR 12\n",
      "  3400930099346 | ETORICOXIB SDZ 30 MG CPR 28\n",
      "  3400930099520 | ETORICOXIB SDZ 60 MG CPR 28\n",
      "  3400930099643 | BASDENE 25 MG CPR 50\n",
      "  3400930099957 | SOLIFENACINE ARW 5MG CPR 30\n",
      "  3400930100035 | SOLIFENACINE ARW 10MG CPR 30\n",
      "  3400930100561 | ENTECAVIR BGA 0,5 MG CPR 30\n",
      "  3400930100585 | ENTECAVIR BGA 1 MG CPR 30\n",
      "  3400930100608 | KEVZARA 150 MG SOL INJ SER 2\n",
      "  3400930100615 | KEVZARA 200 MG SOL INJ SER 2\n",
      "  3400930100622 | KEVZARA 150 MG SOL INJ STYLO 2\n",
      "  3400930100639 | KEVZARA 200 MG SOL INJ STYLO 2\n",
      "  3400930100677 | DULOXETINE EG 30 MG GELULE 28\n",
      "  3400930100738 | DULOXETINE EG 60 MG GELULE 28\n",
      "  3400930100776 | ZONISAMIDE TVC 25 MG GELULE 14\n",
      "  3400930100813 | ZONISAMIDE TVC 50 MG GELULE 14\n",
      "  3400930100844 | BIMATOPROST SDZ 0.1MG/ML COLL 3ML 1\n",
      "  3400930100868 | ZONISAMIDE TVC 100 MG GELULE 56\n",
      "  3400930100882 | EMTRICITABIN TENOF KDD 200/245MG CPR 28\n",
      "  3400930100899 | EMTRICITABIN TENOF KDD 200/245MG CPR 30\n",
      "  3400930100967 | ENTECAVIR TEVA 0,5 MG CPR 30\n",
      "  3400930100981 | ENTECAVIR TEVA 0,5 MG CPR 30\n",
      "  3400930101001 | ENTECAVIR TEVA 1 MG CPR 30\n",
      "  3400930101070 | FEBUXOSTAT BGA 80MG CPR 28\n",
      "  3400930101094 | FEBUXOSTAT BGA 120MG CPR 28\n",
      "  3400930101124 | FEBUXOSTAT ZTL 80MG CPR 28\n",
      "  3400930101148 | FEBUXOSTAT ZTL 120MG CPR 28\n",
      "  3400930101162 | QUETIAPINE EVO LP 50 MG CPR 30\n",
      "  3400930101209 | QUETIAPINE EVO LP 300 MG CPR 30\n",
      "  3400930101223 | QUETIAPINE EVO LP 300 MG CPR 60\n",
      "  3400930101247 | QUETIAPINE EVO LP 400 MG CPR 30\n",
      "  3400930101735 | CELECOXIB ARL 100MG GELULE 30\n",
      "  3400930101766 | QUETIAPINE TVS LP 50 MG CPR 30\n",
      "  3400930101773 | CELECOXIB ARL 200MG GELULE 30\n",
      "  3400930101780 | QUETIAPINE TVS LP 300 MG CPR 30\n",
      "  3400930101797 | QUETIAPINE TVS LP 300 MG CPR 60\n",
      "  3400930101803 | QUETIAPINE TVS LP 400 MG CPR 30\n",
      "  3400930101810 | QUETIAPINE TVS LP 400 MG CPR 60\n",
      "  3400930101834 | ENTECAVIR SDZ 0,5 MG CPR 30\n",
      "  3400930101872 | ENTECAVIR SDZ 1 MG CPR 30\n",
      "  3400930101902 | QUETIAPINE CRT LP 50 MG CPR 30\n",
      "  3400930101964 | QUETIAPINE CRT LP 300 MG CPR 30\n",
      "  3400930101995 | QUETIAPINE CRT LP 300 MG CPR 60\n",
      "  3400930102022 | QUETIAPINE CRT LP 400 MG CPR 30\n",
      "  3400930102053 | QUETIAPINE CRT LP 400 MG CPR 60\n",
      "  3400930102060 | ENTECAVIR EG 0,5 MG CPR 30\n",
      "  3400930102077 | ENTECAVIR EG 1 MG CPR 30\n",
      "  3400930102107 | NEVIRAPINE TVC 400MG CPR LP 30\n",
      "  3400930102152 | RASAGILINE ZEN 1MG CPR 30\n",
      "  3400930102275 | DULOXETINE SDZ 30 MG GELULE 28\n",
      "  3400930102411 | DULOXETINE SDZ 60MG GELULE 28\n",
      "  3400930102596 | LEVOD/C/E TVC 50/12.5/200MG CPR 100\n",
      "  3400930102626 | LEVOD/C/E TVC 75/18,75/200MG CPR 100\n",
      "  3400930102633 | LEVOD/C/E TVC 100/25/200MG CPR 100\n",
      "  3400930102657 | LEVOD/C/E TVC 125/31,25/200 MG CPR 100\n",
      "  3400930102671 | LEVOD/C/E TVC 150/37,5/200MG CPR 100\n",
      "  3400930102688 | LEVOD/C/E TVC 175/43,75/200 MG CPR 100\n",
      "  3400930102701 | LEVOD/C/E TVC 200 MG/50 MG/200 MG, 100\n",
      "  3400930103005 | FULVESTRANT TVC 250 MG SOL INJ 2\n",
      "  3400930103197 | ALEND AC / D3 ZEN 70 MG/2800 UI CPR 4\n",
      "  3400930103203 | ALEND AC / D3 ZEN 70 MG/2800 UI CPR 12\n",
      "  3400930103227 | ALEND AC /D3 ZEN 70 MG/ 5600 UI CPR 4\n",
      "  3400930103234 | ALEND AC /D3 ZEN 70 MG/ 5600 UI CPR 12\n",
      "  3400930103425 | EZETIMIBE CRT 10MG CPR 90\n",
      "  3400930103456 | LEVOD/C/E VTS 50/12.5/200MG CPR 100\n",
      "  3400930103494 | LEVOD/C/E VTS 75/18,75/200MG CPR 100\n",
      "  3400930103531 | LEVOD/C/E VTS 100/25/200MG CPR 100\n",
      "  3400930103579 | LEVOD/C/E VTS 125/31,25/200 MG CPR 100\n",
      "  3400930103623 | LEVOD/C/E MYL 150/37,5/200MG CPR 100\n",
      "  3400930103678 | LEVOD/C/E MYL 175/43,75/200 MG CPR 100\n",
      "  3400930103722 | LEVOD/C/E VTS 200 MG/50 MG/200 MG 100\n",
      "  3400930103777 | IVABRADINE ACC 5 MG CPR 56\n",
      "  3400930103807 | IVABRADINE ACC 7.5 MG CPR 56\n",
      "  3400930103951 | EZETIMIBE ZEN 10MG CPR 30\n",
      "  3400930103999 | EZETIMIBE ZEN 10MG CPR 90\n",
      "  3400930104002 | ISENTRESS 600 MG COMPRIME 60\n",
      "  3400930104781 | DARUNAVIR TVC 600MG CPR 60\n",
      "  3400930104934 | SELEXID 200MG CPR 20\n",
      "  3400930104941 | SELEXID 200MG CPR 28\n",
      "  3400930105108 | ESCITALOPRAM VIATRIS 20MG CPR 28\n",
      "  3400930105115 | ESCITALOPRAM VIATRIS 15MG CPR 28\n",
      "  3400930105122 | ESCITALOPRAM MYL 10 MG CPR 28\n",
      "  3400930105146 | ESCITALOPRAM VIATRIS 5MG CPR 28\n",
      "  3400930105153 | EFAVIR/EMTR/TENO ZEN 600/200/245 CPR 30\n",
      "  3400930105177 | TRAVOPROST/TIMO VTS 40MCG/5MG COLL 1\n",
      "  3400930105184 | TRAVOPROST/TIMO EG 40MCG/5MG COLLYRE 1\n",
      "  3400930105191 | TRAVOPROST/TIMO ZEN 40MCG/5MG COLL 1\n",
      "  3400930105207 | TRAVOPROST/TIMO CRT 40MCG/5MG COLLYR 1\n",
      "  3400930105214 | TRAVOPROST/TIMO BGA 40MCG/5MG COLLYR 1\n",
      "  3400930105221 | TRAVOPROST/TIMO TVC 40MCG/5MG COLLYR 1\n",
      "  3400930105245 | LATANOPROST ZEN 0,005% COLLYRE 1\n",
      "  3400930105252 | LATANOPROST ZEN 0,005% COLLYRE 3\n",
      "  3400930105337 | SOLIFENACINE ZYD 5MG CPR 30\n",
      "  3400930105351 | SOLIFENACINE ZYD 10MG CPR 30\n",
      "  3400930105467 | ENTECAVIR ZYD 0,5 MG CPR 30\n",
      "  3400930105481 | ENTECAVIR CRT 0,5 MG CPR 30\n",
      "  3400930105665 | ESCITALOPRAM BGA 5MG CPR 28\n",
      "  3400930105689 | ESCITALOPRAM BGA 10MG CPR 28\n",
      "  3400930105702 | ESCITALOPRAM BGA 20 MG CPR 28\n",
      "  3400930105733 | PERIND.TOS/INDAP TVC 10MG/2.5MG CPR 30\n",
      "  3400930105795 | RASAGILINE EG 1MG CPR 30\n",
      "  3400930105801 | ESCITALOPRAM VIATRIS 5MG CPR 28\n",
      "  3400930106396 | ARIPIPRAZOLE ARW 10 MG CPR ORODISP 28\n",
      "  3400930106419 | ARIPIPRAZOLE ARW 15 MG CPR ORODISP 28\n",
      "  3400930106464 | LANSOPRAZOLE ALP 15MG GELULE 15\n",
      "  3400930106495 | LANSOPRAZOLE ALP 15MG GELULE 30\n",
      "  3400930106761 | LANSOPRAZOLE ADS PHARM 15 MG, GELULE 15\n",
      "  3400930106792 | LANSOPRAZOLE ADS PHARM 15 MG, GELULE 30\n",
      "  3400930106860 | LANSOPRAZOLE ALP 30MG GELULE 14\n",
      "  3400930106884 | LANSOPRAZOLE ALP 30MG GELULE 28\n",
      "  3400930107195 | LANSOPRAZOLE ADS PH 30MG GELULE 7\n",
      "  3400930107218 | LANSOPRAZOLE ADS PH 30MG GELULE 14\n",
      "  3400930107232 | LANSOPRAZOLE ADS PH 30MG GELULE 28\n",
      "  3400930107447 | XENETIX 300 SOL INJ FL 150ML + NEC 1\n",
      "  3400930107485 | XENETIX 350 SOL INJ FL 150ML + NEC 1\n",
      "  3400930107546 | ENALAPRIL/LER TEVA 20MG/10MG CPR 30\n",
      "  3400930107577 | ENALAPRIL/LER TEVA 20MG/10MG CPR 90\n",
      "  3400930107614 | BIMATOP/TIMOL TVS 0,3/5MG/ML COLLYRE 1\n",
      "  3400930107652 | BIMATOP/TIMOL EG 0,3/5MG/ML COL 1\n",
      "  3400930107683 | BIMATOP/TIMOL VIATRIS 0,3/5MG/ML COL 1\n",
      "  3400930107713 | OROFLUCO 150 MG GELULE 6\n",
      "  3400930107768 | BIMATOP/TIMOL SDZ 0,3/5MG/ML COL 1\n",
      "  3400930107881 | PERINDOPRIL AMLO EG 4/5MG CPR 30\n",
      "  3400930107911 | PERINDOPRIL AMLO EG 4/10MG CPR 30\n",
      "  3400930107935 | PERINDOPRIL AMLO EG 8/5MG CPR 30\n",
      "  3400930107966 | PERINDOPRIL AMLO EG 8/10MG CPR 30\n",
      "  3400930108055 | AMOXICILLINE EGL 125MG/5ML PDR FL 1\n",
      "  3400930108116 | AMOXICILLINE EGL 250MG/5ML PDR FL 1\n",
      "  3400930108192 | AMOXICILLINE EGL 500MG/5ML PDR FL 1\n",
      "  3400930108291 | FEBUXOSTAT SDZ 80MG CPR 28\n",
      "  3400930108338 | ANASTROZOLE SDZ 1MG CPR 20\n",
      "  3400930108345 | ANASTROZOLE SDZ 1MG CPR 90\n",
      "  3400930108383 | EZETIMIBE/SIMVAST SUN 10MG/20MG CPR 30\n",
      "  3400930108420 | EZETIMIBE/SIMVAST SUN 10MG/20MG CPR 90\n",
      "  3400930108468 | EZETIMIBE/SIMVAST SUN 10MG/40MG CPR 30\n",
      "  3400930108512 | EZETIMIBE/SIMVAST SUN 10MG/40MG CPR 90\n",
      "  3400930108543 | FEBUXOSTAT SDZ 120MG CPR 28\n",
      "  3400930108611 | BETADINE SCRUB 4% SOL FP 125ML 1\n",
      "  3400930108703 | VILDAGLIPTINE SANDOZ 50MG CPR 30\n",
      "  3400930108727 | VILDAGLIPTINE SANDOZ 50MG CPR 60\n",
      "  3400930108765 | MAVIRET 100/40MG CPR 84\n",
      "  3400930109205 | ESBRIET 267 MG CPR 63\n",
      "  3400930109229 | ESBRIET 267 MG CPR 252\n",
      "  3400930109236 | ESBRIET 801 MG CPR 84\n",
      "  3400930109250 | TRIMBOW 87/5/9 MCG SOL INH 120 D 1\n",
      "  3400930109335 | KISQALI 200MG CPR 21\n",
      "  3400930109342 | KISQALI 200MG CPR 42\n",
      "  3400930109359 | KISQALI 200MG CPR 63\n",
      "  3400930109397 | SOLIFENACINE EG 5MG CPR 30\n",
      "  3400930109601 | GLYCER/VASEL/PARAF TVC CREME 1\n",
      "  3400930109618 | GLYCER/VASEL/PARAF ZYD 15/8/2% CREME 1\n",
      "  3400930109632 | ALEND AC / D3 CRT 70 MG/2800 UI CPR 4\n",
      "  3400930109649 | ALEND AC / D3 CRT 70 MG/2800 UI CPR 12\n",
      "  3400930109656 | ALEND AC /D3 CRT 70 MG/ 5600 UI CPR 4\n",
      "  3400930109663 | ALEND AC /D3 CRT 70 MG/ 5600 UI CPR 12\n",
      "  3400930109670 | BETNESOL 4 MG SOL INJ 3\n",
      "  3400930109700 | SOLIFENACINE EG 10MG CPR 30\n",
      "  3400930109731 | BETNESOL 0,5MG CPR EFF 30\n",
      "  3400930109892 | PRAMIPEXOLE ZEN 0,26MG CPR LP 30\n",
      "  3400930109915 | PRAMIPEXOLE ZEN 0,52MG CPR LP 30\n",
      "  3400930109960 | BETNESOL 5MG/100ML SOL RECTALE 1\n",
      "  3400930110003 | PRAMIPEXOLE ZEN 1,05MG CPR LP 30\n",
      "  3400930110041 | BETNEVAL 0,1% CREME TUBE 10G 1\n",
      "  3400930110102 | BETNEVAL LOTION 0,1% EMULSION 15G 1\n",
      "  3400930110140 | PRAMIPEXOLE ZEN 2,1MG CPR LP 30\n",
      "  3400930110287 | VOSEVI 400/100/100 MG CPR 28\n",
      "  3400930110621 | BETNEVAL 0,1% POMMADE TUBE 10G 1\n",
      "  3400930110775 | ERLOTINIB MYL 25MG CPR 30\n",
      "  3400930110836 | SOLIFENACINE ACC 5MG CPR 30\n",
      "  3400930110935 | SOLIFENACINE ACC 10 MG CPR 30\n",
      "  3400930110959 | ERLOTINIB MYL 100MG CPR 30\n",
      "  3400930110973 | ERLOTINIB MYL 150MG CPR 30\n",
      "  3400930110980 | REKOVELLE 12 MICROG SOL INJ STYLO 1\n",
      "  3400930110997 | REKOVELLE 36 MICROG/1,08 ML, SOL INJ 1\n",
      "  3400930111000 | REKOVELLE 72MICROGR SOL INJ STYLO 1\n",
      "  3400930111017 | ENBREL 25 MG SOL INJ STYLO 4\n",
      "  3400930111079 | ROSUVASTATINE KRK 5MG CPR 30\n",
      "  3400930111109 | ROSUVASTATINE KRK 5MG CPR 90\n",
      "  3400930111161 | BEVITINE 100 MG/2 ML SOL INJ 5\n",
      "  3400930111192 | ROSUVASTATINE KRK 5MG CPR 30\n",
      "  3400930111239 | ROSUVASTATINE KRK 5MG CPR 90\n",
      "  3400930111260 | ERLOTINIB BGA 25MG CPR 30\n",
      "  3400930111352 | ROSUVASTATINE KRK 10MG CPR 90\n",
      "  3400930111444 | ROSUVASTATINE KRK 10MG CPR 30\n",
      "  3400930111482 | ROSUVASTATINE KRK 10MG CPR 90\n",
      "  3400930111529 | ERLOTINIB BGA 100MG CPR 30\n",
      "  3400930111536 | ERLOTINIB BGA 150MG CPR 30\n",
      "  3400930111727 | ROSUVASTATINE KRK 20MG CPR 30\n",
      "  3400930111765 | ROSUVASTATINE KRK 20MG CPR 90\n",
      "  3400930111796 | MAVENCLAD 10 MG CPR 1\n",
      "  3400930111819 | MAVENCLAD 10 MG CPR 4\n",
      "  3400930111833 | MAVENCLAD 10 MG CPR 6\n",
      "  3400930111864 | ERLOTINIB EG 25MG CPR 30\n",
      "  3400930111871 | ERLOTINIB EG 150MG CPR 30\n",
      "  3400930111888 | ERLOTINIB EG 100MG CPR 30\n",
      "  3400930111963 | TAMSULOSINE ZTL LP 0,4MG GELULE 30\n",
      "  3400930111987 | EMTRICITABIN TENOF SDZ 200/245MG CPR 30\n",
      "  3400930111994 | EMTRICITABIN TENOF SDZ 200/245MG CPR 30\n",
      "  3400930112007 | PANTOPRAZOLE SNP 40 MG PDR INJ 1\n",
      "  3400930112038 | IVABRADINE ARW 5 MG CPR 56\n",
      "  3400930112045 | PANTOPRAZOLE ARG 20 MG CPR 14\n",
      "  3400930112090 | IVABRADINE ARW 7,5 MG CPR 56\n",
      "  3400930112106 | PANTOPRAZOLE ARG 20 MG CPR 28\n",
      "  3400930112168 | PROPAFENONE ACC 300MG CPR 30\n",
      "  3400930112199 | PANTOPRAZOLE ARG 40 MG CPR 7\n",
      "  3400930112205 | PANTOPRAZOLE ARG 40 MG CPR 14\n",
      "  3400930112229 | PANTOPRAZOLE ARG 40 MG CPR 28\n",
      "  3400930112366 | EFAVIR/EMTR/TENO MYL 600/200/245 CPR 30\n",
      "  3400930112427 | ATORVASTATINE ARG 40 MG CPR 30\n",
      "  3400930112441 | ATORVASTATINE ARG 40 MG CPR 90\n",
      "  3400930112489 | ATORVASTATINE ARG 80 MG CPR 30\n",
      "  3400930112502 | ATORVASTATINE ARG 80 MG CPR 90\n",
      "  3400930112793 | AMOXICILLINE EVO 1G CPR DISP 6\n",
      "  3400930112816 | AMOXICILLINE EVO 1G CPR DISP 14\n",
      "  3400930112892 | ROSUVASTATINE EVO 5MG CPR 30\n",
      "  3400930112908 | ROSUVASTATINE EVO 5MG CPR 90\n",
      "  3400930112915 | ROSUVASTATINE EVO 10MG CPR 30\n",
      "  3400930112939 | ROSUVASTATINE EVO 10MG CPR 90\n",
      "  3400930112946 | ROSUVASTATINE EVO 20MG CPR 30\n",
      "  3400930112953 | ROSUVASTATINE EVO 20MG CPR 90\n",
      "  3400930113165 | IVABRADINE SDZ 5 MG CPR 56\n",
      "  3400930113479 | IVABRADINE SDZ 7,5 MG CPR 56\n",
      "  3400930113608 | RYDAPT 25MG CAPS 112\n",
      "  3400930113738 | METHOTREXATE ACC 7,5 MG SOL INJ 1\n",
      "  3400930113745 | METHOTREXATE ACC 10 MG SOL INJ 1\n",
      "  3400930113769 | METHOTREXATE ACC 15 MG SOL INJ 1\n",
      "  3400930113776 | METHOTREXATE ACC 20 MG SOL INJ 1\n",
      "  3400930113783 | METHOTREXATE ACC 25 MG/0,5ML SOL INJ 1\n",
      "  3400930113806 | MOXIFLOXACINE ARW 400 MG CPR 5\n",
      "  3400930113820 | MOXIFLOXACINE ARW 400 MG CPR 7\n",
      "  3400930113936 | NEVIRAPINE SDZ 400MG CPR LP 30\n",
      "  3400930114698 | TRAMADOL/PARACETAMOL VTS CPR 20\n",
      "  3400930114728 | AMOXICILLINE CRT 1G CPR DISP 6\n",
      "  3400930114735 | AMOXICILLINE CRT 1G CPR DISP 14\n",
      "  3400930114759 | EZETIMIBE/SIMVAST ZEN 10MG/20MG CPR 30\n",
      "  3400930114773 | EZETIMIBE/SIMVAST ZEN 10MG/20MG CPR 90\n",
      "  3400930114797 | EZETIMIBE/SIMVAST ZEN 10MG/40MG CPR 30\n",
      "  3400930114810 | EZETIMIBE/SIMVAST ZEN 10MG/40MG CPR 90\n",
      "  3400930114858 | EZETIMIBE/SIMVAST EG 10MG/20MG CPR 30\n",
      "  3400930114940 | EZETIMIBE/SIMVAST EG 10MG/40MG CPR 30\n",
      "  3400930114988 | ALEND AC / D3 EG 70 MG/2800 UI CPR 4\n",
      "  3400930114995 | ALEND AC / D3 EG 70 MG/2800 UI CPR 12\n",
      "  3400930115008 | ALEND AC / D3 EG 70 MG/ 5600 UI CPR 4\n",
      "  3400930115022 | ALEND AC / D3 EG 70 MG/ 5600 UI CPR 12\n",
      "  3400930115343 | FLECAINIDE MYL LP 50MG GELULE 30\n",
      "  3400930115350 | FLECAINIDE MYL LP 100MG GELULE 30\n",
      "  3400930115367 | FLECAINIDE MYL LP 150MG GELULE 30\n",
      "  3400930115374 | FLECAINIDE MYL LP 200MG GELULE 30\n",
      "  3400930115404 | TELMISARTAN/HCTZ ACC 40MG/12,5MG CPR 30\n",
      "  3400930115442 | TELMISARTAN/HCTZ ACC 40MG/12,5MG CPR 90\n",
      "  3400930115480 | TELMISARTAN/HCTZ ACC 80MG/12,5MG CPR 30\n",
      "  3400930115527 | TELMISARTAN/HCTZ ACC 80MG/12,5MG CPR 90\n",
      "  3400930115572 | ENTECAVIR MYL 0,5 MG CPR 30\n",
      "  3400930115602 | ENTECAVIR MYL 1 MG CPR 30\n",
      "  3400930115626 | TELMISARTAN/HCTZ ACC 80MG/25MG CPR 30\n",
      "  3400930115664 | TELMISARTAN/HCTZ ACC 80MG/25MG CPR 90\n",
      "  3400930115848 | VENLAFAXINE EGL LP 37,5MG GELU 30\n",
      "  3400930115947 | VENLAFAXINE EGL LP 75MG GELU 30\n",
      "  3400930116180 | CLOZAPINE TVC 25MG CPR 28\n",
      "  3400930116203 | CLOZAPINE TVC 100MG CPR 14\n",
      "  3400930116210 | CLOZAPINE TVC 100MG CPR 28\n",
      "  3400930116494 | HUMIRA 80 MG SOL INJ SER + TAMP 1\n",
      "  3400930116500 | HUMIRA 80 MG SOL INJ STYLO + TAMP 1\n",
      "  3400930116630 | DUPIXENT 300 MG SOL INJ SER 1\n",
      "  3400930116647 | DUPIXENT 300 MG SOL INJ SER 2\n",
      "  3400930116791 | VILDAGLIPTINE/MET SDZ 50MG/1000MG CP 60\n",
      "  3400930116944 | BIOCIDAN 0,025% COLLYRE 1\n",
      "  3400930117163 | AMLODIPINE BGA 5MG GELULE 30\n",
      "  3400930117248 | EXEMESTANE BGR 25MG CPR 30\n",
      "  3400930117286 | KYNTHEUM 210MG SOL INJ SER 2\n",
      "  3400930117378 | ENTECAVIR EVO 0,5 MG CPR 30\n",
      "  3400930117392 | SIGNIFOR 10 MG PDR SOLV SUSP INJ 1\n",
      "  3400930117408 | SIGNIFOR 30 MG PDR SOLV SUSP INJ 1\n",
      "  3400930117460 | ENTECAVIR ARW 1 MG CPR 30\n",
      "  3400930117507 | ENTECAVIR ARW 0,5 MG CPR 30\n",
      "  3400930117514 | EFAVIR/EMTR/TENO BGA 600/200/245 CPR 30\n",
      "  3400930117576 | EFAVIR/EMTR/TENO SDZ 600/200/245 CPR 30\n",
      "  3400930117583 | EFAVIR/EMTR/TENO EG 600/200/245 CPR 30\n",
      "  3400930117613 | EVEROLIMUS TVC 2,5 MG CPR 30\n",
      "  3400930117637 | EVEROLIMUS TVC 5 MG CPR 30\n",
      "  3400930117644 | XTANDI 40MG CPR 112\n",
      "  3400930117675 | EVEROLIMUS TVC 10 MG CPR 30\n",
      "  3400930117699 | FENTICONAZOLE BLL CREME TUBE 15G 1\n",
      "  3400930117712 | INFLUVAC TETRA INJ SER + AIG 1\n",
      "  3400930117736 | EZETIMIBE/SIMVAST TVC 10MG/20MG CPR 30\n",
      "  3400930117743 | EZETIMIBE/SIMVAST TVC 10MG/40MG CPR 30\n",
      "  3400930118474 | BIMATOP/TIMOL BGA 0.3MG/5MG/ML COL 1\n",
      "  3400930118757 | ENTECAVIR ACC 0,5 MG CPR 30\n",
      "  3400930118788 | METFORMINE BGR 500 MG CPR 30\n",
      "  3400930118795 | METFORMINE BGR 850 MG CPR 30\n",
      "  3400930118801 | METFORMINE BGA 1000 MG CPR 30\n",
      "  3400930118832 | EUTHYROX 25 MICROG CPR 100\n",
      "  3400930118849 | EUTHYROX 50 MICROG CPR 100\n",
      "  3400930118856 | EUTHYROX 75 MICROG CPR 100\n",
      "  3400930118863 | EUTHYROX 100 MICROG CPR 100\n",
      "  3400930118870 | EUTHYROX 125 MICROG CPR SEC 100\n",
      "  3400930118887 | EUTHYROX 150 MICROG CPR 100\n",
      "  3400930118900 | EUTHYROX 175 MICROG CPR 100\n",
      "  3400930118917 | EUTHYROX 200 MICROG CPR 100\n",
      "  3400930118993 | ALPRAZOLAM ARL 0,25MG CPR 30\n",
      "  3400930119006 | ALPRAZOLAM ARL 0,5MG CPR 30\n",
      "  3400930119013 | DORZOLAMIDE BGR 2% COLLYRE 5ML 1\n",
      "  3400930119310 | MOVYMIA 20 MICROG/80 MICROL SOL INJ 1\n",
      "  3400930119365 | IVABRADINE BGA 5 MG CPR 56\n",
      "  3400930119440 | IVABRADINE BGA 7,5 MG CPR 56\n",
      "  3400930119525 | CINACALCET BGA 30MG CPR 28\n",
      "  3400930119570 | CINACALCET BGA 60MG CPR 28\n",
      "  3400930119624 | CINACALCET BGA 90MG CPR 28\n",
      "  3400930119723 | LOSARTAN CRP 100MG CPR 30\n",
      "  3400930119754 | LOSARTAN CRP 100MG CPR 90\n",
      "  3400930119761 | L THYROXIN HNG 25 MICROG CPR 100\n",
      "  3400930119778 | L THYROXIN HNG 50 MICROG CPR 100\n",
      "  3400930119792 | L THYROXIN HNG 75 MICROG CPR 100\n",
      "  3400930119808 | L THYROXIN HNG 100 MICROG CPR 100\n",
      "  3400930119815 | L THYROXIN HNG 125 MICROG CPR SEC 100\n",
      "  3400930119822 | L THYROXIN HNG 150 MICROG CPR 100\n",
      "  3400930119839 | L THYROXIN HNG 175 MICROG CPR 100\n",
      "  3400930119853 | L THYROXIN HNG 200 MICROG CPR 100\n",
      "  3400930119884 | DICLOFENAC VIATRIS LP 75MG CPR 30\n",
      "  3400930120712 | CINACALCET EVO 30MG CPR 28\n",
      "  3400930120767 | CINACALCET EVO 60MG CPR 28\n",
      "  3400930120804 | CINACALCET EVO 90MG CPR 28\n",
      "  3400930121344 | EZETIMIBE EVO 10MG CPR 28\n",
      "  3400930121399 | DARUNAVIR TVC 800MG CPR 30\n",
      "  3400930121405 | LEVOTHYROX 75 MICROG CPR EXC 90\n",
      "  3400930121429 | LEVOTHYROX 100MICROG CPR EXC 90\n",
      "  3400930121443 | LEVOTHYROX 125 MICROG CPR SEC EXC 90\n",
      "  3400930121467 | LEVOTHYROX 150MICROG CPR EXC 90\n",
      "  3400930121481 | LEVOTHYROX 200MICROG CPR EXC 90\n",
      "  3400930121504 | LEVOTHYROX 175MICROG CPR EXC 90\n",
      "  3400930121528 | SEVELAMER CARBONATE ARW 800 MG CPR 180\n",
      "  3400930121818 | RABEPRAZOLE BGR 20MG CPR 14\n",
      "  3400930121849 | RABEPRAZOLE BGR 20MG CPR 28\n",
      "  3400930122112 | ENANTONE LP 3,75 MG PDR INJ SRG 1\n",
      "  3400930122129 | ENANTONE LP 11,25 MG PDR INJ SRG 1\n",
      "  3400930122297 | VISIPAQUE 320MG/ML SOL INJ FPU 150ML 1\n",
      "  3400930122303 | VITAMINE K1 CHP 2MG/0,2ML NR SOL 1\n",
      "  3400930122334 | METFORMINE SDZ 1000MG CPR 30\n",
      "  3400930122372 | RITONAVIR MYL 100 MG CPR 30\n",
      "  3400930122693 | DORZOLAMIDE TIMOLOL BGR COLLYRE 5ML 1\n",
      "  3400930122754 | TREMFYA 100MG SOL INJ 1\n",
      "  3400930123065 | EZETIMIBE EVO 10MG CPR 90\n",
      "  3400930123102 | ABACAVIR/LAM/ZID VTS CPR 60\n",
      "  3400930123157 | DULOXETINE ARW 30MG GELULE 28\n",
      "  3400930123188 | DULOXETINE ARW 60MG GELULE 28\n",
      "  3400930123386 | FUSIDATE DE SODIUM ZEN 250MG CPR PEL 10\n",
      "  3400930123430 | AC GADOTERIQUE GEB 0,5MMOL/ML INJ 10 1\n",
      "  3400930123447 | AC GADOTERIQUE GEB 0,5MMOL/ML INJ 15 1\n",
      "  3400930123454 | AC GADOTERIQUE GEB 0,5MMOL/ML INJ 20 1\n",
      "  3400930123508 | LOCERYL 5% VERNIS MEDIC + SPAT 1\n",
      "  3400930123522 | BRICANYL TURBUHALER 500MCG/D PDR 1\n",
      "  3400930123874 | OROBUPRE 8 MG LYOPHILISAT ORAL 7\n",
      "  3400930123898 | OROBUPRE 2 MG LYOPHILISAT ORAL 7\n",
      "  3400930124086 | ELLAONE 30MG CPR PEL 1\n",
      "  3400930124093 | TASIGNA 50MG GELULE 120\n",
      "  3400930124147 | ENALAPRIL/LER KRK 20MG/10MG CPR 30\n",
      "  3400930124208 | ENALAPRIL/LER KRK 20MG/10MG CPR 90\n",
      "  3400930124215 | ALECENSA 150MG GELULE 240\n",
      "  3400930124277 | ATORVASTATINE ZEN 10MG CPR 30\n",
      "  3400930124314 | ATORVASTATINE ZEN 10MG CPR 90\n",
      "  3400930124369 | ATORVASTATINE ZEN 20MG CPR 30\n",
      "  3400930124406 | ATORVASTATINE ZEN 20MG CPR 90\n",
      "  3400930124451 | ATORVASTATINE ZEN 40MG CPR 30\n",
      "  3400930124505 | ATORVASTATINE ZEN 40MG CPR 90\n",
      "  3400930124567 | ATORVASTATINE ZEN 80MG CPR 30\n",
      "  3400930124604 | ATORVASTATINE ZEN 80MG CPR 90\n",
      "  3400930125076 | RASAGILINE ARW 1MG CPR 30\n",
      "  3400930125113 | RASAGILINE EVO 1 MG, CPR 30\n",
      "  3400930125182 | TRELEGY ELLIPTA 92/55/22 MCG PDR INH 30\n",
      "  3400930125205 | ELEBRATO ELLIPTA92/55/22 MCG PDR INH 30\n",
      "  3400930125212 | EZETIMIBE KRK 10MG CPR 30\n",
      "  3400930125236 | EZETIMIBE KRK 10MG CPR 90\n",
      "  3400930125267 | HUMALOG 300UI KWIKPEN JUNIOR STYLO 5\n",
      "  3400930125496 | DARUNAVIR EG 800MG CPR 30\n",
      "  3400930125533 | NAPROXENE SODIQUE ARW 550MG CPR 16\n",
      "  3400930125564 | ESOMEPRAZOLE ALM 20MG GELU 28\n",
      "  3400930125670 | ESOMEPRAZOLE ALM 40MG GELU 28\n",
      "  3400930125984 | METHOTREXATE ACC 12,5 MG SOL INJ 1\n",
      "  3400930125991 | METHOTREXATE ACC 17,5 MG SOL INJ 1\n",
      "  3400930126004 | METHOTREXATE ACC 50MG/ML S0,45ML 1\n",
      "  3400930126035 | METHOTREXATE ACC 30 MG SOL INJ 1\n",
      "  3400930126103 | ACIDE FOLIQUE CCD 0,4MG CPR 90\n",
      "  3400930126134 | PALMIER DE FLORIDE MYL 160MG GELULE 60\n",
      "  3400930126158 | PALMIER DE FLORIDE MYL 160MG GELULE 180\n",
      "  3400930126165 | HUMIRA 20 MG SOL INJ SER + TAMP 2\n",
      "  3400930126172 | LACOSAMIDE MEDIPHA 50 MG CPR 14\n",
      "  3400930126196 | LACOSAMIDE MEDIPHA 50 MG CPR 56\n",
      "  3400930126219 | LACOSAMIDE MEDIPHA 100 MG CPR 56\n",
      "  3400930126233 | LACOSAMIDE MEDIPHA 150 MG CPR 56\n",
      "  3400930126264 | LACOSAMIDE MEDIPHA 200 MG CPR 56\n",
      "  3400930126295 | ACETYLLEUCINE BGA 500MG CPR 30\n",
      "  3400930126684 | ZEJULA 100MG GELULE 84\n",
      "  3400930126899 | BENLYSTA 200MG SOL INJ STYLO 1\n",
      "  3400930126905 | BENLYSTA 200MG SOL INJ STYLO 4\n",
      "  3400930126929 | GLATIRAMER VIATRIS 40 MG SOL INJ SER 12\n",
      "  3400930127063 | DARUNAVIR EG 400MG CPR 60\n",
      "  3400930127087 | DARUNAVIR EG 600MG CPR 60\n",
      "  3400930127117 | CLOPIDOGREL EGL 75MG CPR 30\n",
      "  3400930127186 | KIPOS 100000UI CAPS MOL 1\n",
      "  3400930127193 | KIPOS 100000UI CAPS MOL 2\n",
      "  3400930127209 | TRAMADOL BGA 50MG GELULE 30\n",
      "  3400930127230 | PREVYMIS 240MG CPR 28\n",
      "  3400930127247 | PREVYMIS 480MG CPR 28\n",
      "  3400930127308 | EZETIMIBE EG 10MG CPR 30\n",
      "  3400930127353 | EZETIMIBE EG 10MG CPR 90\n",
      "  3400930127377 | BRIMONIDINE BGA 0,2% COLLYRE 1\n",
      "  3400930127551 | DARUNAVIR SDZ 400MG CPR 60\n",
      "  3400930127612 | DARUNAVIR SDZ 600MG CPR 60\n",
      "  3400930127667 | DARUNAVIR SDZ 800MG CPR 30\n",
      "  3400930127674 | NEVIRAPINE VTS 400MG CPR LP 30\n",
      "  3400930127797 | PERIND.TOS/INDAP TVC 10MG/2.5MG CPR 90\n",
      "  3400930128060 | RASAGILINE SDZ 1MG CPR 30\n",
      "  3400930128138 | ANAGRELIDE TEVA 0,5MG GELULE 100\n",
      "  3400930128145 | ABACAVIR/LAM ARROW 600/300MG CPR 30\n",
      "  3400930128169 | TRIMEBUTINE BGA 100MG CPR 30\n",
      "  3400930128176 | MIANSERINE BGA 10MG CPR 30\n",
      "  3400930128183 | MIANSERINE BGA 30MG CPR 30\n",
      "  3400930128206 | MIANSERINE BGA 60MG CPR 14\n",
      "  3400930128213 | ENALAPRIL/LER CRT 20MG/10MG CPR 30\n",
      "  3400930128220 | ENALAPRIL/LER CRT 20MG/10MG CPR 90\n",
      "  3400930128398 | LACTULOSE BIP 10G/15ML SOL BUV SAC G 20\n",
      "  3400930128534 | PREGABALINE EGL 25 MG GELULE 56\n",
      "  3400930128572 | PREGABALINE EGL 25 MG GELULE 84\n",
      "  3400930128657 | PREGABALINE EGL 50 MG GELULE 84\n",
      "  3400930128695 | PREGABALINE EGL 75 MG GELULE 56\n",
      "  3400930128787 | PREGABALINE EGL 100 MG GELULE 84\n",
      "  3400930128848 | PREGABALINE EGL 150 MG GELULE 56\n",
      "  3400930128923 | PREGABALINE EGL 200 MG GELULE 84\n",
      "  3400930128930 | ENALAPRIL/LER BGA 20MG/10MG CPR 30\n",
      "  3400930128947 | ENALAPRIL/LER BGA 20MG/10MG CPR 90\n",
      "  3400930128954 | FORMOTEROL EG 12 MICROG PDR INH GEL 60\n",
      "  3400930129159 | PREGABALINE EGL 300 MG GELULE 56\n",
      "  3400930129197 | ARIPIPRAZOLE EVO 5 MG CPR 28\n",
      "  3400930129289 | ARIPIPRAZOLE EVO 10MG CPR 28\n",
      "  3400930129364 | ARIPIPRAZOLE EVO 15MG CPR 28\n",
      "  3400930129500 | PERINDOPRIL AMLO EG 4/5MG CPR 90\n",
      "  3400930129524 | PERINDOPRIL AMLO EG 4/10MG CPR 90\n",
      "  3400930129548 | PERINDOPRIL AMLO EG 8/5MG CPR 90\n",
      "  3400930129562 | PERINDOPRIL AMLO EG 8/10MG CPR 90\n",
      "  3400930129685 | AC TRANEXAMIQUE ACC 500 MG SOL INJ 5\n",
      "  3400930129739 | INHIXA 2000UI AXA/0,2ML INJ SER 2\n",
      "  3400930129746 | INHIXA 2000UI AXA/0,2ML INJ SER 6\n",
      "  3400930129753 | INHIXA 4000UI AXA/0,4ML INJ SER 2\n",
      "  3400930129760 | INHIXA 4000UI AXA/0,4ML INJ SER 6\n",
      "  3400930129777 | INHIXA 6000UI AXA/0,6ML INJ SER 2\n",
      "  3400930129784 | INHIXA 6000UI AXA/0,6ML INJ SER 10\n",
      "  3400930129791 | INHIXA 8000UI AXA/0,8ML INJ SER 2\n",
      "  3400930129807 | INHIXA 8000UI AXA/0,8ML INJ SER 10\n",
      "  3400930129814 | INHIXA 10000UI AXA/ML INJ SER 10\n",
      "  3400930129821 | RYDAPT 25MG CAPS 56\n",
      "  3400930129876 | ELETRIPTAN EG 20MG CPR 6\n",
      "  3400930129968 | ELETRIPTAN EG 40MG CPR 6\n",
      "  3400930129975 | ELETRIPTAN EG 40MG CPR 10\n",
      "  3400930130001 | ANAGRELIDE BGA 0,5MG GELULE 100\n",
      "  3400930130018 | ANAGRELIDE SDZ 0,5MG GELULE 100\n",
      "  3400930130063 | ANAGRELIDE EG 0,5MG GELULE 100\n",
      "  3400930130230 | ABACAVIR/LAM VTS 600 MG/300 MG CPR 30\n",
      "  3400930130254 | MOVENTIG 12.5 MG CPR 30\n",
      "  3400930130285 | MOVENTIG 25MG CPR 30\n",
      "  3400930130308 | ANAGRELIDE MYL 0,5MG GELULE 100\n",
      "  3400930130506 | ENALAPRIL/LER VIATRIS 20MG/10MG CPR 30\n",
      "  3400930130520 | ENALAPRIL/LER VIATRIS 20MG/10MG CPR 90\n",
      "  3400930130858 | ZEJULA 100MG GELULE 56\n",
      "  3400930130872 | NPLATE 125 MCG PDR SOL INJ 1\n",
      "  3400930130919 | EZETIMIBE/SIMVAST TVC 10MG/20MG CPR 90\n",
      "  3400930130926 | EZETIMIBE/SIMVAST TVC 10MG/40MG CPR 90\n",
      "  3400930131077 | ENALAPRIL/LER EG 20MG/10MG CPR 30\n",
      "  3400930131114 | ENALAPRIL/LER EG 20MG/10MG CPR 90\n",
      "  3400930131121 | FORMOTEROL EG 12 MICROG PDR INH GEL 30\n",
      "  3400930131336 | DICLOFENAC BGA LP 75MG CPR 30\n",
      "  3400930131350 | GLUCOSE LAV 5% SOL INJ PP 50ML 1\n",
      "  3400930131367 | GLUCOSE LAV 5% SOL INJ PO 100ML 1\n",
      "  3400930131374 | GLUCOSE LAV 5% SOL INJ POC PP 250ML 1\n",
      "  3400930131398 | GLUCOSE LAV 5% SOL INJ PP 500ML 1\n",
      "  3400930131404 | GLUCOSE LAV 5% SOL INJ POC 1000ML 1\n",
      "  3400930131596 | PREGABALINE ZYD 25 MG GELULE 56\n",
      "  3400930131602 | PREGABALINE ZYD 25 MG GELULE 84\n",
      "  3400930131619 | PREGABALINE ZYD 50 MG GELULE 84\n",
      "  3400930131626 | PREGABALINE ZYD 100 MG GELULE 84\n",
      "  3400930131633 | PREGABALINE ZYD 200 MG GELULE 84\n",
      "  3400930131640 | AMLODIPINE/VALSART ARW 5MG/80MG CP 30\n",
      "  3400930131664 | AMLODIPINE/VALSART ARW 5MG/80MG CP 90\n",
      "  3400930131701 | AMLODIPINE/VALSART ARW 5MG/160MG CP 30\n",
      "  3400930131725 | AMLODIPINE/VALSART ARW 5MG/160MG CP 90\n",
      "  3400930131787 | AMLODIPINE/VALSART ARW 10MG/160MG CP 30\n",
      "  3400930131800 | AMLODIPINE/VALSART ARW 10MG/160MG CP 90\n",
      "  3400930131893 | OXSYNIA 40MG/20MG CPR 28\n",
      "  3400930131978 | OXSYNIA 30MG/15MG CPR 28\n",
      "  3400930132074 | OXSYNIA 20MG/10MG CPR 28\n",
      "  3400930132173 | OXSYNIA 15MG/7.5MG CPR 28\n",
      "  3400930132265 | OXSYNIA 10MG/5MG CPR 28\n",
      "  3400930132371 | OXSYNIA 5MG/2.5MG CPR 28\n",
      "  3400930132432 | FUSIDATE DE SODIUM BGA 250 MG CPR 10\n",
      "  3400930132470 | OXSYNIA 2.5MG/1.25MG CPR 28\n",
      "  3400930132579 | APREPITANT VIATRIS 80 MG GELULE 2\n",
      "  3400930132586 | APREPITANT VIATRIS 80MG+125MG GELULE 3\n",
      "  3400930132821 | ENTECAVIR ZEN K.S 0,5 MG CPR 30\n",
      "  3400930132838 | ENTECAVIR ZEN K.S 1 MG CPR 30\n",
      "  3400930132944 | FASENRA 30MG SOL INJ SRG 1\n",
      "  3400930133415 | CHLORHEX/BENZ/ALC BENZ BGA SOL 100ML 1\n",
      "  3400930133484 | FEBUXOSTAT ALMUS 80MG CPR 28\n",
      "  3400930133507 | FEBUXOSTAT ALMUS 120MG CPR 28\n",
      "  3400930133620 | CALCIPOT/BET SDZ 50 MCRG/0,5MG/G POM 1\n",
      "  3400930133767 | ALEND AC / D3 EVO 70 MG/2800 UI CPR 4\n",
      "  3400930133781 | ALEND AC / D3 EVO 70 MG/2800 UI CPR 12\n",
      "  3400930133828 | ALEND AC / D3 EVO 70 MG/ 5600 UI CPR 4\n",
      "  3400930133842 | ALEND AC / D3 EVO 70 MG/ 5600 UI CPR 12\n",
      "  3400930134009 | CLOZAPINE EG 25MG CPR 28\n",
      "  3400930134047 | CLOZAPINE EG 100MG CPR 28\n",
      "  3400930134085 | FEBUXOSTAT EG 80MG CPR 28\n",
      "  3400930134108 | FEBUXOSTAT EG 120MG CPR 28\n",
      "  3400930134153 | AMLODIPINE/VALSART BIOGARAN 5 MG/8 30\n",
      "  3400930134184 | AMLODIPINE/VALSART BIOGARAN 5 MG/8 90\n",
      "  3400930134221 | AMLODIPINE/VALSARTAN BIOGARAN 5 MG/1 30\n",
      "  3400930134252 | AMLODIPINE/VALSARTAN BIOGARAN 5 MG/1 90\n",
      "  3400930134306 | AMLODIPINE/VALSART BGA 10MG/160MG CP 30\n",
      "  3400930134337 | AMLODIPINE/VALSART BGA 10MG/160MG CP 90\n",
      "  3400930134504 | RIZATRIPTAN ARW 10MG CPR ORODISP 12\n",
      "  3400930135075 | IVABRADINE ZYD 5 MG CPR 56\n",
      "  3400930135167 | IVABRADINE ZYD 7,5 MG CPR 56\n",
      "  3400930135242 | IVABRADINE CRT 5 MG CPR 56\n",
      "  3400930135280 | IVABRADINE CRT 7,5 MG CPR 56\n",
      "  3400930135839 | CINACALCET SDZ 30MG CPR 28\n",
      "  3400930135860 | ENALAPRIL/LER ZEN 20MG/10MG CPR 30\n",
      "  3400930135891 | ENALAPRIL/LER ZEN 20MG/10MG CPR 90\n",
      "  3400930135907 | CINACALCET SDZ 60MG CPR 28\n",
      "  3400930135914 | CINACALCET SDZ 90MG CPR 28\n",
      "  3400930135952 | AMLODIPINE/VALSART CRT 5MG/80MG CP 30\n",
      "  3400930135990 | AMLODIPINE/VALSART CRT 5MG/80MG CP 90\n",
      "  3400930136034 | AMLODIPINE/VALSART CRT 5MG/160MG CPR 30\n",
      "  3400930136072 | AMLODIPINE/VALSART CRT 5MG/160MG CPR 90\n",
      "  3400930136119 | AMLODIPINE/VALSART CRT 10MG/160MG CP 30\n",
      "  3400930136157 | AMLODIPINE/VALSART CRT 10MG/160MG CP 90\n",
      "  3400930136263 | AMLODIPINE/VALSART SDZ 5MG/80MG 30\n",
      "  3400930136300 | AMLODIPINE/VALSART SDZ 5MG/80MG 90\n",
      "  3400930136379 | AMLODIPINE/VALSART SDZ 5MG/160MG 30\n",
      "  3400930136386 | AMLODIPINE/VALSART SDZ 5MG/160MG 90\n",
      "  3400930136430 | AMLODIPINE/VALSART SDZ 10MG/160MG 30\n",
      "  3400930136461 | AMLODIPINE/VALSART SDZ 10MG/160MG 90\n",
      "  3400930136492 | SPIRONOLACTONE BGA 25MG CPR 30\n",
      "  3400930136508 | SPIRONOLACTONE BGA 50 MG CPR 30\n",
      "  3400930136577 | GLICLAZIDE VIATRIS 60MG CPR 30\n",
      "  3400930136652 | CELECOXIB VIATRIS 200MG GELULE 30\n",
      "  3400930136676 | CERTICAN 1 MG CPR 60\n",
      "  3400930136690 | SITAGLIPTINE TEVA 100 MG CPR PEL 30\n",
      "  3400930136737 | SITAGLIPTINE TEVA 50 MG CPR PEL 30\n",
      "  3400930136898 | DESLORATADINE ARL 5 MG CPR 15\n",
      "  3400930136904 | DESLORATADINE ARL 5 MG CPR 30\n",
      "  3400930137147 | AMOXICILLINE VIATRIS 1 G CPR DISP 6\n",
      "  3400930137154 | AMOXICILLINE VIATRIS 1 G CPR DISP 14\n",
      "  3400930137383 | RASAGILINE ACC 1MG CPR 30\n",
      "  3400930138007 | ERLOTINIB TVF 25MG CPR 30\n",
      "  3400930138014 | ERLOTINIB TVF 100MG CPR 30\n",
      "  3400930138052 | ERLOTINIB TVF 150MG CPR 30\n",
      "  3400930138113 | DIAZEPAM ACC 10 MG CPR 30\n",
      "  3400930138342 | DEXTROMETHORPHANE BGA 1,5MG/ML 125ML 1\n",
      "  3400930138380 | DEXTROMETHORPHANE BGA 1,5MG/ML 250ML 1\n",
      "  3400930138410 | DARUNAVIR ZEN 400MG CPR 60\n",
      "  3400930138434 | DARUNAVIR ZEN 600MG CPR 60\n",
      "  3400930138458 | DARUNAVIR ZEN 800MG CPR 30\n",
      "  3400930138496 | SUNITINIB TEVA 50 MG GELULE 28\n",
      "  3400930138540 | SUNITINIB TEVA 25 MG, GELULE 28\n",
      "  3400930138601 | SUNITINIB TEVA 12,5 MG, GELULE 28\n",
      "  3400930138878 | CEFIXIME CRISTERS 200MG CPR 8\n",
      "  3400930138984 | PRAVASTATINE EVP 10MG CPR 28\n",
      "  3400930139080 | PRAVASTATINE EVP 20MG CPR 28\n",
      "  3400930139110 | PRAVASTATINE EVP 20MG CPR 84\n",
      "  3400930139165 | PRAVASTATINE EVP 40MG CPR 28\n",
      "  3400930139202 | PRAVASTATINE EVP 40MG CPR 84\n",
      "  3400930139448 | ABACAVIR VIATRIS 300MG CPR 60\n",
      "  3400930139462 | APREPITANT SDZ 80 MG GELULE 2\n",
      "  3400930139479 | APREPITANT 80MG+125MG SDZ GELULE 3\n",
      "  3400930139561 | EZETIMIBE ARW 10MG CPR 28\n",
      "  3400930139585 | EZETIMIBE ARW 10MG CPR 90\n",
      "  3400930139622 | APREPITANT BGA 80 MG GELULE 2\n",
      "  3400930139691 | IRBESARTAN BGR 150 MG CPR PELL 30\n",
      "  3400930139721 | IRBESARTAN BGR 300 MG CPR PELL 30\n",
      "  3400930139738 | TRAVOPROST BGA 40 MCG/ML COLLYRE 1\n",
      "  3400930139912 | PERINDOPRIL AMLO ZEN 8/10MG CPR 30\n",
      "  3400930139929 | PERINDOPRIL AMLO ZEN 8/10MG CPR 90\n",
      "  3400930139943 | EZETIMIBE/SIMVAST EG 10MG/40MG CPR 90\n",
      "  3400930139967 | PERINDOPRIL AMLO ZEN 8/5MG CPR 30\n",
      "  3400930139974 | PERINDOPRIL AMLO ZEN 8/5MG CPR 90\n",
      "  3400930139998 | EZETIMIBE/SIMVAST EG 10MG/20MG CPR 90\n",
      "  3400930140024 | TRAMADOL/PARACETAMOL ARW CPR EFF 20\n",
      "  3400930140031 | PERINDOPRIL AMLO ZEN 4/10MG CPR 30\n",
      "  3400930140048 | PERINDOPRIL AMLO ZEN 4/10MG CPR 90\n",
      "  3400930140055 | PERINDOPRIL AMLO ZEN 4/5MG CPR 30\n",
      "  3400930140062 | PERINDOPRIL AMLO ZEN 4/5MG CPR 90\n",
      "  3400930140093 | ARIPIPRAZOLE ARW 5 MG CPR 28\n",
      "  3400930140185 | ARIPIPRAZOLE ARW 10 MG CPR 28\n",
      "  3400930140246 | ARIPIPRAZOLE ARW 15 MG CPR 28\n",
      "  3400930140321 | SOLIFENACINE BGR 10MG CPR 30\n",
      "  3400930140383 | SOLIFENACINE BGR 5MG CPR 30\n",
      "  3400930140574 | LOLISTREL CONTINU 100/20 MCG CPR 84\n",
      "  3400930140734 | FULVESTRANT MYL 250 MG SOL INJ SER 1\n",
      "  3400930140772 | IVABRADINE ALT 5 MG CPR 56\n",
      "  3400930140819 | IVABRADINE ALT 7.5 MG CPR 56\n",
      "  3400930140970 | BRIMONIDINE/TIM MYL 2/5MG/ML COLLYRE 1\n",
      "  3400930141403 | ORKAMBI 100/125 MG CPR 112\n",
      "  3400930141410 | HEMLIBRA 30 MG SOL INJ 1\n",
      "  3400930141427 | HEMLIBRA 60 MG SOL INJ FL 0.4 ML 1\n",
      "  3400930141434 | HEMLIBRA 105 MG SOL INJ FL 0.7 ML 1\n",
      "  3400930141441 | HEMLIBRA 150 MG SOL INJ FL 1 ML 1\n",
      "  3400930141601 | APREPITANT 80MG+125MG BGA GELULE 3\n",
      "  3400930141649 | EZETIMIBE/SIMVAST ALM 10MG/20MG CPR 30\n",
      "  3400930141663 | EZETIMIBE/SIMVAST ALM 10MG/20MG CPR 90\n",
      "  3400930141687 | EZETIMIBE/SIMVAST ALM 10MG/40MG CPR 30\n",
      "  3400930141700 | EZETIMIBE/SIMVAST ALM 10MG/40MG CPR 90\n",
      "  3400930141724 | AMGEVITA 40 MG SOL INJ SER 1\n",
      "  3400930141731 | AMGEVITA 40 MG SOL INJ SER 2\n",
      "  3400930141755 | AMGEVITA 40 MG SOL INJ SER 6\n",
      "  3400930141762 | AMGEVITA 40 MG SOL INJ STYLO 1\n",
      "  3400930141779 | AMGEVITA 40 MG SOL INJ STYLO 2\n",
      "  3400930141809 | AMGEVITA 40 MG SOL INJ STYLO 6\n",
      "  3400930141854 | PRASUGREL TVC 10 MG CPR 30\n",
      "  3400930142141 | EFAVIR/EMTR/TENO KRK 600/200/245 CPR 30\n",
      "  3400930142257 | ERLOTINIB SDZ 25MG CPR 30\n",
      "  3400930142264 | ERLOTINIB SDZ 100MG CPR 30\n",
      "  3400930142271 | ERLOTINIB SDZ 150MG CPR 30\n",
      "  3400930142288 | AMGEVITA 20 MG SOL INJ SER 1\n",
      "  3400930142660 | PERINDOPRIL AMLO HCS 4/5MG CPR 30\n",
      "  3400930142684 | PERINDOPRIL AMLO HCS 4/5MG CPR 90\n",
      "  3400930142707 | PERINDOPRIL AMLO HCS 4/10MG CPR 30\n",
      "  3400930142714 | PERINDOPRIL AMLO HCS 4/10MG CPR 90\n",
      "  3400930142721 | PERINDOPRIL AMLO HCS 8/5MG CPR 30\n",
      "  3400930142745 | PERINDOPRIL AMLO HCS 8/5MG CPR 90\n",
      "  3400930142752 | PERINDOPRIL AMLO HCS 8/10MG CPR 30\n",
      "  3400930142769 | PERINDOPRIL AMLO HCS 8/10MG CPR 90\n",
      "  3400930142783 | CLARITHROMYCINE ACC 250MG CPR 10\n",
      "  3400930142875 | CLARITHROMYCINE ACC 500MG CPR 10\n",
      "  3400930142899 | CLARITHROMYCINE ACC 500MG CPR 14\n",
      "  3400930142950 | CICLOPIROX OLAMINE P.F 1% CREME 1\n",
      "  3400930143728 | IMRALDI 40 MG SOL INJ SER 0,8ML 2\n",
      "  3400930143810 | TAKROZEM 0,1 % POMMADE 1\n",
      "  3400930143841 | ROSUVASTATINE ALT 20MG CPR 30\n",
      "  3400930143872 | ROSUVASTATINE ALT 20MG CPR 90\n",
      "  3400930143926 | ETORICOXIB BGA 30 MG CPR 28\n",
      "  3400930143988 | ETORICOXIB BGA 60 MG CPR 28\n",
      "  3400930144114 | IMRALDI 40 MG SOL INJ STYLO 0,8ML 1\n",
      "  3400930144121 | IMRALDI 40 MG SOL INJ STYLO 0,8ML 2\n",
      "  3400930144152 | ENTECAVIR HCS 0,5 MG CPR 30\n",
      "  3400930144176 | ENTECAVIR HCS 1 MG CPR 30\n",
      "  3400930144190 | LYNPARZA 100 MG CPR 112\n",
      "  3400930144213 | LYNPARZA 150 MG CPR 112\n",
      "  3400930144237 | PRASUGREL ARW 10 MG CPR 30\n",
      "  3400930144244 | PRASUGREL CRT 10 MG CPR 30\n",
      "  3400930144251 | EFAVIRENZ ARW 600MG CPR 30\n",
      "  3400930144640 | ROSUVASTATINE ZDF 20MG CPR 90\n",
      "  3400930144657 | ROSUVASTATINE ZDF 10MG CPR 90\n",
      "  3400930144664 | ROSUVASTATINE ZDF 5MG CPR 90\n",
      "  3400930144718 | CEFIXIME ARL 200MG CPR 8\n",
      "  3400930144824 | JULUCA 50MG/25MG CPR 30\n",
      "  3400930144930 | EBASTINE EG 10 MG CPR ORODISP 30\n",
      "  3400930145029 | EBASTINE CRT 10 MG CPR ORODISP 30\n",
      "  3400930145074 | EBASTINE ZYD 10 MG CPR ORODISP 30\n",
      "  3400930145210 | CRYSVITA 10MG SOL INJ 1\n",
      "  3400930145227 | CRYSVITA 20MG SOL INJ 1\n",
      "  3400930145234 | CRYSVITA 30MG SOL INJ 1\n",
      "  3400930145265 | ATORVASTATINE ZYD 10MG CPR 30\n",
      "  3400930145296 | ATORVASTATINE ZYD 10MG CPR 90\n",
      "  3400930145326 | ATORVASTATINE ZYD 20MG CPR 30\n",
      "  3400930145357 | ATORVASTATINE ZYD 20MG CPR 90\n",
      "  3400930145388 | ATORVASTATINE ZYD 40MG CPR 30\n",
      "  3400930145418 | ATORVASTATINE ZYD 40MG CPR 90\n",
      "  3400930145524 | ROACTEMRA 162 MG SOL INJ STYLO 4\n",
      "  3400930145586 | EFFERALGANMED P 30MG/ML SOL BUV90ML 1\n",
      "  3400930145739 | LEVOCETIRIZINE ZYD 5 MG CPR 14\n",
      "  3400930145746 | LEVOCETIRIZINE ZYD 5 MG CPR 28\n",
      "  3400930145784 | ESCITALOPRAM ARL 5MG CPR 14\n",
      "  3400930145791 | ESCITALOPRAM ARL 5MG CPR 28\n",
      "  3400930145821 | ESCITALOPRAM ARL 10MG CPR 28\n",
      "  3400930145852 | ESCITALOPRAM ARL 15MG CPR 28\n",
      "  3400930145906 | ESCITALOPRAM ARL 20MG CPR 28\n",
      "  3400930145951 | LEVOFREE 0,05% COLLYRE FL 1\n",
      "  3400930146033 | RISPERIDONE VIATRIS 1 MG CPR 60\n",
      "  3400930146064 | FLECTOR 50MG CPR 21\n",
      "  3400930146118 | ZYKADIA 150MG GELULE 90\n",
      "  3400930146194 | SOLIFENACINE HCS 10MG CPR 30\n",
      "  3400930146217 | SOLIFENACINE HCS 5MG CPR 30\n",
      "  3400930146224 | BOSULIF 400MG CPR 28\n",
      "  3400930146262 | LOSARTAN HCTZ ZTL 100/25 MG CPR 28\n",
      "  3400930146286 | LOSARTAN HCTZ ZTL 100/25 MG CPR 90\n",
      "  3400930146309 | LOSARTAN HCTZ ZTL 100/12,5 MG CPR 28\n",
      "  3400930146323 | LOSARTAN HCTZ ZTL 100/12,5 MG CPR 90\n",
      "  3400930146347 | LOSARTAN HCTZ ZTL 50/12,5 MG CPR 28\n",
      "  3400930146361 | LOSARTAN HCTZ ZTL 50/12,5 MG CPR 90\n",
      "  3400930146842 | PRASUGREL EG 10 MG CPR 30\n",
      "  3400930146866 | TRAMADOL/PARACETAMOL BGR CPR 20\n",
      "  3400930146927 | IVERMECTINE VIATRIS 3MG CPR 4\n",
      "  3400930146958 | NEVIRAPINE ACC 400MG CPR LP 30\n",
      "  3400930146972 | IVERMECTINE BGA 3MG CPR 4\n",
      "  3400930147023 | IVERMECTINE CRT 3MG CPR 4\n",
      "  3400930147078 | IVERMECTINE EG 3MG CPR 4\n",
      "  3400930147238 | ATORVASTATINE ZYD 80MG CPR 30\n",
      "  3400930147252 | ATORVASTATINE ZYD 80MG CPR 90\n",
      "  3400930147276 | PROPRANOLOL BGA 40MG CPR 50\n",
      "  3400930147474 | AMLODIPINE/VALSART EVO 5MG/80MG CP 30\n",
      "  3400930147481 | AMLODIPINE/VALSART EVO 5MG/80MG CP 90\n",
      "  3400930147498 | AMLODIPINE/VALSART EVO 5MG/160MG CPR 30\n",
      "  3400930147504 | AMLODIPINE/VALSART EVO 5MG/160MG CPR 90\n",
      "  3400930147511 | AMLODIPINE/VALSART EVO 10/160MG CPR 30\n",
      "  3400930147528 | AMLODIPINE/VALSART EVO 10/160MG CPR 90\n",
      "  3400930147535 | CLINDAMYCINE VIATRIS 150MG GELULE 12\n",
      "  3400930147566 | CLINDAMYCINE MYLAN 300 MG GELULE 16\n",
      "  3400930147627 | ENALAPRIL/LER ARW 20MG/10MG CPR 30\n",
      "  3400930147634 | ENALAPRIL/LER ARW 20MG/10MG CPR 90\n",
      "  3400930147658 | METRONIDAZOLE BGA 250 MG CPR 20\n",
      "  3400930147665 | METRONIDAZOLE BGA 500 MG CPR 4\n",
      "  3400930147672 | METRONIDAZOLE BGA 500 MG CPR 14\n",
      "  3400930147689 | PREGABALINE ARW 25 MG GELULE 56\n",
      "  3400930147696 | PREGABALINE ARW 25 MG GELULE 84\n",
      "  3400930147757 | PREGABALINE ARW 50 MG GELULE 84\n",
      "  3400930147801 | PREGABALINE ARW 75 MG GELULE 56\n",
      "  3400930147856 | PREGABALINE ARW 100 MG GELULE 84\n",
      "  3400930147894 | PREGABALINE ARW 150 MG GELULE 56\n",
      "  3400930147955 | PREGABALINE ARW 200 MG GELULE 84\n",
      "  3400930147979 | PREGABALINE ARW 300 MG GELULE 56\n",
      "  3400930148402 | EVEROLIMUS EG 2,5 MG CPR 30\n",
      "  3400930148419 | EVEROLIMUS EG 5 MG CPR 30\n",
      "  3400930148440 | ANAGRELIDE ARW 0,5MG GELULE 100\n",
      "  3400930148464 | EVEROLIMUS EG 10 MG CPR 30\n",
      "  3400930148518 | EMTRICITABIN TENOF ZTL 200/245MG CPR 30\n",
      "  3400930148525 | ABACAVIR/LAM ZEN 600 MG/300 MG CPR 30\n",
      "  3400930148730 | IOPAMIRON 370 SOL INJ FL 100ML + CTE 1\n",
      "  3400930148754 | DONASERT 52MG DISP UTERIN 1\n",
      "  3400930148815 | SOLIFENACINE SDZ 5MG CPR 30\n",
      "  3400930148839 | SOLIFENACINE SDZ 10MG CPR 30\n",
      "  3400930148853 | VALSARTAN/HCTZ ZYF 80/12,5MG CPR 30\n",
      "  3400930148921 | VALSARTAN/HCTZ ZYF 160/12,5MG CPR 30\n",
      "  3400930149089 | VALSARTAN/HCTZ ZYF 160/25MG CPR 30\n",
      "  3400930149126 | VALSARTAN/HCTZ ZYF 160/25MG CPR 90\n",
      "  3400930149157 | ASTERLUNA CONTINU 100MCG/20MCG CPR 84\n",
      "  3400930149171 | ASTERLUNA 100MCG/20MCG CPR 63\n",
      "  3400930149201 | ALGINATE BICAR SODIUM ARW SACH 10ML 24\n",
      "  3400930149225 | GABAPENTINE ZYD 100MG GELULE 90\n",
      "  3400930149263 | GABAPENTINE ZYD 300MG GELULE 90\n",
      "  3400930149379 | CLOZAPINE ACC 100MG CPR 14\n",
      "  3400930149386 | CLOZAPINE ACC 100MG CPR 28\n",
      "  3400930149416 | CLOZAPINE ACC 25MG CPR 14\n",
      "  3400930149430 | CLOZAPINE ACC 25MG CPR 28\n",
      "  3400930149744 | ARIPIPRAZOLE VTS 10MG CPR ORODISP 28\n",
      "  3400930149768 | ARIPIPRAZOLE VTS 15MG CPR ORODISP 28\n",
      "  3400930149805 | MIDODRINE ZEN 2.5 MG CPR 30\n",
      "  3400930149812 | MIDODRINE ZEN 2.5 MG CPR 90\n",
      "  3400930150108 | IZALGI 500 MG/25 MG GELULE 16\n",
      "  3400930150139 | ROSUVASTATINE SUN 5MG CPR 30\n",
      "  3400930150177 | ROSUVASTATINE SUN 5MG CPR 90\n",
      "  3400930150276 | ROSUVASTATINE SUN 10MG CPR 30\n",
      "  3400930150320 | ROSUVASTATINE SUN 10MG CPR 90\n",
      "  3400930150405 | ROSUVASTATINE SUN 20MG CPR 30\n",
      "  3400930150443 | ROSUVASTATINE SUN 20MG CPR 90\n",
      "  3400930150559 | MIDODRINE BGA 2.5 MG 30\n",
      "  3400930150566 | MIDODRINE BGA 2.5 MG 90\n",
      "  3400930150702 | BUPRENORPHINE/NAL VTS 8MG/2MG CPR 7\n",
      "  3400930150726 | BUPRENORPHINE/NAL VTS 8MG/2MG CPR 28\n",
      "  3400930150740 | BUPRENORPHINE/NAL VTS 2MG/0,5MG CPR 7\n",
      "  3400930150764 | BUPRENORPHINE/NAL VTS 2MG/0,5MG CPR 28\n",
      "  3400930150948 | MYALEPTA 11,3MG PDR SOL INJ 30\n",
      "  3400930151037 | APREPITANT TVC 80 MG GELULE 2\n",
      "  3400930151044 | VIZILATAN 0,005% COLLYRE FL 2,5ML 1\n",
      "  3400930151051 | VIZILATAN 0,005% COLLYRE FL 2,5ML 3\n",
      "  3400930151068 | APREPITANT 80MG+125MG TVC GELULE 3\n",
      "  3400930151075 | OZEMPIC 0,25 MG, SOLUTION INJECTABLE 1\n",
      "  3400930151099 | OZEMPIC 0,5 MG, SOLUTION INJECTABLE 1\n",
      "  3400930151105 | OZEMPIC 1 MG, SOLUTION INJECTABLE EN 1\n",
      "  3400930151167 | LEVETIRACETAM VIATRIS 500MG CPR 60\n",
      "  3400930151181 | MOMETASONE VTS 50 MICROG SUSP NAS120 1\n",
      "  3400930151198 | MOMETASONE VTS 50 MICROG SUSP NAS140 1\n",
      "  3400930151211 | IRBESARTAN VIATRIS 300MG CPR 30\n",
      "  3400930151297 | MOMETASONE ZEN 50 MCG NAS 120 DOSE 1\n",
      "  3400930151310 | IRBESARTAN VIATRIS 150MG CPR 30\n",
      "  3400930151365 | MOMETASONE EG 50 MICROG SUSP NAS 120 1\n",
      "  3400930151389 | MOMETASONE EG 50 MICROG SUSP NAS 140 1\n",
      "  3400930151402 | MOMETASONE CRT 50 MICROG SUSP NAS120 1\n",
      "  3400930151419 | MOMETASONE CRT 50 MICROG SUSP NAS140 1\n",
      "  3400930151440 | MOMETASONE BGA 50 MICROG SUSP NASALE 1\n",
      "  3400930151471 | MOMETASONE ARW 50 MICROG SUSP NAS120 1\n",
      "  3400930151488 | MOMETASONE ARW 50 MICROG SUSP NAS140 1\n",
      "  3400930151501 | TODEXAL 3MG/1MG /ML COLL SUSP 1\n",
      "  3400930151655 | MODAFINIL VTS 100MG CPR 30\n",
      "  3400930151884 | BETAHISTINE ARROW 16 MG CPR 45\n",
      "  3400930151921 | TRAMADOL HCS 50MG GELULE 30\n",
      "  3400930152089 | ACEBUTOLOL VTS 200MG CPR 30\n",
      "  3400930152102 | AC ZOLEDRONIQUE AAN 5MG SOL IN 1\n",
      "  3400930152263 | ISTOPEN 1000 MG PDR ET SOL INJ IV 1\n",
      "  3400930152409 | EVEROLIMUS VIATRIS 2,5 MG CPR 30\n",
      "  3400930152423 | EVEROLIMUS VIATRIS 5 MG CPR 30\n",
      "  3400930152447 | EVEROLIMUS VIATRIS 10 MG CPR 30\n",
      "  3400930152621 | EVEROLIMUS ARW 2,5MG CPR 30\n",
      "  3400930152645 | EVEROLIMUS ARW 5MG CPR 30\n",
      "  3400930152669 | EVEROLIMUS ARW 10MG CPR 30\n",
      "  3400930152676 | EVEROLIMUS BGA 2,5 MG CPR 30\n",
      "  3400930152690 | EVEROLIMUS BGA 5 MG CPR 30\n",
      "  3400930152713 | EVEROLIMUS BGA 10 MG CPR 30\n",
      "  3400930152744 | ZOPICLONE ARL 7,5MG CPR 14\n",
      "  3400930152812 | ZOPICLONE ARL 3,75MG CPR 14\n",
      "  3400930152867 | CACIT VIT D3 500MG/1000UI CPR 30\n",
      "  3400930153031 | BIKTARVY 50/200/25MG CPR 30\n",
      "  3400930153062 | CELIPROLOL ALM 200MG CPR 84\n",
      "  3400930153079 | HYDROXYZINE VIATRIS 25MG CPR 30\n",
      "  3400930153109 | AGOMELATINE ZEN 25 MG CPR 28\n",
      "  3400930153284 | EVEROLIMUS ZEN 10 MG CPR 30\n",
      "  3400930153352 | EVEROLIMUS ZEN 5 MG CPR 30\n",
      "  3400930153376 | ATAZANAVIR ZEN 300MG GELULE 30\n",
      "  3400930153611 | CUPRIOR 150 MG CPR 72\n",
      "  3400930153703 | IVABRADINE TVS 7,5 MG CPR 56\n",
      "  3400930153727 | IVABRADINE TVS 5 MG CPR 56\n",
      "  3400930153765 | ACAMPROSATE VIATRIS 333MG CPR 60\n",
      "  3400930153772 | ACAMPROSATE VIATRIS 333MG CPR 180\n",
      "  3400930153789 | CHOLECALCIFEROL EG 2,5MG/2ML SOL BUV 1\n",
      "  3400930153802 | GUIOX 100 000 UI SOL BUV 1\n",
      "  3400930153819 | CHOLECALCIFEROL ZEN 2,5MG/2ML SOL BU 1\n",
      "  3400930154137 | METHOTREXATE ACC 10MG CPR 10\n",
      "  3400930154182 | METHOTREXATE ACC 2,5 MG CPR 24\n",
      "  3400930154243 | ELETRIPTAN ARW 40MG CPR 6\n",
      "  3400930154250 | ELETRIPTAN ARW 40MG CPR 10\n",
      "  3400930154281 | ELETRIPTAN ARW 20MG CPR 6\n",
      "  3400930154571 | PRENOXAD 1.82 MG SOL INJ SER 1\n",
      "  3400930154847 | TEGSEDI 284MG SOL INJ SRG 4\n",
      "  3400930154861 | GEFITINIB BGA 250MG CPR 30\n",
      "  3400930155004 | GEFITINIB ARW 250MG CPR 30\n",
      "  3400930155011 | GEFITINIB SDZ 250MG CPR 30\n",
      "  3400930155080 | HYRIMOZ 40 MG, SOLUTION INJ SRG 2\n",
      "  3400930155097 | HYRIMOZ 40 MG, SOL INJ STYLO 2\n",
      "  3400930155103 | GEFITINIB EG 250MG CPR 30\n",
      "  3400930155141 | IVERMECTINE ARL 3MG CPR 4\n",
      "  3400930155196 | IVERMECTINE PFA 3 MG CPR 4\n",
      "  3400930155288 | IVERMECTINE SDZ 3MG CPR 4\n",
      "  3400930155325 | IVERMECTINE ZEN 3MG CPR 4\n",
      "  3400930155363 | IVERMECTINE SUBSTIPHARM 3 MG CPR 4\n",
      "  3400930155424 | AMOXICILLINE ALM 1G CPR DISP 6\n",
      "  3400930155431 | AMOXICILLINE ALM 1G CPR DISP 14\n",
      "  3400930155585 | AGOMELATINE HCS 25 MG CPR 28\n",
      "  3400930155882 | MILNACIPRAN EG 50MG GELULE 56\n",
      "  3400930155929 | NEBIVOLOL/ HYD TVC 5MG/12.5MG CPR 30\n",
      "  3400930155936 | NEBIVOLOL/ HYD TVC 5MG/12.5MG CPR 90\n",
      "  3400930155943 | NEBIVOLOL/ HYD TVC 5MG/25MG CPR 30\n",
      "  3400930155950 | NEBIVOLOL/ HYD TVC 5MG/25MG CPR 90\n",
      "  3400930155981 | NEBIVOLOL/ HYD VIATRI 5MG/12.5MG CPR 30\n",
      "  3400930155998 | NEBIVOLOL/ HYD VIATRI 5MG/12.5MG CPR 90\n",
      "  3400930156018 | NEBIVOLOL/ HYD VIATRIS 5MG/25MG CPR 30\n",
      "  3400930156025 | NEBIVOLOL/ HYD VIATRIS 5MG/25MG CPR 90\n",
      "  3400930156162 | IMBRUVICA 420 MG CPR 30\n",
      "  3400930156179 | IMBRUVICA 560 MG CPR 30\n",
      "  3400930156469 | EPLERENONE KRK 25MG CPR 30\n",
      "  3400930156483 | EPLERENONE KRK 25MG CPR 90\n",
      "  3400930156506 | EPLERENONE KRKA 50MG CPR 30\n",
      "  3400930156520 | EPLERENONE KRKA 50MG CPR 90\n",
      "  3400930156605 | PRASUGREL KRK 10 MG CPR 30\n",
      "  3400930156612 | NEBIVOLOL/ HYD CRT 5MG/12.5MG CPR 30\n",
      "  3400930156629 | NEBIVOLOL/ HYD CRT 5MG/12.5MG CPR 90\n",
      "  3400930156667 | GEFITINIB MYL 250MG CPR 30\n",
      "  3400930156674 | AGOMELATINE MYL 25 MG CPR 28\n",
      "  3400930156681 | NEBIVOLOL/ HYD ZEN 5MG/12.5MG CPR 30\n",
      "  3400930156698 | NEBIVOLOL/ HYD ZEN 5MG/12.5MG CPR 90\n",
      "  3400930156704 | NEBIVOLOL/ HYD ZEN 5MG/25MG CPR 30\n",
      "  3400930156711 | NEBIVOLOL/ HYD ZEN 5MG/25MG CPR 90\n",
      "  3400930156766 | NEBIVOLOL/ HYD CRT 5MG/25MG CPR 30\n",
      "  3400930156773 | NEBIVOLOL/ HYD CRT 5MG/25MG CPR 90\n",
      "  3400930156803 | DESLORATADINE KRK 5 MG CPR 30\n",
      "  3400930156827 | VERAPAMIL VTS LP 240MG CPR 30\n",
      "  3400930156834 | VERAPAMIL VTS LP 240MG CPR 90\n",
      "  3400930156841 | BRAFTOVI 50 MG GELULES 28\n",
      "  3400930156858 | BRAFTOVI 75 MG GELULES 42\n",
      "  3400930156872 | MEKTOVI 15 MG CPR 84\n",
      "  3400930157046 | MILNACIPRAN EG 25MG GELULE 56\n",
      "  3400930157077 | LANSOPRAZOLE ZYD 15MG CPR OROD 28\n",
      "  3400930157138 | LANSOPRAZOLE ZYD 30MG CPR OROD 28\n",
      "  3400930157183 | OLANZAPINE ARW 5 MG CPR DISP 28\n",
      "  3400930157206 | OLANZAPINE ARW 10MG CPR DISP 28\n",
      "  3400930157312 | FEBUXOSTAT TVS 120MG CPR 30\n",
      "  3400930157336 | FEBUXOSTAT TVS 80MG CPR 30\n",
      "  3400930157374 | HULIO 40 MG SOL INJ SRG + TAMP 2\n",
      "  3400930157381 | HULIO 40 MG SOL INJ SRG + TAMP 6\n",
      "  3400930157404 | HULIO 40 MG SOL INJ STY + TAMP 2\n",
      "  3400930157411 | HULIO 40 MG SOL INJ STY + TAMP 6\n",
      "  3400930157428 | HULIO 40 MG/0,8ML SOL INJ 2\n",
      "  3400930157442 | CHLORHEXIDINE BGA 0,12% SOL BDB 1\n",
      "  3400930157480 | CHLORHEXIDINE VTS 0,12% SOL BDB300ML 1\n",
      "  3400930157510 | CHLORHEXIDINE ARW 0,12% SOL BDB 1\n",
      "  3400930157602 | KIGABEQ 100MG CPR 100\n",
      "  3400930157626 | KIGABEQ 500MG CPR 50\n",
      "  3400930157640 | PELGRAZ 6 MG SER SOL INJ SERINGUE 1\n",
      "  3400930157732 | VERZENIOS 150 MG CPR 14\n",
      "  3400930157848 | SYMKEVI 100 MG/150MG CPR PEL 28\n",
      "  3400930157862 | AGOMELATINE BGA 25 MG CPR 28\n",
      "  3400930157930 | LEVOTHYROX 88MICROG CPR 30\n",
      "  3400930157954 | LEVOTHYROX 88MICROG CPR 90\n",
      "  3400930158043 | LEVOTHYROX 112MICROG CPR 30\n",
      "  3400930158074 | LEVOTHYROX 112MICROG CPR 90\n",
      "  3400930158166 | LEVOTHYROX 137MICROG CPR 30\n",
      "  3400930158180 | LEVOTHYROX 137MICROG CPR 90\n",
      "  3400930158425 | ONPATTRO 10MG SOL INJ 1\n",
      "  3400930158463 | LEVETIRACETAM EG SOL BUV300ML+S10ML 1\n",
      "  3400930158494 | COSTEC 20 MG/ML + 5 MG/ML, COLL 10ML 1\n",
      "  3400930158609 | EZETIMIBE/SIMVAST ZYD 10MG/20MG CPR 30\n",
      "  3400930158623 | EZETIMIBE/SIMVAST ZYD 10MG/20MG CPR 90\n",
      "  3400930158746 | EZETIMIBE/SIMVAST ZYD 10MG/40MG CPR 30\n",
      "  3400930158760 | EZETIMIBE/SIMVAST ZYD 10MG/40MG CPR 90\n",
      "  3400930158890 | LAMISIL 1% CREME TUBE 15 G 1\n",
      "  3400930159040 | LOSARTAN ARL 100MG CPR 30\n",
      "  3400930159057 | LOSARTAN ARL 100MG CPR 90\n",
      "  3400930159064 | LOSARTAN ARL 50MG CPR 30\n",
      "  3400930159071 | LOSARTAN ARL 50MG CPR 90\n",
      "  3400930159095 | IZILOX 400MG CPR 5\n",
      "  3400930159101 | IZILOX 400MG CPR 7\n",
      "  3400930159132 | EVEROLIMUS ZEN 2,5 MG CPR 30\n",
      "  3400930159408 | AGOMELATINE EG 25 MG CPR 28\n",
      "  3400930159453 | XELJANZ 10 MG CPR 56\n",
      "  3400930159484 | KALYDECO 150 MG CPR 28\n",
      "  3400930159927 | EZETIMIBE/SIMVAST KRK 10MG/20MG CPR 30\n",
      "  3400930159989 | EZETIMIBE/SIMVAST KRK 10MG/40MG CPR 30\n",
      "  3400930160244 | PRASUGREL MYL 10 MG CPR 30\n",
      "  3400930160305 | PARACETAMOL KRK 500MG CPR 16\n",
      "  3400930160459 | BUPRENORPHINE/NAL ARW 2MG/0,5MG CPR 7\n",
      "  3400930160473 | BUPRENORPHINE/NAL ARW 2MG/0,5MG CPR 28\n",
      "  3400930160480 | BUPRENORPHINE/NAL ARW 8MG/2MG CPR 7\n",
      "  3400930160503 | BUPRENORPHINE/NAL ARW 8MG/2MG CPR 28\n",
      "  3400930160640 | FROVATRIPTAN BGA 2,5 MG CPR 12\n",
      "  3400930160725 | AGOMELATINE CRT 25 MG CPR 28\n",
      "  3400930160756 | TREMFYA 100MG SOL INJ STYLO 1\n",
      "  3400930160893 | METFORMINE ALM 500MG CPR 30\n",
      "  3400930160985 | METFORMINE ALM 850MG CPR 30\n",
      "  3400930161043 | METFORMINE ALM 1000MG CPR 30\n",
      "  3400930161142 | TRAVOPROST ARW 40 MCG/ML COLLYRE 1\n",
      "  3400930161340 | PIFELTRO 100 MG CPR 30\n",
      "  3400930161357 | DELSTRIGO 100/300/245MG CPR 30\n",
      "  3400930161463 | PRASUGREL ZTL 10 MG CPR 30\n",
      "  3400930161494 | ATAZANAVIR MYL 150MG GELULE 60\n",
      "  3400930161517 | ATAZANAVIR MYL 200MG GELULE 60\n",
      "  3400930161531 | ATAZANAVIR MYL 300MG GELULE 30\n",
      "  3400930161555 | ROSUVASTATINE BGR 5 MG CPR 30\n",
      "  3400930161562 | ROSUVASTATINE BGR 5 MG CPR 90\n",
      "  3400930161579 | ROSUVASTATINE BGR 10 MG CPR PEL 30\n",
      "  3400930161586 | ROSUVASTATINE BGR 10 MG CPR PEL 90\n",
      "  3400930161593 | ROSUVASTATINE BGR 20 MG, COMPRIME PE 30\n",
      "  3400930161616 | ROSUVASTATINE BGR 20 MG, COMPRIME PE 90\n",
      "  3400930161708 | SOLIFENACINE ZEN 5MG CPR 30\n",
      "  3400930161791 | CREON 35000U GELU 60\n",
      "  3400930161869 | SOLIFENACINE ZEN 10MG CPR 30\n",
      "  3400930161883 | FEBUXOSTAT ACC 80MG CPR 28\n",
      "  3400930161913 | FEBUXOSTAT ACC 120MG CPR 28\n",
      "  3400930162019 | CLOZAPINE ARW 25MG CPR 28\n",
      "  3400930162026 | CLOZAPINE ARW 100MG CPR 14\n",
      "  3400930162033 | CLOZAPINE ARW 100MG CPR 28\n",
      "  3400930162262 | SLENYTO LP 1MG CPR 60\n",
      "  3400930162286 | SLENYTO LP 5MG CPR 30\n",
      "  3400930162309 | LETROZOLE ALMUS 2,5 MG, COMPRIME PEL 30\n",
      "  3400930162453 | ENALAPRIL ARL 20MG CPR 30\n",
      "  3400930162477 | ENALAPRIL ARL 20MG CPR 90\n",
      "  3400930162507 | ENALAPRIL ARL 5MG CPR 30\n",
      "  3400930162521 | ENALAPRIL ARL 5MG CPR 90\n",
      "  3400930162712 | ALUNBRIG 90MG CPR 28\n",
      "  3400930162736 | ALUNBRIG 180MG CPR 28\n",
      "  3400930162743 | ZIEXTENZO 6 MG SER SOL INJ 1\n",
      "  3400930162781 | MYALEPTA 5,8MG PDR SOL INJ 30\n",
      "  3400930162965 | VERZENIOS 50 MG CPR 56\n",
      "  3400930162989 | VERZENIOS 100 MG CPR 56\n",
      "  3400930163009 | VERZENIOS 150 MG CPR 56\n",
      "  3400930163016 | RISEDRONATE ZYF 75MG CPR 2\n",
      "  3400930163047 | RISEDRONATE ZYF 75MG CPR 6\n",
      "  3400930163061 | RISEDRONATE ZYF 35MG CPR 4\n",
      "  3400930163078 | TOBRAMYCINE SUN 300MG SOL INH AMP 56\n",
      "  3400930163245 | FULPHILA 6 MG SER SOL INJ SERINGUE 1\n",
      "  3400930163276 | ATAZANAVIR ARW 300MG GELULE 30\n",
      "  3400930163344 | ATAZANAVIR ARW 200MG GELULE 60\n",
      "  3400930163399 | ATAZANAVIR SDZ 300MG GELULE 30\n",
      "  3400930163405 | ATAZANAVIR SDZ 200MG GELULE 60\n",
      "  3400930163474 | GEFITINIB TVC 250MG CPR 30\n",
      "  3400930163481 | PELMEG 6 MG SER SOL INJ 1\n",
      "  3400930163528 | BACLOCUR 10MG CPR 30\n",
      "  3400930163597 | BACLOCUR 20MG CPR 30\n",
      "  3400930163665 | BACLOCUR 40MG CPR 30\n",
      "  3400930163887 | TWICOR 10MG/10MG CPR 30\n",
      "  3400930163917 | TWICOR 10MG/10MG CPR 90\n",
      "  3400930163924 | DASATINIB SDZ 140 MG CPR 30\n",
      "  3400930163955 | TWICOR 20MG/10MG CPR 30\n",
      "  3400930163979 | TWICOR 20MG/10MG CPR 90\n",
      "  3400930163986 | DASATINIB SDZ 100 MG CPR 30\n",
      "  3400930164051 | DASATINIB SDZ 70 MG CPR 60\n",
      "  3400930164136 | DASATINIB SDZ 50 MG CPR 60\n",
      "  3400930164174 | DASATINIB SDZ 20 MG CPR 60\n",
      "  3400930164198 | CYAMEMAZINE VIATRIS100MG CPR 25\n",
      "  3400930164228 | CYAMEMAZINE BGA 100MG CPR 25\n",
      "  3400930164303 | EZETIMIBE/SIMVAST ALT 10MG/40MG CPR 30\n",
      "  3400930164310 | EZETIMIBE/SIMVAST ALT 10MG/40MG CPR 90\n",
      "  3400930164365 | EZETIMIBE/SIMVAST ALT 10MG/20MG CPR 30\n",
      "  3400930164372 | EZETIMIBE/SIMVAST ALT 10MG/20MG CPR 90\n",
      "  3400930164471 | TIMOPTOL 0,25 % COLLYRE FL 5ML 1\n",
      "  3400930164488 | TIMOPTOL 0,50 % COLLYRE FL 5ML 1\n",
      "  3400930164556 | XENETIX 300 SOL INJ FL 100ML + NEC2 1\n",
      "  3400930164594 | XENETIX 350 SOL INJ FL 100ML + NEC2 1\n",
      "  3400930164631 | DARUNAVIR KRK 600MG CPR 60\n",
      "  3400930164648 | DARUNAVIR KRK 800MG CPR 30\n",
      "  3400930164716 | QUETIAPINE KRK LP 400 MG CPR 30\n",
      "  3400930164723 | QUETIAPINE KRK LP 400 MG CPR 60\n",
      "  3400930164839 | FEBUXOSTAT CRT 80MG CPR 28\n",
      "  3400930164853 | RABEPRAZOLE VIATRIS 10MG CPR D 28\n",
      "  3400930164907 | RABEPRAZOLE VIATRIS 20MG CPR D 28\n",
      "  3400930164983 | TRAMADOL KRK LP 200MG CPR 30\n",
      "  3400930165003 | TRAMADOL KRK LP 150MG CPR 30\n",
      "  3400930165027 | TRAMADOL KRK LP 100MG CPR 30\n",
      "  3400930165232 | SOLIFENACINE CRT 5MG CPR 30\n",
      "  3400930165393 | SOLIFENACINE CRT 10MG CPR 30\n",
      "  3400930165478 | ARIPIPRAZOLE ARW 150 MG SOL BUV FL 1\n",
      "  3400930165508 | ACIDE FOLIQUE CCD 5MG CPR 30\n",
      "  3400930165515 | ACIDE FOLIQUE CCD 5MG CPR 90\n",
      "  3400930165607 | SOLIFENACINE EVO 5MG CPR 30\n",
      "  3400930165812 | SOLIFENACINE EVO 10MG CPR 30\n",
      "  3400930165942 | GILENYA 0,25 MG GELULE 28\n",
      "  3400930165959 | FEBUXOSTAT CRT 120MG CPR 28\n",
      "  3400930165973 | ATAZANAVIR BGA 150MG GELULE 60\n",
      "  3400930166024 | ATAZANAVIR BGA 300MG GELULE 30\n",
      "  3400930166048 | RISEDRONATE ZYF 35MG CPR 12\n",
      "  3400930166093 | TRUSOPT 20 MG/ML COLLYRE FL 5ML BD 1\n",
      "  3400930166116 | ANAPEN 500 MCG SOL INJ SER 2\n",
      "  3400930166178 | DICLOFENAC ZYD 1% GEL 50G 1\n",
      "  3400930166192 | DICLOFENAC ZYD 1% GEL 100G 1\n",
      "  3400930166284 | EZETIMIBE/SIMVAST KRK 10MG/20MG CPR 90\n",
      "  3400930166307 | EZETIMIBE/SIMVAST KRK 10MG/40MG CPR 90\n",
      "  3400930166321 | TIMOPTOL LP 0,25% COLLYRE FL 2,5ML 1\n",
      "  3400930166338 | TIMOPTOL LP 0,50% COLL FP BD 2,5ML 1\n",
      "  3400930166345 | COSOPT 20MG/5MG/ML COLLYRE FL PE 5ML 1\n",
      "  3400930166420 | ALPRAZOLAM HCS 0,25MG CPR 30\n",
      "  3400930166703 | ALPRAZOLAM HCS 0,50MG CPR 30\n",
      "  3400930166758 | AMLODIPINE/VALSAT KRK 10MG/160MG CPR 30\n",
      "  3400930166765 | AMLODIPINE/VALSAT KRK 10MG/160MG CPR 90\n",
      "  3400930166772 | AMLODIPINE/VALSAT KRK 5MG/160MG CPR 30\n",
      "  3400930166789 | AMLODIPINE/VALSAT KRK 5MG/160MG CPR 90\n",
      "  3400930166819 | AMLODIPINE/VALSAT KRK 5MG/80MG CPR 30\n",
      "  3400930166826 | AMLODIPINE/VALSAT KRK 5MG/80MG CPR 90\n",
      "  3400930166840 | DEMECLOCYCLINE ATL 150MG GELULE 100\n",
      "  3400930166918 | BETAHISTINE ACC 24MG CPR 60\n",
      "  3400930167106 | TIOTROPIUM VIATRI 18 MCG PDR INH GEL 30\n",
      "  3400930167212 | UNIFLOX 500 MG CPR 1\n",
      "  3400930167236 | FEBUXOSTAT MYL 80MG CPR 28\n",
      "  3400930167243 | FEBUXOSTAT MYL 120MG CPR 28\n",
      "  3400930167267 | ERLEADA 60MG CPR 120\n",
      "  3400930167298 | PARACETAMOL COD TVC 500/30MG CPR 16\n",
      "  3400930167304 | PARACETAMOL COD TVC 500/30MG CPR 16\n",
      "  3400930167373 | SITAGLIPTINE ALTER 100 MG CPR 28\n",
      "  3400930167410 | SITAGLIPTINE ALTER 50 MG CPR 28\n",
      "  3400930167441 | ORKAMBI 100/125 MG GRLS SAC 56\n",
      "  3400930167458 | ORKAMBI 150/188 MG GRLS SAC 56\n",
      "  3400930167489 | STRIVERDI RESPIMAT 2,5MCG SOL INHIR 1\n",
      "  3400930167632 | CALCIPARINE 20 000UI/0,8ML SOL INJ S 2\n",
      "  3400930167793 | DORZOLAMIDE CRT 2% COLLYRE 5ML 1\n",
      "  3400930167809 | ZORYON 5MG GELULE 7\n",
      "  3400930167847 | ZORYON 5MG UNIDOSE SIROP 1\n",
      "  3400930167854 | ZORYON 10MG GELULE 7\n",
      "  3400930167908 | ZORYON 10MG SIROP 1\n",
      "  3400930167915 | ZORYON 20MG GELULE 7\n",
      "  3400930167977 | ZORYON 40MG GELULE 7\n",
      "  3400930168349 | PARACETAMOL ACC 500MG CPR EFF 16\n",
      "  3400930168363 | OMEPRAZOLE BGA 10MG GELULE 14\n",
      "  3400930168370 | OMEPRAZOLE BGA 10MG GELULE 28\n",
      "  3400930168387 | OMEPRAZOLE BGA 20MG GELULE 28\n",
      "  3400930168394 | OMEPRAZOLE BGA 20MG GELULE 28\n",
      "  3400930168400 | OMEPRAZOLE BGA 20MG GELULE 28\n",
      "  3400930168448 | SPIRIVA RESPIMAT 2,5MCG SOL PR INHIR 1\n",
      "  3400930168455 | SPIRIVA RESPIMAT 2,5MCG SOL PR INHIR 1\n",
      "  3400930168493 | PHLOROGLUCINOL BGA 160MG CPR ORODISP 5\n",
      "  3400930168530 | SPIOLTO RESPIMAT 2,5MCG SOL PR INHR 1\n",
      "  3400930168547 | SPIOLTO RESPIMAT 2,5MCG SOL PR INHR 1\n",
      "  3400930168554 | TIXOCORTOL TVC 1% SUSP NASALE 1\n",
      "  3400930168561 | TIXOCORTOL BGA 1% SUSP NASALE 1\n",
      "  3400930168578 | TIXOCORTOL ZENTIVA 1% SUSP NASALE 1\n",
      "  3400930168592 | DUTASTERIDE VIATRIS 0,5MG CAPSULE 30\n",
      "  3400930168912 | RUBRACA 200MG CPR 60\n",
      "  3400930168929 | RUBRACA 250MG CPR 60\n",
      "  3400930168936 | RUBRACA 300MG CPR 60\n",
      "  3400930168950 | APREPITANT 80MG+125MG EVO GELULE 3\n",
      "  3400930168974 | SPIOLTO RESPIMAT 2,5MCG SOL PR INHR 3\n",
      "  3400930168998 | SPIOLTO RESPIMAT 2,5MCG SOL PR INHR 3\n",
      "  3400930169018 | STRIVERDI RESPIMAT 2,5MCG SOL INHIR 3\n",
      "  3400930169162 | ALEND AC / D3 VTS 70 MG/ 2800 UI CPR 4\n",
      "  3400930169186 | ALEND AC / D3 VTS 70 MG/ 2800 UI CPR 12\n",
      "  3400930169209 | ALEND AC / D3 VTS 70 MG/ 5600 UI CPR 4\n",
      "  3400930169223 | ALEND AC / D3 VTS 70 MG/ 5600 UI CPR 12\n",
      "  3400930169346 | APOMORPHINE VIATRIS 50 MG SOL INJ 10\n",
      "  3400930169384 | APOMORPHINE BGA 5MG/1ML SOL INJ 10\n",
      "  3400930169452 | GABAPENTINE VIATRIS 600MG CPR 90\n",
      "  3400930169476 | GABAPENTINE VTS 800MG CPR 90\n",
      "  3400930169650 | APREPITANT 80MG+125MG ZEN GELULE 3\n",
      "  3400930169681 | DIMETRUM 2MG CPR 28\n",
      "  3400930169735 | APREPITANT 80MG+125MG EG GELULE 3\n",
      "  3400930169759 | APREPITANT EG 80 MG GELULE 2\n",
      "  3400930169780 | APREPITANT 80MG ARW GELULE 2\n",
      "  3400930169803 | ATORVASTATINE ALP 80MG CPR 30\n",
      "  3400930169810 | ATORVASTATINE ALP 80MG CPR 90\n",
      "  3400930169834 | ATORVASTATINE ALP 40MG CPR 30\n",
      "  3400930169841 | ATORVASTATINE ALP 40MG CPR 90\n",
      "  3400930169858 | APREPITANT 80MG+125MG ARW GELULE 3\n",
      "  3400930169889 | ATORVASTATINE ALP 20MG CPR 30\n",
      "  3400930169896 | ATORVASTATINE ALP 20MG CPR 90\n",
      "  3400930169919 | ATORVASTATINE ALP 10MG CPR 30\n",
      "  3400930169926 | ATORVASTATINE ALP 10MG CPR 90\n",
      "  3400930169933 | CALCIUM SDZ 500MG CPR EFF 20\n",
      "  3400930169957 | SPIRIVA RESPIMAT 2,5MCG SOL PR INHIR 3\n",
      "  3400930169964 | SPIRIVA RESPIMAT 2,5MCG SOL PR INHIR 3\n",
      "  3400930170168 | APREPITANT 80MG+125MG ACC GELULE 3\n",
      "  3400930170199 | MANIDIPINE ZYD 10MG CPR 30\n",
      "  3400930170212 | MANIDIPINE ZYD 10MG CPR 90\n",
      "  3400930170250 | MANIDIPINE ZYD 20MG CPR 30\n",
      "  3400930170274 | MANIDIPINE ZYD 20MG CPR 90\n",
      "  3400930170335 | EZETIMIBE ALM 10MG CPR 28\n",
      "  3400930170366 | EZETIMIBE ALM 10MG CPR 90\n",
      "  3400930170441 | DAFALGAN 1G CPR 8\n",
      "  3400930170700 | REANUTRIFLEX E PERF 625ML 5\n",
      "  3400930170717 | REANUTRIFLEX E PERF 1250ML 5\n",
      "  3400930170724 | REANUTRIFLEX E PERF 1875ML 5\n",
      "  3400930170786 | MEDNUTRIFLEX E PERF 1250ML 5\n",
      "  3400930170793 | MEDNUTRIFLEX E PERF 1875ML 5\n",
      "  3400930170885 | FEBUXOSTAT ARW 120MG CPR 28\n",
      "  3400930170908 | FEBUXOSTAT ARW 80MG CPR 28\n",
      "  3400930170922 | KETOCONAZOLE BGR 2% CREME 1\n",
      "  3400930171059 | FULVESTRANT ACC 250 MG SOL INJ 2\n",
      "  3400930171066 | ULIPRISTAL ACETATE VTS 30MG CPR 1\n",
      "  3400930171127 | GLICLAZIDE SDZ LM 30MG CPR 30\n",
      "  3400930171158 | GLICLAZIDE SDZ LM 30MG CPR 60\n",
      "  3400930171202 | GLICLAZIDE SDZ LM 30MG CPR 180\n",
      "  3400930171622 | DARUNAVIR ACC 600MG CPR 60\n",
      "  3400930171660 | DARUNAVIR ACC 800MG CPR 30\n",
      "  3400930171684 | EVEROLIMUS SDZ 10 MG CPR 30\n",
      "  3400930171837 | EVEROLIMUS SDZ 5 MG CPR 30\n",
      "  3400930171875 | EVEROLIMUS SDZ 2,5 MG CPR 30\n",
      "  3400930171936 | ALUNBRIG 30MG CPR 28\n",
      "  3400930171950 | ALUNBRIG 90 MG + 180 MG CPR 28\n",
      "  3400930172032 | VERKAZIA 1MG/ML COLLYRE UNIDOSE 120\n",
      "  3400930172056 | ILUMETRI 100MG SOL INJ SER 1\n",
      "  3400930172063 | LEFLUNOMIDE RTP 10MG CPR 30\n",
      "  3400930172070 | LEFLUNOMIDE RTP 20MG CPR 30\n",
      "  3400930172094 | ULIPRISTAL AC.EXL 30MG CPR 1\n",
      "  3400930172100 | BEAGYNE 150MG GELULE 4\n",
      "  3400930172148 | NAMUSCLA 167 MG GELULE 100\n",
      "  3400930172230 | IRBESARTAN HCTZ VTS 150/12,5MG CPR 2 30\n",
      "  3400930172247 | IRBESARTAN HCTZ VTS 150/12,5MG CPR 2 90\n",
      "  3400930172346 | IRBESARTAN HCTZ VTS 300/12,5MG CPR2 30\n",
      "  3400930172353 | IRBESARTAN HCTZ VTS 300/12,5MG CPR2 90\n",
      "  3400930172360 | IRBESARTAN HCTZ VTS 300/25MG CPR 2 30\n",
      "  3400930172377 | IRBESARTAN HCTZ VTS 300/25MG CPR 2 90\n",
      "  3400930172520 | VERAPAMIL VTS LP 120MG CPR 30\n",
      "  3400930172537 | VERAPAMIL VTS LP 120MG CPR 90\n",
      "  3400930172735 | KETOCONAZOLE VIATRIS 2% CREME 1\n",
      "  3400930172780 | IDACIO 40 MG SOL INJ SER 2\n",
      "  3400930172797 | IDACIO 40 MG SOL INJ STYLO 2\n",
      "  3400930172803 | MACROGOL 4000 ZEN 10G PDR ORALE SACH 20\n",
      "  3400930172810 | MACROGOL 4000 EG 10G PDR ORALE SACH 20\n",
      "  3400930172872 | BETAHISTINE CRT 24MG CPR 60\n",
      "  3400930173046 | METFORMINE SDZ 1000MG CPR 90\n",
      "  3400930173077 | ATAZANAVIR BGA 200MG GELULE 60\n",
      "  3400930173138 | DEXAMETHASONE RAFARM 1MG/ML COLL 5ML 1\n",
      "  3400930173367 | NIMOTOP 30MG CPR 90\n",
      "  3400930173398 | SILODOSINE MYL 4MG GELULE 30\n",
      "  3400930173442 | SILODOSINE MYL 8MG GELULE 30\n",
      "  3400930173466 | SILODOSINE EG 4MG GELULE 30\n",
      "  3400930173480 | SILODOSINE EG 8MG GELULE 30\n",
      "  3400930173497 | VILDAGLIPTINE ZEN 50MG CPR 30\n",
      "  3400930173510 | VILDAGLIPTINE ZEN 50MG CPR 60\n",
      "  3400930173534 | TAMSULOSINE ARL LP 0,4MG GELULE 30\n",
      "  3400930173572 | ENALAPRIL/LER TVC 20MG/20MG CP 30\n",
      "  3400930173589 | ENALAPRIL/LER TVC 20MG/20MG CP 90\n",
      "  3400930173848 | TIORFAN 4MG/ML BB/ENF BUV 50ML 1\n",
      "  3400930173855 | TIORFAN 4MG/ML BB/ENF BUV 180ML 1\n",
      "  3400930173886 | ORENCIA 50 MG SOL INJ 4\n",
      "  3400930173909 | ORENCIA 87,5 MG SOL INJ 4\n",
      "  3400930173992 | LOSARTAN /HYD CRP 50/12,5 CPR 30\n",
      "  3400930174043 | LOSARTAN HCTZ CRP 100/25MG CPR 30\n",
      "  3400930174074 | LACOSAMIDE EG 50MG CPR 56\n",
      "  3400930174081 | CINACALCET EG 30MG CPR 28\n",
      "  3400930174128 | CINACALCET EG 60MG CPR 28\n",
      "  3400930174142 | CINACALCET EG 90MG CPR 1\n",
      "  3400930174173 | LACOSAMIDE EG 100MG CPR 56\n",
      "  3400930174197 | LACOSAMIDE EG 150MG CPR 56\n",
      "  3400930174210 | LACOSAMIDE EG 200MG CPR 56\n",
      "  3400930174227 | PARACETAMOL KRK 1 000MG CPR 8\n",
      "  3400930174234 | FYCOMPA 0,5 MG/ML SUSP BUV 1\n",
      "  3400930174241 | SUNITINIB SDZ 12,5 MG GELULE 28\n",
      "  3400930174258 | SUNITINIB SDZ 25 MG GELULE 28\n",
      "  3400930174272 | SUNITINIB SDZ 50 MG GELULE 28\n",
      "  3400930174425 | ACICLOVIR ARG 200MG CPR 25\n",
      "  3400930174807 | OLIMEL N12E EMULS INJ POC 650ML 10\n",
      "  3400930174814 | OLIMEL N12E EMULS INJ POC 1L 6\n",
      "  3400930174821 | OLIMEL N12E EMULS INJ POC 1,5L 4\n",
      "  3400930174883 | SKYRIZI 75MG SOL INJ SERG 2\n",
      "  3400930174913 | MACROGOL 4000 ARW 4G PDR BUV SACH 20\n",
      "  3400930174968 | MACROGOL 4000 ARW 10G PDR BUV SACH 20\n",
      "  3400930174999 | CICLOPIROX OLAMI VENIPHARM 1,5% SHP 1\n",
      "  3400930175002 | SUNITINIB EG 12,5 MG GELULE 28\n",
      "  3400930175033 | SUNITINIB EG 25 MG GELULE 28\n",
      "  3400930175064 | SUNITINIB EG 50 MG GELULE 28\n",
      "  3400930175545 | SUNITINIB VIATRIS 12,5 MG GELULE 28\n",
      "  3400930175576 | SUNITINIB VIATRIS 25 MG GELULE 28\n",
      "  3400930175637 | SUNITINIB VIATRIS 50 MG GELULE 28\n",
      "  3400930176016 | ALIZEM 10 MG CAPSULE MOLLE 30\n",
      "  3400930176023 | ALIZEM 30MG CAPSULE MOLLE 30\n",
      "  3400930176061 | PREMINOR 5MG/10MG GELULE 30\n",
      "  3400930176085 | PREMINOR 10MG/5MG GELULE 30\n",
      "  3400930176115 | PREMINOR 5MG/5MG GELULE 30\n",
      "  3400930176139 | PREMINOR 10MG/10MG GELULE 30\n",
      "  3400930176207 | FLUTICASO/SALM VTS 100/50 MICROG PDR 60\n",
      "  3400930176245 | FLUTICASO/SALM VTS 250/50 MICROG PDR 60\n",
      "  3400930176290 | FLUTICASO/SALM VTS 500/50 MICROG PDR 60\n",
      "  3400930176344 | DULOXETINE ZYD 30MG GELULE 28\n",
      "  3400930176351 | DULOXETINE ZYD 60MG GELULE 28\n",
      "  3400930176375 | SUVREZA 10MG/10MG CPR 30\n",
      "  3400930176382 | SUVREZA 10MG/10MG CPR 90\n",
      "  3400930176399 | SUVREZA 20MG/10MG CPR 30\n",
      "  3400930176405 | SUVREZA 20MG/10MG CPR 90\n",
      "  3400930176412 | RILMENIDINE BGA 1MG CPR 30\n",
      "  3400930176481 | BISOPROLOL EVO 2,5MG CPR 30\n",
      "  3400930176511 | BISOPROLOL EVO 5MG CPR 30\n",
      "  3400930176542 | BISOPROLOL EVO 10MG CPR 30\n",
      "  3400930176559 | BISOPROLOL EVO 10MG CPR 90\n",
      "  3400930176573 | GADOVISTAUTO 1MMOL/ML INJ SER 7,5ML 1\n",
      "  3400930176580 | GADOVISTAUTO 1MMOL/ML INJ SER 10ML 1\n",
      "  3400930176597 | GADOVISTAUTO 1MMOL/ML INJ SER 15ML 1\n",
      "  3400930176665 | EZETIMIBE/SIMVAST ARW 10MG/20MG CPR 30\n",
      "  3400930176689 | EZETIMIBE/SIMVAST ARW 10MG/20MG CPR 90\n",
      "  3400930176702 | EZETIMIBE/SIMVAST ARW 10MG/40MG CPR 30\n",
      "  3400930176719 | EZETIMIBE/SIMVAST ARW 10MG/40MG CPR 90\n",
      "  3400930176740 | VIZITRAV 40 MCG/ML COLLYRE 3\n",
      "  3400930176771 | SIMVASTATINE MYL 20MG CPR 28\n",
      "  3400930176870 | TRAMADOL ALM 50MG GELULE 30\n",
      "  3400930176948 | SANTURIL 500 MG CPR 30\n",
      "  3400930176955 | SOTALOL ARL 80MG CPR 30\n",
      "  3400930176979 | SOTALOL ARL 160MG CPR 30\n",
      "  3400930177006 | LORVIQUA 100 MG, COMPRIME PELLICULE 30\n",
      "  3400930177204 | SILODOSINE TVC 4MG GELU 30\n",
      "  3400930177235 | SILODOSINE TVC 8 MG GELULE 30\n",
      "  3400930177266 | VINORELBINE SDZ 20MG CAPSULE 1\n",
      "  3400930177280 | VINORELBINE SDZ 30MG CAPSULE 1\n",
      "  3400930177464 | DASATINIB EG 100 MG CPR 30\n",
      "  3400930177563 | PARACETAMOL COD VTS 500/30MG CPR 16\n",
      "  3400930177662 | TOUJEO 900U DOUBLESTAR STYLO 3ML 3\n",
      "  3400930177709 | DUPIXENT 200 MG, SOLUTION INJECTABLE 2\n",
      "  3400930177723 | DUPIXENT 200 MG SOL INJ STYLO 2\n",
      "  3400930177730 | TOBRAMYCINE ZEN 300MG SOL INHAL 56\n",
      "  3400930177754 | SILODOSINE RCD 4MG GELU 30\n",
      "  3400930177761 | SILODOSINE RCD 8 MG, GELULE 30\n",
      "  3400930177822 | GLICLAZIDE ARL LM 30MG CPR 30\n",
      "  3400930177846 | GLICLAZIDE ARL LM 30MG CPR 60\n",
      "  3400930177884 | GLICLAZIDE ARL LM 30MG CPR 180\n",
      "  3400930177914 | ATORVASTATINE ARG 10 MG CPR 30\n",
      "  3400930177921 | ATORVASTATINE ARG 10 MG CPR 90\n",
      "  3400930177983 | AMLODIPINE/VALSART EGL 5MG/80MG CPR 30\n",
      "  3400930178027 | AMLODIPINE/VALSART EGL 5MG/80MG CPR 90\n",
      "  3400930178140 | ATORVASTATINE ARG 20 MG CPR 30\n",
      "  3400930178157 | ATORVASTATINE ARG 20 MG CPR 90\n",
      "  3400930178201 | AMLODIPINE/VALSART EGL 5MG/160MG CPR 30\n",
      "  3400930178249 | AMLODIPINE/VALSART EGL 5MG/160MG CPR 90\n",
      "  3400930178416 | AMLODIPINE/VALSART EGL 10MG/160MG 30\n",
      "  3400930178454 | AMLODIPINE/VALSART EGL 10MG/160MG 90\n",
      "  3400930178669 | GLICLAZIDE ZYF LM 60MG CPR 30\n",
      "  3400930178676 | GLICLAZIDE ZYF LM 60MG CPR 90\n",
      "  3400930178775 | PANTOPRAZOLE ARG 40 MG CPR 28\n",
      "  3400930178782 | PANTOPRAZOLE ARG 20 MG CPR 28\n",
      "  3400930178799 | AMIODARONE ARL 200MG CPR 30\n",
      "  3400930178805 | HUMIRA 80 MG SOL INJ STYLO + TAMP 3\n",
      "  3400930178874 | MIFLONIL BREEZHA 200 MCG PDR INH GEL 60\n",
      "  3400930178942 | MIFLONIL BREEZHA 400 MCG PDR INH GEL 60\n",
      "  3400930178966 | CLARITHROMYCINE HCS 500MG CPR 10\n",
      "  3400930178980 | CLARITHROMYCINE HCS 500MG CPR 14\n",
      "  3400930179079 | CLINIMIX N9G15E INJ PDL1L 8\n",
      "  3400930179246 | PHLOROGLUCINOL BGR 80MG CPR DISP 10\n",
      "  3400930179291 | GLICLAZIDE KRKA LM 30MG CPR 30\n",
      "  3400930179307 | GLICLAZIDE KRKA LM 30MG CPR 60\n",
      "  3400930179314 | GLICLAZIDE KRKA LM 30MG CPR 180\n",
      "  3400930179543 | NORDITROPINE FLEXP 5 MG INJ STYLO 1\n",
      "  3400930179567 | NORDITROPINE FLEXPRO 10 MG/1,5 ML, S 1\n",
      "  3400930179581 | NORDITROPINE FLEXP 15 MG INJ STYLO 1\n",
      "  3400930179734 | DEXOCOL 1MG/ML COLL 6ML 1\n",
      "  3400930179772 | IPRATROPIUM ALP 0,5MG/2ML AD INHAL 10\n",
      "  3400930179826 | DASATINIB EG 20 MG CPR 60\n",
      "  3400930179857 | DASATINIB EG 50 MG CPR 60\n",
      "  3400930179864 | DASATINIB EG 70 MG CPR 60\n",
      "  3400930179963 | FEBUXOSTAT EVO 80MG CPR 28\n",
      "  3400930179994 | FEBUXOSTAT EVO 120MG CPR 28\n",
      "  3400930180044 | HYDROCHLOROTHIAZIDE ARW 25 MG CPR 30\n",
      "  3400930180051 | HYDROCHLOROTHIAZIDE ARW 25 MG CPR 90\n",
      "  3400930180082 | PREGABALINE ALT 50 MG GELULE 84\n",
      "  3400930180099 | PREGABALINE ALT 100 MG GELULE 84\n",
      "  3400930180174 | CINACALCET ARW 30MG CPR 28\n",
      "  3400930180181 | CINACALCET ARW 60MG CPR 28\n",
      "  3400930180198 | CINACALCET ARW 90MG CPR 28\n",
      "  3400930180228 | SILODOSINE ZEN 4MG GELU 30\n",
      "  3400930180235 | SILODOSINE ZEN 8MG GELU 30\n",
      "  3400930180334 | FOSFOMYCINE ZYDUS 3G GRANULES SACH 1\n",
      "  3400930180396 | TRAMADOL EVO LP 100MG CPR 30\n",
      "  3400930180440 | TRAMADOL EVO LP 150MG CPR 30\n",
      "  3400930180488 | TRAMADOL EVO LP 200MG CPR 30\n",
      "  3400930180518 | OCTREOTIDE TVC LP 20 MG INJ SER 1\n",
      "  3400930180525 | OCTREOTIDE TVC LP 10 MG INJ SER 1\n",
      "  3400930180532 | OCTREOTIDE TVC LP 30 MG INJ SER 1\n",
      "  3400930180570 | ACEBUTOLOL ARL 200MG CPR 30\n",
      "  3400930180594 | ACEBUTOLOL ARL 200MG CPR 90\n",
      "  3400930180624 | ACEBUTOLOL ARL 400MG CPR 30\n",
      "  3400930180631 | ACEBUTOLOL ARL 400MG CPR 90\n",
      "  3400930180662 | THYROFIX 13MICROG CPR 30\n",
      "  3400930180716 | THYROFIX 62MICROG CPR 30\n",
      "  3400930180723 | THYROFIX 88MICROG CPR 30\n",
      "  3400930180730 | THYROFIX 112MICROG CPR 30\n",
      "  3400930180747 | THYROFIX 125MICROG CPR 30\n",
      "  3400930180754 | THYROFIX 137MICROG CPR 30\n",
      "  3400930180761 | THYROFIX 150MICROG CPR 30\n",
      "  3400930180778 | THYROFIX 175MICROG CPR 30\n",
      "  3400930180785 | THYROFIX 200MICROG CPR 30\n",
      "  3400930180969 | TILLHEPO 250 MG GELULE 100\n",
      "  3400930180990 | LOSARTAN /HYD CRP 50/12,5 CPR 90\n",
      "  3400930181003 | LOSARTAN HCTZ CRP 100/25MG CPR 90\n",
      "  3400930181256 | BICALUTAMIDE CRP 50MG CPR 30\n",
      "  3400930181393 | NYXOID 1,8 MG SOL NASALE UNIDOSE 2\n",
      "  3400930181430 | FEBUXOSTAT NIALEX 80MG CPR 28\n",
      "  3400930181461 | SILODOSINE SDZ 4MG GELULE 30\n",
      "  3400930181485 | SILODOSINE SDZ 8MG GELULE 30\n",
      "  3400930181508 | OMEPRAZOLE ZTL 10MG GELULE 14\n",
      "  3400930181522 | OMEPRAZOLE ZTL 10MG GELULE 28\n",
      "  3400930181560 | OMEPRAZOLE ZTL 10MG GELULE 14\n",
      "  3400930181577 | OMEPRAZOLE ZTL 10MG GELULE 28\n",
      "  3400930181591 | OMEPRAZOLE ZTL 20MG GELULE 7\n",
      "  3400930181607 | OMEPRAZOLE ZTL 20MG GELULE 14\n",
      "  3400930181621 | OMEPRAZOLE ZTL 20MG GELULE 28\n",
      "  3400930181645 | OMEPRAZOLE ZTL 20MG GELULE 7\n",
      "  3400930181652 | OMEPRAZOLE ZTL 20MG GELULE 14\n",
      "  3400930181669 | OMEPRAZOLE ZTL 20MG GELULE 28\n",
      "  3400930181706 | FEBUXOSTAT ZYF 120MG CPR 28\n",
      "  3400930181713 | PENTASA 1G SUPPO 14\n",
      "  3400930181737 | GADOVISTMANUEL 1MMOL/ML INJSER7,5ML 1\n",
      "  3400930181744 | GADOVISTMANUEL 1MMOL/ML INJ SER10ML 1\n",
      "  3400930181751 | GADOVISTMANUEL 1MM INJ SV15ML 1\n",
      "  3400930181775 | ALPRAZOLAM VTS 0,25MG CPR 30\n",
      "  3400930181782 | ALPRAZOLAM VTS 0,50 MG CPR 30\n",
      "  3400930181904 | PENTASA 1G/100ML SUSP RECTALE 7\n",
      "  3400930182017 | NEBIVOLOL ARL 5MG CPR 30\n",
      "  3400930182048 | NEBIVOLOL ARL 5MG CPR 90\n",
      "  3400930182147 | AZITHROMYCINE ARL 500MG CPR 3\n",
      "  3400930182185 | ATAZANAVIR KRK 300MG GELULE 30\n",
      "  3400930182192 | TALZENNA 0.25MG GELULE 30\n",
      "  3400930182208 | TALZENNA 1MG GELULE 30\n",
      "  3400930182451 | FULVESTRANT EG 250 MG SOL INJ 1\n",
      "  3400930182482 | IMBRUVICA 140 MG CPR 30\n",
      "  3400930182505 | IMBRUVICA 280 MG CPR 30\n",
      "  3400930182543 | ACIDE ACETYLSALICYLIQUE VTS 100MG CP 30\n",
      "  3400930182550 | DOVATO 50MG/300MG CPR 30\n",
      "  3400930182567 | TAMSULOSINE EVO LP 0,4MG GELULE 30\n",
      "  3400930183052 | ATORVASTATINE BGA 20 MG CPR 30\n",
      "  3400930183076 | ATORVASTATINE BGA 20 MG CPR 90\n",
      "  3400930183090 | ATORVASTATINE BGA 10 MG CPR 30\n",
      "  3400930183113 | ATORVASTATINE BGA 10 MG CPR 90\n",
      "  3400930183137 | ATORVASTATINE BGA 40MG CPR 30\n",
      "  3400930183151 | ATORVASTATINE BGA 40MG CPR 90\n",
      "  3400930183175 | ATORVASTATINE BGA 80MG CPR 30\n",
      "  3400930183205 | ATORVASTATINE BGA 80MG CPR 90\n",
      "  3400930183564 | BISOPROLOL VIATRIS 1.25 MG CPR 30\n",
      "  3400930183571 | BISOPROLOL VIATRIS 1.25 MG CPR 90\n",
      "  3400930183748 | BISOPROLOL VIATRIS 2,5MG CPR 30\n",
      "  3400930183755 | BISOPROLOL VIATRIS 2,5MG CPR 90\n",
      "  3400930183960 | BISOPROLOL VIATRIS 3.75 MG CPR 30\n",
      "  3400930184318 | BISOPROLOL VIATRIS 7.5 MG CPR 30\n",
      "  3400930184554 | MACROGOL 4000 EG 4G PDR BUV SACH 20\n",
      "  3400930184578 | DARUNAVIR ARW 600MG CPR 60\n",
      "  3400930184585 | DARUNAVIR ARW 800MG CPR 30\n",
      "  3400930184608 | METFORMINE ALM 1000MG CPR 90\n",
      "  3400930184615 | METFORMINE ALM 850MG CPR 90\n",
      "  3400930184684 | METFORMINE ALM 500MG CPR 90\n",
      "  3400930184844 | DAFALGAN 500MG GELULE 16\n",
      "  3400930185537 | ALONEST 1,5MG SOL NAS 20 1\n",
      "  3400930185728 | AZITHROMYCINE ARL 250MG CPR 6\n",
      "  3400930185773 | APREPITANT CRT 80 MG GELULE 2\n",
      "  3400930185797 | APREPITANT 80MG+125MG CRT GELULE 3\n",
      "  3400930185872 | VORICONAZOLE ARW 50 MG CPR 56\n",
      "  3400930185933 | VORICONAZOLE ARW 200 MG CPR 28\n",
      "  3400930185957 | VORICONAZOLE ARW 200 MG CPR 56\n",
      "  3400930186138 | CUFENCE 200 MG GELULE 100\n",
      "  3400930186145 | NUREFLEX 400MG CPR 24\n",
      "  3400930186336 | NUCALA 100MG INJ SRG1ML 1\n",
      "  3400930186343 | NUCALA 100MG INJ STYL1ML 1\n",
      "  3400930186350 | LAMICTAL 5 MG CPR DISP 30\n",
      "  3400930186367 | SAWIS 2MG CPR 28\n",
      "  3400930186374 | SILODOSINE ARW 4MG GELULE 30\n",
      "  3400930186473 | SILODOSINE ARW 8MG GELULE 30\n",
      "  3400930186886 | BACLOCUR 30MG CPR 30\n",
      "  3400930186947 | DAFALGAN 1000MG GELULE 8\n",
      "  3400930187050 | DUTASTE/TAMSU ARW 0,5MG/0,4MG GELULE 30\n",
      "  3400930187074 | MONTELUKAST SDZ 5MG CPR CROQ 28\n",
      "  3400930187159 | PROPRANOLOL ARW 40MG CPR 50\n",
      "  3400930187210 | GLIVEC 100MG CPR 60\n",
      "  3400930187364 | CROMOPTIC 2% COLLYRE FL 10ML 1\n",
      "  3400930187524 | ATENOLOL VTS 50MG CPR 30\n",
      "  3400930187531 | ATENOLOL VTS 100MG CPR 30\n",
      "  3400930187548 | ERLOTINIB ZEN 150MG CPR 30\n",
      "  3400930187555 | ERLOTINIB ZEN 100MG CPR 30\n",
      "  3400930187579 | ERLOTINIB ZEN 25MG CPR 30\n",
      "  3400930187586 | ACICLOVIR AGEPHA 3% POM OPHT 4,5G 1\n",
      "  3400930187661 | MOVYMIA 20 MICROG/80 MICROL SOL INJ 1\n",
      "  3400930187722 | OMNIPAQUE 300MG SOL INJ FP 100ML ULR 1\n",
      "  3400930187739 | OMNIPAQUE 300MG SOL INJ FP 150ML INJ 1\n",
      "  3400930187746 | VISIPAQUE 320MG/ML INJ FP ULR 100ML 1\n",
      "  3400930187838 | FASENRA 30MG INJ STYLO1ML 1\n",
      "  3400930187845 | OPTIJECT 300 SOL INJ SER + P 100ML 1\n",
      "  3400930187869 | OPTIJECT 300 SOL INJ SER + P 125ML 1\n",
      "  3400930187876 | OPTIJECT 350 SOL INJ SER + P 100ML 1\n",
      "  3400930187883 | OPTIJECT 350MG INJ SER125ML +N 1\n",
      "  3400930187951 | PELGRAZ 6 MG, SOL INJ STYLO 1\n",
      "  3400930187968 | EPIDYOLEX 100MG/ML SOL BUV 100ML 1\n",
      "  3400930188187 | SOLIFENACINE TVC 5MG CPR 30\n",
      "  3400930188200 | SOLIFENACINE TVC 10MG CPR 30\n",
      "  3400930188217 | TAMSULOSINE KRK LP 0,4MG GELULE 30\n",
      "  3400930188354 | METRONIDAZOLE ARW 250 MG CPR 20\n",
      "  3400930188361 | METRONIDAZOLE ARW 500 MG CPR 4\n",
      "  3400930188378 | METRONIDAZOLE ARW 500 MG CPR 4\n",
      "  3400930188408 | ALGINATE BICAR SODIUM EG SACH 10ML 24\n",
      "  3400930188545 | RISEDRONATE ZEN K.S. 35MG CPR 4\n",
      "  3400930188552 | RISEDRONATE ZEN K.S. 35MG CPR 12\n",
      "  3400930188606 | DUTASTE/TAMSU VTS 0,5MG/0,4MG GELULE 30\n",
      "  3400930188736 | DUTASTE/TAMSU BGA 0,5MG/0,4MG GELULE 30\n",
      "  3400930188828 | COLISTIMETHATE AMP 1MUI PDR INH 5\n",
      "  3400930188842 | DASATINIB VTS 140MG CPR 30\n",
      "  3400930188873 | DASATINIB VTS 100 MG CPR 30\n",
      "  3400930188941 | DASATINIB VTS 70 MG CPR 60\n",
      "  3400930188989 | DASATINIB VTS 50 MG CPR 60\n",
      "  3400930189016 | DASATINIB VTS 20 MG CPR 60\n",
      "  3400930189092 | FENTANYL ARW 400MCG CPR GINGIVAL 28\n",
      "  3400930189122 | FENTANYL ARW 200MCG CPR GINGIVAL 28\n",
      "  3400930189146 | FENTANYL ARW 100MCG CPR GINGIVAL 28\n",
      "  3400930189214 | ROSUVASTATINE BGA 5MG CPR 30\n",
      "  3400930189528 | DUTASTE/TAMSU ACCORD 0,5MG/0,4MG GEL 30\n",
      "  3400930189641 | LORVIQUA 25 MG CPR 90\n",
      "  3400930189788 | LACOSAMIDE SDZ 50MG CPR 14\n",
      "  3400930189801 | LACOSAMIDE SDZ 50MG CPR 56\n",
      "  3400930189856 | LACOSAMIDE SDZ 100MG CPR 56\n",
      "  3400930189917 | LACOSAMIDE SDZ 150MG CPR 56\n",
      "  3400930189948 | ATOVAQUONE BGA 750 MG/5 ML SUSP BUV 1\n",
      "  3400930189986 | LACOSAMIDE SDZ 200MG CPR 56\n",
      "  3400930190029 | DUTASTE/TAMSU ZTV 0,5MG/0,4MG GELULE 30\n",
      "  3400930190128 | ITULAZAX 12 SQ-BET LYOPHILISAT 30\n",
      "  3400930190142 | DASATINIB KRK 100MG CPR 30\n",
      "  3400930190210 | DASATINIB KRK 50MG CPR 60\n",
      "  3400930190241 | DASATINIB KRK 70MG CPR 60\n",
      "  3400930190272 | DASATINIB ZEN 20MG CPR 60\n",
      "  3400930190302 | DASATINIB ZEN 50MG CPR 60\n",
      "  3400930190333 | DASATINIB ZEN 70MG CPR 60\n",
      "  3400930190364 | DASATINIB ZEN 100MG CPR 30\n",
      "  3400930190432 | ALGINATE BICAR SODIUM CRT SACH 10ML 24\n",
      "  3400930190609 | SILODOSINE BGA 4MG GELU 30\n",
      "  3400930190623 | SILODOSINE BGA 8 MG, GELULE 30\n",
      "  3400930190647 | BORAX/AC BORIQUE VTS SOL OPH UNIDOSE 20\n",
      "  3400930190708 | DULOXETINE TVC 60MG GELULE 28\n",
      "  3400930190746 | DULOXETINE TVC 30MG GELULE 28\n",
      "  3400930190784 | XOSPATA 40MG CPR 84\n",
      "  3400930190791 | IBUPROFENE EVP 400 MG CPR PELL 20\n",
      "  3400930191057 | PARACETAMOL ARL 500MG GELULE 16\n",
      "  3400930191071 | PARACETAMOL ARL 300MG PDR ORALE SACH 12\n",
      "  3400930191088 | PARACETAMOL ARL 500MG PDR ORALE SACH 12\n",
      "  3400930191095 | PARACETAMOL ARL 1G PDR ORALE SACH 8\n",
      "  3400930191163 | CANDAZOL 300MG OVULE 1\n",
      "  3400930191408 | MACROGOL 4000 BFR 4G PDR BUV SACH 20\n",
      "  3400930191521 | SEVELAMER CHLOR WAYMADE 800MG CPR 180\n",
      "  3400930191545 | FLUTICASO/SALM BGR 125/25 MICROG INH 1\n",
      "  3400930191552 | FLUTICASO/SALM BGR 250/25 MICROG INH 1\n",
      "  3400930191576 | DUTASTE/TAMSU EG 0,5MG/0,4MG GELULE 30\n",
      "  3400930191712 | LATANOPROST BGR 50 MCG/ML COLL SOL 1\n",
      "  3400930191729 | LATANOPROST BGR 50 MCG/ML COLL SOL 3\n",
      "  3400930192139 | LERCANIDIPINE BGA 10MG CPR 30\n",
      "  3400930192214 | ABACAVIR ARW 300MG CPR 60\n",
      "  3400930192252 | AURICULARUM PDR ET SOL AURICULAIRE 1\n",
      "  3400930192771 | NICOTINE EG 1MG/DOSE SOL PULV BUC 2\n",
      "  3400930192894 | MIDODRINE VIATRIS 2.5 MG 30\n",
      "  3400930192900 | MIDODRINE VIATRIS 2.5 MG 90\n",
      "  3400930192948 | LOVENOX 12 000UI/0.8ML INJ SER 10\n",
      "  3400930193013 | LOVENOX 15000UI SRG1ML 10\n",
      "  3400930193051 | FOSINOPRIL ARL 10MG CPR 30\n",
      "  3400930193082 | CEBEMYXINE COLLY FP C-GTT 10ML 1\n",
      "  3400930193266 | TOLAK 40MG/G CREME TUBE 20G 1\n",
      "  3400930193303 | NEBIVOLOL KRK 5MG CPR 30\n",
      "  3400930193310 | NEBIVOLOL KRK 5MG CPR 90\n",
      "  3400930193495 | AMOXICILLINE ZYD 1 G CPR DISP 6\n",
      "  3400930193501 | AMOXICILLINE ZYD 1 G CPR DISP 14\n",
      "  3400930193532 | MIDODRINE ARW 2.5 MG 30\n",
      "  3400930193549 | MIDODRINE ARW 2.5 MG 90\n",
      "  3400930193570 | DEFERASIROX MYL 90 MG CPR 30\n",
      "  3400930193600 | DEFERASIROX MYL 180 MG CPR 30\n",
      "  3400930193624 | DEFERASIROX MYL 360 MG CPR 30\n",
      "  3400930193679 | AMISULPRIDE ARL 100MG CPR 30\n",
      "  3400930193792 | AMISULPRIDE ARL 200MG CPR 60\n",
      "  3400930193891 | AMISULPRIDE ARL 400MG CPR 30\n",
      "  3400930193983 | RINVOQ 15MG CPR 28\n",
      "  3400930194508 | MIDODRINE TEVA 2.5 MG 30\n",
      "  3400930194515 | MIDODRINE TEVA 2.5 MG 90\n",
      "  3400930194607 | CELESTENE 4 MG SOL INJ 3\n",
      "  3400930194843 | TOPIRAMATE ARL 200 MG CPR 30\n",
      "  3400930194850 | TOPIRAMATE ARL 100 MG CPR 30\n",
      "  3400930194867 | TOPIRAMATE ARL 50 MG CPR 30\n",
      "  3400930194997 | DASATINIB TVS 20 MG CPR 60\n",
      "  3400930195062 | NEBIVOLOL/ HYD BGR 5MG/12,5MG CPR 30\n",
      "  3400930195079 | NEBIVOLOL/ HYD BGR 5MG/12,5MG CPR 90\n",
      "  3400930195086 | CELESTENE 0,5 MG/ML SOL BUV FL 30ML 1\n",
      "  3400930195093 | NEBIVOLOL/ HYD BGR 5MG/25MG CPR 30\n",
      "  3400930195109 | NEBIVOLOL/ HYD BGR 5MG/25MG CPR 90\n",
      "  3400930195239 | LATANOPROST TVS 0,005% COLLYRE 1\n",
      "  3400930195246 | LATANOPROST TVS 0,005% COLLYRE 3\n",
      "  3400930195260 | PREGABALINE CRT 100 MG GELULE 84\n",
      "  3400930195291 | BAQSIMI 3MG PDR NASAL UNIDOSE 1\n",
      "  3400930195321 | PREGABALINE CRT 200 MG GELULE 84\n",
      "  3400930195352 | RACECADOTRIL ZEN 100MG GELULE 10\n",
      "  3400930195642 | UVEDOSE 50 000 UI SOL BUV 1\n",
      "  3400930195697 | CLOPIDOGREL/AC ACETYLSALIC MYL 75 MG 30\n",
      "  3400930195741 | SUNOSI 75 MG CPR PEL 28\n",
      "  3400930195789 | SUNOSI 150 MG CPR PEL 28\n",
      "  3400930195888 | DASATINIB TVS 50 MG CPR 60\n",
      "  3400930195932 | DASATINIB TVS 70 MG CPR 60\n",
      "  3400930196199 | DASATINIB TVS 100 MG CPR 30\n",
      "  3400930196588 | ATORVASTATINE CRP 10MG CPR 30\n",
      "  3400930196632 | ATORVASTATINE CRP 10MG CPR 90\n",
      "  3400930197011 | ATORVASTATINE CRP 20MG CPR 30\n",
      "  3400930197059 | ATORVASTATINE CRP 20MG CPR 90\n",
      "  3400930197455 | ATORVASTATINE CRP 40MG CPR 30\n",
      "  3400930197493 | ATORVASTATINE CRP 40MG CPR 90\n",
      "  3400930197875 | ATORVASTATINE CRP 80MG CPR 30\n",
      "  3400930197912 | ATORVASTATINE CRP 80MG CPR 90\n",
      "  3400930198209 | TERROSA 20MCG/80MCL INJ CART 1\n",
      "  3400930198223 | TERROSA 20MCG/80MCL INJ CART+STYLO\n",
      "  3400930198285 | BRINZOLAMIDE/TIM EG 10/5MG /ML COLL 1\n",
      "  3400930198667 | EMTRICITABIN TENOF ARW 200/245MG CPR 30\n",
      "  3400930198704 | EFAVIR/EMTR/TENO ARW 600/200/245 CPR 30\n",
      "  3400930198728 | ENDOVELA 2MG CPR 28\n",
      "  3400930198995 | VINORELBINE PFB 20MG CAPSULE MOLLE 1\n",
      "  3400930199008 | VINORELBINE PFB 30MG CAPSULE MOLLE 1\n",
      "  3400930199138 | ZYMAD 50000UI SOL BUV AMP 2\n",
      "  3400930199152 | DOTAREM 0,5MMOL/ML INJ SP PP 15ML 1\n",
      "  3400930199176 | DOTAREM 0,5MMOL/ML INJ SP20ML 1\n",
      "  3400930199190 | DUPIXENT 300MG SOL INJ STYLO 2ML 2\n",
      "  3400930199275 | NEBIVOLOL TVA 5MG CPR 30\n",
      "  3400930199282 | NEBIVOLOL TVA 5MG CPR 90\n",
      "  3400930199305 | BRINZOLAMIDE/TIM MYL 10/5MG /ML COLL 1\n",
      "  3400930199336 | REMSIMA 120MG SOL INJ SER 1\n",
      "  3400930199343 | REMSIMA 120MG SOL INJ SER 2\n",
      "  3400930199350 | REMSIMA 120MG SOL INJ STYLO 1\n",
      "  3400930199367 | REMSIMA 120MG SOL INJ STYLO 2\n",
      "  3400930199374 | GADOVISTAUTO 1MMOL/ML INJ SER 7,5ML 1\n",
      "  3400930199381 | GADOVISTAUTO 1MMOL/ML INJ SER 10ML 1\n",
      "  3400930199404 | GADOVISTAUTO 1MMOL/ML INJ SER 15ML 1\n",
      "  3400930199527 | BISOPROLOL VIATRIS SANTE 10MG CPR 30\n",
      "  3400930199534 | BISOPROLOL VIATRIS SANTE 10MG CPR 90\n",
      "  3400930199640 | RENVELA 0,8 G, PDR SUSP BUV 90\n",
      "  3400930199671 | ENOXAPARINE ARROW 2000UI/0.2ML SER 6\n",
      "  3400930199718 | ENOXAPARINE ARW 4000UI/0,4ML INJ SER 2\n",
      "  3400930199725 | ENOXAPARINE ARW 4000UI/0,4ML INJ SER 6\n",
      "  3400930199879 | FIVASA 1600 MG CPR GR 60\n",
      "  3400930199893 | XELJANZ 11MG CPR LP 28\n",
      "  3400930199947 | RESINSODIUM 400G PDR ORALE/RECTALE 1\n",
      "  3400930200001 | SUNITINIB BGR 12,5 MG GELULE 28\n",
      "  3400930200049 | SUNITINIB BGR 25 MG GELULE 28\n",
      "  3400930200070 | SUNITINIB BGR 37,5 MG GELULE 28\n",
      "  3400930200100 | SUNITINIB BIOGARAN 50 MG, GELULE 28\n",
      "  3400930200193 | JORVEZA 1 MG CPR ORO 90\n",
      "  3400930200544 | THYROFIX 125MICROG CPR 100\n",
      "  3400930200582 | THYROFIX 150MICROG CPR 100\n",
      "  3400930200629 | THYROFIX 175MICROG CPR 100\n",
      "  3400930200650 | THYROFIX 200MICROG CPR 100\n",
      "  3400930200681 | THYROFIX 13MICROG CPR 100\n",
      "  3400930200711 | THYROFIX 62MICROG CPR 100\n",
      "  3400930200742 | THYROFIX 88MICROG CPR 100\n",
      "  3400930200773 | THYROFIX 112MICROG CPR 100\n",
      "  3400930200810 | THYROFIX 137MICROG CPR 100\n",
      "  3400930200971 | ACIDE URSODESOXYCHOLIQUE ARW500MG CP 60\n",
      "  3400930201343 | ENOXAPARINE VEP 10000UI/1ML INJ SER 10\n",
      "  3400930201428 | ENOXAPARINE ARW 8000UI/0,8ML INJ SER 2\n",
      "  3400930201459 | ENOXAPARINE ARW 8000UI/0,8ML INJ SER 10\n",
      "  3400930201749 | ENOXAPARINE ARROW 6000UI SER 2\n",
      "  3400930201763 | ENOXAPARINE ARROW 6000UI SER 10\n",
      "  3400930201824 | TIXOCORTOL ARROW 1% SUSP NASALE 1\n",
      "  3400930201848 | MONTELUKAST VIATRIS 10MG CPR 28\n",
      "  3400930201992 | COMTAN 200MG CPR 100\n",
      "  3400930202029 | CEGFILA 6 MG SER SOL INJ SERINGUE 1\n",
      "  3400930202074 | VYNDAQEL 61 MG CAPSULE MOLLE 30\n",
      "  3400930202326 | BUDESONIDE ZEN 0,5MG/2ML INH 20\n",
      "  3400930202340 | BUDESONIDE ZEN 1MG/2ML SUSP INH 20\n",
      "  3400930202524 | APOKINON 100 MG/20 ML SOL INJ CART 5\n",
      "  3400930202593 | URAPIDIL BGA LP 30MG GELULE 30\n",
      "  3400930202777 | AZITHROMYCINE ZEN 250MG CPR 6\n",
      "  3400930203231 | AMLODIPINE/VALSART ZYD 5MG/80MG CPR 30\n",
      "  3400930203255 | AMLODIPINE/VALSART ZYD 5MG/80MG CPR 90\n",
      "  3400930203316 | AMLODIPINE/VALSART ZYD 5MG/160MG CPR 30\n",
      "  3400930203330 | AMLODIPINE/VALSART ZYD 5MG/160MG CPR 90\n",
      "  3400930203408 | AMLODIPINE/VALSART ZYD 10MG/160MG CP 30\n",
      "  3400930203422 | AMLODIPINE/VALSART ZYD 10MG/160MG CP 90\n",
      "  3400930203545 | NUBEQA 300MG CPR 112\n",
      "  3400930203569 | TILLHEPO 500 MG GELULE 100\n",
      "  3400930203675 | KETOCONAZOLE ZEN 2% CREME 1\n",
      "  3400930203705 | KETOCONAZOLE TEVA 2% CREME 1\n",
      "  3400930203736 | ACIDE URSODESOXYCH MYL 500MG CPR SEC 60\n",
      "  3400930203750 | AC URSODESOXYCHOLIQUE BGA 500MG CPR 60\n",
      "  3400930203767 | AC URSODESOXYCHOLIQUE TEVA 500MG CPR 60\n",
      "  3400930203910 | PHOLCODINE BGA 131MG/100ML SIROP 200 1\n",
      "  3400930203927 | LYUMJEV 100 UI/ML SOL INJ FL 1\n",
      "  3400930203965 | LYUMJEV 300UI KWIKPEN CART 5\n",
      "  3400930204009 | LYUMJEV 300UI KWIKPEN JUNIOR STYLO 5\n",
      "  3400930204023 | LYUMJEV 200 UI KWIKPEN SOL INJ STYLO 5\n",
      "  3400930204108 | DICLOFENAC EG 1% GEL 50G 1\n",
      "  3400930204382 | SITAGLIPTINE HCS 100 MG CPR PEL 28\n",
      "  3400930204412 | SITAGLIPTINE HCS 50 MG CPR 28\n",
      "  3400930204818 | CINACALCET ACP 30MG CPR 28\n",
      "  3400930204825 | CINACALCET ACP 60MG CPR 28\n",
      "  3400930204832 | CINACALCET ACP 90MG CPR 28\n",
      "  3400930204870 | KLIPAL 300/25MG CPR 16\n",
      "  3400930204887 | KLIPAL 600G/50MG CPR 12\n",
      "  3400930205198 | ANAGRELIDE ZEN 0,5MG GELULE 100\n",
      "  3400930205266 | TOLVAPTAN TEVA 15 MG / 45 MG CPR 56\n",
      "  3400930205273 | TOLVAPTAN TEVA 30 MG / 60 MG CPR 56\n",
      "  3400930205280 | TOLVAPTAN TEVA 30 MG / 90 MG CPR 56\n",
      "  3400930205303 | CLOPIDOGREL ALP 75 MG CPR 30\n",
      "  3400930205365 | OSELTAMIVIR VIVANTA 75 MG GELULE 10\n",
      "  3400930205372 | EFLUELDA SUSP INJ SER SS AIG 1\n",
      "  3400930205402 | EFLUELDA SUSP INJ SER AVEC AIG 1\n",
      "  3400930205594 | ULTRAVIST 300 SOL INJ FV100ML MED C 1\n",
      "  3400930205600 | ULTRAVIST 300 SOL INJ FV150ML MED C 1\n",
      "  3400930205617 | ULTRAVIST 37 G SOL INJ MED CENT 1\n",
      "  3400930205624 | ULTRAVIST 55.5 G SOL INJ MED CENT 1\n",
      "  3400930205631 | FLUCONAZOLE ARL 50MG GELULE 7\n",
      "  3400930205686 | FLUCONAZOLE ARL 100MG GELULE 7\n",
      "  3400930205730 | FLUCONAZOLE ARL 200MG GELULE 7\n",
      "  3400930205808 | FLUCONAZOLE ARL 150MG GELULE 1\n",
      "  3400930205822 | FLUCONAZOLE ARL 150MG GELULE 4\n",
      "  3400930205853 | TRAVOPROST/TIMO ARW 40MCG/5MG COLLYR 1\n",
      "  3400930205884 | FENTANYL SDZ 100MICROG CPR SUBLING 10\n",
      "  3400930205891 | FENTANYL SDZ 100MICROG CPR SUBLING 30\n",
      "  3400930205907 | FENTANYL SDZ 200MICROG CPR SUBLING 10\n",
      "  3400930205914 | FENTANYL SDZ 200MICROG CPR SUBLING 30\n",
      "  3400930205938 | FENTANYL SDZ 300MICROG CPR SUBLING 30\n",
      "  3400930205969 | FENTANYL SDZ 400MICROG CPR SUBLING 30\n",
      "  3400930205976 | FENTANYL SDZ 600MICROG CPR SUBLING 30\n",
      "  3400930206164 | DOTAREM 0,5 MMOL/ML INJ SER 15ML+CAT 1\n",
      "  3400930206171 | DOTAREM 0,5 MMOL/ML INJ SER 20ML+CAT 1\n",
      "  3400930206188 | DOTAREM 0,5 MMOL/ML INJ SER 15ML+ADM 1\n",
      "  3400930206195 | DOTAREM 0,5MMOL/ML SOL INJ SER + OPE 1\n",
      "  3400930206232 | INNOVAIR NEXTHALER 100/6 MCG INH 120 3\n",
      "  3400930206379 | SEVELAMER CARB BGA 2,4G PDR ORALE 90\n",
      "  3400930206423 | CLOBETASOL SBP 500 MICROG/G SHAMP 1\n",
      "  3400930206454 | MIDAZOLAM VIATRIS 5 MG INJ AMP 10\n",
      "  3400930206461 | MIDAZOLAM VIATRIS 5 MG SOL INJ AMP 10\n",
      "  3400930206478 | MIDAZOLAM VIATRIS 50 MG INJ AMP 10\n",
      "  3400930207420 | CICLOPIROX OLAMINE MYL 1% CREME 1\n",
      "  3400930207659 | APREXEVO 150 MG/5MG CPR 30\n",
      "  3400930207666 | APREXEVO 150 MG/5MG CPR 90\n",
      "  3400930207673 | APREXEVO 150 MG/10MG CPR 30\n",
      "  3400930207680 | APREXEVO 150 MG/10MG CPR 90\n",
      "  3400930207697 | APREXEVO 300 MG/5MG CPR 30\n",
      "  3400930207703 | APREXEVO 300 MG/5MG CPR 90\n",
      "  3400930207710 | APREXEVO 300 MG/10MG CPR 30\n",
      "  3400930207727 | APREXEVO 300 MG/10MG CPR 90\n",
      "  3400930207741 | ATECTURA BZL 125MCG/62,5MCG GELULE 30\n",
      "  3400930207772 | ATECTURA BZL 125MCG/127,5MCG GELULE 30\n",
      "  3400930207796 | ATECTURA BZL 125MCG/260MCG GELULE 30\n",
      "  3400930207802 | TAVLESSE 100 MG CPR PEL 60\n",
      "  3400930207819 | TAVLESSE 150 MG CPR PEL 60\n",
      "  3400930208229 | CALCIFEDIOL GERDA 0,15MG/ML SOL BUV 1\n",
      "  3400930208458 | RACECADOTRIL ARROW 100MG GELULE 20\n",
      "  3400930208502 | TIXOCORTOL VIATRIS1% SUSP NASALE 1\n",
      "  3400930208519 | REVINTY ELLIPTA 92/22MICROG INH U 90\n",
      "  3400930208526 | REVINTY ELLIPTA 184/22MICROG INH U 90\n",
      "  3400930208533 | RELVAR ELLIPTA 92/22 MICROG PDR INH 90\n",
      "  3400930208540 | RELVAR ELLIPTA 184/22 MICROG PDR INH 90\n",
      "  3400930208557 | ANORO ELLIPTA 55MCG/22MCG PDR INH 90\n",
      "  3400930208564 | LAVENTAIR 55MCG/22MCG PDR INH UNIDO 90\n",
      "  3400930208571 | DEFERASIROX ZEN 90 MG CPR 30\n",
      "  3400930208601 | DEFERASIROX ZEN 180 MG CPR 30\n",
      "  3400930208625 | DEFERASIROX ZEN 360 MG CPR 30\n",
      "  3400930208663 | ENTYVIO 108 MG SOL INJ SER 2\n",
      "  3400930208687 | ENTYVIO 108 MG SOL INJ STYLO 2\n",
      "  3400930208793 | SODIUM ALGI/BICAR ARL BUV SACH 24\n",
      "  3400930208854 | ASPIRINE ARW 100MG CPR GR 30\n",
      "  3400930208861 | FIASP PUMPCART 100U/ML SOL INJ CART 5\n",
      "  3400930208892 | ENERZAIR BRZ 114MCG/46MCG/136MCG PDR 30\n",
      "  3400930208908 | ENERZAIR BRZ 114MCG/46MCG/136MCG PDR 30\n",
      "  3400930208939 | PRASUGREL EGL 10 MG CPR 30\n",
      "  3400930208977 | REPAGLINIDE VIATRIS 0,5MG CPR 90\n",
      "  3400930208984 | REPAGLINIDE VIATRIS 1MG CPR 90\n",
      "  3400930208991 | REPAGLINIDE VIATRIS 2MG CPR 90\n",
      "  3400930209240 | TENOFOVIR DISOPROXIL ACC 245 MG CPR 30\n",
      "  3400930209400 | SYMBICORT RAPIHALER 100/3 MICROG 1\n",
      "  3400930209424 | PERINDOPRIL CRT 5 MG CPR 90\n",
      "  3400930209431 | PERINDOPRIL CRT 2,5 MG CPR 90\n",
      "  3400930209455 | SORAFENIB SDZ 200MG CPR 112\n",
      "  3400930209790 | INNOVAIR NEXT 200/6 MICROG PDR INH 3\n",
      "  3400930210178 | TELMISARTAN/AMLO 40MG/5MG CPR 30\n",
      "  3400930210185 | TELMISARTAN/AMLO ARW 40MG/10MG CPR 30\n",
      "  3400930210192 | TELMISARTAN/AMLO ARW 80MG/5MG CPR 30\n",
      "  3400930210215 | TELMISARTAN /AML ARW 80MG/10MG CPR 30\n",
      "  3400930210338 | FULVESTRANT BGA 250 MG SOL INJ 1\n",
      "  3400930210352 | SORAFENIB ZENTIVA 200MG CPR 112\n",
      "  3400930210369 | EUCREAS 50 MG/1000 MG CPR 60\n",
      "  3400930210741 | TRELEGY ELLIPTA 92/55/22 MCG PDR INH 90\n",
      "  3400930210758 | ELEBRATO ELLIPTA92/55/22 MCG PDR INH 90\n",
      "  3400930210963 | ATORVASTATINE EVOLUGEN 10MG CPR 30\n",
      "  3400930210987 | ATORVASTATINE EVOLUGEN 10MG CPR 90\n",
      "  3400930211014 | ATORVASTATINE EVOLUGEN 20MG CPR 30\n",
      "  3400930211045 | ATORVASTATINE EVOLUGEN 20MG CPR 90\n",
      "  3400930211076 | ATORVASTATINE EVOLUGEN 40MG CPR 30\n",
      "  3400930211090 | ATORVASTATINE EVOLUGEN 40MG CPR 90\n",
      "  3400930211120 | ATORVASTATINE EVOLUGEN 80MG CPR 30\n",
      "  3400930211137 | ATORVASTATINE EVOLUGEN 80MG CPR 90\n",
      "  3400930211274 | DIMETRUM 2MG CPR 84\n",
      "  3400930211380 | KAFTRIO 100/50/75MG CPR 56\n",
      "  3400930211595 | SPIRONOLACTONE VIATRIS 25MG CPR 30\n",
      "  3400930211762 | RASAGILINE ALTER 1MG CPR 30\n",
      "  3400930212028 | INSULINE ASP SANO 100U/ML CART 3ML 5\n",
      "  3400930212042 | INSULINE ASPART SAN100U S3ML STYLO 5 5\n",
      "  3400930212059 | SORAFENIB MYLAN 200MG CPR 112\n",
      "  3400930212141 | REBLOZYL 25 MG PDR INJ FL 1\n",
      "  3400930212172 | REBLOZYL 75 MG PDR INJ FL 1\n",
      "  3400930212240 | NEPEXTO 25 MG SOL INJ SER 4\n",
      "  3400930212257 | NEPEXTO 50 MG SOL INJ SER 4\n",
      "  3400930212264 | NEPEXTO 50 MG SOL INJ STYLO 4\n",
      "  3400930212271 | LIVOGIVA 20MICROG/80 MCL INJ STYLO 1\n",
      "  3400930212349 | AMLODIPINE/VALSARTAN ACC 5/160MG CPR 30\n",
      "  3400930212363 | AMLODIPINE/VALSAT ACC 10 /160 MG CPR 30\n",
      "  3400930212370 | AMLODIPINE/VALSAT ACC 10 /160 MG CPR 90\n",
      "  3400930212547 | DIVALCOTE 250MG CPR GASTRO R 30\n",
      "  3400930212578 | DIVALCOTE 500MG CPR GASTRO R 90\n",
      "  3400930212585 | LAMIVUDINE TBV 150MG CPR 60\n",
      "  3400930212592 | LAMIVUDINE TVP 300MG CPR 30\n",
      "  3400930212608 | TAKHZYRO 300 MG, SOL INJ SER 2 ML 1\n",
      "  3400930212653 | GONAL F 150 UI/0.25ML SOL INJ STYLO 1\n",
      "  3400930212691 | FLUCONAZOLE ARL 200MG GELULE 30\n",
      "  3400930212745 | RESELIP 10 MG/10 MG CPR 30\n",
      "  3400930212752 | RESELIP 10 MG/10 MG CPR 90\n",
      "  3400930212769 | RESELIP 10 MG/20 MG CPR 30\n",
      "  3400930212776 | RESELIP 10 MG/20 MG CPR 90\n",
      "  3400930212783 | RESELIP 10 MG/40 MG CPR 30\n",
      "  3400930212790 | RESELIP 10 MG/40 MG CPR 90\n",
      "  3400930212806 | RESELIP 10 MG/80 MG CPR 30\n",
      "  3400930212813 | RESELIP 10 MG/80 MG CPR 90\n",
      "  3400930212820 | CELIPROLOL VIATRIS 200MG CPR 28\n",
      "  3400930213254 | PREGABALINE ALT 25 MG GELULE 56\n",
      "  3400930213261 | PREGABALINE ALT 25 MG GELULE 84\n",
      "  3400930213292 | DEFERASIROX TEVA 90 MG CPR PEL 30\n",
      "  3400930213315 | DEFERASIROX TEVA 360 MG CPR PEL 30\n",
      "  3400930213346 | DEFERASIROX TEVA 180 MG CPR PEL 30\n",
      "  3400930213520 | TERIPARATIDE BGA 20MICROG/80 MCL INJ 1\n",
      "  3400930213674 | LACOSAMIDE ZENTIVA 50 MG CPR 56\n",
      "  3400930213698 | LACOSAMIDE ZENTIVA 100 MG CPR 56\n",
      "  3400930213711 | LACOSAMIDE ZENTIVA 150 MG CPR 56\n",
      "  3400930213735 | LACOSAMIDE ZENTIVA 200 MG CPR 56\n",
      "  3400930213766 | FULVESTRANT ZEN 250 MG SOL INJ SER 1 1\n",
      "  3400930213865 | ACIDE FOLIQUE VIATRIS 5MG CPR 20\n",
      "  3400930214060 | L-THYROXIN HENNING 63MCG CPR SEC 100\n",
      "  3400930214077 | L-THYROXIN HENNING 88MCG CPR SEC 100\n",
      "  3400930214084 | L-THYROXIN HENNING 112MCG CPR SEC 100\n",
      "  3400930214107 | L-THYROXIN HENNING 137MICROG CPR 100\n",
      "  3400930214732 | EPCLUSA 200MG/50MG CPR PELL 28\n",
      "  3400930215210 | JYSELECA 100 MG, COMPRIME PELLICULE 30\n",
      "  3400930215227 | JYSELECA 200 MG, COMPRIME PELLICULE 30\n",
      "  3400930215296 | SABANLEVA 250MG CPR 60\n",
      "  3400930215357 | SABANLEVA 500MG CPR 60\n",
      "  3400930215418 | SABANLEVA 1000MG CPR 60\n",
      "  3400930215616 | PRALUENT 300MG SOL INJ STYLO 1\n",
      "  3400930215623 | PRASUGREL BGR 10 MG CPR 30\n",
      "  3400930216279 | NYVEPRIA 6 MG, SOL INJ SER 1\n",
      "  3400930216316 | GIVLAARI 189MG/ML INJ FL1ML 1\n",
      "  3400930216323 | AMSPARITY 40 MG SOL INJ SER + TAMP 1\n",
      "  3400930216330 | AMSPARITY 40 MG SOL INJ STYLO + TAMP 1\n",
      "  3400930216361 | COSENTYX 300 MG SOL INJ SER 1\n",
      "  3400930216378 | COSENTYX 300 MG INJ STYLO 1\n",
      "  3400930216453 | TRULICITY 3 MG SOL INJ STYLO 4\n",
      "  3400930216484 | TRULICITY 4,5 MG SOL INJ STYLO 4\n",
      "  3400930216996 | BIMATOP/TIMOL ZEN 0,3/5MG/ML COLLYRE 1\n",
      "  3400930217054 | FOSINOPRIL ARL 10MG CPR 90\n",
      "  3400930217078 | FOSINOPRIL ARL 20MG CPR 90\n",
      "  3400930217191 | LETROZOLE ARL 2,5MG CPR 30\n",
      "  3400930217412 | CHIBRO CADRON COLLYRE FL 5ML 1\n",
      "  3400930217481 | BACTRIM 40 MG/ML + 8 MG/ML, SUSP BUV 1\n",
      "  3400930217726 | LAMIVUDINE ARW 100MG CPR 28\n",
      "  3400930218174 | DULOXETINE ZEN 30 MG GELULE 7\n",
      "  3400930218198 | DULOXETINE ZEN 30 MG GELULE 28\n",
      "  3400930218211 | DULOXETINE ZEN 60 MG GELULE 28\n",
      "  3400930218327 | TRAVOPROST MYL 40 MCG/ML COLLYRE 1\n",
      "  3400930218365 | PERINDOPRIL AMLO ARW 4/5MG CPR 30\n",
      "  3400930218372 | PERINDOPRIL AMLO ARW 4/5MG CPR 90\n",
      "  3400930218402 | PERINDOPRIL AMLO ARW 4/10 CPR 30\n",
      "  3400930218419 | PERINDOPRIL AMLO ARW 4/10 CPR 90\n",
      "  3400930218464 | PERINDOPRIL AMLO ARW 8/5MG CPR 30\n",
      "  3400930218488 | PERINDOPRIL AMLO ARW 8/5MG CPR 90\n",
      "  3400930218495 | PERINDOPRIL AMLO ARW 8/10MG CPR 30\n",
      "  3400930218501 | PERINDOPRIL AMLO ARW 8/10MG CPR 90\n",
      "  3400930218525 | TAMSULOSINE ARW LP 0,4MG CPR 30\n",
      "  3400930218655 | IBUPROFENE ARL 200MG CPR ENR 30\n",
      "  3400930218747 | ANASTROZOLE ARL 1MG CPR PEL 90\n",
      "  3400930218808 | DEXAMETHASONE VTS 4MG SOL INJ 5\n",
      "  3400930219270 | FINGOLIMOD ZEN 0,5MG GELULE 28\n",
      "  3400930219300 | TRIXEO AEROSPHERE 5/7.2MCG INH 120 D 120\n",
      "  3400930219393 | SAWIS 2MG CPR 84\n",
      "  3400930219447 | LOSARTAN ZTL 100MG CPR 84\n",
      "  3400930219492 | LOSARTAN ZTL 50MG CPR 84\n",
      "  3400930219560 | PLEGRIDY 125 MCG SOL INJ SER 2\n",
      "  3400930219584 | SORAFENIB TVS 200MG CPR 112\n",
      "  3400930219669 | PROHANCE 4748,1MG SOL INJ SER NEC 2 1\n",
      "  3400930219676 | KETAZED 0,25 MG/ML COLLYRE FL 10ML 1\n",
      "  3400930219690 | DASATINIB BGA 20 MG CPR 60\n",
      "  3400930219737 | DASATINIB BGA 50MG CPR 60\n",
      "  3400930219768 | DASATINIB BGA 70 MG CPR 60\n",
      "  3400930219799 | DASATINIB BGA 100 MG CPR 30\n",
      "  3400930219829 | DASATINIB BIOGARAN 140 MG, COMPRIME 30\n",
      "  3400930219850 | XARELTO 1 MG/ML GLES SUSP BUV 100ML 1\n",
      "  3400930219867 | XARELTO 1 MG/ML GLES SUSP BUV 250ML 1\n",
      "  3400930219874 | REKAMBYS 900 MG SUSP INJ LP 1\n",
      "  3400930219898 | VOCABRIA 30 MG CPR PEL 30\n",
      "  3400930219904 | VOCABRIA 600 MG SUSP INJ LP 1\n",
      "  3400930219911 | AMOXICILLINE EGL 500MG GELULE 12\n",
      "  3400930219973 | DOTAREM 0,5MMOL/ML INJ SER DISP 1\n",
      "  3400930219980 | DOTAREM 0,5MMOL/ML SOL SER DISP 1\n",
      "  3400930219997 | ZYMAD 50000UI SOL BUV AMP 4\n",
      "  3400930220122 | FENTANYL BIOGARAN 100MCG CPR SUB 10\n",
      "  3400930220139 | FENTANYL BIOGARAN 100MCG CPR SUB 30\n",
      "  3400930220146 | FENTANYL BIOGARAN 200MCG CPR SUB 10\n",
      "  3400930220153 | FENTANYL BIOGARAN 200MCG CPR SUB 30\n",
      "  3400930220160 | FENTANYL BIOGARAN 300MCG CPR SUB 10\n",
      "  3400930220177 | FENTANYL BIOGARAN 300MCG CPR SUB 30\n",
      "  3400930220184 | FENTANYL BIOGARAN 400MCG CPR SUB 10\n",
      "  3400930220207 | FENTANYL BIOGARAN 400MCG CPR SUB 30\n",
      "  3400930220238 | FENTANYL BGA 600MICROG CPR SUBLING 30\n",
      "  3400930220245 | FENTANYL BGA 800MICROG CPR SUBLING 30\n",
      "  3400930220269 | KALYDECO 75MG CPR 28\n",
      "  3400930220276 | SYMKEVI 50MG/75MG CPR 28\n",
      "  3400930220290 | RUKOBIA 600 MG LP CPR 60\n",
      "  3400930220306 | TIVICAY 5 MG, COMPRIME DISPERSIBLE 60\n",
      "  3400930220368 | LANTHANE MYLAN 500 MG CPR CROQUER 90\n",
      "  3400930220375 | ADONTEX 0,12 % BAIN DE BOUCHE 300ML 1\n",
      "  3400930220399 | LANTHANE MYLAN 750 MG CPR CROQUER 90\n",
      "  3400930220863 | ENDOVELA 2MG CPR 84\n",
      "  3400930220870 | LOSARTAN VIATRIS 50MG CPR 28\n",
      "  3400930221198 | GIBITER EASYHALER 320/9MCG INH 60D 180\n",
      "  3400930221228 | GIBITER EASY 160/4,5 MCG INH 120D 360\n",
      "  3400930221310 | LANTHANE MYLAN 1000MG CPR CROQUER 90\n",
      "  3400930221532 | SIMVASTATINE MYL 10MG CPR 28\n",
      "  3400930221563 | FLUTICASO/SALM EG 100/50MCG INH 60 60\n",
      "  3400930221594 | FLUTICASO/SALM EG 250/50MCG INH 60 60\n",
      "  3400930221624 | FLUTICASO/SALM EG 500/50MCG INH 60 60\n",
      "  3400930221907 | TARDYFERON 80MG CPR 90\n",
      "  3400930222133 | NEVIRAPINE ARW 400MG CPR LP 30\n",
      "  3400930222461 | AC GADOTERIQUE GEB 0,5MMOL/ML SER 20 1\n",
      "  3400930222539 | SUNITINIB ZENTIVA 12,5 MG, GELULE 28\n",
      "  3400930222584 | SUNITINIB ZEN 25 MG GELULE 28\n",
      "  3400930222676 | SUNITINIB ZEN 50 MG GELULE 28\n",
      "  3400930222713 | TELMISARTAN/AMLO 40MG/5MG CPR 90\n",
      "  3400930222720 | TELMISARTAN/AMLO ARW 40MG/10MG CPR 90\n",
      "  3400930222737 | TELMISARTAN/AMLO ARW 80MG/5MG CPR 90\n",
      "  3400930222744 | TELMISARTAN /AML ARW 80MG/10MG CPR 90\n",
      "  3400930222751 | FLUTICASO/SALM ARA 100/50MCG INH 60 60\n",
      "  3400930222768 | FLUTICASO/SALM ARA 250/50MCG INH 60 60\n",
      "  3400930222775 | FLUTICASO/SALM ARA 500/50MCG INH 60 60\n",
      "  3400930222867 | SORAFENIB MEDIPHA 200 MG CPR PELL 112\n",
      "  3400930222911 | FLUTICASO/SALM ZEN 100/50 MICROG 60 60\n",
      "  3400930222942 | FLUTICASONE/SALM ZEN 250/50MCG PDR60 60\n",
      "  3400930222973 | FLUTICASO/SALM ZEN 500/50 MICROG 60 60\n",
      "  3400930223703 | PEMAZYRE 9 MG CPR 14\n",
      "  3400930223710 | PEMAZYRE 13,5MG CPR 14\n",
      "  3400930223789 | CONFEROPORT LP 0,5 MG GELULE 30\n",
      "  3400930223802 | CONFEROPORT LP 1 MG, GELULE 30\n",
      "  3400930223826 | CONFEROPORT LP 2 MG GELULE 30\n",
      "  3400930223840 | CONFEROPORT LP 3 MG GELULE 30\n",
      "  3400930223864 | CONFEROPORT LP 5 MG GELULE 30\n",
      "  3400930224021 | FINGOLIMOD TEVA 0,25MG GELULE 30\n",
      "  3400930224038 | FINGOLIMOD TEVA 0,5MG GELULE 30\n",
      "  3400930224311 | DOSTINEX 0,5MG CPR 2\n",
      "  3400930224342 | DOSTINEX 0,5MG CPR 8\n",
      "  3400930224571 | ENALAPRIL/LER EG 20MG/20MG CPR 30\n",
      "  3400930224601 | ENALAPRIL/LER EG 20MG/20MG CPR 90\n",
      "  3400930224618 | ATORVASTATINE BGA 10 MG CPR 30\n",
      "  3400930224632 | ATORVASTATINE BGA 20 MG CPR 30\n",
      "  3400930224649 | ATORVASTATINE BGA 40MG CPR 30\n",
      "  3400930224687 | TRIMBOW 88/5/9 MCG PDR INH 120 D 120\n",
      "  3400930224755 | EZETIMIBE VTS 10MG CPR 30\n",
      "  3400930224762 | EZETIMIBE VTS 10MG CPR 90\n",
      "  3400930224816 | CLOPIDOGREL BGA 75MG CPR PEL 30\n",
      "  3400930225257 | BISOPROLOL ZENTIVA K.S 1,25 MG CPR 30\n",
      "  3400930225271 | BISOPROLOL ZENTIVA K.S 1,25 MG CPR 90\n",
      "  3400930225431 | BISOPROLOL ZENTIVA K.S 2,5 MG CPR 90\n",
      "  3400930225509 | BISOPROLOL ZENTIVA K.S 3,75 MG CPR 30\n",
      "  3400930225721 | BISOPROLOL ZENTIVA K.S 7,5 MG CPR 30\n",
      "  3400930226308 | ENALAPRIL/LER ARW 20MG/20MG CPR 30\n",
      "  3400930226315 | ENALAPRIL/LER ARW 20MG/20MG CPR 90\n",
      "  3400930226377 | YUFLYMA 40 MG SOL INJ SER 1\n",
      "  3400930226384 | YUFLYMA 40 MG SOL INJ SER 2\n",
      "  3400930226391 | YUFLYMA 40 MG SOL INJ SER 4\n",
      "  3400930226421 | YUFLYMA 40 MG SOL INJ STYLO 1\n",
      "  3400930226438 | YUFLYMA 40 MG SOL INJ STYLO 2\n",
      "  3400930226445 | YUFLYMA 40 MG SOL INJ STYLO 4\n",
      "  3400930226452 | YUFLYMA 40 MG SOL INJ STYLO 6\n",
      "  3400930226513 | DEFERASIROX SDZ 90 MG CPR 30\n",
      "  3400930226537 | DEFERASIROX SDZ 180 MG CPR 30\n",
      "  3400930226551 | DEFERASIROX SDZ 360 MG CPR 30\n",
      "  3400930226704 | ROPINIROLE ARG 0,25MG CPR 21\n",
      "  3400930226711 | ROPINIROLE ARG 0,50MG CPR 21\n",
      "  3400930226728 | ROPINIROLE ARG 1MG CPR 21\n",
      "  3400930226735 | ROPINIROLE ARG 2MG CPR 21\n",
      "  3400930226759 | VALGANCICLOVIR TVS 450MG CPR 60\n",
      "  3400930226766 | SIMVASTATINE MYP 10 MG CPR 28\n",
      "  3400930226872 | SIMVASTATINE MYP 20 MG CPR 28\n",
      "  3400930226919 | SIMVASTATINE MYP 20 MG CPR 84\n",
      "  3400930226940 | SIMVASTATINE MYP 20 MG CPR 28\n",
      "  3400930226971 | KESIMPTA 20 MG SOL INJ STYLO 1\n",
      "  3400930227022 | SIMVASTATINE MYLAN PHARMA 40 MG CPR 28\n",
      "  3400930227053 | SIMVASTATINE MYLAN PHARMA 40 MG CPR 84\n",
      "  3400930227121 | ENALAPRIL/LER ZEN 20MG/20MG CP 30\n",
      "  3400930227145 | ENALAPRIL/LER ZEN 20MG/20MG CP 90\n",
      "  3400930227152 | AC ZOLEDRONIQUE BGA 4MG POC100ML 1\n",
      "  3400930227190 | CLOZAPINE ZEN 25 MG CPR 28\n",
      "  3400930227220 | CLOZAPINE ZEN 100MG CPR 14\n",
      "  3400930227244 | CLOZAPINE ZEN 100MG CPR 28\n",
      "  3400930227305 | BISOPROLOL REF 1,25 MG CPR 30\n",
      "  3400930227312 | BISOPROLOL REF 1,25 MG CPR 90\n",
      "  3400930227336 | BISOPROLOL REF 2,5 MG CPR SEC 30\n",
      "  3400930227343 | BISOPROLOL REF 2,5 MG CPR SEC 90\n",
      "  3400930227367 | BISOPROLOL REF 3,75 MG CPR 30\n",
      "  3400930227381 | ORLADEYO 150MG GELULE 28\n",
      "  3400930227398 | BISOPROLOL REF 5 MG CPR 30\n",
      "  3400930227404 | BISOPROLOL REF 5 MG CPR 90\n",
      "  3400930227428 | BISOPROLOL REF 7,5 MG CPR 30\n",
      "  3400930227442 | BISOPROLOL REF 10 MG CPR 30\n",
      "  3400930227459 | BISOPROLOL REF 10 MG CPR 90\n",
      "  3400930227534 | FESOTERODINE BGA LP 4 MG CPR 30\n",
      "  3400930227565 | FESOTERODINE BGA LP 8 MG CPR 30\n",
      "  3400930227596 | FESOTERODINE ZEN LP 4 MG CPR 30\n",
      "  3400930227626 | FESOTERODINE ZEN LP 8 MG CPR 30\n",
      "  3400930227725 | FESOTERODINE EG LP 4 MG CPR 30\n",
      "  3400930227824 | FESOTERODINE EG LP 8 MG CPR 30\n",
      "  3400930227886 | METHYLPHENIDATE ARW LP 10MG GEL 28\n",
      "  3400930227893 | METHYLPHENIDATE ARW LP 20MG GEL 28\n",
      "  3400930227909 | METHYLPHENIDATE ARW LP 30MG GEL 28\n",
      "  3400930227916 | METHYLPHENIDATE ARW LP 40MG GEL 28\n",
      "  3400930227978 | BILASTINE TEVA 20MG CPR 10\n",
      "  3400930227992 | BILASTINE TEVA 20MG CPR 30\n",
      "  3400930228074 | BORAX/AC BORIQUE EG SOL OPH UNIDOSE 20\n",
      "  3400930228111 | BORAX/AC BORIQUE ARW SOL OPH UNIDOSE 20\n",
      "  3400930228142 | SKYRIZI 150MG SOL INJ STYLO 1\n",
      "  3400930228159 | SKYRIZI 150MG SOL INJ SERG 1\n",
      "  3400930228203 | MYRELEZ LP 60 MG SOL INJ 1\n",
      "  3400930228227 | DEFERASIROX ACC 90 MG CPR 30\n",
      "  3400930228319 | DEFERASIROX ACC 360 MG CPR 30\n",
      "  3400930228340 | MYRELEZ LP 90 MG SOL INJ 1\n",
      "  3400930228364 | MYRELEZ LP 120 MG SOL INJ 1\n",
      "  3400930228371 | MIDODRINE VIATRIS 2.5 MG 30\n",
      "  3400930228388 | MIDODRINE VIATRIS 2.5 MG 90\n",
      "  3400930228425 | BIKTARVY 50/200/25MG CPR 30\n",
      "  3400930228432 | BIKTARVY 50/200/25MG CPR 90\n",
      "  3400930228531 | BILASTINE ZEN 20MG CPR 30\n",
      "  3400930229200 | BISOPROLOL NOR 10 MG CPR SEC 30\n",
      "  3400930229255 | BISOPROLOL NOR 10 MG CPR SEC 90\n",
      "  3400930229385 | EVRYSDI 0,75MG/ML SOL BUV FL + SER 1\n",
      "  3400930229620 | LACOSAMIDE ARW 50 MG CPR PEL SEC 56\n",
      "  3400930229637 | LACOSAMIDE ARW 100 MG CPR PEL SEC 56\n",
      "  3400930229644 | LACOSAMIDE ARW 150 MG CPR PEL SEC 56\n",
      "  3400930229651 | LACOSAMIDE ARW 200 MG CPR PEL SEC 56\n",
      "  3400930229750 | RISPERIDONE ZEN 1MG CPR 60\n",
      "  3400930229866 | RISPERIDONE ZEN 2MG CPR 60\n",
      "  3400930229927 | RISPERIDONE ZEN 4MG CPR 30\n",
      "  3400930230039 | ONTOZRY 12,5 + 25 MG CPR 28\n",
      "  3400930230046 | ONTOZRY 50 MG CPR 14\n",
      "  3400930230053 | ONTOZRY 50 MG CPR 28\n",
      "  3400930230060 | ONTOZRY 100MG CPR 14\n",
      "  3400930230084 | ONTOZRY 100MG CPR 28\n",
      "  3400930230091 | ONTOZRY 150 MG CPR 14\n",
      "  3400930230107 | ONTOZRY 150 MG CPR 28\n",
      "  3400930230121 | ONTOZRY 200 MG CPR 14\n",
      "  3400930230145 | ONTOZRY 200 MG CPR 28\n",
      "  3400930230169 | BACLOFENE EG 10MG CPR 30\n",
      "  3400930230213 | ZOPICLONE CRP 7,5MG CPR 14\n",
      "  3400930230268 | ADTRALZA 150 MG SOL INJ SER 4\n",
      "  3400930230329 | FINGOLIMOD BIOGARAN 0,5MG GELULE 28\n",
      "  3400930230398 | ABIRATERONE SDZ 500 MG CPR 60\n",
      "  3400930230497 | VILDAGLIPTINE EG 50 MG, COMPRIME 30\n",
      "  3400930230510 | VILDAGLIPTINE EG 50 MG, COMPRIME 60\n",
      "  3400930230602 | CLOSALIS 50MCG/0.5MG/G GEL T 60G 1\n",
      "  3400930230664 | ONUREG 200MG CPR 7\n",
      "  3400930230671 | ONUREG 300MG CPR PELL 7\n",
      "  3400930231036 | FLUTICASO/SALM BGA 100/50MCG INH 60 60\n",
      "  3400930231043 | FLUTICASO/SALM BGA 250/50MCG INH 60 60\n",
      "  3400930231050 | FLUTICASO/SALM BGA 500/50MCG INH 60 60\n",
      "  3400930231593 | SITAGLIPTINE VIATRIS 50 MG CPR 28\n",
      "  3400930231685 | SITAGLIPTINE VIATRIS 100 MG CPR 28\n",
      "  3400930232071 | ABIRATERONE EG 500 MG CPR 60\n",
      "  3400930232224 | PONVORY 20 MG CPR PEL 28\n",
      "  3400930232231 | PONVORY CPR PACK INITIATION 14\n",
      "  3400930232415 | OZAWADE 4,5 MG CPR PEL 30\n",
      "  3400930232422 | OZAWADE 18 MG CPR PEL 30\n",
      "  3400930232620 | INREBIC 100 MG GELULE 120\n",
      "  3400930232781 | PALIPERIDONE TEVA 75 MG SUSP INJ 1\n",
      "  3400930232798 | PALIPERIDONE TEVA 100 MG SUSP INJ 1\n",
      "  3400930232804 | PALIPERIDONE TEVA 150 MG SUSP INJ 1\n",
      "  3400930232828 | SINETRAV 40 MCG/ML COLLYRE 3\n",
      "  3400930232965 | PERINDOPRIL INDAP ZEN 4/1,25 MG CPR 30\n",
      "  3400930232972 | PERINDOPRIL INDAP ZEN 4/1,25 MG CPR 90\n",
      "  3400930233177 | MIDAZOLAM ACC 5 MG SOL INJ 10\n",
      "  3400930233184 | MIDAZOLAM ACC 5 MG INJ AMP 10\n",
      "  3400930233207 | MIDAZOLAM ACC 50 MG INJ AMP 10\n",
      "  3400930233313 | ACTISKENAN 1MG CPR OROD 14\n",
      "  3400930233337 | ACTISKENAN 2,5MG CPR OROD 14\n",
      "  3400930233344 | ACTISKENAN 5MG CPR OROD 14\n",
      "  3400930233351 | ACTISKENAN 10MG CPR OROD 14\n",
      "  3400930233368 | ACTISKENAN 20MG CPR OROD 14\n",
      "  3400930233375 | ACTISKENAN 30MG CPR OROD 14\n",
      "  3400930233542 | BILASTINE VIATRIS 20MG CPR 30\n",
      "  3400930233931 | INSULINE ASP SANO 100U/ML FL 1\n",
      "  3400930233948 | SUMATRIPTAN ARROW 50MG CPR 6\n",
      "  3400930234006 | RINVOQ 30MG CPR LP 28\n",
      "  3400930234259 | AMOXICILLINE KRK 1G CPR DISP 6\n",
      "  3400930234266 | AMOXICILLINE KRK 1G CPR DISP 14\n",
      "  3400930234303 | DEFERASIROX BGA 90 MG CPR 30\n",
      "  3400930234341 | DEFERASIROX BGA 180 MG CPR 30\n",
      "  3400930234396 | DEFERASIROX BGA 360 MG CPR 30\n",
      "  3400930234563 | XIOP 50MCG/ML COLL UNID 30\n",
      "  3400930234594 | XIOP 50MCG/ML COLL UNID 90\n",
      "  3400930234624 | ARIPIPRAZOLE ALM 5 MG CPR 28\n",
      "  3400930234631 | ARIPIPRAZOLE ALM 10 MG CPR 28\n",
      "  3400930234648 | ARIPIPRAZOLE ALM 15 MG CPR 28\n",
      "  3400930234792 | VILDAGLIPTINE VIATRI 50 MG, COMPRIME 30\n",
      "  3400930234815 | VILDAGLIPTINE VIATRI 50 MG, COMPRIME 60\n",
      "  3400930234976 | UVEDOSE 50 000 UI CAPSULE MOLLE 2\n",
      "  3400930234983 | UVEDOSE 50 000 UI CAPSULE MOLLE 4\n",
      "  3400930235089 | LETROZOLE ALTER 2,5 MG CPR 30\n",
      "  3400930235317 | VILDAGLIPTINE/MET BGA 50MG/1000MG CP 60\n",
      "  3400930235522 | RITONAVIR ARROW 100 MG CPR 30\n",
      "  3400930235669 | VILDAGLIPTINE BGA 50 MG, COMPRIME 30\n",
      "  3400930235683 | VILDAGLIPTINE BGA 50 MG, COMPRIME 60\n",
      "  3400930235966 | ABIRATERONE BLUEPHARMA 500MG CPR 60\n",
      "  3400930236000 | ORYLMYTE 100 IR CPR SUBLING 15\n",
      "  3400930236017 | ORYLMYTE 300 IR CPR SUBLING 30\n",
      "  3400930236024 | ORYLMYTE 100+300 IR CPR SUBLING 31\n",
      "  3400930236086 | MAVIRET 50/20MG GRANULE ENR SACHET 28\n",
      "  3400930236529 | FINGOLIMOD MYLAN 0,5MG GELULE 28\n",
      "  3400930236536 | ELAPRASE 2 MG/ML SOL INJ 1\n",
      "  3400930236635 | PERINDOPRIL AMLO MYL 4/5 CPR 30\n",
      "  3400930236642 | PERINDOPRIL AMLO MYL 4/10 CPR 30\n",
      "  3400930236659 | PERINDOPRIL AMLO MYL 8/5 CPR 30\n",
      "  3400930236666 | PERINDOPRIL AMLO MYL 8/10 CPR 30\n",
      "  3400930236758 | CELESTENE 4 MG SOL INJ 1\n",
      "  3400930236765 | COSENTYX 75 MG SOL INJ SER 1\n",
      "  3400930236826 | BILASTINE EG 20 MG CPR 30\n",
      "  3400930236864 | CHLORHEXIDINE ARW 0,12% SOL BDB200ML 1\n",
      "  3400930237038 | ABIRATERONE EVO 500MG CPR 60\n",
      "  3400930237243 | BIMZELX 160MG INJ SER 2\n",
      "  3400930237250 | BIMZELX 160MG INJ STYLO 2\n",
      "  3400930237588 | PERINDOPRIL AMLO PHARMAKI 4/5 CPR 30\n",
      "  3400930237601 | PERINDOPRIL AMLO PHARMAKI 8/5 CPR 1\n",
      "  3400930237618 | PERINDOPRIL AMLO PHARMAKI 8/10 CPR 30\n",
      "  3400930237625 | PIPER/TAZOB ARW 2 G/0,25 G PDR INJ 1\n",
      "  3400930237663 | PIPER/TAZOB ARW 4 G/500 MG PDR INJ 1\n",
      "  3400930237854 | VILDAGLIPTINE/MET EG 50MG/1000MG CPR 60\n",
      "  3400930237977 | SITAGLIPTINE EG 50 MG CPR 30\n",
      "  3400930238035 | SITAGLIPTINE EG 100 MG CPR 30\n",
      "  3400930238158 | GANIRELIX THERAMEX 0.25MG INJ SER 1\n",
      "  3400930238165 | GANIRELIX THERAMEX 0.25MG INJ SER 5\n",
      "  3400930238257 | MOVIPREP ORANGE PDR ORALE SACHET 2\n",
      "  3400930238264 | PERINDOPRIL AMLO MYL 4/5 CPR 90\n",
      "  3400930238271 | PERINDOPRIL AMLO MYL 4/10 CPR 90\n",
      "  3400930238288 | PERINDOPRIL AMLO MYL 8/5 CPR 90\n",
      "  3400930238295 | PERINDOPRIL AMLO MYL 8/10 CPR 90\n",
      "  3400930238479 | PREGABALINE ZEN 25 MG GELULE 56\n",
      "  3400930238486 | PREGABALINE ZEN 25 MG GELULE 84\n",
      "  3400930238516 | CLOPIDOGREL VIATRIS 75 MG CPR 30\n",
      "  3400930238905 | EZETIMIBE ZEN 10MG CPR 30\n",
      "  3400930238943 | EZETIMIBE ZEN 10MG CPR 90\n",
      "  3400930239001 | SITAGLIPTINE BGR 50MG CPR 30\n",
      "  3400930239087 | SITAGLIPTINE BGR 100MG CPR 30\n",
      "  3400930239193 | SITAGLIPTINE LICONSA 50MG CPR 30\n",
      "  3400930239230 | SITAGLIPTINE LICONSA 100MG CPR 30\n",
      "  3400930239261 | MACROGOL 4000 ZEN 4G PDR BUV SACH 20\n",
      "  3400930239421 | FESOTERODINE TEVA LP 4MG CPR 30\n",
      "  3400930239445 | FESOTERODINE TEVA LP 8MG CPR 30\n",
      "  3400930239469 | CICLOPIROX OLA BGA BI1,5% SHAMPOOING 1\n",
      "  3400930239476 | CICLOPIROX OLAMINE V 1,5% SHAMPOOING 1\n",
      "  3400930239490 | PHLOROGLUCINOL VTS 160MG CPR DISP 5\n",
      "  3400930239919 | QUETIAPINE MEDIPHA LP 50MG CPR 30\n",
      "  3400930239971 | QUETIAPINE MEDIPHA LP 300MG CPR 30\n",
      "  3400930240007 | QUETIAPINE MEDIPHA LP 300MG CPR 60\n",
      "  3400930240038 | QUETIAPINE MEDIPHA LP 400MG CPR 30\n",
      "  3400930240892 | PALIPERIDONE BGA 25 MG SUSP INJ SRG 1\n",
      "  3400930240908 | PALIPERIDONE BGA 50 MG SUSP INJ SRG 1\n",
      "  3400930240915 | PALIPERIDONE BGA 75 MG SUSP INJ SRG 1\n",
      "  3400930240922 | PALIPERIDONE BGA 100 MG SUSP INJ 1\n",
      "  3400930240939 | PALIPERIDONE BGA 150 MG SUSP INJ SRG 1\n",
      "  3400930241257 | BILASTINE BGA 20MG CPR 30\n",
      "  3400930241301 | ABIRATERONE BGA 500MG CPR 60\n",
      "  3400930241349 | AZITHROMYCINE BGR 250MG CPR 6\n",
      "  3400930241370 | DULOXETINE ALM 30MG GELU 28\n",
      "  3400930241387 | DULOXETINE ALM 60MG GELULE 28\n",
      "  3400930241660 | ABIRATERONE ZEN 500MG CPR 60\n",
      "  3400930241684 | VUMERITY 231 MG GELULE GR 120\n",
      "  3400930241752 | ENOXAPARINE TVC 4000UI/0,4ML INJ SER 2\n",
      "  3400930241769 | ENOXAPARINE TVC 4000UI/0,4ML INJ SER 6\n",
      "  3400930241820 | SITAGLIPTINE ZEN 50 MG CPR 30\n",
      "  3400930241868 | SITAGLIPTINE ZEN 100 MG CPR 30\n",
      "  3400930242087 | HUKYNDRA 40 MG SOL INJ SERG + TAMP 2\n",
      "  3400930242117 | HUKYNDRA 40 MG SOL INJ STYLO + TAMP 2\n",
      "  3400930242131 | HUKYNDRA 80 MG SOL INJ SERG + TAMP 1\n",
      "  3400930242360 | AMOXICILLINE TVS 500MG GELULE 12\n",
      "  3400930242506 | ABIRATERONE MYL 500 MG CPR 60\n",
      "  3400930242599 | CIBINQO 100MG CPR PEL 28\n",
      "  3400930242629 | CIBINQO 200MG CPR PEL 28\n",
      "  3400930242667 | TIOTROPIUM BGA 18 MCG PDR INH GEL 30\n",
      "  3400930242803 | BIMATOPROST BGA 0.1MG/ML COLL 3ML 1\n",
      "  3400930242919 | PERINDOPRIL AMLO PHARMAKI 4/5 CPR 90\n",
      "  3400930242926 | PERINDOPRIL AMLO PHARMAKI 8/5 CPR 90\n",
      "  3400930242933 | PERINDOPRIL AMLO PHARMAKI 8/10 CPR 90\n",
      "  3400930242940 | ASUTUL 1% CREME 1\n",
      "  3400930243190 | EMTRICIT/TENOF DIS KRK 200/245MG CPR 30\n",
      "  3400930243381 | VILDAGLIPTINE/MET ZEN 50MG/1000MG CP 60\n",
      "  3400930243442 | KENACORT RET.40MG INJ FL1ML 1\n",
      "  3400930243473 | ABIRATERONE ACC 500 MG CPR 60\n",
      "  3400930243855 | IZIXATE 20 MG/0,40ML SOL INJ STYLO 1\n",
      "  3400930243862 | IZIXATE 22,5 MG/0,45ML SOL INJ STYLO 1\n",
      "  3400930243879 | IZIXATE 25 MG/0,50ML SOL INJ STYLO 1\n",
      "  3400930243916 | IZIXATE 7,5 MG/0,15ML SOL INJ STYLO 1\n",
      "  3400930243923 | IZIXATE 10 MG/0,2ML SOL INJ STYLO 1\n",
      "  3400930243930 | IZIXATE 12,5 MG/0,25ML SOL INJ STYLO 1\n",
      "  3400930243947 | IZIXATE 15 MG/0,30ML SOL INJ STYLO 1\n",
      "  3400930243961 | IZIXATE 17,5 MG/0,35ML SOL INJ STYLO 1\n",
      "  3400930244166 | ABIRATERONE KRKA 500MG CPR 60\n",
      "  3400930244210 | MENQUADFI SOL INJ VACCIN MENINGO 1\n",
      "  3400930244272 | PIPER/TAZOB EG 4G/500MG PDR PERF 1\n",
      "  3400930244609 | ENOXAPARINE TVC 6000UI/0,6ML INJ SER 10\n",
      "  3400930244692 | ENOXAPARINE BGA 2000UI/0,2ML INJ 2\n",
      "  3400930244708 | ENOXAPARINE BGA 2000UI/0,2ML INJ 6\n",
      "  3400930244746 | ENOXAPARINE BGA 4 000 UI/0,4 ML INJ 2\n",
      "  3400930244753 | ENOXAPARINE BGA 4 000 UI/0,4 ML INJ 6\n",
      "  3400930244814 | ENOXAPARINE BGA 6 000 UI/0,6 ML INJ 2\n",
      "  3400930244838 | ENOXAPARINE BGA 6 000 UI/0,6 ML INJ 10\n",
      "  3400930244906 | COLCHIMAX CPR 20\n",
      "  3400930244913 | ENOXAPARINE BGA 8 000 UI/0,8 ML INJ 2\n",
      "  3400930244937 | ENOXAPARINE BGA 8 000 UI/0,8 ML INJ 10\n",
      "  3400930245002 | ENOXAPARINE BGA 10000UI/1ML INJ SER 10\n",
      "  3400930245514 | PAXLOVID 150MG/100MG CPR 30\n",
      "  3400930246023 | IMATINIB ZYDUS 100 MG CPR 60\n",
      "  3400930246078 | IMATINIB ZYDUS 400 MG CPR 30\n",
      "  3400930246467 | LANSOPRAZOLE VIATRIS 15MG GELULE GR 30\n",
      "  3400930246474 | LANSOPRAZOLE VIATRIS 30MG GELULE GR 28\n",
      "  3400930246528 | ULIPRISTAL ACETATE BGA 30MG CPR 1\n",
      "  3400930246870 | YUFLYMA 80 MG SOL INJ SRG 1\n",
      "  3400930246887 | YUFLYMA 80 MG SOL INJ STYLO 1\n",
      "  3400930246979 | AMLODIPINE ARW 10MG GELULE 30\n",
      "  3400930246986 | AMLODIPINE ARW 5MG GELULE 30\n",
      "  3400930246993 | AMOXICILLINE CRT 500MG GELULE 12\n",
      "  3400930247075 | LACOSAMIDE VIATRIS 50 MG CPR 56\n",
      "  3400930247082 | LACOSAMIDE VIATRIS 100 MG CPR 56\n",
      "  3400930247099 | LACOSAMIDE VIATRIS 150 MG CPR 56\n",
      "  3400930247143 | LACOSAMIDE VIATRIS 200 MG CPR 56\n",
      "  3400930247310 | LACOSAMIDE TEVA 50MG CPR 14\n",
      "  3400930247327 | LACOSAMIDE TEVA 50MG CPR 56\n",
      "  3400930247334 | LACOSAMIDE TEVA 100MG CPR 56\n",
      "  3400930247341 | LACOSAMIDE TEVA 150MG CPR 56\n",
      "  3400930247358 | LACOSAMIDE TEVA 200MG CPR 56\n",
      "  3400930247648 | VILDAGLIPTINE/MET VTS 50MG/1000MG CP 60\n",
      "  3400930247730 | SITAGLIPTINE GNR 50 MG CPR 28\n",
      "  3400930247785 | SITAGLIPTINE GNR 100 MG CPR 30\n",
      "  3400930248256 | SONDELBAY 20MICROG/80 MCL INJ STYLO 1\n",
      "  3400930248607 | PARACETAMOL ZEL 1G CPR 8\n",
      "  3400930249161 | STIMUFEND 6 MG SOL INJ SRG 1\n",
      "  3400930249925 | ROSUVASTATINE BGR 5 MG CPR 30\n",
      "  3400930249932 | VILDAGLIPTINE TEVA 50 MG, COMPRIME 30\n",
      "  3400930249949 | VILDAGLIPTINE TEVA 50 MG, COMPRIME 60\n",
      "  3400930250006 | LACOSAMIDE ZYD 50 MG CPR 56\n",
      "  3400930250037 | LACOSAMIDE ZYD 100 MG CPR 56\n",
      "  3400930250075 | LACOSAMIDE ZYD 150 MG CPR 56\n",
      "  3400930250105 | LACOSAMIDE ZYD 200 MG CPR 56\n",
      "  3400930250518 | JORVEZA 0,5 MG CPR ORO 90\n",
      "  3400930252444 | AMIFAMPRIDINE SERB 10 MG CPR 100\n",
      "  3400930252482 | LEFLUNOMIDE BIOGARAN 10MG CPR 30\n",
      "  3400930252499 | LEFLUNOMIDE BIOGARAN 20MG CPR 30\n",
      "  3400930252994 | AMLODIPINE/VALSARTAN TVS 5/80MG C 30\n",
      "  3400930253007 | AMLODIPINE/VALSARTAN TVS 5/80MG C 90\n",
      "  3400930253014 | AMLODIPINE/VALSARTAN TVS 5/160MG C 30\n",
      "  3400930253038 | AMLODIPINE/VALSARTAN TVS 5/160MG C 90\n",
      "  3400930253045 | AMLODIPINE/VALSARTAN TVS 10/160MG C 30\n",
      "  3400930253052 | AMLODIPINE/VALSARTAN TVS 10/160MG C 90\n",
      "  3400930253403 | DIMETHYL FUMARATE MYL 120 MG GELULE 14\n",
      "  3400930253427 | DIMETHYL FUMARATE MYL 240 MG GELULE 56\n",
      "  3400930254097 | IMRALDI 40 MG, SOLUTION INJ SERINGUE 2\n",
      "  3400930254134 | IMRALDI 40 MG, SOLUTION INJ STYLO 2\n",
      "  3400930254301 | ABIRATERONE TEVA 500 MG CPR 60\n",
      "  3400930255216 | SITAGLIPTINE ARROW 50MG CPR 30\n",
      "  3400930255223 | SITAGLIPTINE ARROW 100MG CPR 30\n",
      "  3400930255452 | DIMETHYL FUMARATE NEURAX 240 MG GELU 56\n",
      "  3400930256503 | CORDARONE 200 MG CPR 30\n",
      "  3400930258972 | CORTANCYL 1MG CPR 30\n",
      "  3400930259054 | CORTANCYL 5MG CPR 30\n",
      "  3400930264546 | COUMADINE 2MG CPR 20\n",
      "  3400930267219 | ARACYTINE 100MG PDR ET SOL INJ 1\n",
      "  3400930277553 | CYNOMEL 0,025MG CPR 30\n",
      "  3400930280973 | DAONIL 5MG CPR 100\n",
      "  3400930281055 | DAONIL 5MG CPR 20\n",
      "  3400930282526 | DEBRIDAT 4,8MG/ML GRANULES ORAL FL 1\n",
      "  3400930285367 | DECTANCYL 0,5MG CPR 30\n",
      "  3400930292921 | DEPAKINE 200MG CPR 40\n",
      "  3400930293003 | DEPAKINE 200MG/ML SOL BUV FL 40ML 1\n",
      "  3400930298374 | DESFERAL 100MG/ML PDR + SOL INJ 5ML 1\n",
      "  3400930303030 | DI HYDAN 100MG CPR 60\n",
      "  3400930305270 | DIAMOX 250MG CPR 24\n",
      "  3400930305331 | DIAMOX 500 MG PDR ET SOL INJ 1\n",
      "  3400930313893 | DIGOXINE NATIVELLE 0,5 MG SOL INJ 6\n",
      "  3400930317686 | DILATRANE LP 200MG GELULE 30\n",
      "  3400930317747 | DILATRANE LP 100MG GELULE 30\n",
      "  3400930317808 | DILATRANE 50MG/5ML SIROP 1\n",
      "  3400930323199 | DIPIPERON 40 MG CPR 20\n",
      "  3400930325612 | DISULONE CPR 100\n",
      "  3400930328804 | DOGMATIL 200MG CPR 12\n",
      "  3400930328972 | DOGMATIL 50MG GELULE 30\n",
      "  3400930329054 | DOGMATIL 25 MG/5 ML SOL BUV 1\n",
      "  3400930345191 | CLARITHROMYCINE EG LM 500MG CPR 10\n",
      "  3400930348444 | EDUCTYL AD SUPPO 12\n",
      "  3400930348673 | EDUCTYL ENF SUPPO 12\n",
      "  3400930351635 | ELAVIL 25 MG CPR 60\n",
      "  3400930358900 | ENDOXAN 50MG CPR 50\n",
      "  3400930370155 | ANAFRANIL 10MG CPR 60\n",
      "  3400930373576 | ESIDREX 25 MG CPR 20\n",
      "  3400930374696 | ESPERAL 500MG CPR 20\n",
      "  3400930385173 | EUPHON SIROP FL 150ML 1\n",
      "  3400930390894 | EXTENCILLINE 1,2MUI SOL INJ 1\n",
      "  3400930390955 | EXTENCILLINE 2,4MUI/8ML PDR 1\n",
      "  3400930396988 | FERROSTRANE 34MG/5ML SIROP 1\n",
      "  3400930400005 | FLAGYL 250 MG CPR 20\n",
      "  3400930400173 | FLAGYL 500MG OVULE 10\n",
      "  3400930408919 | SPECIAFOLDINE 5MG CPR 20\n",
      "  3400930417034 | FUCIDINE 2% POMMADE 1\n",
      "  3400930418093 | FUMAFER 66MG CPR 100\n",
      "  3400930418673 | FUNGIZONE 10% SUSP BUV FL 40ML 1\n",
      "  3400930425077 | GARDENAL 10MG CPR 80\n",
      "  3400930425138 | GARDENAL 50MG CPR 30\n",
      "  3400930425367 | GARDENAL 100MG CPR 20\n",
      "  3400930428559 | GASTROPULGITE PDR ORALE SACHET 30\n",
      "  3400930448021 | GLUCOPHAGE 850MG CPR 30\n",
      "  3400930461327 | CLARITHROMYCINE ARW LM 500MG CPR 5\n",
      "  3400930464458 | GRISEFULINE 250MG CPR 30\n",
      "  3400930467879 | GYNERGENE CAFEINE 1 MG/100 MG CPR 20\n",
      "  3400930471432 | HALDOL 1MG CPR 40\n",
      "  3400930471890 | HALDOL 5 MG SOL INJ 5\n",
      "  3400930476574 | HELICIDINE 10% SIROP FL 125ML 1\n",
      "  3400930484500 | HEPARINE NA CHOAY 25 000UI/5ML INJ 1\n",
      "  3400930512685 | HYDREA 500MG GELULE 20\n",
      "  3400930514177 | HYDROCORTISONE ROUSS 10MG CPR 25\n",
      "  3400930515587 | HYDROCORTANCYL 125 MG SUSP INJ 1\n",
      "  3400930515648 | HYDROCORTANCYL 2,5 P. 100 (ACETATE DE PREDNISOLONE\n",
      "  3400930525692 | INDOCID 25 MG GELULE 30\n",
      "  3400930525753 | INDOCID 100MG SUPPO 10\n",
      "  3400930545805 | ISOPTINE 40MG CPR 75\n",
      "  3400930558751 | KENACORT RETARD 40 MG SUSP INJ AMP 1\n",
      "  3400930571187 | LARGACTIL 25 MG CPR 50\n",
      "  3400930571248 | LARGACTIL 100MG CPR 30\n",
      "  3400930571477 | LARGACTIL 40 MG/ML SOL BUV FL 30ML 1\n",
      "  3400930572948 | LAROXYL 50 MG SOL INJ 12\n",
      "  3400930573020 | LAROXYL 25MG CPR 60\n",
      "  3400930573198 | LAROXYL 50MG CPR 20\n",
      "  3400930573259 | LAROXYL 40 MG/ML BUV FL 20ML 1\n",
      "  3400930573310 | LASILIX 20 MG SOL INJ 1\n",
      "  3400930575031 | SODIUM BIC LAV 1,4% INJ FV 250ML 1\n",
      "  3400930575260 | SODIUM BIC LAV 1,4% INJ FV 500ML 1\n",
      "  3400930576151 | CLARITHROMYCINE ARW LM 500MG CPR 10\n",
      "  3400930578391 | SODIUM CHL LAV 0,9% SOL INJ FV 1L 1\n",
      "  3400930578452 | SODIUM CHL LAV 0,9% SOL INJ FV 125ML 1\n",
      "  3400930578971 | SODIUM CHL LAV 0,9% SOL INJ FV 250ML 1\n",
      "  3400930579404 | SODIUM CHL LAV 0,9% SOL INJ FV 500ML 1\n",
      "  3400930581933 | ACARBOSE ZEN 100MG CPR 90\n",
      "  3400930583715 | ACARBOSE ZEN 50MG CPR 90\n",
      "  3400930585146 | GLUCOSE LAV 30% SOL INJ FV 250ML 1\n",
      "  3400930585436 | GLUCOSE LAV 30% SOL INJ FV 500ML 1\n",
      "  3400930585894 | GLUCOSE LAV 5% SOL INJ FV 1L 1\n",
      "  3400930585955 | GLUCOSE LAV 5% SOL INJ FV 125ML 1\n",
      "  3400930586327 | GLUCOSE LAV 5% SOL INJ FV 250ML 1\n",
      "  3400930586556 | GLUCOSE LAV 5% SOL INJ FV 500ML 1\n",
      "  3400930617694 | CALENDULA LHF PDE 20G 1\n",
      "  3400930645789 | MALOCIDE 50MG CPR 20\n",
      "  3400930652473 | MAXIDEX 0,1% COLLYRE FL 3ML 1\n",
      "  3400930652534 | MAXIDROL COLLYRE FL 3ML 1\n",
      "  3400930655955 | MEDROL 4MG CPR 30\n",
      "  3400930656617 | MELADININE 10MG CPR 30\n",
      "  3400930656785 | MELADININE 0,1% SOL 1\n",
      "  3400930656846 | MELADININE 0,75% SOL 1\n",
      "  3400930668092 | DALACINE 75 MG GELULE 12\n",
      "  3400930668153 | DALACINE 150MG GELULE 12\n",
      "  3400930669334 | METEOXANE GELULE 60\n",
      "  3400930669624 | METHERGIN 0,2 MG SOL INJ 3\n",
      "  3400930670682 | METHOTREXATE BLN 2,5 MG CPR 20\n",
      "  3400930698259 | MYSOLINE 250MG CPR 50\n",
      "  3400930698488 | MYTELASE 10MG CPR 50\n",
      "  3400930701362 | NATI K 500MG CPR 40\n",
      "  3400930702482 | NATULAN 50MG GELULE 50\n",
      "  3400930710067 | NEO CODION AD SIROP 1\n",
      "  3400930716960 | NEULEPTIL 10 MG/ML SOL BUV FL 30ML 1\n",
      "  3400930728796 | NIFLURIL 250MG GELULE 30\n",
      "  3400930731000 | NIVAQUINE 100MG CPR 100\n",
      "  3400930731178 | NIVAQUINE 100MG CPR 20\n",
      "  3400930742815 | NOZINAN 25MG CPR 20\n",
      "  3400930742983 | NOZINAN 100MG CPR 20\n",
      "  3400930743126 | NOZINAN 40 MG/ML SOL BUV 30ML 1\n",
      "  3400930747728 | RODOGYL 0,75MUI/125MG CPR 20\n",
      "  3400930775981 | PADERYL 19,5MG CPR 20\n",
      "  3400930776063 | PADERYL 0,1% SIROP 1\n",
      "  3400930819968 | PERNAZENE 50 MG/100 ML SOL NASALE 1\n",
      "  3400930849316 | POLERY AD SIROP 1\n",
      "  3400930852446 | PONSTYL 250MG GELULE 20\n",
      "  3400930853627 | ATROPINE ALCON 1% COLLYRE FL 10ML 1\n",
      "  3400930853795 | ATROPINE ALCON 0,3% COLLYRE FL 10ML 1\n",
      "  3400930853856 | ATROPINE ALCON 0,5% COLLYRE FL 10ML 1\n",
      "  3400930861202 | PRIMPERAN 10MG CPR 40\n",
      "  3400930861431 | PRIMPERAN 0,1% SOL BUV 1\n",
      "  3400930861660 | PRIMPERAN 10 MG SOL INJ 12\n",
      "  3400930865972 | PROGESTERONE RETARD PHAR 500MG INJ 3\n",
      "  3400930870365 | PROSTIGMINE 0,5 MG SOL INJ 6\n",
      "  3400930894668 | RADIOSELECTAN U 30% SOL INJ 1\n",
      "  3400930915004 | RIFADINE 300MG GELULE 30\n",
      "  3400930915172 | RIFADINE 300MG GELULE 8\n",
      "  3400930915233 | RIFAMYCINE CHIBRET 1MUI COLLYRE 10ML 1\n",
      "  3400930915462 | RIFAMYCINE CHIBRET 1 MUI POMMADE OPH 1\n",
      "  3400930916292 | RIMACTAN 300MG GELULE 30\n",
      "  3400930935453 | RYTHMODAN 100MG GELULE 40\n",
      "  3400930959695 | SERESTA 50MG CPR 20\n",
      "  3400930971703 | SOLUMEDROL 20 MG PDR ET SOL INJ 1\n",
      "  3400930971871 | SOLUMEDROL 40 MG PDR ET SOL INJ 1\n",
      "  3400930975206 | SOLUPRED 5MG CPR EFF 30\n",
      "  3400930984710 | SPAGULAX MUCILAGE PUR GRANULES 700G 1\n",
      "  3400930985830 | SPASFON SOL INJ 6\n",
      "  3400930986080 | SPASFON CPR 30\n",
      "  3400930986141 | SPASFON SUPPO 10\n",
      "  3400930998267 | STEROGYL 2MUI/100ML SOL BUV 1\n",
      "  3400930998328 | STEROGYL 15A 600 000UI/1,5ML SOL BUV 1\n",
      "  3400930998557 | STEROGYL 15H 600 000UI/1,5ML SOL INJ 1\n",
      "  3400931011095 | SULFARLEM 12,5MG CPR 60\n",
      "  3400931022503 | SURMONTIL 4% SOL BUV FL 30ML 1\n",
      "  3400931022671 | SURMONTIL 100MG CPR 20\n",
      "  3400931022961 | SURMONTIL 25MG CPR 50\n",
      "  3400931025863 | SYNACTHENE RETARD 1 MG SUSP INJ 1\n",
      "  3400931035398 | TEDRALAN LP 200MG GELULE 30\n",
      "  3400931035459 | TEGRETOL 200 MG CPR 50\n",
      "  3400931037460 | TENSIONORME CPR 24\n",
      "  3400931052838 | THERALENE 5MG CPR 50\n",
      "  3400931053088 | THERALENE 40 MG/ML SOL BUV 30ML 1\n",
      "  3400931067627 | TOFRANIL 10MG CPR 60\n",
      "  3400931067795 | TOFRANIL 25MG CPR 100\n",
      "  3400931077503 | TREDEMINE 500MG CPR 4\n",
      "  3400931086086 | TRIVASTAL 20MG CPR 30\n",
      "  3400931096542 | TUSSIPAX SOL BUV 1\n",
      "  3400931096603 | TUSSIPAX SIROP 1\n",
      "  3400931109761 | PERINDOPRIL ZEN 4MG CPR 30\n",
      "  3400931112433 | VALIUM 10 MG SOL INJ 6\n",
      "  3400931112662 | VALIUM ROCHE 2MG CPR 40\n",
      "  3400931112723 | VALIUM 10MG CPR 30\n",
      "  3400931112891 | VALIUM ROCHE 5MG CPR 40\n",
      "  3400931113034 | VALIUM 10 MG/30 GOUTTE SOL BUV 1\n",
      "  3400931132134 | VITAMINE D3 BON 200 000 UI/1 ML INJ 1\n",
      "  3400931134435 | VITAMINE A DULCIS 25 000UI% POMMADE 1\n",
      "  3400931136385 | VIT B12 GERDA 1MG/4ML INJ IM BUV AMP 6\n",
      "  3400931149453 | VOGALENE 10 MG SOL INJ 10\n",
      "  3400931152125 | XYLOCAINE 10 MG/ML ADR SOL INJ 20ML 1\n",
      "  3400931152415 | XYLOCAINE 20 MG/ML ADR SOL INJ 20ML 1\n",
      "  3400931152705 | XYLOCAINE 5% NAPHAZOLINE SOL 1\n",
      "  3400931153184 | XYLOCAINE 1 P 100 SANS CONSERVATEUR (CHLORHYDRATE\n",
      "  3400931153764 | XYLOCAINE VISQUEUSE 2% GEL ORAL 1\n",
      "  3400931157557 | EXACYL 1000 MG/10ML SOL BUV 5\n",
      "  3400931157618 | EXACYL 500 MG SOL INJ 5\n",
      "  3400931162179 | DEXAMBUTOL 500 MG CPR 50\n",
      "  3400931163411 | DIGOXINE NATIVELLE 0,05MG/ML SOL BUV 1\n",
      "  3400931178200 | SULFARLEM S 25MG CPR 60\n",
      "  3400931186762 | RIFADINE 100 MG/5 ML SUSP BUV 1\n",
      "  3400931187943 | FERO GRAD VITAMINE C 105MG/500MG CPR 30\n",
      "  3400931226895 | ASPEGIC 500MG PDR ORALE SACHET 20\n",
      "  3400931241683 | ROVAMYCINE 1,5 MUI CPR 16\n",
      "  3400931261506 | SODIUM BIC BSD 1,4% INJ FV 500ML 1\n",
      "  3400931300458 | DIPIPERON 40MG/ML SOL BUV FL 30ML 1\n",
      "  3400931303299 | TERCIAN 40 MG/ML SOL BUV 30ML 1\n",
      "  3400931304180 | POTASSIUM RCA 3% SIROP FL 250ML 1\n",
      "  3400931305361 | BACTRIM NR ENF SUSP BUV FL 100ML 1\n",
      "  3400931307143 | ORAP 1MG CPR 30\n",
      "  3400931307204 | ORAP 4MG CPR 30\n",
      "  3400931307372 | NORMACOL LAVEMENT AD SOL RECTALE 1\n",
      "  3400931307433 | NORMACOL LAVEMENT ENF SOL RECTALE 1\n",
      "  3400931308614 | COLPRONE 5MG CPR 20\n",
      "  3400931314127 | PROGESTOGEL 1% GEL 1\n",
      "  3400931316947 | FLAGYL 4% SUSP BUV 1\n",
      "  3400931321330 | NIFLURIL 700MG AD SUPPO 8\n",
      "  3400931331094 | CALCIPARINE 12 500UI/0,5ML SOL INJ S 2\n",
      "  3400931357520 | KEFORAL 500MG CPR 10\n",
      "  3400931358589 | PYOSTACINE 500MG CPR 16\n",
      "  3400931372318 | PIPORTIL L4 25 MG SOL INJ 3\n",
      "  3400931375388 | SANMIGRAN 0,5MG CPR 50\n",
      "  3400931375449 | SANMIGRAN 0,5MG CPR 100\n",
      "  3400931376330 | TERALITHE 250MG CPR 100\n",
      "  3400931384144 | STERDEX POMMADE OPH UNIDOSE 12\n",
      "  3400931402336 | LUDIOMIL 25MG CPR 50\n",
      "  3400931404866 | PIPORTIL L4 100 MG SOL INJ 1\n",
      "  3400931405009 | LEPTICUR 10MG CPR 30\n",
      "  3400931406297 | COMBANTRIN 125MG CPR 6\n",
      "  3400931407188 | COMBANTRIN 125 MG/2,5 ML SUSP BUV 1\n",
      "  3400931419136 | PIPORTIL 10 MG CPR 20\n",
      "  3400931443728 | FLUDEX 2,5MG CPR 30\n",
      "  3400931457855 | ALLIUM CEPA COMPOSE GR 1\n",
      "  3400931458746 | POMMADE ARNICA TM 4% BOIRON POM 1\n",
      "  3400931459057 | ARUM TRIPHYL COMP BOIR GRLS 80 80\n",
      "  3400931459576 | AESCULUS COMPOSE GRL 4G 80\n",
      "  3400931461418 | CHELIDONIUM COMPOSE GRLS 4G 80\n",
      "  3400931462477 | DROSERA COMP BOIR GRLS 80\n",
      "  3400931463658 | HAMAMELIS COMPOSE BOIRON 1\n",
      "  3400931463719 | HAMEMELIS COMP BOIR GRLS TB80 1\n",
      "  3400931465201 | IPECA COMP BOIR GRLS TB80\n",
      "  3400931466901 | PASSIFLORA COMPOSE GRANULES TUBE 4G 80\n",
      "  3400931468103 | CASTOR EQUI BOIRON POMMADE 20 G 1\n",
      "  3400931475835 | LERCANIDIPINE SDZ 10MG CPR 30\n",
      "  3400931489962 | TEMESTA 2,5MG CPR 30\n",
      "  3400931492405 | MODURETIC CPR 30\n",
      "  3400931498896 | AKINETON LP 4MG CPR 30\n",
      "  3400931499558 | COLCHICINE HOUDE 1 MG 1 BOITE DE 20, COMPRIMES\n",
      "  3400931499787 | BETADINE DERMIQUE 10% SOL FP 125ML 1\n",
      "  3400931501251 | METHOTREXATE BDM 5 MG SOL INJ 1\n",
      "  3400931502081 | MODAMIDE 5 MG CPR 30\n",
      "  3400931502722 | QUESTRAN 4G PDR ORALE SACHET 50\n",
      "  3400931517160 | LERCANIDIPINE SDZ 10MG CPR 90\n",
      "  3400931520122 | MAGINJECTABLE 0.8% SOL INJ 12\n",
      "  3400931531876 | LERCANIDIPINE SDZ 20MG CPR 30\n",
      "  3400931532996 | LERCANIDIPINE SDZ 20MG CPR 90\n",
      "  3400931533429 | POLYDEXA SOL AURICULAIRE FL 1\n",
      "  3400931533719 | MANTADIX 100MG CAPSULE 50\n",
      "  3400931534778 | ANXYREX 6 MG (BROMAZEPAM) GE, 1 BOITE DE 30, COMPR\n",
      "  3400931545774 | TROPHIGIL GELULE VAGINALE 14\n",
      "  3400931552819 | SOLUMEDROL 120 MG PDR ET SOL INJ 1\n",
      "  3400931562573 | LERCANIDIPINE ACT 10MG CPR 30\n",
      "  3400931584575 | KENACORT RETARD 80 MG SUSP INJ 1\n",
      "  3400931585756 | TRIDESONIT 0,05% CREME 1\n",
      "  3400931587538 | CLAMOXYL 500MG GELULE 12\n",
      "  3400931602187 | METHOTREXATE BDM 25 MG SOL INJ 1\n",
      "  3400931608851 | TANGANILPRO 500 MG CPR 30\n",
      "  3400931611981 | LERCANIDIPINE ACT 10MG CPR 90\n",
      "  3400931623298 | COLPOTROPHINE 10MG CAPSULE VAGINALE 20\n",
      "  3400931623359 | TERCIAN 50 MG SOL INJ 5\n",
      "  3400931631163 | LERCANIDIPINE ACT 20MG CPR 30\n",
      "  3400931648543 | NEBCINE 25 MG SOL INJ 1\n",
      "  3400931648604 | NEBCINE 75 MG SOL INJ 1\n",
      "  3400931648772 | NEBCINE 100 MG SOL INJ 1\n",
      "  3400931650263 | HEMI DAONIL 2,5MG CPR 60\n",
      "  3400931654285 | TADENAN 50MG CAPSULE 30\n",
      "  3400931654865 | LERCANIDIPINE ACT 20MG CPR 90\n",
      "  3400931655527 | FLUANXOL 4% SOL BUV FL 10ML 1\n",
      "  3400931684381 | NAPROSYNE 250MG CPR 10\n",
      "  3400931689294 | OESTROGEL 0,06% GEL FL 80G 1\n",
      "  3400931698289 | DODECAVIT 0,5 MG/ML SOL INJ 6\n",
      "  3400931704294 | MODOPAR 125 (100MG/25MG) GELULE 60\n",
      "  3400931704874 | MODOPAR 250 (200MG/50MG) GELULE 60\n",
      "  3400931705246 | RIVOTRIL 2,5 MG/ML SOL BUV 1\n",
      "  3400931710509 | VIT B12 DELAGR 1MG/2ML INJ BUV 6\n",
      "  3400931714811 | VOGALENE 0,1% SOL BUV FL 1\n",
      "  3400931716013 | TELEBRIX 12 SODIUM SOL INJ 1\n",
      "  3400931716181 | LIORESAL 10MG CPR 50\n",
      "  3400931723806 | URBANYL 5MG GELULE 30\n",
      "  3400931724636 | SINEMET 250MG/25MG CPR 50\n",
      "  3400931738015 | ALDOMET 500MG CPR 30\n",
      "  3400931742494 | TIAPRIDAL 100MG CPR 20\n",
      "  3400931742555 | TIAPRIDAL 100 MG SOL INJ 12\n",
      "  3400931742845 | LEXOMIL 6MG CPR 30\n",
      "  3400931747178 | PARKINANE LP 2MG GELULE 50\n",
      "  3400931747239 | PARKINANE LP 5MG GELULE 20\n",
      "  3400931754732 | LERCANIDIPINE ZYD 20MG CPR 30\n",
      "  3400931756163 | LEPTICUR 10 MG SOL INJ 1\n",
      "  3400931762775 | EFFEDERM 0,05% CREME 1\n",
      "  3400931779285 | SURGAM 100MG CPR 30\n",
      "  3400931786320 | DEDROGYL 0,15MG/ML SOL BUV 1\n",
      "  3400931788560 | LERCANIDIPINE ZYD 20MG CPR 90\n",
      "  3400931792932 | PROFENID 100MG SUPPO 12\n",
      "  3400931793823 | FASIGYNE 500MG CPR 4\n",
      "  3400931796435 | ANCOTIL 500MG CPR 100\n",
      "  3400931808534 | NOCERTONE 60MG CPR 30\n",
      "  3400931810315 | ORACILLINE 250 000 UI/5 ML SUSP BUV 1\n",
      "  3400931813736 | URBANYL 10MG CPR 30\n",
      "  3400931815686 | PRIMALAN 5 MG CPR 14\n",
      "  3400931815808 | SOTALEX 80MG CPR 30\n",
      "  3400931820369 | TIMACOR 10MG CPR 30\n",
      "  3400931823902 | MINIDRIL 0,15/0,03MG CPR 21\n",
      "  3400931824091 | MINIDRIL 0,15/0,03MG CPR 63\n",
      "  3400931828693 | SYNACTHENE 0,25 MG SOL INJ 1\n",
      "  3400931836629 | LYSANXIA 10MG CPR 40\n",
      "  3400931840640 | ADEPAL CPR 21\n",
      "  3400931840879 | ADEPAL CPR 63\n",
      "  3400931841302 | HEXATRIONE 40 MG SUSP INJ 1\n",
      "  3400931843832 | CHLORURE DE SODIUM AGUETTANT 0,9 P. 100 1 BOITE DE\n",
      "  3400931844082 | CHLORURE DE SODIUM AGUETTANT 0,9 P. 100 1 BOITE DE\n",
      "  3400931844143 | SODIUM CHL AGT 0,9% INJ FV 1L 1\n",
      "  3400931850984 | LERCANIDIPINE ZYD 10MG CPR 30\n",
      "  3400931851356 | PRESTOLE GELULE 30\n",
      "  3400931852247 | PEVARYL 1% CREME 1\n",
      "  3400931863014 | SPASFON LYOC 80MG LYOPHILISAT ORAL 10\n",
      "  3400931869627 | NEULEPTIL 25MG CPR 50\n",
      "  3400931878551 | CALCIPARINE 7 500UI/0,3ML SOL INJ S 2\n",
      "  3400931878612 | CALCIPARINE 5 000UI/0,2ML SOL INJ S 2\n",
      "  3400931886075 | IMODIUM 2MG GELULE 20\n",
      "  3400931886365 | NIFLURIL 400MG ENF SUPPO 8\n",
      "  3400931890676 | TRIVASTAL LP 50MG CPR 30\n",
      "  3400931893639 | ASPEGIC 100MG NR PDR ORALE SACHET 20\n",
      "  3400931895930 | ARTANE 4 MG/ML SOL BUV FL 30ML 1\n",
      "  3400931898191 | ASPEGIC 1G AD PDR ORALE SACHET 20\n",
      "  3400931906339 | ARTHROCINE 100MG CPR 40\n",
      "  3400931906568 | ARTHROCINE 200MG CPR 30\n",
      "  3400931908869 | PROTHIADEN 25 MG (CHLORYDRATE DE DOSULEPINE) 50 GE\n",
      "  3400931911999 | ZYMAFLUOR 0,25MG CPR 200\n",
      "  3400931914723 | LERCANIDIPINE ZYD 10MG CPR 90\n",
      "  3400931919926 | TERCIAN 100MG CPR 25\n",
      "  3400931922537 | PANOTILE SOL AURICULAIRE FL 8ML 1\n",
      "  3400931922766 | DEPAKINE 500MG CPR 40\n",
      "  3400931923077 | SMECTA PDR ORALE SACHET 30\n",
      "  3400931923138 | SMECTA PDR ORALE SACHET 60\n",
      "  3400931927501 | STAGID 700MG CPR 30\n",
      "  3400931927679 | STAGID 700MG CPR 100\n",
      "  3400931927969 | LOCAPRED 0,1% CREME 1\n",
      "  3400931939047 | TRANDOLAPRIL EG 2MG GELULE 90\n",
      "  3400931939337 | ORBENINE 500MG GELULE 16\n",
      "  3400931941057 | DAKTARIN 2% PDR 1\n",
      "  3400931949152 | ORACILLINE 1MUI CPR 12\n",
      "  3400931952572 | BICARBONATE DE SODIUM 1,4 P. 100 AGUETTANT 1 BOITE\n",
      "  3400931971092 | CEBUTID 50MG CPR 30\n",
      "  3400931972273 | TRANDOLAPRIL EG 4MG GELULE 90\n",
      "  3400931983569 | MAXIDROL POMMADE OPH 1\n",
      "  3400931984399 | DIPROSONE 0,05% LOTION FL 30G 1\n",
      "  3400931986522 | KEFORAL 1G CPR 6\n",
      "  3400931994046 | COLPOTROPHINE 1% (PROMESTRIENE) 1 TUBE DE 15 G, CR\n",
      "  3400931994107 | COLPOTROPHINE 1% CREME VAGINALE 1\n",
      "  3400932005093 | DIPROSTENE SUSP INJ 1\n",
      "  3400932008056 | SINEMET 100MG/10MG CPR 100\n",
      "  3400932014668 | SOLUPRED 20MG CPR EFF 20\n",
      "  3400932021581 | ERYTHROCINE 500MG GRANULES SACHET 12\n",
      "  3400932022533 | PEVARYL 1% EMULSION 1\n",
      "  3400932022762 | GYNO PEVARYL 150MG OVULE 3\n",
      "  3400932026555 | PARLODEL 2,5MG CPR 30\n",
      "  3400932029396 | PLUREXID LOC SOL FP 250ML 1\n",
      "  3400932029808 | OPTICRON 2% COLLYRE FL 5ML 1\n",
      "  3400932031696 | TROLOVOL 300MG CPR 30\n",
      "  3400932043293 | DERMOVAL 0,05% CREME 10G 1\n",
      "  3400932043354 | DERMOVAL 0,05% CR TB15G 1\n",
      "  3400932046546 | CYTEAL SOL FL 250ML 1\n",
      "  3400932054411 | VOGALENE 15 MG GELULE 20\n",
      "  3400932057771 | CELESTENE CHRONO 5,70 MG/ML INJ+NEC 1\n",
      "  3400932059324 | NOLVADEX 10 MG CPR 30\n",
      "  3400932061105 | PIVALONE 1% SUSP NASALE FL 10ML 1\n",
      "  3400932067657 | LERCANIDIPINE TVC 10MG CPR 30\n",
      "  3400932070268 | FLAMMAZINE 1% CREME TUBE 50G 1\n",
      "  3400932070619 | DEPAMIDE 300MG CPR 30\n",
      "  3400932082506 | HALDOL 5MG CPR 30\n",
      "  3400932095513 | NOOTROPYL 1000 MG/5 ML SOL BUV FL 1\n",
      "  3400932102129 | LERCANIDIPINE TVC 10MG CPR 90\n",
      "  3400932102938 | EPITOPIC 0,05% CREME 1\n",
      "  3400932111053 | CLAMOXYL 125MG/5ML PDR ORALE FL 1\n",
      "  3400932111282 | CLAMOXYL 250MG/5ML PDR ORALE FL 1\n",
      "  3400932121458 | KEFORAL 250MG/5ML PDR ORALE FL 1\n",
      "  3400932129904 | VAXIGRIP SUSP INJ 1\n",
      "  3400932141159 | HYDROCORTISONE UPJOHN 100MG INJ 1\n",
      "  3400932153565 | LASILIX FAIBLE 20MG CPR 30\n",
      "  3400932156009 | DANTRIUM 25MG GELULE 50\n",
      "  3400932156177 | DANTRIUM 100MG GELULE 30\n",
      "  3400932167234 | ROCGEL 1,2G/10ML SUSP BUV SACHET 24\n",
      "  3400932172085 | NEOSYNEPHRINE 5% FAURE COLLYRE 5ML 1\n",
      "  3400932172146 | NEOSYNEPHRINE FAURE 10% COLLYRE 5ML 1\n",
      "  3400932179060 | NUCTALON 2MG CPR 20\n",
      "  3400932184323 | EFUDIX 5% CREME TUBE 20G 1\n",
      "  3400932189465 | LOCOID 0,1% LOTION 1\n",
      "  3400932189694 | LOCOID 0,1% CREME 1\n",
      "  3400932190294 | LOCOID 0,1% POMMADE 1\n",
      "  3400932192946 | DUPHASTON 10MG CPR 10\n",
      "  3400932197040 | BACTRIM FORTE CPR 10\n",
      "  3400932197569 | PHOSPHALUGEL 12,38G SUSP BUV SACHET 26\n",
      "  3400932200672 | MICROVAL 0,03MG CPR 28\n",
      "  3400932200733 | MICROVAL 0,03MG CPR 84\n",
      "  3400932207718 | SECTRAL 400MG CPR 30\n",
      "  3400932209378 | MODUCREN CPR 30\n",
      "  3400932214341 | VOLTARENE 100 MG SUPPO 10\n",
      "  3400932223046 | FAZOL 2% CREME 1\n",
      "  3400932223565 | NERISONE 0,1% POMMADE 1\n",
      "  3400932223626 | NERISONE GRAS POMMADE 1\n",
      "  3400932223794 | NERISONE 0,1% CREME 1\n",
      "  3400932225637 | SOTALEX 160MG CPR 30\n",
      "  3400932226757 | CEBUTID 100MG CPR 15\n",
      "  3400932227709 | LOXAPAC 25MG CPR 30\n",
      "  3400932229130 | LUDIOMIL 75MG CPR 28\n",
      "  3400932229598 | ZYLORIC 300 MG CPR 28\n",
      "  3400932234622 | MAGINJECTABLE 0.8% SOL INJ 10\n",
      "  3400932234790 | ADALATE 10 MG CAPSULE 30\n",
      "  3400932238873 | ERY 500MG CPR 20\n",
      "  3400932241484 | PLITICAN 50 MG SOL INJ 6\n",
      "  3400932242665 | VISKEN QUINZE 15MG CPR 30\n",
      "  3400932242955 | TIMOPTOL 0,50 % COLLYRE FL 3ML 1\n",
      "  3400932243266 | TIMOPTOL 0,25 % COLLYRE FL 3ML 1\n",
      "  3400932250479 | LOPRESSOR 100MG CPR 30\n",
      "  3400932250998 | EXTOVYL 12MG GELULE 60\n",
      "  3400932252602 | XYLLOMAC 1G PDR INJ IM/IV 1\n",
      "  3400932265268 | TRANDATE 200 MG CPR 30\n",
      "  3400932268801 | SALAZOPYRINE 500MG CPR 100\n",
      "  3400932270699 | EFFEDERM 0,05% SOL APPL CUT 1\n",
      "  3400932279807 | VITABACT 0,05% COLLYRE FL 10ML 1\n",
      "  3400932285020 | GAVISCON SUSP BUV FL 250ML 1\n",
      "  3400932285778 | STRESAM 50 MG GELULE 60\n",
      "  3400932297955 | ESTRACYT 140 MG GELULE 100\n",
      "  3400932300020 | CLAMOXYL 500MG/5ML PDR ORALE FL 60ML 1\n",
      "  3400932301089 | DANATROL 200MG GELULE 40\n",
      "  3400932301140 | DANATROL 200MG GELULE 100\n",
      "  3400932303502 | ZADITEN 1MG GELULE 60\n",
      "  3400932303731 | LOPRESSOR LP 200MG CPR 30\n",
      "  3400932306282 | JOSACINE 125MG/5ML GRANULES 1\n",
      "  3400932306923 | JOSACINE 500 MG CPR 20\n",
      "  3400932307005 | JOSACINE 250MG/5ML GRANULES FL 1\n",
      "  3400932308293 | DIPROSONE 0,05% POMMADE TUBE 30G 1\n",
      "  3400932309016 | DIPROSONE 0,05% CREME TUBE 30G 1\n",
      "  3400932309245 | DIPROSALIC POMMADE TUBE 30G 1\n",
      "  3400932310135 | CHRONO INDOCID 75 MG GELULE 20\n",
      "  3400932317929 | PRIMPERAN 10 MG SUPPO 10\n",
      "  3400932320189 | DOLIPRANE 500MG CPR 16\n",
      "  3400932327515 | UTROGESTAN 100MG CAPSULE 30\n",
      "  3400932331536 | DOLIPRANE 500MG PDR ORALE SACHET 12\n",
      "  3400932331994 | MINIRIN 0,1MG/ML SOL ENDONAS 2,5ML 1\n",
      "  3400932332076 | CLAMOXYL 1G PDR ET SOL INJ IM 1\n",
      "  3400932332366 | ALFATIL 250MG GELULE 12\n",
      "  3400932332427 | ALFATIL 125MG/5ML PDR ORALE FL 1\n",
      "  3400932334209 | LOXAPAC 25MG/ML SOL BUV FL 30ML 1\n",
      "  3400932340170 | FLUVERMAL 100MG CPR 6\n",
      "  3400932340750 | URSOLVAN 200 MG GELULE 30\n",
      "  3400932341641 | DELURSAN 250MG CPR PEL 20\n",
      "  3400932345205 | AMODEX 500MG GELULE 12\n",
      "  3400932345373 | AMODEX 250MG/5ML PDR ORALE FL 1\n",
      "  3400932345434 | AMODEX 500MG/5ML PDR ORALE FL 1\n",
      "  3400932349746 | FAZOL G 300 MG OVULE 3\n",
      "  3400932350865 | KAYEXALATE 454G PDR ORALE ET RECTALE 1\n",
      "  3400932351008 | ANDROCUR 50MG CPR 20\n",
      "  3400932351176 | VOLTARENE 50MG CPR 30\n",
      "  3400932360161 | JOSACINE 500MG/5ML GRANULES 1\n",
      "  3400932381791 | TILDIEM 60MG CPR 30\n",
      "  3400932382743 | ESTRACYT 140 MG GELULE 40\n",
      "  3400932386994 | DEPO PROVERA 150 MG SUSP INJ 1\n",
      "  3400932387076 | PIRILENE 500MG CPR 60\n",
      "  3400932387656 | FLUOGEL (FLUORURE DE SODIUM, BIFLUORURE D\"AMMONIUM\n",
      "  3400932389438 | LERCANIDIPINE TVC 20MG CPR 30\n",
      "  3400932399192 | DIPROSALIC LOTION FL 30G 1\n",
      "  3400932399482 | SURGAM 200MG CPR 15\n",
      "  3400932400874 | SERECOR LP 300 MG GELULE 60\n",
      "  3400932403028 | VICTAN 2MG CPR 30\n",
      "  3400932404438 | RISORDAN 20MG CPR 60\n",
      "  3400932407620 | MODOPAR 62,5 (50MG/12,5MG) GELULE 60\n",
      "  3400932409860 | FLUOGEL 2000 GEL DENTAIRE 1\n",
      "  3400932410811 | CORVASAL 2MG CPR 30\n",
      "  3400932411061 | CORVASAL 2MG CPR 90\n",
      "  3400932420285 | FLUCON 0,1% COLLYRE FL 3ML 1\n",
      "  3400932421756 | ACUPAN 20MG SOL INJ 5\n",
      "  3400932425549 | ERY 250MG ENF GRANULES SACHET 24\n",
      "  3400932425600 | ERY 125MG NR GRANULES SACHET 24\n",
      "  3400932428731 | ANDRACTIM 2,5% GEL 1\n",
      "  3400932430161 | TRANXENE 20 MG PDR ET SOL INJ 5\n",
      "  3400932434824 | PNEUMO 23 SOL INJ SER 1\n",
      "  3400932440276 | GELOX SUSP BUV SACHET 30\n",
      "  3400932440795 | FLUVERMAL 100MG/5ML SUSP BUV 1\n",
      "  3400932448432 | ANAFRANIL 75MG CPR 20\n",
      "  3400932448951 | ZADITEN 1MG/5ML SOL BUV FL 150ML 1\n",
      "  3400932454006 | ARTISIAL SOL ENDOBUCCALE 1\n",
      "  3400932456246 | ALFATIL 250MG/5ML PDR ORALE FL 1\n",
      "  3400932458776 | IOPAMIRON 200 SOL INJ FL 10ML 1\n",
      "  3400932458837 | IOPAMIRON 300 SOL INJ FL 10ML 1\n",
      "  3400932459087 | IOPAMIRON 300 SOL INJ FL 50ML 1\n",
      "  3400932459148 | IOPAMIRON 300 SOL INJ FL 100ML 1\n",
      "  3400932459209 | IOPAMIRON 300 SOL INJ FL 200ML 1\n",
      "  3400932459377 | IOPAMIRON 370 SOL INJ FL 20ML 1\n",
      "  3400932459438 | IOPAMIRON 370 SOL INJ FL 50ML 1\n",
      "  3400932459667 | IOPAMIRON 370 SOL INJ FL 100ML 1\n",
      "  3400932459728 | IOPAMIRON 370 SOL INJ FL 200ML 1\n",
      "  3400932460267 | RYTHMODAN LP 250MG CPR 20\n",
      "  3400932460496 | VOLTARENE LP 100MG CPR 15\n",
      "  3400932462629 | PHOSPHALUGEL 12,38G/15ML SUSP BUV FL 1\n",
      "  3400932473335 | BETNEVAL 0,1% CREME TUBE 30G 1\n",
      "  3400932473564 | BETNEVAL 0,1% POMMADE TUBE 30G 1\n",
      "  3400932487813 | HAVLANE 1MG CPR 20\n",
      "  3400932492374 | LASILIX RETARD 60 MG GELULE 30\n",
      "  3400932495856 | ERYTHROCINE 1G GRANULES SACHET 10\n",
      "  3400932500390 | APRANAX 275MG CPR 30\n",
      "  3400932500970 | PROTHIADEN 75MG CPR 20\n",
      "  3400932507955 | ZARONTIN 250MG/5ML SIROP 200ML 1\n",
      "  3400932513819 | BILTRICIDE 600MG CPR 6\n",
      "  3400932520732 | URBANYL 20MG CPR 30\n",
      "  3400932530908 | DIAZEPAM TEVA 5MG CPR 40\n",
      "  3400932531097 | DIAZEPAM TEVA 2MG CPR 40\n",
      "  3400932531158 | DIAZEPAM TEVA 10MG CPR 30\n",
      "  3400932539543 | ZOVIRAX 3% POMMADE OPH TB 4,5G 1\n",
      "  3400932544455 | NIVAQUINE 25MG/5ML SIROP 1\n",
      "  3400932548828 | TRISEQUENS CPR 28\n",
      "  3400932549429 | KERLONE 20MG CPR 28\n",
      "  3400932555222 | IOPAMIRON 200 SOL INJ FL 15ML 1\n",
      "  3400932557462 | MYCOSTER 1% CREME 1\n",
      "  3400932560134 | FUROSEMIDE BGA 20 MG CPR 30\n",
      "  3400932567577 | EFFERALGANMED 500MG CPR 16\n",
      "  3400932570010 | EFFERALGANMED 500MG CPR EFF 16\n",
      "  3400932575503 | IMOVAX POLIO SUSP INJ SER SS AIG 1\n",
      "  3400932576562 | NAFTILUX 200 MG GELULE 20\n",
      "  3400932586158 | GELUPRANE 500MG GELULE 16\n",
      "  3400932598335 | ZYLORIC 100 MG CPR 28\n",
      "  3400932606122 | COLOFOAM 10% MOUSSE RECTALE 1\n",
      "  3400932606351 | LIPUR 450MG CPR 60\n",
      "  3400932606641 | VERATRAN 5MG CPR 30\n",
      "  3400932606702 | VERATRAN 10MG CPR 30\n",
      "  3400932606870 | ZOVIRAX 250MG PDR INJ IV 1\n",
      "  3400932608423 | UN ALFA 0,1 MICROGRAMME SOL BUV 1\n",
      "  3400932610204 | ASPEGIC 1G PDR ET SOL INJ 6\n",
      "  3400932613045 | DERMOVAL 0,05% GEL 1\n",
      "  3400932614394 | DEPO PRODASONE 500 MG SUSP INJ 1\n",
      "  3400932621729 | BEFIZAL 200MG CPR 84\n",
      "  3400932623389 | CLOMID 50MG CPR 5\n",
      "  3400932634095 | URISPAS 200MG CPR 42\n",
      "  3400932634507 | DEPAKINE 57,64MG/ML SIROP FL 150ML 1\n",
      "  3400932634965 | FLUANXOL LP 100 MG SOL INJ 1\n",
      "  3400932635108 | HALDOL DECANOAS 50 MG SOL INJ 5\n",
      "  3400932636228 | FLECAINE 100MG CPR 30\n",
      "  3400932636808 | PRIMALAN 1,25MG/2,5ML SIROP FL 60ML 1\n",
      "  3400932636976 | FELDENE 20MG GELULE 15\n",
      "  3400932637058 | LACTULOSE BIP 10G/15ML SOL BUV SAC 20\n",
      "  3400932638239 | FELDENE 20MG SUPPO 15\n",
      "  3400932644322 | ROCALTROL 0,25 MICROGRAMMES CAPSULE 30\n",
      "  3400932644490 | XANAX 0,25MG CPR 30\n",
      "  3400932644551 | XANAX 0,50MG CPR 30\n",
      "  3400932645213 | FRAKIDEX POMMADE OPH 1\n",
      "  3400932645503 | TOCO 500MG CAPSULE 30\n",
      "  3400932657100 | RYTHMOL 300MG CPR 30\n",
      "  3400932661121 | LUTENYL 5MG CPR 10\n",
      "  3400932661350 | APRANAX 550MG CPR 16\n",
      "  3400932669684 | VIROPHTA 1G/100ML PDR ET SOL OPH 1\n",
      "  3400932670345 | NAAXIA 4,9% COLLYRE FL 10ML 1\n",
      "  3400932670406 | TROSYD 1% CREME 1\n",
      "  3400932670925 | ERYTHROGEL 4% GEL 1\n",
      "  3400932671007 | ERYFLUID 4% SOL 100ML 1\n",
      "  3400932674886 | ROCEPHINE 1000 MG INJ 10 ML IV 1\n",
      "  3400932675258 | ROCEPHINE 1000 MG INJ 3,5 ML IM 1\n",
      "  3400932676729 | ANTADYS 100MG CPR 15\n",
      "  3400932678679 | ECLARAN 5% GEL 1\n",
      "  3400932679041 | DAFALGAN 500MG GELULE 16\n",
      "  3400932680689 | DAKTARIN 2% GEL BUCCAL TUBE 40G 1\n",
      "  3400932681051 | OMNIPAQUE 180MG SOL INJ FV 10ML 1\n",
      "  3400932681570 | OMNIPAQUE 300MG INJ FV 10ML 1\n",
      "  3400932681921 | OMNIPAQUE 350MG SOL INJ FV 20ML 1\n",
      "  3400932682812 | LONOTEN 10MG CPR 40\n",
      "  3400932683062 | LONOTEN 5MG CPR 40\n",
      "  3400932687374 | SODIUM CHL BLZ 0,9% SOL INJ PO 500ML 1\n",
      "  3400932687435 | SODIUM CHL BLZ 0,9% SOL INJ PO 1L 1\n",
      "  3400932691517 | THEOSTAT LP 100MG CPR 30\n",
      "  3400932695010 | GENTAMICINE PAN 80 MG SOL INJ 1\n",
      "  3400932695188 | GENTAMICINE PAN 160 MG SOL INJ 1\n",
      "  3400932695249 | GENTAMICINE PAN 40 MG SOL INJ 1\n",
      "  3400932695300 | GENTAMICINE PAN 10 MG SOL INJ 1\n",
      "  3400932696888 | LIPANOR 100MG GELULE 30\n",
      "  3400932699322 | HALDOL DECANOAS 50 MG SOL INJ 1\n",
      "  3400932703616 | ASPEGIC 250MG ENF PDR ORALE SACHET 20\n",
      "  3400932708178 | ZOVIRAX 200 MG CPR 25\n",
      "  3400932708987 | RENITEC 5MG CPR 28\n",
      "  3400932709069 | RENITEC 20MG CPR 28\n",
      "  3400932722426 | LARGACTIL 25 MG SOL INJ 5\n",
      "  3400932722594 | TANGANIL 500 MG SOL INJ 5\n",
      "  3400932723836 | DICETEL 50MG CPR 20\n",
      "  3400932725496 | BECILAN 250 MG SOL INJ 5\n",
      "  3400932725786 | NOZINAN 25 MG SOL INJ 5\n",
      "  3400932725847 | NEULEPTIL 40 MG/ML SOL BUV FL 30ML 1\n",
      "  3400932726677 | GLUCANTIME 1500 MG SOL INJ 5\n",
      "  3400932727278 | ZYLORIC 200 MG CPR 28\n",
      "  3400932729111 | FLOXYFRAL 50MG CPR 30\n",
      "  3400932729579 | NORDAZ 15MG CPR 30\n",
      "  3400932729630 | NORDAZ 7,5MG CPR 30\n",
      "  3400932730759 | DITROPAN 5MG CPR 60\n",
      "  3400932731121 | CUTACNYL 2,5% GEL 1\n",
      "  3400932731411 | THEOSTAT LP 300MG CPR 30\n",
      "  3400932736492 | CLARADOL 500MG CPR EFF 16\n",
      "  3400932736553 | DAFALGAN 600MG SUPPO 10\n",
      "  3400932740116 | ADALATE LP 20 MG CPR 30\n",
      "  3400932742417 | ZYMAFLUOR MYLAN 1MG CPR 100\n",
      "  3400932748099 | TELEBRIX GASTRO 33G/50ML SOL BUV/REC 1\n",
      "  3400932748150 | TELEBRIX GASTRO 66G/0,1L SOL BUV/REC 1\n",
      "  3400932748501 | AMYCOR 1% CREME 1\n",
      "  3400932758265 | DIPROLENE 0,05% POMMADE 1\n",
      "  3400932762057 | LERCANIDIPINE TVC 20MG CPR 90\n",
      "  3400932767199 | TRANSILANE 40% PDR SUSP BUVABLE 1\n",
      "  3400932781737 | LOXEN 20MG CPR 30\n",
      "  3400932782048 | LOXEN 20MG CPR 90\n",
      "  3400932782567 | FRAXIPARINE 2850UI AXA/0,3ML SOL INJ 2\n",
      "  3400932782796 | FRAXIPARINE 2850UI AXA/0,3ML SOL INJ 10\n",
      "  3400932782857 | FRAXIPARINE 5700UI AXA/0,6ML SOL INJ 2\n",
      "  3400932783229 | FRAXIPARINE 9500UI AXA/1ML SOL INJ 2\n",
      "  3400932785179 | LOCOID 0,1% CREME EPAISSE 1\n",
      "  3400932787531 | THEOSTAT LP 200MG CPR 30\n",
      "  3400932787821 | DILATRANE LP 50MG GELULE 30\n",
      "  3400932787999 | DILATRANE LP 300MG GELULE 30\n",
      "  3400932790661 | OTIPAX SOL AURICULAIRE FL 1\n",
      "  3400932805204 | OTOFA 2,6% SOL AURICULAIRE 1\n",
      "  3400932805372 | TOBREX 0,3% POMMADE OPH 1\n",
      "  3400932805433 | TOBREX 0,3% COLLYRE FL 5ML 1\n",
      "  3400932807093 | TRINORDIOL CPR SUREMBALLE 21\n",
      "  3400932807154 | TRINORDIOL CPR SUREMBALLE 63\n",
      "  3400932807215 | GYNO TROSYD 300MG OVULE 1\n",
      "  3400932810574 | TUSSIPAX CPR 15\n",
      "  3400932812585 | CUTACNYL 10% GEL 1\n",
      "  3400932825653 | CUTACNYL 5% GEL 1\n",
      "  3400932825943 | PROFENID LP 200MG CPR 14\n",
      "  3400932826605 | ORACILLINE 500 000 UI/5 ML SUSP BUV 1\n",
      "  3400932827084 | ORACILLINE 1 MUI/10 ML SUSP BUV 1\n",
      "  3400932829446 | SIBELIUM 10MG CPR 30\n",
      "  3400932830336 | NITRIDERM TTS 5MG/24H DISP TRANSDERM 30\n",
      "  3400932830565 | NITRIDERM TTS 10MG/24H DISP TRANSDER 30\n",
      "  3400932838080 | LACTULOSE BGA 10G/15ML SOL BUV FL 1\n",
      "  3400932840212 | ERYFLUID 4% SOL 30ML 1\n",
      "  3400932843633 | LUTRELEF 3,2 MG PDR ET SOL INJ 1\n",
      "  3400932849895 | IMOVANE 7,5 MG CPR 5\n",
      "  3400932850266 | DECAPEPTYL 0,1 MG PDR ET SOL INJ 7\n",
      "  3400932851218 | ARTEX 5 MG CPR 30\n",
      "  3400932852048 | LODINE 200MG CPR 30\n",
      "  3400932855520 | EXACYL 500 MG CPR 20\n",
      "  3400932858422 | BURINEX 2 MG SOL INJ 5\n",
      "  3400932861033 | FELDENE 20 MG SOL INJ IM 2\n",
      "  3400932862092 | GARDENAL 40 MG PDR ET SOL INJ 1\n",
      "  3400932865284 | NOLVADEX 20 MG CPR 30\n",
      "  3400932867417 | ISOPTINE LP 240MG CPR 30\n",
      "  3400932869718 | MOSCONTIN LP 10MG CPR 14\n",
      "  3400932869886 | MOSCONTIN LP 30MG CPR 14\n",
      "  3400932869947 | MOSCONTIN LP 60MG CPR 14\n",
      "  3400932870028 | MOSCONTIN LP 100MG CPR 14\n",
      "  3400932874798 | TENSTATEN 50MG GELULE 30\n",
      "  3400932876112 | SPASMAG 1,2 G SOL INJ IV 5\n",
      "  3400932882724 | ANANDRON 50MG CPR 90\n",
      "  3400932886227 | FORTRANS PDR ORALE SACHET 4\n",
      "  3400932886975 | VOLTARENE EMULGEL 1% GEL TUBE 1\n",
      "  3400932889709 | PAXELADINE 0,2% SIROP 250ML 1\n",
      "  3400932892198 | GAMMATETANOS LFB 250UI/2ML SOL INJ 1\n",
      "  3400932896103 | ALEPSAL 100MG CPR 30\n",
      "  3400932896271 | ALEPSAL 15MG CPR 30\n",
      "  3400932902057 | PARALYOC 500MG LYOPHILISAT ORAL 16\n",
      "  3400932902866 | BECOTIDE 250 MICROG SOL INHAL FL 200 1\n",
      "  3400932903238 | OFLOCET 200 MG CPR 10\n",
      "  3400932903818 | RULID 150MG AD CPR 10\n",
      "  3400932904587 | BETOPTIC 0,5% SUSP OPH 1\n",
      "  3400932905997 | DIFFU-K 600MG GELULE 40\n",
      "  3400932910731 | DICLOFENAC SDZ 50MG CPR 30\n",
      "  3400932912742 | ISOCARD 1% SOL SUBLINGUALE 1\n",
      "  3400932913282 | BISEPTINE SOL APPLI LOCALE FL 100ML 1\n",
      "  3400932922277 | PARACETAMOL BGA 500MG GELULE 16\n",
      "  3400932924400 | DUPHALAC 10 G/15 ML SOL BUV SACHET 20\n",
      "  3400932924639 | SEPTEAL 0,5% SOL 1\n",
      "  3400932924929 | KETODERM 2% CREME 1\n",
      "  3400932929252 | BECONASE 50 MICROG SUSP NASALE 200 1\n",
      "  3400932931491 | BEFIZAL LP 400MG CPR 30\n",
      "  3400932931842 | FUCIDINE 2% CREME 1\n",
      "  3400932932672 | ZOLADEX 3,6MG IMPLANT INJ 1\n",
      "  3400932934744 | PENTASA 1G/100ML SUSP RECTALE 5\n",
      "  3400932935055 | CELECTOL 200MG CPR 28\n",
      "  3400932935345 | CLARADOL CAFEINE 500MG/50MG CPR 16\n",
      "  3400932936694 | POTASSIUM RCA SIROP SACHET 20\n",
      "  3400932936984 | NATISPRAY 0,15MG SOL BUCCALE 1\n",
      "  3400932939657 | BURINEX 1MG CPR 30\n",
      "  3400932945160 | LERCANIDIPINE VIATRIS 10MG CPR 30\n",
      "  3400932945450 | LERCANIDIPINE VIATRIS 10MG CPR 90\n",
      "  3400932946921 | HYPERIUM 1MG CPR 30\n",
      "  3400932947461 | RILMENIDINE BGA 1MG CPR 30\n",
      "  3400932947980 | CLOPIXOL 20 MG/ML SOL BUV FL 20ML 1\n",
      "  3400932948062 | CLOPIXOL AP 200 MG SOL INJ 1\n",
      "  3400932952724 | TEMGESIC 0,2 MG CPR 20\n",
      "  3400932953615 | UNACIM 1000 MG/500 MG PDR INJ AD 1\n",
      "  3400932954094 | RIFINAH CPR 30\n",
      "  3400932954506 | CALCIDIA 1,54G GRANULES SACHET 20\n",
      "  3400932955107 | LOXEN LP 50MG GELULE 60\n",
      "  3400932955336 | TROPHICREME 0,1% CREME VAGINALE 1\n",
      "  3400932956395 | TEGRETOL 20 MG/ML SUSP BUV FL 150ML 1\n",
      "  3400932959419 | ADVILMED 400MG CPR ENR 20\n",
      "  3400932963898 | TERCIAN 25MG CPR 30\n",
      "  3400932964499 | FURADANTINE 50MG GELULE 21\n",
      "  3400932969005 | PHYSIOGINE 0,5MG OVULE 15\n",
      "  3400932969173 | PHYSIOGINE 0,1% CREME VAGINALE 1\n",
      "  3400932970414 | ZENTEL 0,4G/10ML SUSP BUV 1\n",
      "  3400932973484 | ANAUSIN METOCLOPRAMIDE LP 15MG CPR 30\n",
      "  3400932975785 | LOGIRENE CPR 30\n",
      "  3400932975846 | PROKINYL LP 15 MG GELULE 30\n",
      "  3400932976157 | AOTAL 333MG CPR 60\n",
      "  3400932980468 | INDAPAMIDE BGA 2,5MG CPR 30\n",
      "  3400932981359 | CIFLOX 500MG CPR 12\n",
      "  3400932984312 | TEGRETOL LP 400 MG CPR 30\n",
      "  3400932985371 | MODOPAR LP 125 (100MG/25MG) GELULE 60\n",
      "  3400932989164 | CLARITYNE 10MG CPR 15\n",
      "  3400932989225 | CLARITYNE 10MG CPR 0\n",
      "  3400932989393 | ISORYTHM LP 125MG GELULE 20\n",
      "  3400932989454 | ISORYTHM LP 250MG GELULE 20\n",
      "  3400932992935 | VENTOLINE 0,5 MG SOL INJ 6\n",
      "  3400932993536 | RIFATER CPR 60\n",
      "  3400932999040 | ZESTRIL 20MG CPR 28\n",
      "  3400932999101 | ZESTRIL 5 MG CPR 28\n",
      "  3400932999859 | CACIT 500MG CPR EFF 60\n",
      "  3400933000042 | CACIT 1000MG CPR EFF 30\n",
      "  3400933000912 | LASILIX 10 MG/ML SOL BUV 1\n",
      "  3400933010737 | FRAGMINE 5 000UI AXA/0,2ML SOL INJ 2\n",
      "  3400933010966 | FRAGMINE 2 500UI AXA/0,2ML SOL INJ 2\n",
      "  3400933016012 | XATRAL 2,5 MG CPR 30\n",
      "  3400933018023 | DEPAKINE CHRONO 500 MG CPR 30\n",
      "  3400933022105 | PSYLIA PDR ORALE EFF SACHET 20\n",
      "  3400933023454 | VIRLIX 10MG CPR 15\n",
      "  3400933024055 | CO RENITEC CPR 28\n",
      "  3400933024116 | GYNO PEVARYL LP 150MG OVULE 1\n",
      "  3400933035921 | CORVASAL 4MG CPR 30\n",
      "  3400933040253 | LEVMENTIN 1000 MG/200 MG PDR INJ IV 1\n",
      "  3400933040314 | AUGMENTIN 1000 MG/200 MG PDR+SOL INJ 1\n",
      "  3400933041144 | MYCOSTER 1% SOL CUTANEE 1\n",
      "  3400933046057 | SECTRAL 40MG/ML SOL BUV 1\n",
      "  3400933046347 | MUPIDERM 2% POMMADE 1\n",
      "  3400933047467 | DOLIPRANE 1G AD SUPPO 8\n",
      "  3400933050368 | VACCIN GENHEVAC B PASTEUR SUSP INJ 1\n",
      "  3400933053901 | MICROPAQUE SCANNER SUSP BUV 1\n",
      "  3400933054212 | BISEPTINE SOL APPLI LOCALE FL 250ML 1\n",
      "  3400933054960 | CLAMOXYL 1G CPR DISP 6\n",
      "  3400933055042 | MINIRIN SPRAY 10MICROGR SOL ENDONAS 1\n",
      "  3400933055103 | TRIFLUCAN 50MG GELULE 7\n",
      "  3400933056223 | HELMINTOX 125 MG/2,5 ML SUSP BUV 1\n",
      "  3400933056391 | HELMINTOX 250MG CPR 3\n",
      "  3400933068578 | RUBOZINC 15MG GELULE 30\n",
      "  3400933069001 | EFFICORT LIPOPHILE 0,127% CREME 30G 1\n",
      "  3400933069988 | IMPORTAL 10G PDR ORALE SACHET 20\n",
      "  3400933071998 | DOLIPRANE 500MG CPR EFF 16\n",
      "  3400933072889 | FAZOL 2% PDR 1\n",
      "  3400933073770 | FOLINORAL 5MG GELULE 28\n",
      "  3400933081065 | TOPREC 25MG CPR 20\n",
      "  3400933086039 | DEFANYL 50MG CPR 25\n",
      "  3400933090289 | ULTRAVIST 300 SOL INJ FL 20ML 1\n",
      "  3400933090340 | ULTRAVIST 300 SOL INJ FL 50ML 1\n",
      "  3400933090401 | ULTRAVIST 300 SOL INJ FL 100ML 1\n",
      "  3400933090630 | ULTRAVIST 7.4 G SOL INJ 1\n",
      "  3400933090869 | ULTRAVIST 18.5 G SOL INJ 1\n",
      "  3400933091002 | ULTRAVIST 37 G SOL INJ 1\n",
      "  3400933094881 | FONGAMIL 1% SOL 1\n",
      "  3400933095253 | GAVISCON SUSP BUV SACHET 24\n",
      "  3400933100957 | PROZAC 20 MG GELULE 14\n",
      "  3400933102449 | PERINDOPRIL ARG 4MG CPR 30\n",
      "  3400933102678 | PERINDOPRIL ARG 4MG CPR 90\n",
      "  3400933103279 | PERINDOPRIL ARG 2MG CPR 30\n",
      "  3400933103569 | PERINDOPRIL ARG 2MG CPR 90\n",
      "  3400933104160 | PERINDOPRIL MYL 4 MG CPR 30\n",
      "  3400933104399 | PERINDOPRIL MYL 4 MG CPR 90\n",
      "  3400933104801 | PERINDOPRIL MYL 2 MG CPR 30\n",
      "  3400933105051 | PERINDOPRIL MYL 2 MG CPR 90\n",
      "  3400933105570 | PERINDOPRIL BGA 2MG CPR 30\n",
      "  3400933105860 | PERINDOPRIL BGA 2MG CPR 90\n",
      "  3400933106461 | PERINDOPRIL BGA 4MG CPR 30\n",
      "  3400933106690 | PERINDOPRIL BGA 4MG CPR 90\n",
      "  3400933107703 | MESOCAINE 25 MG SOL INJ 1\n",
      "  3400933108014 | MESOCAINE 50 MG SOL INJ 1\n",
      "  3400933108472 | SELOZOK LP 95 MG CPR 28\n",
      "  3400933108991 | SELOZOK LP 190 MG CPR 28\n",
      "  3400933111434 | MOXYDAR CPR 30\n",
      "  3400933114107 | ERYTHROMYCINE BLL 4% SOL 1\n",
      "  3400933115517 | FLAGYL 500MG CPR 4\n",
      "  3400933115685 | FLAGYL 500MG CPR 14\n",
      "  3400933116866 | LYSANXIA 15 MG/ML SOL BUV FL 20ML 1\n",
      "  3400933117238 | ALPRESS LP 5MG CPR 30\n",
      "  3400933117757 | ALPRESS LP 2,5MG CPR 30\n",
      "  3400933121488 | ZINNAT 250MG CPR 8\n",
      "  3400933121549 | ZINNAT 125MG CPR 8\n",
      "  3400933121600 | CEFUROXIME BGA 250MG CPR 8\n",
      "  3400933122089 | CEFUROXIME ZEN 250 MG CPR 8\n",
      "  3400933126162 | CONDYLINE 0,5% SOL FL 3,5ML 1\n",
      "  3400933126391 | SORIATANE 10 MG GELULE 30\n",
      "  3400933126742 | SORIATANE 25 MG GELULE 30\n",
      "  3400933127343 | CALTRATE 600MG CPR 60\n",
      "  3400933129415 | PARALYOC 250MG LYOPHILISAT ORAL 10\n",
      "  3400933131135 | OROKEN 200MG CPR 8\n",
      "  3400933132255 | CHIBROXINE 0,3% COLLYRE FL 5ML 1\n",
      "  3400933133085 | ALEPSAL 150MG CPR 30\n",
      "  3400933143312 | SELOKEN 100 MG (TARTRATE DE METOPROLOL) 1 BOITE DE\n",
      "  3400933145262 | DAKIN CPF STABILISE SOL FL 250ML 1\n",
      "  3400933145552 | KLIOGEST CPR 28\n",
      "  3400933148744 | TEGRETOL LP 200 MG CPR 30\n",
      "  3400933158330 | PROFENID LP 200MG GELULE 14\n",
      "  3400933167035 | GELDENE 0,5% GEL 1\n",
      "  3400933170806 | EXOCINE 0,3% COLLYRE FL 5ML 1\n",
      "  3400933171346 | DOTAREM 0,5 MMOL/ML SOL INJ FV 10ML 1\n",
      "  3400933171407 | DOTAREM 0,5 MMOL/ML SOL INJ FV 15ML 1\n",
      "  3400933171575 | DOTAREM 0,5 MMOL/ML SOL INJ FV 20ML 1\n",
      "  3400933172237 | ACUITEL 20MG CPR 28\n",
      "  3400933172527 | ACUITEL 5MG CPR 28\n",
      "  3400933173128 | SECTRAL LP 500MG CPR 28\n",
      "  3400933180850 | LINDILANE 400MG/25MG CPR 16\n",
      "  3400933186654 | NIFLUGEL 2,5% GEL 1\n",
      "  3400933187545 | FAZOL 2% EMULSION FLUIDE 1\n",
      "  3400933189846 | MEDROL 16MG CPR 20\n",
      "  3400933191337 | FUCITHALMIC 1% GEL OPH 1\n",
      "  3400933193577 | LERCANIDIPINE VIATRIS 20MG CPR 30\n",
      "  3400933193928 | FELDENE DISP 20MG CPR 15\n",
      "  3400933194758 | GEL LARMES 0,3% GEL OPH TUBE 5G 1\n",
      "  3400933194819 | GEL LARMES 0,3% GEL OPH TUBE 10G 1\n",
      "  3400933198312 | FLOXYFRAL 100MG CPR 15\n",
      "  3400933199081 | CEBUTID LP 200MG GELULE 16\n",
      "  3400933207977 | CLARADOL CAFEINE 500MG/50MG CPR EFF 16\n",
      "  3400933209230 | MONURIL 3G GRANULES SACHET 1\n",
      "  3400933217334 | KALEORID LP 600MG CPR 30\n",
      "  3400933218515 | SPREGAL 0,63% LOTION FL 1\n",
      "  3400933220754 | CODOLIPRANE 400MG/20MG CPR 16\n",
      "  3400933221355 | VASTEN 10MG CPR 28\n",
      "  3400933221416 | VASTEN 20 MG CPR 28\n",
      "  3400933222185 | UVEDOSE 2,5MG/2ML SOL BUV 1\n",
      "  3400933222475 | EURELIX 6MG GELULE 30\n",
      "  3400933226558 | KARDEGIC 300MG PDR ORALE SACHET 30\n",
      "  3400933227159 | FUCIDINE 100MG/2ML NR SUSP BUV 50ML 1\n",
      "  3400933227210 | FUCIDINE 250MG/5ML ENF SUSP BUV 90ML 1\n",
      "  3400933228910 | PENTACARINAT 300MG PDR INJ 1\n",
      "  3400933229160 | OROCAL 500MG CPR 60\n",
      "  3400933239794 | TRANSILANE 3G PDR ORALE SACHET 20\n",
      "  3400933246549 | FRAXIPARINE 7600UI AXA/0,8ML SOL INJ 2\n",
      "  3400933247089 | ROVAMYCINE 3MUI CPR 10\n",
      "  3400933247379 | KARDEGIC 160MG PDR ORALE SACHET 30\n",
      "  3400933248611 | DISCOTRINE 5MG/24H DISP TRANSDERM 30\n",
      "  3400933248840 | DISCOTRINE 10MG/24H DISP TRANSDERM 30\n",
      "  3400933254063 | METEOSPASMYL CAPSULE 20\n",
      "  3400933257026 | LEDERFOLINE 15MG CPR 30\n",
      "  3400933257606 | ISOPTO PILOCARPINE 2 % COLLYRE 1\n",
      "  3400933263577 | LIPANTHYL 200MG MICRONISE GELULE 30\n",
      "  3400933264529 | ANANDRON 150MG CPR 30\n",
      "  3400933265878 | TRIFLUCAN 200MG GELULE 30\n",
      "  3400933270551 | FONGAMIL 1% CREME 1\n",
      "  3400933271152 | NABUCOX 500MG CPR 28\n",
      "  3400933271732 | NABUCOX 1G CPR DISP 28\n",
      "  3400933275174 | LERCANIDIPINE VIATRIS 20MG CPR 90\n",
      "  3400933275815 | DAFALGAN CODEINE 500 MG/30 MG CPR 16\n",
      "  3400933276294 | OPTIRAY 300 SOL INJ FV 100ML 1\n",
      "  3400933276645 | OPTIRAY 350 SOL INJ FV 50ML 1\n",
      "  3400933276874 | OPTIRAY 350 SOL INJ FV 100ML 1\n",
      "  3400933276935 | OPTIRAY 350 SOL INJ FV 200ML 1\n",
      "  3400933277826 | KALEORID LP 1000MG CPR 30\n",
      "  3400933278885 | PENTASA 500MG CPR 100\n",
      "  3400933282387 | URIDOZ 3G GRANULES SACHET 1\n",
      "  3400933283858 | CORTANCYL 20MG CPR 20\n",
      "  3400933292324 | EMLA 5% CREME 5G 1\n",
      "  3400933295226 | AMOX/AC CLAV ZTL 100/12,5MG/ML PDR 1\n",
      "  3400933298296 | CALCIFORTE SOL BUV AMP 10ML 30\n",
      "  3400933302061 | PROFENID 100MG CPR 30\n",
      "  3400933304072 | DIPENTUM 250MG GELULE 100\n",
      "  3400933304652 | CLARADOL CODEINE 500MG/20MG CPR 16\n",
      "  3400933306953 | KETODERM 2% GEL SACHET DOSE 8\n",
      "  3400933307844 | GLUCOSE BLZ 5% SOL INJ POC 500ML 1\n",
      "  3400933307905 | GLUCOSE BLZ 5% SOL INJ POC 1L 1\n",
      "  3400933308094 | GLUCOSE BLZ 5% SOL INJ POC 250ML 1\n",
      "  3400933308155 | GLUCOSE BLZ 5% SOL INJ POC 50ML 1\n",
      "  3400933308216 | GLUCOSE BLZ 5% SOL INJ POC 100ML 1\n",
      "  3400933308445 | GLUCOSE BLZ 10% SOL INJ POC 500ML 1\n",
      "  3400933308506 | GLUCOSE BLZ 10% SOL INJ POC 1L 1\n",
      "  3400933308674 | SODIUM CHL BLZ 0,9% SOL INJ PO 250ML 1\n",
      "  3400933308735 | SODIUM CHL BLZ 0,9% SOL INJ PO 100ML 1\n",
      "  3400933308964 | SODIUM CHL BLZ 0,9% SOL INJ PO 50ML 1\n",
      "  3400933313128 | MODOPAR 125 (100MG/25MG) CPR 60\n",
      "  3400933313357 | AMLOR 10MG GELULE 30\n",
      "  3400933313586 | AMLOR 5MG GELULE 30\n",
      "  3400933314019 | AUGMENTIN 100 MG/12,5 MG/ML NR PDR 1\n",
      "  3400933314248 | ORELOX 100MG CPR 10\n",
      "  3400933314309 | CEFPODOXIME ZTV 100MG CPR 10\n",
      "  3400933315139 | PHYLARM 0,9 P. 100 (CHLORURE DE SODIUM) 1 BOITE DE\n",
      "  3400933316259 | VOGALENE LYOC 7,5MG LYOPHILISAT ORAL 16\n",
      "  3400933316778 | DAFALGAN CODEINE 500MG/30MG CPR EFF 16\n",
      "  3400933318901 | TIAPRIDE VIATRIS 100 MG CPR 20\n",
      "  3400933323523 | SKENAN LP 10MG GELULE 14\n",
      "  3400933323691 | SKENAN LP 30MG GELULE 14\n",
      "  3400933323752 | SKENAN LP 60MG GELULE 14\n",
      "  3400933323813 | SKENAN LP 100MG GELULE 14\n",
      "  3400933324933 | MOCLAMINE 150MG CPR 30\n",
      "  3400933327545 | PULMICORT TURBUHALER 200 MICROG PDR 1\n",
      "  3400933329266 | QUITAXON 10MG CPR 40\n",
      "  3400933329327 | QUITAXON 50MG CPR 20\n",
      "  3400933332518 | CLARADOL 500MG CPR 16\n",
      "  3400933333577 | ICAZ LP 5MG GELULE 30\n",
      "  3400933333928 | ICAZ LP 5MG GELULE 30\n",
      "  3400933338022 | LEVOTONINE 100MG GELULE 100\n",
      "  3400933338602 | DEFANYL 100MG CPR 30\n",
      "  3400933340780 | ICAZ LP 2,5MG GELULE 30\n",
      "  3400933341091 | ICAZ LP 2,5MG GELULE 30\n",
      "  3400933341671 | AMLODIPINE PFZ 5MG GELULE 30\n",
      "  3400933341961 | AMLODIPINE PFZ 10MG GELULE 30\n",
      "  3400933349776 | OMNIPAQUE 350MG SOL INJ FP 50ML NEC 1\n",
      "  3400933349837 | OMNIPAQUE 300MG INJ FV 50ML + NEC 1\n",
      "  3400933352967 | IOPAMIRON 370 SOL INJ FL 50ML + NEC 1\n",
      "  3400933366636 | ALFACALCIDOL THERAMEX 0.25MCG CAPS 30\n",
      "  3400933366865 | ALFACALCIDOL THERAMEX 1MCG CAPSULE 30\n",
      "  3400933366926 | ROZEX 0,75% GEL 1\n",
      "  3400933370718 | SECNOL 2G GRANULES SACHET 1\n",
      "  3400933373320 | UNACIM 1000 MG/500 MG PDR INJ AD IM 1\n",
      "  3400933381943 | DOLKO 60MG/2ML SOL BUV FL 90ML 1\n",
      "  3400933382315 | ROWASA 500MG CPR 90\n",
      "  3400933382544 | ROWASA 250MG CPR 90\n",
      "  3400933383084 | LOMEXIN 2% CREME TUBE 15G 1\n",
      "  3400933384616 | FLECTOR 1% GEL TUBE 60G 1\n",
      "  3400933386856 | FONX 1% CREME TUBE 1\n",
      "  3400933388119 | DOLKO 500MG CPR 16\n",
      "  3400933389178 | FRAXIPARINE 2850UI AXA/0,3ML SOL INJ 6\n",
      "  3400933403119 | ZECLAR 250MG CPR 10\n",
      "  3400933403287 | ZINNAT 125MG/5ML GLE SUSP BUV 40ML 1\n",
      "  3400933403577 | ZINNAT 125MG/5ML GLE SUSP BUV 80ML 1\n",
      "  3400933411213 | ZOVIRAX 800MG CPR 35\n",
      "  3400933411381 | ZOVIRAX 200MG/5ML SUSP BUV 125ML 1\n",
      "  3400933413224 | FONX 1% PDR FL 1\n",
      "  3400933418946 | MYCOSTER 8% SOL 1\n",
      "  3400933423629 | PEVARYL 1% PDR FL 30G 1\n",
      "  3400933423797 | MIANSERINE VIATRIS 10MG CPR 30\n",
      "  3400933423858 | MIANSERINE VIATRIS 30MG CPR 30\n",
      "  3400933429591 | ACULAR 0,5% COLLYRE FL 5ML 1\n",
      "  3400933433093 | INNOHEP 2 500UI AXA/0,25ML SOL INJ 2\n",
      "  3400933433215 | INNOHEP 3 500UI AXA/0,35ML SOL INJ 2\n",
      "  3400933435745 | LOXAPAC 50MG CPR 30\n",
      "  3400933443498 | OCUFEN 0,03% COLLYRE UNIDOSE 20\n",
      "  3400933443559 | DIVINA CPR 21\n",
      "  3400933449582 | PERMIXON 160MG GELULE 60\n",
      "  3400933449933 | NAPROSYNE 1G CPR 8\n",
      "  3400933450243 | EXACOR 130MG CPR 30\n",
      "  3400933457808 | SEREVENT 25 MICROG SUSP INHAL 1\n",
      "  3400933462888 | SPORANOX 100MG GELULE 30\n",
      "  3400933464660 | MODIODAL 100MG CPR 30\n",
      "  3400933466091 | DIGOXINE NATIVELLE 0,25MG CPR 30\n",
      "  3400933467562 | NICOTINELL TTS 7 MG/24H DISP TRANSD 7\n",
      "  3400933467852 | NICOTINELL TTS 7 MG/24H DISP TRANSD 28\n",
      "  3400933467913 | NICOTINELL TTS 14 MG/24H DISP TRANSD 7\n",
      "  3400933468392 | NICOTINELL TTS 14 MG/24H DISP TRANSD 28\n",
      "  3400933468453 | NICOTINELL TTS 21 MG/24H DISP TRANSD 7\n",
      "  3400933468743 | NICOTINELL TTS 21 MG/24H DISP TRANSD 28\n",
      "  3400933472016 | ACT HIB 10 MICROG/0,5ML PDR SOL INJ 1\n",
      "  3400933472184 | ROZAGEL 0,75% GEL 1\n",
      "  3400933479978 | SEVREDOL 10MG CPR 14\n",
      "  3400933480059 | SEVREDOL 20MG CPR 14\n",
      "  3400933480400 | LODINE 300MG CPR 20\n",
      "  3400933484132 | PREVISCAN 20MG CPR 30\n",
      "  3400933487614 | FRAXIPARINE 5700UI AXA/0,6ML SOL INJ 6\n",
      "  3400933488383 | AGYRAX 25MG CPR 15\n",
      "  3400933488734 | LOCERYL 5% VERNIS MEDICAMENTEUX 1\n",
      "  3400933488963 | FRAXIPARINE 7600UI AXA/0,8ML SOL INJ 10\n",
      "  3400933489045 | HEMIGOXINE NATIVELLE 0,125MG CPR 30\n",
      "  3400933494186 | AMYCOR 1% PDR 1\n",
      "  3400933495657 | LAMISIL 250 MG CPR 14\n",
      "  3400933495718 | LAMISIL 250 MG CPR 28\n",
      "  3400933495947 | LAMISIL 1% CREME TUBE 15 G 1\n",
      "  3400933496777 | TIORFAN 100MG GELULE 20\n",
      "  3400933498269 | NOVATREX 2,5MG CPR 12\n",
      "  3400933499501 | FENOFIBRATE VIATRIS 100MG GELULE 30\n",
      "  3400933499730 | FENOFIBRATE VIATRIS 300MG GELULE 30\n",
      "  3400933502614 | OCUFEN 0,03% COLLYRE UNIDOSE 50\n",
      "  3400933502843 | PENTASA 1G SUPPO 15\n",
      "  3400933503673 | ROWASA 500MG SUPPO 15\n",
      "  3400933503734 | ROWASA 500MG SUPPO 30\n",
      "  3400933515102 | ASPIRINE UPSA 500 MG CPR EFF 20\n",
      "  3400933516390 | PARACETAMOL VIATRIS 500MG CPR 16\n",
      "  3400933518004 | TARDYFERON 80MG CPR 30\n",
      "  3400933521134 | LACRIGEL 0,2% GEL OPH 10G 1\n",
      "  3400933523084 | UMULINE PROFIL 30 1000UI/10ML INJ FL 1\n",
      "  3400933523435 | UMULINE NPH 1000UI/10ML S INJ FL 1\n",
      "  3400933523664 | UMULINE RAPIDE 1000UI/10ML S INJ FL 1\n",
      "  3400933524784 | GRANIONS ZINC 15MG/2ML SOL BUV 30\n",
      "  3400933524845 | CHIBRO-PROSCAR 5MG CPR 28\n",
      "  3400933525385 | DEROXAT 20MG CPR 14\n",
      "  3400933527167 | LIPANTHYL 67MG MICRONISE GELULE 60\n",
      "  3400933527228 | LIPANTHYL 67MG MICRONISE GELULE 90\n",
      "  3400933529697 | INOFER CPR 100\n",
      "  3400933529819 | FRAGMINE 5 000UI AXA/0,2ML SOL INJ 6\n",
      "  3400933530129 | FRAGMINE 2 500UI AXA/0,2ML SOL INJ 6\n",
      "  3400933531539 | ASPIRINE UPSA 1G CPR EFF 20\n",
      "  3400933532369 | LERCANIDIPINE SUN 20MG CPR 30\n",
      "  3400933536442 | APRANAX 750MG CPR 15\n",
      "  3400933539283 | ZOPHREN 4 MG SOL INJ AMP 1\n",
      "  3400933539344 | ZOPHREN 8 MG SOL INJ AMP 1\n",
      "  3400933546328 | OPHTIM 0,25% COLLYRE UNIDOSE 0,25ML 60\n",
      "  3400933546496 | OPHTIM 0,50% COLLYRE UNIDOSE 0,25ML 60\n",
      "  3400933547097 | TRIFLUCAN 50MG/5ML PDR ORALE FL 1\n",
      "  3400933547158 | TRIFLUCAN 200MG/5ML PDR ORALE FL35ML 1\n",
      "  3400933548100 | IKOREL 10MG CPR 30\n",
      "  3400933548278 | IKOREL 20MG CPR 30\n",
      "  3400933549749 | LERCANIDIPINE SUN 20MG CPR 90\n",
      "  3400933551759 | PHOSPHONEUROS SOL BUV FL 120ML 1\n",
      "  3400933553180 | ATENOLOL BIOGARAN 100 MG 1 BOITE DE 28, COMPRIMES\n",
      "  3400933553302 | ATENOLOL SUN 100MG CPR 28\n",
      "  3400933559793 | VERAPAMIL MYL LP 240MG CPR 30\n",
      "  3400933560393 | VERAPAMIL MYL LP 120MG CPR 60\n",
      "  3400933563585 | NAABAK 4,9% COLLYRE FL 10ML 1\n",
      "  3400933564308 | SINTROM 4 MG CPR 30\n",
      "  3400933566548 | SINEMET LP 100MG/25MG CPR 30\n",
      "  3400933566777 | LOPERAMIDE ZEN 2MG GELULE 20\n",
      "  3400933569389 | SINEMET LP 200MG/50MG CPR 30\n",
      "  3400933569969 | PROPRANOLOL TVC 40MG CPR 50\n",
      "  3400933572112 | MONO TILDIEM LP 300MG GELULE 28\n",
      "  3400933572280 | MONO TILDIEM LP 200 MG GELULE 28\n",
      "  3400933572341 | HYDROCORTISONE SUB 100MG LYO SOL INJ 1\n",
      "  3400933575991 | ALFATIL LP 500MG CPR 8\n",
      "  3400933576943 | PEVARYL 1% SOLUTION 1\n",
      "  3400933582166 | INNOHEP 3 500UI AXA/0,35ML SOL INJ 6\n",
      "  3400933582456 | INNOHEP 2 500UI AXA/0,25ML SOL INJ 6\n",
      "  3400933586478 | IMPORTAL ENF 5G PDR ORALE SACHET 10\n",
      "  3400933586539 | IMPORTAL JEUNE ENF 2,5G PDR ORALE 10\n",
      "  3400933589899 | OROKEN 100MG/5ML ENF PDR ORALE 1\n",
      "  3400933589950 | OROKEN 40MG/5ML NR PDR ORALE 1\n",
      "  3400933590499 | GLUCAGEN KIT 1MG/ML PDR INJ SER 1\n",
      "  3400933590550 | GLUCAGEN 1MG/1ML PDR INJ FL 1\n",
      "  3400933592042 | VOLTARENE LP 75MG CPR 30\n",
      "  3400933593971 | ZOVIRAX 800MG/10ML SUSP BUVABLE 1\n",
      "  3400933595692 | DEBRIDAT 74,4MG GRANULES ORAL SACHET 30\n",
      "  3400933595982 | BREXIN 20MG CPR 14\n",
      "  3400933602130 | KLEAN PREP PDR ORALE SACHET 2\n",
      "  3400933603601 | CEFPODOXIME ZTV ENF/NR 40MG/5ML 50ML 1\n",
      "  3400933603779 | CEFPODOXIME ZTV ENF/NR40MG/5ML 100ML 1\n",
      "  3400933603830 | ORELOX 40MG/5ML GRANULES 50ML 1\n",
      "  3400933604080 | ORELOX 40MG/5ML GRANULES 100ML 1\n",
      "  3400933604202 | PROZAC 20 MG/5 ML BUV FL 1\n",
      "  3400933604370 | CLIMENE CPR 21\n",
      "  3400933604721 | MEGACE 160MG CPR 30\n",
      "  3400933605490 | CALPEROS 500MG CPR 60\n",
      "  3400933606961 | ANSATIPINE 150 MG GELULE 30\n",
      "  3400933608743 | KETOSTERIL CPR 100\n",
      "  3400933609573 | CYCLADOL 20MG CPR 14\n",
      "  3400933620578 | CALCIPRAT 750MG CPR 60\n",
      "  3400933623760 | DERMAZOL 1% CREME 1\n",
      "  3400933639389 | ZOVIRAX 500MG PDR INJ 1\n",
      "  3400933640620 | ADVILMED 20 MG/ML ENF ET NR SUSP BUV 1\n",
      "  3400933640798 | ACUILIX 20MG/12,5MG CPR 28\n",
      "  3400933649616 | PULMICORT TURBUHALER 100 MICROG PDR 1\n",
      "  3400933651565 | LORAZEPAM VIATRIS 2,5MG CPR 30\n",
      "  3400933652166 | INFLUVAC SUSP INJ AVEC AIG 1\n",
      "  3400933652395 | UNIFLOX 500 MG CPR 1\n",
      "  3400933661090 | CROMEDIL 2 P. 100 (CROMOGLYCATE DE SODIUM) 1 FLACO\n",
      "  3400933662912 | MINI-SINTROM 1MG CPR 20\n",
      "  3400933665814 | ANTARENE 200MG CPR 30\n",
      "  3400933666354 | KLEAN PREP PDR ORALE SACHET 4\n",
      "  3400933666644 | LACRINORM 0,2% GEL OPH 1\n",
      "  3400933670375 | FLIXOTIDE 50 MICROGRAMMES SUSP INH 1\n",
      "  3400933670665 | FLIXOTIDE 125 MICROGRAMMES SUSP INH 1\n",
      "  3400933670894 | FLIXOTIDE 250 MICROGRAMMES SUSP INH 1\n",
      "  3400933672966 | FOLINORAL 25MG GELULE 14\n",
      "  3400933677640 | LERCANIDIPINE SUN 10MG CPR 30\n",
      "  3400933681951 | IBUPROFENE EG 400MG CPR PELL 30\n",
      "  3400933683962 | FLIXOVATE 0,05% CREME 1\n",
      "  3400933684105 | FLIXOVATE 0,005% POMMADE 1\n",
      "  3400933684792 | DICODIN LP 60MG CPR 20\n",
      "  3400933684914 | LOCOID 0,1% EMULSION 1\n",
      "  3400933686635 | TRANSIPEG 2,95G PDR ORALE SACHET 30\n",
      "  3400933689766 | MIGPRIV PDR ORALE SACHET 6\n",
      "  3400933692148 | ZADITEN LP 2MG CPR 30\n",
      "  3400933695620 | DRIPTANE 5MG CPR 60\n",
      "  3400933696511 | LARMES ART MART COLLYRE 10ML 1\n",
      "  3400933699062 | CHLORAMINOPHENE 2MG GELULE 30\n",
      "  3400933708788 | LERCANIDIPINE SUN 10MG CPR 90\n",
      "  3400933713751 | OXEOL 10MG CPR 30\n",
      "  3400933715762 | KYTRIL 1MG CPR 2\n",
      "  3400933727130 | PULMICORT 0,5MG/2ML SUSP INHAL 20\n",
      "  3400933727369 | TERALITHE LP 400MG CPR 60\n",
      "  3400933728489 | PREXIDINE 0,12% SOL PR BDB FL 200ML 1\n",
      "  3400933730611 | FRAGMINE 7 500UI AXA/0,75ML SOL INJ 2\n",
      "  3400933730840 | FRAGMINE 10 000UI AXA/1ML SOL INJ 2\n",
      "  3400933733971 | TIMOPTOL LP 0,25% COLLYRE FL 2,5ML 1\n",
      "  3400933734053 | TIMOPTOL LP 0,50% COLLYRE FL 2,5ML 1\n",
      "  3400933735234 | SOMATULINE LP 30 MG PDR + SOL INJ 1\n",
      "  3400933735692 | PULMICORT 1MG/2ML SUSP INHAL 20\n",
      "  3400933737535 | CILOXAN 0,3% COLLYRE FL 5ML 1\n",
      "  3400933747879 | PULMICORT TURBUHALER 400 MICROG PDR 1\n",
      "  3400933752903 | GLUCOR 50MG CPR 90\n",
      "  3400933753153 | GLUCOR 100MG CPR 90\n",
      "  3400933753672 | GAVISCON NR SUSP BUV FL 150ML 1\n",
      "  3400933761028 | ODRIK 2MG GELULE 30\n",
      "  3400933761318 | RULID 150MG AD CPR 16\n",
      "  3400933764098 | TADENAN 50MG CAPSULE 60\n",
      "  3400933765620 | LACRYVISC 0,3% GEL OPH TUBE 15G 1\n",
      "  3400933766689 | PARACETAMOL EG 500MG GELULE 16\n",
      "  3400933770532 | XENETIX 300 SOL INJ FL 200ML 1\n",
      "  3400933771072 | XENETIX 350 SOL INJ FL 20ML 1\n",
      "  3400933771133 | XENETIX 350 SOL INJ FL 50ML 1\n",
      "  3400933771362 | XENETIX 350 SOL INJ FL 100ML 1\n",
      "  3400933771423 | XENETIX 350 SOL INJ FL 150ML 1\n",
      "  3400933771591 | XENETIX 350 SOL INJ FL 200ML 1\n",
      "  3400933773205 | BECLOJET 250MICROG SOL INHAL 1\n",
      "  3400933773373 | FORADIL 12 MICROG PDR INH GELULE 30\n",
      "  3400933773434 | FORADIL 12 MICROG PDR INH GELULE 60\n",
      "  3400933775155 | HAVRIX 1440U/1ML AD SUSP INJ 1\n",
      "  3400933775735 | LOPERAMIDE SUN 2MG GELULE 20\n",
      "  3400933776794 | XENETIX 300 SOL INJ FL 20ML 1\n",
      "  3400933776855 | XENETIX 300 SOL INJ FL 50ML 1\n",
      "  3400933777166 | XENETIX 300 SOL INJ FL 100ML 1\n",
      "  3400933777227 | XENETIX 300 SOL INJ FL 150ML 1\n",
      "  3400933778286 | PHYSIOTENS 0,2MG CPR 30\n",
      "  3400933778927 | PHYSIOTENS 0,4MG CPR 30\n",
      "  3400933780418 | SABRIL 500MG CPR 60\n",
      "  3400933780647 | SABRIL 500MG GRANULES 60\n",
      "  3400933782597 | IMIJECT 6 MG SOL INJ 2\n",
      "  3400933782887 | IMIJECT 6 MG SOL INJ AUTO-INJ 2\n",
      "  3400933783310 | TERLOMEXIN 200 MG CAPSULE VAGINALE 3\n",
      "  3400933783488 | LOMEXIN 600MG CAPSULE VAGINALE 1\n",
      "  3400933785260 | PROHANCE 2793MG/10ML SOL INJ FL 1\n",
      "  3400933785321 | PROHANCE 4189,5MG/15ML SOL INJ FL 1\n",
      "  3400933785499 | PROHANCE 5586MG/20ML SOL INJ FL 1\n",
      "  3400933788513 | LOGIMAX 5 MG/47,5 MG (FELODIPINE, SUCCINATE DE MET\n",
      "  3400933788742 | DIFFERINE 0,1% GEL 1\n",
      "  3400933789862 | NEURONTIN 100 MG GELULE 90\n",
      "  3400933790172 | NEURONTIN 300MG GELULE 90\n",
      "  3400933791643 | IOMERON 150 SOL INJ FL 250ML 1\n",
      "  3400933792763 | IOMERON 250 SOL INJ FL 100ML 1\n",
      "  3400933793593 | IOMERON 300 SOL INJ FL 50ML 1\n",
      "  3400933793715 | IOMERON 300 SOL INJ FL 100ML 1\n",
      "  3400933793944 | IOMERON 300 SOL INJ FL 200ML 1\n",
      "  3400933794316 | IOMERON 350 SOL INJ FL 50ML 1\n",
      "  3400933794545 | IOMERON 350 SOL INJ FL 100ML 1\n",
      "  3400933794606 | IOMERON 350 SOL INJ FL 150ML 1\n",
      "  3400933794774 | IOMERON 350 SOL INJ FL 200ML 1\n",
      "  3400933795146 | IOMERON 400 SOL INJ FL 50ML 1\n",
      "  3400933795375 | IOMERON 400 SOL INJ FL 100ML 1\n",
      "  3400933795436 | IOMERON 400 SOL INJ FL 150ML 1\n",
      "  3400933795665 | IOMERON 400 SOL INJ FL 200ML 1\n",
      "  3400933796037 | REFRESH COLLYRE UNIDOSE 30\n",
      "  3400933796266 | REFRESH COLLYRE UNIDOSE 90\n",
      "  3400933797447 | CELLUVISC 1% COLLYRE UNIDOSE 30\n",
      "  3400933797508 | CELLUVISC 1% COLLYRE UNIDOSE 90\n",
      "  3400933799229 | FENTANYL ZEN 12MICROG/H DISP TRANSD 5\n",
      "  3400933801380 | ZECLAR 500MG CPR 10\n",
      "  3400933801441 | NEURONTIN 400 MG GELULE 90\n",
      "  3400933807245 | TRINIPATCH 5MG/24H DISP TRANSDERM 30\n",
      "  3400933807306 | TRINIPATCH 10MG/24H DISP TRANSDERM 30\n",
      "  3400933808884 | AMYCOR ONYCHOSET 1% POMMADE 1\n",
      "  3400933809775 | IDEOS 500MG/400UI CPR 60\n",
      "  3400933811266 | OESCLIM 25 MICROG/24H DISP 8\n",
      "  3400933811846 | OESCLIM 50 MICROG/24H DISP 8\n",
      "  3400933814458 | VOLTARENE 25MG CPR 30\n",
      "  3400933814687 | DIAMICRON LM 60MG CPR 30\n",
      "  3400933817930 | LARMABAK 0,9% COLLYRE FL 10ML 1\n",
      "  3400933823382 | DIAMICRON LM 60MG CPR 90\n",
      "  3400933825973 | BROMAZEPAM RPG 6 MG 1 BOITE DE 30, COMPRIMES QUADR\n",
      "  3400933826345 | PHYSIOGINE 1MG CPR 30\n",
      "  3400933827465 | FLUDEX LP 1,5MG CPR 30\n",
      "  3400933828066 | ZECLAR 500MG CPR 14\n",
      "  3400933829247 | OESTRODOSE 0,06% GEL FL 80G 1\n",
      "  3400933830595 | ALLERGODIL 0,1% SOL NASALE 1\n",
      "  3400933830885 | CALCIDOSE VIT D3 500MG/400UI PDR 60\n",
      "  3400933832377 | INDAPAMIDE BGA LP 1,5MG CPR 30\n",
      "  3400933833619 | SEROPRAM 20MG CPR 28\n",
      "  3400933838980 | IOPIDINE 0,5% COLLYRE FL 5ML 1\n",
      "  3400933840303 | DOTAREM 0,5MMOL/ML SOL INJ SER 15ML 1\n",
      "  3400933840471 | DOTAREM 0,5MMOL/ML SOL INJ SER 20ML 1\n",
      "  3400933844493 | ZELITREX 500MG CPR 42\n",
      "  3400933845384 | LASILIX SPECIAL 500MG CPR 30\n",
      "  3400933845735 | TANGANILPRO 500 MG CPR 30\n",
      "  3400933846336 | VISIPAQUE 270MG/ML INJ FV 20ML 1\n",
      "  3400933846855 | VISIPAQUE 320MG/ML INJ FV 20ML 1\n",
      "  3400933851248 | LOCATOP 0,1% CREME 1\n",
      "  3400933851309 | TRUSOPT 20 MG/ML COLLYRE FL 5ML HD 1\n",
      "  3400933852078 | HYZAAR 50MG/12,5MG CPR 28\n",
      "  3400933852429 | COZAAR 50MG CPR 28\n",
      "  3400933857042 | AMOXICILLINE BGA 500 MG GELULE 12\n",
      "  3400933858681 | AMOXICILLINE BGA 125 MG/5ML PDR 1\n",
      "  3400933858803 | AMOXICILLINE BGA 250 MG/5ML PDR 1\n",
      "  3400933859053 | AMOXICILLINE BGA 500 MG/5ML PDR 1\n",
      "  3400933861872 | VITAMINE A FAURE COLLYRE FL 10ML 1\n",
      "  3400933863425 | ECONAZOLE TVS 1% EMULS FL 30G 1\n",
      "  3400933863593 | ECONAZOLE TVS 1% CREME 1\n",
      "  3400933863715 | ECONAZOLE TVS 1% SOL FL 30G 1\n",
      "  3400933864774 | NORPROLAC 25 ET 50 MICROG CPR 6\n",
      "  3400933865085 | NORPROLAC 75 MICROG CPR 30\n",
      "  3400933865146 | NORPROLAC 150 MICROG CPR 30\n",
      "  3400933867737 | FLUCONAZOLE PFZ 200MG GELULE 30\n",
      "  3400933867966 | FLUCONAZOLE PFZ 50MG GELULE 7\n",
      "  3400933868277 | FLUCONAZOLE PFZ 50MG PDR ORALE 1\n",
      "  3400933870577 | APOKINON 30 MG SOL INJ STYLO 1\n",
      "  3400933870638 | APOKINON 30 MG SOL INJ STYLO 5\n",
      "  3400933876203 | DICETEL 100MG CPR 30\n",
      "  3400933877262 | CALCIPRAT 500MG CPR 60\n",
      "  3400933878733 | CACIT VIT D3 1000MG/880UI GRANULES 30\n",
      "  3400933880453 | RETROVIR 250 MG GELULE 40\n",
      "  3400933880514 | RETROVIR 100 MG GELULE 100\n",
      "  3400933884246 | RETROVIR 100 MG/10 ML SOL BUV+SRG 1\n",
      "  3400933888787 | MOBIC 7,5 MG CPR 10\n",
      "  3400933890568 | MOBIC 15 MG CPR 10\n",
      "  3400933890629 | MOBIC 15 MG CPR 14\n",
      "  3400933894351 | METHADONE AP-HP 10MG/7,5ML SIROP 1\n",
      "  3400933894412 | METHADONE AP-HP 20MG/15ML SIROP 1\n",
      "  3400933894580 | METHADONE AP-HP 5MG/3,75ML SIROP 1\n",
      "  3400933894870 | RISPERDAL 1 MG CPR 60\n",
      "  3400933895013 | RISPERDAL 2 MG CPR 60\n",
      "  3400933898205 | DAIVONEX 50 MICROG/G CREME 30G 1\n",
      "  3400933898434 | LAMICTAL 25MG CPR DISP 30\n",
      "  3400933898663 | LAMICTAL 100 MG CPR DISP 30\n",
      "  3400933899554 | SPOTOF 500MG CPR 20\n",
      "  3400933899615 | SPOTOF 1G/10ML SOL BUV 5\n",
      "  3400933903619 | STILNOX 10MG CPR 7\n",
      "  3400933904678 | DEBRIDAT 100MG CPR 30\n",
      "  3400933905330 | EFFERALGANMED 80MG NR PDR ORALE EFF 12\n",
      "  3400933905569 | EFFERALGANMED 80MG SUPPO 10\n",
      "  3400933905620 | DAFALGAN 150MG PDR ORALE EFF 12\n",
      "  3400933905798 | EFFERALGANMED 150MG SUPPO 10\n",
      "  3400933905859 | EFFERALGANMED 300MG SUPPO 10\n",
      "  3400933905910 | COLOPEG PDR ORALE SACHET 4\n",
      "  3400933911881 | TOPALGIC 50MG GELULE 30\n",
      "  3400933912482 | MONOFLOCET 200MG CPR 2\n",
      "  3400933913083 | ESTREVA 0,1% GEL 1\n",
      "  3400933916336 | CASODEX 50MG CPR 30\n",
      "  3400933916794 | TRANSULOSE GELEE ORALE 1\n",
      "  3400933917227 | MELAXOSE PATE ORALE POT 150G 1\n",
      "  3400933919467 | SEREVENT DISKUS 50 MICROG PDR INHAL 60\n",
      "  3400933922368 | CALCIDOSE 500MG PDR ORALE SACHET 60\n",
      "  3400933927561 | ATROVENT 0,03% SOL NASALE FL 15ML 1\n",
      "  3400933927912 | KETUM 100MG CPR 30\n",
      "  3400933928162 | KETUM LP 200MG GELULE 14\n",
      "  3400933929282 | MIRENA 52MG DISP INTRA UTERIN 1\n",
      "  3400933929404 | RITALINE 10MG CPR 30\n",
      "  3400933933074 | FLIXOTIDE DISKUS 100 MICROG PDR INH 60\n",
      "  3400933933364 | FLIXOTIDE DISKUS 250 MICROG PDR INH 60\n",
      "  3400933935436 | KYTRIL 3 MG SOL INJ 1\n",
      "  3400933936327 | FLIXOTIDE DISKUS 500 MICROG PDR INH 60\n",
      "  3400933937218 | PYOSTACINE 250MG CPR 16\n",
      "  3400933940119 | CALCIUM VTS 500MG CPR 60\n",
      "  3400933940287 | DIPENTUM 500MG CPR 60\n",
      "  3400933941178 | JOSACINE 1000MG CPR AD DISP 10\n",
      "  3400933941468 | CALCIPRAT 1000MG CPR 30\n",
      "  3400933943301 | LUTERAN 10MG CPR 12\n",
      "  3400933943769 | DECAPEPTYL LP 3MG PDR ET SOL INJ 1\n",
      "  3400933943998 | SUBUTEX 8MG CPR 7\n",
      "  3400933944421 | SUBUTEX 0,4MG CPR 7\n",
      "  3400933951283 | VIRGAN 1,5 MG/G GEL OPH 1\n",
      "  3400933951405 | SUBUTEX 2MG CPR 7\n",
      "  3400933952235 | TAMOXIFENE VIATRIS 10MG CPR 30\n",
      "  3400933952464 | TAMOXIFENE VIATRIS 20MG CPR 30\n",
      "  3400933953645 | RULID 50MG CPR 10\n",
      "  3400933953935 | OZIDIA 5MG CPR 30\n",
      "  3400933954185 | OZIDIA 10MG CPR 30\n",
      "  3400933956547 | DISCOTRINE 15MG/24H DISP TRANDERM 30\n",
      "  3400933958329 | PRIMALAN 10 MG CPR 14\n",
      "  3400933960858 | MOBIC 7,5 MG CPR 14\n",
      "  3400933961688 | LARIAM 250MG CPR 8\n",
      "  3400933963460 | CAVERJECT 0,01MG/1ML PDR ET SOL INJ 1\n",
      "  3400933963521 | CAVERJECT 0,02MG/1ML PDR ET SOL INJ 1\n",
      "  3400933963811 | ZOLADEX 10,8MG IMPLANT INJ 1\n",
      "  3400933965242 | TOLEXINE 50MG CPR 14\n",
      "  3400933965303 | TOLEXINE 50MG CPR 28\n",
      "  3400933965532 | TOLEXINE 100MG CPR 15\n",
      "  3400933967543 | PIROXICAM PFZ 20 MG SOL INJ IM 2\n",
      "  3400933968892 | PIROXICAM PFZ 20MG CPR 15\n",
      "  3400933969554 | CALTRATE VITAMINE D3 600MG/400UI CPR 60\n",
      "  3400933970673 | CIMETIDINE MYL 200MG CPR 30\n",
      "  3400933971335 | CIMETIDINE MYL 400MG CPR 30\n",
      "  3400933972394 | INNOHEP 10 000UI ANTI XA SOL INJ 2\n",
      "  3400933972516 | INNOHEP 10 000UI ANTI XA SOL INJ 10\n",
      "  3400933972684 | INNOHEP 14 000UI AXA SOL INJ 2\n",
      "  3400933972806 | INNOHEP 14 000UI AXA SOL INJ 10\n",
      "  3400933972974 | INNOHEP 18 000UI AXA SOL INJ 2\n",
      "  3400933973117 | INNOHEP 18 000UI AXA SOL INJ 10\n",
      "  3400933978839 | MYDRIATICUM 2MG/0,4ML COLLYRE UNIDOS 20\n",
      "  3400933983512 | IOPAMIRON 300 SOL INJ FL 100ML + NEC 1\n",
      "  3400933983680 | IOPAMIRON 370 SOL INJ FL 100ML + NEC 1\n",
      "  3400933984052 | LACTULOSE VTS 10G/15ML SOL BUV SAC 20\n",
      "  3400933984281 | LOXAPAC 100MG CPR 30\n",
      "  3400933986124 | NUREFLEX 200MG CPR 30\n",
      "  3400933986353 | OFLOCET 1,5MG/0,5ML SOL AURICULAIRE 20\n",
      "  3400933991265 | IOMERON 350 SOL INJ FL 50ML + NEC 1\n",
      "  3400933998189 | OMIX LP 0,4MG GELULE 30\n",
      "  3400933998240 | JOSIR LP 0,4MG GELULE 30\n",
      "  3400934000713 | EMLAPATCH 5% PANSEMENT 1\n",
      "  3400934001024 | MOVICOL PDR ORALE SACHET 20\n",
      "  3400934003905 | EFFERALGANMED 250MG PDR ORALE EFF 12\n",
      "  3400934004155 | METHADONE AP-HP 40MG/15ML SIROP 1\n",
      "  3400934004216 | METHADONE AP-HP 60MG/15ML SIROP 1\n",
      "  3400934008009 | ECONAZOLE L X.O 1% CREME TUBE 30G 1\n",
      "  3400934017452 | GLUCOSE AGUETTANT 5 P. 100 1 BOITE DE 1, 500 ML EN\n",
      "  3400934018572 | CHLORURE DE SODIUM AGUETTANT 0,9 P. 100 1 BOITE DE\n",
      "  3400934021305 | MORPHINE CHL LAV 10 MG INJ 1ML 10\n",
      "  3400934031649 | HELICIDINE 10% SIROP FL 250ML 1\n",
      "  3400934034190 | ZOLOFT 50MG GELULE 28\n",
      "  3400934035371 | KESTIN 10MG CPR 15\n",
      "  3400934035661 | KESTIN 10MG CPR 30\n",
      "  3400934035890 | ARTELAC 1,6MG/0,5ML COLLYRE UNIDOSE 60\n",
      "  3400934038563 | UMULINE RAPIDE 300UI/3ML SOL INJ CAR 5\n",
      "  3400934038792 | UMULINE NPH 300UI SUSP INJ CART 5\n",
      "  3400934039454 | UMULINE PROFIL 30 300U INJ CART 5\n",
      "  3400934042416 | LYTOS 520MG CPR 30\n",
      "  3400934042874 | DOSTINEX 0,5MG CPR 8\n",
      "  3400934043017 | TIMABAK 0,25% COLLYRE FL 5ML 1\n",
      "  3400934043185 | TIMABAK 0,50% COLLYRE FL 5ML 1\n",
      "  3400934043765 | HYTRINE 1MG CPR 15\n",
      "  3400934043826 | LORAZEPAM VIATRIS 1MG CPR 30\n",
      "  3400934045547 | DILTIAZEM VIATRIS 60MG CPR 30\n",
      "  3400934047039 | SECTRAL 200MG CPR 30\n",
      "  3400934052460 | MOPRAL 10 MG GELULE 30\n",
      "  3400934052750 | ZOLTUM 10 MG GELULE 30\n",
      "  3400934053061 | CROMABAK 2% COLLYRE FL 10ML 1\n",
      "  3400934053290 | MULTICROM 2% COLLYRE FL 10ML 1\n",
      "  3400934053702 | SKENAN LP 200MG GELULE 14\n",
      "  3400934057144 | TOCOLION 500MG CAPSULE 30\n",
      "  3400934060335 | AIROMIR AUTOHALER 100 MICROG SUSP 1\n",
      "  3400934062056 | FARESTON 60MG CPR 30\n",
      "  3400934064357 | SPAGULAX MUCILAGE PUR GRANULES SACH 20\n",
      "  3400934065187 | MUCOMYST 200MG PDR ORALE SACHET 18\n",
      "  3400934069550 | SPAGULAX 2,143 G PDR ORALE EFF 20\n",
      "  3400934075124 | NITRIDERM TTS 15MG/24H DISP TRANSDER 30\n",
      "  3400934081095 | MOPRAL 20 MG GELULE GASTRO-RESIS 7\n",
      "  3400934081217 | MOPRAL 20 MG GELULE GASTRO-RESIS 14\n",
      "  3400934081446 | MOPRAL 20 MG GELULE GASTRO-RESIS 28\n",
      "  3400934083228 | OPTIJECT 300 SOL INJ SER 50ML 1\n",
      "  3400934083686 | OPTIJECT 300 SOL INJ SER + P 100ML 1\n",
      "  3400934083808 | OPTIJECT 300 SOL INJ SER + P 125ML 1\n",
      "  3400934086298 | OPTIJECT 350 SOL INJ SER 50ML 1\n",
      "  3400934086649 | OPTIJECT 350 SOL INJ SER + P 100ML 1\n",
      "  3400934086878 | OPTIJECT 350 SOL INJ SER + P 125ML 1\n",
      "  3400934089480 | ZYMAFLUOR 0,50MG CPR 100\n",
      "  3400934090141 | CYPROTERONE MYL 50MG CPR 20\n",
      "  3400934090370 | DERMESTRIL 100 MICROG/24H DISP 8\n",
      "  3400934090431 | DERMESTRIL 50 MICROG/24H DISP 8\n",
      "  3400934090660 | DERMESTRIL 25 MICROG/24H DISP 8\n",
      "  3400934090899 | THAIS 50 MICROG/24H DISP 8\n",
      "  3400934090950 | THAIS 25 MICROG/24H DISP 8\n",
      "  3400934097126 | ZOLTUM 20 MG GELULE 28\n",
      "  3400934097645 | SPIRONOLACTONE ALTIZIDE VIATRIS CPR 30\n",
      "  3400934103650 | DALACINE 300 MG GELULE 16\n",
      "  3400934104831 | DEBRIDAT 4,8MG/ML ENF NR ORAL 125ML 1\n",
      "  3400934105432 | IOPIDINE 1% M/V COLLYRE UNIDOSE 2\n",
      "  3400934115608 | CALCIPRAT VIT D3 500MG/400UI CPR 60\n",
      "  3400934115776 | CALPEROS D3 500MG/400UI CPR 60\n",
      "  3400934116896 | MYNOCINE 100 MG GELULE 15\n",
      "  3400934124471 | CELESTENE 2MG CPR DISP 20\n",
      "  3400934124822 | MYCOSTER 1% PDR 1\n",
      "  3400934125652 | DECAPEPTYL LP 11,25MG PDR ET SOL INJ 1\n",
      "  3400934125942 | GYDRELLE 0,1% CREME VAGINALE 1\n",
      "  3400934126024 | GABITRIL 5MG CPR 50\n",
      "  3400934126253 | GABITRIL 10MG CPR 50\n",
      "  3400934126482 | GABITRIL 15MG CPR 50\n",
      "  3400934127373 | TIMOLOL NOV 0,50% COLLYRE FL 5ML 1\n",
      "  3400934130045 | MOPRAL 10 MG GELULE 14\n",
      "  3400934130106 | MOPRAL 10 MG GELULE 28\n",
      "  3400934130274 | HYTRINE 5MG CPR 28\n",
      "  3400934135019 | QUINIMAX 500MG CPR 9\n",
      "  3400934136139 | XOLAAM CPR 40\n",
      "  3400934138201 | ORAVIR 500MG CPR 21\n",
      "  3400934142680 | HUMALOG 1000 UI SOL INJ FL 1\n",
      "  3400934145124 | EPIVIR 10 MG/ML SOL BUV 1\n",
      "  3400934145292 | EPIVIR 150 MG CPR 60\n",
      "  3400934147135 | LAMICTAL 50 MG CPR DISP 30\n",
      "  3400934147364 | LAMICTAL 200 MG CPR DISP 30\n",
      "  3400934147425 | FEMARA 2,5MG CPR 30\n",
      "  3400934147715 | ENTOCORT 3MG GELULE 45\n",
      "  3400934147883 | ENTOCORT 3MG GELULE 90\n",
      "  3400934152566 | TERGYNAN CPR VAGINAL 10\n",
      "  3400934164682 | RILUTEK 50MG CPR 56\n",
      "  3400934164743 | CIMETIDINE MYL 800MG CPR 15\n",
      "  3400934165634 | ZOPHREN 4 MG/5 ML SIROP 1\n",
      "  3400934166525 | AVAXIM 160U SUSP INJ SER AIG ATTACHE 1\n",
      "  3400934168475 | NUREFLEX 400MG CPR 20\n",
      "  3400934170836 | ZELITREX 500MG CPR 10\n",
      "  3400934171727 | CLAMOXYL 1G CPR DISP 14\n",
      "  3400934175220 | SICCAFLUID 0,25% GEL OPH FL 10G 1\n",
      "  3400934176579 | OXYBUTINE CRISTERS 5 MG 1 BOITE DE 60, COMPRIMES S\n",
      "  3400934177002 | ZYRTEC 10MG/ML BUV FL 15ML 1\n",
      "  3400934178122 | BECLO RHINO 50MICROG SUSP NAS 100 1\n",
      "  3400934178290 | BECLO RHINO 50MICROG SUSP NAS 200 1\n",
      "  3400934195211 | MONAZOL 300MG OVULE 1\n",
      "  3400934195389 | INDOCOLLYRE 0,1% COLLYRE FL 5ML 1\n",
      "  3400934197741 | IXEL 25MG GELULE 56\n",
      "  3400934198571 | IXEL 50MG GELULE 56\n",
      "  3400934199691 | GENOTONORM 12 MG/1ML PDR ET SOL INJ 1\n",
      "  3400934201684 | CYPROTERONE BGA 100MG CPR 60\n",
      "  3400934207259 | CLOMIPRAMINE MYL 10MG CPR 60\n",
      "  3400934207839 | CLOMIPRAMINE VIATRIS 25MG CPR 50\n",
      "  3400934210211 | AMAREL 1MG CPR 30\n",
      "  3400934210389 | AMAREL 2MG CPR 30\n",
      "  3400934210440 | AMAREL 3MG CPR 30\n",
      "  3400934210501 | AMAREL 4MG CPR 30\n",
      "  3400934212970 | FRAGMINE 7 500UI AXA/0,75ML SOL INJ 10\n",
      "  3400934213052 | FRAGMINE 10 000UI AXA/1ML SOL INJ 10\n",
      "  3400934215063 | XYLOCAINE 5 MG/ML SOL INJ 20ML 1\n",
      "  3400934215872 | UMATROPE 6 MG/3 ML PDR ET SOL INJ 1\n",
      "  3400934215933 | UMATROPE 12 MG/3 ML PDR ET SOL INJ 1\n",
      "  3400934216015 | UMATROPE 24 MG/3 ML PDR ET SOL INJ 1\n",
      "  3400934216992 | INNOHEP 4 500UI AXA/0,45ML SOL INJ 2\n",
      "  3400934217074 | INNOHEP 4 500UI AXA/0,45ML SOL INJ 6\n",
      "  3400934218194 | XOLAAM SUSP BUV FL 1\n",
      "  3400934223228 | SERTRALINE PFZ 50MG GELULE 28\n",
      "  3400934223976 | XYLOCAINE 10 MG/ML SOL INJ FL 20ML 1\n",
      "  3400934224058 | XYLOCAINE 400 MG SS CONS SOL INJ 1\n",
      "  3400934232732 | CYPROTERONE BGA 50MG CPR 20\n",
      "  3400934234453 | KREDEX 6,25MG CPR 28\n",
      "  3400934234743 | KREDEX 12,5MG CPR 28\n",
      "  3400934236525 | ARIMIDEX 1MG CPR 30\n",
      "  3400934237355 | EFFICORT HYDROPHILE 0,127% CREME 30G 1\n",
      "  3400934237706 | ZYPREXA 5MG CPR 28\n",
      "  3400934238307 | DUROGESIC 25 MICROG/H DISP TRANSDERM 5\n",
      "  3400934238475 | DUROGESIC 50 MICROG/H DISP TRANSDERM 5\n",
      "  3400934238536 | DUROGESIC 75 MICROG/H DISP TRANSDERM 5\n",
      "  3400934238765 | DUROGESIC 100MICROG/H DISP TRANSDERM 5\n",
      "  3400934239076 | NUTRIVISC 20MG COLLYRE UNIDOSE 30\n",
      "  3400934239946 | DELIDOSE 1MG/1G GEL 28\n",
      "  3400934240195 | DELIDOSE 0,5MG/0,5G GEL 28\n",
      "  3400934240485 | ZOFORA 20MG SOL INJ IM 2\n",
      "  3400934242908 | DYSALFA 1MG CPR 15\n",
      "  3400934243158 | DYSALFA 5MG CPR 28\n",
      "  3400934243677 | OROMONE 2 MG CPR 28\n",
      "  3400934244100 | SANDOSTATINE 0,05 MG SOL INJ 6\n",
      "  3400934244278 | SANDOSTATINE 0,1 MG SOL INJ 6\n",
      "  3400934244339 | SANDOSTATINE 500 MCG SOL INJ 6\n",
      "  3400934250071 | EUROBIOL 25 000 U. 1 BOITE DE 90, MICROGRANULES GA\n",
      "  3400934252891 | LACRYVISC 0,3% GEL OPH UNIDOSE 30\n",
      "  3400934254093 | QUADRASA 2G PDR RECTALE 7\n",
      "  3400934263729 | VERAPAMIL BGA LP 240MG GELULE 30\n",
      "  3400934263958 | KREDEX 25MG CPR 28\n",
      "  3400934291234 | MORPHINE CHL LAV 10MG/ML 5ML 10\n",
      "  3400934291463 | MORPHINE CHL LAV 100 MG INJ 10\n",
      "  3400934292125 | PROFENID 100 MG SOL INJ IM 6\n",
      "  3400934292293 | NASACORT 55 MCG SUSP NASALE 1\n",
      "  3400934300141 | ASPIRINE PROTECT 300MG CPR 30\n",
      "  3400934300660 | MOSCONTIN LP 200 MG CPR 14\n",
      "  3400934301261 | NASONEX 50 MCG/DOSE SUSP NASALE 120 1\n",
      "  3400934301322 | PIROXICAM BGA 10MG GELULE 30\n",
      "  3400934301490 | PIROXICAM BGA 20MG GELULE 15\n",
      "  3400934301551 | KYTRIL 2MG CPR 1\n",
      "  3400934304392 | POTASSIUM GLUCONATE H2 SIROP 250ML 1\n",
      "  3400934306754 | TAHOR 10MG CPR 28\n",
      "  3400934306815 | TAHOR 20MG CPR 28\n",
      "  3400934306983 | TAHOR 40MG CPR 28\n",
      "  3400934307065 | NATISPRAY 0,30MG SOL BUCCALE 1\n",
      "  3400934309885 | LOPERAMIDE SDZ 2MG GELULE 20\n",
      "  3400934313219 | HELIKIT 75 MG PDR ORALE 1\n",
      "  3400934314278 | TOPALGIC LP 100MG CPR 30\n",
      "  3400934314568 | TOPALGIC LP 150MG CPR 30\n",
      "  3400934314797 | TOPALGIC LP 200MG CPR 30\n",
      "  3400934315800 | EDEX 0,01MG/1ML PDR ET SOL INJ CART 2\n",
      "  3400934318061 | SPIRONOLACTONE PFZ 75MG CPR 30\n",
      "  3400934318580 | EDEX 0,02MG/1ML PDR ET SOL INJ CART 2\n",
      "  3400934323263 | AVONEX 0,03MG/0,5ML SOL INJ SER 4\n",
      "  3400934324215 | CEBEMYXINE COLLYRE 1\n",
      "  3400934326165 | MYDRIATICUM 2MG/0,4ML COLLYRE UNIDOS 1\n",
      "  3400934331138 | OXYBUTYNINE EG 5MG CPR 60\n",
      "  3400934333729 | AZADOSE 600MG CPR 8\n",
      "  3400934338113 | IMIGRANE 20MG/0,1ML SOL NASALE 6\n",
      "  3400934338342 | IMIGRANE 10MG/0,1ML SOL NASALE 2\n",
      "  3400934361692 | LOPERAMIDE TEVA 2MG CPR 20\n",
      "  3400934362415 | DICLOFENAC EG 50MG CPR 30\n",
      "  3400934364884 | QUINIMAX 125MG CPR 18\n",
      "  3400934366376 | CEFUROXIME BGA 500MG CPR 8\n",
      "  3400934368219 | LEVODOPA CARBIDOPA TVC 250/25 MG CPR 50\n",
      "  3400934368509 | LEVODOPA CARBIDOPA TVC 100/10 MG CPR 100\n",
      "  3400934373299 | RULID 50MG CPR 16\n",
      "  3400934373930 | HUMALOG 300 UI SOL INJ CART 5\n",
      "  3400934375361 | ECONAZOLE BGA 1% CREME TUBE 30G 1\n",
      "  3400934375590 | ECONAZOLE BGA 1% PDR FL 30G 1\n",
      "  3400934376313 | DIFFERINE 0,1% CREME 1\n",
      "  3400934380792 | CARTEOL 1% COLLYRE FL 3ML 1\n",
      "  3400934380914 | CARTEOL 2% COLLYRE FL 3ML 1\n",
      "  3400934384066 | XALATAN 0,005% COLLYRE FL 2,5ML 1\n",
      "  3400934384127 | XALATAN 0,005% COLLYRE FL 2,5ML 3\n",
      "  3400934384417 | GENOTONORM MINIQUICK 0,6MG/0,25ML 7\n",
      "  3400934384585 | GENOTONORM MINIQUICK 0,8MG/0,25ML 7\n",
      "  3400934384646 | GENOTONORM MINIQUICK 1MG/0,25ML 7\n",
      "  3400934384707 | GENOTONORM MINIQUICK 1,2MG/0,25ML 7\n",
      "  3400934384875 | GENOTONORM MINIQUICK 1,4MG/0,25ML 7\n",
      "  3400934384936 | GENOTONORM MINIQUICK 1,6MG/0,25ML 7\n",
      "  3400934385018 | GENOTONORM MINIQUICK 1,8MG/0,25ML 7\n",
      "  3400934385186 | GENOTONORM MINIQUICK 2MG/0,25ML 7\n",
      "  3400934385247 | CLIMASTON 2MG/10MG CPR 28\n",
      "  3400934387258 | ORAMORPH 10MG/5ML BUV UNIDOSE 5ML 10\n",
      "  3400934387487 | ORAMORPH 30MG/5ML BUV UNIDOSE 5ML 10\n",
      "  3400934387609 | ORAMORPH 100MG/5ML BUV UNIDOSE 5ML 10\n",
      "  3400934392511 | AUGMENTIN 100 MG/12,5 MG/ML ENF PDR 1\n",
      "  3400934394232 | NARAMIG 2,5MG CPR 6\n",
      "  3400934394461 | ZOPHREN 4MG LYOPHILISAT ORAL 2\n",
      "  3400934394522 | ZOPHREN 4MG LYOPHILISAT ORAL 4\n",
      "  3400934394812 | ZOPHREN 8MG LYOPHILISAT ORAL 2\n",
      "  3400934394980 | ZOPHREN 8MG LYOPHILISAT ORAL 4\n",
      "  3400934398025 | RISPERDAL 1 MG/ML SOL BUV FL 30ML 1\n",
      "  3400934398193 | RISPERDAL 1 MG/ML SOL BUV FL 60ML 1\n",
      "  3400934398483 | RISPERDAL 1 MG/ML SOL BUV FL 120 ML 1\n",
      "  3400934405969 | DICLOFENAC ARW 1% GEL 1\n",
      "  3400934407512 | NORVIR 100 MG CPR 30\n",
      "  3400934410413 | LANSOPRAZOLE BGR 15MG GELULE 15\n",
      "  3400934410642 | LANSOPRAZOLE BGR 15MG GELULE 30\n",
      "  3400934410932 | MORPHINE LAV 20MG/ML INJ 1ML 10\n",
      "  3400934415494 | LANSOPRAZOLE BGR 30MG GELULE 7\n",
      "  3400934415555 | LANSOPRAZOLE BGR 30MG GELULE 14\n",
      "  3400934415784 | LANSOPRAZOLE BGR 30MG GELULE 28\n",
      "  3400934416446 | PRAVASTATINE ACC 40 MG CPR 28\n",
      "  3400934419409 | CIFLOX 500MG/5ML GRANULES ORAL 1\n",
      "  3400934423079 | ADRIGYL 10 000UI/ML SOL BUV FL 10ML 1\n",
      "  3400934424021 | TRANSIPEG 5,9G PDR ORALE SACHET 20\n",
      "  3400934424779 | PENTASA 1G GRANULES SACHET 120\n",
      "  3400934427381 | RISPERDAL 4 MG CPR 30\n",
      "  3400934428043 | OROCAL VIT D3 500MG/400UI CPR 60\n",
      "  3400934428272 | RIVOTRIL 1 MG SOL INJ 6\n",
      "  3400934429804 | MALARONE 250MG/100MG CPR 12\n",
      "  3400934429972 | TOBRADEX COLLYRE FL 5ML 1\n",
      "  3400934433474 | GRANUDOXY 100MG CPR 15\n",
      "  3400934433535 | GRANUDOXY 100MG CPR 28\n",
      "  3400934433825 | AMODEX 1 G CPR DISP 6\n",
      "  3400934433993 | AMODEX 1 G CPR DISP 14\n",
      "  3400934436147 | VERAPAMIL TEVA 40MG CPR 75\n",
      "  3400934436376 | CARBAMAZEPINE SDZ LP 200MG CPR 30\n",
      "  3400934436895 | CARBAMAZEPINE SDZ LP 400MG CPR 30\n",
      "  3400934438738 | VENTOLINE 100 MICROGRAMMES SUSP INH 1\n",
      "  3400934446023 | SODIUM CHL FRF 0,9% INJ PS 50ML 40\n",
      "  3400934446191 | SODIUM CHL FRF 0,9% INJ 100ML 40\n",
      "  3400934450853 | AUGMENTIN 1G/125MG AD PDR ORALE SACH 8\n",
      "  3400934451164 | AUGMENTIN 1G/125MG AD PDR ORALE SACH 12\n",
      "  3400934453984 | ZOMIG 2,5MG CPR 6\n",
      "  3400934454127 | NORSET 15MG CPR 30\n",
      "  3400934455186 | OGAST 30MG GELULE 28\n",
      "  3400934456138 | TILCOTIL 20MG CPR 15\n",
      "  3400934464171 | PAROEX 0,12% SOL PR BDB FL 300ML 1\n",
      "  3400934466304 | ALDACTONE 25MG CPR 30\n",
      "  3400934466823 | OESCLIM 37,5 MICROG/24H DISP 8\n",
      "  3400934475696 | LANZOR 30MG GELULE 28\n",
      "  3400934483561 | LAMICTAL 5 MG CPR DISP 30\n",
      "  3400934499821 | NUTRIVISC 5% COLLYRE FL 10ML 1\n",
      "  3400934502064 | SPORANOX 10MG/ML SOL BUV 150ML 1\n",
      "  3400934502125 | CEFADROXIL MYL 500MG GELULE 12\n",
      "  3400934505317 | PROZAC 20 MG CPR 28\n",
      "  3400934507038 | PERINDOPRIL INDAP 2MG/0,625MG CPR 30\n",
      "  3400934507328 | PERINDOPRIL INDAP ARL 4MG/1,25MG CPR 30\n",
      "  3400934507786 | DOLIPRANE 500MG GELULE 16\n",
      "  3400934508677 | PERINDOPRIL INDAP BGA 2/0,625MG CPR 30\n",
      "  3400934508967 | PERINDOPRIL INDAP BGA 2/0,625MG CPR 90\n",
      "  3400934509100 | PERINDOPRIL INDAP BGA 4/1,25MG CPR 30\n",
      "  3400934509339 | PERINDOPRIL INDAP BGA 4/1,25MG CPR 90\n",
      "  3400934521393 | BURINEX 5MG CPR 30\n",
      "  3400934535932 | CAFEINE CPF 25MG/ML INJ BUV AMP 2ML 10\n",
      "  3400934543807 | ALLOPURINOL VIATRIS 100MG CPR 28\n",
      "  3400934543975 | ALLOPURINOL VIATRIS 200MG CPR 28\n",
      "  3400934544057 | ALLOPURINOL VIATRIS 300MG CPR 28\n",
      "  3400934544408 | AMIODARONE VIATRIS 200MG CPR 30\n",
      "  3400934544576 | AMIODARONE VIATRIS 200MG CPR 30\n",
      "  3400934544927 | TELFAST 120MG CPR 15\n",
      "  3400934545467 | TELFAST 180MG CPR 15\n",
      "  3400934545818 | FEXOFENADINE ZTV 120MG CPR 15\n",
      "  3400934546297 | FEXOFENADINE ZTV 180MG CPR 15\n",
      "  3400934546648 | TASMAR 100MG CPR 100\n",
      "  3400934547300 | ALPHAGAN 0,2% (2MG/ML) COLLYRE 1\n",
      "  3400934548420 | OGAST 15MG GELULE 30\n",
      "  3400934549021 | LANZOR 15MG GELULE 30\n",
      "  3400934549311 | DOXY 100MG CPR 5\n",
      "  3400934549540 | DOXY 100MG CPR 15\n",
      "  3400934549779 | DOXY 50MG CPR 14\n",
      "  3400934549830 | DOXY 50MG CPR 28\n",
      "  3400934557415 | TRIFLUCAN 100MG GELULE 7\n",
      "  3400934557583 | TRIFLUCAN 200MG GELULE 7\n",
      "  3400934563157 | ALPRAZOLAM ARW 0,25MG CPR 30\n",
      "  3400934563218 | ALPRAZOLAM ARW 0,50MG CPR 30\n",
      "  3400934565519 | ZECLAR 25MG/ML GRANULES FL 100 ML 1\n",
      "  3400934566578 | CARTREX 100MG CPR 30\n",
      "  3400934568350 | LOPERAMIDE EG 2MG GELULE 20\n",
      "  3400934568701 | NIFEDIPINE MYL LP 20MG CPR 30\n",
      "  3400934569180 | PIROXICAM EG 20MG GELULE 15\n",
      "  3400934586101 | BETAGAN 0,5% COLLYRE UNIDOSE 0,4ML 60\n",
      "  3400934591761 | CROMOPTIC 2% COLLYRE FL 10ML 1\n",
      "  3400934593482 | CALPRIMUM 500MG CPR 60\n",
      "  3400934595325 | DILTIAZEM VIATRIS LP 90MG GELULE 30\n",
      "  3400934595493 | DILTIAZEM VTS LP 120MG GELULE 30\n",
      "  3400934599057 | RECHOLAN 24,4/10,8G SOL BUV 2\n",
      "  3400934600500 | OMNIPAQUE 240MG SOL INJ FP 50ML 1\n",
      "  3400934600678 | OMNIPAQUE 300 MG IODE/ML (IOHEXOL) 1 BOITE DE 1, F\n",
      "  3400934600739 | OMNIPAQUE 300MG SOL INJ FP 50ML 1\n",
      "  3400934601040 | OMNIPAQUE 350 MG IODE/ML (IOHEXOL) 1 BOITE DE 1, F\n",
      "  3400934601101 | OMNIPAQUE 350MG SOL INJ FP 50ML 1\n",
      "  3400934605703 | ACICLOVIR VIATRIS 200MG CPR 25\n",
      "  3400934606182 | INIPOMP 40 MG PDR INJ 1\n",
      "  3400934606533 | EUPANTOL 40 MG PDR INJ 1\n",
      "  3400934609725 | BEMEDREX EASYHALER 200 MICROG INH 1\n",
      "  3400934610493 | FLORGYNAL GELULE VAGINALE 14\n",
      "  3400934610554 | FEMSEPT 100 MICROG/24H DISP 4\n",
      "  3400934610615 | FEMSEPT 75 MICROG/24H DISP 4\n",
      "  3400934610783 | FEMSEPT 50 MICROG/24H DISP 4\n",
      "  3400934611094 | TIAPRIDAL 138 MG/ML SOL BUV 1\n",
      "  3400934611445 | VIRAMUNE 200MG CPR 60\n",
      "  3400934612855 | SINGULAIR 5MG CPR 28\n",
      "  3400934614118 | SINGULAIR 10MG CPR 28\n",
      "  3400934615467 | DOLIPRANE 2,4% SS SUCRE SUSP BUV 1\n",
      "  3400934624223 | FUNGIZONE 10% NR ENF SUSP BUV 1\n",
      "  3400934625923 | LETROZOLE ARW 2,5MG CPR 30\n",
      "  3400934626524 | CEFTRIAXONE CRT 1G PDR SOLV INJ IM 1\n",
      "  3400934626753 | CEFTRIAXONE EVO 1G/3,5ML PDR INJ IM 1\n",
      "  3400934627583 | RILUZOLE BGA 50MG CPR 56\n",
      "  3400934628184 | CEFPODOXIME VTS 100MG CPR 10\n",
      "  3400934628245 | REPAGLINIDE TVC 0,5 MG CPR 90\n",
      "  3400934628474 | REPAGLINIDE TVC 0,5 MG CPR 270\n",
      "  3400934628535 | REPAGLINIDE TVC 1 MG CPR 90\n",
      "  3400934630484 | NEORAL 25MG CAPSULE 60\n",
      "  3400934630545 | NEORAL 50MG CAPSULE 60\n",
      "  3400934630606 | NEORAL 100MG CAPSULE 60\n",
      "  3400934630774 | NEORAL 10MG CAPSULE 60\n",
      "  3400934631436 | REPAGLINIDE TVC 1 MG CPR 270\n",
      "  3400934631665 | REPAGLINIDE TVC 2 MG CPR 90\n",
      "  3400934631726 | REPAGLINIDE TVC 2 MG CPR 270\n",
      "  3400934633157 | NEORAL 100MG/ML SOL BUV FL 50ML 1\n",
      "  3400934636578 | EFFERALGANMED 250MG CPR DISP 12\n",
      "  3400934638879 | ACICLOVIR VIATRIS 800MG CPR 35\n",
      "  3400934639302 | TAMOXIFENE BGA 10MG CPR 30\n",
      "  3400934639470 | TAMOXIFENE BGA 20MG CPR 30\n",
      "  3400934641022 | PREDNISONE ZEN 20MG CPR 20\n",
      "  3400934641190 | PREDNISONE ZEN 5MG CPR 30\n",
      "  3400934641251 | PREDNISONE ZEN 1MG CPR 30\n",
      "  3400934642203 | NARAMIG 2,5MG CPR 12\n",
      "  3400934646683 | INDOCOLLYRE 0,1% COLLYRE UNIDOSE 20\n",
      "  3400934648694 | VERAPAMIL TVC 120MG CPR 30\n",
      "  3400934648816 | VERAPAMIL TVC 120MG CPR 90\n",
      "  3400934650185 | NABUCOX 1G CPR DISP 14\n",
      "  3400934653728 | SEROPRAM 40 MG/ML SOL BUV FL 12ML 1\n",
      "  3400934654039 | ZAMUDOL LP 50MG GELULE 30\n",
      "  3400934654329 | ZAMUDOL LP 100MG GELULE 30\n",
      "  3400934654558 | ZAMUDOL LP 150MG GELULE 30\n",
      "  3400934654787 | ZAMUDOL LP 200MG GELULE 30\n",
      "  3400934655678 | EFFEXOR LP 75MG GELULE 30\n",
      "  3400934656330 | EFFEXOR LP 37,5MG GELULE 30\n",
      "  3400934656798 | VENLAFAXINE VTSG LP 75MG GELULE 30\n",
      "  3400934658570 | STILNOX 10MG CPR 14\n",
      "  3400934659003 | FLUCONAZOLE PFZ 200MG GELULE 7\n",
      "  3400934659171 | FLUCONAZOLE PFZ 100MG GELULE 7\n",
      "  3400934661822 | VENLAFAXINE VTSG LP 37,5MG GELULE 30\n",
      "  3400934662713 | COMBIVIR 150MG/300MG CPR 60\n",
      "  3400934665325 | ALLOPURINOL BGR 300MG CPR 28\n",
      "  3400934666674 | PROVAMES 1MG CPR 30\n",
      "  3400934670527 | SPIRONOLACTONE PFZ 50MG CPR 30\n",
      "  3400934672248 | NAPROXENE SODIQUE TVC 550MG CPR 16\n",
      "  3400934675720 | LERCANIDIPINE EG 10MG CPR 30\n",
      "  3400934676031 | LERCANIDIPINE EG 10MG CPR 90\n",
      "  3400934677212 | LERCANIDIPINE EG 20MG CPR 30\n",
      "  3400934677670 | LERCANIDIPINE EG 20MG CPR 90\n",
      "  3400934680861 | CHLORHEX/CHLOROBUT VTS SOL BDB 90ML 1\n",
      "  3400934681462 | CHLORHEX/CHLOROBUT ZEN SOL BDB 90ML 1\n",
      "  3400934681813 | CHLORHEX/CHLOROBUT ARW SOL BDB 90ML 1\n",
      "  3400934685545 | DOMPERIDONE ZEN 10MG CPR DISP 20\n",
      "  3400934688096 | ACICLOVIR CRT 200MG CPR 25\n",
      "  3400934692239 | CROMOFREE 2% COLLYRE FL 10ML 1\n",
      "  3400934696831 | IRBESARTAN HCTZ SDZ 300/25MG CPR 30\n",
      "  3400934697371 | IRBESARTAN HCTZ SDZ 300/25MG CPR 90\n",
      "  3400934698613 | IRBESARTAN HCTZ SDZ 150/12,5MG CPR 30\n",
      "  3400934699092 | IRBESARTAN HCTZ SDZ 150/12,5MG CPR 90\n",
      "  3400934702785 | NIQUITIN MENTHE 4MG CPR SS SUCRE 96\n",
      "  3400934702846 | NIQUITIN MENTHE 2MG CPR SS SUCRE 96\n",
      "  3400934703386 | VALACICLOVIR CRT 500MG CPR 42\n",
      "  3400934712081 | ANASTROZOLE EG 1MG CPR 90\n",
      "  3400934712722 | OLANZAPINE ZYD 5MG CPR 28\n",
      "  3400934713842 | INDAPAMIDE ZYD LP 1,5MG CPR 30\n",
      "  3400934714443 | FENOFIBRATE CRT 200MG GELULE 90\n",
      "  3400934715563 | FIRDAPSE 10 MG CPR 100\n",
      "  3400934718816 | COLOKIT CPR 32\n",
      "  3400934718984 | KETOPROFENE ZEN LP 100MG CPR 20\n",
      "  3400934730061 | LACTULOSE BGA 10G/15ML SOL BUV SAC 20\n",
      "  3400934730580 | PARACETAMOL EGL 500MG CPR 16\n",
      "  3400934731181 | TRIMEBUTINE VIATRIS 100MG CPR 30\n",
      "  3400934732881 | FRAXODI 11 400UI AXA/0,6ML SOL INJ 2\n",
      "  3400934733024 | FRAXODI 11 400UI AXA/0,6ML SOL INJ 10\n",
      "  3400934733192 | FRAXODI 15 200UI AXA/0,8ML SOL INJ 2\n",
      "  3400934733314 | FRAXODI 15 200UI AXA/0,8ML SOL INJ 10\n",
      "  3400934733482 | FRAXODI 19 000UI AXA/1ML SOL INJ 2\n",
      "  3400934733604 | FRAXODI 19 000UI AXA/1ML SOL INJ 10\n",
      "  3400934733772 | CALCIUM VIT D3 VTS 500MG/400UI CPR 60\n",
      "  3400934734953 | FRAKIDEX COLLYRE FL 5ML 1\n",
      "  3400934736216 | SOLIAN 200MG CPR 60\n",
      "  3400934737046 | IMIGRANE 50MG CPR 6\n",
      "  3400934738227 | DIERGOSPRAY 4MG/ML SOL NASALE FL 1\n",
      "  3400934739866 | LEVOPHTA 0,05% COLLYRE FL 5ML 1\n",
      "  3400934741296 | MULTIHANCE 0,5MMOL/ML SOL INJ 10ML 1\n",
      "  3400934741357 | MULTIHANCE 0,5MMOL/ML SOL INJ 15ML 1\n",
      "  3400934741418 | MULTIHANCE 0,5MMOL/ML SOL INJ 20ML 1\n",
      "  3400934741708 | REBIF 22 MCG SOL INJ SER 0,5ML 12\n",
      "  3400934742309 | PARLODEL 10MG GELULE 30\n",
      "  3400934742828 | PARLODEL 5MG GELULE 30\n",
      "  3400934744198 | KARDEGIC 75MG PDR ORALE SACHET 30\n",
      "  3400934745140 | DENSICAL VIT D3 500MG/400UI CPR 60\n",
      "  3400934747960 | RANITIDINE MYL 300MG CPR 14\n",
      "  3400934748271 | TOLEXINE 100MG CPR 28\n",
      "  3400934748561 | IMOVANE 7,5 MG CPR 14\n",
      "  3400934750922 | SPIFEN 400MG GRANULES SACHET 20\n",
      "  3400934751691 | CAPTOPRIL VIATRIS 50MG CPR 30\n",
      "  3400934751981 | CAPTOPRIL VIATRIS 50MG CPR 90\n",
      "  3400934752872 | CAPTOPRIL VIATRIS 25MG CPR 30\n",
      "  3400934753183 | CAPTOPRIL VIATRIS 25MG CPR 90\n",
      "  3400934754944 | LEDERFOLINE 5MG CPR 30\n",
      "  3400934757785 | DILTIAZEM BGA LP 90MG GELULE 28\n",
      "  3400934757846 | DILTIAZEM BGA LP 120MG GELULE 28\n",
      "  3400934758218 | TRANXENE 10MG GELULE 30\n",
      "  3400934760457 | HAVRIX 720U/0,5ML NR ENF SUSP INJ 1\n",
      "  3400934761638 | UN ALFA 0,5 MICROGRAMMES CAPSULE 30\n",
      "  3400934763298 | SCOPOLAMINE CPF 0,5 MG SOL INJ 10\n",
      "  3400934763878 | ZANIDIP 10 MG (CHLORHYDRATE DE LERCANIDIPINE) 1 BO\n",
      "  3400934767081 | TRINIPATCH 15MG/24H DISP TRANSDERM 30\n",
      "  3400934767203 | ALLERGODIL 0,05% COLLYRE FL 6ML 1\n",
      "  3400934772283 | BROMAZEPAM BGA 6MG CPR 30\n",
      "  3400934774416 | PENTAVAC PDR ET SUSP INJ 1\n",
      "  3400934777196 | FENOFIBRATE VIATRIS 200MG GELULE 30\n",
      "  3400934779619 | RIMIFON 50MG CPR 200\n",
      "  3400934779787 | RIMIFON 150MG CPR 100\n",
      "  3400934780509 | ZYMADUO 150UI SOL BUV 1\n",
      "  3400934783289 | CORGARD 80 MG CPR 28\n",
      "  3400934783869 | FUROSEMIDE BGA 40 MG CPR 30\n",
      "  3400934785351 | ZECLAR 50MG/ML GRANULES 1\n",
      "  3400934786181 | FIVASA 400MG CPR GR 100\n",
      "  3400934793226 | MAXALT 5MG CPR 12\n",
      "  3400934793684 | MAXALT 10MG CPR 12\n",
      "  3400934794346 | MAXALTLYO 10MG LYOPHILISAT ORAL 6\n",
      "  3400934794407 | MAXALTLYO 10MG LYOPHILISAT ORAL 12\n",
      "  3400934796708 | DACUDOSES SOL PR LAVAGE OPH UNIDOSE 24\n",
      "  3400934797187 | LEDERFOLINE 25MG CPR 30\n",
      "  3400934802362 | ZUMALGIC 50MG CPR EFF 30\n",
      "  3400934802591 | BUSPIRONE MYL 10MG CPR 20\n",
      "  3400934802652 | BUSPIRONE MYL 10MG CPR 20\n",
      "  3400934803833 | CAPTOPRIL EG 50MG CPR 30\n",
      "  3400934804434 | CAPTOPRIL EG 50MG CPR 90\n",
      "  3400934806384 | COSOPT 20MG/5MG/ML COLLYRE FL 5ML 1\n",
      "  3400934808166 | CONTRAMAL 50MG GELULE 30\n",
      "  3400934809118 | DOLIPRANE 100MG SUPPO 10\n",
      "  3400934809408 | DOLIPRANE 150MG SUPPO 10\n",
      "  3400934809866 | DOLIPRANE 200MG SUPPO 10\n",
      "  3400934810176 | DOLIPRANE 300MG SUPPO 10\n",
      "  3400934810695 | ZYMADUO 300UI SOL BUV 1\n",
      "  3400934814020 | CAPTOPRIL EG 25MG CPR 30\n",
      "  3400934814549 | CAPTOPRIL EG 25MG CPR 90\n",
      "  3400934822353 | TETRAVAC ACELLULAIRE INJ 1\n",
      "  3400934824593 | ROZEX 0,75% CREME 1\n",
      "  3400934825484 | GUTRON 2,5MG CPR 30\n",
      "  3400934825545 | GUTRON 2,5MG CPR 90\n",
      "  3400934827266 | EVISTA 60MG CPR 28\n",
      "  3400934827327 | EVISTA 60MG CPR 84\n",
      "  3400934827617 | CONTRAMAL LP 100MG CPR 30\n",
      "  3400934827846 | CONTRAMAL LP 150MG CPR 30\n",
      "  3400934828096 | CONTRAMAL LP 200MG CPR 30\n",
      "  3400934828157 | BIRODOGYL 1,5MUI/250MG CPR 10\n",
      "  3400934828966 | LOPERAMIDE VIATRIS 2MG GELULE 20\n",
      "  3400934829109 | DICLOFENAC VIATRIS 50MG CPR GR 30\n",
      "  3400934830228 | VITAMINE K1 ROCHE 10MG/1ML SOL 3\n",
      "  3400934830518 | EPITOMAX 15 MG GELULE 28\n",
      "  3400934830686 | EPITOMAX 25 MG GELULE 28\n",
      "  3400934830747 | EPITOMAX 50 MG GELULE 28\n",
      "  3400934830808 | DAKTARIN 2% GEL BUCCAL TUBE 80G 1\n",
      "  3400934831287 | ACICLOVIR EG 200MG CPR 25\n",
      "  3400934832468 | ALPRAZOLAM VTS 0,50 MG CPR 30\n",
      "  3400934832529 | ALPRAZOLAM VTS 0,50 MG CPR 30\n",
      "  3400934833298 | MIANSERINE VIATRIS 60 MG CPR 14\n",
      "  3400934833359 | MIANSERINE VIATRIS 60 MG CPR 14\n",
      "  3400934835131 | OXYBUTYNINE VTS 5MG CPR 60\n",
      "  3400934837432 | ALPRAZOLAM VTS 0,25MG CPR 30\n",
      "  3400934837661 | ALPRAZOLAM VTS 0,25MG CPR 30\n",
      "  3400934839504 | HELICOBACTER TEST INFAI 75MG PDR 1\n",
      "  3400934839962 | UTROGESTAN 200MG CAPSULE 15\n",
      "  3400934840272 | NOVONORM 0,5 MG CPR 90\n",
      "  3400934840333 | NOVONORM 1 MG CPR 90\n",
      "  3400934840562 | NOVONORM 2 MG CPR 90\n",
      "  3400934840852 | DERMOBACTER SOL FL 300ML 1\n",
      "  3400934841453 | UN ALFA 0,25 MICROGRAMMES CAPSULE 30\n",
      "  3400934841514 | UN ALFA 1 MICROGRAMME CAPSULE 30\n",
      "  3400934841682 | IBUPROFENE BGA 200MG CPR PELL 30\n",
      "  3400934845826 | MIFLASONE 200 MICROG PDR INH GELULE 60\n",
      "  3400934847318 | DERMAZOL 1% PDR FL 30G 1\n",
      "  3400934847486 | SPIRONOLACTONE BGA 75 MG CPR 30\n",
      "  3400934848438 | OPTRUMA 60 MG CPR 28\n",
      "  3400934848667 | OPTRUMA 60 MG CPR 84\n",
      "  3400934850509 | SPIRONOLACTONE PFZ 25MG CPR 30\n",
      "  3400934850738 | SPIRONOLACTONE BGA 25MG CPR 30\n",
      "  3400934854811 | SPIRONOLACTONE ALTIZIDE PFZ CPR 30\n",
      "  3400934857423 | ALPRAZOLAM EG 0,25MG CPR 30\n",
      "  3400934857591 | ALPRAZOLAM EG 0,50MG CPR 30\n",
      "  3400934857713 | CAPTOPRIL BGA 25MG CPR 30\n",
      "  3400934857881 | CAPTOPRIL BGA 50MG CPR 30\n",
      "  3400934858604 | CIMETIDINE MYL 200MG CPR EFF 60\n",
      "  3400934860492 | CEFADROXIL BGA 500MG GELULE 12\n",
      "  3400934861505 | ACICLOVIR BGA 200MG CPR 25\n",
      "  3400934861673 | ACICLOVIR BGA 800MG CPR 35\n",
      "  3400934864865 | VITAMINE K 1 ROCHE 2 MG/0,2 ML NOURRISSON (PHYTOME\n",
      "  3400934865237 | COMTAN 200MG CPR 100\n",
      "  3400934869778 | SOTALOL VTS 80MG CPR 30\n",
      "  3400934869839 | SOTALOL VTS 80MG CPR 30\n",
      "  3400934870088 | SOTALOL VTS 160MG CPR 30\n",
      "  3400934872730 | VERCYTE 25MG CPR 30\n",
      "  3400934874741 | SOLIAN 100MG CPR 30\n",
      "  3400934874802 | SOLIAN 400MG CPR 30\n",
      "  3400934876233 | DEPAKOTE 250MG CPR 30\n",
      "  3400934877353 | CYCLADOL 20MG CPR EFF 14\n",
      "  3400934877704 | BREXIN 20MG CPR EFF 14\n",
      "  3400934878244 | UMULINE PROFIL 30 KWIKPEN 300UI/3ML 5\n",
      "  3400934878824 | UMULINE NPH KWIKPEN 300UI/3ML SUSP 5\n",
      "  3400934879944 | ACTIVELLE CPR 28\n",
      "  3400934882555 | CIMETIDINE ARW 200MG CPR EFF 60\n",
      "  3400934883507 | BROMAZEPAM VIATRIS 6MG CPR 30\n",
      "  3400934883675 | BROMAZEPAM ZYD 6MG CPR 30\n",
      "  3400934884276 | BROMAZEPAM EG 6MG CPR 30\n",
      "  3400934884627 | CROMADOSES 2% COLLYRE UNIDOSE 30\n",
      "  3400934887000 | ZOPICLONE VIATRIS 7,5MG CPR 5\n",
      "  3400934887468 | ZOPICLONE VIATRIS 7,5MG CPR 14\n",
      "  3400934889479 | BETAHISTINE VTS 8MG CPR 90\n",
      "  3400934890130 | SOPHIDONE LP 4 MG GELULE 14\n",
      "  3400934890420 | SOPHIDONE LP 8MG GELULE 14\n",
      "  3400934890659 | SOPHIDONE LP 16MG GELULE 14\n",
      "  3400934890888 | SOPHIDONE LP 24MG GELULE 14\n",
      "  3400934891021 | ALPRAZOLAM BGA 0,25MG CPR 30\n",
      "  3400934891199 | ALPRAZOLAM BGA 0,50MG CPR 30\n",
      "  3400934891779 | TRIMEBUTINE EG 100MG CPR 30\n",
      "  3400934892141 | DILTIAZEM BGA 60MG CPR 30\n",
      "  3400934897054 | GLIPIZIDE MYL 5MG CPR 30\n",
      "  3400934898815 | ELVORINE 25 MG SOL INJ 1\n",
      "  3400934898983 | ELVORINE 50 MG SOL INJ 1\n",
      "  3400934902819 | GLICLAZIDE BGA 80MG CPR 20\n",
      "  3400934902987 | GLICLAZIDE BGA 80MG CPR 60\n",
      "  3400934903700 | CARBOSYMAG GELULE 24\n",
      "  3400934903878 | CARBOSYMAG GELULE 48\n",
      "  3400934904189 | MOXYDAR SUSP BUV SACHET DOSE 30\n",
      "  3400934906190 | CEFADROXIL MYL 250MG/5ML PDR ORALE 1\n",
      "  3400934912405 | MONAZOL 2% CREME TUBE 15 G 1\n",
      "  3400934913174 | AMOXICILLINE VIATRIS 500 MG GELULE 12\n",
      "  3400934917547 | COTRIMOXAZOLE TEVA 800MG/160MG CPR 10\n",
      "  3400934920448 | ALDARA 5% CREME 12\n",
      "  3400934928604 | DEROXAT 20MG/10ML SUSP BUV FL 150ML 1\n",
      "  3400934931215 | EPREX 10 000UI/1ML SOL INJ SER 6\n",
      "  3400934935527 | INSUMAN INFUSAT 100UI/ML S INJ CART 5\n",
      "  3400934936708 | SOLUPRED 5MG CPR ORODISP 30\n",
      "  3400934936876 | SOLUPRED 20MG CPR ORODISP 20\n",
      "  3400934944512 | HUMALOG MIX 25 300UI SUSP INJ CART 5\n",
      "  3400934944680 | HUMALOG MIX 50 300UI SUSP INJ CART 5\n",
      "  3400934951374 | ACTISKENAN 5MG GELULE 14\n",
      "  3400934965562 | TAVANIC 500MG CPR 5\n",
      "  3400934965913 | SPIRONOLACTONE BGA 50 MG CPR 30\n",
      "  3400934966163 | SPIRONOLACTONE ALTIZIDE BGA CPR 30\n",
      "  3400934966743 | NOCTAMIDE 1MG CPR 14\n",
      "  3400934968174 | SPIRONOLACTONE VIATRIS 75MG CPR 30\n",
      "  3400934975509 | GENOTONORM 5,3 MG/1ML PDR ET SOL INJ 1\n",
      "  3400934975677 | GRANOCYTE 13 MUI PDR ET SOL INJ SER 1\n",
      "  3400934976100 | GRANOCYTE 34 MUI PDR ET SOL INJ SER 1\n",
      "  3400934976278 | TRAMADOL MYL 50MG CPR EFF 30\n",
      "  3400934976339 | TRAMADOL VIATRIS 50MG GELULE 30\n",
      "  3400934977220 | INDAPAMIDE ARW LP 1,5MG CPR 30\n",
      "  3400934989346 | PIROXICAM VIATRIS 20MG CPR 15\n",
      "  3400934990007 | ACTISKENAN 10MG GELULE 14\n",
      "  3400934991295 | ACTISKENAN 20MG GELULE 14\n",
      "  3400934992308 | ACTISKENAN 30MG GELULE 14\n",
      "  3400934998331 | DOLIPRANE 100MG PDR ORALE SACHET 12\n",
      "  3400934998799 | DOLIPRANE 150MG PDR ORALE SACHET 12\n",
      "  3400934999161 | DOLIPRANE 200MG PDR ORALE SACHET 12\n",
      "  3400934999451 | DOLIPRANE 300MG PDR ORALE SACHET 12\n",
      "  3400935001863 | LAMISILDERMGEL 1% GEL 1\n",
      "  3400935002525 | FIXICAL 500MG CPR 60\n",
      "  3400935002815 | NEORECORMON 2000UI/0,3ML SOL INJ SER 6\n",
      "  3400935003065 | NEORECORMON 3000UI/0,3ML SOL INJ SER 6\n",
      "  3400935003294 | NEORECORMON 5000UI/0,3ML SOL INJ SER 6\n",
      "  3400935003416 | NEORECORMON 10 000UI/0,6ML INJ SER 6\n",
      "  3400935003645 | NEORECORMON 20 000UI/0,6ML INJ SER 6\n",
      "  3400935005076 | FIXICAL VITAMINE D3 500 MG/400UI CPR 60\n",
      "  3400935009159 | ZINNAT 750MG PDR INJ IM IV 1\n",
      "  3400935011169 | ROZEX 0,75% GEL 50G 1\n",
      "  3400935020734 | ACEBUTOLOL VTS 200MG CPR 30\n",
      "  3400935020963 | ACEBUTOLOL VTS 400MG CPR 30\n",
      "  3400935024176 | NAPROSYNE 500MG CPR 10\n",
      "  3400935025128 | PHLOROGLUCINOL ARL 80MG CPR DISP 10\n",
      "  3400935036582 | RIZATRIPTAN TVC 10MG CPR ORODISP 12\n",
      "  3400935038593 | PERINDOPRIL KRK 2MG CPR 30\n",
      "  3400935038944 | PERINDOPRIL KRK 2MG CPR 90\n",
      "  3400935041784 | PERINDOPRIL KRK 4MG CPR 30\n",
      "  3400935042217 | PERINDOPRIL KRK 4MG CPR 90\n",
      "  3400935045119 | PERINDOPRIL KRK 8MG CPR 30\n",
      "  3400935045638 | PERINDOPRIL KRK 8MG CPR 90\n",
      "  3400935060594 | SPIRONOLACTONE EG 50MG CPR 30\n",
      "  3400935066169 | POLERY ENF SIROP 1\n",
      "  3400935067050 | BETAHISTINE BGA 8MG CPR 30\n",
      "  3400935067111 | BETAHISTINE BGA 8MG CPR 90\n",
      "  3400935067340 | BIODALGIC 50MG CPR EFF 30\n",
      "  3400935067401 | AMOXICILLINE ZYD 500MG GELULE 12\n",
      "  3400935068811 | POVIDONE IODEE TVC 10% SOL FL 125ML 1\n",
      "  3400935072191 | MEBEVERINE ZEN 200MG CPR 30\n",
      "  3400935073433 | SODIUM BIC CPF 1,4% SOL INJ FV 250ML 1\n",
      "  3400935073723 | SODIUM BIC CPF 1,4% SOL INJ FV 500ML 1\n",
      "  3400935080936 | REBIF 44 MCG SOL INJ SER 0,5ML 12\n",
      "  3400935081827 | LEVMENTIN 500 MG/50 MG PDR INJ IV 10\n",
      "  3400935082077 | LEVMENTIN 2000 MG/200 MG PDR INJ IV 10\n",
      "  3400935082718 | PROHANCE 2793MG/10ML SOL INJ SER 1\n",
      "  3400935082886 | PROHANCE 4189,5MG/15ML SOL INJ SER 1\n",
      "  3400935082947 | PROHANCE 4748,1MG/17ML SOL INJ SER 1\n",
      "  3400935086501 | TRANSILANE SS SUCRE PDR ORALE SACHET 20\n",
      "  3400935102911 | FLUOXETINE MYL 20MG GELULE 14\n",
      "  3400935105752 | GLICLAZIDE VIATRIS 80MG CPR 20\n",
      "  3400935105813 | GLICLAZIDE VIATRIS 80MG CPR 60\n",
      "  3400935109484 | SODIUM CHL CPF 0,9% SOL INJ FV 250ML 1\n",
      "  3400935109545 | SODIUM CHL CPF 0,9% SOL INJ FV 1L 1\n",
      "  3400935109774 | SODIUM CHL CPF 0,9% SOL INJ FV 500ML 1\n",
      "  3400935110664 | XATRAL LP 10MG CPR 30\n",
      "  3400935111036 | ALFUZOSINE ZTV LP 10MG CPR 30\n",
      "  3400935111784 | SILKIS 3MICROG/G POMMADE 100G 1\n",
      "  3400935114228 | VASTEN 40 MG CPR 28\n",
      "  3400935116758 | OROMONE 1 MG CPR 28\n",
      "  3400935124623 | GLUCOSE CPF 5% SOL INJ FV 500ML 1\n",
      "  3400935124791 | GLUCOSE CPF 5% SOL INJ FV 1L 1\n",
      "  3400935125392 | ALDACTONE 50MG CPR 30\n",
      "  3400935125453 | ALDACTONE 75MG CPR 30\n",
      "  3400935125514 | ALDACTAZINE CPR SECABLE 30\n",
      "  3400935130594 | TRAMADOL EG 50MG CPR 30\n",
      "  3400935133786 | ECONAZOLE EG 1% POUDRE 30G 1\n",
      "  3400935134097 | ECONAZOLE EG 1% CREME 1\n",
      "  3400935134158 | ECONAZOLE EG 1% EMULSION 1\n",
      "  3400935134219 | ECONAZOLE EG 1% SOLUTION 1\n",
      "  3400935136398 | ATENOLOL RPG 50MG CPR 28\n",
      "  3400935136749 | DICLOFENAC TVC 25MG CPR 30\n",
      "  3400935136800 | DICLOFENAC TVC 50MG CPR 30\n",
      "  3400935137340 | PRIORIX PDR ET SOL INJ 2A 1\n",
      "  3400935147394 | LOPERAMIDE LYOC 2MG LYOPHILISAT ORAL 10\n",
      "  3400935147684 | SPIRONOLACTONE ALTIZIDE EG CPR 30\n",
      "  3400935149176 | CAPTOPRIL SDZ 25MG CPR 30\n",
      "  3400935153609 | SULPIRIDE VIATRIS 50MG GELULE 30\n",
      "  3400935154439 | NEXPLANON 68MG IMPLANT 1\n",
      "  3400935154958 | LAMALINE GELULE 16\n",
      "  3400935156150 | OSSEANS VIT D3 500MG/400UI CPR 60\n",
      "  3400935157331 | TOPREC 1MG/1ML ENF ET NR SIROP 1\n",
      "  3400935158222 | RHINOCORT 64 MICROG SUSP NASALE 1\n",
      "  3400935159281 | SCOBUREN 20 MG SOL INJ 10\n",
      "  3400935160232 | QVARSPRAY 100 MICROGRAMMES SOL INHAL 1\n",
      "  3400935160690 | QVAR AUTOHALER 100 MICROG SOL INHAL 1\n",
      "  3400935161581 | CERIS 20 MG CPR 30\n",
      "  3400935166906 | ENGERIX B 20 AD SUSP INJ 1\n",
      "  3400935167095 | ENGERIX B 10 ENF ET NR SUSP INJ 1\n",
      "  3400935173010 | LAMALINE SUPPO 10\n",
      "  3400935176950 | SUSTIVA 100MG GELULE 30\n",
      "  3400935177032 | SUSTIVA 200MG GELULE 90\n",
      "  3400935177322 | ZITHROMAX 250MG CPR 6\n",
      "  3400935177551 | AZITHROMYCINE PFZ 250MG CPR 6\n",
      "  3400935177780 | ZITHROMAX MONODOSE 250MG CPR 4\n",
      "  3400935177902 | CETROTIDE 0,25 MG PDR ET SOL INJ 1\n",
      "  3400935179043 | MYCOSTATINE 100 000UI/ML SUSP BUV 1\n",
      "  3400935183293 | FENOFIBRATE VIATRIS 67MG GELULE 60\n",
      "  3400935186256 | FORTZAAR 100MG/25MG CPR 28\n",
      "  3400935186836 | AMOXICILLINE EG 500MG GELULE 12\n",
      "  3400935192059 | AMILORIDE HCTZ TVC 5/50MG CPR 30\n",
      "  3400935193759 | ANTARENE 400MG CPR 30\n",
      "  3400935196712 | ZEFFIX 100 MG CPR 28\n",
      "  3400935196941 | ZEFFIX 5 MG/ML SOL BUV 1\n",
      "  3400935197023 | DAFALGAN 30 MG/ML PEDIA SOL BUV FL 1\n",
      "  3400935199904 | ANTARENE 100MG CPR 40\n",
      "  3400935200426 | VISIPAQUE 320 MG D\"I/ML (IODIXANOL) 1 BOITE DE 1,\n",
      "  3400935200884 | VISIPAQUE 320MG/ML SOL INJ FP 50ML 1\n",
      "  3400935201256 | VISIPAQUE 320MG/ML SOL INJ FP 100ML 1\n",
      "  3400935201485 | VISIPAQUE 320MG/ML SOL INJ FP 150ML 1\n",
      "  3400935201836 | VISIPAQUE 320MG/ML SOL INJ FP 200ML 1\n",
      "  3400935202376 | VISIPAQUE 270 MG D\"I/ML (IODIXANOL) 1 BOITE DE 1,\n",
      "  3400935202895 | VISIPAQUE 270MG/ML SOL INJ FP 50ML 1\n",
      "  3400935203328 | VISIPAQUE 270MG/ML SOL INJ FP 100ML 1\n",
      "  3400935203908 | VISIPAQUE 270MG/ML SOL INJ FP 200ML 1\n",
      "  3400935208231 | LECTIL 16MG CPR 45\n",
      "  3400935211132 | TIORFAN 10 MG NR PDR ORALE SACHET 16\n",
      "  3400935211422 | TIORFAN 30 MG ENF PDR ORALE SACHET 30\n",
      "  3400935218285 | ESTIMA 100MG CAPSULE 30\n",
      "  3400935224200 | ZELITREX 500MG CPR 112\n",
      "  3400935228390 | GLUCOSE MACO 5% SOL INJ P 500ML 1\n",
      "  3400935228451 | GLUCOSE MACO 5% SOL INJ P 1L 1\n",
      "  3400935233073 | SEBIPROX 1,5% SHAMPOOING 1\n",
      "  3400935235145 | DUPHALAC 66,5% SOL BUV FL 200ML 1\n",
      "  3400935236036 | ZUMALGIC 100MG CPR EFF 20\n",
      "  3400935236906 | ORAVIR 125MG CPR 10\n",
      "  3400935238856 | STROMECTOL 3MG CPR 4\n",
      "  3400935239167 | DERMESTRIL SEPTEM 50 MICROG/24H DISP 4\n",
      "  3400935239396 | DERMESTRIL SEPTEM 25 MICROG/24H DISP 4\n",
      "  3400935239518 | DERMESTRIL SEPTEM 75 MICROG/24H DISP 4\n",
      "  3400935239747 | THAISSEPT 25 MICROG/24H DISP 4\n",
      "  3400935239976 | THAISSEPT 50 MICROG/24H DISP 4\n",
      "  3400935243300 | AMOXICILLINE BGA 1G CPR DISP 14\n",
      "  3400935243478 | ECONAZOLE LXO 1% PDR FL 30G 1\n",
      "  3400935244130 | ECONAZOLE RTP 1% PDR FL 30G 1\n",
      "  3400935244369 | FUROSEMIDE EVO 40MG CPR 30\n",
      "  3400935247490 | ZOPICLONE EG 7,5MG CPR 14\n",
      "  3400935248442 | TRAMADOL BGA 50MG GELULE 30\n",
      "  3400935250971 | TRIMEBUTINE ZYD 100MG CPR 30\n",
      "  3400935251862 | AMOXICILLINE VIATRIS 500 MG/5 ML FL 1\n",
      "  3400935251923 | AMOXICILLINE VIATRIS 250MG/5ML FL 1\n",
      "  3400935252005 | AMOXICILLINE VIATRIS 125MG/5ML PDR 1\n",
      "  3400935252173 | AMOXICILLINE ZYD 500MG/5ML PDR FL 1\n",
      "  3400935252234 | AMOXICILLINE ZYD 250MG/5ML PDR FL 1\n",
      "  3400935252463 | AMOXICILLINE ZYD 125MG/5ML PDR FL 1\n",
      "  3400935253354 | GLICLAZIDE EG 80MG CPR 60\n",
      "  3400935259097 | NOVORAPID 1000 U SOL INJ FL 1\n",
      "  3400935259219 | NOVORAPID PENFILL 300 U SOL INJ 5\n",
      "  3400935259967 | REVAXIS 1 BOITE DE 1, VACCIN DIPHTERIQUE, TETANIQU\n",
      "  3400935264299 | FLECTOR 50 MG GRANULES SACHET 21\n",
      "  3400935264350 | CLIMASTON 1 MG/10 MG CPR 28\n",
      "  3400935265012 | ROZEX 0,75% EMULSION 1\n",
      "  3400935265470 | ARTOTEC 75MG/0,2MG CPR 20\n",
      "  3400935268433 | SPIRONOLACTONE EG 75MG CPR 30\n",
      "  3400935279668 | AROMASINE 25MG CPR 30\n",
      "  3400935279897 | DYNEXAN 2% CREME BUCCALE TUBE 10G 1\n",
      "  3400935281388 | LASILIX 40MG CPR 30\n",
      "  3400935281678 | GLUCOPHAGE 500MG CPR 30\n",
      "  3400935284112 | ACEBUTOLOL BGA 400MG CPR 30\n",
      "  3400935285751 | ZOPICLONE CRT 7,5MG CPR 14\n",
      "  3400935286291 | ZOPICLONE BGA 7,5MG CPR 5\n",
      "  3400935286352 | ZOPICLONE BGA 7,5MG CPR 14\n",
      "  3400935287014 | SOLIAN 100 MG/ML SOL BUV FL 60ML 1\n",
      "  3400935291035 | DAFALGAN 1 G CPR EFF 8\n",
      "  3400935291783 | EFFERALGANMED 1G CPR EFF 8\n",
      "  3400935294227 | DOLIPRANE 1G CPR EFF 8\n",
      "  3400935294395 | PARACETAMOL ZEN 1000MG CPR EFF 8\n",
      "  3400935295408 | BISOPROLOL BGR 1,25MG CPR 30\n",
      "  3400935295576 | BISOPROLOL BGR 1,25MG CPR 90\n",
      "  3400935295637 | BISOPROLOL BGR 2,5MG CPR 30\n",
      "  3400935295866 | BISOPROLOL BGR 2,5MG CPR 90\n",
      "  3400935295927 | BISOPROLOL BGR 3,75MG CPR 30\n",
      "  3400935296177 | BISOPROLOL BGR 5MG CPR 30\n",
      "  3400935296238 | BISOPROLOL BGR 5MG CPR 90\n",
      "  3400935296467 | BISOPROLOL BGR 7,5MG CPR 30\n",
      "  3400935296696 | BISOPROLOL BGR 10MG CPR 30\n",
      "  3400935296818 | CARDENSIEL 1,25MG CPR 30\n",
      "  3400935296986 | CARDENSIEL 1,25MG CPR 90\n",
      "  3400935297068 | CARDENSIEL 2,5MG CPR 30\n",
      "  3400935297129 | CARDENSIEL 2,5MG CPR 90\n",
      "  3400935297297 | CARDENSIEL 3,75MG CPR 30\n",
      "  3400935297419 | CARDENSIEL 5MG CPR 30\n",
      "  3400935298539 | ZOPICLONE TEVA 7,5MG CPR 14\n",
      "  3400935301413 | CLOMIPRAMINE VIATRIS 75MG CPR 20\n",
      "  3400935305145 | CARBAMAZEPINE VIATRIS LP 400MG CPR 30\n",
      "  3400935306326 | CARBAMAZEPINE VIATRIS LP 200MG CPR 30\n",
      "  3400935306906 | FLANID 200MG CPR 15\n",
      "  3400935307095 | FLANID 100MG CPR 30\n",
      "  3400935307446 | ACEBUTOLOL BGA 200 MG CPR 30\n",
      "  3400935309747 | PUREGON 300 UI SOL INJ CART 1\n",
      "  3400935309808 | PUREGON 600 UI SOL INJ CART 1\n",
      "  3400935310866 | NEORECORMON 4000UI/0,3ML SOL INJ SER 6\n",
      "  3400935311009 | NEORECORMON 6000UI/0,3ML SOL INJ SER 6\n",
      "  3400935312877 | CARDENSIEL 5 MG (HEMIFUMARATE DE BISOPROLOL) 1 BOI\n",
      "  3400935312938 | CARDENSIEL 7,5MG CPR 30\n",
      "  3400935313188 | CARDENSIEL 10MG CPR 30\n",
      "  3400935313249 | CARDENSIEL 10 MG (HEMIFUMARATE DE BISOPROLOL) 1 BO\n",
      "  3400935313997 | BISOCE 1,25MG CPR 30\n",
      "  3400935314079 | BISOCE 1,25MG CPR 90\n",
      "  3400935314130 | BISOCE 2,5MG CPR 30\n",
      "  3400935314369 | BISOCE 2,5MG CPR 90\n",
      "  3400935314420 | BISOCE 3,75MG CPR 30\n",
      "  3400935314659 | BISOCE 5MG CPR 30\n",
      "  3400935314710 | BISOCE 5MG CPR 90\n",
      "  3400935314888 | BISOCE 7,5MG CPR 30\n",
      "  3400935315021 | BISOCE 10 MG CPR 30\n",
      "  3400935315199 | BISOCE 10 MG CPR 90\n",
      "  3400935318091 | OMNIPAQUE 350MG SOL INJ FP 100ML 1\n",
      "  3400935318152 | OMNIPAQUE 350MG SOL INJ FP 150ML 1\n",
      "  3400935318381 | OMNIPAQUE 350MG SOL INJ FP 200ML 1\n",
      "  3400935318503 | OMNIPAQUE 300MG SOL INJ FP 100ML 1\n",
      "  3400935318671 | OMNIPAQUE 300MG SOL INJ FP 150ML 1\n",
      "  3400935318961 | OMNIPAQUE 300MG SOL INJ FP 200ML 1\n",
      "  3400935320742 | VENTOLINE 2,5MG/2,5ML SOL INHAL 60\n",
      "  3400935321114 | VENTOLINE 5MG/2,5ML SOL INHAL 60\n",
      "  3400935322982 | TRAMADOL TVC 50MG CPR 30\n",
      "  3400935324016 | LACTULOSE EG 66 P.100 1 FLACON DE 200 ML , SOLUTIO\n",
      "  3400935325594 | AMOXICILLINE EG 250MG/5ML PDR FL 1\n",
      "  3400935329219 | METOCLOPRAMIDE VIATRIS 10MG CPR 40\n",
      "  3400935330918 | KETOPROFENE BGR 200MG GELULE 14\n",
      "  3400935332639 | DOXYCYCLINE BGA 100MG CPR 5\n",
      "  3400935332868 | DOXYCYCLINE BGA 100MG CPR 15\n",
      "  3400935334060 | TOBRABACT 0,3% COLLYRE FL 5ML 1\n",
      "  3400935334640 | AMOXICILLINE EG 500MG/5ML PDR FL 1\n",
      "  3400935334879 | AMOX/AC CLAV BGA 1G/125MG AD SACH 8\n",
      "  3400935335012 | AMOX/AC CLAV BGA 1G/125MG AD SACH 12\n",
      "  3400935335241 | AMOX/AC CLAV BGA 500MG/62,5MG AD CPR 16\n",
      "  3400935335470 | AMOX/AC CLAV BGA 500MG/62,5MG AD CPR 24\n",
      "  3400935336422 | ZOMIGORO 2,5MG CPR 6\n",
      "  3400935336651 | ZOMIGORO 2,5MG CPR 12\n",
      "  3400935337023 | AUGMENTIN 500 MG/62,5 MG AD CPR 16\n",
      "  3400935337252 | AUGMENTIN 500 MG/62,5 MG AD CPR 24\n",
      "  3400935337542 | AMOX/AC CLAV ZTL 500MG/62,5MG 16\n",
      "  3400935337771 | AMOX/AC CLAV ZTL 500MG/62,5MG 24\n",
      "  3400935338723 | AMOX/AC CLAV ZTL 1G/125MG SAC 8\n",
      "  3400935338952 | AMOX/AC CLAV ZTL 1G/125MG SAC 12\n",
      "  3400935339492 | PRAZEPAM BGA 10MG CPR 40\n",
      "  3400935339843 | PRAZEPAM ARW 10MG CPR 40\n",
      "  3400935345936 | ROZACREME 0,75% CREME 1\n",
      "  3400935349200 | FEGENOR 200MG GELULE 30\n",
      "  3400935352101 | SYNAREL 0,2MG SOL NASALE 8ML 1\n",
      "  3400935355522 | AMOX/AC CLAV BGA 100MG/12,5MG/ML NR 1\n",
      "  3400935355690 | AMOX/AC CLAV BGA 100MG/12,5MG/ML ENF 1\n",
      "  3400935355751 | AMOX/AC CLAV ZTL 100MG/12,5 ENF 1\n",
      "  3400935356642 | CROMOPTIC 2% COLLYRE UNIDOSE 0,35ML 30\n",
      "  3400935357014 | TRILEPTAL 150MG CPR 50\n",
      "  3400935357243 | TRILEPTAL 300MG CPR 50\n",
      "  3400935357472 | TRILEPTAL 600MG CPR 50\n",
      "  3400935358134 | ZYMAD 80000UI SOL BUV AMP 1\n",
      "  3400935358363 | ZYMAD 10000UI/ML SOL BUV GOUTTES 1\n",
      "  3400935377524 | AMIODARONE CRT 200MG CPR 30\n",
      "  3400935377692 | AMIODARONE BGA 200MG CPR 30\n",
      "  3400935377982 | AMOXICILLINE EGL 1G CPR DISP 6\n",
      "  3400935378064 | AMOXICILLINE EGL 1G CPR DISP 14\n",
      "  3400935378583 | ALLOPURINOL EG 100MG CPR 28\n",
      "  3400935378644 | ALLOPURINOL EG 300MG CPR 28\n",
      "  3400935378705 | ALLOPURINOL EG 200MG CPR 28\n",
      "  3400935386229 | ACEBUTOLOL ZYD 400MG CPR 30\n",
      "  3400935395153 | NEUPOGEN 48 MU SOL INJ SER 1\n",
      "  3400935395382 | NEUPOGEN 30 MU SOL INJ SER 1\n",
      "  3400935395504 | TUBERTEST SOL INJECTABLE 1\n",
      "  3400935397454 | MOBIC 15 MG SOL INJ 3\n",
      "  3400935403988 | ENALAPRIL VIATRIS 5 MG CPR 28\n",
      "  3400935404060 | ENALAPRIL VIATRIS 5 MG CPR 30\n",
      "  3400935407191 | AMIODARONE EG 200MG CPR 30\n",
      "  3400935409614 | ACEBUTOLOL ZYD 200MG CPR 30\n",
      "  3400935416476 | ARAVA 10 MG CPR 30\n",
      "  3400935416995 | ARAVA 20 MG CPR 30\n",
      "  3400935417138 | ARAVA 100 MG CPR 3\n",
      "  3400935420909 | OXYCONTIN LP 10MG CPR 28\n",
      "  3400935421500 | OXYCONTIN LP 20MG CPR 28\n",
      "  3400935422279 | OXYCONTIN LP 40MG CPR 28\n",
      "  3400935427182 | NEULEPTIL 10MG GELULE 50\n",
      "  3400935428134 | AMOXICILLINE EG 125MG/5ML PDR FL 1\n",
      "  3400935429315 | ALLERGOCOMOD 2% COLLYRE FL 10ML 1\n",
      "  3400935429483 | OXYCONTIN LP 80MG CPR 28\n",
      "  3400935434975 | AZOPT 10MG/ML COLLYRE FL 5ML 1\n",
      "  3400935436238 | ACTONEL 5 MG CPR 28\n",
      "  3400935436696 | ACTONEL 30 MG CPR 28\n",
      "  3400935436818 | CELEBREX 100MG GELULE 30\n",
      "  3400935437068 | CELEBREX 200MG GELULE 30\n",
      "  3400935439079 | CETIRIZINE CRT 10MG CPR 15\n",
      "  3400935440488 | FENOFIBRATE ZYD 300MG GELULE 30\n",
      "  3400935443090 | ZOMIG 2,5MG CPR 12\n",
      "  3400935444271 | DEPAKOTE 500MG CPR 90\n",
      "  3400935444912 | METFORMINE EG LABO 500 MG 1 BOITE DE 30, COMPRIMES\n",
      "  3400935447005 | NOCTAMIDE 2MG CPR 14\n",
      "  3400935451316 | AZATHIOPRINE MYL 50MG CPR 100\n",
      "  3400935454218 | ZYPREXA VELOTAB 5MG CPR 28\n",
      "  3400935458179 | LAMICTAL 2MG CPR DISP 30\n",
      "  3400935459060 | INDOBIOTIC COLLYRE UNIDOSE 0,35ML 20\n",
      "  3400935459350 | SERETIDE DISKUS 100/50 MICROG PDR 60 60\n",
      "  3400935459701 | SERETIDE DISKUS 250/50 MICROG PDR 60 60\n",
      "  3400935463203 | LANTUS 300U SOL INJ CART 5\n",
      "  3400935466563 | ACEBUTOLOL EG 400MG CPR 30\n",
      "  3400935466624 | ACEBUTOLOL EG 200MG CPR 30\n",
      "  3400935469236 | IOMERON 300 SOL INJ FL 20ML 1\n",
      "  3400935469526 | IOMERON 350 SOL INJ FL 20ML 1\n",
      "  3400935469694 | IOMERON 350 SOL INJ FL 150ML AN 1\n",
      "  3400935473547 | SERETIDE DISKUS 500/50 MICROG PDR 60 60\n",
      "  3400935476500 | CALCIUM VIT D3 TVC 500MG/400UI CPR 60\n",
      "  3400935477279 | FENOFIBRATE BGA 67 MG GELULE 60\n",
      "  3400935477330 | FENOFIBRATE BGA 200MG GELULE 30\n",
      "  3400935477910 | ISOPTINE 120 MG GELULE 30\n",
      "  3400935479341 | PROVAMES 2MG CPR 28\n",
      "  3400935482471 | ZOPICLONE ARW 7,5MG CPR 14\n",
      "  3400935485724 | FLUOXETINE BGA 20MG GELULE 14\n",
      "  3400935485953 | FENOFIBRATE EG 67MG GELULE 60\n",
      "  3400935486264 | FENOFIBRATE EG 200MG GELULE 30\n",
      "  3400935489975 | SOTALOL CRT 80MG CPR 30\n",
      "  3400935490575 | SOTALOL EG 80MG CPR 30\n",
      "  3400935490865 | SOTALOL EG 160MG CPR 30\n",
      "  3400935492586 | TICLOPIDINE EG 250MG CPR 30\n",
      "  3400935495259 | NOVOMIX 30 PENFILL 300U/3ML CARTOUCH 5\n",
      "  3400935495839 | INFANRIX HEXA PDR INJ SER AVEC AIG 1\n",
      "  3400935496430 | LUVERIS 75 UI PDR ET SOL INJ 1\n",
      "  3400935496669 | LUVERIS 75 UI PDR ET SOL INJ 3\n",
      "  3400935497031 | EPREX 5 000 UI/0,5ML SOL INJ SER 6\n",
      "  3400935497260 | EPREX 6 000 UI/0,6ML SOL INJ SER 6\n",
      "  3400935497499 | EPREX 8 000 UI/0,8ML SOL INJ SER 6\n",
      "  3400935499622 | ENALAPRIL BGA 20 MG CPR 28\n",
      "  3400935500144 | ENALAPRIL BGA 5 MG CPR 28\n",
      "  3400935504975 | ENALAPRIL VIATRIS 20 MG CPR 28\n",
      "  3400935505057 | ENALAPRIL VIATRIS 20 MG CPR 30\n",
      "  3400935506528 | IBUPROFENE ZYD 200MG CPR ENR 30\n",
      "  3400935507587 | FENOFIBRATE ARW 67MG GELULE 60\n",
      "  3400935507877 | FENOFIBRATE ARW 200MG GELULE 30\n",
      "  3400935508300 | FENOFIBRATE CRT 67MG GELULE 60\n",
      "  3400935508768 | FENOFIBRATE CRT 200MG GELULE 30\n",
      "  3400935509130 | PULMODEXANE 300MG/100ML SOL BUV 1\n",
      "  3400935510259 | FAMOTIDINE EG 20MG CPR 30\n",
      "  3400935511140 | IOMERON 300 SOL INJ FL 150ML ME 1\n",
      "  3400935511201 | IOMERON 350 SOL INJ FL 150ML ME 1\n",
      "  3400935513670 | LEPONEX 25 MG (CLOZAPINE) 1 BOITE DE 28, COMPRIMES\n",
      "  3400935514561 | PARIET 20MG CPR 14\n",
      "  3400935514790 | PARIET 20MG CPR 28\n",
      "  3400935524676 | INFANRIXTETRA IM SUSP INJ 1\n",
      "  3400935524737 | INFANRIXQUINTA PDR INJ SER 1\n",
      "  3400935527400 | NOVORAPID FLEXPEN 300 U SOL INJ 5\n",
      "  3400935528001 | PNEUMOVAX SOL INJ FL 1\n",
      "  3400935528698 | LACRIFLUID 0,13% COLLYRE 1\n",
      "  3400935528988 | IBUFETUM 5% GEL 1\n",
      "  3400935530189 | ORGALUTRAN 0,25 MG SOL INJ 1\n",
      "  3400935530240 | ORGALUTRAN 0,25 MG SOL INJ 5\n",
      "  3400935530769 | VISUDYNE 15 MG PDR INJ 1\n",
      "  3400935531131 | FEMSEPTCOMBI 0,05MG/0,01MG/24H DISP 4\n",
      "  3400935531650 | TAKADOL 100MG CPR EFF 30\n",
      "  3400935533203 | INEXIUM 20MG CPR 7\n",
      "  3400935533371 | INEXIUM 20MG CPR 14\n",
      "  3400935533432 | INEXIUM 20MG CPR 28\n",
      "  3400935533890 | INEXIUM 40MG CPR 14\n",
      "  3400935533951 | INEXIUM 40MG CPR 28\n",
      "  3400935537164 | ZYPREXA 7,5MG CPR 28\n",
      "  3400935537393 | LIPANTHYL 160MG CPR 30\n",
      "  3400935539755 | SERC 8 MG CPR 90\n",
      "  3400935545787 | TERBINAFINE EG 1% CREME 1\n",
      "  3400935545848 | MONTELUKAST BGA 5MG CPR CROQ 28\n",
      "  3400935546968 | NARATRIPTAN SDZ 2,5MG CPR 12\n",
      "  3400935547040 | MONTELUKAST BGA 10MG CPR 28\n",
      "  3400935547279 | SPIRAM/METRO ZEN 1,5MUI/250MG CPR 10\n",
      "  3400935547910 | CEFTRIAXONE CRT 1G/10ML PRD INJ IV 1\n",
      "  3400935548399 | CEFTRIAXONE EG 1G PDR INJ IV 1\n",
      "  3400935554192 | MOLSIDOMINE BGA 2MG CPR 30\n",
      "  3400935554253 | MOLSIDOMINE BGA 2MG CPR 90\n",
      "  3400935554314 | MOLSIDOMINE BGA 4MG CPR 30\n",
      "  3400935555144 | MOLSIDOMINE MYL 2MG CPR 30\n",
      "  3400935555205 | MOLSIDOMINE MYL 2MG CPR 90\n",
      "  3400935555373 | MOLSIDOMINE MYL 4MG CPR 30\n",
      "  3400935555892 | MOLSIDOMINE EG 2MG CPR 30\n",
      "  3400935555953 | MOLSIDOMINE EG 2MG CPR 90\n",
      "  3400935556035 | MOLSIDOMINE EG 4MG CPR 30\n",
      "  3400935556844 | HYTACAND 16MG/12,5MG CPR 30\n",
      "  3400935557506 | TAHOR 80MG CPR 28\n",
      "  3400935561466 | ALMOGRAN 12,5MG CPR 6\n",
      "  3400935561756 | ISIMIG 2,5MG CPR 6\n",
      "  3400935561817 | SERTRALINE PFZ 25MG GELULE 7\n",
      "  3400935562067 | ZOLOFT 25MG GELULE 7\n",
      "  3400935562708 | ANTARENE 5% GEL TUBE 50G 1\n",
      "  3400935564719 | BETASERC 24MG CPR 60\n",
      "  3400935565259 | TRACUTIL SOL INJ 5\n",
      "  3400935566140 | ACICLOVIR EG 800MG CPR 35\n",
      "  3400935566201 | ACICLOVIR TVC 800MG CPR 35\n",
      "  3400935566720 | LOPERAMIDE ZYD 2MG GELULE 20\n",
      "  3400935567260 | CEFTRIAXONE VIATR 1G/10ML PDR INJ IV 1\n",
      "  3400935567550 | CEFTRIAXONE VIAT 0,5G/5ML PDR INJ IV 1\n",
      "  3400935568960 | CEFTRIAXONE VTS 1G/3,5ML PDR INJ IM 1\n",
      "  3400935569271 | CEFTRIAXONE VIATRIS 500MG/2ML INJ IM 1\n",
      "  3400935570802 | CALCIUM SDZ 500MG PDR ORALE 30\n",
      "  3400935575135 | ATENOLOL VTS 50MG CPR 30\n",
      "  3400935575654 | ATENOLOL VTS 100MG CPR 30\n",
      "  3400935581976 | DOXYCYCLINE VIATRIS 100MG CPR 5\n",
      "  3400935582119 | DOXYCYCLINE VIATRIS 100MG CPR 15\n",
      "  3400935582348 | DOXYCYCLINE VIATRIS 100MG CPR 30\n",
      "  3400935582867 | AMOXICILLINE TVS 1G CPR DISP 6\n",
      "  3400935582928 | AMOXICILLINE TVS 1G CPR DISP 14\n",
      "  3400935584069 | EUPANTOL 40 MG (PANTOPRAZOLE SODIQUE SESQUIHYDRATE\n",
      "  3400935584410 | INIPOMP 20 MG CPR 28\n",
      "  3400935584700 | INIPOMP 40 MG CPR 14\n",
      "  3400935584878 | INIPOMP 40 MG CPR 28\n",
      "  3400935585301 | EUPANTOL 20 MG CPR 28\n",
      "  3400935585530 | LAMISIL 1% SOL FL PULV 15ML 1\n",
      "  3400935588081 | AMIODARONE ALM 200MG CPR 30\n",
      "  3400935589262 | ZOPICLONE ZYD 7,5MG CPR 14\n",
      "  3400935589781 | PARACETAMOL ZYD 500MG CPR 16\n",
      "  3400935590503 | CEFTRIAXONE EG 1G/3,5ML PDR INJ IM 1\n",
      "  3400935599209 | SPANOR 100MG CPR 15\n",
      "  3400935599377 | SPANOR 100MG CPR 30\n",
      "  3400935601360 | KEPPRA 250MG CPR 60\n",
      "  3400935601650 | KEPPRA 500MG CPR 60\n",
      "  3400935601711 | GLUCOPHAGE 1000MG CPR 30\n",
      "  3400935602251 | KEPPRA 1000MG CPR 60\n",
      "  3400935602312 | GLUCOPHAGE 1000MG CPR 90\n",
      "  3400935607744 | ZALERG 0,25MG/ML COLLYRE UNIDOSE 30\n",
      "  3400935608055 | BISOPROLOL TVC 5MG CPR 30\n",
      "  3400935609816 | BISOPROLOL TVC 10MG CPR 30\n",
      "  3400935613028 | GLUCOSE MACO 5% SOL INJ POC 50ML 1\n",
      "  3400935613196 | GLUCOSE MACO 5% SOL INJ POC 100ML 1\n",
      "  3400935613318 | GLUCOSE MACO 5% SOL INJ POC 250ML 1\n",
      "  3400935613486 | GLUCOSE MACO 5% SOL INJ POC 500ML 1\n",
      "  3400935613547 | GLUCOSE MACO 5% SOL INJ POC 1L 1\n",
      "  3400935615787 | CROMEDIL 2% COLLYRE UNIDOSE 30\n",
      "  3400935616449 | DOXY 100MG CPR 30\n",
      "  3400935619921 | MORPHINE SULF LAV 500 MG INJ 1\n",
      "  3400935620170 | MORPHINE SULF LAV 500 MG INJ 10\n",
      "  3400935620699 | MORPHINE SULF LAV 1 MG INJ 10\n",
      "  3400935624482 | MEBEVERINE ZYD 200MG CPR 30\n",
      "  3400935626325 | SULPIRIDE VIATRIS 200MG CPR 12\n",
      "  3400935628855 | PERINDOPRIL INDAP 2MG/0,625MG CPR 90\n",
      "  3400935628916 | PERINDOPRIL INDAP ARL 4MG/1,25MG CPR 90\n",
      "  3400935629395 | DOXYPALU 100MG CPR 28\n",
      "  3400935631466 | SODIUM CHL MACO 0,9% INJ POC 50ML 1\n",
      "  3400935631527 | SODIUM CHL MACO 0,9% INJ POC 100ML 1\n",
      "  3400935631756 | SODIUM CHL MACO 0,9% INJ POC 250ML 1\n",
      "  3400935631817 | SODIUM CHL MACO 0,9% INJ POC 500ML 1\n",
      "  3400935631985 | SODIUM CHL MACO 0,9% INJ POC 1L 1\n",
      "  3400935634139 | EPITOMAX 50 MG CPR 28\n",
      "  3400935634429 | EPITOMAX 100 MG CPR 28\n",
      "  3400935634658 | EPITOMAX 200 MG CPR 28\n",
      "  3400935634887 | DAIVONEX 50 POMMADE 120G 1\n",
      "  3400935634948 | DAIVONEX 50 MICROG/G CREME 120G 1\n",
      "  3400935635600 | CLINIMIX N9G15E SOL INJ 0,5L+0,5L 8\n",
      "  3400935644183 | ATENOLOL BIOGARAN 50 MG 1 BOITE DE 28, COMPRIMES S\n",
      "  3400935644244 | ATENOLOL BGA 50 MG CPR 30\n",
      "  3400935645883 | CALCIUM VIT D3 EG 500MG/400UI CPR 60\n",
      "  3400935646026 | CALCIUM VIT D3 BGA 500MG/400UI CPR 60\n",
      "  3400935646835 | FLUVOXAMINE VIATRIS 50MG CPR 30\n",
      "  3400935647085 | FLUVOXAMINE VIATRIS 100MG CPR 15\n",
      "  3400935650627 | GEL LARMES 0,3% GEL OPH UNIDOSE 30\n",
      "  3400935651518 | NAABAK 19,6MG/0,4ML COLLYRE UNIDOSE 36\n",
      "  3400935652638 | FENOFIBRATE BGA 100MG GELULE 30\n",
      "  3400935652867 | VERAPAMIL EG LP 240MG CPR 30\n",
      "  3400935653178 | VITAMINE A NEP 100 000 UI SOL INJ 6\n",
      "  3400935653468 | VITAMINE E PRO 100 MG/2 ML SOL INJ 6\n",
      "  3400935655769 | AERIUS 5MG CPR 15\n",
      "  3400935656070 | AERIUS 5MG CPR 30\n",
      "  3400935656421 | ZITHROMAX 40MG/ML PDR ORALE 29,3G 1\n",
      "  3400935656599 | ZITHROMAX 40MG/ML PDR ORALE 35,6G 1\n",
      "  3400935657190 | CERNEVIT PDR INJ 10\n",
      "  3400935658203 | SYMBICORT TURBUHALER 100/6 MICROG 1\n",
      "  3400935658432 | SYMBICORT TURBUHALER 200/6 MICROG 1\n",
      "  3400935658661 | SERETIDE 50/25 MICROG SUSP INHAL 1\n",
      "  3400935658722 | SERETIDE 125/25 MICROG SUSP INHAL 1\n",
      "  3400935658890 | SERETIDE 250/25 MICROG SUSP INHAL 1\n",
      "  3400935659552 | MIFLASONE 400 MICROG PDR INH GELULE 60\n",
      "  3400935660381 | CLIMASTON 1 MG/5 MG CPR 28\n",
      "  3400935665065 | ESTRAPATCH 60 MICROG/24H DISP 4\n",
      "  3400935665126 | ESTRAPATCH 40 MICROG/24H DISP 4\n",
      "  3400935668196 | KALETRA 80MG/20MG/ML SOL BUV FL 60ML 5\n",
      "  3400935668257 | CALCIFORTE VITAMINE D3 CPR 60\n",
      "  3400935671387 | ESTIMA 200MG CAPSULE 15\n",
      "  3400935673169 | LUDEAL CPR 21\n",
      "  3400935673220 | LUDEAL CPR 63\n",
      "  3400935673459 | AMIODARONE ARW 200MG CPR 30\n",
      "  3400935674401 | PARIET 10MG CPR 28\n",
      "  3400935676641 | NOVOMIX 30 FLEXPEN 300U STYLO 5\n",
      "  3400935677242 | AVAXIM 80U PED SUSP INJ SER AIG A 1\n",
      "  3400935678133 | ARANESP 10 MICROG/0,4ML INJ SER 1\n",
      "  3400935681614 | MENOPUR 75 UI PDR ET SOL INJ 5\n",
      "  3400935684516 | AMOXICILLINE MYL 1G CPR DISP 6\n",
      "  3400935684684 | AMOXICILLINE MYL 1G CPR DISP 14\n",
      "  3400935688477 | RAPAMUNE 1MG/1ML SOL BUV FL 60ML 1\n",
      "  3400935692610 | MIKICORT 3MG GELULE 50\n",
      "  3400935692788 | MIKICORT 3MG GELULE 90\n",
      "  3400935693099 | COUMADINE 5MG CPR 30\n",
      "  3400935697691 | TRINITRINE VIATRI 5MG/24H DISP TRANS 30\n",
      "  3400935697752 | TRINITRINE VTS 10MG/24H DISP TRANS 30\n",
      "  3400935703828 | CLOZAPINE VIATRIS 25MG CPR 7\n",
      "  3400935704078 | CLOZAPINE VIATRIS 25MG CPR 28\n",
      "  3400935704658 | CLOZAPINE VIATRIS 100MG CPR 14\n",
      "  3400935704719 | CLOZAPINE VIATRIS 100MG CPR 28\n",
      "  3400935705778 | MOLSIDOMINE MYL 4MG CPR 90\n",
      "  3400935706140 | TIMOFEROL GELULE 30\n",
      "  3400935706669 | UNIFLUID 6MG/0,4ML COLLYRE UNIDOSE 36\n",
      "  3400935708670 | MEBEVERINE ZEN 100MG GELULE 30\n",
      "  3400935712004 | TICLOPIDINE ARW 250MG CPR 30\n",
      "  3400935713063 | TRAMADOL ZYD 50MG GELULE 30\n",
      "  3400935715135 | IBUPROFENE ARW 200MG CPR ENR 30\n",
      "  3400935715654 | BISOPROLOL ALMUS 10 MG 1 BOITE DE 28, COMPRIMES SE\n",
      "  3400935715715 | BISOPROLOL ALM 10MG CPR 30\n",
      "  3400935718495 | FLUOSTEROL SOL BUV 1\n",
      "  3400935719676 | NIQUITIN 7MG/24H DISP TRANSDER 28\n",
      "  3400935721518 | BIOCALYPTOL 131MG/100ML SIROP 200ML 1\n",
      "  3400935726599 | RENAGEL 800 MG CPR 180\n",
      "  3400935728722 | SOMATULINE LP 60 MG SOL INJ 1\n",
      "  3400935728890 | SOMATULINE LP 90 MG SOL INJ 1\n",
      "  3400935728951 | SOMATULINE LP 120 MG SOL INJ 1\n",
      "  3400935730961 | MOLSIDOMINE ARW 2MG CPR 30\n",
      "  3400935731043 | MOLSIDOMINE ARW 2MG CPR 90\n",
      "  3400935731104 | MOLSIDOMINE ARW 4MG CPR 30\n",
      "  3400935736994 | MIANSERINE CRT 10MG CPR 30\n",
      "  3400935737137 | MIANSERINE CRT 30MG CPR 30\n",
      "  3400935737366 | MIANSERINE CRT 60MG CPR 14\n",
      "  3400935737885 | MIANSERINE EG 10MG CPR 30\n",
      "  3400935738028 | MIANSERINE EG 30MG CPR 30\n",
      "  3400935738196 | MIANSERINE EG 60MG CPR 14\n",
      "  3400935740328 | PREDNISOLONE EG 20MG CPR EFF 20\n",
      "  3400935740557 | PREDNISOLONE BGA 20MG CPR EFF 20\n",
      "  3400935741158 | DICLOFENAC ARW 50MG CPR 30\n",
      "  3400935741738 | ATENOLOL ARW 50MG CPR 30\n",
      "  3400935742100 | ATENOLOL ARW 100MG CPR 30\n",
      "  3400935742568 | PARACETAMOL ALM 500MG CPR 16\n",
      "  3400935743800 | CEFTRIAXONE ARW 0,5G/2ML PDR INJ IM 1\n",
      "  3400935744050 | CEFTRIAXONE ARW 1G/3,5ML PDR INJ IM 1\n",
      "  3400935744869 | CEFTRIAXONE ARW 1G/10ML PDR INJ IV 1\n",
      "  3400935745460 | MOLSIDOMINE ARW 4MG CPR 90\n",
      "  3400935745521 | TERAZOSINE MYL 5MG CPR 28\n",
      "  3400935745989 | ALLOPURINOL ARW 100MG CPR 28\n",
      "  3400935746061 | ALLOPURINOL ARW 100MG CPR 30\n",
      "  3400935746412 | ALLOPURINOL ARW 300MG CPR 28\n",
      "  3400935746641 | ALLOPURINOL ARW 200MG CPR 28\n",
      "  3400935746931 | TEMESTA 1MG CPR 30\n",
      "  3400935748652 | PARACETAMOL /COD PFB 300MG/25MG CPR 16\n",
      "  3400935748713 | PARACETAMOL /COD PFB 600MG/50MG CPR 12\n",
      "  3400935750662 | STROMECTOL 3MG CPR 1\n",
      "  3400935755407 | TIGREAT 2,5MG CPR 6\n",
      "  3400935756466 | SONOVUE 8 MICROLITRES/ML PDR INJ 1\n",
      "  3400935757876 | IZILOX 400MG CPR 5\n",
      "  3400935757937 | IZILOX 400MG CPR 7\n",
      "  3400935760197 | FEGENOR 140MG GELULE 30\n",
      "  3400935760258 | XALACOM COLLYRE FL 2,5ML 1\n",
      "  3400935760319 | XALACOM COLLYRE FL 2,5ML 3\n",
      "  3400935763730 | CAPTOPRIL ARW 25MG CPR 30\n",
      "  3400935764102 | CAPTOPRIL ARW 50MG CPR 30\n",
      "  3400935765680 | AMOXICILLINE ARW 500MG GELULE 12\n",
      "  3400935765741 | AMOXICILLINE ARW 500MG/5ML PDR FL 1\n",
      "  3400935765802 | AMOXICILLINE ARW 250MG/5ML PDR FL 1\n",
      "  3400935765970 | AMOXICILLINE ARW 125MG/5ML PDR FL 1\n",
      "  3400935766052 | ACIDE FOLIQUE CCD 5MG CPR 20\n",
      "  3400935770424 | PIRACETAM ARW 1000 MG/5 ML SOL BUV 1\n",
      "  3400935770714 | CLOZAPINE PAN 25 MG CPR 28\n",
      "  3400935770943 | CLOZAPINE BGR 100MG CPR 14\n",
      "  3400935771025 | CLOZAPINE BGR 100MG CPR 28\n",
      "  3400935772374 | METFORMINE ARW 500MG CPR 30\n",
      "  3400935772664 | METFORMINE ARW 850MG CPR 30\n",
      "  3400935772893 | CELIPROLOL ARW 200MG CPR 28\n",
      "  3400935772954 | CELIPROLOL VIATRIS 200MG CPR 28\n",
      "  3400935779298 | GONAL F 75UI/1ML PDR INJ FL ET SER 1\n",
      "  3400935780188 | GONAL F 1050UI/1,75ML PDR INJ ET SER 1\n",
      "  3400935781420 | FLUDEX LP 1,5MG CPR 90\n",
      "  3400935781659 | INDAPAMIDE ARW LP 1,5MG CPR 90\n",
      "  3400935781888 | INDAPAMIDE BGA LP 1,5MG CPR 90\n",
      "  3400935783660 | PROCUTA 20MG CAPSULE MOLLE 30\n",
      "  3400935783899 | PROCUTA 10MG CAPSULE MOLLE 30\n",
      "  3400935784032 | PROCUTA 5MG CAPSULE MOLLE 30\n",
      "  3400935784902 | DUOVA 1MG/2,5MG CPR 28\n",
      "  3400935785152 | DUOVA 1MG/5MG CPR 28\n",
      "  3400935785381 | DUOVA 2MG/5MG CPR 28\n",
      "  3400935786104 | RELPAX 20MG CPR 6\n",
      "  3400935786852 | RELPAX 40MG CPR 6\n",
      "  3400935786913 | RELPAX 40MG CPR 10\n",
      "  3400935788924 | CARTEOL LP 1% COLLYRE FL 3ML 1\n",
      "  3400935789525 | CARTEOL LP 2% COLLYRE FL 3ML 1\n",
      "  3400935790125 | TRILEPTAL 60MG/ML SUSP BUV FL 250ML 1\n",
      "  3400935794147 | SOTALOL BGA 80MG CPR 30\n",
      "  3400935794208 | SOTALOL BGA 80MG CPR 30\n",
      "  3400935794376 | SOTALOL BGA 160MG CPR 30\n",
      "  3400935796158 | AMOXICILLINE BGA 1G CPR DISP 6\n",
      "  3400935802972 | VALACICLOVIR CRT 500MG CPR 112\n",
      "  3400935804983 | PROGESTERONE BGA 100MG CAPSULE 30\n",
      "  3400935805294 | FLECAINE LP 50MG GELULE 30\n",
      "  3400935805416 | FLECAINE LP 150MG GELULE 30\n",
      "  3400935805645 | FLECAINE LP 100MG GELULE 30\n",
      "  3400935805874 | FLECAINE LP 200MG GELULE 30\n",
      "  3400935806307 | ACTIQ 200MICROG CPR 3\n",
      "  3400935806826 | ACTIQ 400MICROG CPR 3\n",
      "  3400935807366 | ACTIQ 600MICROG CPR 3\n",
      "  3400935811387 | PROGESTAN 100MG CAPSULE 90\n",
      "  3400935811677 | CONTRACNE 20MG CAPSULE MOLLE 30\n",
      "  3400935812049 | CONTRACNE 10MG CAPSULE MOLLE 30\n",
      "  3400935812568 | CURACNE 5MG CAPSULE MOLLE 30\n",
      "  3400935813169 | CURACNE 10MG CAPSULE MOLLE 30\n",
      "  3400935813688 | CURACNE 20MG CAPSULE MOLLE 30\n",
      "  3400935817181 | FLUOXETINE ARW 20MG/5ML BUV FL 70ML 1\n",
      "  3400935817303 | ALPRAZOLAM EVO 0,25MG CPR 30\n",
      "  3400935817532 | PARACETAMOL ARW 500MG CPR 16\n",
      "  3400935823274 | IBUPROFENE VIATRIS 200MG CPR ENR 30\n",
      "  3400935825056 | PROGESTERONE BGA 200MG CAPSULE 15\n",
      "  3400935825117 | FLUOXETINE ZYD 20MG GELULE 14\n",
      "  3400935825407 | TAMOXIFENE EG 10MG CPR 30\n",
      "  3400935829597 | ALPRAZOLAM EVO 0,50MG CPR 30\n",
      "  3400935830777 | TRIMEBUTINE ARW 100MG CPR 30\n",
      "  3400935833440 | TAMOXIFENE EG 20MG CPR 30\n",
      "  3400935834799 | MIANSERINE ARW 10MG CPR 30\n",
      "  3400935834911 | MIANSERINE ARW 30MG CPR 30\n",
      "  3400935835161 | MIANSERINE ARW 60MG CPR 14\n",
      "  3400935835680 | METFORMINE ARW 500MG CPR 90\n",
      "  3400935835802 | METFORMINE ARW 850MG CPR 90\n",
      "  3400935835970 | CELIPROLOL BGA 200MG CPR 28\n",
      "  3400935836113 | CELIPROLOL EG 200MG CPR 28\n",
      "  3400935836571 | CELIPROLOL CRT 200MG CPR 28\n",
      "  3400935837004 | CELIPROLOL ZYD 200MG CPR 28\n",
      "  3400935838582 | LACTULOSE VIATRIS SA 10G SOL BUV SAC 20\n",
      "  3400935842664 | SALBUTAMOL TVC 100MICROG SUSP INH 1\n",
      "  3400935843494 | ACTIQ 800MICROG CPR 3\n",
      "  3400935843845 | ACTIQ 1200MICROG CPR 3\n",
      "  3400935844217 | ACTIQ 1600MICROG CPR 3\n",
      "  3400935844675 | GONAPEPTYL LP 3,75 MG PDR ET SOL INJ 1\n",
      "  3400935845276 | BIOCALYPTOL SS SUCRE SIROP 200ML 1\n",
      "  3400935845856 | ACIDE FOLIQUE CCD 0,4MG CPR 30\n",
      "  3400935845917 | ADVILMED 100MG CPR ENR 30\n",
      "  3400935846747 | SELOZOK LP 23,75 MG CPR 28\n",
      "  3400935847638 | TRAVATAN 0,004% COLLYRE FL 2,5ML 1\n",
      "  3400935847928 | NOVOFEMME CPR 28\n",
      "  3400935848178 | PARACETAMOL EG 500MG CPR EFF 16\n",
      "  3400935848819 | EPIVIR 300 MG CPR 30\n",
      "  3400935849588 | COZAAR 100MG CPR 28\n",
      "  3400935849649 | ZYMAD 200000UI SOL BUV AMP 1\n",
      "  3400935850010 | VIREAD 245 MG CPR 30\n",
      "  3400935850249 | XYZALL 5MG CPR 14\n",
      "  3400935850539 | XYZALL 5MG CPR 28\n",
      "  3400935853202 | FLUDARA 10MG CPR 15\n",
      "  3400935853370 | FLUDARA 10MG CPR 20\n",
      "  3400935856043 | MIFLONIL 200 MICROG PDR INH GELULE 60\n",
      "  3400935856333 | MIFLONIL 400 MICROG PDR INH GELULE 60\n",
      "  3400935856852 | FIVASA 800 MG CPR GR 90\n",
      "  3400935856913 | ZALDIAR 37,5MG/325MG CPR 20\n",
      "  3400935857392 | IXPRIM 37,5MG/325MG CPR 20\n",
      "  3400935858054 | VIVELLEDOT 37,5 MICROG/24H DISP 8\n",
      "  3400935858344 | VIVELLEDOT 50 MICROG/24H DISP 8\n",
      "  3400935858634 | VIVELLEDOT 75 MICROG/24H DISP 8\n",
      "  3400935859006 | VIVELLEDOT 100 MICROG/24H DISP 8\n",
      "  3400935860705 | ALMOGRAN 12,5MG CPR 12\n",
      "  3400935863195 | MIANSERINE BGA 60MG CPR 14\n",
      "  3400935866738 | MIANSERINE BGA 10MG CPR 30\n",
      "  3400935867049 | MIANSERINE BGA 30MG CPR 30\n",
      "  3400935875723 | PROGRAF 5 MG GELULE 50\n",
      "  3400935876324 | PROGESTAN 200MG CAPSULE 45\n",
      "  3400935876553 | NEFOPAM VTS 20 MG SOL INJ 5\n",
      "  3400935876782 | UTROGESTAN 100MG CAPSULE 60\n",
      "  3400935876843 | UTROGESTAN 200MG CAPSULE 45\n",
      "  3400935877154 | TRAMADOL ARW 50MG CPR 30\n",
      "  3400935881175 | FIVASA 500MG SUPPO 30\n",
      "  3400935881755 | DETENSIEL 10 MG CPR 30\n",
      "  3400935883766 | FLUOXETINE EG 20 MG GELULE 14\n",
      "  3400935884138 | DAILY CPR 21\n",
      "  3400935884367 | DAILY CPR 63\n",
      "  3400935884428 | CETIRIZINE SDZ 10MG CPR 15\n",
      "  3400935887559 | SERESTA 10MG CPR 30\n",
      "  3400935895134 | VOLTARENE EMULGEL 1% GEL FLACON 1\n",
      "  3400935895424 | DOTAREM 0,5 MMOL/ML SOL INJ FV 5ML 1\n",
      "  3400935895714 | PROGRAF 1 MG GELULE 50\n",
      "  3400935895882 | PROGRAF 0,5 MG GELULE 50\n",
      "  3400935898845 | EPINITRIL 5MG/24H DISP TRANSDERM 30\n",
      "  3400935899095 | EPINITRIL 10MG/24H DISP TRANSDERM 30\n",
      "  3400935899217 | EPINITRIL 15MG/24H DISP TRANSDERM 30\n",
      "  3400935900258 | NEURONTIN 600MG CPR 90\n",
      "  3400935900487 | NEURONTIN 800MG CPR 90\n",
      "  3400935901149 | ANASTROZOLE BGA 1MG CPR 30\n",
      "  3400935901897 | ANASTROZOLE BGA 1MG CPR 90\n",
      "  3400935902269 | DUOPLAVIN 75 MG/75 MG CPR 30\n",
      "  3400935904270 | FLUVOXAMINE EG 50MG CPR 30\n",
      "  3400935905451 | MEBEVERINE EG 200 MG 1 BOITE DE 30, GELULES\n",
      "  3400935905970 | FLUOXETINE ARW 20MG GELULE 14\n",
      "  3400935919410 | DEBRIDAT 200MG CPR 30\n",
      "  3400935919588 | TRIMEBUTINE VIATRIS 200MG CPR 30\n",
      "  3400935922021 | LUMIGAN 0,3 MG/ML COLLYRE FL 3ML 1\n",
      "  3400935922199 | PROTOPIC 0,03 % POMMADE 1\n",
      "  3400935922311 | PROTOPIC 0,1 % POMMADE 1\n",
      "  3400935922540 | ARIXTRA 2,5MG/0,5ML SOL INJ 2\n",
      "  3400935922601 | ARIXTRA 2,5MG/0,5ML SOL INJ 7\n",
      "  3400935922779 | CILOXAN 0,3% POMMADE OPH 1\n",
      "  3400935924490 | ASMANEX TWISTHALER 200 MCG 60 DOSES 1\n",
      "  3400935924551 | ASMANEX TWISTHALER 400 MCG 30 DOSES 1\n",
      "  3400935924612 | ASMANEX TWISTHALER 400 MCG 60 DOSES 1\n",
      "  3400935925671 | ENALAPRIL EVO 20MG CPR 28\n",
      "  3400935926104 | ENALAPRIL EVO 5MG CPR 28\n",
      "  3400935928863 | VFEND 50MG CPR 28\n",
      "  3400935928924 | VFEND 50MG CPR 56\n",
      "  3400935929006 | VFEND 200MG CPR 14\n",
      "  3400935929174 | VFEND 200MG CPR 28\n",
      "  3400935929235 | VFEND 200MG CPR 56\n",
      "  3400935930583 | ACICLOVIR ARW 200MG CPR 25\n",
      "  3400935931016 | LIPOSIC GEL OPH 1\n",
      "  3400935931245 | ACICLOVIR ARW 800MG CPR 35\n",
      "  3400935940698 | CATAPRESSAN 0,15MG CPR 30\n",
      "  3400935941411 | TRANSACALM 100MG CPR 30\n",
      "  3400935946492 | LANTUS 1000 U SOL INJ FL 10 ML 1\n",
      "  3400935948274 | AMOX/AC CLAV ARW 100MG/12,5MG/ML NR 1\n",
      "  3400935948335 | AMOX/AC CLAV ARW 100MG/12,5MG/ML ENF 1\n",
      "  3400935948564 | AMOX/AC CLAV VIAT 100MG/12,5MG/ML NR 1\n",
      "  3400935948625 | AMOX/AC CLAV VTS 100MG/12,5MG/ML ENF 1\n",
      "  3400935948793 | AMOX/AC CLAV ALM 100MG/12,5MG/ML NR 1\n",
      "  3400935948854 | AMOX/AC CLAV ALM 100MG/12,5MG/ML ENF 1\n",
      "  3400935948915 | AMOX/AC CLAV SDZ 100MG/12,5MG/ML NR 1\n",
      "  3400935949165 | AMOX/AC CLAV SDZ 100MG/12,5MG/ML ENF 1\n",
      "  3400935949684 | ACEBUTOLOL ARW 200MG CPR 30\n",
      "  3400935949745 | ACEBUTOLOL ARW 400MG CPR 30\n",
      "  3400935949974 | ACEBUTOLOL CRT 200MG CPR 30\n",
      "  3400935952417 | LITHIODERM 8% GEL 1\n",
      "  3400935952585 | CELLCEPT 250 MG GELULE 100\n",
      "  3400935952707 | CELLCEPT 500 MG CPR 50\n",
      "  3400935952936 | CELLCEPT 1 G/5 ML PDR ORALE 1\n",
      "  3400935953018 | RAPAMUNE 1MG CPR 30\n",
      "  3400935954657 | ESTRAPATCH 80 MICROG/24H DISP 4\n",
      "  3400935954718 | LOPERAMIDE ARW 2MG GELULE 20\n",
      "  3400935955838 | DOLIPRANE 1G CPR 8\n",
      "  3400935956378 | FOSAMAX 70MG CPR 4\n",
      "  3400935956668 | FOSAMAX 70MG CPR 12\n",
      "  3400935959560 | OXYBUTYNINE BGA 5MG CPR 60\n",
      "  3400935959799 | OXYBUTYNINE TVS 5MG CPR 60\n",
      "  3400935964243 | REPEVAX SUSP INJ SER SA 1\n",
      "  3400935973696 | DOXYCYCLINE BGA 100MG CPR 30\n",
      "  3400935974419 | INIPOMP 20 MG CPR 14\n",
      "  3400935974648 | DOSISEPTINE 0,05% SOL FL 5ML 20\n",
      "  3400935978660 | FAMOTIDINE EG 40MG CPR 15\n",
      "  3400935978721 | SPIRONOLACTONE ALTIZIDE ARW CPR 30\n",
      "  3400935979780 | AMOXICILLINE ARW 1G CPR DISP 6\n",
      "  3400935979841 | AMOXICILLINE ARW 1G CPR DISP 14\n",
      "  3400935980380 | CEFTRIAXONE TVS 1G/10ML PDR INJ IV 1\n",
      "  3400935981332 | CEFTRIAXONE TVS 1G PDR INJ IM 1\n",
      "  3400935985293 | LUMIGAN 0,1 MG/ML COLLYRE FL 3ML 1\n",
      "  3400935985354 | ANASTROZOLE VIATRIS 1MG CPR 90\n",
      "  3400935985583 | NPLATE 250 MICROG PDR SOL INJ 1\n",
      "  3400935989727 | OPATANOL 1MG/ML COLLYRE FL 5ML 1\n",
      "  3400935991386 | ARTIREM 0,0025 MMOL/ML SOL INJ 1\n",
      "  3400935993519 | SEROPLEX 5MG CPR 28\n",
      "  3400935993748 | SEROPLEX 10 MG CPR 28\n",
      "  3400935993977 | SEROPLEX 15MG CPR 28\n",
      "  3400935994110 | SEROPLEX 20MG CPR 28\n",
      "  3400935995810 | PEGASYS 135 MICROG SOL INJ SER 1\n",
      "  3400935995988 | PEGASYS 135 MICROG SOL INJ SER 4\n",
      "  3400935996060 | PEGASYS 180 MCG SOL INJ SER 1\n",
      "  3400935996121 | PEGASYS 180 MCG SOL INJ SER 4\n",
      "  3400935996299 | TAMIFLU 75 MG GELULE 10\n",
      "  3400935996411 | NPLATE 500 MICROG PDR ET SOL INJ 1\n",
      "  3400935996640 | SUSTIVA 600MG CPR 30\n",
      "  3400935997302 | SYMBICORT TURBUHALER 400/12 MICROG 1\n",
      "  3400935997531 | PARACETAMOL BGA 1G CPR EFF 8\n",
      "  3400935998712 | PAROXETINE VIATRIS 20MG CPR 14\n",
      "  3400936003736 | PERMIXON 160MG GELULE 60\n",
      "  3400936005167 | SPAGULAX SANS SUCRE PDR ORALE EFF SA 20\n",
      "  3400936006638 | CARTEOL LP 1% COLLYRE UNIDOSE 0,2ML 30\n",
      "  3400936009011 | CARTEOL LP 2% COLLYRE UNIDOSE 0,2ML 30\n",
      "  3400936011250 | DIVARIUS 20MG CPR 14\n",
      "  3400936011311 | DIVARIUS 20MG CPR 28\n",
      "  3400936012431 | CALCIPRAT VIT D3 1000MG/800UI CPR 30\n",
      "  3400936013032 | CILOXAN 3MG/ML SOL AURIC FL 5ML 1\n",
      "  3400936013612 | ROVALCYTE 450MG CPR 60\n",
      "  3400936014961 | SOTALOL ARW 160MG CPR 30\n",
      "  3400936015104 | SOTALOL ARW 80MG CPR 30\n",
      "  3400936016392 | KETOPROFENE ARW LP 200MG GELULE 14\n",
      "  3400936019416 | ENALAPRIL TVS 5 MG CPR 30\n",
      "  3400936020016 | ENALAPRIL TVS 20MG CPR 30\n",
      "  3400936023208 | FLUIDABAK 1,5% COLLYRE FL 10ML 1\n",
      "  3400936024267 | FLUVOXAMINE ARW 50 MG CPR 30\n",
      "  3400936024496 | FLUVOXAMINE ARW 100 MG CPR 15\n",
      "  3400936025158 | LISINOPRIL EG 5MG CPR 28\n",
      "  3400936025219 | LISINOPRIL EG 20MG CPR 28\n",
      "  3400936025967 | ZOLPIDEM EG 10MG CPR 7\n",
      "  3400936026049 | ZOLPIDEM EG 10MG CPR 14\n",
      "  3400936027220 | AMOX/AC CLAV ZYF 100MG/12,5MG/ML 1\n",
      "  3400936027398 | AMOX/AC CLAV ZYD 100/12,5MG/ML PDR 1\n",
      "  3400936030879 | OFLOXACINE VIATRIS 200MG CPR 10\n",
      "  3400936033832 | SPIRONOLACTONE CRT 50MG CPR 30\n",
      "  3400936034723 | CETIRIZINE VIATRIS 10MG CPR 15\n",
      "  3400936035843 | AMOXICILLINE RATIO 125MG/5ML PDR FL 1\n",
      "  3400936035904 | AMOXICILLINE RATIO 250MG/5ML PDR FL 1\n",
      "  3400936036093 | AMOXICILLINE TVS 500MG/5ML PDR FL 1\n",
      "  3400936037625 | ANASTROZOLE ZEN 1MG CPR 90\n",
      "  3400936038974 | BISOPROLOL HCTZ ARW 2,5/6,25MG CPR 30\n",
      "  3400936048850 | SODIUM CHL BBM 0,9% INJ PE 100ML 1\n",
      "  3400936048911 | SODIUM CHL BBM 0,9% INJ PE 250ML 1\n",
      "  3400936049161 | SODIUM CHL BBM 0,9% INJ PE 500ML 1\n",
      "  3400936049222 | SODIUM CHL BBM 0,9% INJ PE 1L 1\n",
      "  3400936052123 | FORLAX 4G PDR ORALE SACHET 20\n",
      "  3400936052413 | IMOVANE 3,75MG CPR 5\n",
      "  3400936052581 | IMOVANE 3,75MG CPR 14\n",
      "  3400936053472 | BISOPROLOL HCTZ ARW 2,5/6,25MG CPR 90\n",
      "  3400936054363 | BISOPROLOL HCTZ ARW 5/6,25MG CPR 30\n",
      "  3400936055834 | CIPROFIBRATE BGA 100MG GELULE 30\n",
      "  3400936056664 | CEFTRIAXONE BGA 1G/3,5ML PDR INJ IM 1\n",
      "  3400936057036 | CEFTRIAXONE BGA 1G/10ML PDR INJ IV 1\n",
      "  3400936057845 | SPIRONOLACTONE ARW 75MG CPR 30\n",
      "  3400936058675 | LORATADINE ARW 10MG CPR 15\n",
      "  3400936058965 | ALGINATE BICAR SODIUM BGA BUV FL 1\n",
      "  3400936060456 | IBUPROFENE TVC 200MG CPR ENR 30\n",
      "  3400936061637 | AMOX/AC CLAV ALM 500MG/62,5MG AD CPR 16\n",
      "  3400936061866 | AMOX/AC CLAV ALM 500MG/62,5MG AD CPR 24\n",
      "  3400936064188 | PENTAVAC 1 BOITE DE 1, VACCIN DIPHTERIQUE, TETANIQ\n",
      "  3400936064997 | ENBREL 25MG PDR ET SOL INJ 4\n",
      "  3400936065659 | GLUCOSE BBM 5% SOL INJ POC 100ML 1\n",
      "  3400936065710 | GLUCOSE BBM 5% SOL INJ POC 250ML 1\n",
      "  3400936065888 | GLUCOSE BBM 5% SOL INJ POC 500ML 1\n",
      "  3400936065949 | GLUCOSE BBM 5% SOL INJ POC 1L 1\n",
      "  3400936075474 | BISOPROLOL HCTZ ARW 5/6,25MG CPR 90\n",
      "  3400936075993 | ALKERAN 2MG CPR 50\n",
      "  3400936076136 | PIROXICAM VIATRIS 20MG GELULE 15\n",
      "  3400936077546 | NEULASTA 6 MG (PEGFILGRASTIM) 1 BOITE DE 1, SOLUTI\n",
      "  3400936078376 | SOMAVERT 10MG PDR ET SOL INJ 30\n",
      "  3400936078437 | SOMAVERT 15MG PDR ET SOL INJ 30\n",
      "  3400936078727 | BISOPROLOL HCTZ ARW 10/6,25MG CPR 30\n",
      "  3400936080218 | GADOVIST 1MMOL/ML INJ SER 10ML 1\n",
      "  3400936080386 | GADOVIST 1MMOL/ML SOL INJ SER 15ML 1\n",
      "  3400936081918 | SPIFEN 200MG CPR 30\n",
      "  3400936082687 | DAIVOBET 50 MICROG/0,5MG/G POM 1\n",
      "  3400936086999 | BRONCHODUAL 50/20 MICROG INHAL 1\n",
      "  3400936087422 | PREDNISOLONE VIATRIS 20 MG CPR EFF 20\n",
      "  3400936087880 | PREDNISOLONE ARW 20MG CPR EFF 20\n",
      "  3400936087941 | AMOX/AC CLAV VTS 500MG/62,5MG AD CPR 16\n",
      "  3400936088023 | AMOX/AC CLAV VTS 500MG/62,5MG AD CPR 24\n",
      "  3400936088542 | LORATADINE VIATRIS 10MG CPR 15\n",
      "  3400936089082 | AMOX/AC CLAV SDZ 500MG/62,5MG AD CPR 16\n",
      "  3400936089143 | AMOX/AC CLAV SDZ 500MG/62,5MG AD CPR 24\n",
      "  3400936089204 | FENOFIBRATE BGA 300MG GELULE 30\n",
      "  3400936089372 | RILMENIDINE VIATRIS 1MG CPR 30\n",
      "  3400936091443 | ROXITHROMYCINE SDZ 150MG CPR SEC 10\n",
      "  3400936091504 | ROXITHROMYCINE SDZ 150MG CPR SEC 16\n",
      "  3400936093164 | EUPRESSYL LP 30 MG GELULE 30\n",
      "  3400936093225 | EUPRESSYL LP 60 MG GELULE 30\n",
      "  3400936093393 | MEDIATENSYL LP 30 MG GELULE 30\n",
      "  3400936093515 | MEDIATENSYL LP 60MG GELULE 30\n",
      "  3400936093973 | BISOPROLOL HCTZ ARW 10/6,25MG CPR 90\n",
      "  3400936094406 | ADVILMED 5% GEL TUBE 100G 1\n",
      "  3400936097766 | BISOPROLOL HCTZ SDZ 2,5/6,25 CPR 30\n",
      "  3400936098138 | BISOPROLOL HCTZ SDZ 2,5/6,25 CPR 90\n",
      "  3400936100640 | AMOX/AC CLAV ZYF 500MG/62,5MG 16\n",
      "  3400936100701 | AMOX/AC CLAV ZYF 500MG/62,5MG 24\n",
      "  3400936101999 | LECTIL 24MG CPR 60\n",
      "  3400936102651 | PARACETAMOL COD MYL 500/30MG CPR EFF 16\n",
      "  3400936103023 | ZOLPIDEM BGA 10MG CPR 14\n",
      "  3400936105034 | PARACETAMOL COD BGA 500/30MG CPR EFF 16\n",
      "  3400936106734 | BROMAZEPAM ARW 6MG CPR 30\n",
      "  3400936108974 | ZIAGEN 300MG CPR 60\n",
      "  3400936109056 | ZIAGEN 20MG/ML SOL BUV 1\n",
      "  3400936109285 | TRIZIVIR CPR 60\n",
      "  3400936110694 | ZOCOR 40MG CPR 28\n",
      "  3400936111066 | NEO MERCAZOLE 5MG CPR 50\n",
      "  3400936111585 | ACICLOVIR TVC 200MG CPR 25\n",
      "  3400936112766 | AMOXICILLINE TVC 500MG GELULE 12\n",
      "  3400936114258 | AMIODARONE TVC 200MG CPR 30\n",
      "  3400936114548 | TRAMADOL TVC 50MG GELULE 30\n",
      "  3400936114609 | TERAZOSINE TVC 5MG CPR 28\n",
      "  3400936114777 | ACNETRAIT 10MG CAPSULE MOLLE 30\n",
      "  3400936114838 | ACNETRAIT 20MG CAPSULE MOLLE 30\n",
      "  3400936115088 | PARACETAMOL TVC 500MG CPR 16\n",
      "  3400936115378 | PIROXICAM TVC 20 MG SOL INJ IM 2\n",
      "  3400936115668 | PIROXICAM TVC 20MG GELULE 15\n",
      "  3400936116269 | SPIRONOLACTONE TVC 50MG CPR 30\n",
      "  3400936116320 | SPIRONOLACTONE TVC 75MG CPR 30\n",
      "  3400936116498 | SPIRONOLACTONE ALTIZIDE TVC CPR 30\n",
      "  3400936116788 | CALCIUM ARW 500MG CPR 60\n",
      "  3400936117389 | PREDNISOLONE TVC 20MG CPR EFF 20\n",
      "  3400936118041 | FLUOXETINE TVC 20MG GELULE 14\n",
      "  3400936118102 | SOMAVERT 20MG PDR ET SOL INJ 30\n",
      "  3400936118270 | ACTRAPID PENFILL 300UI INJ CART 5\n",
      "  3400936118331 | INSULATARD PENFILL 300 UI INJ CAR 5\n",
      "  3400936119970 | INSULATARD INNOLET 300 UI INJ STY 5\n",
      "  3400936120112 | ACTRAPID 1000 UI SOL INJ FL 10 ML 1\n",
      "  3400936120280 | INSULATARD 1000 UI SUSP INJ FL 1\n",
      "  3400936120341 | MIXTARD 30 1000 UI SUSP INJ 10 ML 1\n",
      "  3400936120921 | INSULATARD FLEXPEN 300 UI INJ STY 5\n",
      "  3400936122581 | METFORMINE CRT 500MG CPR 30\n",
      "  3400936122871 | METFORMINE CRT 500MG CPR 90\n",
      "  3400936122932 | METFORMINE CRT 850MG CPR 30\n",
      "  3400936123243 | METFORMINE CRT 850MG CPR 90\n",
      "  3400936124363 | BISOPROLOL ARW 10MG CPR 30\n",
      "  3400936124592 | BISOPROLOL MYL 10MG CPR 30\n",
      "  3400936124714 | BISOPROLOL BGA 10MG CPR PELL 30\n",
      "  3400936125254 | BISOPROLOL ZEN 10MG CPR 28\n",
      "  3400936125315 | BISOPROLOL ZEN 10MG CPR 30\n",
      "  3400936125605 | ROXITHROMYCINE BGA 150MG CPR 10\n",
      "  3400936125773 | ROXITHROMYCINE BGA 150MG CPR 16\n",
      "  3400936126145 | ROXITHROMYCINE ARW 150MG CPR 10\n",
      "  3400936126206 | ROXITHROMYCINE ARW 150MG CPR 16\n",
      "  3400936126374 | ROXITHROMYCINE TVC 150MG CPR 10\n",
      "  3400936126435 | ROXITHROMYCINE TVC 150MG CPR 16\n",
      "  3400936127036 | CIPROFLOXACINE VTS 250 MG CPR 12\n",
      "  3400936127326 | CIPROFLOXACINE VIATRIS 500 MG CPR 12\n",
      "  3400936128385 | CIPROFLOXACINE EG 500MG CPR 12\n",
      "  3400936128446 | CIPROFLOXACINE EG 250MG CPR 12\n",
      "  3400936130517 | DOXYCYCLINE ARW 100MG CPR 15\n",
      "  3400936130685 | DOXYCYCLINE ARW 100MG CPR 30\n",
      "  3400936131576 | ROXITHROMYCINE TVC 100MG CPR 10\n",
      "  3400936131637 | ROXITHROMYCINE TVC 100MG CPR 16\n",
      "  3400936133358 | PARACETAMOL BGA 500MG CPR EFF 16\n",
      "  3400936133648 | LORATADINE EG 10MG CPR 15\n",
      "  3400936133709 | ALGINATE BICAR SODIUM LXO SACHET 24\n",
      "  3400936137080 | PREDNISOLONE CRT 20MG CPR EFF 20\n",
      "  3400936141452 | CELIPROLOL TVC 200MG CPR 28\n",
      "  3400936143173 | SULPIRIDE TVC 50MG GELULE 30\n",
      "  3400936143234 | SULPIRIDE TVC 200MG CPR 12\n",
      "  3400936143463 | TAMOXIFENE TVC 10MG CPR 30\n",
      "  3400936143524 | TAMOXIFENE TVC 20MG CPR 30\n",
      "  3400936144415 | VERAPAMIL TVC LP 240 MG GELULE 30\n",
      "  3400936144583 | MIANSERINE TVC 10MG CPR 30\n",
      "  3400936144644 | MIANSERINE TVC 30MG CPR 30\n",
      "  3400936144705 | MIANSERINE TVC 60MG CPR 14\n",
      "  3400936145245 | FUROSEMIDE TVC 40MG CPR 30\n",
      "  3400936145764 | TOCOPHEROL TVC 500MG CAPSULE 30\n",
      "  3400936145825 | FENOFIBRATE TVC 100MG GELULE 30\n",
      "  3400936145993 | FENOFIBRATE TVC 300MG GELULE 30\n",
      "  3400936146365 | ACEBUTOLOL TVC 200MG CPR 30\n",
      "  3400936146426 | ACEBUTOLOL TVC 400MG CPR 30\n",
      "  3400936146594 | DILTIAZEM TVC LP 90MG GELULE 28\n",
      "  3400936146655 | DILTIAZEM TVC LP 120MG GELULE 28\n",
      "  3400936150966 | BISOPROLOL ZYD 10MG CPR 30\n",
      "  3400936151567 | BISOPROLOL EG 10MG CPR 30\n",
      "  3400936153059 | BISOPROLOL HCTZ SDZ 5/6,25MG CPR 30\n",
      "  3400936153868 | TRIATEC 10MG CPR 30\n",
      "  3400936155411 | CONCERTA LP 18MG CPR 28\n",
      "  3400936155589 | CONCERTA LP 36MG CPR 28\n",
      "  3400936155640 | CONCERTA LP 54MG CPR 28\n",
      "  3400936155701 | SPECIAFOLDINE 0,4MG CPR 28\n",
      "  3400936156470 | TIGREAT 2,5MG CPR 12\n",
      "  3400936156531 | EPTAVIT 1000MG/880UI CPR EFF 30\n",
      "  3400936156760 | HEPSERA 10MG CPR 30\n",
      "  3400936156821 | RAPAMUNE 2MG CPR 30\n",
      "  3400936157071 | ANAPEN 0,15 MG SOL INJ SER 1\n",
      "  3400936157132 | ANAPEN 0,3 MG SOL INJ SER 1\n",
      "  3400936157361 | ANAPEN 0,15 MG SOL INJ SER 2\n",
      "  3400936157422 | ANAPEN 0,3 MG SOL INJ SER 2\n",
      "  3400936157712 | ACTONEL 35 MG CPR 4\n",
      "  3400936158832 | DAFALGAN 1G CPR 8\n",
      "  3400936159952 | DILTIAZEM TVC 60MG CPR 30\n",
      "  3400936160033 | DILTIAZEM TVC LP 300MG GELULE 28\n",
      "  3400936161214 | METFORMINE TVC 500MG CPR 30\n",
      "  3400936161382 | METFORMINE TVC 850MG CPR 30\n",
      "  3400936161504 | SOTALOL TVC 80MG CPR 30\n",
      "  3400936161672 | SOTALOL TVC 160MG CPR 30\n",
      "  3400936161733 | IOMERON 400 SOL INJ FL 150ML AN 1\n",
      "  3400936161962 | IOMERON 400 SOL INJ FL 150ML ME 1\n",
      "  3400936162044 | ZOPHREN 8MG CPR 4\n",
      "  3400936162273 | NEO MERCAZOLE 20MG CPR 30\n",
      "  3400936162792 | MESTINON 60MG CPR 20\n",
      "  3400936163683 | ZOPHREN 4MG CPR 2\n",
      "  3400936163805 | ZOPHREN 4MG CPR 4\n",
      "  3400936164116 | ZOPHREN 8MG CPR 2\n",
      "  3400936166707 | OFLOXACINE TVC 200MG CPR 10\n",
      "  3400936167766 | CITALOPRAM MYL 20MG CPR 28\n",
      "  3400936168428 | BISOPROLOL HCTZ SDZ 5/6,25MG CPR 90\n",
      "  3400936169319 | FUROSEMIDE EG 20MG CPR 30\n",
      "  3400936169548 | FUROSEMIDE EG 40MG CPR 30\n",
      "  3400936170728 | ROXITHROMYCINE EG 150MG CPR 10\n",
      "  3400936170896 | ROXITHROMYCINE EG 150MG CPR 16\n",
      "  3400936171558 | TRIMEBUTINE ARG 100MG CPR 30\n",
      "  3400936172210 | AMOX/AC CLAV EG 1G/125MG AD SCH 8\n",
      "  3400936173859 | PARACETAMOL ZEN 500MG CPR 16\n",
      "  3400936173910 | BISOPROLOL HCTZ SDZ 10/6,25MG CPR 30\n",
      "  3400936174450 | BISOPROLOL HCTZ SDZ 10/6,25MG CPR 90\n",
      "  3400936175051 | DOXYCYCLINE TVC 100MG CPR 15\n",
      "  3400936175280 | DOXYCYCLINE TVC 100MG CPR 30\n",
      "  3400936178991 | PROGESTERONE VIATRIS 100 MG CAPSULE 30\n",
      "  3400936179882 | OFLOXACINE BGA 200MG CPR 10\n",
      "  3400936180314 | DOMPERIDONE BGA 10 MG CPR 40\n",
      "  3400936182554 | AVODART 0,5MG CAPSULE 30\n",
      "  3400936191259 | ZOLPIDEM SDZ 10MG CPR 14\n",
      "  3400936192959 | ANTARENE 20 MG/ML NR ENF SUSP BUV 1\n",
      "  3400936196223 | AMOX/AC CL TEVA 100MG/12,5MG/ML 1\n",
      "  3400936196452 | PREDNISOLONE ZEN 20MG CPR ORODISP 20\n",
      "  3400936198005 | IOMERON 400 SOL INJ FL 100ML AN 1\n",
      "  3400936198173 | IOMERON 400 SOL INJ FL 100ML ME 1\n",
      "  3400936206601 | CLASTOBAN 800MG CPR 60\n",
      "  3400936206779 | TOPALGIC 100 MG/ML SOL BUV FL 10ML 1\n",
      "  3400936206830 | CONTRAMAL 100 MG/ML SOL BUV FL 10ML 1\n",
      "  3400936208261 | BISOPROLOL HCTZ EG 2,5/6,25MG CPR 30\n",
      "  3400936208490 | PROGESTAN 200MG CAPSULE 15\n",
      "  3400936208841 | PROGESTAN 100MG CAPSULE 30\n",
      "  3400936209503 | ALPRAZOLAM TVC 0,50MG CPR 30\n",
      "  3400936209671 | ALPRAZOLAM CRT 0,50MG CPR 30\n",
      "  3400936209961 | ALPRAZOLAM CRT 0,25MG CPR 30\n",
      "  3400936210042 | ALPRAZOLAM TVC 0,25MG CPR 30\n",
      "  3400936213692 | TERAZOSINE BGA 5MG CPR 28\n",
      "  3400936215993 | ZOLPIDEM TEVA 10MG CPR 14\n",
      "  3400936217027 | AMISULPRIDE BGA 200MG CPR 60\n",
      "  3400936217836 | ROXITHROMYCINE ZYD 150MG CPR 10\n",
      "  3400936218086 | ROXITHROMYCINE ZYD 150MG CPR 16\n",
      "  3400936221628 | FORSTEO 20 MICROG/80 MICROL SOL INJ 1\n",
      "  3400936221857 | FUZEON 90 MG/ML PDR ET SOL INJ 60\n",
      "  3400936224759 | GLIVEC 100MG CPR 60\n",
      "  3400936224988 | GLIVEC 400MG CPR 30\n",
      "  3400936225060 | SOMAVERT 20MG PDR ET SOL INJ 1\n",
      "  3400936225640 | EMTRIVA 200MG GELULE 30\n",
      "  3400936225701 | BRUFEN 400MG CPR 30\n",
      "  3400936226531 | PURIVIST 0,5MG/ML COLLYRE 1\n",
      "  3400936226760 | TUSSIDANE 1,5MG/ML SIROP FL 125ML 1\n",
      "  3400936226821 | TUSSIDANE 1,5MG/ML SIROP FL 250ML 1\n",
      "  3400936226999 | EZETROL 10MG CPR 28\n",
      "  3400936227071 | EZETROL 10MG CPR 28\n",
      "  3400936238428 | OFLOXACINE ARW 200MG CPR 10\n",
      "  3400936239029 | BISOPROLOL CRP 5MG CPR 30\n",
      "  3400936239258 | BISOPROLOL CRP 10MG CPR 30\n",
      "  3400936239777 | ALLOPURINOL BGA 100MG CPR 28\n",
      "  3400936240087 | ALLOPURINOL BGA 200MG CPR 28\n",
      "  3400936240209 | CIPROFIBRATE MYL 100MG GELULE 30\n",
      "  3400936240667 | BUDESONIDE ARW 0,5MG/2ML SUSP INH 20\n",
      "  3400936241909 | OXYNORM 5MG GELULE 14\n",
      "  3400936242159 | OXYNORM 10MG GELULE 14\n",
      "  3400936242388 | OXYNORM 20MG GELULE 14\n",
      "  3400936246690 | DOLKO 1G CPR 8\n",
      "  3400936246751 | PARACETAMOL ZEN 1000 MG CPR 8\n",
      "  3400936246980 | DOLIPRANE 1G PDR ORALE SACHET 8\n",
      "  3400936247123 | MONOCRIXO LP 100MG GELULE MONODOSE 15\n",
      "  3400936247642 | MONOCRIXO LP 150MG GELULE MONODOSE 15\n",
      "  3400936248182 | MONOCRIXO LP 200MG GELULE MONODOSE 15\n",
      "  3400936249134 | RISPERDALCONSTA LP 25 MG INJ 1\n",
      "  3400936249363 | RISPERDALCONSTA LP 37,5 MG INJ 1\n",
      "  3400936249424 | RISPERDALCONSTA LP 50 MG INJ 1\n",
      "  3400936250314 | PERINDOPRIL ARG 8MG CPR 30\n",
      "  3400936250543 | PERINDOPRIL ARG 8MG CPR 90\n",
      "  3400936251373 | SPIFEN 400MG CPR 20\n",
      "  3400936254107 | PROCAINE LAV 100 MG/5 ML SOL INJ AB 10\n",
      "  3400936256576 | DAFALGAN 500MG CPR EFF 16\n",
      "  3400936260948 | NORMACOL 62G/100G GRANULES SACH 1KG 1\n",
      "  3400936261020 | NORMACOL 62G/100G GRANULES SACH 10G 30\n",
      "  3400936263260 | BUDESONIDE ARW 1MG/2ML SUSP INH 20\n",
      "  3400936266162 | CETIRIZINE EG 10MG CPR 15\n",
      "  3400936266513 | DIMETANE SS SUCRE 133MG/100ML SIROP 1\n",
      "  3400936269705 | CYPROTERONE EG 50MG CPR 20\n",
      "  3400936271883 | FLUCONAZOLE ZEN 200MG GELULE 7\n",
      "  3400936273085 | PRIMALAN 1,25MG/2,5ML SIROP FL 125ML 1\n",
      "  3400936274617 | BISOPROLOL HCTZ EG 2,5/6,25MG CPR 90\n",
      "  3400936275096 | COLCHICINE OPOCALCIUM 1MG CPR 20\n",
      "  3400936275508 | PARACETAMOL VIATRIS 500 MG GELULE 16\n",
      "  3400936277229 | VARILRIX PDR ET SOL INJ 1\n",
      "  3400936277397 | NEISVAC SUSP INJ 2A 1\n",
      "  3400936279988 | BISOPROLOL HCTZ EG 5/6,25MG CPR 30\n",
      "  3400936280359 | BISOPROLOL HCTZ EG 5/6,25MG CPR 90\n",
      "  3400936280878 | FLUCONAZOLE ZEN 200MG GELULE 30\n",
      "  3400936281011 | BEAGYNE 150MG GELULE 1\n",
      "  3400936281301 | FLUCONAZOLE ZEN 100MG GELULE 7\n",
      "  3400936281769 | FLUCONAZOLE ZEN 50MG GELULE 7\n",
      "  3400936282421 | OMEPRAZOLE VIATRIS 20MG GELULE 7\n",
      "  3400936282889 | OMEPRAZOLE VIATRIS 20MG GELULE 14\n",
      "  3400936282940 | OMEPRAZOLE VIATRIS 20MG GELULE 28\n",
      "  3400936284432 | OMEPRAZOLE BGA 20MG GELULE 7\n",
      "  3400936284661 | OMEPRAZOLE BGA 20MG GELULE 14\n",
      "  3400936284890 | CEFTRIAXONE SUN 1G/3,5ML PDR INJ IM 1\n",
      "  3400936285552 | TUSSIDANE 3 MG/ML SANS SUCRE (BROMHYDRATE DE DEXTR\n",
      "  3400936286214 | OMEPRAZOLE BGA 20MG GELULE 28\n",
      "  3400936286443 | AMISULPRIDE ARW 200MG CPR 60\n",
      "  3400936289284 | PARACETAMOL COD EG 500/30MG CPR EFF 16\n",
      "  3400936289406 | PARACETAMOL COD ARW 500/30MG CPR EFF 16\n",
      "  3400936292246 | PERINDOPRIL MYL 8MG CPR 30\n",
      "  3400936292475 | PERINDOPRIL MYL 8MG CPR 90\n",
      "  3400936293137 | PERINDOPRIL BGA 8MG CPR 30\n",
      "  3400936293427 | PERINDOPRIL BGA 8MG CPR 90\n",
      "  3400936293885 | NOVOPULMON NOVOLIZER 200 MICROG INH 1\n",
      "  3400936294028 | NOVOPULMON NOVOLIZER 200MICROG PDR 1\n",
      "  3400936298859 | TRANXENE 20MG GELULE 28\n",
      "  3400936299221 | GLUCOSE LAV 5% SOL INJ AB 10ML 10\n",
      "  3400936299399 | GLUCOSE LAV 5% SOL INJ AB 20ML 10\n",
      "  3400936299689 | GLUCOSE LAV 30% SOL INJ AB 10ML 10\n",
      "  3400936299740 | GLUCOSE LAV 30% SOL INJ AB 20ML 10\n",
      "  3400936308718 | MYFORTIC 180MG CPR 120\n",
      "  3400936309197 | MYFORTIC 360MG CPR 120\n",
      "  3400936309319 | BISOPROLOL HCTZ EG 10/6,25MG CPR 30\n",
      "  3400936312500 | FLUOXETINE CRT 20MG GELULE 14\n",
      "  3400936313798 | CAPTOPRIL HCTZ BGA 50/25MG CPR 28\n",
      "  3400936314979 | NICOTINELL 2MG GOMME MENT F SS SUCRE 36\n",
      "  3400936315341 | NICOTINELL 2MG GOMME MENT F SS SUCRE 96\n",
      "  3400936315860 | NICOTINELL 4MG GOMME MENT F SS SUCRE 36\n",
      "  3400936316232 | NICOTINELL 4MG GOMME MENT F SS SUCRE 96\n",
      "  3400936317123 | NICOTINELL 2MG GOMME FRUI SS SUCRE 96\n",
      "  3400936318304 | PARACETAMOL SDZ 500MG GELULE 16\n",
      "  3400936318991 | CAPTOPRIL HCTZ ARW 50/25MG CPR 28\n",
      "  3400936320482 | FLUOXETINE VIATRIS 20MG CPR 28\n",
      "  3400936321083 | LORATADINE TVC 10MG CPR 15\n",
      "  3400936326118 | AMISULPRIDE EG 200MG CPR 60\n",
      "  3400936327986 | CHLORMADINONE VIATRIS 5MG CPR 10\n",
      "  3400936329539 | RAMIPRIL ZEN 10MG CPR 30\n",
      "  3400936336681 | PARACETAMOL ARW 1G CPR EFF 8\n",
      "  3400936341593 | RETROVIR 100 MG/10 ML SOL BUV+SRG 1 1\n",
      "  3400936341654 | BACTROBAN 2% POMMADE NASALE 1\n",
      "  3400936344266 | BI TILDIEM LP 120MG CPR 28\n",
      "  3400936344495 | BI TILDIEM LP 90MG CPR 28\n",
      "  3400936344617 | XYLOCAINE 2% GEL URETRAL 10G SER 1\n",
      "  3400936344846 | EMTRIVA 10 MG/ML SOL BUV FL 170ML 1\n",
      "  3400936345386 | STALEVO 50MG/12,5MG/200MG CPR 100\n",
      "  3400936345737 | STALEVO 100MG/25MG/200MG CPR 100\n",
      "  3400936346277 | STALEVO 150MG/37,5MG/200MG CPR 100\n",
      "  3400936346628 | NEORECORMON 30 000UI/0,6ML INJ SER 4\n",
      "  3400936346918 | SIFROL 0,18 MG CPR 30\n",
      "  3400936347168 | SIFROL 0,18 MG CPR 100\n",
      "  3400936347458 | SIFROL 0,7 MG CPR 30\n",
      "  3400936347519 | SIFROL 0,7 MG CPR 100\n",
      "  3400936347977 | GONAL F 300UI/0,5ML SOL INJ STYLO 1\n",
      "  3400936348059 | GONAL F 450UI/0,75ML SOL INJ STYLO 1\n",
      "  3400936348110 | GONAL F 900UI/1,5ML SOL INJ STYLO 1\n",
      "  3400936349001 | FASLODEX 250 MG SOL INJ 1\n",
      "  3400936350700 | EMEND 80 MG GELULE 2\n",
      "  3400936351189 | EMEND 80 MG ET 125 MG GELULES 3\n",
      "  3400936358393 | OFLOXACINE EG 200MG CPR 10\n",
      "  3400936359925 | CETIRIZINE ARW 10MG CPR 15\n",
      "  3400936362185 | CEFUROXIME ZEN 250MG CPR ENR 8\n",
      "  3400936363366 | BISOPROLOL HCTZ EG 10/6,25MG CPR 90\n",
      "  3400936366848 | MONOSEPT 0,025% COLLYRE UNIDOSE 30\n",
      "  3400936380684 | AMOX/AC CLAV ARW 1G/125MG AD SACH 8\n",
      "  3400936380745 | AMOX/AC CLAV ARW 1G/125MG AD SACH 12\n",
      "  3400936381056 | AMISULPRIDE ARW 100MG CPR 30\n",
      "  3400936381575 | PARACETAMOL ARW 1G CPR 8\n",
      "  3400936381636 | PARACETAMOL TVC 1G CPR 8\n",
      "  3400936381865 | PARACETAMOL BGA 1G CPR 8\n",
      "  3400936381926 | PARACETAMOL EG 1G CPR 8\n",
      "  3400936384019 | COPAXONE 20 MG/ML, SOLUTION INJECTAB 28\n",
      "  3400936384248 | CIPROFLOXACINE BGA 250MG CPR 12\n",
      "  3400936384309 | CIPROFLOXACINE BGA 500MG CPR 12\n",
      "  3400936387089 | TERBINAFINE VIATRIS 250MG CPR 14\n",
      "  3400936387140 | TERBINAFINE VIATRIS 250MG CPR 28\n",
      "  3400936388901 | ZOLPIDEM ARW 10MG CPR 14\n",
      "  3400936393172 | AMISULPRIDE MYL 200MG CPR 60\n",
      "  3400936393523 | CITALOPRAM TVS 20MG CPR 28\n",
      "  3400936394643 | CITALOPRAM SDZ 20MG CPR 28\n",
      "  3400936395534 | CREON 25000U GELULE 60\n",
      "  3400936396425 | CREON 10000 U GELULE 60\n",
      "  3400936396654 | CREON 10000 U GELULE 120\n",
      "  3400936396883 | NORDITROPINE NORDI 10 MG INJ 1\n",
      "  3400936396944 | NORDITROPINE NORDI 15 MG INJ 1\n",
      "  3400936397026 | RHOPHYLAC 0,2MG SOL INJ SER 1\n",
      "  3400936397194 | RHOPHYLAC 0,3MG SOL INJ SER 1\n",
      "  3400936397774 | MIZOLLEN LM 10MG CPR 15\n",
      "  3400936398085 | MIZOLLEN LM 10MG CPR 30\n",
      "  3400936401488 | AURICULARUM PDR ET SOL AURICULAIRE 1\n",
      "  3400936401549 | PROTHIADEN 25MG GELULE 50\n",
      "  3400936404380 | REYATAZ 150MG GELULE 60\n",
      "  3400936404502 | REYATAZ 200MG GELULE 60\n",
      "  3400936406162 | VFEND 40MG/ML PDR ORALE FL 1\n",
      "  3400936406223 | NUTROPINAQ 10 MG (30 UI) SOL INJ 1\n",
      "  3400936406391 | TELZIR 700 MG CPR 60\n",
      "  3400936406681 | LITAK 10 MG SOL INJ SC 1\n",
      "  3400936406742 | LITAK 10 MG SOL INJ SC 5\n",
      "  3400936406971 | ABILIFY 5 MG CPR 28\n",
      "  3400936407343 | ABILIFY 10 MG CPR 28\n",
      "  3400936407862 | ABILIFY 15 MG CPR 28\n",
      "  3400936409064 | NICOTINELL 1MG CPR MENT SS SUCRE 96\n",
      "  3400936409705 | MOVICOL ENFANT PDR ORALE SACHET 20\n",
      "  3400936410305 | CERTICAN 0,75MG CPR 60\n",
      "  3400936410824 | CERTICAN 0,50MG CPR 60\n",
      "  3400936411135 | CERTICAN 0,25MG CPR 60\n",
      "  3400936411593 | CERTICAN 0,1MG CPR DISP 60\n",
      "  3400936411883 | CERTICAN 0,25MG CPR DISP 60\n",
      "  3400936412026 | VENTILASTIN NOVOLIZ 100MCG CART+INH 1\n",
      "  3400936412194 | VENTILASTIN NOVOLIZ 100MCG CART 1\n",
      "  3400936413726 | NORLEVO 1,5MG CPR 1\n",
      "  3400936414327 | IMUREL 25 MG CPR PELLICULE 50\n",
      "  3400936414907 | IMUREL 50 MG CPR PELLICULE 100\n",
      "  3400936415737 | LISINOPRIL SDZ 20MG CPR 28\n",
      "  3400936416628 | SEPTIVON 1,5% SOL FL 250ML 1\n",
      "  3400936422650 | DOXYLIS 100MG CPR 30\n",
      "  3400936424722 | FIXICAL VITAMINE D3 1000MG/800UI CPR 30\n",
      "  3400936425262 | FLECAINIDE VIATRIS 100MG CPR 30\n",
      "  3400936428973 | SEROPLEX 5MG CPR 14\n",
      "  3400936429055 | ALPRAZOLAM BGA 0,50MG CPR 30\n",
      "  3400936429116 | ALPRAZOLAM BGA 0,25MG CPR 30\n",
      "  3400936429345 | CIFLOX 250 MG CPR 12\n",
      "  3400936429635 | CIFLOX 500MG CPR 12\n",
      "  3400936430815 | CIPROFLOXACINE ZYD 500MG CPR 12\n",
      "  3400936430983 | CIPROFLOXACINE ZYD 250MG CPR 12\n",
      "  3400936431126 | PURINETHOL 50 MG CPR 25\n",
      "  3400936434608 | OESTRODOSE 0,06% GEL FL 80G 1\n",
      "  3400936438040 | ANTARENE 5% GEL TUBE 100G 1\n",
      "  3400936439740 | TRIATEC 1,25MG CPR 30\n",
      "  3400936440111 | TRIATEC 2,5 MG CPR 30\n",
      "  3400936440579 | TRIATEC 5MG CPR 30\n",
      "  3400936440920 | CACIT VIT D3 500MG/440UI CPR 60\n",
      "  3400936441460 | PLAQUENIL 200MG CPR PELLICULE 30\n",
      "  3400936442412 | AMISULPRIDE SDZ 100MG CPR 30\n",
      "  3400936443471 | AMISULPRIDE MYL 100MG CPR 30\n",
      "  3400936446953 | AMISULPRIDE BGA 100MG CPR 30\n",
      "  3400936450455 | ZOLPIDEM VIATRIS 10MG CPR 7\n",
      "  3400936450516 | ZOLPIDEM VIATRIS 10MG CPR 14\n",
      "  3400936450974 | ZOLPIDEM VIATRIS 10MG CPR 14\n",
      "  3400936452985 | OFLOXACINE SDZ 200MG CPR 10\n",
      "  3400936453067 | LORATADINE ZEN 10MG CPR 15\n",
      "  3400936453357 | FLUOXETINE BGA 20MG/5ML BUV FL 70ML 1\n",
      "  3400936453647 | FLUOXETINE TVS 20MG CPR 28\n",
      "  3400936453708 | NOMEGESTROL VIATRIS 5MG CPR 10\n",
      "  3400936454477 | ZOLPIDEM ACT 10MG CPR 14\n",
      "  3400936455719 | ZOLPIDEM IV 10MG CPR 14\n",
      "  3400936456839 | ZOLPIDEM ALM 10MG CPR 14\n",
      "  3400936457898 | CETIRIZINE TVC 10MG CPR 15\n",
      "  3400936466425 | VACCIN BCG AJV PDR ET SOL INJ + NEC 1\n",
      "  3400936466654 | EPREX 1000UI SOL INJ SER 6\n",
      "  3400936466715 | EPREX 2000 UI SOL INJ SER 6\n",
      "  3400936466883 | EPREX 3 000 UI/0,3ML SOL INJ SER 6\n",
      "  3400936466944 | EPREX 4 000 UI/0,4ML SOL INJ SER 6\n",
      "  3400936467545 | PULMOZYME 2,5MG/2,5ML SOL INHAL 30\n",
      "  3400936468375 | LOVENOX 2000UI AXA/0,2ML INJ SER +S 2\n",
      "  3400936468436 | LOVENOX 2000UI AXA/0,2ML INJ SER +S 6\n",
      "  3400936468665 | LOVENOX 4000UI AXA/0,4ML INJ SER +S 2\n",
      "  3400936468726 | LOVENOX 4000UI AXA/0,4ML INJ SER +S 6\n",
      "  3400936468955 | LOVENOX 10 000UI AXA/1ML INJ SER +S 10\n",
      "  3400936469037 | LOVENOX 6000UI AXA/0,6ML INJ SER +S 2\n",
      "  3400936469266 | LOVENOX 6000UI AXA/0,6ML INJ SER +S 10\n",
      "  3400936469327 | LOVENOX 8000UI AXA/0,8ML INJ SER +S 2\n",
      "  3400936469495 | LOVENOX 8000UI AXA/0,8ML INJ SER +S 10\n",
      "  3400936475939 | IBUPROFENE EG 200 MG CPR PELL 30\n",
      "  3400936476240 | TAMOXIFENE ARW 20MG CPR 30\n",
      "  3400936476769 | FUROSEMIDE ARW 40MG CPR 30\n",
      "  3400936476998 | FUROSEMIDE VIATRIS 40MG CPR 30\n",
      "  3400936477131 | CITALOPRAM ALM 20MG CPR 28\n",
      "  3400936477940 | CIPROFIBRATE SDZ 100MG GELULE 30\n",
      "  3400936478541 | LISINOPRIL VIATRIS 20MG CPR 28\n",
      "  3400936481732 | PREDNISOLONE TVC 5MG CPR EFF 30\n",
      "  3400936483743 | OMEPRAZOLE BCR 20MG GELULE 28\n",
      "  3400936486294 | CETIRIZINE BGA 10 MG CPR 15\n",
      "  3400936487307 | PREDNISONE EG 5MG CPR 30\n",
      "  3400936497931 | VOGALENE 5 MG SUPPO 10\n",
      "  3400936498990 | NICOPASS 1,5MG PAST MENT F SS SUCRE 96\n",
      "  3400936499881 | NICOPASS 1,5MG PAST REGL SS SUCRE 96\n",
      "  3400936499942 | AMISULPRIDE EG 100MG CPR 30\n",
      "  3400936501126 | METFORMINE ZYD 1000MG CPR 30\n",
      "  3400936501584 | METFORMINE ARW 1000MG CPR 30\n",
      "  3400936501935 | METFORMINE EG 1000MG CPR 30\n",
      "  3400936505896 | COLISTIMETHATE AMP 1MUI PDR INH 1\n",
      "  3400936510920 | SANDOSTATINE LP 30 MG INJ SER 1\n",
      "  3400936511811 | LEVEMIR PENFILL 300UI SOL INJ CART 5\n",
      "  3400936511989 | LEVEMIR FLEXPEN 300UI SOL INJ STY 5\n",
      "  3400936512061 | LEVEMIR INNOLET 300UI SOL INJ STY 5\n",
      "  3400936512702 | LYRICA 25 MG GELULE 56\n",
      "  3400936512870 | LYRICA 50 MG GELULE 84\n",
      "  3400936512931 | LYRICA 75 MG GELULE 56\n",
      "  3400936513013 | LYRICA 100 MG GELULE 84\n",
      "  3400936513181 | LYRICA 150 MG GELULE 56\n",
      "  3400936513242 | LYRICA 200 MG GELULE 84\n",
      "  3400936513303 | LYRICA 300 MG GELULE 56\n",
      "  3400936513532 | LYRICA 25 MG GELULE 84\n",
      "  3400936514133 | PUREGON 900 UI SOL INJ CART 1\n",
      "  3400936515543 | MIMPARA 30MG CPR 28\n",
      "  3400936515772 | MIMPARA 30MG CPR 30\n",
      "  3400936516083 | MIMPARA 60MG CPR 28\n",
      "  3400936516205 | MIMPARA 60MG CPR 30\n",
      "  3400936516434 | MIMPARA 90MG CPR 28\n",
      "  3400936517905 | XAGRID 0,5MG GELULE 100\n",
      "  3400936518094 | APIDRA 1000 U/10 ML SOL INJ FL 1\n",
      "  3400936518506 | PREDNISONE VIATRIS 5MG CPR 30\n",
      "  3400936519275 | PREDNISONE BGA 5 MG CPR 30\n",
      "  3400936519916 | PREDNISONE ARW 5MG CPR 30\n",
      "  3400936520806 | PREDNISONE EG 20MG CPR 20\n",
      "  3400936521407 | PREDNISONE VIATRIS 20MG CPR 20\n",
      "  3400936522527 | PREDNISONE BGA 20MG CPR 20\n",
      "  3400936523418 | PREDNISONE ARW 20MG CPR 20\n",
      "  3400936523708 | PREDNISONE SDZ 20MG CPR 20\n",
      "  3400936526310 | CHLORMADINONE TVC 5MG CPR 10\n",
      "  3400936534933 | RITALINE LP 20MG GELULE 28\n",
      "  3400936535015 | RITALINE LP 30MG GELULE 28\n",
      "  3400936535183 | RITALINE LP 40MG GELULE 28\n",
      "  3400936551152 | MICROPAKINE LP 100MG GRANULE SACHET 30\n",
      "  3400936551213 | MICROPAKINE LP 250MG GRANULE SACHET 30\n",
      "  3400936551381 | MICROPAKINE LP 500MG GRANULE SACHET 30\n",
      "  3400936551442 | MICROPAKINE LP 750MG GRANULE SACHET 30\n",
      "  3400936551503 | VESICARE 5MG CPR 30\n",
      "  3400936551671 | VESICARE 10MG CPR 30\n",
      "  3400936551732 | MICROPAKINE LP 1000MG GRANULE SACHET 30\n",
      "  3400936557185 | PARACETAMOL EG 1G CPR EFF 8\n",
      "  3400936557246 | LUTENYL 3,75MG CPR 14\n",
      "  3400936557475 | VIVELLEDOT 25 MICROG/24H DISP 8\n",
      "  3400936558076 | AMISULPRIDE ZEN 400MG CPR 30\n",
      "  3400936560147 | CHLORMADINONE SDZ 5MG CPR 10\n",
      "  3400936561847 | CHLORMADINONE TVC 10MG CPR 12\n",
      "  3400936562219 | AMOX/AC CLAV VIATRI 1G/125MG AD SACH 8\n",
      "  3400936562387 | AMOX/AC CLAV VIATRI 1G/125MG AD SACH 12\n",
      "  3400936562738 | AMOX/AC CLAV ARW 500MG/62,5MG AD CPR 16\n",
      "  3400936562967 | AMOX/AC CLAV ARW 500MG/62,5MG AD CPR 24\n",
      "  3400936563278 | AMOX/AC CLAV SDZ 1G/125MG AD SACH 8\n",
      "  3400936563339 | AMOX/AC CLAV SDZ 1G/125MG AD SACH 12\n",
      "  3400936564459 | CETIRIZINE BGA 10MG/ML BUV FL 15ML 1\n",
      "  3400936564749 | ARIXTRA 5 MG/0,4ML SOL INJ 2\n",
      "  3400936564978 | ARIXTRA 5 MG/0,4ML SOL INJ 10\n",
      "  3400936565050 | ARIXTRA 7,5 MG/0,6ML SOL INJ 2\n",
      "  3400936565289 | ARIXTRA 7,5 MG/0,6ML SOL INJ 10\n",
      "  3400936565340 | ARIXTRA 10 MG/0,8ML SOL INJ 2\n",
      "  3400936565579 | ARIXTRA 10 MG/0,8ML SOL INJ 10\n",
      "  3400936565630 | TRUVADA 200MG/245MG CPR 30\n",
      "  3400936566460 | SALBUTAMOL VTS 5MG/2,5ML INHAL 60\n",
      "  3400936567641 | PROPRANOLOL EG 40MG CPR 50\n",
      "  3400936568242 | ECONAZOLE SDZ 1% CREME TUBE 30G 1\n",
      "  3400936568303 | ACICLOVIR SDZ 200MG CPR 25\n",
      "  3400936568471 | PARACETAMOL SDZ 500MG CPR 16\n",
      "  3400936568532 | ALLOPURINOL SDZ 100MG CPR 28\n",
      "  3400936569423 | APIDRA 300 U/3 ML SOL INJ CART 5\n",
      "  3400936571082 | SUCCICAPTAL 200MG GELULE 15\n",
      "  3400936571143 | LEVOCARNIL 1000 MG SOL BUV 10\n",
      "  3400936571204 | LEVOCARNIL 1000 MG SOL INJ 5\n",
      "  3400936572324 | TOBI 300MG/5ML SOL INHAL 56\n",
      "  3400936572614 | NIMOTOP 30MG CPR 90\n",
      "  3400936572782 | WELLVONE 750 MG/5 ML SUSP BUV 1\n",
      "  3400936572843 | KIVEXA 600MG/300MG CPR 30\n",
      "  3400936573093 | ATROVENT 0,5MG/2ML AD SOL INHAL 10\n",
      "  3400936573154 | ATROVENT 0,25MG/2ML ENF SOL INHAL 10\n",
      "  3400936573215 | BRICANYL 5MG SOL INHAL UNIDOSE 20\n",
      "  3400936573383 | BRICANYL 5MG SOL INHAL UNIDOSE 50\n",
      "  3400936574564 | XELODA 150 MG CPR 60\n",
      "  3400936574625 | XELODA 500 MG CPR 120\n",
      "  3400936574793 | TARGRETIN 75MG CAPSULE 100\n",
      "  3400936575806 | CELLTOP 50 MG CAPSULE 20\n",
      "  3400936578067 | VENTOLINE 1,25MG/2,5ML SOL INHAL 20\n",
      "  3400936578357 | AZILECT 1MG CPR 30\n",
      "  3400936578418 | IPRATROPIUM ARW 0,5MG/2ML AD INHAL 10\n",
      "  3400936578937 | TERBUTALINE ARW 5MG/2ML SOL INHAL 20\n",
      "  3400936579019 | TERBUTALINE ARW 5MG/2ML SOL INHAL 50\n",
      "  3400936579538 | SALBUTAMOL ARW 2,5MG/2,5ML INHAL 60\n",
      "  3400936580138 | SALBUTAMOL ARW 5MG/2,5ML INHAL 60\n",
      "  3400936580367 | IPRATROPIUM VIATR 0,5MG/2ML AD INHAL 10\n",
      "  3400936580596 | IPRATROPIUM VIATRIS 0,25MG/1ML ENF 10\n",
      "  3400936580947 | ATROVENT 0,5MG/1ML AD SOL INHAL 30\n",
      "  3400936581319 | ATROVENT 0,25MG/1ML ENF SOL INHAL 30\n",
      "  3400936581777 | IPRATROPIUM AGT 0,5MG/2ML AD INHAL 10\n",
      "  3400936582439 | AMOXICILLINE SDZ 250MG/5ML PDR FL 1\n",
      "  3400936582729 | AMIODARONE SDZ 200MG CPR 30\n",
      "  3400936582897 | ALPRAZOLAM SDZ 0,25MG CPR 30\n",
      "  3400936582958 | ALLOPURINOL SDZ 200MG CPR 28\n",
      "  3400936583030 | IBUPROFENE SDZ 200MG CPR ENR 30\n",
      "  3400936583320 | BROMAZEPAM SDZ 6MG CPR 30\n",
      "  3400936583849 | ZOPICLONE SDZ 7,5 MG CPR 14\n",
      "  3400936583900 | ACEBUTOLOL SDZ 200MG CPR 30\n",
      "  3400936584099 | ACEBUTOLOL SDZ 400MG CPR 30\n",
      "  3400936584150 | ALPRAZOLAM SDZ 0,50MG CPR 30\n",
      "  3400936584211 | FLUOXETINE SDZ 20MG GELULE 14\n",
      "  3400936584389 | SALBUTAMOL VTS 2,5MG/2,5ML INHAL 60\n",
      "  3400936584969 | VITALIPIDE AD EMULSION INJ 10\n",
      "  3400936586451 | CYMBALTA 30MG GELULE 28\n",
      "  3400936586512 | CYMBALTA 60MG GELULE 28\n",
      "  3400936587113 | ACLASTA 5 MG SOL INJ FL 1\n",
      "  3400936587281 | ORAMORPH 20MG/1ML BUV FL 20ML 1\n",
      "  3400936587632 | ORAMORPH 10MG/5ML SOL BUV 1\n",
      "  3400936588523 | ARANESP 40 MICROG INJ STYLO 1\n",
      "  3400936588752 | ARANESP 60 MICROG/0,3ML INJ STYLO 1\n",
      "  3400936592834 | TERBINAFINE EG 250MG CPR 14\n",
      "  3400936593084 | TERBINAFINE EG 250MG CPR 28\n",
      "  3400936593145 | ARANESP 80 MICROG/0,4ML INJ STYLO 1\n",
      "  3400936593206 | ARANESP 100 MICROG/0,5ML INJ STYLO 1\n",
      "  3400936593374 | ARANESP 150 MICROG INJ STYLO 1\n",
      "  3400936593435 | ARANESP 300 MICROG INJ STYLO 1\n",
      "  3400936593664 | ARANESP 500 MICROG/1ML INJ STYLO 1\n",
      "  3400936594265 | ZONEGRAN 25 MG GELULE 14\n",
      "  3400936594555 | ZONEGRAN 100 MG GELULE 56\n",
      "  3400936594845 | NAVELBINE 20MG CAPSULE 1\n",
      "  3400936594906 | NAVELBINE 30MG CAPSULE 1\n",
      "  3400936595736 | IBUPROFENE SDZ 400MG CPR ENR 30\n",
      "  3400936596047 | ECONAZOLE SDZ 1% EMULS FL 30G 1\n",
      "  3400936596108 | FENOFIBRATE SDZ 100MG GELULE 30\n",
      "  3400936596627 | TIAPRIDE SDZ 100MG CPR 20\n",
      "  3400936597167 | ALLOPURINOL SDZ 300MG CPR 28\n",
      "  3400936597396 | FENOFIBRATE SDZ 67MG GELULE 60\n",
      "  3400936613577 | GABAPENTINE TVC 600MG CPR 90\n",
      "  3400936617889 | SULPIRIDE SDZ 50MG GELULE 30\n",
      "  3400936618190 | METOCLOPRAMIDE SDZ 10MG CPR 40\n",
      "  3400936618251 | MIANSERINE SDZ 10MG CPR 30\n",
      "  3400936618480 | MIANSERINE SDZ 60MG CPR 14\n",
      "  3400936618541 | MIANSERINE SDZ 30MG CPR 30\n",
      "  3400936646865 | CAPTOPRIL HCTZ VIATRIS 50/25 MG CPR 28\n",
      "  3400936647466 | CHLORMADINONE VIATRIS 10MG CPR 12\n",
      "  3400936647527 | CHLORMADINONE SDZ 10MG CPR 12\n",
      "  3400936648296 | SIMVASTATINE EVO 20MG CPR 28\n",
      "  3400936648418 | ENALAPRIL HCTZ ARW 20/12,5MG CP 28\n",
      "  3400936648586 | ENALAPRIL/HYDROCHLOROTHIAZIDE ARROW 20 MG/12,5 MG\n",
      "  3400936648876 | ENALAPRIL HCTZ BGA 20/12,5MG CPR 28\n",
      "  3400936649187 | ENALAPRIL HCTZ VTS 20/12,5MG CPR 30\n",
      "  3400936650367 | ALENDRONATE TVC 10MG CPR 28\n",
      "  3400936650657 | LISINOPRIL TVC 5MG CPR 28\n",
      "  3400936650718 | LISINOPRIL TVC 20MG CPR 28\n",
      "  3400936650886 | CITALOPRAM CRT 20MG CPR 28\n",
      "  3400936651548 | OROZAMUDOL 50MG CPR 30\n",
      "  3400936652149 | FLUCONAZOLE TVC 200MG GELULE 7\n",
      "  3400936652200 | FLUCONAZOLE TVC 200MG GELULE 30\n",
      "  3400936652378 | FLUCONAZOLE TVC 100MG GELULE 7\n",
      "  3400936652668 | FLUCONAZOLE TVC 50MG GELULE 7\n",
      "  3400936654501 | AMISULPRIDE TVC 200MG CPR 60\n",
      "  3400936654730 | FUROSEMIDE ARW 20MG CPR 30\n",
      "  3400936655041 | FUROSEMIDE VIATRIS 20MG CPR 30\n",
      "  3400936655799 | IBUPROFENE SDZ 400MG CPR PELL 20\n",
      "  3400936656161 | IBUPROFENE ARW 400MG CPR PELL 20\n",
      "  3400936656222 | IBUPROFENE ARW 400MG CPR PELL 30\n",
      "  3400936657052 | INSPRA 25 MG CPR 30\n",
      "  3400936657403 | INSPRA 50MG CPR 30\n",
      "  3400936658752 | COVERSYL 2,5MG CPR 30\n",
      "  3400936659063 | COVERSYL 2,5MG CPR 90\n",
      "  3400936659582 | COVERSYL 5MG CPR 30\n",
      "  3400936659872 | COVERSYL 5MG CPR 90\n",
      "  3400936660304 | COVERSYL 10MG CPR 30\n",
      "  3400936660762 | COVERSYL 10MG CPR 90\n",
      "  3400936664036 | TAMOXIFENE ZYD 20MG CPR 30\n",
      "  3400936665736 | AMOXICILLINE SDZ 500MG/5ML PDR FL 1\n",
      "  3400936666856 | ACTONEL 35 MG CPR 12\n",
      "  3400936668119 | OMEPRAZOLE BGA 10MG GELULE 14\n",
      "  3400936668287 | OMEPRAZOLE BGA 10MG GELULE 28\n",
      "  3400936670709 | METFORMINE GNR 1000 MG, COMPRIME 0\n",
      "  3400936670877 | METFORMINE GNR 1000 MG, COMPRIME 30\n",
      "  3400936671010 | METFORMINE GNR 1000 MG, COMPRIME 90\n",
      "  3400936677272 | CITALOPRAM ARW 20MG CPR 28\n",
      "  3400936677623 | CITALOPRAM EG 20MG CPR 28\n",
      "  3400936677852 | GABAPENTINE TVC 100MG GELULE 90\n",
      "  3400936678514 | GABAPENTINE TVC 300MG GELULE 90\n",
      "  3400936678743 | GABAPENTINE TVC 400MG GELULE 90\n",
      "  3400936679054 | GABAPENTINE ARW 400 MG GELULE 90\n",
      "  3400936680463 | GABAPENTINE BGA 400MG GELULE 90\n",
      "  3400936681293 | GABAPENTINE VIATRIS 400MG GELULE 90\n",
      "  3400936681415 | GABAPENTINE MYLAN 400 MG 1 BOITE DE 90, GELULES EN\n",
      "  3400936681644 | LISINOPRIL HCTZ TVC 20/12,5MG CPR 28\n",
      "  3400936682016 | LISINOPRIL HCTZ VTS 20/12,5MG CPR 28\n",
      "  3400936682184 | LISINOPRIL HCTZ BGA 20/12,5MG CPR 28\n",
      "  3400936682245 | VOLTARENOPHTABAK 0,1% COLLY FL 10ML 1\n",
      "  3400936682474 | PRAVASTATINE EG 10MG CPR 28\n",
      "  3400936682764 | PRAVASTATINE EG 40 MG 1 BOITE DE 28, COMPRIMES PEL\n",
      "  3400936683075 | AMOX/AC CLAV EG 500/62,5MG AD CPR 16\n",
      "  3400936683136 | AMOX/AC CLAV EG 500/62,5MG AD CPR 24\n",
      "  3400936685147 | AMAREL 1MG CPR 90\n",
      "  3400936685666 | AMAREL 2MG CPR 90\n",
      "  3400936686038 | AMAREL 3MG CPR 90\n",
      "  3400936686557 | AMAREL 4MG CPR 90\n",
      "  3400936687509 | PAROXETINE ZEN 20MG CPR 14\n",
      "  3400936690349 | OXYCONTIN LP 5MG CPR 28\n",
      "  3400936690868 | ELIGARD 7,5MG PDR ET SOL INJ 1\n",
      "  3400936690929 | ELIGARD 22,5MG PDR ET SOL INJ 1\n",
      "  3400936698734 | FLUCONAZOLE BGA 50MG GELULE 7\n",
      "  3400936699106 | FLUCONAZOLE BGA 100MG GELULE 7\n",
      "  3400936699625 | FLUCONAZOLE BGA 200MG GELULE 7\n",
      "  3400936699793 | FLUCONAZOLE BGA 200MG GELULE 30\n",
      "  3400936702097 | SIMVASTATINE TEVA 10 MG 1 BOITE DE 28, COMPRIMES P\n",
      "  3400936702158 | SIMVASTATINE TVC 10MG CPR 30\n",
      "  3400936702509 | SIMVASTATINE TVC 20MG CPR 30\n",
      "  3400936703049 | SIMVASTATINE TVC 40MG CPR 30\n",
      "  3400936703919 | RAMIPRIL ZEN 1,25MG CPR 30\n",
      "  3400936704459 | RAMIPRIL ZEN 2,5MG CPR 30\n",
      "  3400936704800 | RAMIPRIL ZEN 5MG CPR 30\n",
      "  3400936705289 | SPIRAM/METRO BGA 0,75 MUI/125 MG CPR 20\n",
      "  3400936705340 | SPIRAM/METRO TVC 0,75MUI/125MG CPR 20\n",
      "  3400936708013 | AMOX/AC CLAV EG 1G/125MG PDR 8\n",
      "  3400936708181 | AMOX/AC CLAV EG 1G/125MG PDR 12\n",
      "  3400936708990 | METFORMINE TVC 1000MG CPR 30\n",
      "  3400936709072 | METFORMINE TVC 1000MG CPR 90\n",
      "  3400936709591 | SIMVASTATINE CRT 20MG CPR 28\n",
      "  3400936709713 | SIMVASTATINE CRT 40MG CPR 28\n",
      "  3400936711204 | ECONAZOLE TVC LP 150MG OVULE 1\n",
      "  3400936711372 | LISINOPRIL ARW 20MG CPR 28\n",
      "  3400936712843 | ZOLPIDEM SUN 10MG CPR 14\n",
      "  3400936713093 | ZOLPIDEM ZYD 10MG CPR 14\n",
      "  3400936713505 | SPIRAM/METRO SDZ 1,5MUI/250MG CPR 10\n",
      "  3400936713963 | SPIRAM/METRO BGA 1,5MUI/250MG CPR 10\n",
      "  3400936714274 | SPIRAM/METRO VIATRI 1,5MUI/250MG CPR 10\n",
      "  3400936714625 | SPIRAM/METRO TVC 1,5MUI/250MG CPR 10\n",
      "  3400936715394 | IPRATROPIUM ARW 0,25MG/1ML ENF INHAL 30\n",
      "  3400936716117 | OFLOXACINE ZEN 200 MG CPR 10\n",
      "  3400936716346 | FLUCONAZOLE ARW 50MG GELULE 7\n",
      "  3400936716865 | FLUCONAZOLE ARW 100MG GELULE 7\n",
      "  3400936717756 | FLUCONAZOLE ARW 200MG GELULE 7\n",
      "  3400936717817 | FLUCONAZOLE ARW 200MG GELULE 30\n",
      "  3400936718067 | FLUCONAZOLE ARROW 200 MG 1 BOITE DE 30, GELULES SO\n",
      "  3400936721487 | BUDESONIDE SDZ 0,5MG SUSP INH UNID 20\n",
      "  3400936722088 | BUDESONIDE SDZ 1MG SUSP INH UNID 20\n",
      "  3400936722668 | BUDESONIDE BGA 0,5MG/2ML SUSP INH 20\n",
      "  3400936723269 | BUDESONIDE BGA 1MG/2ML SUSP INH 20\n",
      "  3400936723788 | BUDESONIDE EG 0,5MG/2ML SUSP INH 20\n",
      "  3400936724211 | BUDESONIDE EG 1MG/2ML SUSP INH 20\n",
      "  3400936724679 | CIPROFLOXACINE TVC 250MG CPR 12\n",
      "  3400936724730 | CIPROFLOXACINE TVC 500MG CPR 12\n",
      "  3400936726451 | ECONAZOLE VIATRIS LP 150MG OVULE 1\n",
      "  3400936726680 | ECONAZOLE EG LP 150MG OVULE 1\n",
      "  3400936726741 | ECONAZOLE ZYD LP 150MG OVULE 1\n",
      "  3400936726802 | ECONAZOLE BGA LP 150MG OVULE 1\n",
      "  3400936726970 | ECONAZOLE SDZ LP 150MG OVULE 1\n",
      "  3400936727342 | CEFUROXIME SDZ 250MG CPR 8\n",
      "  3400936727861 | CEFUROXIME SDZ 500MG CPR 8\n",
      "  3400936727922 | AMISULPRIDE EG 400MG CPR 30\n",
      "  3400936728172 | AMISULPRIDE BGA 400MG CPR 30\n",
      "  3400936728813 | AMISULPRIDE TVC 100MG CPR 30\n",
      "  3400936729414 | ITRACONAZOLE SDZ 100MG GELULE 30\n",
      "  3400936730472 | DAFALGAN 500MG CPR 16\n",
      "  3400936730762 | LISINOPRIL BGA 5MG CPR 28\n",
      "  3400936730991 | LISINOPRIL BGA 20MG CPR 28\n",
      "  3400936731882 | AMOX/AC CLAV TEVA 500/62,5MG CPR 16\n",
      "  3400936731943 | AMOX/AC CLAV TEVA 500/62,5MG CPR 24\n",
      "  3400936732025 | AMOX/AC CLA TEVA 100MG/12,5MG/ML 1\n",
      "  3400936732315 | AMOX/AC CLAV SUN 500MG/62,5 AD CPR 16\n",
      "  3400936732483 | AMOX/AC CLAV SUN 500MG/62,5 AD CPR 24\n",
      "  3400936735965 | TIAPROFENIQUE AC ZTV 100MG CPR 30\n",
      "  3400936736047 | AMIODARONE ZTV 200MG CPR 30\n",
      "  3400936736108 | AMOXICILLINE ZEN 250MG/5ML PDR FL 1\n",
      "  3400936736276 | AMOXICILLINE ZEN 500 MG BUV 60ML 1\n",
      "  3400936736337 | AMOXICILLINE ZTV 500MG GELULE 12\n",
      "  3400936736917 | FUROSEMIDE ZTV 20MG CPR 30\n",
      "  3400936737167 | FUROSEMIDE ZTV 40MG CPR 30\n",
      "  3400936737228 | METFORMINE ZENTIVA 850MG CPR 30\n",
      "  3400936737808 | SPIRONOLACTONE ALTIZIDE ZEN CPR 30\n",
      "  3400936738058 | SPIRONOLACTONE ZEN 50MG CPR 30\n",
      "  3400936738287 | SPIRONOLACTONE ZEN 75MG CPR 30\n",
      "  3400936738638 | VALPROATE NA ZEN 500MG CPR 40\n",
      "  3400936742079 | ALPRAZOLAM ZEN 0,25MG CPR 0\n",
      "  3400936742420 | AMISULPRIDE ZEN 100MG CPR 30\n",
      "  3400936742598 | AMISULPRIDE ZEN 200MG CPR 60\n",
      "  3400936742659 | AMOXICILLINE ZTV 1G CPR DISP 6\n",
      "  3400936742710 | AMOXICILLINE ZTV 1G CPR DISP 14\n",
      "  3400936743199 | BACLOFENE ZEN 10MG CPR 30\n",
      "  3400936743250 | CITALOPRAM ZEN 20MG CPR 28\n",
      "  3400936743311 | BETAHISTINE ZEN 8MG CPR 90\n",
      "  3400936743489 | BROMAZEPAM ZTV 6MG CPR 30\n",
      "  3400936744080 | CEFTRIAXONE ZEN 0,5G/5ML PDR INJ IV 1\n",
      "  3400936744141 | CEFTRIAXONE ZEN 1G/10ML PDR INJ IV 1\n",
      "  3400936744202 | CEFTRIAXONE ZEN 0,5G/2ML PDR INJ IM 1\n",
      "  3400936744370 | CEFTRIAXONE ZEN 1G/3,5ML PDR INJ IM 1\n",
      "  3400936744660 | CETIRIZINE ZEN 10MG CPR 15\n",
      "  3400936744721 | CIPROFIBRATE ZEN 100MG GELULE 30\n",
      "  3400936744899 | CIPROFLOXACINE ZEN 250MG CPR 12\n",
      "  3400936744950 | CIPROFLOXACINE ZEN 500MG CPR 12\n",
      "  3400936745261 | ENALAPRIL ZEN 5MG CPR 28\n",
      "  3400936745322 | ENALAPRIL ZEN 20MG CPR 28\n",
      "  3400936745490 | FENOFIBRATE ZEN 67MG GELULE 60\n",
      "  3400936745551 | FENOFIBRATE ZEN 200MG GELULE 30\n",
      "  3400936745612 | FLUOXETINE ZEN 20MG GELULE 14\n",
      "  3400936746091 | LACTULOSE ZEN 10G/15ML SOL BUV SAC 20\n",
      "  3400936746213 | MIANSERINE ZEN 10MG CPR 30\n",
      "  3400936746381 | MIANSERINE ZEN 30MG CPR 30\n",
      "  3400936746442 | MIANSERINE ZEN 60MG CPR 14\n",
      "  3400936747562 | OMEPRAZOLE ZEN 20MG GELULE 28\n",
      "  3400936747913 | PREDNISOLONE ZEN 20MG CPR EFF 20\n",
      "  3400936748514 | SOTALOL ZEN 80MG CPR 30\n",
      "  3400936748682 | SOTALOL ZEN 160MG CPR 30\n",
      "  3400936748804 | TRAMADOL ZEN 50MG CPR EFF 30\n",
      "  3400936748972 | TRIMEBUTINE ZEN 100MG CPR 30\n",
      "  3400936749283 | ZOLPIDEM ZENTIVA 10MG CPR 7\n",
      "  3400936749344 | ZOLPIDEM ZENTIVA 10MG CPR 14\n",
      "  3400936750234 | BIONOLYTE G5 INJ PO SIS-SEB 500ML 1\n",
      "  3400936750463 | BIONOLYTE G5 INJ PO SIS-SEB 1000ML 1\n",
      "  3400936751125 | SODIUM CHL FRF 0,9% INJ PO PSS 50ML 1\n",
      "  3400936751293 | SODIUM CHL FRF 0,9% INJ PO PSS 100ML 1\n",
      "  3400936751354 | SODIUM CHL FRF 0,9% INJ PO PSS 250ML 1\n",
      "  3400936751415 | SODIUM CHL FRF 0,9% INJ PO PSS 500ML 1\n",
      "  3400936751583 | SODIUM CHL FRF 0,9% INJ PO PSS 1L 1\n",
      "  3400936753365 | METFORMINE SUN 850MG CPR 30\n",
      "  3400936753716 | LORATADINE CRT 10MG CPR 15\n",
      "  3400936755727 | CEFUROXIME VIATRIS 250MG CPR 8\n",
      "  3400936757219 | NALTREXONE VTS 50MG CPR 28\n",
      "  3400936757509 | ECONAZOLE ARW LP 150MG OVULE 1\n",
      "  3400936757738 | PREDNISONE SDZ 5MG CPR 30\n",
      "  3400936758797 | PENTASA 2G GRANULES SACHET DOSE 60\n",
      "  3400936759169 | KESTINLYO 10MG LYOPHILISAT ORAL 30\n",
      "  3400936759459 | FEMSEPTEVO 0,05MG/0,007MG/24H DISP 4\n",
      "  3400936759800 | TETRALYSAL 300MG GELULE 28\n",
      "  3400936760349 | CURACNE 40MG CAPSULE MOLLE GE 30\n",
      "  3400936762640 | GLUCOSE FRF 5% SOL INJ POC PSS 50ML 1\n",
      "  3400936762701 | GLUCOSE FRF 5% SOL INJ POC PSS 100ML 1\n",
      "  3400936762879 | GLUCOSE FRF 5% SOL INJ POC PSS 250ML 1\n",
      "  3400936762930 | GLUCOSE FRF 5% SOL INJ POC PSS 500ML 1\n",
      "  3400936763012 | GLUCOSE FRF 5% SOL INJ POC PSS 1L 1\n",
      "  3400936766372 | FUCIDINE 250 MG CPR 10\n",
      "  3400936766891 | ZOCOR 20MG CPR 28\n",
      "  3400936766952 | SOLUVIT PDR INJ 10\n",
      "  3400936772465 | PAROXETINE BGA 20MG CPR 14\n",
      "  3400936773295 | SODIUM CHLORURE 0,9 P. 100 BIOLUZ 500 ML EN POCHE\n",
      "  3400936773356 | SODIUM CHLORURE 0,9 P. 100 BIOLUZ 1 000 ML EN POCH\n",
      "  3400936773875 | BOOSTRIXTETRA SUSP INJ 1\n",
      "  3400936773936 | BOOSTRIXTETRA SUSP INJ 0\n",
      "  3400936774476 | EUROBIOL 12500U/DOSE GRANULES 1\n",
      "  3400936780330 | CLARITHROMYCINE SUN 250MG CPR 10\n",
      "  3400936780569 | CLARITHROMYCINE EG 250MG CPR 10\n",
      "  3400936782341 | CIPROFLOXACINE SDZ 250MG CPR 12\n",
      "  3400936783171 | CIPROFLOXACINE SDZ 500MG CPR 12\n",
      "  3400936785533 | SIMVASTATINE ZEN 20MG CPR 28\n",
      "  3400936786073 | SIMVASTATINE ZEN 10MG CPR 28\n",
      "  3400936786363 | SIMVASTATINE ZEN 40MG CPR 28\n",
      "  3400936786592 | SIMVASTATINE MYL 20MG CPR 28\n",
      "  3400936787193 | MONOALGIC LP 100MG CPR 15\n",
      "  3400936788084 | PROCUTA 40MG CAPSULE MOLLE 30\n",
      "  3400936788435 | CONTRACNE 40MG CAPSULE MOLLE 30\n",
      "  3400936789555 | EFFIZINC 15MG GELULE 30\n",
      "  3400936789784 | EFFIZINC 15MG GELULE 60\n",
      "  3400936790964 | GAVISCON MENTHE CPR 20\n",
      "  3400936794238 | MONOALGIC LP 200 MG CPR 15\n",
      "  3400936795709 | FENOFIBRATE SDZ 300MG GELULE 30\n",
      "  3400936796010 | AMOXICILLINE SDZ 500MG GELULE 12\n",
      "  3400936797598 | TAMOXIFENE SDZ 10MG CPR 30\n",
      "  3400936797659 | TAMOXIFENE SDZ 20MG CPR 30\n",
      "  3400936797710 | LACTULOSE SDZ 10G/15ML SOL BUV SAC 20\n",
      "  3400936800243 | SIMVASTATINE MYL 40MG CPR 28\n",
      "  3400936803374 | AMOX/AC CLAV RBX 100/12,5MG/ML 1\n",
      "  3400936803435 | AMOX/AC CLAV SUN 100/12,5 MG/ML 1\n",
      "  3400936804845 | OMEPRAZOLE CRT 20MG GELULE 28\n",
      "  3400936805965 | OMEPRAZOLE ZEN 10MG GELULE 28\n",
      "  3400936806795 | PREDNISOLONE SDZ 20MG CPR EFF 20\n",
      "  3400936806856 | AMISULPRIDE SDZ 200MG CPR 60\n",
      "  3400936806917 | CLOMIPRAMINE SDZ 75MG CPR 20\n",
      "  3400936807457 | SOTALOL SDZ 160MG CPR 30\n",
      "  3400936807518 | SOTALOL SDZ 80MG CPR 30\n",
      "  3400936808348 | SPIRONOLACTONE SDZ 75MG CPR 30\n",
      "  3400936808577 | ECONAZOLE SDZ 1% SOL FL 30G 1\n",
      "  3400936809178 | MONOALGIC LP 300MG CPR 15\n",
      "  3400936818453 | GLICLAZIDE SDZ 80MG CPR 20\n",
      "  3400936818514 | GLICLAZIDE SDZ 80MG CPR 60\n",
      "  3400936818972 | FENOFIBRATE SDZ 200MG GELULE 30\n",
      "  3400936819054 | FUROSEMIDE SDZ 20MG CPR 30\n",
      "  3400936819344 | TRAMADOL SDZ 50MG CPR 30\n",
      "  3400936819634 | FUROSEMIDE SDZ 40MG CPR 30\n",
      "  3400936820814 | GLIBENCLAMIDE TVC 2,5MG CPR 60\n",
      "  3400936820982 | GLIBENCLAMIDE TVC 5MG CPR 20\n",
      "  3400936821125 | CIPROFLOXACINE ARW 250MG CPR 12\n",
      "  3400936822306 | CIPROFLOXACINE ARW 500MG CPR 12\n",
      "  3400936831179 | CARVEDILOL VTS 6,25MG CPR 28\n",
      "  3400936832060 | RAMIPRIL SDZ 1,25MG CPR 30\n",
      "  3400936832879 | RAMIPRIL SDZ 2,5MG CPR 30\n",
      "  3400936833760 | RAMIPRIL SDZ 5MG CPR 30\n",
      "  3400936834651 | RAMIPRIL SDZ 10MG CPR 30\n",
      "  3400936848269 | ZENTEL 400MG CPR 1\n",
      "  3400936852860 | CIPROFLOXACINE ALT 250MG CPR 12\n",
      "  3400936852921 | CIPROFLOXACINE ALT 500MG CPR 12\n",
      "  3400936853461 | CELIPROLOL SUN 200MG CPR 28\n",
      "  3400936854703 | PAROXETINE ARW 20MG CPR 14\n",
      "  3400936855182 | PAROXETINE ARROW 20 MG 1 BOITE DE 14, COMPRIMES PE\n",
      "  3400936856714 | AMISULPRIDE SDZ 400MG CPR 30\n",
      "  3400936857193 | AMISULPRIDE TVC 400MG CPR 30\n",
      "  3400936860094 | CLARITHROMYCINE EG 500MG CPR 10\n",
      "  3400936860155 | CLARITHROMYCINE EG 500MG CPR 14\n",
      "  3400936860384 | CLARITHROMYCINE RBX 500MG CPR 10\n",
      "  3400936860445 | CLARITHROMYCINE RBX 500MG CPR 14\n",
      "  3400936862685 | OMEPRAZOLE VIATRIS 10MG GELULE 14\n",
      "  3400936862746 | OMEPRAZOLE VIATRIS 10MG GELULE 28\n",
      "  3400936863057 | GABAPENTINE ZYD 400MG GELULE 90\n",
      "  3400936863118 | PRAVASTATINE TVC 10MG CPR 28\n",
      "  3400936863347 | PRAVASTATINE TVC 20MG CPR 28\n",
      "  3400936863576 | PRAVASTATINE TVC 40MG CPR 28\n",
      "  3400936863637 | ANESDERM 5% CREME 5G GE 1\n",
      "  3400936864009 | MYCOSTER 10 MG/G SHAMPOOING 1\n",
      "  3400936868540 | NICOTINELL 2MG CPR MENT SS SUCRE 96\n",
      "  3400936869202 | SPIRIVA 18 MICROG PDR INH EN GELULE 30\n",
      "  3400936873971 | REPEVAX SUSP INJ SER 2A 1\n",
      "  3400936874343 | PENTAVAC PDR ET SUSP INJ 2AIG 1\n",
      "  3400936874923 | TETRAVAC ACELLULAIRE INJ 2AIG 1\n",
      "  3400936876293 | REVAXIS SUSP INJ SER 0,5ML 2AIG 1\n",
      "  3400936876415 | VARIVAX PDR ET SOL INJ SRG + 2 AIG 1\n",
      "  3400936882447 | ECONAZOLE SDZ 1% PDR FL 30G 1\n",
      "  3400936882966 | AMOXICILLINE SDZ 125MG/5ML PDR FL 1\n",
      "  3400936883338 | VERAPAMIL SDZ LP 240MG CPR 30\n",
      "  3400936883628 | CLOMIPRAMINE SDZ 25MG CPR 50\n",
      "  3400936889422 | GABAPENTINE EVO 400MG GELULE 90\n",
      "  3400936889651 | FLUOXETINE ALM 20MG GELULE 14\n",
      "  3400936890251 | LISINOPRIL HCTZ EG 20/12,5MG CPR 28\n",
      "  3400936890312 | METFORMINE ZEN 1000MG CPR 30\n",
      "  3400936891661 | NIFEDIPINE ARW LP 30MG CPR 30\n",
      "  3400936892033 | NIFEDIPINE VTS LP 30MG CPR 30\n",
      "  3400936892613 | CLOMIPRAMINE SDZ 10MG CPR 60\n",
      "  3400936894044 | OPTICRON 2% COLLYRE UNIDOSE 0,35ML 24\n",
      "  3400936894273 | TRIMEBUTINE SDZ 100MG CPR 30\n",
      "  3400936894334 | DILTIAZEM SDZ LP 300MG GELULE 30\n",
      "  3400936894563 | PARACETAMOL COD SDZ 500/30MG CPR EFF 16\n",
      "  3400936894624 | METFORMINE SUN 500MG CPR 30\n",
      "  3400936895164 | ORALAIR 100IR/300IR CPR SUBLINGUAL 31\n",
      "  3400936895225 | ORALAIR 300IR CPR SUBLINGUAL 30\n",
      "  3400936895454 | OXOMEMAZINE BGA 0,33MG/ML SIROP 1\n",
      "  3400936895744 | ELUDRIL SOL PR BDB FL 90ML 1\n",
      "  3400936902299 | SPIRONOLACTONE VIATRIS 50MG CPR 30\n",
      "  3400936902589 | SPIRONOLACTONE VIATRIS 50MG CPR 90\n",
      "  3400936905771 | MORPHINE CHL AGT 400 MG INJ 10\n",
      "  3400936906143 | MORPHINE CHL AGT 0,5 MG INJ 10\n",
      "  3400936907553 | MORPHINE CHL CPF 10 MG INJ 10\n",
      "  3400936908383 | TRIATEC 1,25MG CPR 90\n",
      "  3400936908444 | TRIATEC 2,5 MG CPR 90\n",
      "  3400936908505 | TRIATEC 5MG CPR 90\n",
      "  3400936908673 | TRIATEC 10MG CPR 90\n",
      "  3400936908734 | VASTEN 20 MG CPR 84\n",
      "  3400936908963 | VASTEN 40 MG CPR 84\n",
      "  3400936910683 | MORPHINE CHL AGT 10 MG INJ 10\n",
      "  3400936910744 | SPIRONOLACTONE SDZ 50MG CPR 30\n",
      "  3400936911055 | MORPHINE CHL AGT 50 MG INJ 10\n",
      "  3400936911345 | SPIRONOLACTONE SDZ 50MG CPR 90\n",
      "  3400936911635 | MORPHINE CHL AGT 100 MG INJ 10\n",
      "  3400936914476 | XENETIX 300 SOL INJ POC 100ML 1\n",
      "  3400936915428 | XENETIX 350 SOL INJ POC 100ML 1\n",
      "  3400936915657 | XENETIX 350 SOL INJ POC150ML PP 1\n",
      "  3400936918498 | DIASEPTYL 0,5% SOL FL PULV 125ML 1\n",
      "  3400936919211 | TAZOCILLINE 2000 MG/250 MG PDR INJ 1\n",
      "  3400936919440 | TAZOCILLINE 4000 MG/500 MG PDR INJ 1\n",
      "  3400936920330 | ZONEGRAN 50 MG GELULE 14\n",
      "  3400936920859 | AZACTAM 1G PDR INJ 1\n",
      "  3400936921450 | ABILIFY 10 MG CPR DISP 28\n",
      "  3400936921740 | ABILIFY 15 MG CPR DISP 28\n",
      "  3400936923171 | MYLERAN 2MG CPR 25\n",
      "  3400936923232 | TARCEVA 25MG CPR 30\n",
      "  3400936923461 | TARCEVA 100MG CPR 30\n",
      "  3400936923522 | TARCEVA 150MG CPR 30\n",
      "  3400936923690 | RIFADINE 600 MG PDR ET SOL INJ 1\n",
      "  3400936924291 | HBVAXPRO 5 MCG INJ SER AVEC AIG 1\n",
      "  3400936924642 | HBVAXPRO 10 MCG SUSP INJ SER AIG 1\n",
      "  3400936925182 | FOSAVANCE 70 MG/2800 UI CPR 4\n",
      "  3400936925243 | APTIVUS 250 MG CAPSULE 120\n",
      "  3400936927544 | FOSRENOL 500MG CPR 90\n",
      "  3400936928374 | FOSRENOL 750MG CPR 90\n",
      "  3400936929036 | FOSRENOL 1000MG CPR 90\n",
      "  3400936929845 | CADUET 10 MG/10 MG CPR 30\n",
      "  3400936930506 | CADUET 5 MG/10 MG CPR 30\n",
      "  3400936931046 | MINIRINMELT 60MICROGR LYOPHILISAT 30\n",
      "  3400936931107 | MINIRINMELT 60MICROGR LYOPHILISAT 100\n",
      "  3400936931336 | MINIRINMELT 120MICROGR LYOPHILISAT 30\n",
      "  3400936931565 | MINIRINMELT 120MICROGR LYOPHILISAT 100\n",
      "  3400936931794 | MINIRINMELT 240MICROGR LYOPHILISAT 30\n",
      "  3400936931916 | XENAZINE 25MG CPR 112\n",
      "  3400936933866 | AMISULPRIDE ARW 400MG CPR 30\n",
      "  3400936935297 | CYPROTERONE MYL 100MG CPR 60\n",
      "  3400936942103 | GABAPENTINE ZEN 400MG GELULE 90\n",
      "  3400936945524 | SERTRALINE BGA 50MG GELULE 28\n",
      "  3400936945814 | CYPROTERONE EG 100MG CPR 60\n",
      "  3400936946125 | PARACETAMOL SDZ 1G CPR 8\n",
      "  3400936946583 | MIRTAZAPINE TVC 15MG CPR 30\n",
      "  3400936951037 | KENZEN 32MG CPR 30\n",
      "  3400936951266 | FORMOAIR 12 MICROG/DOSE SOL INH 1\n",
      "  3400936953857 | PAROXETINE SDZ 20MG CPR 14\n",
      "  3400936954168 | CLOPIXOL 10MG CPR 30\n",
      "  3400936954397 | CLOPIXOL 25MG CPR 30\n",
      "  3400936960602 | OROCAL VIT D3 500MG/200UI CPR 60\n",
      "  3400936961371 | INEGY 10MG/20MG CPR 30\n",
      "  3400936961661 | INEGY 10MG/40MG CPR 30\n",
      "  3400936962491 | OMEXEL LP 0,4MG CPR 30\n",
      "  3400936962552 | MECIR LP 0,4MG CPR 30\n",
      "  3400936962903 | COTRIATEC 5MG/12,5MG CPR 30\n",
      "  3400936963443 | BECLOSPIN 400MICROG/1ML SUSP INH 400\n",
      "  3400936963504 | BECLOSPIN 800MICROG/2ML SUSP INH 400\n",
      "  3400936964105 | LIPANTHYL 145 MG CPR 30\n",
      "  3400936964273 | LIPANTHYL 145 MG CPR 90\n",
      "  3400936964334 | FENOFIBRATE VIATRIS 145MG CPR 30\n",
      "  3400936964563 | FENOFIBRATE VIATRIS 145MG CPR 90\n",
      "  3400936965973 | VALPROATE NA EG LP 500MG CPR 30\n",
      "  3400936966284 | VALPROATE NA TVS LP 500MG CPR 30\n",
      "  3400936966925 | VALPROATE NA BGA LP 500MG CPR 30\n",
      "  3400936967007 | VALPROATE NA VIATRIS LP 500MG CPR 30\n",
      "  3400936967175 | LAMOTRIGINE SDZ 25MG CPR DISP 30\n",
      "  3400936967816 | LAMOTRIGINE SDZ 100MG CPR DISP 30\n",
      "  3400936968417 | LAMOTRIGINE SDZ 200MG CPR DISP 30\n",
      "  3400936970885 | PHLOROGLUCINOL VIATRIS 80MG CPR DISP 10\n",
      "  3400936971486 | PHLOROGLUCINOL TVC 80MG CPR DISP 10\n",
      "  3400936972957 | PHLOROGLUCINOL EG 80MG CPR DISP 10\n",
      "  3400936974210 | PHLOROGLUCINOL SDZ 80MG CPR DISP 10\n",
      "  3400936974449 | PAROXETINE EG 20MG CPR 14\n",
      "  3400936975569 | SERTRALINE ARW 50MG GELULE 28\n",
      "  3400936980181 | SERTRALINE SUN 50MG GELULE 28\n",
      "  3400936980532 | SERTRALINE EG 50MG GELULE 28\n",
      "  3400936981652 | SERTRALINE ZEN 50MG GELULE 28\n",
      "  3400936981942 | SERTRALINE TVC 50MG GELULE 28\n",
      "  3400936982253 | SERTRALINE EVO 50MG GELULE 28\n",
      "  3400936984615 | NOVOPULMON NOVOLIZER 400 MICROG INH 1\n",
      "  3400936984783 | NOVOPULMON NOVOLIZER 400 MICROG INH 2\n",
      "  3400936984905 | NOVOPULMON NOVOLIZER 400 MICROG PDR 1\n",
      "  3400936985155 | DUROGESIC 12 MICROG/H DISP TRANSDERM 5\n",
      "  3400936985384 | CRESTOR 5MG CPR 30\n",
      "  3400936985674 | BECLOSPRAY 50MICROG SOL INHAL 1\n",
      "  3400936987746 | AMINOMIX 500E SOL POUR PERF POC 1L 6\n",
      "  3400936987807 | AMINOMIX 500E SOL POUR PERF POC 1,5L 4\n",
      "  3400936988057 | AMINOMIX 800E SOL INJ POC 1L 6\n",
      "  3400936988118 | AMINOMIX 800E SOL INJ POC 1,5L 4\n",
      "  3400936988286 | AMINOMIX 800E SOL INJ POC 2L 4\n",
      "  3400936991996 | EPREX 20 000UI SOL INJ SER 1\n",
      "  3400936992368 | EPREX 40 000UI/1ML SOL INJ SER 1\n",
      "  3400936995321 | SERTRALINE VIATRIS 50MG GELULE 28\n",
      "  3400936995789 | LIDOCAINE/PRILOCAINE ZEN 5% CREME 5G 1\n",
      "  3400937005319 | RAMIPRIL VIATRIS 1,25MG CPR 30\n",
      "  3400937005777 | RAMIPRIL VIATRIS 1,25MG CPR 30\n",
      "  3400937006200 | RAMIPRIL VTS 2,5MG CPR 30\n",
      "  3400937006729 | RAMIPRIL VTS 2,5MG CPR 30\n",
      "  3400937007269 | RAMIPRIL VIATRIS 5MG CPR 30\n",
      "  3400937007610 | RAMIPRIL VIATRIS 5MG CPR 30\n",
      "  3400937008099 | RAMIPRIL VIATRIS 10MG CPR 30\n",
      "  3400937008440 | RAMIPRIL VIATRIS 10MG CPR 30\n",
      "  3400937014243 | GADOVIST 1MMOL/ML SOL INJ SER 7,5ML 1\n",
      "  3400937016254 | GLIBENCLAMIDE TVC 5MG CPR 90\n",
      "  3400937016315 | BECLOSPRAY 250MICROG SOL INHAL 1\n",
      "  3400937016605 | SERTRALINE ALM 50MG GELULE 28\n",
      "  3400937018616 | PRAVASTATINE BGA 10MG CPR 28\n",
      "  3400937018845 | PRAVASTATINE BGA 20MG CPR 28\n",
      "  3400937019095 | PRAVASTATINE BIOGARAN 40 MG 1 BOITE DE 28, COMPRIM\n",
      "  3400937019675 | PRAVASTATINE EVOLUGEN 40 MG 1 BOITE DE 28, COMPRIM\n",
      "  3400937021685 | ALENDRONIQUE ACIDE EG 70MG CPR 4\n",
      "  3400937021807 | ALENDRONIQUE ACIDE EG 70MG CPR 12\n",
      "  3400937022347 | FOSAVANCE 70 MG/2800 UI CPR 12\n",
      "  3400937022576 | XOLAIR 150 MG (OMALIZUMAB) 1 BOITE DE 1, POUDRE EN\n",
      "  3400937022927 | AXEPIM 500MG PDR INJ 1\n",
      "  3400937023009 | AXEPIM 1G PDR INJ 1\n",
      "  3400937023467 | AXEPIM 2G PDR INJ 1\n",
      "  3400937023696 | NEULASTA 6MG SOL INJ SER 1\n",
      "  3400937023818 | KEPPRA 100MG/ML SOL BUV 300ML+S10ML 1\n",
      "  3400937024297 | NOVOMIX 50 FLEXPEN 300U STYLO 5\n",
      "  3400937030502 | FLUCONAZOLE VIATRIS 50MG GELULE 7\n",
      "  3400937032452 | FLUCONAZOLE VIATRIS 100MG GELULE 7\n",
      "  3400937034692 | FLUCONAZOLE VIATRIS 200MG GELULE 7\n",
      "  3400937034982 | FLUCONAZOLE VIATRIS 200MG GELULE 30\n",
      "  3400937039086 | ENALAPRIL HCTZ TVC 20/12,5MG CPR 28\n",
      "  3400937039895 | ENALAPRIL HCTZ ZEN 20/12,5MG CPR 28\n",
      "  3400937044868 | ALFUZOSINE TVS LP 10MG CPR 30\n",
      "  3400937045230 | ALFUZOSINE VTS LP 10MG CPR 30\n",
      "  3400937045469 | ALFUZOSINE EG LP 10MG CPR 30\n",
      "  3400937045520 | ALFUZOSINE SDZ LP 10MG CPR 30\n",
      "  3400937047302 | PRAVASTATINE ARW GEN 20MG CPR 28\n",
      "  3400937047760 | PRAVASTATINE ARW GEN 40MG CPR 28\n",
      "  3400937049771 | BUPRENORPHINE VTS 8MG CPR 7\n",
      "  3400937050371 | PINAVERIUM ARW 100MG CPR 30\n",
      "  3400937050432 | BUPRENORPHINE VTS 0,4MG CPR 7\n",
      "  3400937051552 | TERBINAFINE ZEN 250MG CPR 14\n",
      "  3400937051613 | TERBINAFINE ZEN 250MG CPR 28\n",
      "  3400937051903 | CARVEDILOL BGA 6,25MG CPR 28\n",
      "  3400937052092 | CARVEDILOL BGA 12,5MG CPR 28\n",
      "  3400937052153 | CARVEDILOL BGA 25MG CPR 28\n",
      "  3400937052382 | PARACETAMOL ALM 1G CPR 8\n",
      "  3400937052733 | GLIMEPIRIDE ZEN 1MG CPR 30\n",
      "  3400937053914 | AMOXICILLINE ALM 500MG/5ML PDR FL 1\n",
      "  3400937054393 | AMOXICILLINE ALM 500MG GELULE 12\n",
      "  3400937054454 | RUBOZINC 15MG GELULE 60\n",
      "  3400937056007 | PINAVERIUM VIATRIS 100MG CPR 30\n",
      "  3400937056175 | PINAVERIUM TVS 100MG CPR 30\n",
      "  3400937056236 | PINAVERIUM BIOGARAN 100 MG 1 BOITE DE 30, COMPRIME\n",
      "  3400937056984 | TAMSULOSINE BGA LP 0,4MG GELULE 30\n",
      "  3400937057356 | TAMSULOSINE VIATRIS LP 0,4MG GELULE 30\n",
      "  3400937061957 | GLIMEPIRIDE ZEN 1MG CPR 90\n",
      "  3400937062329 | GLIMEPIRIDE ZEN 2MG CPR 30\n",
      "  3400937062787 | GLIMEPIRIDE ZEN 3MG CPR 30\n",
      "  3400937063098 | GLIMEPIRIDE ZEN 2MG CPR 90\n",
      "  3400937063210 | GLIMEPIRIDE ZEN 4MG CPR 30\n",
      "  3400937068291 | GELTIM LP 1MG/G GEL OPHT 30\n",
      "  3400937071024 | RINOCLENIL 100MICROG/DOSE SUSP NAS 1\n",
      "  3400937071253 | RHINOMAXIL 100MICROG/DOSE SUSP NAS 1\n",
      "  3400937076807 | TAMSULOSINE VIATRIS LP 0,4MG GELULE 30\n",
      "  3400937077637 | TAMSULOSINE ALM LP 0,4MG GELULE 30\n",
      "  3400937082020 | AVAXIM 160U SUSP INJ SER + AIG SEPAR 1\n",
      "  3400937085960 | SPIRONOLACTONE ZYD 50MG CPR 30\n",
      "  3400937086561 | ALENDRONIQUE ACIDE ARW 70MG CPR 4\n",
      "  3400937086790 | ALENDRONIQUE ACIDE ARW 70MG CPR 12\n",
      "  3400937087681 | ALENDRONIQUE ACIDE BGA 70MG CPR 4\n",
      "  3400937087803 | ALENDRONIQUE ACIDE BGA 70MG CPR 12\n",
      "  3400937092425 | GLIMEPIRIDE BGR 2MG CPR 30\n",
      "  3400937094085 | MELOXICAM TEVA 7,5MG CPR 14\n",
      "  3400937094726 | MELOXICAM TEVA 15MG CPR 14\n",
      "  3400937096966 | NICORETTE 2MG GOMME MENT G SS SUCRE 105\n",
      "  3400937098397 | NICORETTE 4MG GOMME MENT G SS SUCRE 105\n",
      "  3400937099578 | NICORETTE 2MG GOMME FRUI SS SUCRE 105\n",
      "  3400937100731 | NICORETTE 4MG GOMME FRUI SS SUCRE 105\n",
      "  3400937103633 | PINAVERIUM SDZ 100MG CPR 30\n",
      "  3400937103923 | SPIRAM/METRO ZYD 1,5MUI/250MG CPR 10\n",
      "  3400937105934 | SPIRAM/METRO EG 1,5MUI/250MG CPR 10\n",
      "  3400937107655 | SPIRAM/METRO ARW 1,5MUI/250MG CPR 10\n",
      "  3400937108195 | SPIRAM/METRO ARW 0,75MUI/125MG CPR 20\n",
      "  3400937108317 | SPIRAM/METRO VTS 0,75MUI/125MG CPR 20\n",
      "  3400937108546 | SPIRAM/METRO SUN 1,5MUI/250MG CPR 10\n",
      "  3400937110266 | BI MISSILOR 1,5MUI/250MG CPR 10\n",
      "  3400937118590 | FUNGSTER 250MG CPR 14\n",
      "  3400937118651 | FUNGSTER 250MG CPR 28\n",
      "  3400937118712 | GLIMEPIRIDE ZEN 3MG CPR 90\n",
      "  3400937118880 | GLIMEPIRIDE ZEN 4MG CPR 90\n",
      "  3400937119832 | TAMSULOSINE EG LP 0,4MG GELULE 30\n",
      "  3400937120371 | SERTRALINE ZYF 50MG GELULE 28\n",
      "  3400937121033 | SERTRALINE ZYF 25MG GELULE 7\n",
      "  3400937123624 | RAMIPRIL ZEN 2,5MG CPR 90\n",
      "  3400937123792 | RAMIPRIL ZEN 5MG CPR 90\n",
      "  3400937123853 | RAMIPRIL ZEN 10MG CPR 90\n",
      "  3400937124164 | LERCAN 10MG CPR 30\n",
      "  3400937124225 | LERCAN 10MG CPR 90\n",
      "  3400937124393 | LERCAN 20MG CPR 30\n",
      "  3400937124454 | LERCAN 20MG CPR 90\n",
      "  3400937124515 | BISOPROLOL ZYD 10MG CPR 90\n",
      "  3400937124744 | CELIPROLOL ZYD 200MG CPR 90\n",
      "  3400937124973 | ATENOLOL ZYD 50MG CPR 90\n",
      "  3400937125055 | ATENOLOL ZYD 100MG CPR 90\n",
      "  3400937125284 | ACEBUTOLOL ZYD 200MG CPR 90\n",
      "  3400937125574 | TARKA LP 180 MG/2 MG CPR 30\n",
      "  3400937127936 | OMEPRAZOLE SDZ 20MG GELULE 7\n",
      "  3400937128018 | OMEPRAZOLE SDZ 20MG GELULE 14\n",
      "  3400937128186 | OMEPRAZOLE SDZ 20MG GELULE 28\n",
      "  3400937129138 | OMEPRAZOLE SDZ 10MG GELULE 14\n",
      "  3400937129367 | OMEPRAZOLE SDZ 10MG GELULE 28\n",
      "  3400937136860 | TARKA LP 180 MG/2 MG CPR 90\n",
      "  3400937137232 | ODRIK 4MG GELULE 30\n",
      "  3400937137522 | ODRIK 4MG GELULE 90\n",
      "  3400937137812 | CO RENITEC CPR 90\n",
      "  3400937140423 | ISOPTINE 120 MG GELULE 90\n",
      "  3400937140881 | FORTZAAR 100MG/25MG CPR 90\n",
      "  3400937140942 | COKENZEN 8MG/12,5MG CPR 30\n",
      "  3400937141192 | COKENZEN 8MG/12,5MG CPR 90\n",
      "  3400937141772 | COKENZEN 16MG/12,5MG CPR 30\n",
      "  3400937142083 | COKENZEN 16MG/12,5MG CPR 90\n",
      "  3400937142205 | TENORMINE 100MG CPR 30\n",
      "  3400937142434 | TENORMINE 100MG CPR 90\n",
      "  3400937142724 | TENORMINE 50MG CPR 30\n",
      "  3400937142953 | TENORMINE 50MG CPR 90\n",
      "  3400937143615 | FLODIL LP 5MG CPR 30\n",
      "  3400937143844 | FLODIL LP 5MG CPR 90\n",
      "  3400937144094 | LOGIMAX LP 5MG/47,5MG CPR 30\n",
      "  3400937144216 | LOGIMAX LP 5MG/47,5MG CPR 90\n",
      "  3400937144674 | HYZAAR 50MG/12,5MG CPR 90\n",
      "  3400937145046 | COZAAR 100MG CPR 90\n",
      "  3400937146166 | COZAAR 50MG CPR 90\n",
      "  3400937146456 | KERLONE 20MG CPR 84\n",
      "  3400937146746 | VISKEN 5MG CPR 90\n",
      "  3400937147057 | VISKEN QUINZE 15MG CPR 90\n",
      "  3400937148528 | PHYSIOTENS 0,2MG CPR 90\n",
      "  3400937148696 | PHYSIOTENS 0,4MG CPR 90\n",
      "  3400937148818 | FENOFIBRATE FOR 67 MG GELULE 90\n",
      "  3400937150309 | SELOKEN 100MG CPR 30\n",
      "  3400937152310 | TENSTATEN 50MG GELULE 90\n",
      "  3400937152488 | ISOPTINE LP 240MG CPR 90\n",
      "  3400937152600 | ODRIK 2MG GELULE 90\n",
      "  3400937152778 | ATACAND 16 MG CPR 30\n",
      "  3400937153089 | ATACAND 16 MG CPR 90\n",
      "  3400937153201 | ATACAND 8 MG CPR 30\n",
      "  3400937153430 | ATACAND 8 MG CPR 90\n",
      "  3400937153720 | ZESTORETIC 20MG/12,5MG CPR 30\n",
      "  3400937153959 | ZESTORETIC 20MG/12,5MG CPR 90\n",
      "  3400937154321 | SIMVASTATINE ZEN 20MG CPR 90\n",
      "  3400937155960 | CIBADREX 10MG/12,5MG CPR 30\n",
      "  3400937156103 | CIBADREX 10MG/12,5MG CPR 90\n",
      "  3400937156912 | BUPRENORPHINE ARW 0,4MG CPR 7\n",
      "  3400937157223 | BUPRENORPHINE ARW 8MG CPR 7\n",
      "  3400937157452 | VALPROATE NA ARW LP 500MG CPR 30\n",
      "  3400937157513 | SERTRALINE ZEN 25MG GELULE 7\n",
      "  3400937162715 | BUPRENORPHINE ARW 2MG CPR 7\n",
      "  3400937163484 | RAMIPRIL BGA 1,25 MG CPR 30\n",
      "  3400937164085 | RAMIPRIL BGA 1,25 MG CPR 30\n",
      "  3400937164665 | RAMIPRIL BGA 2,5MG CPR 30\n",
      "  3400937165266 | RAMIPRIL BGA 2,5MG CPR 30\n",
      "  3400937165327 | NOVOMIX 70 FLEXPEN 300U STYLO 5\n",
      "  3400937166447 | NOVONORM 0,5 MG CPR 270\n",
      "  3400937166508 | NOVONORM 1 MG CPR 270\n",
      "  3400937166676 | NOVONORM 2 MG CPR 270\n",
      "  3400937166737 | PRITORPLUS 40MG/12,5MG CPR 90\n",
      "  3400937166966 | PRITORPLUS 80MG/12,5MG CPR 90\n",
      "  3400937167109 | PRITOR 40MG CPR 90\n",
      "  3400937167277 | PRITOR 80MG CPR 90\n",
      "  3400937167628 | PROCORALAN 5 MG CPR 56\n",
      "  3400937167918 | PROCORALAN 7,5 MG CPR 56\n",
      "  3400937172240 | COMBIGAN 2MG/5MG/ML COLLYRE FL 5ML 1\n",
      "  3400937177092 | BEFIZAL 200MG CPR 90\n",
      "  3400937177382 | BEFIZAL LP 400MG CPR 90\n",
      "  3400937178044 | LIPANTHYL 160MG CPR 90\n",
      "  3400937178105 | FENOFIBRATE FOR 160MG CPR 90\n",
      "  3400937178563 | LIPANTHYL 200MG MICRONISE GELULE 90\n",
      "  3400937178853 | FENOFIBRATE BGA 200MG GELULE 90\n",
      "  3400937181693 | MELOXICAM ZEN 7,5MG CPR 14\n",
      "  3400937182645 | MELOXICAM ZEN 15MG CPR 14\n",
      "  3400937183307 | FOSINOPRIL TVC 10MG CPR 30\n",
      "  3400937183765 | FOSINOPRIL TVC 20MG CPR 30\n",
      "  3400937185608 | TAMSULOSINE TVC LP 0,4MG GELULE 30\n",
      "  3400937186148 | TAMSULOSINE ZEN LP 0,4MG GELULE 30\n",
      "  3400937186209 | TAMSULOSINE ZYF LP 0,4MG GELULE 30\n",
      "  3400937186438 | TAMSULOSINE SDZ LP 0,4MG GELULE 30\n",
      "  3400937186896 | GLIMEPIRIDE BGR 1MG CPR 30\n",
      "  3400937187268 | GLIMEPIRIDE BGR 1MG CPR 90\n",
      "  3400937189620 | GLIMEPIRIDE BGR 2MG CPR 90\n",
      "  3400937189910 | GLIMEPIRIDE BGR 3MG CPR 30\n",
      "  3400937190398 | GLIMEPIRIDE BGR 3MG CPR 90\n",
      "  3400937190688 | GLIMEPIRIDE BGR 4MG CPR 30\n",
      "  3400937190978 | GLIMEPIRIDE BGR 4MG CPR 90\n",
      "  3400937196482 | LOXEN LP 50MG GELULE 180\n",
      "  3400937196543 | ESIDREX 25 MG CPR 30\n",
      "  3400937196604 | ESIDREX 25 MG CPR 90\n",
      "  3400937197434 | FENOFIBRATE ZYD 300MG GELULE 90\n",
      "  3400937197953 | SIMVASTATINE MYL 40MG CPR 84\n",
      "  3400937198493 | SIMVASTATINE MYL 20MG CPR 84\n",
      "  3400937199155 | SIMVASTATINE ZEN 40MG CPR 90\n",
      "  3400937199216 | TAHOR 10MG CPR 90\n",
      "  3400937199384 | TAHOR 20MG CPR 90\n",
      "  3400937199445 | TAHOR 40MG CPR 90\n",
      "  3400937199506 | TAHOR 80MG CPR 90\n",
      "  3400937200608 | DAONIL 5MG CPR 180\n",
      "  3400937200837 | TENORETIC CPR 30\n",
      "  3400937201148 | TENORETIC CPR 90\n",
      "  3400937201728 | HYTACAND 8MG/12,5MG CPR 30\n",
      "  3400937201957 | HYTACAND 8MG/12,5MG CPR 90\n",
      "  3400937202787 | HYTACAND 16MG/12,5MG CPR 90\n",
      "  3400937202909 | ATACAND 4 MG CPR 30\n",
      "  3400937203159 | ATACAND 4 MG CPR 90\n",
      "  3400937203388 | KENZEN 4MG CPR 30\n",
      "  3400937203739 | KENZEN 8MG CPR 30\n",
      "  3400937204040 | KENZEN 8MG CPR 90\n",
      "  3400937204279 | KENZEN 16MG CPR 30\n",
      "  3400937204569 | KENZEN 16MG CPR 90\n",
      "  3400937204859 | GLUCOPHAGE 500MG CPR 90\n",
      "  3400937204910 | BISOPROLOL ZEN 10MG CPR 90\n",
      "  3400937205221 | LISINOPRIL ZEN 20MG CPR 30\n",
      "  3400937205689 | ATACAND 32 MG CPR 30\n",
      "  3400937205801 | OROCAL VIT D3 500MG/400UI CPR 180\n",
      "  3400937206402 | EUPRESSYL 30 MG (URAPIDIL) 1 BOITE DE 180, GELULES\n",
      "  3400937207980 | LESCOL LP 80MG CPR 30\n",
      "  3400937208062 | LESCOL LP 80MG CPR 90\n",
      "  3400937208581 | SECTRAL 200MG CPR 90\n",
      "  3400937222549 | SECTRAL 400MG CPR 90\n",
      "  3400937223089 | MONO-TILDIEM LP 300 MG (CHLORHYDRATE DE DILTIAZEM)\n",
      "  3400937223430 | CALPEROS D3 (CHOLECALCIFEROL, CARBONATE DE CALCIUM\n",
      "  3400937224321 | PERMIXON 160MG GELULE 180\n",
      "  3400937224499 | PERMIXON 160MG GELULE 180\n",
      "  3400937224550 | DETENSIEL 10 MG CPR 90\n",
      "  3400937224611 | GLUCOPHAGE 850MG CPR 90\n",
      "  3400937225212 | SELOKEN LP 200 MG CPR 30\n",
      "  3400937225441 | SELOKEN LP 200 MG CPR 90\n",
      "  3400937225731 | HYPERIUM 1MG CPR 90\n",
      "  3400937225960 | ZANIDIP 10MG CPR 30\n",
      "  3400937226042 | ZANIDIP 10MG CPR 90\n",
      "  3400937226851 | ATENOLOL EVO 100MG CPR 30\n",
      "  3400937227162 | ATENOLOL EVO 100MG CPR 90\n",
      "  3400937227223 | ATENOLOL EVO 50MG CPR 30\n",
      "  3400937227452 | ATENOLOL EVO 50MG CPR 90\n",
      "  3400937227681 | METFORMINE ZYD 1000MG CPR 90\n",
      "  3400937228633 | ZANIDIP 20MG CPR 30\n",
      "  3400937228862 | ZANIDIP 20MG CPR 90\n",
      "  3400937229814 | MONO TILDIEM LP 200 MG GELULE 84\n",
      "  3400937229982 | MONO TILDIEM LP 300MG GELULE 84\n",
      "  3400937230414 | VOLTARENE EMULGEL 1% GEL TUBE 50G 1\n",
      "  3400937230933 | PROPRANOLOL TVC 160MG GELULE 30\n",
      "  3400937231183 | PROPRANOLOL TVC 160MG GELULE 90\n",
      "  3400937232425 | MEDROL 100MG CPR 30\n",
      "  3400937232654 | FORTUM 250MG ENF NR PDR INJ 1\n",
      "  3400937232883 | FORTUM 500MG ENF NR PDR INJ 1\n",
      "  3400937233026 | FORTUM 1G PDR INJ 1\n",
      "  3400937233255 | FORTUM 2G PDR INJ 1\n",
      "  3400937233484 | ALDACTAZINE CPR SECABLE 90\n",
      "  3400937233545 | ALDACTONE 50MG CPR 90\n",
      "  3400937234146 | PROPRANOLOL TVC 80MG GELULE 30\n",
      "  3400937234375 | PROPRANOLOL TVC 80MG GELULE 90\n",
      "  3400937235327 | VERAPAMIL SDZ LP 240MG CPR 90\n",
      "  3400937239349 | CELECTOL 200MG CPR 84\n",
      "  3400937241069 | CACIT VIT D3 1000MG/880UI GRANULES 90\n",
      "  3400937242240 | BISOPROLOL MYL 10MG CPR 90\n",
      "  3400937242301 | LISINOPRIL VIATRIS 20MG CPR 84\n",
      "  3400937242530 | ENALAPRIL VIATRIS 20 MG CPR 84\n",
      "  3400937242769 | ENALAPRIL VIATRIS 20 MG CPR 90\n",
      "  3400937242820 | NITRENDIPINE VIATRIS 20MG CPR 30\n",
      "  3400937243070 | NITRENDIPINE VIATRIS 20MG CPR 90\n",
      "  3400937243599 | CAPTOPRIL HCTZ VIATRIS 50/25 MG CPR 84\n",
      "  3400937243711 | AMLOR 5MG GELULE 90\n",
      "  3400937243889 | AMLOR 10MG GELULE 90\n",
      "  3400937243940 | ACUILIX 20MG/12,5MG CPR 90\n",
      "  3400937253765 | RAMIPRIL BGA 5MG CPR 30\n",
      "  3400937254366 | RAMIPRIL BGA 5MG CPR 30\n",
      "  3400937254885 | RAMIPRIL BGA 10MG CPR 30\n",
      "  3400937255318 | RAMIPRIL BGA 10MG CPR 30\n",
      "  3400937264761 | RAMIPRIL ARROW 1,25 MG 1 BOITE DE 30, COMPRIMES\n",
      "  3400937265881 | RAMIPRIL ARROW 2,5 MG 1 BOITE DE 30, COMPRIMES SEC\n",
      "  3400937269155 | RAMIPRIL EG 1,25MG CPR 30\n",
      "  3400937270274 | RAMIPRIL EG 2,5MG CPR 30\n",
      "  3400937271455 | RAMIPRIL EG 5MG CPR 30\n",
      "  3400937272407 | RAMIPRIL EG 10MG CPR 30\n",
      "  3400937278898 | LAMOTRIGINE SDZ 50MG CPR DISP 30\n",
      "  3400937279550 | TRIMEBUTINE BGA 200 MG CPR 30\n",
      "  3400937279789 | TRIMEBUTINE BGA 100MG CPR 30\n",
      "  3400937279840 | ACECLOFENAC VIATRIS 100MG CPR 30\n",
      "  3400937280440 | FENOFIBRATE BGA 160MG CPR 30\n",
      "  3400937280730 | FENOFIBRATE BGA 160MG CPR 90\n",
      "  3400937281270 | FENOFIBRATE SDZ 160MG CPR 30\n",
      "  3400937281621 | FENOFIBRATE SDZ 160MG CPR 90\n",
      "  3400937283571 | FENOFIBRATE ARW 160MG CPR 30\n",
      "  3400937283922 | FENOFIBRATE ARW 160MG CPR 90\n",
      "  3400937285582 | TRIMEBUTINE EG 200MG CPR 30\n",
      "  3400937285933 | TRIMEBUTINE ALM 200MG CPR 30\n",
      "  3400937286534 | AMILORIDE HCTZ TVC 5/50MG CPR 90\n",
      "  3400937286824 | ATENOLOL TVC 50MG CPR 90\n",
      "  3400937286992 | ATENOLOL TVC 50MG CPR 30\n",
      "  3400937287135 | ATENOLOL TVC 100MG CPR 90\n",
      "  3400937287364 | ATENOLOL TVC 100MG CPR 30\n",
      "  3400937287425 | CELIPROLOL TVC 200MG CPR 84\n",
      "  3400937289146 | LISINOPRIL TVC 20MG CPR 84\n",
      "  3400937289436 | METFORMINE TVC 500MG CPR 90\n",
      "  3400937289665 | METFORMINE TVC 850MG CPR 90\n",
      "  3400937290265 | SIMVASTATINE TVC 20MG CPR 90\n",
      "  3400937290494 | SIMVASTATINE TVC 40MG CPR 90\n",
      "  3400937290555 | SPIRONOLACTONE ALTIZIDE TVC CPR 90\n",
      "  3400937290616 | SPIRONOLACTONE TVC 50MG CPR 90\n",
      "  3400937290784 | SPIRONOLACTONE TVC 75MG CPR 90\n",
      "  3400937292047 | SPIRONOLACTONE SDZ 75MG CPR 90\n",
      "  3400937292627 | ACEBUTOLOL SDZ 200MG CPR 90\n",
      "  3400937292856 | ACEBUTOLOL SDZ 400MG CPR 90\n",
      "  3400937294058 | FENOFIBRATE SDZ 200MG GELULE 90\n",
      "  3400937294119 | FENOFIBRATE SDZ 300MG GELULE 90\n",
      "  3400937294287 | LISINOPRIL HCTZ SDZ 20/12,5MG CPR 30\n",
      "  3400937294409 | LISINOPRIL HCTZ SDZ 20/12,5MG CPR 90\n",
      "  3400937295987 | ALDACTONE 25MG CPR 90\n",
      "  3400937296069 | ALDACTONE 75MG CPR 90\n",
      "  3400937296359 | ACUITEL 5MG CPR 90\n",
      "  3400937296410 | ACUITEL 20MG CPR 90\n",
      "  3400937296588 | ALPRESS LP 2,5MG CPR 90\n",
      "  3400937296649 | ALPRESS LP 5MG CPR 90\n",
      "  3400937296700 | SPIRONOLACTONE PFZ 50MG CPR 90\n",
      "  3400937296878 | SPIRONOLACTONE PFZ 75MG CPR 90\n",
      "  3400937296939 | SPIRONOLACTONE ALTIZIDE PFZ CPR 90\n",
      "  3400937299190 | ATENOLOL VTS 50MG CPR 90\n",
      "  3400937299541 | ATENOLOL VTS 100MG CPR 90\n",
      "  3400937300124 | ENALAPRIL HCTZ VTS 20/12,5MG CPR 90\n",
      "  3400937300414 | RILMENIDINE VIATRIS 1MG CPR 90\n",
      "  3400937300582 | RAMIPRIL VIATRIS 1,25MG CPR 90\n",
      "  3400937300643 | RAMIPRIL VIATRIS 10MG CPR 90\n",
      "  3400937300704 | RAMIPRIL VTS 2,5MG CPR 90\n",
      "  3400937300872 | RAMIPRIL VIATRIS 5MG CPR 90\n",
      "  3400937300933 | NITRENDIPINE VIATRIS 10MG CPR 30\n",
      "  3400937301244 | ACEBUTOLOL VTS 200MG CPR 90\n",
      "  3400937302715 | FEGENOR 140MG GELULE 90\n",
      "  3400937302883 | EPTAVIT 1000MG/880UI CPR EFF 90\n",
      "  3400937304375 | BISOPROLOL CRP 10MG CPR 90\n",
      "  3400937307567 | LEVONORGESTREL BGA 1,5MG CPR 1\n",
      "  3400937308458 | METFORMINE SUN 850MG CPR 90\n",
      "  3400937308748 | METFORMINE SUN 500MG CPR 90\n",
      "  3400937310697 | RAMIPRIL SDZ 1,25MG CPR 90\n",
      "  3400937310758 | RAMIPRIL SDZ 2,5MG CPR 90\n",
      "  3400937310819 | RAMIPRIL SDZ 5MG CPR 90\n",
      "  3400937310987 | RAMIPRIL SDZ 10MG CPR 90\n",
      "  3400937311069 | ACEBUTOLOL TVC 200MG CPR 90\n",
      "  3400937312011 | VERAPAMIL TVC LP 240 MG GELULE 90\n",
      "  3400937312479 | CIBACENE 10MG CPR 30\n",
      "  3400937314022 | ENALAPRIL SDZ 5MG CPR 30\n",
      "  3400937314251 | ENALAPRIL SDZ 5MG CPR 90\n",
      "  3400937314480 | ENALAPRIL SDZ 20MG CPR 30\n",
      "  3400937314602 | ENALAPRIL SDZ 20MG CPR 90\n",
      "  3400937315081 | CELIPROLOL SDZ 200MG CPR 84\n",
      "  3400937316781 | ATENOLOL SDZ 50MG CPR 30\n",
      "  3400937316903 | ATENOLOL SDZ 50MG CPR 90\n",
      "  3400937317733 | ATENOLOL SDZ 100MG CPR 30\n",
      "  3400937318044 | ATENOLOL SDZ 100MG CPR 90\n",
      "  3400937319393 | SERTRALINE SUN 25MG GELULE 7\n",
      "  3400937319744 | SERTRALINE EG 25MG GELULE 7\n",
      "  3400937320573 | SERTRALINE SDZ 25MG GELULE 7\n",
      "  3400937321006 | ALFUZOSINE BGA LP 10MG CPR 30\n",
      "  3400937321174 | GLIBENCLAMIDE BGA 2,5MG CPR 60\n",
      "  3400937321464 | GLIBENCLAMIDE BGA 5MG CPR 20\n",
      "  3400937324076 | TRIMEBUTINE ARW 200MG CPR 30\n",
      "  3400937324366 | SERTRALINE TVC 25MG GELULE 7\n",
      "  3400937324656 | SERTRALINE VTS 25MG GELULE 7\n",
      "  3400937325776 | FENOFIBRATE CRT 160MG CPR 90\n",
      "  3400937327848 | M-M-RVAXPRO PDR & SOLV INJ 1\n",
      "  3400937328210 | M-M-RVAXPRO PDR & SOLV INJ SER 2A 1\n",
      "  3400937328500 | NEUPRO 2 MG/24H DISP TRANSDERM 7\n",
      "  3400937328739 | NEUPRO 4 MG/24H DISP TRANSDERM 7\n",
      "  3400937329798 | ABILIFY 150 MG SOL BUV 1\n",
      "  3400937332989 | RAMIPRIL ALM 1,25MG CPR 30\n",
      "  3400937334471 | RAMIPRIL ALM 5 MG CPR 30\n",
      "  3400937335652 | RAMIPRIL ALM 10 MG CPR 30\n",
      "  3400937336604 | RAMIPRIL ALM 2,5MG CPR 30\n",
      "  3400937337205 | RAMIPRIL ARL 1,25MG CPR 30\n",
      "  3400937338493 | RAMIPRIL ARL 2,5MG CPR 30\n",
      "  3400937339445 | RAMIPRIL ARL 5MG CPR 30\n",
      "  3400937340625 | RAMIPRIL ARL 10MG CPR 30\n",
      "  3400937345996 | FENOFIBRATE ZEN 160MG CPR 30\n",
      "  3400937346368 | FENOFIBRATE ZEN 160MG CPR 90\n",
      "  3400937347488 | FENOFIBRATE CRT 160MG CPR 30\n",
      "  3400937348140 | FENOFIBRATE ZYD 160MG CPR 30\n",
      "  3400937348430 | FENOFIBRATE ZYD 160MG CPR 90\n",
      "  3400937348959 | FENOFIBRATE ALM 160MG CPR 30\n",
      "  3400937349550 | AMLODIPINE TVC 5MG GELULE 30\n",
      "  3400937349901 | AMLODIPINE TVC 10MG GELULE 30\n",
      "  3400937350389 | SIMVASTATINE ARW 10MG CPR 30\n",
      "  3400937351621 | LISINOPRIL HCTZ ZEN 20/12,5MG CPR 28\n",
      "  3400937353052 | MOXONIDINE MYLAN 0,2 MG 1 BOITE DE 28, COMPRIMES P\n",
      "  3400937353113 | MOXONIDINE VIATRIS 0,2MG CPR 30\n",
      "  3400937353403 | MOXONIDINE VIATRIS 0,2MG CPR 90\n",
      "  3400937353632 | MOXONIDINE MYLAN 0,4 MG 1 BOITE DE 28, COMPRIMES P\n",
      "  3400937353861 | MOXONIDINE VIATRIS 0,4MG CPR 30\n",
      "  3400937354172 | MOXONIDINE VIATRIS 0,4MG CPR 90\n",
      "  3400937354523 | RAMIPRIL ARROW 2,5 MG 1 BOITE DE 90, COMPRIMES SEC\n",
      "  3400937356534 | FENOFIBRATE VIATRIS 160MG CPR 30\n",
      "  3400937356824 | FENOFIBRATE EG 160MG CPR 30\n",
      "  3400937358026 | RAMIPRIL TVS 1,25MG CPR 30\n",
      "  3400937359207 | PRAVASTATINE BIOGARAN 20 MG 1 BOITE DE 84, COMPRIM\n",
      "  3400937359436 | PRAVASTATINE BGA 40MG CPR 84\n",
      "  3400937360555 | EZETROL 10MG CPR 30\n",
      "  3400937360906 | LISINOPRIL ZEN 20MG CPR 90\n",
      "  3400937362917 | METOPROLOL VTS 100MG CPR 90\n",
      "  3400937364577 | SPIRONOLACTONE ARW 50MG CPR 90\n",
      "  3400937365758 | ACEBUTOLOL ARW 200MG CPR 90\n",
      "  3400937365987 | PRAVASTATINE TVC 20MG CPR 84\n",
      "  3400937366069 | PRAVASTATINE TVC 40MG CPR 84\n",
      "  3400937366410 | CELIPROLOL CRT 200MG CPR 84\n",
      "  3400937366649 | ACEBUTOLOL CRT 200MG CPR 90\n",
      "  3400937366700 | SIMVASTATINE CRT 40MG CPR 84\n",
      "  3400937366939 | SIMVASTATINE CRT 20MG CPR 84\n",
      "  3400937373791 | LACTULOSE VIATRIS 66,5 % SOL BUV 1\n",
      "  3400937374514 | TRAMADOL TVC LP 100MG CPR 30\n",
      "  3400937377355 | METFORMINE ZEN 1000MG CPR 90\n",
      "  3400937377416 | CALCIFORTE VITAMINE D3 CPR 180\n",
      "  3400937377645 | CELIPROLOL SUN 200MG CPR 84\n",
      "  3400937382786 | FENOFIBRATE VIATRIS 300MG GELULE 90\n",
      "  3400937382908 | NIFEDIPINE VTS LP 30MG CPR 90\n",
      "  3400937383158 | SPIRONOLACTONE ALTIZIDE VIATRIS CPR 90\n",
      "  3400937383387 | SPIRONOLACTONE VIATRIS 75MG CPR 90\n",
      "  3400937383967 | FENOFIBRATE VIATRIS 200MG GELULE 90\n",
      "  3400937384339 | ACEBUTOLOL VTS 400MG CPR 90\n",
      "  3400937384568 | LISINOPRIL HCTZ VTS 20/12,5MG CPR 30\n",
      "  3400937384629 | LISINOPRIL HCTZ VTS 20/12,5MG CPR 84\n",
      "  3400937384797 | LISINOPRIL HCTZ VTS 20/12,5MG CPR 90\n",
      "  3400937384919 | CELIPROLOL VIATRIS 200MG CPR 84\n",
      "  3400937387521 | BISOPROLOL TEVA 5 MG 1 BOITE DE 90, COMPRIMES PELL\n",
      "  3400937387811 | BISOPROLOL TVC 10MG CPR 90\n",
      "  3400937388290 | CALTRATE VITAMINE D3 600MG/400UI CPR 180\n",
      "  3400937388412 | OROCAL VIT D3 500MG/200UI CPR 180\n",
      "  3400937389532 | CALCIPRAT VIT D3 1000MG/800UI CPR 90\n",
      "  3400937390712 | FENOFIBRATE EG 200MG GELULE 90\n",
      "  3400937390941 | ATENOLOL EG 50MG CPR 90\n",
      "  3400937391191 | ATENOLOL EG 100MG CPR 90\n",
      "  3400937391252 | SPIRONOLACTONE EG 50MG CPR 90\n",
      "  3400937391313 | SPIRONOLACTONE EG 75MG CPR 90\n",
      "  3400937391542 | SIMVASTATINE EG 20MG CPR 90\n",
      "  3400937391832 | METFORMINE EG 1 000 MG 1 BOITE DE 90, COMPRIMES PE\n",
      "  3400937392082 | LISINOPRIL EG 5MG CPR 84\n",
      "  3400937392204 | LISINOPRIL EG 20MG CPR 84\n",
      "  3400937392891 | VERAPAMIL EG LP 240MG CPR 90\n",
      "  3400937393324 | ENALAPRIL EG 5MG CPR 90\n",
      "  3400937393492 | ENALAPRIL EG 20MG CPR 90\n",
      "  3400937393553 | LOPRESSOR 100MG CPR 90\n",
      "  3400937393614 | LOPRESSOR LP 200MG CPR 90\n",
      "  3400937393782 | ICAZ LP 2,5MG GELULE 90\n",
      "  3400937393904 | ICAZ LP 5MG GELULE 90\n",
      "  3400937394444 | METFORMINE ARW 1000MG CPR 90\n",
      "  3400937394734 | ENALAPRIL HCTZ ARW 20/12,5MG CP 84\n",
      "  3400937395793 | ATENOLOL ARW 50MG CPR 90\n",
      "  3400937395915 | ATENOLOL ARW 100MG CPR 90\n",
      "  3400937396394 | LISINOPRIL ARW 20MG CPR 84\n",
      "  3400937397056 | SPIRONOLACTONE ARW 75MG CPR 90\n",
      "  3400937397117 | CELIPROLOL ARW 200MG CPR 84\n",
      "  3400937397407 | FENOFIBRATE ARW 200MG GELULE 90\n",
      "  3400937398008 | BISOPROLOL ARW 10MG CPR 90\n",
      "  3400937399586 | RAMIPRIL BGA 2,5MG CPR 90\n",
      "  3400937399647 | RAMIPRIL BGA 1,25 MG CPR 90\n",
      "  3400937399708 | RAMIPRIL BGA 5MG CPR 90\n",
      "  3400937402989 | RAMIPRIL TVS 2,5MG CPR 30\n",
      "  3400937403702 | RAMIPRIL TVS 5MG CPR 30\n",
      "  3400937404532 | RAMIPRIL TVS 10MG CPR 30\n",
      "  3400937405362 | CARVEDILOL MYL 12,5MG CPR 28\n",
      "  3400937405942 | CARVEDILOL VTS 25MG CPR 28\n",
      "  3400937406772 | PARACETAMOL ZYD 1G CPR 8\n",
      "  3400937407083 | GLIBENCLAMIDE BGA 5MG CPR 90\n",
      "  3400937407144 | SIMVASTATINE EVO 40MG CPR 28\n",
      "  3400937411394 | GABAPENTINE SDZ 300MG GELULE 90\n",
      "  3400937411455 | GABAPENTINE SDZ 100MG GELULE 90\n",
      "  3400937412865 | FLIXONASE 50 MICROG SUSP FP 120 1\n",
      "  3400937414876 | ESTIMA 200MG CAPSULE 45\n",
      "  3400937415019 | ESTIMA 100MG CAPSULE 90\n",
      "  3400937415477 | ADOPORT 0,5MG GELULE 50\n",
      "  3400937417310 | PAROXETINE VIATRIS 20MG CPR 14\n",
      "  3400937419789 | ZOFENIL 15MG CPR 30\n",
      "  3400937419840 | ZOFENIL 15MG CPR 90\n",
      "  3400937419901 | ZOFENIL 30MG CPR 30\n",
      "  3400937420099 | ZOFENIL 30MG CPR 90\n",
      "  3400937420389 | TEMERIT 5MG CPR 30\n",
      "  3400937420440 | TEMERIT 5MG CPR 90\n",
      "  3400937420730 | NEBILOX 5MG CPR 30\n",
      "  3400937420969 | NEBILOX 5MG CPR 90\n",
      "  3400937421560 | ENALAPRIL HCTZ ZEN 20/12,5MG CPR 84\n",
      "  3400937422970 | STERIDOSE SOL LAVAGE OPHT UNIDOSE 20\n",
      "  3400937426473 | PAROXETINE ACT 20MG CPR 14\n",
      "  3400937426992 | PAROXETINE EVO 20MG CPR 14\n",
      "  3400937427425 | PAROXETINE ALT 20MG CPR 14\n",
      "  3400937428606 | AMOX/AC CLAV ZEN 500/62,5 CPR 16\n",
      "  3400937436069 | ALENDRONIQUE ACIDE VIATRIS 70MG CPR 4\n",
      "  3400937436298 | ALENDRONIQUE ACIDE VIATRIS 70MG CPR 12\n",
      "  3400937439602 | AMLODIPINE VTS 5MG GELULE 30\n",
      "  3400937439831 | AMLODIPINE VTS 5MG GELULE 90\n",
      "  3400937440141 | AMLODIPINE VTS 5MG GELULE 30\n",
      "  3400937440660 | AMLODIPINE VTS 10MG GELULE 30\n",
      "  3400937440721 | AMLODIPINE VTS 10MG GELULE 90\n",
      "  3400937440950 | AMLODIPINE VTS 10MG GELULE 30\n",
      "  3400937441902 | GABAPENTINE EVO 300MG GELULE 90\n",
      "  3400937442442 | GABAPENTINE BGA 300MG GELULE 90\n",
      "  3400937443043 | GABAPENTINE BGA 100MG GELULE 90\n",
      "  3400937443791 | GABAPENTINE ZEN 100MG GELULE 90\n",
      "  3400937444453 | GABAPENTINE ZEN 300MG GELULE 90\n",
      "  3400937444972 | GABAPENTINE CRT 400MG GELULE 90\n",
      "  3400937445405 | LISINOPRIL VIATRIS 5MG CPR 28\n",
      "  3400937445863 | LISINOPRIL VIATRIS 5MG CPR 84\n",
      "  3400937446693 | GABAPENTINE EVO 100MG GELULE 90\n",
      "  3400937450607 | MOXONIDINE TVS 0,2MG CPR 30\n",
      "  3400937450836 | MOXONIDINE TVS 0,2MG CPR 90\n",
      "  3400937451147 | MOXONIDINE TVS 0,4MG CPR 30\n",
      "  3400937451376 | MOXONIDINE TVS 0,4MG CPR 90\n",
      "  3400937452328 | LISINOPRIL HCTZ ARL 20/12,5MG CPR 28\n",
      "  3400937452557 | PINAVERIUM EG 100MG CPR 30\n",
      "  3400937455220 | PRAVASTATINE ZEN 10MG CPR 28\n",
      "  3400937455459 | PRAVASTATINE ZYD 40MG CPR 28\n",
      "  3400937455510 | PRAVASTATINE ZYD 40MG CPR 84\n",
      "  3400937455688 | PRAVASTATINE ZYD 20MG CPR 28\n",
      "  3400937455749 | PRAVASTATINE ZYD 20MG CPR 84\n",
      "  3400937456111 | ALGINATE BICAR SODIUM SDZ SUSP BUV 1\n",
      "  3400937456289 | ALGINATE DE SODIUM/BICARBONATE DE SODIUM EG 250 MG\n",
      "  3400937456340 | SERTRALINE BGA 25MG GELULE 7\n",
      "  3400937458580 | REVOLADE 25 MG CPR 14\n",
      "  3400937458641 | REVOLADE 25 MG CPR 28\n",
      "  3400937458870 | REVOLADE 50 MG CPR 14\n",
      "  3400937458931 | REVOLADE 50 MG CPR 28\n",
      "  3400937459013 | ELONVA 100 MCG SOL INJ 1\n",
      "  3400937459181 | ELONVA 150 MCG SOL INJ 1\n",
      "  3400937459990 | AZITHROMYCINE EVO 250MG CPR 6\n",
      "  3400937460590 | SPIRAMYCINE CRT 3MUI CPR 10\n",
      "  3400937460880 | SPIRAMYCINE CRT 3MUI CPR 16\n",
      "  3400937461191 | SPIRAMYCINE VIATRIS 3MUI CPR 10\n",
      "  3400937461481 | SPIRAMYCINE VIATRIS 3MUI CPR 16\n",
      "  3400937463843 | AMLODIPINE BCR 5MG GELULE 30\n",
      "  3400937464215 | BUPRENORPHINE VTS 2MG CPR 7\n",
      "  3400937466516 | CYPROTERONE ZEN 50MG CPR 20\n",
      "  3400937466745 | KETOPROFENE PMY 100 MG SOL INJ IM 6\n",
      "  3400937471657 | GLIMEPIRIDE EG 1MG CPR 30\n",
      "  3400937471947 | GLIMEPIRIDE EG 1MG CPR 90\n",
      "  3400937472258 | GLIMEPIRIDE EG 2MG CPR 30\n",
      "  3400937472548 | GLIMEPIRIDE EG 2MG CPR 90\n",
      "  3400937472838 | GLIMEPIRIDE EG 3MG CPR 30\n",
      "  3400937477680 | DEXAFREE 0,1% COLLYRE 30\n",
      "  3400937479462 | TRAMADOL TVC LP 150MG CPR 30\n",
      "  3400937479981 | GLIMEPIRIDE EG 3MG CPR 90\n",
      "  3400937480291 | GLIMEPIRIDE EG 4MG CPR 30\n",
      "  3400937480581 | GLIMEPIRIDE EG 4MG CPR 90\n",
      "  3400937480642 | GLIMEPIRIDE SDZ 1MG CPR 30\n",
      "  3400937480871 | GLIMEPIRIDE SDZ 2MG CPR 30\n",
      "  3400937481014 | GLIMEPIRIDE SDZ 3MG CPR 30\n",
      "  3400937481243 | GLIMEPIRIDE SDZ 4MG CPR 30\n",
      "  3400937482363 | TRANDATE 200 MG CPR 180\n",
      "  3400937482424 | IPERTEN 10MG CPR 30\n",
      "  3400937482653 | IPERTEN 10MG CPR 90\n",
      "  3400937482714 | IPERTEN 20MG CPR 30\n",
      "  3400937482943 | IPERTEN 20MG CPR 90\n",
      "  3400937483315 | EUPHON SIROP FL 300ML 1\n",
      "  3400937483773 | EUTHYRAL CPR 50\n",
      "  3400937484145 | TRAMADOL TVC LP 200MG CPR 30\n",
      "  3400937484893 | STELARA 45 MG SOL INJ SER 1\n",
      "  3400937484954 | STELARA 90 MG SOL INJ SER 1\n",
      "  3400937485326 | ADOPORT 1MG GELULE 50\n",
      "  3400937485616 | ADOPORT 5MG GELULE 50\n",
      "  3400937489928 | TRAMADOL ZYD LP 100MG CPR 30\n",
      "  3400937490757 | SILODYX 4MG GELULE 30\n",
      "  3400937492539 | GLIMEPIRIDE SDZ 4MG CPR 90\n",
      "  3400937492768 | GLIMEPIRIDE SDZ 3MG CPR 90\n",
      "  3400937492829 | GLIMEPIRIDE SDZ 2MG CPR 90\n",
      "  3400937492997 | GLIMEPIRIDE SDZ 1MG CPR 90\n",
      "  3400937493420 | SILODYX 8MG GELULE 30\n",
      "  3400937493888 | UROREC 4 MG GELULE 30\n",
      "  3400937494250 | UROREC 8 MG GELULE 30\n",
      "  3400937498913 | TERBINAFINE BGA 250MG CPR 28\n",
      "  3400937499163 | IBUPROFENE VIATRIS 400MG CPR PELL 20\n",
      "  3400937499224 | IBUPROFENE VIATRIS 400MG CPR PELL 30\n",
      "  3400937499453 | RILMENIDINE ZEN 1MG CPR 30\n",
      "  3400937499682 | RILMENIDINE ZEN 1MG CPR 90\n",
      "  3400937499804 | RILMENIDINE SUN 1MG CPR 30\n",
      "  3400937500036 | RILMENIDINE SUN 1MG CPR 90\n",
      "  3400937500326 | RILMENIDINE EG 1MG CPR 30\n",
      "  3400937500555 | RILMENIDINE EG 1MG CPR 90\n",
      "  3400937500784 | RILMENIDINE ARW 1MG CPR 30\n",
      "  3400937500906 | RILMENIDINE ARW 1MG CPR 90\n",
      "  3400937501095 | AMLODIPINE EVO 10MG GELULE 30\n",
      "  3400937501217 | AMLODIPINE EVO 5MG GELULE 30\n",
      "  3400937501385 | AMLODIPINE EVO 5MG GELULE 90\n",
      "  3400937501446 | AMOX/AC CLAV CRT 500MG/62,5MG AD CPR 16\n",
      "  3400937501507 | AMOX/AC CLAV CRT 500MG/62,5MG AD CPR 24\n",
      "  3400937514514 | NEBIVOLOL ARW 5MG CPR 30\n",
      "  3400937514972 | NEBIVOLOL ARW 5MG CPR 90\n",
      "  3400937515115 | CAYSTON 75MG PDR SOL INHAL 84\n",
      "  3400937515573 | LOSARTAN ACC 100MG CPR 30\n",
      "  3400937515924 | LOSARTAN ACC 100MG CPR 90\n",
      "  3400937516693 | LOSARTAN ITA 50MG CPR 30\n",
      "  3400937516983 | LOSARTAN ITA 50MG CPR 90\n",
      "  3400937517065 | AOTAL 333MG CPR 180\n",
      "  3400937521666 | GABAPENTINE ARW 100MG GELULE 90\n",
      "  3400937522496 | PROFEMIGR 150 MG CPR 10\n",
      "  3400937523158 | GABAPENTINE ARW 300 MG GELULE 90\n",
      "  3400937524568 | FINASTERIDE SDZ 5MG CPR 28\n",
      "  3400937527460 | LEVOFLOXACINE ZYD 500MG CPR 5\n",
      "  3400937530941 | PANTOPRAZOLE CRP 40MG CPR 14\n",
      "  3400937531191 | PANTOPRAZOLE CRP 40MG CPR 28\n",
      "  3400937531542 | PRODINAN 160MG GELULE 60\n",
      "  3400937531832 | PRODINAN 160MG GELULE 180\n",
      "  3400937533324 | ZOLMITRIPTAN EVO 2,5MG CPR 12\n",
      "  3400937539876 | ZOLMITRIPTAN ZYF 2,5MG CPR 6\n",
      "  3400937539937 | ZOLMITRIPTAN ZYF 2,5MG CPR 12\n",
      "  3400937540827 | AMOX/AC CLAV TVS 500/62,5MG CPR AD 16\n",
      "  3400937540995 | AMOX/AC CLAV TVS 500/62,5MG CPR AD 24\n",
      "  3400937541138 | AMOX/AC CLAV TVS 1G/125MG AD SACH 2 8\n",
      "  3400937541367 | AMOX/AC CLAV TVS 1G/125MG AD SACH 2 12\n",
      "  3400937541596 | AMOX/AC CLAV GXK 100MG/12,5MG ENF 1\n",
      "  3400937541657 | AMOX/AC CLAV GLAXO 100MG/12,5MG/ML 1\n",
      "  3400937545730 | OLANZAPINE ZYD 7,5MG CPR 28\n",
      "  3400937558518 | RILMENIDINE ZYD 1MG CPR 30\n",
      "  3400937558747 | RILMENIDINE ZYD 1MG CPR 90\n",
      "  3400937559409 | AMLODIPINE ARG 10MG GELULE 30\n",
      "  3400937559638 | AMLODIPINE ARG 10MG GELULE 30\n",
      "  3400937559867 | AMLODIPINE ARG 5MG GELULE 30\n",
      "  3400937559928 | AMLODIPINE ARG 5MG GELULE 30\n",
      "  3400937561419 | FINASTERIDE BGA 5MG CPR 28\n",
      "  3400937561877 | FINASTERIDE BGA 5MG CPR 28\n",
      "  3400937562768 | FINASTERIDE ZEN 5MG CPR 28\n",
      "  3400937573474 | CELIPROLOL EVO 200MG CPR 28\n",
      "  3400937574136 | GANFORT 0,3MG/ML + 5MG/ML COLLYRE 1\n",
      "  3400937574945 | DUOTRAV 0,04MG/5MG/ML COLLYRE 1\n",
      "  3400937575256 | ENANTONE LP 3,75 MG PDR INJ + NEC 1\n",
      "  3400937575317 | ENANTONE LP 11,25 MG PDR INJ + NEC 1\n",
      "  3400937575485 | CADUET 5 MG/10 MG CPR 90\n",
      "  3400937575546 | CADUET 10 MG/10 MG CPR 90\n",
      "  3400937576666 | CELIPROLOL ALM 200MG CPR 28\n",
      "  3400937576956 | NICORETTE 2MG GOMME FRUI SS SUCRE 210\n",
      "  3400937582520 | GLIMEPIRIDE ARW 2MG CPR 30\n",
      "  3400937582810 | GLIMEPIRIDE ARW 2MG CPR 90\n",
      "  3400937583060 | GLIMEPIRIDE ARW 4MG CPR 30\n",
      "  3400937583350 | GLIMEPIRIDE ARW 4MG CPR 90\n",
      "  3400937584012 | GLIMEPIRIDE ARW 3MG CPR 30\n",
      "  3400937584302 | GLIMEPIRIDE ARW 3MG CPR 90\n",
      "  3400937584531 | GLIMEPIRIDE ARW 1MG CPR 30\n",
      "  3400937584999 | GLIMEPIRIDE ARW 1MG CPR 90\n",
      "  3400937593007 | ZOSTAVAX PDR INJ SRG 1\n",
      "  3400937595247 | AMOX/AC CLAV CRT 100MG/12,5MG/ML NR 1\n",
      "  3400937595308 | AMOX/AC CLAV CRT 100MG/12,5MG/ML ENF 1\n",
      "  3400937603782 | ULTRAVIST 300 SOL INJ FL 150ML 1\n",
      "  3400937603843 | ULTRAVIST 55.5 G SOL INJ 1\n",
      "  3400937604215 | PINAVERIUM BGA 100MG CPR 30\n",
      "  3400937609418 | FOSTIMONKIT 75 UI/ML PDR ET SOL INJ 5\n",
      "  3400937609708 | FOSTIMONKIT 150 UI/ML PDR ET SOL INJ 5\n",
      "  3400937609937 | KALETRA 200MG/50MG CPR 120\n",
      "  3400937611657 | BICALUTAMIDE EG 50MG CPR 30\n",
      "  3400937613729 | NEXAVAR 200MG CPR 112\n",
      "  3400937614610 | AMOXICILLINE ALM 1G CPR DISP S 6\n",
      "  3400937614788 | AMOXICILLINE ALM 1G CPR DISP S 14\n",
      "  3400937620932 | LEVODOPA CARBID TVC LP 100/25 MG CPR 30\n",
      "  3400937621304 | LEVODOPA CARBID TVC LP 200/50MG CPR 30\n",
      "  3400937622363 | ROTATEQ SOL BUV 1\n",
      "  3400937622653 | IBUPROFENE ARW 5% GEL 1\n",
      "  3400937622714 | CIFLOX 200 MG SOL INJ FL 1\n",
      "  3400937625494 | CELIPROLOL EG 200MG CPR 84\n",
      "  3400937625616 | DOXAZOSINE VIATRIS LP 4MG CPR 28\n",
      "  3400937625784 | DOXAZOSINE VIATRIS LP 8MG CPR LP 28\n",
      "  3400937626217 | LAMOTRIGINE BGA 25MG CPR DISP 30\n",
      "  3400937627276 | LAMOTRIGINE BGA 50MG CPR DISP 30\n",
      "  3400937627795 | LAMOTRIGINE BGA 100MG CPR DISP 30\n",
      "  3400937628228 | LAMOTRIGINE BGA 200MG CPR DISP 30\n",
      "  3400937628747 | FIXICAL VITAMINE D3 1000MG/800UI CPR 90\n",
      "  3400937628976 | BARACLUDE 0,5 MG CPR 30\n",
      "  3400937629119 | BARACLUDE 1 MG CPR 30\n",
      "  3400937629287 | BARACLUDE 0,05 MG/ML SOL BUV 1\n",
      "  3400937629867 | PRAVASTATINE ALT 20MG CPR 28\n",
      "  3400937630009 | PRAVASTATINE ALT 40MG CPR 28\n",
      "  3400937630757 | NICORETTE 4MG GOMME SS SUCRE 105\n",
      "  3400937631129 | NICORETTE 2MG GOMME SS SUCRE 105\n",
      "  3400937631297 | NICORETTE 2MG GOMME SS SUCRE 210\n",
      "  3400937631358 | NICORETTE 2MG GOMME MENT F SS SUCRE 105\n",
      "  3400937631419 | NICORETTE 2MG GOMME MENT F SS SUCRE 210\n",
      "  3400937631587 | NICORETTE 4MG GOMME MENT F SS SUCRE 105\n",
      "  3400937632249 | TRIMEBUTINE ALS 100MG CPR 30\n",
      "  3400937634199 | SPIRAMYCINE TVC 3MUI CPR 10\n",
      "  3400937634250 | SPIRAMYCINE TVC 3MUI CPR 16\n",
      "  3400937634311 | SPIRAMYCINE EG 3MUI CPR 10\n",
      "  3400937634489 | SPIRAMYCINE EG 3MUI CPR 16\n",
      "  3400937634540 | SPIRAMYCINE BGA 3MUI CPR 10\n",
      "  3400937634601 | SPIRAMYCINE BGA 3MUI CPR 16\n",
      "  3400937634779 | SPIRAMYCINE SDZ 3MUI CPR 10\n",
      "  3400937634830 | SPIRAMYCINE SDZ 3MUI CPR 16\n",
      "  3400937635141 | ONDANSETRON BGA 8 MG CPR 2\n",
      "  3400937635202 | ONDANSETRON BGA 8 MG CPR 4\n",
      "  3400937635431 | ONDANSETRON BGA 8 MG CPR 2\n",
      "  3400937635660 | ONDANSETRON BGA 8 MG CPR 4\n",
      "  3400937635899 | ONDANSETRON ZEN 8MG CPR 2\n",
      "  3400937635950 | ONDANSETRON ZEN 8MG CPR 4\n",
      "  3400937636322 | ONDANSETRON ZEN 8MG CPR 4\n",
      "  3400937643825 | FERTIFOL 0,4 MG CPR 28\n",
      "  3400937645195 | PERINDOPRIL TVS 2MG CPR 30\n",
      "  3400937645485 | PERINDOPRIL TVS 2MG CPR 90\n",
      "  3400937646086 | PERINDOPRIL TVS 4MG CPR 30\n",
      "  3400937646376 | PERINDOPRIL TVS 4MG CPR 90\n",
      "  3400937654821 | FIXICAL VITAMINE D3 500 MG/400UI CPR 180\n",
      "  3400937655071 | MELOXICAM SDZ 15MG CPR 14\n",
      "  3400937655361 | ENALAPRIL HCTZ BGA 20/12,5MG CPR 84\n",
      "  3400937656313 | IBUPROFENE BGA 400MG CPR PELL 20\n",
      "  3400937656603 | FLUOXETINE CRST 20MG GELULE 14\n",
      "  3400937657433 | GLIMEPIRIDE VIATRIS 4MG CPR 30\n",
      "  3400937657891 | GLIMEPIRIDE VIATRIS 4MG CPR 90\n",
      "  3400937658553 | GLIMEPIRIDE VIATRIS 3MG CPR 30\n",
      "  3400937658843 | GLIMEPIRIDE VIATRIS 3MG CPR 90\n",
      "  3400937658904 | GLIMEPIRIDE VIATRIS 2MG CPR 30\n",
      "  3400937659215 | GLIMEPIRIDE VIATRIS 2MG CPR 90\n",
      "  3400937659383 | GLIMEPIRIDE VIATRIS 1MG CPR 30\n",
      "  3400937659673 | GLIMEPIRIDE VIATRIS 1MG CPR 90\n",
      "  3400937663984 | IBUPROFENE ALM 400MG CPR PELL 20\n",
      "  3400937665537 | BUSPIRONE SDZ 10MG CPR 20\n",
      "  3400937665995 | CYPROTERONE SDZ 50MG CPR 20\n",
      "  3400937666138 | DOXYCYCLINE SDZ 100MG CPR 5\n",
      "  3400937666367 | DOXYCYCLINE SDZ 100MG CPR 15\n",
      "  3400937666428 | GABAPENTINE SDZ 400MG GELULE 90\n",
      "  3400937666886 | METOPROLOL SDZ 50MG CPR 30\n",
      "  3400937666947 | METOPROLOL SDZ 100MG CPR 30\n",
      "  3400937667029 | OXYBUTYNINE SDZ 5MG CPR 60\n",
      "  3400937667487 | SERTRALINE SDZ 50MG GELULE 28\n",
      "  3400937667777 | TIMOLOL SANDOZ 0,25 P. 100 1 FLACON DE 3 ML, COLLY\n",
      "  3400937667838 | TIMOLOL SANDOZ 0,50 P. 100 1 FLACON DE 3 ML, COLLY\n",
      "  3400937668088 | VERAPAMIL SDZ 120MG CPR 28\n",
      "  3400937668729 | SIMVASTATINE EG 10 MG 1 BOITE DE 28, COMPRIMES PEL\n",
      "  3400937669269 | ONDANSETRON VTS 4 MG SOL INJ AMP 1\n",
      "  3400937669320 | ONDANSETRON VTS 8 MG SOL INJ AMP 1\n",
      "  3400937672689 | ASMELOR NOVOLIZ 12 MICROG/DOSE INH 1\n",
      "  3400937672740 | ASMELOR NOVOLIZ 12 MICROG/DOSE CART 1\n",
      "  3400937673402 | OFLOXACINE CRT 200MG CPR 10\n",
      "  3400937673860 | MIRTAZAPINE BGA 15 MG CPR ORODISP 30\n",
      "  3400937674690 | OFLOXACINE SUN 200 MG CPR 10\n",
      "  3400937674751 | GABAPENTINE TVC 800MG CPR 90\n",
      "  3400937675871 | CARVEDILOL ZEN 6,25MG CPR 28\n",
      "  3400937676304 | CARVEDILOL ZEN 12,5MG CPR 28\n",
      "  3400937677073 | CARVEDILOL ZEN 25MG CPR 28\n",
      "  3400937680554 | NICOPASS 1,5MG PAST EUCALY SS SUCRE 96\n",
      "  3400937680844 | ACEBUTOLOL EG 200MG CPR 90\n",
      "  3400937680905 | ACEBUTOLOL EG 400MG CPR 90\n",
      "  3400937682626 | ENALAPRIL HCTZ EG 20/12,5MG CPR 90\n",
      "  3400937682794 | LISINOPRIL HCTZ EG 20/12,5MG CPR 84\n",
      "  3400937683227 | RAMIPRIL EG 1,25MG CPR 90\n",
      "  3400937683395 | RAMIPRIL EG 2,5MG CPR 90\n",
      "  3400937683456 | RAMIPRIL EG 5MG CPR 90\n",
      "  3400937683746 | MOXONIDINE EG 0,2MG CPR 90\n",
      "  3400937683975 | MOXONIDINE EG 0,4MG CPR 90\n",
      "  3400937684057 | RAMIPRIL EG 10MG CPR 90\n",
      "  3400937685467 | BISOPROLOL EG 10MG CPR 90\n",
      "  3400937686877 | ONDANSETRON EG 8MG CPR 2\n",
      "  3400937686938 | ONDANSETRON EG 8MG CPR 4\n",
      "  3400937687249 | EFUDIX 5% CREME TUBE 40G 1\n",
      "  3400937689021 | LACRIFLUID 0,13% COLLYRE UNIDOSE 60\n",
      "  3400937692212 | ECONAZOLE CRISTERS LP 150MG OVULE 1\n",
      "  3400937693332 | IBUPROFENE ALM 200MG CPR PELL 30\n",
      "  3400937693561 | OFLOXACINE EVO 200MG CPR 10\n",
      "  3400937693622 | OFLOXACINE ALM 200 MG CPR 10\n",
      "  3400937694513 | AMLODIPINE ZEN 10MG GELULE 30\n",
      "  3400937694681 | AMLODIPINE ZEN 5MG GELULE 30\n",
      "  3400937701297 | TRANXENE 5 MG GELULE 30\n",
      "  3400937701358 | TRANXENE 10MG GELULE 30\n",
      "  3400937712354 | AMLODIPINE ZEN 10MG GELULE 90\n",
      "  3400937712644 | AMLODIPINE ZEN 5MG GELULE 90\n",
      "  3400937713016 | GARDASIL SUSP INJ SER + AIG 1\n",
      "  3400937713306 | GARDASIL 1 BOITE DE 1, VACCIN PAPILLOMAVIRUS HUMAI\n",
      "  3400937713474 | LIDOCAINE/PRILOCAINE BGA 5% CREME 5G 1\n",
      "  3400937714136 | FINASTERIDE VTS 5MG CPR 28\n",
      "  3400937715317 | FLUOXETINE SDZ 20MG CPR 28\n",
      "  3400937716208 | BECLOMETASONE TVC 50MICROG SOL INH 1\n",
      "  3400937716376 | BECLOMETASONE TVC 250MICROG SOL INH 1\n",
      "  3400937718097 | CHAMPIX 0,5 MG ET 1 MG CPR 0\n",
      "  3400937718448 | CHAMPIX 0,5 MG CPR 56\n",
      "  3400937718677 | CHAMPIX 1 MG CPR 56\n",
      "  3400937719100 | ENBREL 25 MG SOL INJ SER 4\n",
      "  3400937719568 | ENBREL 50 MG SOL INJ SER 4\n",
      "  3400937719629 | TAMSULOSINE ARW LP 0,4MG GELULE 30\n",
      "  3400937719858 | METVIXIA 168MG/G CREME 1\n",
      "  3400937720229 | BETAFERON 0,25MG/ML PDR ET SOL INJ 15\n",
      "  3400937720977 | NEUPRO 2 MG/24H DISP TRANSDERM 30\n",
      "  3400937721110 | NEUPRO 4 MG/24H DISP TRANSDERM 30\n",
      "  3400937721349 | NEUPRO 6 MG/24H DISP TRANSDERM 30\n",
      "  3400937721578 | NEUPRO 8 MG/24H DISP TRANSDERM 30\n",
      "  3400937722001 | APIDRA SOLOSTAR 300 U/3 ML SOL INJ 5\n",
      "  3400937722988 | LANTUS SOLOSTAR 300U SOL INJ STY 5\n",
      "  3400937723411 | CARVEDILOL TVC 25MG CPR 28\n",
      "  3400937723640 | LORAMYC 50MG CPR GINGIVAL 14\n",
      "  3400937726313 | MIRTAZAPINE VIATRIS 15MG CPR 30\n",
      "  3400937726481 | MIRTAZAPINE ZEN 15MG CPR 30\n",
      "  3400937726771 | AZITHROMYCINE TVC 250MG CPR 6\n",
      "  3400937728263 | BICALUTAMIDE ARW LAB 50MG CPR 30\n",
      "  3400937729505 | GABAPENTINE MYL 800MG CPR 90\n",
      "  3400937731454 | ITRACONAZOLE VIATRIS 100MG GELULE 30\n",
      "  3400937732284 | ECONAZOLE VIATRIS 1% CREME 1\n",
      "  3400937732345 | ECONAZOLE VIATRIS 1% EMULSION 1\n",
      "  3400937732406 | ECONAZOLE VIATRIS 1% SOL FL 1\n",
      "  3400937732635 | FINASTERIDE TEVA 5MG CPR 28\n",
      "  3400937733175 | VERAPAMIL MYL LP 240MG CPR 90\n",
      "  3400937733236 | FENOFIBRATE VIATRIS 160MG CPR 90\n",
      "  3400937733755 | GLICLAZIDE VIATRIS 80MG CPR 180\n",
      "  3400937734066 | GABAPENTINE MYL 600MG CPR 90\n",
      "  3400937734127 | AMOX/AC CLAV ALT 500MG/62,5MG AD CPR 16\n",
      "  3400937734295 | AMOX/AC CLAV ALT 500MG/62,5MG AD CPR 24\n",
      "  3400937736428 | AMOX/AC CLAV BGR 1G/125MG AD SACH 8\n",
      "  3400937736596 | AMOX/AC CLAV BGR 1G/125MG AD SACH 12\n",
      "  3400937737487 | AMOX/AC CLAV BGR 100MG/12,5MG/ML ENF 1\n",
      "  3400937737548 | AMOX/AC CLAV BGR 100MG/12,5MG/ML 1\n",
      "  3400937742160 | SIMVASTATINE EG 40MG CPR 90\n",
      "  3400937743570 | AMLODIPINE TVC 5MG GELULE 90\n",
      "  3400937743631 | AMLODIPINE TVC 10MG GELULE 90\n",
      "  3400937745871 | INDAPAMIDE TVS LP 1,5MG CPR 30\n",
      "  3400937746243 | INDAPAMIDE TVS LP 1,5MG CPR 90\n",
      "  3400937747653 | RISPERIDONE EG 1MG CPR 60\n",
      "  3400937748315 | CEFTRIAXONE ZYD 1G/3,5ML PDR INJ IM 1\n",
      "  3400937748483 | FORTZAAR 100MG/12,5MG CPR 28\n",
      "  3400937748834 | FORTZAAR 100MG/12,5MG CPR 90\n",
      "  3400937750783 | RISPERIDONE EG 2MG CPR 60\n",
      "  3400937751506 | RISPERIDONE EG 4MG CPR 30\n",
      "  3400937752107 | ECONAZOLE ZEN LP 150MG OVULE 1\n",
      "  3400937752336 | FENOFIBRATE CRSTP 160MG CPR 30\n",
      "  3400937752565 | FENOFIBRATE CRSTP 160MG CPR 90\n",
      "  3400937758420 | RISPERIDONE ZEN 1MG CPR 60\n",
      "  3400937759540 | RISPERIDONE ZEN 2MG CPR 60\n",
      "  3400937760430 | RISPERIDONE ZEN 4MG CPR 30\n",
      "  3400937761321 | SUBOXONE 2MG/0,5MG CPR SUBLING 7\n",
      "  3400937761499 | SUBOXONE 2MG/0,5MG CPR SUBLING 28\n",
      "  3400937761550 | SUBOXONE 8MG/2MG CPR SUBLING 7\n",
      "  3400937761611 | SUBOXONE 8MG/2MG CPR SUBLING 28\n",
      "  3400937762380 | ZOCOR 20MG CPR 84\n",
      "  3400937762502 | ZOCOR 40MG CPR 84\n",
      "  3400937763103 | ONDANSETRON VIATRIS 8MG CPR 2\n",
      "  3400937763271 | ONDANSETRON VIATRIS 8MG CPR 4\n",
      "  3400937763790 | SPRYCEL 20 MG CPR 60\n",
      "  3400937764162 | SPRYCEL 50 MG CPR 60\n",
      "  3400937764452 | SPRYCEL 70 MG CPR 60\n",
      "  3400937764803 | PANTESTONE 40MG CAPSULE MOLLE 60\n",
      "  3400937765343 | GLIBENCLAMIDE VIATRIS 2,5MG CPR 60\n",
      "  3400937765572 | GLIBENCLAMIDE VIATRIS 5MG CPR 20\n",
      "  3400937765633 | GLIBENCLAMIDE VIATRIS 5MG CPR 90\n",
      "  3400937770026 | SIMVASTATINE BGA 10MG CPR 28\n",
      "  3400937774567 | PERIKABIVEN EMULSION INJ PCE 1440ML 4\n",
      "  3400937774796 | PERIKABIVEN EMULSION INJ PCE 1920ML 4\n",
      "  3400937774918 | PERIKABIVEN EMULSION INJ PCE 2400ML 3\n",
      "  3400937775229 | KABIVEN EMULSION INJ POC PCE 1026ML 4\n",
      "  3400937775519 | KABIVEN EMULSION INJ POC PCE 1540ML 4\n",
      "  3400937775748 | KABIVEN EMULSION INJ POC PCE 2053ML 4\n",
      "  3400937776110 | MICARDIS 40MG CPR 30\n",
      "  3400937776288 | MICARDIS 40MG CPR 90\n",
      "  3400937776349 | MICARDIS 80MG CPR 30\n",
      "  3400937776400 | MICARDIS 80MG CPR 90\n",
      "  3400937776578 | MICARDISPLUS 40MG/12,5MG CPR 30\n",
      "  3400937776639 | MICARDISPLUS 40MG/12,5MG CPR 90\n",
      "  3400937776868 | MICARDISPLUS 80MG/12,5MG CPR 30\n",
      "  3400937776929 | MICARDISPLUS 80MG/12,5MG CPR 90\n",
      "  3400937777179 | PRITOR 40MG CPR 30\n",
      "  3400937777230 | PRITOR 80MG CPR 30\n",
      "  3400937777469 | PRITORPLUS 40MG/12,5MG CPR 30\n",
      "  3400937777520 | PRITORPLUS 80MG/12,5MG CPR 30\n",
      "  3400937778701 | ONDANSETRON ARW 8MG CPR 2\n",
      "  3400937778879 | ONDANSETRON ARW 8MG CPR 4\n",
      "  3400937780421 | LERCANIDIPINE EVO 10MG CPR 30\n",
      "  3400937782951 | ISIMIG 2,5MG CPR 12\n",
      "  3400937783613 | FLUCONAZOLE EG 50MG GELULE 7\n",
      "  3400937783842 | FLUCONAZOLE EG 100MG GELULE 7\n",
      "  3400937784092 | FLUCONAZOLE EG 200MG GELULE 7\n",
      "  3400937784153 | FLUCONAZOLE EG 200MG GELULE 30\n",
      "  3400937784214 | FLECTOR 1% GEL FL 100G 1\n",
      "  3400937784382 | EFFERALGANMED PEDIA 30MG/ML SOL BUV 1\n",
      "  3400937788236 | GABAPENTINE BGA 600MG CPR 90\n",
      "  3400937788984 | GABAPENTINE BGA 800MG CPR 90\n",
      "  3400937789875 | GABAPENTINE VIATRIS 100MG GELULE 90\n",
      "  3400937791137 | GABAPENTINE VIATRIS 300MG GELULE 90\n",
      "  3400937792486 | GABAPENTINE ZEN 600MG CPR 90\n",
      "  3400937793209 | GABAPENTINE ZEN 800MG CPR 90\n",
      "  3400937795500 | LERCANIDIPINE EVO 10MG CPR 90\n",
      "  3400937797740 | BETESIL 2,25MG EMPLATRE 8\n",
      "  3400937799461 | FENOFIBRATE TVS 67MG GELULE 60\n",
      "  3400937799522 | FENOFIBRATE TVS 67MG GELULE 90\n",
      "  3400937800044 | FENOFIBRATE TVS 200MG GELULE 30\n",
      "  3400937800273 | FENOFIBRATE TVS 200MG GELULE 90\n",
      "  3400937800334 | QUINAPRIL BGA 20MG CPR 28\n",
      "  3400937800853 | ALPRAZOLAM ZYD 0,50MG CPR 30\n",
      "  3400937800914 | ALPRAZOLAM ZYD 0,25MG CPR 30\n",
      "  3400937801164 | GRAZAX 75000 SQ-T LYOP ORAL 30\n",
      "  3400937801683 | TERBINAFINE VEL 250MG CPR 28\n",
      "  3400937803526 | NICORANDIL ZEN 10MG CPR 30\n",
      "  3400937803694 | NICORANDIL ZEN 20 MG CPR 30\n",
      "  3400937803755 | CEFTAZIDIME ARROW 1G PDR INJ 1\n",
      "  3400937803816 | CEFTAZIDIME ARROW 2G PDR INJ 1\n",
      "  3400937806886 | FLUCONAZOLE SDZ 50MG GELULE 7\n",
      "  3400937806947 | FLUCONAZOLE SDZ 100MG GELULE 7\n",
      "  3400937807029 | FLUCONAZOLE SDZ 150MG GELULE 1\n",
      "  3400937807197 | FLUCONAZOLE SDZ 200MG GELULE 7\n",
      "  3400937807258 | FLUCONAZOLE SDZ 200MG GELULE 30\n",
      "  3400937807319 | FLUCONAZOLE BGA 50MG/5ML PDR ORALE 1\n",
      "  3400937807487 | LISINOPRIL HCTZ BGA 20/12,5MG CPR 84\n",
      "  3400937807609 | FLUCONAZOLE ARW 50MG/5ML PDR ORALE 1\n",
      "  3400937807777 | RAMIPRIL BGA 10MG CPR 90\n",
      "  3400937807838 | CAPTOPRIL HCTZ BGA 50/25MG CPR 84\n",
      "  3400937808088 | RILMENIDINE BGA 1MG CPR 90\n",
      "  3400937808200 | ATENOLOL BGA 100 MG CPR 90\n",
      "  3400937808439 | ATENOLOL BGA 50 MG CPR 90\n",
      "  3400937808729 | ADROVANCE 70MG/2800UI CPR 4\n",
      "  3400937808958 | ADROVANCE 70MG/2800UI CPR 12\n",
      "  3400937809269 | BYETTA 5 MICROG SOL INJ 1\n",
      "  3400937809498 | BYETTA 10 MICROG SOL INJ 1\n",
      "  3400937809610 | FLUCONAZOLE VTS 10 MG/ML PDR ORALE 1\n",
      "  3400937809788 | FLUCONAZOLE SDZ 50MG/5ML PDR ORALE 1\n",
      "  3400937810159 | LUCENTIS 2,3MG SOL INJ FL 1\n",
      "  3400937812160 | GABAPENTINE EG 400 MG 1 BOITE DE 90, GELULES\n",
      "  3400937812399 | CELIPROLOL SDZ 200MG CPR 28\n",
      "  3400937813112 | ROXITHROMYCINE ZEN 150MG CPR 10\n",
      "  3400937813280 | ROXITHROMYCINE ZEN 150MG CPR 16\n",
      "  3400937813341 | ACEBUTOLOL BGA 200 MG CPR 90\n",
      "  3400937813570 | GABAPENTINE EG 100 MG 1 BOITE DE 90, GELULES\n",
      "  3400937813921 | GABAPENTINE EG 300MG GELULE 90\n",
      "  3400937814461 | FLUCONAZOLE EG 50 MG/5ML PDR ORALE 1\n",
      "  3400937814522 | FLUCONAZOLE ZEN 50MG/5ML PDR ORALE 1\n",
      "  3400937814690 | ACICLOVIR ZYD 200MG CPR 25\n",
      "  3400937814812 | ACICLOVIR ZEN 200MG CPR 25\n",
      "  3400937815123 | ONDANSETRON ARW 8MG CPR DISP 2\n",
      "  3400937815291 | ONDANSETRON ARW 8MG CPR DISP 4\n",
      "  3400937815581 | ONDANSETRON ARW 8MG CPR DISP 2\n",
      "  3400937815642 | ONDANSETRON ARW 8MG CPR DISP 4\n",
      "  3400937817592 | EXFORGE 5MG/80MG CPR 30\n",
      "  3400937817714 | EXFORGE 5MG/80MG CPR 90\n",
      "  3400937817882 | EXFORGE 5MG/160MG CPR 30\n",
      "  3400937818025 | EXFORGE 5MG/160MG CPR 90\n",
      "  3400937818193 | EXFORGE 10MG/160MG CPR 30\n",
      "  3400937818315 | EXFORGE 10MG/160MG CPR 90\n",
      "  3400937818834 | ONDANSETRON BGA 8MG CPR DISP 2\n",
      "  3400937819084 | ONDANSETRON BGA 8MG CPR DISP 4\n",
      "  3400937823227 | PRETERAX 2,5MG/0,625MG CPR 30\n",
      "  3400937823456 | PRETERAX 2,5MG/0,625MG CPR 90\n",
      "  3400937824057 | BIPRETERAX 5MG/1,25MG CPR 30\n",
      "  3400937824286 | BIPRETERAX 5MG/1,25MG CPR 90\n",
      "  3400937826877 | GLIBENCLAMIDE VIATRIS 5MG CPR 180\n",
      "  3400937827997 | LANSOPRAZOLE ARW 30MG GELULE 7\n",
      "  3400937828079 | LANSOPRAZOLE ARW 30MG GELULE 14\n",
      "  3400937828130 | LANSOPRAZOLE ARW 30MG GELULE 28\n",
      "  3400937828369 | LANSOPRAZOLE ARW 15MG GELULE 15\n",
      "  3400937828598 | LANSOPRAZOLE ARW 15MG GELULE 30\n",
      "  3400937828710 | PARACETAMOL RTP 500MG GELULE 16\n",
      "  3400937828888 | PULMODEXANE 30MG CPR 12\n",
      "  3400937828949 | ACICLOVIR ALM 200MG CPR 25\n",
      "  3400937829021 | ACICLOVIR RBX 200MG CPR 25\n",
      "  3400937831031 | AMLODIPINE ARW 5MG GELULE 30\n",
      "  3400937831260 | AMLODIPINE ARW 10MG GELULE 30\n",
      "  3400937832212 | DIACOMIT 250MG GELULE 60\n",
      "  3400937832502 | DIACOMIT 500MG GELULE 60\n",
      "  3400937832960 | DIACOMIT 250MG PDR PR SUSP BUV 60\n",
      "  3400937833271 | DIACOMIT 500MG PDR PR SUSP BUV 60\n",
      "  3400937833851 | LERCANIDIPINE EVO 20MG CPR 30\n",
      "  3400937834513 | KETOPROFENE CRT LP 200MG CPR 14\n",
      "  3400937836173 | LERCANIDIPINE EVO 20MG CPR 90\n",
      "  3400937838474 | MANIDIPINE TVC 10MG CPR 30\n",
      "  3400937838535 | MANIDIPINE TVC 10MG CPR 90\n",
      "  3400937838825 | MANIDIPINE TVC 20MG CPR 30\n",
      "  3400937838993 | MANIDIPINE TVC 20MG CPR 90\n",
      "  3400937841207 | METFORMINE ZENTIVA 850MG CPR 90\n",
      "  3400937842495 | BENAZEPRIL EG 5MG CPR 30\n",
      "  3400937842617 | BENAZEPRIL EG 10MG CPR 30\n",
      "  3400937842846 | GLICLAZIDE BGA 80MG CPR 180\n",
      "  3400937842907 | CIPROFIBRATE BGA 100MG GELULE 90\n",
      "  3400937844048 | AMLODIPINE SDZ 5MG GELULE 30\n",
      "  3400937844109 | AMLODIPINE SDZ 5MG GELULE 90\n",
      "  3400937845458 | AMLODIPINE SDZ 10MG GELULE 30\n",
      "  3400937845519 | AMLODIPINE SDZ 10MG GELULE 90\n",
      "  3400937846578 | MIRTAZAPINE SDZ 15MG CPR 30\n",
      "  3400937847230 | SPIRONOLACTONE BGA 75 MG CPR 90\n",
      "  3400937847469 | SPIRONOLACTONE BGA 50 MG CPR 90\n",
      "  3400937847520 | CELIPROLOL BGA 200MG CPR 84\n",
      "  3400937848121 | SPIRONOLACTONE ALTIZIDE BGA CPR 90\n",
      "  3400937848299 | KETOPROFENE CRISTERS 100MG CPR 30\n",
      "  3400937848350 | NOVORAPID INNOLET 100U/ML INJ 0\n",
      "  3400937848701 | FELODIPINE ZEN LP 5MG CPR 28\n",
      "  3400937850711 | ACEBUTOLOL ZEN 200MG CPR 30\n",
      "  3400937850889 | ACEBUTOLOL ZEN 200MG CPR 90\n",
      "  3400937851770 | BICALUTAMIDE BGA 50MG CPR 30\n",
      "  3400937853323 | ORMANDYL 50MG CPR 30\n",
      "  3400937855914 | RAMIPRIL TVS 1,25MG CPR 90\n",
      "  3400937856164 | RAMIPRIL TVS 2,5MG CPR 90\n",
      "  3400937856225 | RAMIPRIL TVS 5MG CPR 90\n",
      "  3400937856393 | RAMIPRIL TVS 10MG CPR 90\n",
      "  3400937859707 | FELODIPINE SDZ LP 5MG CPR 30\n",
      "  3400937859875 | FELODIPINE SDZ LP 5MG CPR 90\n",
      "  3400937860185 | PHLOROGLUCINOL ARW 80MG CPR DISP 10\n",
      "  3400937861717 | TERBINAFINE ALM 250MG CPR 28\n",
      "  3400937861946 | ACEBUTOLOL ZEN 400MG CPR 30\n",
      "  3400937867979 | LAMOTRIGINE EG 200MG CPR DISP 30\n",
      "  3400937870290 | LAMOTRIGINE EG 100MG CPR DISP 30\n",
      "  3400937871761 | LAMOTRIGINE EG 25MG CPR DISP 30\n",
      "  3400937874205 | SPIRONOLACTONE ALTIZIDE ZEN CPR 90\n",
      "  3400937874724 | LISINOPRIL HCTZ ZEN 20/12,5MG CPR 84\n",
      "  3400937874953 | SPIRONOLACTONE ZEN 50MG CPR 90\n",
      "  3400937875035 | SPIRONOLACTONE ZEN 75MG CPR 90\n",
      "  3400937881647 | MOVIPREP PDR ORALE SACHET 2\n",
      "  3400937884310 | SIMVASTATINE SDZ 10MG CPR 28\n",
      "  3400937888912 | MANIDIPINE VIATRIS 20MG CPR 30\n",
      "  3400937889452 | SIMVASTATINE SDZ 20MG CPR 30\n",
      "  3400937890052 | SIMVASTATINE SDZ 40MG CPR 30\n",
      "  3400937892292 | MANIDIPINE VIATRIS 20MG CPR 90\n",
      "  3400937901499 | CETIRIZINE ARW 10 MG/ML BUV FL 15ML 1\n",
      "  3400937901840 | RISPERIDONE SDZ 1MG CPR 60\n",
      "  3400937902151 | RISPERIDONE SDZ 2MG CPR 60\n",
      "  3400937902380 | RISPERIDONE SDZ 4MG CPR 30\n",
      "  3400937903271 | NISISCO 80 MG/12,5 MG CPR 30\n",
      "  3400937903790 | NISISCO 80 MG/12,5 MG CPR 90\n",
      "  3400937903851 | MANIDIPINE VIATRIS 10MG CPR 30\n",
      "  3400937904162 | NISISCO 160 MG/12,5 MG CPR 30\n",
      "  3400937904513 | NISISCO 160 MG/12,5 MG CPR 90\n",
      "  3400937904803 | NISISCO 160 MG/25 MG CPR 30\n",
      "  3400937905282 | NISISCO 160 MG/25 MG CPR 90\n",
      "  3400937905633 | NISIS 40MG CPR 30\n",
      "  3400937906005 | NISIS 40MG CPR 90\n",
      "  3400937906463 | NISIS 80 MG CPR 30\n",
      "  3400937906753 | NISIS 80 MG CPR 90\n",
      "  3400937907064 | NISIS 160 MG CPR 30\n",
      "  3400937907354 | NISIS 160 MG CPR 90\n",
      "  3400937907415 | MANIDIPINE VIATRIS 10MG CPR 90\n",
      "  3400937909426 | ALLOPURINOL SUN 100MG CPR 28\n",
      "  3400937909594 | ALLOPURINOL SUN 200MG CPR 28\n",
      "  3400937909655 | ALLOPURINOL SUN 300MG CPR 28\n",
      "  3400937910026 | CEFPODOXIME ZYD 100MG CPR 10\n",
      "  3400937910194 | AMOX/AC CLAV ZTK 100/12,5MG/ML 1\n",
      "  3400937910255 | AMOX/AC CLAV ZTK 100MG/12,5MG/ML ENF 1\n",
      "  3400937910316 | AMOX/AC CLAV ZTK 500MG/62,5MG A 16\n",
      "  3400937910545 | AMOX/AC CLAV ZTK 500MG/62,5MG A 24\n",
      "  3400937911085 | AMOX/AC CLAV ZEN100MG/12,5MG/ML 1\n",
      "  3400937913737 | LISINOPRIL BGA 5MG CPR 84\n",
      "  3400937914277 | LISINOPRIL BGA 20MG CPR 84\n",
      "  3400937914628 | METHADONE AP-HP 1MG GELULE 7\n",
      "  3400937914796 | METHADONE AP-HP 5MG GELULE 7\n",
      "  3400937914857 | METHADONE AP-HP 10MG GELULE 7\n",
      "  3400937914918 | METHADONE AP-HP 20MG GELULE 7\n",
      "  3400937915168 | ATENOLOL BGA 100 MG CPR 30\n",
      "  3400937915687 | AMLODIPINE ZYD 5MG GELULE 30\n",
      "  3400937915748 | AMLODIPINE ZYD 5MG GELULE 90\n",
      "  3400937915809 | AMLODIPINE SUN 5MG GELULE 30\n",
      "  3400937915977 | AMLODIPINE SUN 5MG GELULE 90\n",
      "  3400937916059 | AMLODIPINE SUN 10MG GELULE 30\n",
      "  3400937916110 | AMLODIPINE SUN 10MG GELULE 90\n",
      "  3400937916288 | FENOFIBRATE CRSTP 300MG GELULE 30\n",
      "  3400937916349 | FENOFIBRATE CRSTP 300MG GELULE 90\n",
      "  3400937920070 | AZATHIOPRINE TVC 50 MG CPR 100\n",
      "  3400937920360 | BROMAZEPAM TVC 6MG CPR 30\n",
      "  3400937921541 | REQUIP LP 2MG CPR 28\n",
      "  3400937922142 | REQUIP LP 4MG CPR 28\n",
      "  3400937922371 | REQUIP LP 8MG CPR 28\n",
      "  3400937924962 | JANUVIA 50 MG CPR 28\n",
      "  3400937925044 | JANUVIA 100 MG CPR 28\n",
      "  3400937928007 | AMLODIPINE ZYD 10MG GELULE 30\n",
      "  3400937928175 | AMLODIPINE ZYD 10MG GELULE 90\n",
      "  3400937932837 | XELEVIA 50 MG CPR 28\n",
      "  3400937933087 | XELEVIA 100 MG CPR 28\n",
      "  3400937935388 | AZITHROMYCINE SDZ 250MG CPR 6\n",
      "  3400937935968 | MOXONIDINE BGA 0,2MG CPR 30\n",
      "  3400937936620 | MOXONIDINE BGA 0,4MG CPR 30\n",
      "  3400937936859 | FLUCONAZOLE ZYD 50MG GELULE 7\n",
      "  3400937937160 | FLUCONAZOLE ZYD 100MG GELULE 7\n",
      "  3400937937399 | ECONAZOLE VIATRIS 1% PDR FL 30G 1\n",
      "  3400937937450 | FLUCONAZOLE ZYD 200MG GELULE 7\n",
      "  3400937937511 | FLUCONAZOLE ZYD 200MG GELULE 30\n",
      "  3400937938402 | BICALUTAMIDE ZEN 50MG CPR 30\n",
      "  3400937938860 | FLUOXETINE ZEN 20MG CPR 28\n",
      "  3400937939003 | PRAMIPEXOLE BGA 0,18MG CPR 30\n",
      "  3400937939522 | PRAMIPEXOLE BGA 0,18MG CPR 100\n",
      "  3400937939690 | PRAMIPEXOLE BGA 0,7MG CPR 30\n",
      "  3400937939751 | PRAMIPEXOLE BGA 0,7MG CPR 100\n",
      "  3400937943833 | AMIODARONE SUN 200MG CPR 30\n",
      "  3400937944892 | AMLODIPINE EG 5MG GELULE 30\n",
      "  3400937944953 | AMLODIPINE EG 10MG GELULE 30\n",
      "  3400937945493 | AZITHROMYCINE EG 250MG CPR 6\n",
      "  3400937945783 | AZITHROMYCINE VIATRIS 250MG CPR 6\n",
      "  3400937946094 | METFORMINE VTS 1000MG CPR DISP 30\n",
      "  3400937946384 | METFORMINE MYLAN 1 000 MG 1 BOITE DE 90, COMPRIMES\n",
      "  3400937949637 | ACICLOVIR ZEN 800MG CPR 35\n",
      "  3400937950527 | MACROGOL 4000 BGA 10G PDR ORALE SACH 20\n",
      "  3400937952309 | CLOBEX 500 MICROG/G SHAMPOOING 1\n",
      "  3400937953887 | MOXONIDINE EG 0,2MG CPR 30\n",
      "  3400937954020 | MOXONIDINE EG 0,4MG CPR 30\n",
      "  3400937954839 | CEFPODOXIME SDZ 100MG CPR 10\n",
      "  3400937955959 | NIQUITIN 21MG/24H DISP TRANSDER 28\n",
      "  3400937956321 | NIQUITIN 14MG/24H DISP TRANSDER 28\n",
      "  3400937970518 | GABAPENTINE ARW 800MG CPR 90\n",
      "  3400937970747 | GABAPENTINE ARW 600MG CPR 90\n",
      "  3400937974240 | PAROXETINE ZYD 20MG CPR 14\n",
      "  3400937974998 | EUPANTOL 40 MG CPR 28\n",
      "  3400937975889 | SULPIRIDE ZEN 50MG GELULE 30\n",
      "  3400937976602 | AMLODIPINE ALM 5MG GELULE 30\n",
      "  3400937976770 | AMLODIPINE ALM 5MG GELULE 90\n",
      "  3400937977081 | CEFPODOXIME ARW 100MG CPR 10\n",
      "  3400937977142 | AMLODIPINE ALM 10MG GELULE 30\n",
      "  3400937977203 | AMLODIPINE ALM 10MG GELULE 90\n",
      "  3400937977371 | AMLODIPINE BGA 10MG GELULE 30\n",
      "  3400937977432 | AMLODIPINE BGA 10MG GELULE 90\n",
      "  3400937977661 | AMLODIPINE BGA 5MG GELULE 30\n",
      "  3400937977722 | AMLODIPINE BGA 5MG GELULE 90\n",
      "  3400937977951 | CEFPODOXIME EG 100 MG CPR 10\n",
      "  3400937978781 | OXCARBAZEPINE VTS150MG CPR 50\n",
      "  3400937979962 | SUMATRIPTAN TVC 50MG CPR 6\n",
      "  3400937982863 | OXCARBAZEPINE VTS 300MG CPR 50\n",
      "  3400937983464 | OXCARBAZEPINE VIATRIS 600MG CPR 50\n",
      "  3400937985536 | TUSSIDANE 1,5MG/ML SS BUV FL 125ML 1\n",
      "  3400937985994 | TUSSIDANE 1,5MG/ML SS BUV FL 250ML 1\n",
      "  3400937986946 | NICORETTE MICROTAB CITRON 2MG CPR 100\n",
      "  3400937992398 | NICORETTE MICROTAB 2MG CPR SUBL+ETUI 100\n",
      "  3400937993050 | SELEXID 200MG CPR 12\n",
      "  3400937995290 | FELODIPINE ZEN LP 5MG CPR 30\n",
      "  3400937995412 | FELODIPINE ZEN LP 5MG CPR 90\n",
      "  3400937996303 | CAPTOPRIL HCTZ EG 50/25MG CPR 90\n",
      "  3400938002157 | GABAPENTINE EGL 100MG GELULE 90\n",
      "  3400938002386 | SIMVASTATINE MYL 10MG CPR 28\n",
      "  3400938006810 | GABAPENTINE EGL 300MG GELULE 90\n",
      "  3400938007589 | METFORMINE VTS 500MG CPR DISP 30\n",
      "  3400938007879 | METFORMINE MYLAN 500 MG 1 BOITE DE 90, COMPRIMES D\n",
      "  3400938010251 | METFORMINE VTS 850MG CPR DISP 30\n",
      "  3400938010541 | METFORMINE MYLAN 850 MG 1 BOITE DE 90, COMPRIMES D\n",
      "  3400938014273 | CEFPODOXIME BGA 100MG CPR 10\n",
      "  3400938014563 | APROVEL 75MG CPR PELL 30\n",
      "  3400938014624 | APROVEL 75MG CPR PELL 90\n",
      "  3400938014792 | APROVEL 150MG CPR PELL 30\n",
      "  3400938014853 | APROVEL 150MG CPR PELL 90\n",
      "  3400938014914 | APROVEL 300MG CPR PELL 30\n",
      "  3400938015164 | APROVEL 300MG CPR PELL 90\n",
      "  3400938015225 | COAPROVEL 150/12,5MG CPR 30\n",
      "  3400938015393 | COAPROVEL 150/12,5MG CPR 90\n",
      "  3400938015454 | COAPROVEL 300/12,5MG CPR 30\n",
      "  3400938015515 | COAPROVEL 300/12,5MG CPR 90\n",
      "  3400938015683 | COAPROVEL 300/25MG CPR 30\n",
      "  3400938015744 | COAPROVEL 300/25MG CPR 90\n",
      "  3400938016284 | GLIMEPIRIDE TVS 1MG CPR 30\n",
      "  3400938016574 | GLIMEPIRIDE TVS 1MG CPR 90\n",
      "  3400938016925 | GLIMEPIRIDE TVS 2MG CPR 30\n",
      "  3400938017236 | GLIMEPIRIDE TVS 2MG CPR 90\n",
      "  3400938017694 | GLIMEPIRIDE TVS 3MG CPR 30\n",
      "  3400938017984 | GLIMEPIRIDE TVS 3MG CPR 90\n",
      "  3400938018295 | GLIMEPIRIDE TVS 4MG CPR 30\n",
      "  3400938018585 | GLIMEPIRIDE TVS 4MG CPR 90\n",
      "  3400938020946 | ZOPICLONE SUN 7,5MG CPR 14\n",
      "  3400938021547 | CEFPODOXIME SUN 100MG CPR 10\n",
      "  3400938022087 | CEFPODOXIME TVC 100MG CPR 10\n",
      "  3400938022209 | PLAVIX 75MG CPR 30\n",
      "  3400938022377 | PLAVIX 75MG CPR 30\n",
      "  3400938023787 | GLIBENCLAMIDE SDZ 5MG CPR 100\n",
      "  3400938023909 | TERBINAFINE TVC 250MG CPR 28\n",
      "  3400938024159 | TERBINAFINE TVC 250MG CPR 28\n",
      "  3400938025569 | AZITHROMYCINE CRP 250MG CPR 6\n",
      "  3400938026399 | MUCOMYSTENDO 1G/5ML SOL INSTIL TRAC 6\n",
      "  3400938027051 | SERTRALINE ARW 25MG GELULE 7\n",
      "  3400938029123 | TERBINAFINE ZYD 250MG CPR 28\n",
      "  3400938041019 | PRAVASTATINE ALT 20MG CPR 84\n",
      "  3400938042139 | OXYNORMORO 5MG CPR DISP 14\n",
      "  3400938042597 | OXYNORMORO 10MG CPR DISP 14\n",
      "  3400938042887 | OXYNORMORO 20MG CPR DISP 14\n",
      "  3400938043488 | ONDANSETRON ARW 8MG CPR 2\n",
      "  3400938043549 | ONDANSETRON ARW 8MG CPR 4\n",
      "  3400938044201 | FLUOXETINE ZYD 20MG CPR 28\n",
      "  3400938044430 | CEFIXIME ALM 200MG CPR 8\n",
      "  3400938045789 | CEFIXIME BGA 200MG CPR 8\n",
      "  3400938046960 | COLISTIMETHATE AMP 1MUI PDR INH 30\n",
      "  3400938048452 | MANIDIPINE SDZ 10MG CPR 30\n",
      "  3400938048513 | MANIDIPINE SDZ 10MG CPR 90\n",
      "  3400938049053 | MANIDIPINE SDZ 20MG CPR 30\n",
      "  3400938049282 | MANIDIPINE SDZ 20MG CPR 90\n",
      "  3400938049862 | RESIKALI PDR SUSP BUV OU RECT 1\n",
      "  3400938050813 | METHADONE AP-HP 40MG GELULE 7\n",
      "  3400938052183 | TOPIRAMATE BGA 50MG CPR 28\n",
      "  3400938055375 | SIMVASTATINE BGA 40MG CPR 28\n",
      "  3400938055665 | SIMVASTATINE BGA 40MG CPR 84\n",
      "  3400938056327 | TOPIRAMATE BGA 100MG CPR 28\n",
      "  3400938069044 | FLUOXETINE ARW 20 MG CPR 28\n",
      "  3400938069105 | DICLOFENAC BGR 1% GEL 1\n",
      "  3400938069273 | ADVAGRAF LP 0,5 MG GELULE 30\n",
      "  3400938069624 | ADVAGRAF LP 1MG GELULE 30\n",
      "  3400938069914 | ADVAGRAF LP 5MG GELULE 30\n",
      "  3400938070804 | TERBINAFINE EVO 250MG CPR 28\n",
      "  3400938071054 | TERBINAFINE ARL 250MG CPR 28\n",
      "  3400938073065 | NEBIVOLOL EG 5MG CPR 30\n",
      "  3400938073355 | NEBIVOLOL EG 5MG CPR 90\n",
      "  3400938073584 | AMLODIPINE ARW 5MG GELULE 90\n",
      "  3400938073645 | AMLODIPINE ARW 10MG GELULE 90\n",
      "  3400938080339 | LAMOTRIGINE VIATRIS 25MG CPR DISP 30\n",
      "  3400938081459 | SALVACYL LP 11,25 MG PDR+SOL INJ 1\n",
      "  3400938083989 | LAMOTRIGINE VIATRIS 50MG CPR DISP 30\n",
      "  3400938084931 | LAMOTRIGINE VIATRIS 100MG CPR DISP 30\n",
      "  3400938086072 | LAMOTRIGINE VIATRIS 200MG CPR DISP 30\n",
      "  3400938086713 | CLARITHROMYCINE VTSL 250MG CPR 10\n",
      "  3400938087253 | CLARITHROMYCINE VTS 500MG CPR 10\n",
      "  3400938087314 | CLARITHROMYCINE VTS 500MG CPR 14\n",
      "  3400938087772 | CLARITHROMYCINE SDZ 250MG CPR 10\n",
      "  3400938088373 | CLARITHROMYCINE ARW 250MG CPR 10\n",
      "  3400938089554 | CLARITHROMYCINE SDZ 500 MG CPR 10\n",
      "  3400938089615 | CLARITHROMYCINE SDZ 500 MG CPR 14\n",
      "  3400938090673 | CLARITHROMYCINE ARW 500MG CPR 10\n",
      "  3400938090734 | CLARITHROMYCINE ARW 500MG CPR 14\n",
      "  3400938093056 | LACTULOSE ARW 10G/15ML SOL BUV SACH 20\n",
      "  3400938093346 | CIPROFLOXACINE SUN 250MG CPR 12\n",
      "  3400938093636 | CIPROFLOXACINE EVO 500MG CPR 12\n",
      "  3400938094527 | FINASTERIDE EG 5MG CPR 28\n",
      "  3400938095418 | CIPROFLOXACINE SUN 500MG CPR 12\n",
      "  3400938098488 | AERIUS 0,5 MG/ML SOL BUV 150ML 1\n",
      "  3400938101942 | SIKLOS 1000MG CPR 30\n",
      "  3400938104844 | LANSOPRAZOLE VIATRIS 30MG GELULE GR 7\n",
      "  3400938104905 | LANSOPRAZOLE VIATRIS 30MG GELULE GR 14\n",
      "  3400938105094 | LANSOPRAZOLE VIATRIS 30MG GELULE GR 28\n",
      "  3400938108576 | LANSOPRAZOLE ZEN 15MG GELULE 15\n",
      "  3400938108866 | LANSOPRAZOLE ZEN 15MG GELULE 30\n",
      "  3400938109696 | LANSOPRAZOLE ZEN 30MG GELULE 7\n",
      "  3400938109757 | LANSOPRAZOLE ZEN 30MG GELULE 14\n",
      "  3400938109986 | LANSOPRAZOLE ZEN 30MG GELULE 28\n",
      "  3400938112139 | LANSOPRAZOLE ALM 30MG GELULE 28\n",
      "  3400938112658 | L THYROXINE SERB SOL BUV GTES 1\n",
      "  3400938112887 | LANSOPRAZOLE SDZ 15MG GELULE 15\n",
      "  3400938112948 | LANSOPRAZOLE SDZ 15MG GELULE 30\n",
      "  3400938116502 | LANSOPRAZOLE EG 15MG GELULE 15\n",
      "  3400938116731 | LANSOPRAZOLE EG 15MG GELULE 30\n",
      "  3400938117042 | LANSOPRAZOLE EG 30MG GELULE 7\n",
      "  3400938117103 | LANSOPRAZOLE EG 30MG GELULE 14\n",
      "  3400938117271 | LANSOPRAZOLE EG 30MG GELULE 28\n",
      "  3400938117561 | LANSOPRAZOLE TVS 15MG GELULE 15\n",
      "  3400938117790 | LANSOPRAZOLE TVS 15MG GELULE 30\n",
      "  3400938117912 | LANSOPRAZOLE TVS 30MG GELULE 7\n",
      "  3400938118162 | LANSOPRAZOLE TVS 30MG GELULE 14\n",
      "  3400938118223 | LANSOPRAZOLE TVS 30MG GELULE 28\n",
      "  3400938118452 | LANSOPRAZOLE SDZ 30MG GELULE 7\n",
      "  3400938118513 | LANSOPRAZOLE SDZ 30MG GELULE 14\n",
      "  3400938118681 | LANSOPRAZOLE SDZ 30MG GELULE 28\n",
      "  3400938121124 | FORMODUAL 100/6 MCG/DOSE SOL INH 1\n",
      "  3400938122763 | ZOPICLONE ALT 7,5MG CPR 14\n",
      "  3400938123135 | PIPER/TAZOB VIATRI 2G/250MG PDR PERF 1\n",
      "  3400938124255 | TRAMADOL MYG LP 100MG CPR 30\n",
      "  3400938125955 | TRAMADOL MYG LP 150MG CPR 30\n",
      "  3400938127676 | TRAMADOL MYG LP 200MG CPR 30\n",
      "  3400938129397 | PIPER/TAZOB VTS 4G/500MG PDR PERF 1\n",
      "  3400938129748 | METFORMINE CRT 1000MG CPR 30\n",
      "  3400938130058 | METFORMINE CRT 1000MG CPR 90\n",
      "  3400938130119 | PROPYLEX 50MG CPR 30\n",
      "  3400938130287 | PROPYLEX 50MG CPR 90\n",
      "  3400938130577 | ACTONELCOMBI 35+1000MG/880UI CPR+GLE 4\n",
      "  3400938134599 | ONDANSETRON TVC 8MG CPR 0\n",
      "  3400938134650 | ONDANSETRON TVC 8MG CPR 4\n",
      "  3400938137552 | ALFUZOSINE ZYD LP 10MG CPR 30\n",
      "  3400938139853 | LANSOPRAZOLE VIATRIS 15MG GELULE GR 15\n",
      "  3400938140163 | LANSOPRAZOLE VIATRIS 15MG GELULE GR 30\n",
      "  3400938141283 | INNOVAIR 100/6 MICROG SOL INH 1\n",
      "  3400938146608 | PHOSPHOSORB 660MG CPR 200\n",
      "  3400938146776 | INCRELEX 40 MG SOL INJ 1\n",
      "  3400938149500 | FENTANYL SDZ 12MICROG/H DISP TRANSD 5\n",
      "  3400938150629 | AMLODIPINE EG 5MG GELULE 90\n",
      "  3400938150797 | AMLODIPINE EG 10MG GELULE 90\n",
      "  3400938151459 | MIRCERA 50 MCG SOL INJ SER 1\n",
      "  3400938151510 | MIRCERA 75 MCG SOL INJ SER 1\n",
      "  3400938151749 | MIRCERA 100 MCG SOL INJ SER 1\n",
      "  3400938151800 | MIRCERA 150 MCG SOL INJ SER 1\n",
      "  3400938152050 | MIRCERA 200 MCG SOL INJ SER 1\n",
      "  3400938152111 | MIRCERA 250 MCG SOL INJ SER 1\n",
      "  3400938154061 | TAREG 40MG CPR 30\n",
      "  3400938154351 | TAREG 40MG CPR 90\n",
      "  3400938154641 | TAREG 80MG CPR 30\n",
      "  3400938154931 | TAREG 80MG CPR 90\n",
      "  3400938155242 | TAREG 160 MG CPR 30\n",
      "  3400938155532 | TAREG 160 MG CPR 90\n",
      "  3400938155822 | COTAREG 80MG/12,5MG CPR 30\n",
      "  3400938156362 | COTAREG 80MG/12,5MG CPR 90\n",
      "  3400938156652 | COTAREG 160MG/12,5MG CPR 30\n",
      "  3400938157024 | COTAREG 160MG/12,5MG CPR 90\n",
      "  3400938157314 | COTAREG 160MG/25MG CPR 30\n",
      "  3400938157772 | COTAREG 160MG/25MG CPR 90\n",
      "  3400938158373 | RILMENIDINE SDZ 1MG CPR 30\n",
      "  3400938158434 | RILMENIDINE SDZ 1MG CPR 90\n",
      "  3400938158892 | RILMENIDINE TVC 1MG CPR 30\n",
      "  3400938159035 | RILMENIDINE TVC 1MG CPR 90\n",
      "  3400938159783 | RISPERIDONE BGA 1 MG CPR 60\n",
      "  3400938160154 | RISPERIDONE BGA 2MG CPR 60\n",
      "  3400938160383 | RISPERIDONE BGA 4MG CPR 30\n",
      "  3400938160734 | RISPERIDONE ALM 1MG CPR 60\n",
      "  3400938161274 | RISPERIDONE ALM 2MG CPR 60\n",
      "  3400938161564 | RISPERIDONE ALM 4MG CPR 30\n",
      "  3400938161793 | GABAPENTINE EGL 400MG GELULE 90\n",
      "  3400938164237 | CERVARIX SUSP INJ SER AVEC AIG 1\n",
      "  3400938164985 | RIVOTRIL 2MG CPR 28\n",
      "  3400938167368 | BORAX/AC BORIQUE BGA SOL OPH UNIDOSE 20\n",
      "  3400938168020 | ITRACONAZOLE TVC 100MG GELULE 30\n",
      "  3400938172799 | NOMEGESTROL EG 5MG CPR 10\n",
      "  3400938173451 | NOMEGESTROL BGA 5MG CPR 10\n",
      "  3400938176124 | INOVELON 200MG CPR 60\n",
      "  3400938176292 | INOVELON 400MG CPR 60\n",
      "  3400938177534 | RISPERIDONE EVO 1MG CPR 60\n",
      "  3400938177824 | RISPERIDONE EVO 2MG CPR 60\n",
      "  3400938178074 | RISPERIDONE EVO 4MG CPR 30\n",
      "  3400938178425 | RISPERIDONE ARL 1MG CPR 60\n",
      "  3400938178593 | RISPERIDONE ARL 1MG CPR 60\n",
      "  3400938178654 | RISPERIDONE ARL 2MG CPR 60\n",
      "  3400938178715 | RISPERIDONE ARL 2MG CPR 60\n",
      "  3400938178883 | RISPERIDONE ARL 4MG CPR 30\n",
      "  3400938178944 | RISPERIDONE ARL 4MG CPR 30\n",
      "  3400938179255 | CLARITHROMYCINE TVC 500MG CPR 10\n",
      "  3400938179316 | CLARITHROMYCINE TVC 500MG CPR 14\n",
      "  3400938180374 | PARACETAMOL ALT 1G CPR 8\n",
      "  3400938183047 | CEFTAZIDIME VIATRIS 1G PDR INJ 1\n",
      "  3400938183337 | CEFTAZIDIME VIATRIS 2G PDR INJ IV 1\n",
      "  3400938186758 | LANSOPRAZOLE ALM 15MG GELULE 30\n",
      "  3400938192032 | SPIRIVA RESPIMAT 2,5MCG SOL PR INHAL 1\n",
      "  3400938193213 | FLUCONAZOLE TVC 50MG/5ML PDR ORALE 1\n",
      "  3400938195163 | GALVUS 50MG CPR 30\n",
      "  3400938196863 | PARACETAMOL CRT 500MG CPR 16\n",
      "  3400938197235 | PARACETAMOL RMO 1G CPR 8\n",
      "  3400938197464 | BUPRENORPHINE ARW 1MG CPR 7\n",
      "  3400938197693 | BUPRENORPHINE ARW 4MG CPR 7\n",
      "  3400938197815 | BUPRENORPHINE ARW 6MG CPR 7\n",
      "  3400938198065 | PARACETAMOL CRT 1G CPR 8\n",
      "  3400938198294 | PARACETAMOL VIATRIS 1G CPR 8\n",
      "  3400938199017 | VENLAFAXINE ZENTIVA LP 37,5MG GELULE 30\n",
      "  3400938199536 | VENLAFAXINE ZENTIVA LP 75MG GELULE 30\n",
      "  3400938200348 | TIORFANOR 175 MG CPR 12\n",
      "  3400938200577 | PARACETAMOL BGA 500MG CPR 16\n",
      "  3400938200867 | BUPRENORPHINE VTS 1MG CPR 7\n",
      "  3400938201000 | BUPRENORPHINE VTS 4MG CPR 7\n",
      "  3400938201239 | BUPRENORPHINE VTS 6MG CPR 7\n",
      "  3400938201529 | TAMIFLU 30 MG GELULE 10\n",
      "  3400938201697 | TAMIFLU 45 MG GELULE 10\n",
      "  3400938201819 | FOSAVANCE 70MG/5600UI CPR 4\n",
      "  3400938201987 | FOSAVANCE 70MG/5600UI CPR 12\n",
      "  3400938202120 | ADROVANCE 70MG/5600UI CPR 4\n",
      "  3400938202298 | ADROVANCE 70MG/5600UI CPR 12\n",
      "  3400938203820 | AZYTER 15MG/G COLLYRE UNIDOSE 6\n",
      "  3400938204599 | SEROPLEX 20MG/ML SOL BUV 1\n",
      "  3400938205251 | CYPROTERONE TVC 50MG CPR 20\n",
      "  3400938206203 | CYPROTERONE TVC 100MG CPR 60\n",
      "  3400938206371 | DUOPLAVIN 75 MG/75 MG CPR 30\n",
      "  3400938206661 | RISPERIDONE CRT 1MG CPR 60\n",
      "  3400938207262 | RISPERIDONE CRT 2MG CPR 60\n",
      "  3400938207323 | RISPERIDONE CRT 4MG CPR 30\n",
      "  3400938210224 | SUTENT 12,5 MG GELULE 28\n",
      "  3400938210392 | SUTENT 25 MG GELULE 28\n",
      "  3400938210453 | SUTENT 50 MG GELULE 28\n",
      "  3400938212983 | TRAMADOL VTS LP 100MG CPR 30\n",
      "  3400938213874 | AZITHROMYCINE ARW 250MG CPR 6\n",
      "  3400938214765 | BINOCRIT 1000UI SOL INJ SER 6\n",
      "  3400938214994 | BINOCRIT 2000UI SOL INJ SER 6\n",
      "  3400938215137 | BINOCRIT 3000UI/0,3ML SOL INJ SER 6\n",
      "  3400938215427 | BINOCRIT 4000UI SOL INJ SER 6\n",
      "  3400938215656 | BINOCRIT 5000UI SOL INJ SER 6\n",
      "  3400938215885 | BINOCRIT 6000UI SOL INJ SER 6\n",
      "  3400938216318 | BINOCRIT 8000UI SOL INJ SER 6\n",
      "  3400938216608 | RISPERIDONE ARW 1MG CPR 60\n",
      "  3400938216776 | BINOCRIT 10000 UI SOL INJ SER 1\n",
      "  3400938216837 | BINOCRIT 10000 UI SOL INJ SER 6\n",
      "  3400938217667 | RISPERIDONE ARW 2MG CPR 60\n",
      "  3400938221688 | BISOPROLOL HCTZ TVC 2,5/6,25MG CPR 30\n",
      "  3400938222920 | TRAMADOL MYP LP 150MG CPR 30\n",
      "  3400938223699 | BISOPROLOL HCTZ TVC 5/6,25MG CPR 30\n",
      "  3400938224641 | BISOPROLOL HCTZ TVC 10/6,25MG CPR 30\n",
      "  3400938225532 | TRAMADOL BGA LP 200MG CPR 30\n",
      "  3400938227024 | TRAMADOL ZTV LP 50MG CPR 30\n",
      "  3400938228373 | TRAMADOL ZTV LP 100MG CPR 30\n",
      "  3400938229783 | TRAMADOL ZTV LP 150MG CPR 30\n",
      "  3400938231045 | TRAMADOL ZTV LP 200MG CPR 30\n",
      "  3400938231915 | TRIMEBUTINE TVS 200MG CPR 30\n",
      "  3400938232226 | DOMPERIDONE BGA 10MG CPR DISP 20\n",
      "  3400938232394 | DOMPERIDONE BGA 10MG CPR DISP 30\n",
      "  3400938232745 | DOMPERIDONE EG 10MG CPR DISP 20\n",
      "  3400938234466 | DOMPERIDONE VIATRIS 10 MG CPR DISP 20\n",
      "  3400938234817 | CELSENTRI 150MG CPR 60\n",
      "  3400938234985 | CELSENTRI 300MG CPR 60\n",
      "  3400938235128 | AMLODIPINE PFZ 10MG GELULE 90\n",
      "  3400938235296 | AMLODIPINE PFZ 5MG GELULE 90\n",
      "  3400938239898 | ONDANSETRON ZYD 8MG CPR 2\n",
      "  3400938240030 | ONDANSETRON ZYD 8MG CPR 4\n",
      "  3400938240610 | AZITHROMYCINE ZYD 250MG CPR 6\n",
      "  3400938241501 | FLECAINIDE BGA 100MG CPR 30\n",
      "  3400938244861 | LAMIVUDINE TVP 300MG CPR 30\n",
      "  3400938248593 | FLECAINIDE SDZ 100MG CPR 30\n",
      "  3400938249835 | ALENDRONIQUE ACIDE ALT 70MG CPR 4\n",
      "  3400938250084 | ALENDRONIQUE ACIDE ALT 70MG CPR 12\n",
      "  3400938250374 | PHLOROGLUCINOL BGA 80MG CPR DISP 10\n",
      "  3400938255058 | LOSARTAN HCTZ TVC 50/12,5MG CPR 30\n",
      "  3400938255409 | LOSARTAN HCTZ TVC 50/12,5MG CPR 90\n",
      "  3400938259131 | LOSARTAN HCTZ TVC 100/25MG CPR 30\n",
      "  3400938259650 | LOSARTAN HCTZ TVC 100/25MG CPR 90\n",
      "  3400938260199 | CONTRACNE 5MG CAPSULE MOLLE 30\n",
      "  3400938260311 | GLIMEPIRIDE ZYD 1MG CPR 30\n",
      "  3400938260489 | GLIMEPIRIDE ZYD 1MG CPR 90\n",
      "  3400938260540 | GLIMEPIRIDE ZYD 2MG CPR 30\n",
      "  3400938260601 | GLIMEPIRIDE ZYD 2MG CPR 90\n",
      "  3400938261080 | GLIMEPIRIDE ZYD 3MG CPR 30\n",
      "  3400938261141 | GLIMEPIRIDE ZYD 3MG CPR 90\n",
      "  3400938261202 | GLIMEPIRIDE ZYD 4MG CPR 30\n",
      "  3400938261370 | GLIMEPIRIDE ZYD 4MG CPR 90\n",
      "  3400938263381 | ELIGARD 45MG PDR ET SOL INJ 1\n",
      "  3400938264913 | GABAPENTINE RBX 400MG GELULE 90\n",
      "  3400938267235 | PARACETAMOL SUN 1G CPR 8\n",
      "  3400938268355 | DICLOFENAC BGA 1% GEL 1\n",
      "  3400938268706 | PANTOPRAZOLE ALT 40MG CPR 28\n",
      "  3400938269017 | DICLOFENAC EG 1% GEL 100G 1\n",
      "  3400938269185 | DICLOFENAC EGL 1% GEL 1\n",
      "  3400938270426 | TOPIRAMATE VIATRIS 50MG CPR 28\n",
      "  3400938270884 | TOPIRAMATE VIATRIS 100MG CPR 28\n",
      "  3400938271256 | TOPIRAMATE VIATRIS 200MG CPR 28\n",
      "  3400938279702 | RISPERIDONE VIA 1MG/ML SOL BUV 30ML 1\n",
      "  3400938279870 | RISPERIDONE VIA 1MG/ML SOL BUV 60ML 1\n",
      "  3400938280180 | RISPERIDONE VIA 1MG/ML SOL BUV 120ML 1\n",
      "  3400938281651 | RISPERIDONE EG 1MG/ML SOL BUV 60ML 1\n",
      "  3400938281880 | RISPERIDONE EG 1MG/ML SOL BUV 120ML 1\n",
      "  3400938282023 | RISPERIDONE ZEN 1MG/ML SOL BUV 30ML 1\n",
      "  3400938282191 | RISPERIDONE ZEN 1MG/ML SOL BUV 60ML 1\n",
      "  3400938282313 | RISPERIDONE ZEN 1MG/ML SOL BUV 120ML 1\n",
      "  3400938282542 | DICLOFENAC EG LABO 1 % FLACON PRESSURISE DE 100 ML\n",
      "  3400938284263 | ONDANSETRON ZEN 8MG CPR DISP 4\n",
      "  3400938284553 | ACTONELCOMBI 35+1000MG/880UI CPR+GLE 12\n",
      "  3400938284614 | INOVELON 100MG CPR 10\n",
      "  3400938285215 | VERSATIS 700 MG (LIDOCAINE) 1 BOITE DE 5, EMPLATRE\n",
      "  3400938285444 | VERSATIS 700MG EMPLATRE 20\n",
      "  3400938285673 | VERSATIS 700MG EMPLATRE 30\n",
      "  3400938288407 | WYSTAMM 10MG CPR 15\n",
      "  3400938288926 | GRISEFULINE 500MG CPR 30\n",
      "  3400938289237 | FEXOFENADINE BGA 120MG CPR 15\n",
      "  3400938289985 | FEXOFENADINE BGA 180MG CPR 15\n",
      "  3400938291247 | FEXOFENADINE VIATRIS 120MG CPR 15\n",
      "  3400938291827 | FEXOFENADINE VIATRIS 180MG CPR 15\n",
      "  3400938294088 | LETROZOLE TVC 2,5MG CPR 30\n",
      "  3400938298512 | LOSARTAN TVS 50MG CPR 30\n",
      "  3400938299403 | LOSARTAN TVS 50MG CPR 90\n",
      "  3400938301625 | LOSARTAN TVS 100MG CPR 30\n",
      "  3400938302684 | LOSARTAN TVS 100MG CPR 90\n",
      "  3400938306996 | ATRIPLA CPR 30\n",
      "  3400938307658 | SPIRONOLACTONE ARW 50MG CPR 30\n",
      "  3400938307719 | TIAPROFENIQUE AC ARW 100MG CPR 30\n",
      "  3400938308488 | ISENTRESS 400MG CPR 60\n",
      "  3400938308600 | HELICOBACTER TEST INFAI 45MG PDR 1\n",
      "  3400938309959 | VAQTA 50U/1ML SUSP INJ PE AA 1\n",
      "  3400938310788 | ECONAZOLE ARW 1% SOLUTION 1\n",
      "  3400938310849 | ECONAZOLE ARW 1% POUDRE 30G 1\n",
      "  3400938310900 | ECONAZOLE ARW 1% EMULSION 1\n",
      "  3400938311099 | ECONAZOLE ARW 1% CREME 1\n",
      "  3400938322156 | GALVUS 50MG CPR 60\n",
      "  3400938322446 | AVAMYS 27,5 MICROG/PULV SUSP NASALE 1\n",
      "  3400938326000 | FINASTERIDE SUN 5MG CPR 28\n",
      "  3400938327298 | FLUOXETINE LBR 20MG GELULE 14\n",
      "  3400938327649 | EPREX 30 000UI/0,75ML SOL INJ SER 1\n",
      "  3400938328301 | LEVODOPA BSRZ TVC 50/12,5MG GELULE 60\n",
      "  3400938328998 | LEVODOPA BSRZ TVC 100MG/25MG GELULE 60\n",
      "  3400938329599 | LEVODOPA BSRZ TVC 200MG/50MG GELULE 60\n",
      "  3400938334913 | RISPERIDONE SDZ 0,5MG CPR DISP 28\n",
      "  3400938335224 | RISPERIDONE SDZ 1MG CPR DISP 28\n",
      "  3400938335453 | RISPERIDONE SDZ 2MG CPR DISP 28\n",
      "  3400938335682 | CIPROFIBRATE ARW 100MG GELULE 30\n",
      "  3400938337006 | TIENAM 500MG/500MG PDR PERF IV 1\n",
      "  3400938337464 | DICLOFENAC VIATRIS 1% GEL 1\n",
      "  3400938337525 | DICLOFENAC VTS 1% GEL 1\n",
      "  3400938338294 | BETAHISTINE TVC 24MG CPR 60\n",
      "  3400938339017 | BETAHISTINE SDZ 24MG CPR 60\n",
      "  3400938339475 | BETAHISTINE ZEN 24MG CPR 60\n",
      "  3400938339994 | BETAHISTINE ARW 24MG CPR 60\n",
      "  3400938340655 | BETAHISTINE BGA 24MG CPR 60\n",
      "  3400938341027 | BETAHISTINE EG 24MG CPR 60\n",
      "  3400938346169 | RISPERIDONE RTP 1MG CPR PEL 60\n",
      "  3400938346510 | RISPERIDONE TVS 2MG CPR 60\n",
      "  3400938346978 | OLANZAPINE TVC 5MG CPR 28\n",
      "  3400938347111 | OLANZAPINE TVC 7,5MG CPR 28\n",
      "  3400938347401 | OLANZAPINE TVC 10MG CPR 28\n",
      "  3400938348170 | OLANZAPINE TVC 5MG CPR DISP 28\n",
      "  3400938348460 | OLANZAPINE TVC 10MG CPR DISP 28\n",
      "  3400938349351 | FLUVASTATINE SDZ 20 MG GELULE 30\n",
      "  3400938349702 | FLUVASTATINE SDZ 20 MG GELULE 90\n",
      "  3400938351712 | FLUVASTATINE SDZ 40 MG GELULE 30\n",
      "  3400938352191 | FLUVASTATINE SDZ 40 MG GELULE 90\n",
      "  3400938354904 | RISPERIDONE TVS 4MG CPR 30\n",
      "  3400938355505 | LOSARTAN VIATRIS 50MG CPR 28\n",
      "  3400938356045 | LOSARTAN VIATRIS 50MG CPR 90\n",
      "  3400938356564 | LOSARTAN VIATRIS 100MG CPR 28\n",
      "  3400938356915 | LOSARTAN VIATRIS 100MG CPR 90\n",
      "  3400938365900 | KETOCONAZOLE ARW 2% GEL SACHET DOSE 8\n",
      "  3400938366501 | NEBIVOLOL SDZ 5MG CPR 30\n",
      "  3400938367102 | NEBIVOLOL SDZ 5MG CPR 90\n",
      "  3400938380118 | NICOTINE EG 7MG/24H DISP TRANSD 28\n",
      "  3400938380576 | NICOTINE EG 14MG/24H DISP TRANSD 28\n",
      "  3400938381009 | NICOTINE EG 21MG/24H DISP TRANSD 28\n",
      "  3400938381177 | KETOCONAZOLE ARW 2% GEL UNIDOSE 1\n",
      "  3400938382587 | KETOCONAZOLE EG 2% GEL UNIDOSE 1\n",
      "  3400938382709 | KETOCONAZOLE EG 2% GEL SACHET DOSE 8\n",
      "  3400938384949 | FLUOXETINE EG 20 MG CPR DISP 28\n",
      "  3400938385540 | FLUOXETINE BGA 20MG CPR 28\n",
      "  3400938392814 | SIMVASTATINE SDZ 20MG CPR 90\n",
      "  3400938393293 | SIMVASTATINE SDZ 40MG CPR 90\n",
      "  3400938394764 | ATENOLOL ZYD 50MG CPR 30\n",
      "  3400938395594 | ATENOLOL ZYD 100MG CPR 30\n",
      "  3400938395716 | FENOFIBRATE TVS 160MG CPR 30\n",
      "  3400938396027 | FENOFIBRATE TVS 160MG CPR 90\n",
      "  3400938398618 | TRAMADOL SDZ LP 100MG CPR 30\n",
      "  3400938399097 | TRAMADOL SDZ LP 200MG CPR 30\n",
      "  3400938407815 | BICALUTAMIDE TVC 50MG CPR 30\n",
      "  3400938408416 | OMEPRAZOLE EVO 10MG GELULE 28\n",
      "  3400938410075 | PARACETAMOL ARW 500MG GELULE 16\n",
      "  3400938411775 | LORATADINE BGA 10MG CPR 15\n",
      "  3400938412956 | PARACETAMOL ARW 500MG GELULE 16\n",
      "  3400938414448 | KETOCONAZOLE BGA 2% GEL UNIDOSE 1\n",
      "  3400938415797 | KETOCONAZOLE BGA 2% GEL SACHET DOSE 8\n",
      "  3400938416220 | WYSTAMM 10MG CPR 30\n",
      "  3400938416459 | CITRAFLEET BUV PDR SACH DOSE 2\n",
      "  3400938417920 | VALACICLOVIR SDZ 500MG CPR 10\n",
      "  3400938418170 | VALACICLOVIR SDZ 500MG CPR 42\n",
      "  3400938418521 | VALACICLOVIR SDZ 500MG CPR 112\n",
      "  3400938421361 | VALACICLOVIR ARG 500MG CPR 10\n",
      "  3400938422771 | VALACICLOVIR ALT 500MG CPR 10\n",
      "  3400938423082 | VALACICLOVIR ALT 500MG CPR 42\n",
      "  3400938426915 | INDAPAMIDE VIATRIS LP 1,5MG CPR 30\n",
      "  3400938427165 | INDAPAMIDE VIATRIS LP 1,5MG CPR 90\n",
      "  3400938432886 | BICALUTAMIDE VTS 50MG CPR 30\n",
      "  3400938434439 | ANASTROZOLE KRKA 1MG CPR 30\n",
      "  3400938435610 | ANASTROZOLE VIATRIS 1MG CPR 30\n",
      "  3400938436679 | ANASTROZOLE ZEN 1MG CPR 30\n",
      "  3400938439113 | BICALUTAMIDE CRT 50MG CPR 30\n",
      "  3400938441352 | ATENOLOL EG 50MG CPR 30\n",
      "  3400938441413 | ATENOLOL EG 100MG CPR 30\n",
      "  3400938441581 | SIMVASTATINE EG 40MG CPR 30\n",
      "  3400938441642 | SIMVASTATINE EG 20MG CPR 30\n",
      "  3400938442014 | KALETRA 100MG/25MG CPR 60\n",
      "  3400938442182 | CETIRIZINE EVO 10MG CPR 15\n",
      "  3400938443363 | AMOXICILLINE SUN 1G CPR DISP 6\n",
      "  3400938443424 | AMOXICILLINE SUN 1G CPR DISP 14\n",
      "  3400938448795 | VENLAFAXINE BIPHAR LP 150MG CPR 30\n",
      "  3400938450637 | VENLAFAXINE BIPHAR LP 225MG CPR 30\n",
      "  3400938453768 | SIMVASTATINE SUN 10MG CPR 28\n",
      "  3400938454659 | SIMVASTATINE SUN 20MG CPR 28\n",
      "  3400938455489 | SIMVASTATINE SUN 40MG CPR 28\n",
      "  3400938456899 | ACTONEL 75 MG CPR 2\n",
      "  3400938457032 | ACTONEL 75 MG CPR 6\n",
      "  3400938457902 | VALSARTAN/HCTZ RBX 160/12,5MG CPR 30\n",
      "  3400938458381 | ENANTONE LP 30 MG INJ SER 1\n",
      "  3400938458442 | OXYCONTIN LP 15MG CPR 28\n",
      "  3400938458732 | OXYCONTIN LP 30MG CPR 28\n",
      "  3400938459852 | OXYCONTIN LP 60MG CPR 28\n",
      "  3400938460223 | OXYCONTIN LP 120MG CPR 28\n",
      "  3400938460803 | VALSARTAN/HCTZ RBX 160/12,5MG CPR 90\n",
      "  3400938461114 | MIRTAZAPINE EG 15MG CPR 30\n",
      "  3400938461282 | MIRTAZAPINE ARW 15MG CPR 30\n",
      "  3400938461633 | CITALOPRAM SUN 20MG CPR 28\n",
      "  3400938462005 | HEXAMIDINE MYL 0,1% SOL FL 45ML 1\n",
      "  3400938462173 | HEXAMIDINE MYL 0,1% SOL FL 250ML 1\n",
      "  3400938471977 | TRANDOLAPRIL MYL 0,5MG GELULE 28\n",
      "  3400938472868 | TRANDOLAPRIL MYL 2MG GELULE 28\n",
      "  3400938473230 | TRANDOLAPRIL MYL 2MG GELULE 84\n",
      "  3400938473759 | TRANDOLAPRIL MYL 4MG GELULE 28\n",
      "  3400938474121 | TRANDOLAPRIL MYL 4MG GELULE 84\n",
      "  3400938478372 | IBUPROFENE TVS 400MG CPR PELL 20\n",
      "  3400938478723 | ACIDE FUSIDIQUE ARW 2% CREME 1\n",
      "  3400938479263 | LEELOO 0,1 MG/0,02 MG CPR 21\n",
      "  3400938479324 | LEELOO 0,1 MG/0,02 MG CPR 63\n",
      "  3400938481853 | PERINDOPRIL SDZ 2MG CPR 30\n",
      "  3400938482393 | PERINDOPRIL SDZ 2MG CPR 90\n",
      "  3400938485066 | PERINDOPRIL SDZ 4MG CPR 30\n",
      "  3400938485417 | PERINDOPRIL SDZ 4MG CPR 90\n",
      "  3400938487657 | HYCAMTIN 0,25MG GELULE 10\n",
      "  3400938487718 | HYCAMTIN 1MG GELULE 10\n",
      "  3400938487886 | REYATAZ 300MG GELULE 30\n",
      "  3400938490497 | CLARITHROMYCINE ALM 500MG CPR 10\n",
      "  3400938490619 | CLARITHROMYCINE ALM 500MG CPR 14\n",
      "  3400938491500 | CLARITHROMYCINE BGA 500MG CPR 10\n",
      "  3400938491739 | CLARITHROMYCINE BGA 500MG CPR 14\n",
      "  3400938493160 | CLARITHROMYCINE EVO 500MG CPR 14\n",
      "  3400938494112 | CLARITHROMYCINE EVO 250MG CPR 10\n",
      "  3400938498134 | CLARITHROMYCINE BGA 250MG CPR 10\n",
      "  3400938498943 | CLARITHROMYCINE ALM 250MG CPR 10\n",
      "  3400938500417 | MYCOPHENOLATE TVC 250MG GELULE 100\n",
      "  3400938500646 | MYCOPHENOLATE TVC 500MG CPR 50\n",
      "  3400938501308 | CLARITHROMYCINE SDZ 25MG/ML GRANULES 1\n",
      "  3400938501537 | CLARITHROMYCINE SDZ 50MG/ML GRANULES 1\n",
      "  3400938501995 | CLARITHROMYCINE ARW 25MG/ML GRANULES 1\n",
      "  3400938502138 | CLARITHROMYCINE ARW 50MG/ML GRANULES 1\n",
      "  3400938502596 | CLARITHROMYCINE VTS 25MG/ML GRANULES 1\n",
      "  3400938502718 | CLARITHROMYCINE VTS 50MG/ML GRANULES 1\n",
      "  3400938503548 | CABERGOLINE TVC 0,5MG CPR 8\n",
      "  3400938504897 | FENTANYL TVS 12MICROG/H DISP TRANSD 5\n",
      "  3400938509342 | FENTANYL ZEN 25MICROG/H DISP TRANSD 5\n",
      "  3400938509571 | FENTANYL ZEN 50MICROG/H DISP TRANSD 5\n",
      "  3400938509861 | FENTANYL ZEN 75MICROG/H DISP TRANSD 5\n",
      "  3400938510232 | FENTANYL ZEN 100MICROG/H DISP TRANSD 5\n",
      "  3400938510980 | HUMALOG 300UI KWIKPEN SOL INJ 5\n",
      "  3400938511062 | HUMALOG MIX25 300UI KWIKPEN INJ 5\n",
      "  3400938511123 | HUMALOG MIX50 300UI KWIKPEN INJ 5\n",
      "  3400938515145 | ANASTROZOLE TVC 1MG CPR 30\n",
      "  3400938515664 | ANASTROZOLE TVC 1MG CPR 90\n",
      "  3400938520347 | BICALUTAMIDE SDZ 50MG CPR 30\n",
      "  3400938523188 | METFORMINE EG 1000MG CPR 90\n",
      "  3400938524598 | KETOPROFENE CRISTERS 50 MG 1 BOITE DE 24, GELULES\n",
      "  3400938524659 | KETOPROFENE CRISTERS 50MG GELULE 24\n",
      "  3400938524710 | KETOPROFENE CRISTERS 100 MG 1 BOITE DE 30, COMPRIM\n",
      "  3400938524888 | KETOPROFENE CRT LP 200MG CPR 14\n",
      "  3400938524949 | METOPROLOL VTS 100MG CPR 30\n",
      "  3400938525311 | PARACETAMOL CRP 500MG GELULE 16\n",
      "  3400938525540 | PRADAXA 75 MG GELULE 10\n",
      "  3400938525601 | PRADAXA 75 MG GELULE 30\n",
      "  3400938525779 | PRADAXA 75 MG GELULE 60\n",
      "  3400938526080 | PRADAXA 110 MG GELULE 10\n",
      "  3400938526141 | PRADAXA 110 MG GELULE 30\n",
      "  3400938526202 | PRADAXA 110 MG GELULE 60\n",
      "  3400938527032 | MICARDISPLUS 80MG/25MG CPR 30\n",
      "  3400938527322 | MICARDISPLUS 80MG/25MG CPR 90\n",
      "  3400938527841 | LOSARTAN ZYD 50MG CPR 30\n",
      "  3400938528152 | LOSARTAN ZYD 50MG CPR 90\n",
      "  3400938529272 | LOSARTAN ZYD 100MG CPR 30\n",
      "  3400938529562 | LOSARTAN ZYD 100MG CPR 90\n",
      "  3400938535365 | VENLAFAXINE VIATRIS 50MG CPR 30\n",
      "  3400938536546 | CLARITHROMYCINE ZYD 250MG CPR 10\n",
      "  3400938538847 | STALEVO 200MG/50MG/200MG CPR 100\n",
      "  3400938539219 | CLARITHROMYCINE ZYD 500MG CPR 10\n",
      "  3400938539448 | CLARITHROMYCINE ZYD 500MG CPR 14\n",
      "  3400938547771 | INDAPAMIDE EG LP 1,5MG CPR 30\n",
      "  3400938548143 | INDAPAMIDE EG LP 1,5MG CPR 90\n",
      "  3400938548433 | TERBINAFINE BAILLEUL 250MG CPR 28\n",
      "  3400938549904 | AZATHIOPRINE EG 50MG CPR 100\n",
      "  3400938550092 | CEFUROXIME ARW 500 MG CPR 8\n",
      "  3400938550382 | CEFUROXIME ARW 250 MG CPR 8\n",
      "  3400938551853 | AMOXICILLINE SUN 500MG GELULE 12\n",
      "  3400938552454 | TRAMADOL SDZ LP 150MG CPR 30\n",
      "  3400938553635 | CLARITHROMYCINE TVC 250 MG CPR 10\n",
      "  3400938554465 | BROMAZEPAM CRT 6MG CPR 30\n",
      "  3400938557718 | RISPERIDONE SDZ 1MG/ML SOL BUV 30ML 1\n",
      "  3400938557886 | RISPERIDONE SDZ 1MG/ML SOL BUV 60ML 1\n",
      "  3400938558197 | RISPERIDONE SDZ 1MG/ML SOL BUV 120ML 1\n",
      "  3400938558838 | PREDNISONE VIATRIS 1MG CPR 30\n",
      "  3400938559200 | PREDNISONE ARROW 1 MG 1 BOITE DE 30, COMPRIMES\n",
      "  3400938561388 | GLICLAZIDE ARL LM 30MG CPR 30\n",
      "  3400938561678 | GLICLAZIDE ARL LM 30MG CPR 60\n",
      "  3400938563160 | GLICLAZIDE SDZ LM 30MG CPR 30\n",
      "  3400938563399 | GLICLAZIDE SDZ LM 30MG CPR 60\n",
      "  3400938563801 | GLICLAZIDE SDZ LM 30MG CPR 180\n",
      "  3400938564631 | GLICLAZIDE TVC LM 30MG CPR 30\n",
      "  3400938564921 | GLICLAZIDE TVC LM 30MG CPR 60\n",
      "  3400938565522 | GLICLAZIDE TVC LM 30MG CPR 180\n",
      "  3400938567991 | GLICLAZIDE VIATRIS LM 30MG CPR 30\n",
      "  3400938568134 | GLICLAZIDE VIATRIS LM 30MG CPR 60\n",
      "  3400938568714 | GLICLAZIDE VIATRIS LM 30MG CPR 180\n",
      "  3400938570953 | FOSINOPRIL HCTZ ACT 20/12,5MG CPR 30\n",
      "  3400938572445 | ADENURIC 80MG CPR 28\n",
      "  3400938572506 | ADENURIC 120MG CPR 28\n",
      "  3400938573107 | FOSINOPRIL HCTZ BGA 20/12,5MG CPR 30\n",
      "  3400938573626 | FOSINOPRIL HCTZ VTS 20/12,5MG CPR 30\n",
      "  3400938577648 | GLIBENCLAMIDE EG 5MG CPR 20\n",
      "  3400938577709 | GLIBENCLAMIDE EG 5MG CPR 100\n",
      "  3400938580259 | COVERAM 5MG/5MG CPR 30\n",
      "  3400938580600 | COVERAM 5MG/5MG CPR 90\n",
      "  3400938581430 | COVERAM 5MG/10MG CPR 30\n",
      "  3400938581959 | COVERAM 5MG/10MG CPR 90\n",
      "  3400938582789 | COVERAM 10MG/5MG CPR 30\n",
      "  3400938583151 | COVERAM 10MG/5MG CPR 90\n",
      "  3400938583960 | COVERAM 10MG/10MG CPR 30\n",
      "  3400938584332 | COVERAM 10MG/10MG CPR 90\n",
      "  3400938588293 | BICALUTAMIDE ALM 50MG CPR 30\n",
      "  3400938596397 | LERCAPRESS 20MG/10MG CP 30\n",
      "  3400938596748 | ZANEXTRA 20MG/10MG CPR 30\n",
      "  3400938602814 | IRBESARTAN EG 75MG CPR PELL 30\n",
      "  3400938603293 | VALACICLOVIR TVC 500MG CPR 10\n",
      "  3400938603583 | VALACICLOVIR TVC 500MG CPR 42\n",
      "  3400938609097 | FOSINOPRIL HCTZ BGA 20/12,5MG CPR 90\n",
      "  3400938609219 | LORATADINE RBX 10MG CPR 15\n",
      "  3400938609677 | CEFIXIME TVC 200MG CPR 8\n",
      "  3400938613988 | NARATRIPTAN TVC 2,5MG CPR 6\n",
      "  3400938614060 | NARATRIPTAN TVC 2,5MG CPR 12\n",
      "  3400938614930 | CEFTRIAXONE ALM 1G/3,5ML PDR IM 1\n",
      "  3400938615470 | INDAPAMIDE KRKA LP 1,5MG CPR 30\n",
      "  3400938615821 | INDAPAMIDE KRKA LP 1,5MG CPR 90\n",
      "  3400938617542 | PRAVASTATINE SUN 40MG CPR 28\n",
      "  3400938617603 | IRBESARTAN EG 75MG CPR PELL 90\n",
      "  3400938617771 | PRAVASTATINE SUN 40MG CPR 84\n",
      "  3400938617832 | PRAVASTATINE SUN 20MG CPR 28\n",
      "  3400938618143 | PRAVASTATINE SUN 20MG CPR 84\n",
      "  3400938619492 | PERINDOPRIL ARW 2MG CPR 30\n",
      "  3400938619843 | PERINDOPRIL ARW 2MG CPR 90\n",
      "  3400938621914 | IRBESARTAN EG 150MG CPR PELL 30\n",
      "  3400938622805 | PERINDOPRIL ARW 4MG CPR 30\n",
      "  3400938623284 | PERINDOPRIL ARW 4MG CPR 90\n",
      "  3400938626018 | PERINDOPRIL ARW 8MG CPR 30\n",
      "  3400938626476 | PERINDOPRIL ARW 8MG CPR 90\n",
      "  3400938627886 | RAMIPRIL ARL 1,25MG CPR 90\n",
      "  3400938627947 | RAMIPRIL ARL 2,5MG CPR 90\n",
      "  3400938630268 | RAMIPRIL ARL 5MG CPR 90\n",
      "  3400938630329 | RAMIPRIL ARL 10MG CPR 90\n",
      "  3400938631968 | ALFUZOSINE EVO LP 10MG CPR 30\n",
      "  3400938632040 | IRBESARTAN EG 150MG CPR PELL 90\n",
      "  3400938639025 | OLANZAPINE SDZ 5MG CPR 28\n",
      "  3400938640892 | OLANZAPINE SDZ 7,5MG CPR 28\n",
      "  3400938641905 | OLANZAPINE SDZ 10MG CPR 28\n",
      "  3400938643275 | ENALAPRIL HCTZ SDZ 20/12,5MG CPR 30\n",
      "  3400938643855 | ENALAPRIL HCTZ SDZ 20/12,5MG CPR 90\n",
      "  3400938649130 | ACEBUTOLOL ALM 200MG CPR 30\n",
      "  3400938649369 | ACEBUTOLOL ALM 200MG CPR 90\n",
      "  3400938649420 | TEVAGRASTIM 30 MUI/0,5 ML SRG INJ 1\n",
      "  3400938649659 | TEVAGRASTIM 48 MUI/0,8 ML SER INJ 1\n",
      "  3400938650488 | MATRIFEN 12MICROG/H DISP TRANSDER 5\n",
      "  3400938651089 | MATRIFEN 25MICROG/H DISP TRANSDER 5\n",
      "  3400938651720 | MATRIFEN 50MICROG/H DISP TRANSDER 5\n",
      "  3400938652321 | MATRIFEN 75MICROG/H DISP TRANSDER 5\n",
      "  3400938652840 | MATRIFEN 100MICROG/H DISP TRANSDER 5\n",
      "  3400938653212 | METFORMINE ZYD 500MG CPR 30\n",
      "  3400938653441 | METFORMINE ZYD 500MG CPR 90\n",
      "  3400938655162 | PRITORPLUS 80MG/25MG CPR 30\n",
      "  3400938655223 | PRITORPLUS 80MG/25MG CPR 90\n",
      "  3400938656282 | BETAHISTINE EG 8MG CPR 30\n",
      "  3400938657005 | BUDESONIDE TVC 0,5MG/2ML SUSP INH 20\n",
      "  3400938658293 | BUDESONIDE TVC 1MG/2ML SUSP 20\n",
      "  3400938659535 | BETAHISTINE EG 8MG CPR 90\n",
      "  3400938660593 | OLIMEL N7E EMULS INJ POC 1L 6\n",
      "  3400938660654 | OLIMEL N7E EMULS INJ POC 1,5L 4\n",
      "  3400938660715 | OLIMEL N7E EMULS INJ POC 2L 4\n",
      "  3400938661316 | OLIMEL N9E EMULS INJ POC 1L 6\n",
      "  3400938661484 | OLIMEL N9E EMULS INJ POC 1,5L 4\n",
      "  3400938661545 | OLIMEL N9E EMULS INJ POC 2L 4\n",
      "  3400938661835 | IBUPROFENE VTS 20MG/ML SUSP 200ML 1\n",
      "  3400938670479 | PAROXETINE TVC 20MG CPR 14\n",
      "  3400938672022 | FLUVASTATINE SDZ LP 80 MG CPR 30\n",
      "  3400938673081 | INEXIUM 10MG GRANULES SUSP BUV SACH 28\n",
      "  3400938673371 | ROVALCYTE 50 MG/ML SOL BUV FL 100ML 1\n",
      "  3400938673661 | FOSINOPRIL ZEN 20MG CPR 30\n",
      "  3400938673890 | FOSINOPRIL ZEN 20MG CPR 90\n",
      "  3400938674033 | FOSINOPRIL ZEN 10MG CPR 30\n",
      "  3400938674323 | FOSINOPRIL ZEN 10MG CPR 90\n",
      "  3400938675214 | TRAMADOL BGR LP 100MG CPR 30\n",
      "  3400938675443 | TRAMADOL BGR LP 200MG CPR 30\n",
      "  3400938675962 | RAMIPRIL ALM 2,5MG CPR 90\n",
      "  3400938676105 | RAMIPRIL ALM 5 MG CPR 90\n",
      "  3400938677225 | SOLUMEDROL 1000 MG PDR ET SOL INJ 1\n",
      "  3400938677973 | VELMETIA 50MG/1000MG CPR 56\n",
      "  3400938678116 | JANUMET 50MG/1000MG CPR 56\n",
      "  3400938679007 | IRBESARTAN EG 300MG CPR PELL 30\n",
      "  3400938681185 | IRBESARTAN EG 300MG CPR PELL 90\n",
      "  3400938682595 | AMOX/AC CLAV EG 100/12,5MG/ML FL NR 1\n",
      "  3400938689921 | FENOFIBRATE EG 160MG CPR 90\n",
      "  3400938691870 | NOMEGESTROL ARW 5MG CPR 10\n",
      "  3400938696325 | LODOZ 2,5MG/6,25MG CPR 30\n",
      "  3400938696615 | LODOZ 2,5MG/6,25MG CPR 90\n",
      "  3400938696844 | LODOZ 5MG/6,25MG CPR 30\n",
      "  3400938697155 | LODOZ 5MG/6,25MG CPR 90\n",
      "  3400938697384 | LODOZ 10MG/6,25MG CPR 30\n",
      "  3400938697674 | LODOZ 10MG/6,25MG CPR 90\n",
      "  3400938698046 | AMOX/AC CLAV EGL 100MG/12,5MG/ML ENF 1\n",
      "  3400938698916 | QUINAPRIL HCTZ MYL 20/12,5MG CPR 28\n",
      "  3400938699395 | FOSINOPRIL HCTZ ZEN 20/12,5MG CPR 30\n",
      "  3400938699517 | FOSINOPRIL HCTZ ZEN 20/12,5MG CPR 90\n",
      "  3400938702101 | LOSARTAN ARW 50MG CPR 28\n",
      "  3400938702910 | LOSARTAN ARW 100MG CPR 28\n",
      "  3400938703740 | PANTOPRAZOLE ALT 20MG CPR 14\n",
      "  3400938703979 | PANTOPRAZOLE ALT 20MG CPR 28\n",
      "  3400938704280 | FLUOXETINE ALT 20MG GELULE 14\n",
      "  3400938706871 | TIMOFEROL GELULE 90\n",
      "  3400938709544 | CLARELUX 0,05% CREME 1\n",
      "  3400938709834 | TERBINAFINE VTS 1% CREME 1\n",
      "  3400938711325 | TADIM 1 MUI PDR ET SOL INH 30\n",
      "  3400938721898 | VENLAFAXINE BGA LP 37,5MG GELULE 30\n",
      "  3400938722499 | VENLAFAXINE ARW LP 75MG GELULE 30\n",
      "  3400938723670 | ROPINIROLE VTS 0,25MG CPR 21\n",
      "  3400938723731 | ROPINIROLE VTS 0,5MG CPR 21\n",
      "  3400938723960 | ROPINIROLE VTS 1MG CPR 21\n",
      "  3400938724042 | ROPINIROLE VTS 2MG CPR 21\n",
      "  3400938724103 | ROPINIROLE VTS 5MG CPR 21\n",
      "  3400938728583 | VENLAFAXINE BGA LP 75MG GELULE 30\n",
      "  3400938729535 | NICOPASS 2,5MG PAST RE M SS SUCRE 96\n",
      "  3400938730715 | NICOPASS 2,5MG PAST MENT F SS SUCRE 96\n",
      "  3400938731255 | LISINOPRIL HCTZ ARL 20/12,5MG CPR 84\n",
      "  3400938732146 | AMLODIPINE ARG 5MG GELULE 90\n",
      "  3400938732375 | AMLODIPINE ARG 10MG GELULE 90\n",
      "  3400938732894 | CEFPODOXIME BGA ENF/NR40MG/5ML 50ML 1\n",
      "  3400938732955 | CEFPODOXIME BGA ENF/NR40MG/5ML 100ML 1\n",
      "  3400938733327 | CEFPODOXIME TVC ENF/NR 40MG/5ML 50ML 1\n",
      "  3400938733495 | CEFPODOXIME TVC ENF/NR40MG/5ML 100ML 1\n",
      "  3400938733556 | CEFPODOXIME EG ENF/NR 40MG/5ML 50ML 1\n",
      "  3400938733617 | CEFPODOXIME EG ENF/NR 40MG/5ML 100ML 1\n",
      "  3400938734737 | FINASTERIDE ARL 5MG CPR 28\n",
      "  3400938736397 | CEFPODOXIME VTS ENF/NR 40MG/5ML 50ML 1\n",
      "  3400938736458 | CEFPODOXIME VTS ENF/NR40MG/5ML 100ML 1\n",
      "  3400938736748 | RELISTOR 12 MG SOL INJ 7\n",
      "  3400938737578 | LERCAPRESS 20MG/10MG CP 90\n",
      "  3400938739299 | ZANEXTRA 20MG/10MG CPR 90\n",
      "  3400938742312 | FUSIDATE NA 2% POMMADE TUBE 1\n",
      "  3400938742602 | INTELENCE 100 MG CPR 120\n",
      "  3400938743890 | FLUVASTATINE TVC 20MG GELULE 30\n",
      "  3400938744552 | FLUVASTATINE TVC 20MG GELULE 90\n",
      "  3400938745504 | FLUVASTATINE TVC 40MG GELULE 30\n",
      "  3400938746105 | FLUVASTATINE TVC 40MG GELULE 90\n",
      "  3400938747393 | TRAMADOL BGR LP 150MG CPR 30\n",
      "  3400938749816 | CEFPODOXIME SDZ ENF/NR40MG/5ML 50ML 1\n",
      "  3400938749984 | CEFPODOXIME SDZ ENF/NR40MG/5ML 100ML 1\n",
      "  3400938750065 | CEFPODOXIME ARW ENF/NR 40MG/5ML 50ML 1\n",
      "  3400938750126 | CEFPODOXIME ARW ENF/NR40MG/5ML 100ML 1\n",
      "  3400938752946 | GLIBENCLAMIDE TVC 2,5MG CPR 180\n",
      "  3400938753318 | GLIBENCLAMIDE TVC 5MG CPR 180\n",
      "  3400938756449 | VENLAFAXINE CRT LP 75MG GELULE 30\n",
      "  3400938756678 | CAPTOPRIL HCTZ EG 50/25MG CPR 30\n",
      "  3400938757101 | VENLAFAXINE SDZ LP 75MG GELULE 30\n",
      "  3400938757620 | VENLAFAXINE ALM LP 37,5 MG GELULE 30\n",
      "  3400938759112 | MIRTAZAPINE AUR 15MG CPR OROD 30\n",
      "  3400938761870 | VENLAFAXINE ALT LP 75MG GELULE 30\n",
      "  3400938762303 | VENLAFAXINE ALM LP 75 MG GELULE 30\n",
      "  3400938762761 | LISINOPRIL HCTZ TVC 20/12,5MG CPR 90\n",
      "  3400938762822 | AZITHROMYCINE SDZ MONODOSE 250MG CPR 4\n",
      "  3400938764482 | VALACICLOVIR BGA 500MG CPR 10\n",
      "  3400938764604 | VALACICLOVIR BGA 500MG CPR 42\n",
      "  3400938765144 | VALACICLOVIR BGA 500MG CPR 112\n",
      "  3400938765373 | VALACICLOVIR ZEN 500MG CPR 10\n",
      "  3400938765663 | VALACICLOVIR ZEN 500MG CPR 42\n",
      "  3400938766035 | VALACICLOVIR ZEN 500MG CPR 112\n",
      "  3400938769807 | NEBIVOLOL ZEN 5MG CPR 30\n",
      "  3400938771008 | LOSARTAN SDZ 100MG CPR 30\n",
      "  3400938771695 | LOSARTAN SDZ 100MG CPR 90\n",
      "  3400938771756 | NEBIVOLOL ZEN 5MG CPR 90\n",
      "  3400938775198 | VENLAFAXINE ZYF LP 75MG GELULE 30\n",
      "  3400938780802 | PANTOPRAZOLE ZEN 20MG CPR 14\n",
      "  3400938781052 | PANTOPRAZOLE ZEN 20MG CPR 28\n",
      "  3400938782004 | PANTOPRAZOLE ZEN 40MG CPR 7\n",
      "  3400938782172 | PANTOPRAZOLE ZEN 40MG CPR 14\n",
      "  3400938782462 | PANTOPRAZOLE ZEN 40MG CPR 28\n",
      "  3400938783063 | MERONEM 1 G PDR INJ 10\n",
      "  3400938783414 | VENLAFAXINE ZYF LP 37,5MG GELULE 30\n",
      "  3400938784015 | PANTOPRAZOLE SDZ 20MG CPR 14\n",
      "  3400938784305 | PANTOPRAZOLE SDZ 20MG CPR 28\n",
      "  3400938785074 | PANTOPRAZOLE SDZ 40MG CPR 7\n",
      "  3400938785364 | PANTOPRAZOLE SDZ 40MG CPR 14\n",
      "  3400938785654 | PANTOPRAZOLE SDZ 40MG CPR 28\n",
      "  3400938789676 | ENALAPRIL HCTZ EG 20/12,5MG CPR 30\n",
      "  3400938789966 | LISINOPRIL EG 20MG CPR 30\n",
      "  3400938790047 | ENALAPRIL EG 5MG CPR 30\n",
      "  3400938790108 | ENALAPRIL EG 20MG CPR 30\n",
      "  3400938791686 | FLUVASTATINE MYL LP 80MG CPR 30\n",
      "  3400938792058 | FLUVASTATINE MYL LP 80MG CPR 90\n",
      "  3400938792577 | ARCOXIA 60MG CPR 28\n",
      "  3400938797541 | FLUVASTATINE SDZ LP 80 MG CPR 90\n",
      "  3400938798081 | ARCOXIA 30 MG CPR 28\n",
      "  3400938799613 | CARVEDILOL EG 6,25MG CPR 28\n",
      "  3400938799903 | REQUIP 0,25 MG CPR 21\n",
      "  3400938800593 | CARVEDILOL EG 12,5MG CPR 28\n",
      "  3400938801316 | CARVEDILOL EG 25MG CPR 28\n",
      "  3400938801774 | REQUIP 0,50 MG CPR 21\n",
      "  3400938801835 | REQUIP 1 MG CPR 21\n",
      "  3400938802146 | REQUIP 2 MG CPR 21\n",
      "  3400938802375 | REQUIP 5 MG CPR 21\n",
      "  3400938803785 | QUINAPRIL HCTZ MYL 20/12,5MG CPR 90\n",
      "  3400938806229 | CLOPIDOGREL ZEN 75 MG CPR 30\n",
      "  3400938806397 | CLOPIDOGREL ZEN 75 MG CPR 30\n",
      "  3400938811940 | VENLAFAXINE ALT LP 37,5MG GELULE 30\n",
      "  3400938812480 | VENLAFAXINE CRT LP 37,5MG GELULE 30\n",
      "  3400938813081 | VENLAFAXINE SDZ LP 37,5MG GELULE 30\n",
      "  3400938814552 | TRANDOLAPRIL BGA 0,5MG GELULE 28\n",
      "  3400938814781 | TRANDOLAPRIL BGA 0,5MG GELULE 84\n",
      "  3400938814903 | TRANDOLAPRIL BGA 2MG GELULE 28\n",
      "  3400938815153 | TRANDOLAPRIL BGA 2MG GELULE 84\n",
      "  3400938815962 | TRANDOLAPRIL BGA 4MG GELULE 28\n",
      "  3400938816105 | TRANDOLAPRIL BGA 4MG GELULE 84\n",
      "  3400938816334 | BISOPROLOL HCTZ TVC 2,5/6,25MG CPR 90\n",
      "  3400938816563 | BISOPROLOL HCTZ TVC 5/6,25MG CPR 90\n",
      "  3400938816624 | BISOPROLOL HCTZ TVC 10/6,25MG CPR 90\n",
      "  3400938817164 | CITALOPRAM ZYD 20MG CPR 28\n",
      "  3400938818925 | CEFIXIME EG 200MG CPR 8\n",
      "  3400938820065 | OLANZAPINE ZYD 10MG CPR 28\n",
      "  3400938822656 | CICLOPIROX TVC 8% VERNIS 1\n",
      "  3400938822885 | CICLOPIROX VTS 8% VERNIS 1\n",
      "  3400938823486 | VENLAFAXINE ARW LP 37,5MG GELULE 30\n",
      "  3400938823837 | CICLOPIROX BGA 8% VERNIS 1\n",
      "  3400938824728 | DICLOFENAC TVC 1% GEL TUBE 50G 1\n",
      "  3400938825558 | DICLOFENAC TCL 1% GEL TUBE 100G 1\n",
      "  3400938826500 | VENLAFAXINE EVP LP 75MG GELULE 30\n",
      "  3400938827040 | VENLAFAXINE EVP LP 37,5MG GELULE 30\n",
      "  3400938828511 | ENALAPRIL HCTZ TVC 20/12,5MG CPR 90\n",
      "  3400938829112 | AMOXICILLINE TEVA 1G CPR DISP 6\n",
      "  3400938829341 | AMOXICILLINE TEVA 1G CPR DISP 14\n",
      "  3400938829570 | VIMPAT 50MG CPR 14\n",
      "  3400938829631 | VIMPAT 50MG CPR 56\n",
      "  3400938829921 | VIMPAT 100MG CPR 56\n",
      "  3400938830170 | VIMPAT 150MG CPR 56\n",
      "  3400938830460 | VIMPAT 200MG CPR 56\n",
      "  3400938831290 | METFORMINE ZYF 850MG CPR 30\n",
      "  3400938831580 | METFORMINE ZYF 850MG CPR 90\n",
      "  3400938833423 | SIMVASTATINE ARL 10MG CPR 30\n",
      "  3400938834253 | SIMVASTATINE ARL 20MG CPR 28\n",
      "  3400938834604 | SIMVASTATINE ARL 20MG CPR 84\n",
      "  3400938835205 | SIMVASTATINE ARL 40 MG CPR 28\n",
      "  3400938835724 | SIMVASTATINE ARL 40 MG CPR 84\n",
      "  3400938838275 | XARELTO 10 MG CPR 10\n",
      "  3400938838336 | XARELTO 10 MG CPR 30\n",
      "  3400938839166 | INDAPAMIDE ZEN LP 1,5MG CPR 30\n",
      "  3400938839456 | INDAPAMIDE ZEN LP 1,5MG CPR 90\n",
      "  3400938841527 | VENLAFAXINE VIATRIS LP 37,5MG GELULE 30\n",
      "  3400938841817 | TAMSULOSINE CRISTERS LP 0,4MG GELULE 30\n",
      "  3400938842586 | VENLAFAXINE VTS LP 75MG GELULE 30\n",
      "  3400938844368 | CYPROTERONE ARW 50MG CPR 20\n",
      "  3400938844597 | CYPROTERONE ARW 100MG CPR 60\n",
      "  3400938844948 | FOSINOPRIL HCTZ EG 20/12,5MG CPR 30\n",
      "  3400938845778 | GLIMEPIRIDE AHL 1MG CPR 30\n",
      "  3400938846201 | GLIMEPIRIDE AHL 2MG CPR 30\n",
      "  3400938846720 | GLIMEPIRIDE AHL 3MG CPR 30\n",
      "  3400938847321 | GLIMEPIRIDE AHL 4MG CPR 30\n",
      "  3400938849622 | PARACETAMOL BGA 300MG PDR ORALE SACH 12\n",
      "  3400938858907 | PHLOROGLUCINOL ZEN 80MG CPR DISP 10\n",
      "  3400938860108 | KETOCONAZOLE VIATRIS 2% GEL UNIDOSE 1\n",
      "  3400938860337 | KETOCONAZOLE VTS 2% GEL SACHET DOSE 8\n",
      "  3400938860795 | KETOCONAZOLE CRT 2% GEL UNIDOSE 1\n",
      "  3400938860856 | KETOCONAZOLE SDZ 2% GEL UNIDOSE 1\n",
      "  3400938861396 | KETOCONAZOLE ZYD 2% GEL SACHET DOSE 8\n",
      "  3400938861518 | KETOCONAZOLE CRT 2% GEL SACHET DOSE 8\n",
      "  3400938861747 | KETOCONAZOLE SDZ 2% GEL SACHET DOSE 8\n",
      "  3400938861976 | NALTREXONE ACC 50MG CPR 28\n",
      "  3400938863468 | PARACETAMOL ARW 300MG PDR ORALE SACH 12\n",
      "  3400938863529 | PARACETAMOL ARW 500MG PDR ORALE SACH 12\n",
      "  3400938863697 | PARACETAMOL ARW 1G PDR ORALE SACH 8\n",
      "  3400938864649 | SIMVASTATINE AHL 10 MG CPR 28\n",
      "  3400938865530 | SIMVASTATINE AHL 20MG CPR 28\n",
      "  3400938866070 | SIMVASTATINE AHL 20MG CPR 84\n",
      "  3400938866650 | SIMVASTATINE AHL 40MG CPR 28\n",
      "  3400938867022 | SIMVASTATINE AHL 40MG CPR 84\n",
      "  3400938868722 | PERINDOPRIL TVS 8MG CPR 30\n",
      "  3400938869033 | PERINDOPRIL TVS 8MG CPR 90\n",
      "  3400938870152 | BUPRENORPHINE BGA 0,4MG CPR 7\n",
      "  3400938870381 | BUPRENORPHINE TVC 0,4MG CPR 7\n",
      "  3400938870503 | BUPRENORPHINE SDZ 0,4MG CPR 7\n",
      "  3400938871043 | BUPRENORPHINE TVC 2MG CPR 7\n",
      "  3400938871272 | BUPRENORPHINE BGA 2MG CPR 7\n",
      "  3400938871562 | BUPRENORPHINE SDZ 2MG CPR 7\n",
      "  3400938871913 | WYTENS 2,5MG/6,25MG CPR 30\n",
      "  3400938872514 | WYTENS 5MG/6,25MG CPR 30\n",
      "  3400938873054 | WYTENS 10MG/6,25MG CPR 30\n",
      "  3400938873573 | BUPRENORPHINE BGA 8MG CPR 7\n",
      "  3400938873863 | BUPRENORPHINE TVC 8MG CPR 7\n",
      "  3400938874235 | BUPRENORPHINE SDZ 8MG CPR 7\n",
      "  3400938875416 | BETAMETHASONE BGA 2MG CPR DISP 20\n",
      "  3400938875584 | ACIDE FUSIDIQUE EG 2% CREME 1\n",
      "  3400938875706 | ACIDE FUSIDIQUE VTS 2% CREME 1\n",
      "  3400938876475 | LOSARTAN SDZ 50MG CPR 30\n",
      "  3400938877595 | BETAMETHASONE ZTV 2MG CPR DISP 20\n",
      "  3400938877885 | BETAMETHASONE ARW 2MG CPR DISP 20\n",
      "  3400938878196 | BETAMETHASONE EG 2MG CPR DISP 20\n",
      "  3400938879667 | MULTIHANCE 0,5MMOL/ML INJ SER 10ML 1\n",
      "  3400938879728 | MULTIHANCE 0,5MMOL/ML INJ SER 15ML 1\n",
      "  3400938879896 | MULTIHANCE 0,5MMOL/ML INJ SER 20ML 1\n",
      "  3400938882278 | RAMIPRIL EVO 10MG CPR 30\n",
      "  3400938882568 | RAMIPRIL EVO 10MG CPR 90\n",
      "  3400938883978 | RAMIPRIL EVO 1,25MG CPR 30\n",
      "  3400938885750 | RAMIPRIL EVO 2,5MG CPR 30\n",
      "  3400938885989 | RAMIPRIL EVO 2,5MG CPR 90\n",
      "  3400938887303 | RAMIPRIL EVO 5MG CPR 30\n",
      "  3400938887532 | RAMIPRIL EVO 5MG CPR 90\n",
      "  3400938892963 | ROPINIROLE EG 0,25MG CPR 21\n",
      "  3400938895056 | ROPINIROLE EG 0,50MG CPR 21\n",
      "  3400938907094 | DOMPERIDONE ARW 10MG CPR DISP 20\n",
      "  3400938908916 | PERINDOPRIL EG 2MG CPR 30\n",
      "  3400938909517 | PERINDOPRIL EG 2MG CPR 90\n",
      "  3400938910575 | PERINDOPRIL EG 4MG CPR 30\n",
      "  3400938911176 | PERINDOPRIL EG 4MG CPR 90\n",
      "  3400938919622 | LOSARTAN HCTZ EG 100/25MG CPR 30\n",
      "  3400938919912 | NICOTINELL 1MG CPR MENT SS SUCRE 144\n",
      "  3400938920222 | LOSARTAN HCTZ EG 100/25MG CPR 90\n",
      "  3400938923582 | FOSINOPRIL HCTZ ACT 20/12,5MG CPR 90\n",
      "  3400938923933 | LOSARTAN HCTZ EG 50/12,5MG CPR 30\n",
      "  3400938924244 | LOSARTAN HCTZ EG 50/12,5MG CPR 90\n",
      "  3400938924473 | NICOTINELL 2MG CPR MENT SS SUCRE 144\n",
      "  3400938931457 | MONTELUKAST SDZ 5MG CPR CROQ 28\n",
      "  3400938933987 | COMBODART 0,5MG/0,4MG GELULE 30\n",
      "  3400938934410 | BISOPROLOL ALM 10MG CPR 90\n",
      "  3400938940091 | IPRATROPIUM TVC 0,25MG/1ML ENF INHAL 30\n",
      "  3400938940671 | IPRATROPIUM TVC 0,5MG/2ML AD INHAL 10\n",
      "  3400938942163 | DORZOLAMIDE BGA 2% COLLYRE 5ML 1\n",
      "  3400938942224 | KETOCONAZOLE ZEN 2% GEL UNIDOSE 1\n",
      "  3400938942453 | KETOCONAZOLE ZEN 2% GEL SACHET DOSE 8\n",
      "  3400938943054 | ANASTROZOLE ZYD 1MG CPR 30\n",
      "  3400938946994 | BETAMETHASONE BGA 0,5MG/ML SOL BUV 1\n",
      "  3400938947076 | BETAMETHASONE ARW 0,5MG/ML SOL BUV 1\n",
      "  3400938947137 | BETAMETHASONE EG 0,5MG/ML SOL BUV 1\n",
      "  3400938947366 | BETAMETHASONE ZTV 0,5MG/ML SOL BUV 1\n",
      "  3400938949957 | MACROGOL 4000 VTS 10G PDR ORAL SACH 20\n",
      "  3400938950496 | PERINDOPRIL ZYD 2MG CPR 30\n",
      "  3400938951158 | PERINDOPRIL ZYD 4MG CPR 30\n",
      "  3400938951738 | PERINDOPRIL ZYD 8MG CPR 30\n",
      "  3400938952339 | FOSINOPRIL TVC 10MG CPR 90\n",
      "  3400938952858 | FOSINOPRIL TVC 20MG CPR 90\n",
      "  3400938953688 | SALBUTAMOL TVC 2,5MG/2,5ML INHAL 60\n",
      "  3400938954111 | SALBUTAMOL TVC 5MG/2,5ML INHAL 60\n",
      "  3400938954920 | FLUCONAZOLE EVO 50MG GELULE 7\n",
      "  3400938955231 | FLUCONAZOLE EVO 100MG GELULE 7\n",
      "  3400938956931 | PIPER/TAZOB SDZ 2 G/0,25 G PDR INJ 1\n",
      "  3400938957303 | PIPER/TAZOB SDZ 4 G/500 MG PDR INJ 1\n",
      "  3400938958423 | BRIMONIDINE MYL 0,2% COLLYRE 1\n",
      "  3400938959482 | BRIMONIDINE EG 0,2% COLLYRE 1\n",
      "  3400938960082 | TOCTINO 10MG CAPSULE MOLLE 30\n",
      "  3400938960204 | TOCTINO 30MG CAPSULE MOLLE 30\n",
      "  3400938961492 | FOSINOPRIL HCTZ VTS 20/12,5MG CPR 90\n",
      "  3400938962093 | MONTELUKAST TVC 10MG CPR 28\n",
      "  3400938962383 | CETIRIZINE RPG 10MG CPR 15\n",
      "  3400938963045 | MONTELUKAST TVC 5MG CPR CROQ 28\n",
      "  3400938966527 | LOSARTAN BGA 50MG CPR 30\n",
      "  3400938966985 | LOSARTAN BGA 50MG CPR 90\n",
      "  3400938968019 | LOSARTAN BGA 100MG CPR 30\n",
      "  3400938968477 | LOSARTAN BGA 100MG CPR 90\n",
      "  3400938969368 | DAIVOBET 50 MICROG/0,5MG/G GEL 1\n",
      "  3400938969719 | XAMIOL 50MICROG/0,5MG/G GEL 1\n",
      "  3400938970319 | BUPRENORPHINE SDZ 1MG CPR 7\n",
      "  3400938970777 | BUPRENORPHINE SDZ 4MG CPR 7\n",
      "  3400938971200 | BUPRENORPHINE SDZ 6MG CPR 7\n",
      "  3400938972559 | CELIPROLOL ZEN 200MG CPR 90\n",
      "  3400938974041 | IMETH 10MG CPR 10\n",
      "  3400938979305 | TOPIRAMATE ARG 100MG CPR 30\n",
      "  3400938979992 | ZOPICLONE ZEN 7,5MG CPR 5\n",
      "  3400938980073 | ZOPICLONE ZEN 7,5MG CPR 14\n",
      "  3400938980363 | DICLOFENAC ZEN 1% GEL TUBE 50G 1\n",
      "  3400938980592 | IBUPROFENE CRT 200MG CPR ENR 30\n",
      "  3400938980943 | GLIBENCLAMIDE ARW 2,5MG CPR 60\n",
      "  3400938981193 | DICLOFENAC REF 1% GEL FL 1\n",
      "  3400938982664 | GLIBENCLAMIDE ARW 5MG CPR 20\n",
      "  3400938984156 | IMETH 2,5MG CPR 24\n",
      "  3400938987119 | ACECLOFENAC EG 100MG CPR 30\n",
      "  3400938987638 | TERBINAFINE BGA 1% CREME 1\n",
      "  3400938991598 | LANSOPRAZOLE KRK 30MG GEL 14\n",
      "  3400938991710 | LANSOPRAZOLE KRK 30MG GEL 28\n",
      "  3400938993660 | LANSOPRAZOLE KRK 15MG GELU 15\n",
      "  3400938993899 | LANSOPRAZOLE KRK 15MG GELU 30\n",
      "  3400938994780 | INDAPAMIDE ZYD LP 1,5MG CPR 90\n",
      "  3400938997682 | CITALOPRAM ALT 20MG CPR 28\n",
      "  3400938999815 | EVANECIA CPR 63\n",
      "  3400939002538 | ALVESCO 80 MCG/DOSE SOL INH 1\n",
      "  3400939002996 | ALVESCO 160MCG/DOSE SOL INH 1\n",
      "  3400939003368 | NICORETTE 2MG GOMME MENT G SS SUCRE 210\n",
      "  3400939012704 | PRAVASTATINE SDZ 10 MG CPR 30\n",
      "  3400939013824 | PRAVASTATINE SDZ 20 MG CPR 30\n",
      "  3400939014944 | PRAVASTATINE SDZ 40 MG CPR 30\n",
      "  3400939016207 | NOMEGESTROL SDZ 5MG CPR 10\n",
      "  3400939016955 | TOPIRAMATE SDZ 100MG CPR 28\n",
      "  3400939020228 | ROTARIX SUSP BUV 1\n",
      "  3400939023410 | MIRTAZAPINE ALM 15MG CPR ORODISP 30\n",
      "  3400939023649 | PARACETAMOL COD CRT 500/30MG CPR EFF 16\n",
      "  3400939024479 | CODOLIPRANE 500/30MG CPR EFF 16\n",
      "  3400939028033 | BENAZEPRIL HCTZ EG 10/12,5MG CPR 30\n",
      "  3400939028262 | BENAZEPRIL HCTZ EG 10/12,5MG CPR 90\n",
      "  3400939029214 | FINASTERIDE ALM 5MG CPR 28\n",
      "  3400939030104 | PANTOPRAZOLE EG 20MG CPR 14\n",
      "  3400939030272 | PANTOPRAZOLE EG 20MG CPR 28\n",
      "  3400939030333 | PANTOPRAZOLE EG 40MG CPR 7\n",
      "  3400939030562 | PANTOPRAZOLE EG 40MG CPR 14\n",
      "  3400939030623 | PANTOPRAZOLE EG 40MG CPR 28\n",
      "  3400939037257 | MIRCERA 30 MCG SOL INJ SER 1\n",
      "  3400939038087 | MIRCERA 120 MCG SOL INJ SER 1\n",
      "  3400939038148 | MIRCERA 360 MCG SOL INJ SER 1\n",
      "  3400939047423 | RISPERIDONE VIATRIS 1 MG CPR 60\n",
      "  3400939047881 | RISPERIDONE VIATRIS 2MG CPR 60\n",
      "  3400939048543 | RISPERIDONE VIATRIS 4MG CPR 30\n",
      "  3400939049892 | GLICLAZIDE BGR LM 30MG CPR 30\n",
      "  3400939050034 | GLICLAZIDE BGR LM 30MG CPR 60\n",
      "  3400939052274 | ACNETRAIT 5MG CAPSULE MOLLE 30\n",
      "  3400939054926 | SIMVASTATINE EG 10MG CPR 30\n",
      "  3400939060439 | FLUCORTAC 50 MICROGRAMMES (FLUDROCORTISONE) 1 BOIT\n",
      "  3400939060668 | FLUCORTAC 50MICROGRAMMES CPR 60\n",
      "  3400939062389 | CEFEPIME VIATRIS 1G PDR INJ 1\n",
      "  3400939062969 | CEFEPIME VIATRIS 2G PDR INJ 1\n",
      "  3400939065922 | FINASTERIDE ALT 5MG CPR 28\n",
      "  3400939066233 | LORATADINE ALM 10MG CPR 15\n",
      "  3400939069593 | PARACETAMOL BGA 500MG PDR ORALE SACH 12\n",
      "  3400939069715 | PARACETAMOL BGA 1G PDR ORALE SACH 8\n",
      "  3400939070254 | CEFIXIME ARW 200MG CPR 8\n",
      "  3400939073385 | FENOFIBRATE CRSTP 200MG GELULE 30\n",
      "  3400939073446 | FENOFIBRATE CRSTP 200MG GELULE 90\n",
      "  3400939074566 | PANTOPRAZOLE CRT 20MG CPR 28\n",
      "  3400939074856 | PANTOPRAZOLE CRT 20MG CPR 14\n",
      "  3400939075167 | PANTOPRAZOLE CRT 20MG CPR 28\n",
      "  3400939076287 | ALFUZOSINE SUN LP 10MG CPR 30\n",
      "  3400939080130 | PANTOPRAZOLE CRT 40MG CPR 28\n",
      "  3400939080598 | PANTOPRAZOLE CRT 40MG CPR 14\n",
      "  3400939080710 | PANTOPRAZOLE CRT 40MG CPR 28\n",
      "  3400939080888 | PANTOPRAZOLE CRISTERS 40 MG, 1 BOITE DE 30, COMPRI\n",
      "  3400939082660 | CELIPROLOL ZEN 200MG CPR 30\n",
      "  3400939082721 | GLIBENCLAMIDE ARW 5MG CPR 100\n",
      "  3400939092546 | LOSARTAN ZTL 50MG CPR 28\n",
      "  3400939093956 | LOSARTAN ZTL 100MG CPR 28\n",
      "  3400939094618 | QUINAPRIL HCTZ EG 20/12,5MG CPR 30\n",
      "  3400939094786 | QUINAPRIL HCTZ EG 20/12,5MG CPR 90\n",
      "  3400939095219 | ARIMIDEX 1MG CPR 90\n",
      "  3400939095677 | INEGY 10MG/20MG CPR 90\n",
      "  3400939095738 | INEGY 10MG/40MG CPR 90\n",
      "  3400939098111 | INSPRA 25 MG CPR 90\n",
      "  3400939098579 | BISOPROLOL SDZ 1,25MG CPR 30\n",
      "  3400939099460 | INSPRA 50MG CPR 90\n",
      "  3400939099989 | BISOPROLOL SDZ 2,5MG CPR 30\n",
      "  3400939100913 | BISOPROLOL SDZ 3,75MG CPR 30\n",
      "  3400939101804 | BISOPROLOL SDZ 7,5MG CPR 30\n",
      "  3400939102863 | RISPERIDONE TVS 1MG/ML SOL BUV 30ML 1\n",
      "  3400939102924 | RISPERIDONE TVS 1MG/ML SOL BUV 60ML 1\n",
      "  3400939103235 | RISPERIDONE TVS 1MG/ML SOL BUV 120ML 1\n",
      "  3400939103464 | PREDNISOLONE VTS 20MG CPR ORODISP 20\n",
      "  3400939104294 | ABSTRAL 100MICROG CPR 10\n",
      "  3400939104355 | ABSTRAL 100MICROG CPR 30\n",
      "  3400939104416 | ABSTRAL 200 MICROG CPR 10\n",
      "  3400939104584 | ABSTRAL 200 MICROG CPR 30\n",
      "  3400939104645 | ABSTRAL 300MICROG CPR 10\n",
      "  3400939104706 | ABSTRAL 300MICROG CPR 30\n",
      "  3400939104874 | ABSTRAL 400MICROG CPR 10\n",
      "  3400939104935 | ABSTRAL 400MICROG CPR 30\n",
      "  3400939105185 | ABSTRAL 600MICROG CPR 30\n",
      "  3400939105765 | ABSTRAL 800MICROG CPR 30\n",
      "  3400939106595 | PREDNISOLONE ZEN LAB 20MG CPR OROD 20\n",
      "  3400939106885 | PREDNISOLONE ARW 20MG CPR ORODISP 20\n",
      "  3400939107196 | PREDNISOLONE BGA 20MG CPR ORODISP 20\n",
      "  3400939107486 | PREDNISOLONE CRT 20MG CPR ORODISP 20\n",
      "  3400939108087 | LOVAVULO 20MICROG/100MICROG CPR PELL 63\n",
      "  3400939108209 | PREDNISOLONE SDZ 20MG CPR ORODISP 20\n",
      "  3400939108957 | PREDNISOLONE TVC 20MG CPR ORODISP 20\n",
      "  3400939109329 | PREDNISOLONE SUN 20MG CPR ORODISP 20\n",
      "  3400939109619 | PREDNISOLONE EG 20MG CPR ORODISP 20\n",
      "  3400939110158 | LEVOFLOXACINE TVC 500MG CPR 5\n",
      "  3400939111568 | THYROZOL 5MG CPR 30\n",
      "  3400939111919 | THYROZOL 10MG CPR 30\n",
      "  3400939112459 | THYROZOL 20MG CPR 30\n",
      "  3400939118314 | BISOPROLOL SDZ 5MG CPR 30\n",
      "  3400939119892 | BISOPROLOL SDZ 10MG CPR PELL 30\n",
      "  3400939126357 | ACIDE FUSIDIQ SDZ 2% CR TB 15G 1\n",
      "  3400939126647 | AZARGA 10MG/5MG/ML COLLYRE FL 5ML 1\n",
      "  3400939131320 | LEVOFREE 0,05% COLLYRE UNIDOSE 0,3ML 30\n",
      "  3400939131788 | VENLAFAXINE EGL LP 37,5MG GELULE 30\n",
      "  3400939132501 | VENLAFAXINE EGL LP 75MG GELULE 30\n",
      "  3400939133560 | FLUOXETINE CRT 20MG CPR 28\n",
      "  3400939134680 | MACROGOL 4000 SDZ 10G PDR ORALE SACH 20\n",
      "  3400939137582 | VENLAFAXINE SUN LP 37,5 MG 1 BOITE DE 30, GELULES\n",
      "  3400939138015 | TOPIRAMATE BGR 50 MG CPR 28\n",
      "  3400939138473 | TOPIRAMATE BGR 100MG CPR 28\n",
      "  3400939139135 | TOPIRAMATE BGR 200 MG CPR 28\n",
      "  3400939142784 | ACIDE ALENDRONIQUE CRT 70MG CPR 4\n",
      "  3400939142906 | ACIDE ALENDRONIQUE CRT 70MG CPR 12\n",
      "  3400939144337 | ALENDRONIQUE ACIDE TVS 70MG CPR 4\n",
      "  3400939144627 | ALENDRONIQUE ACIDE TVS 70MG CPR 12\n",
      "  3400939156682 | AQUAREST 0,2% GEL OPH UNIDOSE 60\n",
      "  3400939157283 | LERCANIDIPINE BCR 10MG CPR 30\n",
      "  3400939157573 | LERCANIDIPINE BCR 10MG CPR 90\n",
      "  3400939158006 | LERCANIDIPINE BGA 10MG CPR 30\n",
      "  3400939158464 | LERCANIDIPINE BGA 10MG CPR 90\n",
      "  3400939158815 | LERCANIDIPINE ZEN 10MG CPR 30\n",
      "  3400939159126 | LERCANIDIPINE ZEN 10MG CPR 90\n",
      "  3400939159584 | SPRYCEL 100 MG CPR 30\n",
      "  3400939160535 | LERCANIDIPINE ZEN 20MG CPR 30\n",
      "  3400939161365 | ANASTROZOLE ARW 1MG CPR 30\n",
      "  3400939169002 | CRESTOR 5MG CPR 90\n",
      "  3400939169460 | CRESTOR 10MG CPR 30\n",
      "  3400939169699 | CRESTOR 10MG CPR 90\n",
      "  3400939169750 | CRESTOR 20MG CPR 30\n",
      "  3400939169989 | CRESTOR 20MG CPR 90\n",
      "  3400939170060 | EZETROL 10MG CPR 90\n",
      "  3400939170411 | LERCANIDIPINE BCR 20MG CPR 30\n",
      "  3400939170701 | LERCANIDIPINE BGA 20MG CPR 30\n",
      "  3400939174723 | OLANZAPINE ALT 5MG CPR 28\n",
      "  3400939175324 | OLANZAPINE ALT 10MG CPR 28\n",
      "  3400939180236 | RISPERIDONE MYL 0,5MG CPR DISP 28\n",
      "  3400939180526 | RISPERIDONE MYL 1MG CPR DISP 28\n",
      "  3400939181066 | PACILIA CPR 21\n",
      "  3400939181127 | PACILIA CPR 63\n",
      "  3400939184609 | TRIMEBUTINE SDZ 200MG CPR 30\n",
      "  3400939185668 | TRAMADOL ARW LP 100MG GELULE 30\n",
      "  3400939185897 | TRAMADOL ARW LP 200MG GELULE 30\n",
      "  3400939186788 | TRAMADOL ARW LP 150MG GELULE 30\n",
      "  3400939190051 | IXPRIM 37,5MG/325MG CPR EFF 20\n",
      "  3400939191690 | ZOLMITRIPTAN ZYF 2,5MG CPR ORODISP 6\n",
      "  3400939191812 | ZOLMITRIPTAN ZYF 2,5MG CPR ORODISP 12\n",
      "  3400939192123 | ZOLMITRIPTAN EVO 2,5MG CPR ORODISP 6\n",
      "  3400939193304 | ZOLMITRIPTAN EVO 2,5MG CPR ORODISP 12\n",
      "  3400939196664 | PERINDOPRIL INDAP ARW 4/1,25 MG CPR 30\n",
      "  3400939197036 | PERINDOPRIL INDAP ARW 4/1,25 MG CPR 90\n",
      "  3400939199795 | ACIDE FUSIDIQ ZEN 2% CR TB 15G 1\n",
      "  3400939200439 | FENTANYL BGA 25MICROG/H DISP TRANSD 5\n",
      "  3400939200668 | FENTANYL BGA 50MICROG/H DISP TRANSD 5\n",
      "  3400939200729 | FENTANYL BGA 75MICROG/H DISP TRANSD 5\n",
      "  3400939201030 | FINASTERIDE ACC 5MG CPR 28\n",
      "  3400939202099 | FENTANYL BGA 100MICROG/H DISP TRANSD 5\n",
      "  3400939203799 | GABAPENTINE EGL 600MG CPR 90\n",
      "  3400939204741 | GABAPENTINE EGL 800MG CPR 90\n",
      "  3400939207414 | AMOXICILLINE SDZ 1G CPR DISP 6\n",
      "  3400939207872 | AMOXICILLINE SDZ 1G CPR DISP 14\n",
      "  3400939212265 | XOLAIR 75 MG SOL INJ SER 1\n",
      "  3400939212494 | XOLAIR 150 MG SOL INJ SER 1\n",
      "  3400939213095 | PANTOPRAZOLE BGA 40MG CPR 28\n",
      "  3400939213156 | PANTOPRAZOLE BGA 40MG CPR 7\n",
      "  3400939213217 | PANTOPRAZOLE BGA 40MG CPR 14\n",
      "  3400939213385 | PANTOPRAZOLE BGA 40MG CPR 28\n",
      "  3400939215747 | BRICANYL 0,5MG SOL INJ 10\n",
      "  3400939220710 | EFFENTORA 100MICROG CPR GINGIVAL 4\n",
      "  3400939220888 | EFFENTORA 100MICROG CPR GINGIVAL 28\n",
      "  3400939220949 | EFFENTORA 200MICROG CPR GINGIVAL 4\n",
      "  3400939221021 | EFFENTORA 200MICROG CPR GINGIVAL 28\n",
      "  3400939221250 | EFFENTORA 400MICROG CPR GINGIVAL 28\n",
      "  3400939221489 | EFFENTORA 600MICROG CPR GINGIVAL 28\n",
      "  3400939222950 | BISOPROLOL HCTZ BGA 2,5/6,25MG CPR 30\n",
      "  3400939223322 | BISOPROLOL HCTZ BGA 2,5/6,25MG CPR 90\n",
      "  3400939223612 | BISOPROLOL HCTZ BGA 5/6,25MG CPR 30\n",
      "  3400939223902 | BISOPROLOL HCTZ BGA 5/6,25MG CPR 90\n",
      "  3400939224213 | BISOPROLOL HCTZ BGA 10/6,25MG CPR 30\n",
      "  3400939224503 | BISOPROLOL HCTZ BGA 10/6,25MG CPR 90\n",
      "  3400939239521 | OGASTORO 15MG CPR 14\n",
      "  3400939239699 | OGASTORO 15MG CPR 28\n",
      "  3400939239811 | OGASTORO 30MG CPR 14\n",
      "  3400939239989 | OGASTORO 30MG CPR 28\n",
      "  3400939240879 | LERCANIDIPINE BCR 20MG CPR 90\n",
      "  3400939241180 | LERCANIDIPINE BGA 20MG CPR 90\n",
      "  3400939241470 | LERCANIDIPINE ZEN 20MG CPR 90\n",
      "  3400939255439 | PANTOPRAZOLE KRK 20MG CPR 14\n",
      "  3400939255729 | PANTOPRAZOLE KRK 20MG CPR 28\n",
      "  3400939257440 | PANTOPRAZOLE KRK 40MG CPR 14\n",
      "  3400939257679 | PANTOPRAZOLE KRK 40MG CPR 28\n",
      "  3400939258331 | RAMIPRIL ALM 10 MG CPR 90\n",
      "  3400939258621 | STELARA 45MG SOL INJ FL 0,5ML 1\n",
      "  3400939259802 | ANASTROZOLE EG 1MG CPR 30\n",
      "  3400939263991 | FENOFIBRATE ZEN 145MG CPR 30\n",
      "  3400939264363 | FENOFIBRATE ZEN 145MG CPR 90\n",
      "  3400939266664 | FENOFIBRATE SDZ 145MG CPR 30\n",
      "  3400939266954 | FENOFIBRATE SDZ 145MG CPR 90\n",
      "  3400939267494 | FENOFIBRATE BGA 145MG CPR 30\n",
      "  3400939267784 | FENOFIBRATE BGA 145MG CPR 90\n",
      "  3400939268156 | FENOFIBRATE EG 145MG CPR 30\n",
      "  3400939268446 | FENOFIBRATE EG 145MG CPR 90\n",
      "  3400939270685 | CEFPODOXIME SDZ 100MG CPR 10\n",
      "  3400939271286 | PANTOPRAZOLE MYP 40MG CPR 28\n",
      "  3400939273129 | LOSARTAN HCTZ SDZ 100/25MG CPR 30\n",
      "  3400939273648 | LOSARTAN HCTZ SDZ 100/25MG CPR 90\n",
      "  3400939274249 | LOSARTAN HCTZ SDZ 50/12,5MG CPR 30\n",
      "  3400939274829 | LOSARTAN HCTZ SDZ 50/12,5MG CPR 90\n",
      "  3400939275369 | LEVOCETIRIZINE TVC 5MG CPR 14\n",
      "  3400939275710 | LEVOCETIRIZINE TVC 5MG CPR 28\n",
      "  3400939276250 | RAMIPRIL ARG 5MG CPR 30\n",
      "  3400939277431 | IRBESARTAN SUN 75MG CPR PELL 30\n",
      "  3400939277950 | IRBESARTAN SUN 75MG CPR PELL 90\n",
      "  3400939278551 | IRBESARTAN SUN 150MG CPR PELL 30\n",
      "  3400939278902 | IRBESARTAN SUN 150MG CPR PELL 90\n",
      "  3400939279442 | IRBESARTAN SUN 300MG CPR PELL 30\n",
      "  3400939279961 | IRBESARTAN SUN 300MG CPR PELL 90\n",
      "  3400939280790 | SMOFKABIVEN E EMULS INJ POC 986ML 4\n",
      "  3400939280912 | SMOFKABIVEN E EMULS INJ POC 1477ML 4\n",
      "  3400939281223 | SMOFKABIVEN E EMULS INJ POC 1970ML 4\n",
      "  3400939281742 | LAMOTRIGINE TVC 5MG CPR DISP 30\n",
      "  3400939282114 | LAMOTRIGINE TVC 25MG CPR DISP 30\n",
      "  3400939282572 | LAMOTRIGINE TVC 50MG CPR DISP 30\n",
      "  3400939283005 | LAMOTRIGINE TVC 100MG CPR DISP 30\n",
      "  3400939283524 | LAMOTRIGINE TVC 200MG CPR DISP 30\n",
      "  3400939285306 | ROPINIROLE ARG 0,25MG CPR 21\n",
      "  3400939286945 | ROPINIROLE ARG 0,50MG CPR 21\n",
      "  3400939289908 | PERINDOPRIL INDAP VIAT 2/0,625MG CPR 30\n",
      "  3400939290447 | PERINDOPRIL INDAP VIAT 2/0,625MG CPR 90\n",
      "  3400939295350 | PERINDOPRIL INDAP VTS 4/1,25MG CPR 30\n",
      "  3400939295701 | PERINDOPRIL INDAP VTS 4/1,25MG CPR 90\n",
      "  3400939299372 | ROPINIROLE ARG 1MG CPR 21\n",
      "  3400939300764 | ROPINIROLE ARG 2MG CPR 21\n",
      "  3400939302485 | ROPINIROLE TVC 0,25MG CPR 21\n",
      "  3400939303895 | ROPINIROLE TVC 0,50MG CPR 21\n",
      "  3400939303956 | ROPINIROLE TVC 0,50MG CPR 28\n",
      "  3400939304847 | ROPINIROLE TVC 1MG CPR 21\n",
      "  3400939305509 | ROPINIROLE TVC 2MG CPR 21\n",
      "  3400939305677 | ROPINIROLE TVC 2MG CPR 28\n",
      "  3400939307510 | PANTOPRAZOLE MYP 40MG CPR 7\n",
      "  3400939307688 | PANTOPRAZOLE MYP 40MG CPR 14\n",
      "  3400939307749 | PANTOPRAZOLE MYP 40MG CPR 28\n",
      "  3400939308869 | BRIMONIDINE SDZ 0,2% COLLYRE 1\n",
      "  3400939311241 | SINGULAIR 4MG CPR 28\n",
      "  3400939312361 | SINGULAIR 4MG GRANULES 28\n",
      "  3400939313832 | PREZISTA 400MG CPR 60\n",
      "  3400939314082 | PREZISTA 600MG CPR 60\n",
      "  3400939314204 | TARKA LP 240MG/2MG CPR 30\n",
      "  3400939314433 | TARKA LP 240MG/2MG CPR 90\n",
      "  3400939314662 | REBIF 66 MCG SOL INJ CART 1,5ML 4\n",
      "  3400939314723 | REBIF 132 MCG SOL INJ CART 1,5ML 4\n",
      "  3400939315492 | BIPRETERAX 10MG/2,5MG CPR 30\n",
      "  3400939315843 | BIPRETERAX 10MG/2,5MG CPR 90\n",
      "  3400939316963 | TARKA LP 240MG/4MG CPR 30\n",
      "  3400939317106 | TARKA LP 240MG/4MG CPR 90\n",
      "  3400939318516 | BICALUTAMIDE EVO 50MG CPR 30\n",
      "  3400939320465 | CEFUROXIME TVC 250MG CPR 8\n",
      "  3400939320694 | PANTOPRAZOLE MYP 20MG CPR 28\n",
      "  3400939320755 | PANTOPRAZOLE MYP 20MG CPR 14\n",
      "  3400939320816 | PANTOPRAZOLE MYP 20MG CPR 28\n",
      "  3400939320984 | CEFUROXIME TVC 500MG CPR 8\n",
      "  3400939321936 | PANTOPRAZOLE BGA 20MG CPR 28\n",
      "  3400939322018 | PANTOPRAZOLE BGA 20MG CPR 14\n",
      "  3400939322186 | PANTOPRAZOLE BGA 20MG CPR 28\n",
      "  3400939322827 | AZITHROMYCINE ZEN 250MG CPR 6\n",
      "  3400939323947 | VALACICLOVIR EG LABO 500 MG 1 BOITE DE 10, COMPRIM\n",
      "  3400939324197 | VALACICLOVIR EG LABO 500 MG 1 BOITE DE 42, COMPRIM\n",
      "  3400939324487 | VALACICLOVIR EG LABO 500 MG 1 BOITE DE 112, COMPRI\n",
      "  3400939326849 | LOSARTAN EG 50MG CPR 30\n",
      "  3400939327150 | LOSARTAN EG 50MG CPR 90\n",
      "  3400939329161 | NEBIVOLOL VTS 5MG CPR 30\n",
      "  3400939329680 | NEBIVOLOL VTS 5MG CPR 90\n",
      "  3400939332703 | LOSARTAN EG 100MG CPR 30\n",
      "  3400939333014 | LOSARTAN EG 100MG CPR 90\n",
      "  3400939333182 | LATANOPROST ARW 0,005% COLLYRE 1\n",
      "  3400939333243 | LATANOPROST ARW 0,005% COLLYRE 3\n",
      "  3400939339047 | RISPERIDONE TVC 0,5MG CPR DISP 28\n",
      "  3400939339856 | RISPERIDONE TVC 1MG CPR DISP 28\n",
      "  3400939340456 | PAROXETINE CRT 20MG CPR 14\n",
      "  3400939343129 | PRAMIPEXOLE EG 0,18MG CPR 30\n",
      "  3400939343358 | PRAMIPEXOLE EG 0,18MG CPR 100\n",
      "  3400939343587 | PRAMIPEXOLE EG 0,7MG CPR 30\n",
      "  3400939343709 | PRAMIPEXOLE EG 0,7MG CPR 100\n",
      "  3400939347431 | LORATADINE ZYD 10MG CPR 15\n",
      "  3400939349381 | RILUZOLE ARW 50MG CPR 56\n",
      "  3400939354415 | ZARZIO 30 MUI SOL INJ SER 1\n",
      "  3400939354644 | ZARZIO 30 MUI SOL INJ SER 5\n",
      "  3400939354873 | ZARZIO 48 MUI SOL INJ SER 1\n",
      "  3400939355016 | ZARZIO 48 MUI SOL INJ SER 5\n",
      "  3400939367071 | TERBINAFINE PFA 1% CREME 1\n",
      "  3400939369204 | OLANZAPINE EG 5 MG CPR 28\n",
      "  3400939370613 | OLANZAPINE EG 7,5 MG CPR 28\n",
      "  3400939371214 | OLANZAPINE EG 10 MG CPR 28\n",
      "  3400939374925 | NEBIVOLOL RBX 5MG CPR 30\n",
      "  3400939375236 | NEBIVOLOL RBX 5MG CPR 90\n",
      "  3400939378138 | FLUVASTATINE BGA LP 80MG CPR 30\n",
      "  3400939378428 | FLUVASTATINE BGA LP 80MG CPR 90\n",
      "  3400939383620 | RAMIPRIL ARG 10MG CPR 30\n",
      "  3400939388243 | PANTOPRAZOLE ALM 20MG CPR 14\n",
      "  3400939388472 | PANTOPRAZOLE ALM 20MG CPR 28\n",
      "  3400939389653 | PANTOPRAZOLE ALM 40MG CPR 14\n",
      "  3400939389882 | PANTOPRAZOLE ALM 40MG CPR 28\n",
      "  3400939390543 | FENTANYL SDZ 25MICROG/H DISP TRANSD 5\n",
      "  3400939391144 | FENTANYL SDZ 50MICROG/H DISP TRANSD 5\n",
      "  3400939391892 | FENTANYL SDZ 75MICROG/H DISP TRANSD 5\n",
      "  3400939392325 | FENTANYL SDZ 100MICROG/H DISP TRANSD 5\n",
      "  3400939394626 | PERINDOPRIL ARROW 4 MG CPR 30\n",
      "  3400939394855 | PERINDOPRIL ARROW 4 MG CPR 90\n",
      "  3400939396347 | CONEBILOX 5MG/12,5MG CPR 30\n",
      "  3400939396637 | CONEBILOX 5MG/12,5MG CPR 90\n",
      "  3400939396866 | TERBINAFINE SUN 250 MG CPR 28\n",
      "  3400939397177 | CONEBILOX 5MG/25MG CPR 30\n",
      "  3400939397528 | CONEBILOX 5MG/25MG CPR 90\n",
      "  3400939397696 | TEMERITDUO 5MG/12,5MG CPR 30\n",
      "  3400939397757 | TEMERITDUO 5MG/12,5MG CPR 90\n",
      "  3400939397818 | TEMERITDUO 5MG/25MG CPR 30\n",
      "  3400939397986 | TEMERITDUO 5MG/25MG CPR 90\n",
      "  3400939399188 | PERINDOPRIL ARROW 2 MG CPR 30\n",
      "  3400939399300 | PERINDOPRIL ARROW 2 MG CPR 90\n",
      "  3400939399768 | FINASTERIDE ZYD 5MG CPR 28\n",
      "  3400939401690 | PERINDOPRIL ARROW 8 MG CPR 30\n",
      "  3400939401812 | PERINDOPRIL ARROW 8 MG CPR 90\n",
      "  3400939404073 | SIMVASTATINE BGA 20MG CPR 28\n",
      "  3400939409627 | CHLORHEX/CHLOROBUT BGA SOL BDB 90ML 1\n",
      "  3400939409917 | CHLORHEX/CHLOROBUT TVC SOL BDB 90ML 1\n",
      "  3400939410807 | CHLORHEX/CHLOROBUT EG SOL BDB 90ML 1\n",
      "  3400939412467 | CHLORHEX/CHLOROBUT SDZ SOL BDB 90ML 1\n",
      "  3400939416830 | SIMVASTATINE ZYF 20MG CPR 90\n",
      "  3400939417370 | TRAMADOL ZYD LP 150MG CPR 30\n",
      "  3400939417899 | TRAMADOL ZYD LP 200MG CPR 30\n",
      "  3400939418261 | FOSFOMYCINE ARW 3G GRANULES SACHET 1\n",
      "  3400939419671 | FLUVASTATINE ARW LP 80MG CPR 30\n",
      "  3400939419961 | FLUVASTATINE ARW LP 80MG CPR 90\n",
      "  3400939423524 | FOSFOMYCINE BGA 3G GRANULES SACHET 1\n",
      "  3400939423692 | FOSFOMYCINE EG 3G GRANULES SACHET 1\n",
      "  3400939423814 | FOSFOMYCINE VTS 3G GRANULES SACHET 1\n",
      "  3400939425764 | FLUVASTATINE ZEN LP 80MG CPR 30\n",
      "  3400939425993 | FLUVASTATINE ZEN LP 80MG CPR 90\n",
      "  3400939431338 | FLUVASTATINE TVC LP 80MG CPR 30\n",
      "  3400939432687 | FIRMAGON 80MG PDR ET SOL INJ 1\n",
      "  3400939432748 | FIRMAGON 120MG PDR ET SOL INJ 2\n",
      "  3400939433059 | VALDOXAN 25 MG CPR 28\n",
      "  3400939434698 | TOPIRAMATE SDZ 50MG CPR 28\n",
      "  3400939439372 | LETROZOLE AHL 2,5MG CPR 30\n",
      "  3400939440842 | SIMVASTATINE ZYF 40MG CPR 90\n",
      "  3400939441962 | STALEVO 75MG/18,75MG/200MG CPR 100\n",
      "  3400939442563 | STALEVO 125MG/31,25MG/200MG CPR 100\n",
      "  3400939446417 | DOXAZOSINE TVC LP 4MG CPR 28\n",
      "  3400939450377 | ELLAONE 30MG CPR 1\n",
      "  3400939454221 | OLANZAPINE MYL 5MG CPR 28\n",
      "  3400939454399 | OLANZAPINE MYL 5MG CPR 28\n",
      "  3400939454511 | OLANZAPINE MYL 7,5MG CPR 28\n",
      "  3400939454689 | OLANZAPINE MYL 7,5MG CPR 28\n",
      "  3400939454979 | OLANZAPINE MYL 10MG CPR PEL 28\n",
      "  3400939455051 | OLANZAPINE MYL 10MG CPR PEL 28\n",
      "  3400939457413 | RISPERIDONE ZYD 1MG CPR 60\n",
      "  3400939457703 | RISPERIDONE ZYD 2MG CPR 60\n",
      "  3400939458472 | RISPERIDONE ZYD 4MG CPR 30\n",
      "  3400939461724 | PHLOROGLUCINOL CRT 80MG CPR DISP 10\n",
      "  3400939462783 | VALACICLOVIR CRT 500MG CPR 10\n",
      "  3400939463506 | FOSFOMYCINE CRT 3G GRANULES SACHET 1\n",
      "  3400939464565 | PERINDOPRIL SDZ 8MG CPR 30\n",
      "  3400939464916 | PERINDOPRIL SDZ 8MG CPR 90\n",
      "  3400939466927 | LOSARTAN EVO 50MG CPR 30\n",
      "  3400939467009 | LOSARTAN EVO 50MG CPR 90\n",
      "  3400939467757 | SIMVASTATINE ZYF 10MG CPR 30\n",
      "  3400939468129 | SIMVASTATINE ZYF 40MG CPR 30\n",
      "  3400939468297 | SIMVASTATINE ZYF 20MG CPR 30\n",
      "  3400939473901 | SIMVASTATINE BGA 20MG CPR 84\n",
      "  3400939476803 | TRAMADOL ARW LP 200MG CPR 30\n",
      "  3400939478814 | TRAMADOL ACT LP 100MG CPR 30\n",
      "  3400939479873 | OLANZAPINE EG 5 MG CPR DISP 28\n",
      "  3400939480244 | OLANZAPINE EG 10 MG CPR DISP 28\n",
      "  3400939482255 | DIOSMECTITE VIATRIS 3G PDR SUSP BUV 30\n",
      "  3400939482316 | DIOSMECTITE VIATRIS 3G PDR SUSP BUV 60\n",
      "  3400939491301 | ONDANSETRON CRT 8MG CPR 2\n",
      "  3400939491530 | ONDANSETRON CRT 8MG CPR 4\n",
      "  3400939492711 | VALACICLOVIR EG 500MG CPR 10\n",
      "  3400939492940 | VALACICLOVIR EG 500MG CPR 42\n",
      "  3400939493251 | VALACICLOVIR EG 500MG CPR 112\n",
      "  3400939497914 | LEVOFLOXACINE CRT 500MG CPR 5\n",
      "  3400939498744 | LEVOFLOXACINE EG 500MG CPR 5\n",
      "  3400939499284 | FLUVASTATINE VTS 20MG GELULE 30\n",
      "  3400939499406 | FLUVASTATINE VTS 20MG GELULE 90\n",
      "  3400939500157 | FLUVASTATINE VTS 40MG GELULE 30\n",
      "  3400939500386 | FLUVASTATINE VTS 40MG GELULE 90\n",
      "  3400939500966 | AZITHROMYCINE CRT 250MG CPR 6\n",
      "  3400939501048 | ONYTEC 80 MG/G (CICLOPIROX) 1 FLACON DE 3,3 ML, VE\n",
      "  3400939501109 | ONYTEC 8% VERNIS 1\n",
      "  3400939503868 | IRBESARTAN SDZ 75MG CPR PELL 30\n",
      "  3400939504520 | IRBESARTAN SDZ 75MG CPR PELL 90\n",
      "  3400939507361 | IRBESARTAN SDZ 150MG CPR PELL 30\n",
      "  3400939507941 | IRBESARTAN SDZ 150MG CPR PELL 90\n",
      "  3400939510491 | IRBESARTAN SDZ 300MG CPR PELL 30\n",
      "  3400939511092 | IRBESARTAN SDZ 300MG CPR PELL 90\n",
      "  3400939517308 | OROFLUCO 150 MG GELULE 1\n",
      "  3400939520896 | BRIMONIDINE CHV 0,2% COLLYRE 1\n",
      "  3400939521787 | LOSARTAN HCTZ VIATRIS 50/12,5MG CPR 28\n",
      "  3400939522500 | LOSARTAN HCTZ VIATRIS 100/25MG CPR 28\n",
      "  3400939524450 | PANTOPRAZOLE SUN 20MG CPR 14\n",
      "  3400939524689 | PANTOPRAZOLE SUN 20MG CPR 28\n",
      "  3400939526461 | FLUCONAZOLE CRT 50MG GELULE 7\n",
      "  3400939526690 | FLUCONAZOLE CRT 100MG GELULE 7\n",
      "  3400939526812 | FLUCONAZOLE CRT 200MG GELULE 7\n",
      "  3400939528304 | OLANZAPINE ARG 10MG CPR DISP 28\n",
      "  3400939528762 | OLANZAPINE ARG 10MG CPR DISP 28\n",
      "  3400939533384 | EUROBIOL 25000U GELULE 100\n",
      "  3400939534626 | ADVAGRAF LP 3MG GELULE 30\n",
      "  3400939534794 | ORDIPHA 500MG CPR 3\n",
      "  3400939535166 | NEULASTA 6 MG SER SOL INJ 1\n",
      "  3400939535456 | SIROCTID 0,05 MG SOL INJ SER 1ML 6\n",
      "  3400939536057 | PRAMIPEXOLE TVC 0,18MG CPR 30\n",
      "  3400939536637 | PRAMIPEXOLE TVC 0,7MG CPR 30\n",
      "  3400939538587 | SIROCTID 0,1 MG SOL INJ SER 1ML 6\n",
      "  3400939540948 | OMEPRAZOLE SDZ 10MG GELULE 14\n",
      "  3400939541198 | OMEPRAZOLE SDZ 10MG GELULE 28\n",
      "  3400939541488 | OMEPRAZOLE SDZ 20MG GELULE 7\n",
      "  3400939541549 | OMEPRAZOLE SDZ 20MG GELULE 14\n",
      "  3400939541778 | OMEPRAZOLE SDZ 20MG GELULE 28\n",
      "  3400939542379 | SIROCTID 0,5 MG SOL INJ SER 1ML 6\n",
      "  3400939544441 | OLANZAPINE EVO 5MG CPR 28\n",
      "  3400939545103 | OLANZAPINE EVO 10MG CPR 28\n",
      "  3400939546803 | VALACICLOVIR MYP 500MG CPR 10\n",
      "  3400939547053 | VALACICLOVIR MYP 500MG CPR 42\n",
      "  3400939554785 | OLANZAPINE EVO 7,5MG CPR 28\n",
      "  3400939559230 | LOSARTAN HCTZ VIATRIS 50/12,5MG CPR 90\n",
      "  3400939559520 | LOSARTAN HCTZ VIATRIS 100/25MG CPR 90\n",
      "  3400939559759 | VALACICLOVIR TVC 500MG CPR 112\n",
      "  3400939565033 | VALACICLOVIR CRTP 500MG CPR 10\n",
      "  3400939565323 | VALACICLOVIR CRTP 500MG CPR 42\n",
      "  3400939565613 | VALACICLOVIR CRTP 500MG CPR 112\n",
      "  3400939569574 | BISOPROLOL BGA 10MG CPR PELL 90\n",
      "  3400939574486 | FOSINOPRIL BGA 10MG CPR 30\n",
      "  3400939574776 | FOSINOPRIL BGA 20MG CPR 30\n",
      "  3400939578330 | FOSINOPRIL BGA 20MG CPR 90\n",
      "  3400939580289 | LEVOFLOXACINE SUN 500MG CPR 5\n",
      "  3400939582290 | LEVOFLOXACINE EVO 500MG CPR 5\n",
      "  3400939584133 | LEVOFLOXACINE BGA 500MG CPR 5\n",
      "  3400939585543 | VALACICLOVIR EVO 500MG CPR 10\n",
      "  3400939585772 | VALACICLOVIR EVO 500MG CPR 42\n",
      "  3400939586373 | FOSINOPRIL BGA 10MG CPR 90\n",
      "  3400939591575 | ARANESP 20 MICROG INJ SER 1\n",
      "  3400939591865 | ARANESP 30 MICROG INJ SER 1\n",
      "  3400939592008 | ARANESP 40 MICROG INJ SER 1\n",
      "  3400939592237 | ARANESP 50 MICROG INJ SER 1\n",
      "  3400939592527 | ARANESP 60 MICROG/0,3ML INJ SER 1\n",
      "  3400939592756 | ARANESP 80 MICROG/0,4ML INJ SER 1\n",
      "  3400939592985 | ARANESP 100 MICROG/0,5ML INJ SER 1\n",
      "  3400939593128 | ARANESP 130 MICROG/0,65ML INJ SER 1\n",
      "  3400939593357 | ARANESP 150 MICROG INJ SER 1\n",
      "  3400939593586 | ARANESP 300 MICROG INJ SER 1\n",
      "  3400939593708 | ARANESP 500 MICROG INJ SER 1\n",
      "  3400939594828 | MODIGRAF 0,2 MG SUSP BUV 50\n",
      "  3400939594996 | MODIGRAF 1 MG SUSP BUV 50\n",
      "  3400939595078 | IRESSA 250MG CPR 30\n",
      "  3400939595368 | PREZISTA 150MG CPR 240\n",
      "  3400939598840 | SPIRONOLACTONE TVC 25MG CPR 30\n",
      "  3400939598901 | SPIRONOLACTONE TVC 25MG CPR 90\n",
      "  3400939599212 | FLUVASTATINE ACT 20MG GELULE 30\n",
      "  3400939599441 | FLUVASTATINE ACT 20MG GELULE 90\n",
      "  3400939599731 | FLUVASTATINE ACT 40MG GELULE 30\n",
      "  3400939600024 | FLUVASTATINE ACT 40MG GELULE 90\n",
      "  3400939600543 | VALSARTAN/HCTZ TVC 160/25MG CPR 30\n",
      "  3400939601083 | VALSARTAN/HCTZ TVC 160/25MG CPR 90\n",
      "  3400939601892 | VALSARTAN/HCTZ TVC 80/12,5MG CPR 30\n",
      "  3400939602325 | VALSARTAN/HCTZ TVC 80/12,5MG CPR 90\n",
      "  3400939602905 | VALSARTAN/HCTZ TVC 160/12,5MG CPR 30\n",
      "  3400939603384 | VALSARTAN/HCTZ TVC 160/12,5MG CPR 90\n",
      "  3400939605227 | ENBREL 50MG SOL INJ STYLO 4\n",
      "  3400939606866 | TRANDOLAPRIL ARW 2MG GELULE 28\n",
      "  3400939614731 | SPIRONOLACTONE CRT 25MG CPR 30\n",
      "  3400939615103 | SPIRONOLACTONE EG 25MG CPR 30\n",
      "  3400939615271 | SPIRONOLACTONE EG 25MG CPR 90\n",
      "  3400939616742 | SPIRONOLACTONE SDZ 25MG CPR 30\n",
      "  3400939616803 | SPIRONOLACTONE SDZ 25MG CPR 90\n",
      "  3400939618524 | FLUVASTATINE BGA 20MG GELULE 30\n",
      "  3400939618753 | FLUVASTATINE BGA 20MG GELULE 90\n",
      "  3400939621425 | LOSARTAN KRK 100MG CPR 30\n",
      "  3400939627748 | SPIRONOLACTONE BGA 25MG CPR 90\n",
      "  3400939627977 | SPIRONOLACTONE PFZ 25MG CPR 90\n",
      "  3400939628110 | AFINITOR 5 MG CPR 30\n",
      "  3400939628288 | AFINITOR 10 MG CPR 30\n",
      "  3400939628349 | CLOPIDOGREL TPH 75 MG CPR 30\n",
      "  3400939628400 | TRIMEBUTINE ZEN 200MG CPR 30\n",
      "  3400939629810 | TRIMEBUTINE EVO 200MG CPR 30\n",
      "  3400939630069 | TRIMEBUTINE SUN 200MG CPR 30\n",
      "  3400939630939 | VALSARTAN TVC 40MG CPR 30\n",
      "  3400939631301 | VALSARTAN TVC 40MG CPR 90\n",
      "  3400939631769 | TRIMEBUTINE PFZ 200MG CPR 30\n",
      "  3400939632131 | TRIMEBUTINE PFZ 100MG CPR 30\n",
      "  3400939632360 | VICTOZA 18 MG SOL INJ STYLO 2\n",
      "  3400939636153 | VALSARTAN TVC 80MG CPR 30\n",
      "  3400939637044 | VALSARTAN TVC 80MG CPR 90\n",
      "  3400939638973 | VALSARTAN TVC 160MG CPR 30\n",
      "  3400939639864 | VALSARTAN TVC 160MG CPR 90\n",
      "  3400939640983 | FENTANYL ARW 25MICROG/H DISP TRANSD 5\n",
      "  3400939641355 | FENTANYL ARW 100MICROG/H DISP TRANSD 5\n",
      "  3400939641706 | FENTANYL ARW 50MICROG/H DISP TRANSD 5\n",
      "  3400939645087 | LOSARTAN ZEN 50MG CPR 28\n",
      "  3400939645667 | LOSARTAN ZEN 50MG CPR 90\n",
      "  3400939646497 | LOSARTAN ZEN 100MG CPR 28\n",
      "  3400939646909 | LOSARTAN ZEN 100MG CPR 90\n",
      "  3400939647678 | LOSARTAN HCTZ ZEN 50/12,5 MG CPR 28\n",
      "  3400939648620 | LOSARTAN HCTZ ZEN 100/12,5MG CPR 28\n",
      "  3400939649221 | LOSARTAN HCTZ ZEN 100/12,5MG CPR 90\n",
      "  3400939649689 | LOSARTAN HCTZ ZEN 100/25MG CPR 28\n",
      "  3400939650111 | LOSARTAN HCTZ ZEN 100/25MG CPR 90\n",
      "  3400939650340 | NICORETTESKIN 10MG/16H D TRANSDERM 7\n",
      "  3400939650579 | NICORETTESKIN 10MG/16H D TRANSDERM 28\n",
      "  3400939650630 | NICORETTESKIN 15MG/16H D TRANSDERM 7\n",
      "  3400939650920 | NICORETTESKIN 15MG/16H D TRANSDERM 28\n",
      "  3400939651002 | NICORETTESKIN 25MG/16H D TRANSDERM 7\n",
      "  3400939651231 | NICORETTESKIN 25MG/16H D TRANSDERM 28\n",
      "  3400939652290 | GLIMEPIRIDE CRT 2 MG CPR 30\n",
      "  3400939652351 | GLIMEPIRIDE CRT 2 MG CPR 90\n",
      "  3400939652580 | GLIMEPIRIDE CRT 1MG CPR 30\n",
      "  3400939652641 | GLIMEPIRIDE CRT 1MG CPR 90\n",
      "  3400939652931 | LOSARTAN SDZ 50MG CPR 90\n",
      "  3400939653242 | GLIMEPIRIDE CRT 4MG CPR 30\n",
      "  3400939653303 | GLIMEPIRIDE CRT 4MG CPR 90\n",
      "  3400939653990 | GLIMEPIRIDE CRT 3 MG CPR 30\n",
      "  3400939654072 | GLIMEPIRIDE CRT 3 MG CPR 90\n",
      "  3400939660974 | MELOXICAM BGA 7,5MG CPR 14\n",
      "  3400939663586 | MELOXICAM BGA 15MG CPR 14\n",
      "  3400939665429 | ANASTROZOLE CRT 1MG CPR 30\n",
      "  3400939666259 | OLANZAPINE SUN 5MG CPR 28\n",
      "  3400939668031 | OLANZAPINE SUN 7,5MG CPR 28\n",
      "  3400939668901 | OLANZAPINE SUN 10MG CPR 28\n",
      "  3400939670270 | RENVELA 800MG CPR 180\n",
      "  3400939670799 | RENVELA 2,4G PDR ORALE SACHET 90\n",
      "  3400939671741 | OLANZAPINE SUN 5MG CPR DISP 28\n",
      "  3400939672861 | OLANZAPINE SUN 10MG CPR DISP 28\n",
      "  3400939674643 | AMLODIPINE CRT 5MG GELULE 30\n",
      "  3400939674704 | AMLODIPINE CRT 5MG GELULE 90\n",
      "  3400939674933 | KETOPROFENE EG 150 MG 1 BOITE DE 20, COMPRIMES SEC\n",
      "  3400939675183 | AMLODIPINE CRT 10MG GELULE 30\n",
      "  3400939675244 | AMLODIPINE CRT 10MG GELULE 90\n",
      "  3400939678207 | SPIRONOLACTONE ZYD 25MG CPR 30\n",
      "  3400939678726 | CLOPIDOGREL EG 75MG CPR 30\n",
      "  3400939679495 | SPIRONOLACTONE ZEN 25MG CPR 30\n",
      "  3400939679556 | SPIRONOLACTONE ZEN 25MG CPR 90\n",
      "  3400939680507 | LOSARTAN CRT 50MG CPR 30\n",
      "  3400939680965 | LOSARTAN CRT 50MG CPR 90\n",
      "  3400939681917 | SPIRONOLACTONE ARW 25MG CPR 30\n",
      "  3400939682167 | SPIRONOLACTONE ARW 25MG CPR 90\n",
      "  3400939682228 | PRAMIPEXOLE ZEN 0,7MG CPR 30\n",
      "  3400939682396 | PRAMIPEXOLE ZEN 0,7MG CPR 100\n",
      "  3400939682457 | PRAMIPEXOLE ZEN 0,18MG CPR 30\n",
      "  3400939682518 | PRAMIPEXOLE ZEN 0,18MG CPR 100\n",
      "  3400939683119 | NEBIVOLOL TVS 5MG CPR 30\n",
      "  3400939683638 | NEBIVOLOL TVS 5MG CPR 90\n",
      "  3400939686820 | CANDESARTAN SDZ 4 MG CPR 30\n",
      "  3400939687421 | CANDESARTAN SDZ 4 MG CPR 90\n",
      "  3400939689203 | LEVOCETIRIZINE SDZ 5MG CPR 14\n",
      "  3400939689432 | LEVOCETIRIZINE SDZ 5MG CPR 28\n",
      "  3400939689951 | CLOPIDOGREL ARG 75MG CPR 30\n",
      "  3400939691381 | CANDESARTAN SDZ 8 MG CPR 30\n",
      "  3400939691961 | CANDESARTAN SDZ 8 MG CPR 90\n",
      "  3400939695006 | CANDESARTAN SDZ 16 MG CPR 30\n",
      "  3400939695693 | CANDESARTAN SDZ 16 MG CPR 90\n",
      "  3400939699257 | FENTANYL ARW 75MICROG/H DISP TRANSD 5\n",
      "  3400939699837 | CANDESARTAN SDZ 32 MG CPR 30\n",
      "  3400939702889 | METFORMINE SDZ 500MG CPR 30\n",
      "  3400939703480 | METFORMINE SDZ 500MG CPR 90\n",
      "  3400939705903 | METFORMINE SDZ 850MG CPR 30\n",
      "  3400939706504 | METFORMINE SDZ 850MG CPR 90\n",
      "  3400939710525 | CLOPIDOGREL EVO 75MG CPR 30\n",
      "  3400939711355 | CLOPIDOGREL EVO 75MG CPR 30\n",
      "  3400939711874 | INSTANYL 50 MICROG/DOSE SOL NASALE 1\n",
      "  3400939711935 | INSTANYL 100 MICROG/DOSE SOL NASALE 1\n",
      "  3400939712017 | INSTANYL 200 MICROG/DOSE SOL NASALE 1\n",
      "  3400939712475 | CLOPIDOGREL CRT 75MG CPR 30\n",
      "  3400939715896 | CLOPIDOGREL ALT 75MG CPR 30\n",
      "  3400939717210 | METFORMINE BGR 500 MG CPR 30\n",
      "  3400939717449 | METFORMINE BGR 500 MG CPR 90\n",
      "  3400939717968 | METFORMINE BGR 850 MG CPR 30\n",
      "  3400939718101 | METFORMINE BGR 850 MG CPR 90\n",
      "  3400939718330 | METFORMINE BGA 1000 MG CPR 30\n",
      "  3400939718620 | METFORMINE BGA 1000 MG CPR 90\n",
      "  3400939723471 | TRAMADOL EG LP 100MG CPR 30\n",
      "  3400939724133 | TRIMEBUTINE CRT 200MG CPR 30\n",
      "  3400939725192 | TRAMADOL EG LP 200MG CPR 30\n",
      "  3400939726205 | TRAMADOL EG LP 150MG CPR 30\n",
      "  3400939728155 | FLUVASTATINE BGA 40MG GELULE 30\n",
      "  3400939728384 | FLUVASTATINE BGA 40MG GELULE 90\n",
      "  3400939728506 | FOSINOPRIL ARG10MG CPR 30\n",
      "  3400939728964 | FOSINOPRIL ARG10MG CPR 90\n",
      "  3400939729794 | FOSINOPRIL ARG 20MG CPR 30\n",
      "  3400939730165 | FOSINOPRIL ARG 20MG CPR 90\n",
      "  3400939730745 | SIMPONI 50 MG INJ STYLO 1\n",
      "  3400939730974 | SIMPONI 50 MG INJ SRG 1\n",
      "  3400939732008 | CIMZIA 200 MG SOL INJ SER 1ML 2\n",
      "  3400939734996 | ZEBINIX 800MG CPR 30\n",
      "  3400939735887 | ONGLYZA 5 MG CPR 30\n",
      "  3400939736198 | TERBINAFINE CRT 250MG CPR 14\n",
      "  3400939736259 | TERBINAFINE CRT 250MG CPR 28\n",
      "  3400939736600 | VALSARTAN/HCTZ BGA 80/12,5MG CPR 30\n",
      "  3400939737140 | VALSARTAN/HCTZ BGA 80/12,5MG CPR 90\n",
      "  3400939738031 | VALSARTAN/HCTZ BGA 160/25MG CPR 30\n",
      "  3400939738550 | VALSARTAN/HCTZ BGA 160/25MG CPR 90\n",
      "  3400939740270 | RILMENIDINE CRT 1MG CPR 30\n",
      "  3400939740560 | RILMENIDINE CRT 1MG CPR 90\n",
      "  3400939740911 | NEBIVOLOL BGA 5 MG CPR 30\n",
      "  3400939741451 | NEBIVOLOL BGA 5 MG CPR 90\n",
      "  3400939742403 | SPIRONOLACTONE VIATRIS 25MG CPR 30\n",
      "  3400939742571 | SPIRONOLACTONE VIATRIS 25MG CPR 90\n",
      "  3400939743004 | FRAGMINE 7 500UI AXA/0,3ML SOL INJ 10\n",
      "  3400939743233 | FRAGMINE 12 500UI AXA/0,5ML SOL INJ 5\n",
      "  3400939743462 | FRAGMINE 15 000UI AXA/0,6ML SOL INJ 5\n",
      "  3400939743523 | FRAGMINE 18 000UI AXA/0,72ML SOL INJ 5\n",
      "  3400939747606 | EPORATIO 20 000 UI/1ML INJ SER 1\n",
      "  3400939749266 | SIFROL LP 0,26 MG CPR 30\n",
      "  3400939749556 | SIFROL LP 0,52 MG CPR 30\n",
      "  3400939749785 | SIFROL LP 1,05 MG CPR 30\n",
      "  3400939749907 | SIFROL LP 2,1 MG CPR 30\n",
      "  3400939752976 | SERTRALINE CRT 25MG GELULE 7\n",
      "  3400939754000 | SERTRALINE CRT 50MG GELULE 28\n",
      "  3400939755120 | PRAZEPAM EG 10MG CPR 40\n",
      "  3400939755588 | ANTARENE CODEINE 200MG/30MG CPR 20\n",
      "  3400939755878 | ANTARENE CODEINE 400MG/60MG CPR 10\n",
      "  3400939758312 | FIXORINOX 50 MCG/DOSE SUSP NAS 120 1\n",
      "  3400939763163 | ACNETRAIT 40MG CAPSULE MOLLE 30\n",
      "  3400939765174 | TRANDOLAPRIL EG 0,5MG GELULE 30\n",
      "  3400939765693 | TRANDOLAPRIL EG 2MG GELULE 30\n",
      "  3400939765815 | TRANDOLAPRIL EG 4MG GELULE 30\n",
      "  3400939791838 | NATECAL 600MG/400UI CPR 60\n",
      "  3400939792088 | TERBINAFINE ARW 1% CREME 1\n",
      "  3400939792200 | CLOPIDOGREL SANDOZ 75 MG 1 BOITE DE 30, COMPRIMES\n",
      "  3400939793320 | PROGESTERONE BGA 200MG CAPSULE 45\n",
      "  3400939796451 | LEVOFLOXACINE SDZ 500MG CPR 5\n",
      "  3400939803296 | GLUCOSE LAV 10% SOL INJ FP 250ML 1\n",
      "  3400939803418 | GLUCOSE LAV 10% SOL INJ FP 500ML 1\n",
      "  3400939803708 | GLUCOSE LAV 10% SOL INJ FP 1000ML 1\n",
      "  3400939808901 | VALACICLOVIR VIATRIS 500MG CPR 10\n",
      "  3400939809151 | VALACICLOVIR VIATRIS 500MG CPR 42\n",
      "  3400939809212 | VALACICLOVIR VIATRIS 500MG CPR 112\n",
      "  3400939815763 | OMEPRAZOLE EVO 20MG GELULE 7\n",
      "  3400939815824 | OMEPRAZOLE EVO 20MG GELULE 14\n",
      "  3400939826240 | TRAMADOL ACT LP 150MG CPR 30\n",
      "  3400939827599 | KEPPRA 100MG/ML SOL BUV 150ML+S3ML 1\n",
      "  3400939827650 | KEPPRA 100MG/ML SOL BUV 150ML+S1ML 1\n",
      "  3400939829890 | NEBIVOLOL CRT 5MG CPR 30\n",
      "  3400939830261 | NEBIVOLOL CRT 5MG CPR 90\n",
      "  3400939831503 | NEBIVOLOL ZYD 5MG CPR 30\n",
      "  3400939831961 | NEBIVOLOL ZYD 5MG CPR 90\n",
      "  3400939833514 | NEBIVOLOL EVO 5MG CPR 30\n",
      "  3400939833804 | NEBIVOLOL EVO 5MG CPR 90\n",
      "  3400939835983 | DEPRENYL 5MG CPR 30\n",
      "  3400939836065 | MELOXICAM EG 7,5MG CPR 14\n",
      "  3400939836874 | REPAGLINIDE ARROW 1 MG 1 BOITE DE 90, COMPRIMES\n",
      "  3400939837475 | REPAGLINIDE ARW 2 MG CPR 90\n",
      "  3400939837994 | REPAGLINIDE EG 0,5MG CPR 90\n",
      "  3400939838366 | REPAGLINIDE EG 0,5MG CPR 270\n",
      "  3400939838595 | REPAGLINIDE EG 1MG CPR 90\n",
      "  3400939838885 | REPAGLINIDE EG 1MG CPR 270\n",
      "  3400939839028 | REPAGLINIDE EG 2MG CPR 90\n",
      "  3400939839547 | FINASTERIDE CRT 5MG CPR 28\n",
      "  3400939843629 | FENTANYL EG 12MICROG/H DISP TRANSD 5\n",
      "  3400939844510 | FENTANYL EG 25MICROG/H DISP TRANSD 5\n",
      "  3400939845340 | FENTANYL EG 50MICROG/H DISP TRANSD 5\n",
      "  3400939845869 | POLERY AD SIROP SS SUCRE 1\n",
      "  3400939846460 | FENTANYL EG 75MICROG/H DISP TRANSD 5\n",
      "  3400939848532 | VALPROATE NA SDZ LP 500MG CPR 30\n",
      "  3400939851952 | LETROZOLE ZYD 2,5MG CPR 30\n",
      "  3400939852782 | LOSARTAN HCTZ BGR 50/12,5MG CPR 30\n",
      "  3400939853154 | LOSARTAN HCTZ BGR 50/12,5MG CPR 90\n",
      "  3400939853505 | LOSARTAN HCTZ BGR 100/25MG CPR 30\n",
      "  3400939855394 | LEVOCETIRIZINE EG 5MG CPR 14\n",
      "  3400939855516 | LEVOCETIRIZINE EG 5MG CPR 28\n",
      "  3400939856636 | LEVOCETIRIZINE VIATRIS 5MG CPR 14\n",
      "  3400939856926 | LEVOCETIRIZINE VIATRIS 5MG CPR 28\n",
      "  3400939857817 | LEVOCETIRIZINE BGA 5MG CPR 14\n",
      "  3400939858067 | LEVOCETIRIZINE BGA 5MG CPR 28\n",
      "  3400939858647 | LEVOCETIRIZINE ARW 5MG CPR 14\n",
      "  3400939858876 | LEVOCETIRIZINE ARW 5MG CPR 28\n",
      "  3400939863900 | TOPIRAMATE ARW 25MG GELULE 28\n",
      "  3400939872254 | ACARBOSE BGA 50MG CPR 90\n",
      "  3400939872544 | ACARBOSE BGA 100MG CPR 90\n",
      "  3400939879697 | EFIENT 10 MG CPR 30\n",
      "  3400939882710 | LEVOFLOXACINE ZEN 500MG CPR 5\n",
      "  3400939883199 | LEVOFLOXACINE ARW 500MG CPR 5\n",
      "  3400939884370 | VALACICLOVIR ALM 500MG CPR 10\n",
      "  3400939884660 | VALACICLOVIR ALM 500MG CPR 42\n",
      "  3400939885261 | DICLOFENAC ZEN 1% GEL FLACON 100ML 1\n",
      "  3400939888743 | BUDESONIDE SDZ 64 MICROG SUSP NASALE 1\n",
      "  3400939889054 | FOSFOMYCINE SDZ 3G GRANULES SACHET 1\n",
      "  3400939889115 | FOSFOMYCINE SUN 3G GRANULES SACHET 1\n",
      "  3400939889344 | FOSFOMYCINE ZEN 3G GRANULES SACHET 1\n",
      "  3400939889405 | FOSFOMYCINE TVS 3G GRANULES SACHET 1\n",
      "  3400939890173 | DECAPEPTYL LP 22,5MG PDR+SOL INJ 1\n",
      "  3400939891125 | BISOPROLOL HCTZ ZEN 10/6,25MG CPR 30\n",
      "  3400939891415 | BISOPROLOL HCTZ ZEN 10/6,25MG CPR 90\n",
      "  3400939892016 | BISOPROLOL HCTZ ZEN 5/6,25MG CPR 30\n",
      "  3400939892306 | BISOPROLOL HCTZ ZEN 5/6,25MG CPR 90\n",
      "  3400939892993 | BISOPROLOL HCTZ ZEN 2,5/6,25MG CPR 30\n",
      "  3400939893365 | BISOPROLOL HCTZ ZEN 2,5/6,25MG CPR 90\n",
      "  3400939897158 | MELOXICAM EG 15MG CPR 14\n",
      "  3400939897738 | OLANZAPINE BGA 5MG CPR DISP 28\n",
      "  3400939898049 | OLANZAPINE BGA 10MG CPR DISP 28\n",
      "  3400939900490 | BINOCRIT 30 000 UI/0,75 ML (EPOETINE ALFA) 1 BOITE\n",
      "  3400939900612 | BINOCRIT 40 000 UI/1 ML (EPOETINE ALFA) 1 BOITE DE\n",
      "  3400939901152 | PREVENAR 13 SUSP INJ A SRG 1\n",
      "  3400939903392 | FENTANYL EG 100MICROG/H DISP TRANSD 5\n",
      "  3400939904344 | IRBESARTAN ZYD 75MG CPR PELL 30\n",
      "  3400939904634 | IRBESARTAN ZYD 75MG CPR PELL 90\n",
      "  3400939906294 | VALSARTAN/HCTZ ARL 80/12,5MG CPR 30\n",
      "  3400939907475 | VALSARTAN/HCTZ ARL 160/25MG CPR 30\n",
      "  3400939907994 | VALSARTAN/HCTZ ARL 160/25MG CPR 90\n",
      "  3400939909608 | IRBESARTAN ZYD 150MG CPR PELL 30\n",
      "  3400939911496 | LEVOFLOXACINE VIATRIS 500MG CPR 5\n",
      "  3400939914169 | IRBESARTAN ZYD 300MG CPR PELL 30\n",
      "  3400939914459 | IRBESARTAN ZYD 300MG CPR PELL 90\n",
      "  3400939914749 | IRBESARTAN ZYD 150MG CPR PELL 90\n",
      "  3400939921082 | VALSARTAN/HCTZ ZTL 80/12,5MG CPR 30\n",
      "  3400939921433 | VALSARTAN/HCTZ ZTL 80/12,5MG CPR 90\n",
      "  3400939922492 | VALSARTAN/HCTZ ZTL 160/25MG CPR 30\n",
      "  3400939922843 | VALSARTAN/HCTZ ZTL 160/25MG CPR 90\n",
      "  3400939924106 | INDAPAMIDE SDZ LP 1,5MG CPR 30\n",
      "  3400939924564 | INDAPAMIDE SDZ LP 1,5MG CPR 90\n",
      "  3400939925226 | INDAPAMIDE SDZ LP 1,5MG CPR 30\n",
      "  3400939925516 | INDAPAMIDE SDZ LP 1,5MG CPR 90\n",
      "  3400939932439 | LOSARTAN HCTZ BGR 100/25MG CPR 90\n",
      "  3400939935799 | LOSARTAN HCTZ ZEN 50/12,5 MG CPR 90\n",
      "  3400939968568 | REPAGLINIDE ZEN 0,5 MG CPR 90\n",
      "  3400939968797 | REPAGLINIDE ZEN 0,5 MG CPR 270\n",
      "  3400939969749 | REPAGLINIDE ZEN 1 MG CPR 90\n",
      "  3400939969978 | REPAGLINIDE ZEN 1 MG CPR 270\n",
      "  3400939970929 | REPAGLINIDE ZEN 2 MG CPR 90\n",
      "  3400939971179 | REPAGLINIDE ZEN 2 MG CPR 270\n",
      "  3400939975481 | REPAGLINIDE VIATRIS 0,5MG CPR 90\n",
      "  3400939975603 | REPAGLINIDE VIATRIS 0,5MG CPR 270\n",
      "  3400939976723 | REPAGLINIDE VIATRIS 1MG CPR 90\n",
      "  3400939976952 | REPAGLINIDE VIATRIS 1MG CPR 270\n",
      "  3400939977904 | REPAGLINIDE VIATRIS 2MG CPR 90\n",
      "  3400939978154 | REPAGLINIDE VIATRIS 2MG CPR 270\n",
      "  3400939980225 | BIPROFENID LP 100MG CPR 20\n",
      "  3400939982236 | ONBREZ BREEZHALER 150MCG INH GELULE 30\n",
      "  3400939982526 | ONBREZ BREEZHALER 300MCG INH GELULE 30\n",
      "  3400939983936 | CLOPIDOGREL TPH 75 MG CPR 30\n",
      "  3400939984247 | CLOPIDOGREL SDZ 75MG CPR 30\n",
      "  3400939985138 | SERTRALINE ALT 50MG GELULE 28\n",
      "  3400939987378 | ANASTROZOLE SUN 1MG CPR 30\n",
      "  3400939987668 | ANASTROZOLE SUN 1MG CPR 90\n",
      "  3400939988610 | CLARITHROMYCINE BGA LM 500MG CPR 5\n",
      "  3400939989099 | CLARITHROMYCINE BGA LM 500MG CPR 10\n",
      "  3400941507366 | MONTELUKAST ZYD 5MG CPR CROQ 28\n",
      "  3400941509087 | PARACETAMOL AHCL 1G CPR EFF 8\n",
      "  3400941509377 | EXEMESTANE ARW 25 MG CPR 30\n",
      "  3400941511509 | PARACETAMOL ZENTIVA 500MG GELULE 16\n",
      "  3400941513510 | LOSARTAN HCTZ EVO 50/12,5MG CPR 30\n",
      "  3400941513688 | LOSARTAN HCTZ EVO 50/12,5MG CPR 90\n",
      "  3400941513800 | LOSARTAN HCTZ EVO 100/25MG CPR 90\n",
      "  3400941515002 | RISPERIDONE MYL 3MG CPR DISP 28\n",
      "  3400941520204 | EXEMESTANE CRT 25MG CPR 30\n",
      "  3400941529368 | CARVEDILOL TVC 6,25MG CPR 28\n",
      "  3400941529597 | CARVEDILOL TVC 12,5MG CPR 28\n",
      "  3400941530548 | ATORVASTATINE SDZ 10MG CPR 30\n",
      "  3400941530777 | ATORVASTATINE SDZ 10MG CPR 90\n",
      "  3400941531668 | ATORVASTATINE SDZ 20MG CPR 30\n",
      "  3400941531897 | ATORVASTATINE SDZ 20MG CPR 90\n",
      "  3400941532610 | ATORVASTATINE SDZ 40MG CPR 30\n",
      "  3400941532849 | ATORVASTATINE SDZ 40MG CPR 90\n",
      "  3400941533150 | BISOPROLOL SDZ 1,25MG CPR 90\n",
      "  3400941533211 | BISOPROLOL SDZ 2,5MG CPR 90\n",
      "  3400941533730 | BISOPROLOL SDZ 10MG CPR PELL 90\n",
      "  3400941533969 | DOLIPRANE 1G GELULE 8\n",
      "  3400941537813 | DORZOLAMIDE ARW 2% COLLYRE 5ML 1\n",
      "  3400941553899 | LETROZOLE SDZ 2,5MG CPR 30\n",
      "  3400941557392 | ANASTROZOLE KRKA 1MG CPR 90\n",
      "  3400941557453 | SAIZEN 5,83 MG/ML SOL INJ 1\n",
      "  3400941557682 | SAIZEN 8 MG/ML SOL INJ CART 1.5 ML 1\n",
      "  3400941557743 | SAIZEN 8 MG/ML SOL INJ CART 2.5 ML 1\n",
      "  3400941558054 | TUSSIDANE 30MG CPR 12\n",
      "  3400941560125 | VALSARTAN/HCTZ BGA 160/12,5MG CPR 30\n",
      "  3400941560583 | VALSARTAN/HCTZ BGA 160/12,5MG CPR 90\n",
      "  3400941561474 | VALSARTAN/HCTZ ZTL 160/12,5MG CPR 30\n",
      "  3400941561993 | VALSARTAN/HCTZ ZTL 160/12,5MG CPR 90\n",
      "  3400941564895 | CANDESARTAN BGA 16MG CPR 30\n",
      "  3400941565328 | CANDESARTAN BGA 16MG CPR 90\n",
      "  3400941565908 | CANDESARTAN BGA 4MG CPR 30\n",
      "  3400941566448 | CANDESARTAN BGA 4MG CPR 90\n",
      "  3400941567339 | CANDESARTAN BGA 8MG CPR 30\n",
      "  3400941567919 | CANDESARTAN BGA 8MG CPR 90\n",
      "  3400941572821 | RISEDRONATE BGA 75MG CPR 2\n",
      "  3400941573071 | RISEDRONATE ARW 75MG CPR 2\n",
      "  3400941573132 | RISEDRONATE EG 75MG CPR 2\n",
      "  3400941580574 | SIKLOS 100MG CPR 60\n",
      "  3400941581984 | METFORMINE EVO 500MG CPR 30\n",
      "  3400941582356 | METFORMINE EVO 500MG CPR 90\n",
      "  3400941583995 | METFORMINE EVO 850MG CPR 30\n",
      "  3400941584428 | METFORMINE EVO 850MG CPR 90\n",
      "  3400941585777 | CANDESARTAN/HCTZ BGA 16/12,5 CPR 30\n",
      "  3400941586378 | CANDESARTAN/HCTZ BGA 16/12,5 CPR 90\n",
      "  3400941587030 | METFORMINE EVO 1000 MG CPR 30\n",
      "  3400941587559 | METFORMINE EVO 1000 MG CPR 90\n",
      "  3400941588099 | TETRALYSAL 150MG GELULE 56\n",
      "  3400941591051 | CANDESARTAN VTS 4 MG CPR 30\n",
      "  3400941591570 | CANDESARTAN VTS 4 MG CPR 90\n",
      "  3400941592522 | CANDESARTAN VTS 8 MG CPR 30\n",
      "  3400941593062 | CANDESARTAN VTS 8 MG CPR 90\n",
      "  3400941593871 | CANDESARTAN VTS 16 MG CPR 30\n",
      "  3400941594304 | CANDESARTAN VTS 16 MG CPR 90\n",
      "  3400941595363 | CANDESARTAN VTS 32 MG CPR 30\n",
      "  3400941598494 | PRAVASTATINE ALS 20MG CPR 28\n",
      "  3400941598555 | PRAVASTATINE ALS 20MG CPR 84\n",
      "  3400941600838 | CANDESARTAN/HCTZ BGA 8/12,5 CPR 30\n",
      "  3400941601439 | CANDESARTAN/HCTZ BGA 8/12,5 CPR 90\n",
      "  3400941602849 | ACIDE FOLIQUE ARW 5MG CPR 20\n",
      "  3400941602900 | ACIDE FOLIQUE ARROW 5 MG 1 BOITE DE 20, COMPRIMES\n",
      "  3400941603099 | PRAVASTATINE ALS 40MG CPR 28\n",
      "  3400941603440 | CALCIUM VIT D3 ZYD 500MG/400UI CPR 60\n",
      "  3400941607523 | CYPROTERONE ZEN 100MG CPR 60\n",
      "  3400941607981 | PANTOPRAZOLE ARL 20 MG CPR 14\n",
      "  3400941608292 | PANTOPRAZOLE ARL 20 MG CPR 28\n",
      "  3400941609244 | PANTOPRAZOLE ARL 20 MG CPR 28\n",
      "  3400941609824 | PANTOPRAZOLE ARL 40 MG CPR 7\n",
      "  3400941610073 | PANTOPRAZOLE ARL 40 MG CPR 14\n",
      "  3400941610424 | PANTOPRAZOLE ARL 40 MG CPR 28\n",
      "  3400941611834 | PANTOPRAZOLE ARL 40 MG CPR 28\n",
      "  3400941615276 | MONTELUKAST VTS 5MG CPR CROQ 28\n",
      "  3400941619410 | LATANOPROST EG 0,005% COLLYRE 1\n",
      "  3400941619588 | LATANOPROST EG 0,005% COLLYRE 3\n",
      "  3400941619878 | RALOXIFENE VTS 60MG CPR 28\n",
      "  3400941620010 | RALOXIFENE VTS 60MG CPR 84\n",
      "  3400941626104 | LEVETIRACETAM VIATRIS 250MG CPR 60\n",
      "  3400941626623 | FUROSEMIDE TVC 500MG CPR 30\n",
      "  3400941626913 | LEVETIRACETAM VIATRIS 500MG CPR 60\n",
      "  3400941627224 | LEVETIRACETAM VIATRIS 1000MG CPR 60\n",
      "  3400941627682 | EXEMESTANE ZYF 25MG CPR 30\n",
      "  3400941628115 | ANTALNOX 550MG CPR 16\n",
      "  3400941635267 | MONTELUKAST CRT 5MG CPR CROQ 28\n",
      "  3400941636509 | MONTELUKAST CRT 10 MG CPR 28\n",
      "  3400941637858 | ROPINIROLE SDZ LP 2MG CPR 28\n",
      "  3400941638398 | ROPINIROLE KRK LP 2MG CPR 28\n",
      "  3400941639111 | ROPINIROLE SDZ LP 4MG CPR 28\n",
      "  3400941639579 | ROPINIROLE KRK LP 4MG CPR 28\n",
      "  3400941640001 | ROPINIROLE SDZ LP 8MG CPR 28\n",
      "  3400941640520 | ROPINIROLE KRK LP 8MG CPR 28\n",
      "  3400941655548 | METOPROLOL ACT 100MG CPR 30\n",
      "  3400941655838 | METOPROLOL ACT 100MG CPR 90\n",
      "  3400941656378 | LEVETIRACETAM BGA 500 MG CPR 60\n",
      "  3400941656729 | LEVETIRACETAM BGA 1000 MG CPR 60\n",
      "  3400941656958 | LEVETIRACETAM BGA 250 MG CPR 60\n",
      "  3400941660511 | ROPINIROLE TVC LP 2MG CPR 28\n",
      "  3400941660979 | ROPINIROLE TVC LP 4MG CPR 28\n",
      "  3400941661341 | ROPINIROLE TVC LP 8 MG CPR 28\n",
      "  3400941666025 | AMOROLFINE ZYD 5% VERNIS MED 1\n",
      "  3400941668326 | ATORVASTATINE CRT 40MG CPR 30\n",
      "  3400941670565 | ATORVASTATINE CRT 20MG CPR 30\n",
      "  3400941670916 | ATORVASTATINE CRT 20MG CPR 90\n",
      "  3400941672637 | ATORVASTATINE CRT 10MG CPR 30\n",
      "  3400941673177 | ATORVASTATINE CRT 10MG CPR 90\n",
      "  3400941681271 | LOPERAMIDE BGA 2MG GELULE 20\n",
      "  3400941685415 | VENLAFAXINE EVO LP 37,5MG GELULE 30\n",
      "  3400941686245 | SPASFON LYOC 160MG LYOPHILISAT ORAL 5\n",
      "  3400941686535 | RITALINE LP 10MG GELULE 28\n",
      "  3400941688195 | NICORANDIL ALM 10MG CPR 30\n",
      "  3400941688485 | ESBRIET 267MG GELULE 252\n",
      "  3400941689727 | CANDESARTAN/HCTZ HCS 8/12,5 CPR 30\n",
      "  3400941690266 | CANDESARTAN/HCTZ HCS 8/12,5 CPR 90\n",
      "  3400941691447 | CANDESARTAN/HCTZ HCS 16/12,5 CPR 30\n",
      "  3400941691966 | CANDESARTAN/HCTZ HCS 16/12,5 CPR 90\n",
      "  3400941693519 | RISEDRONATE ACC 75MG CPR 2\n",
      "  3400941694059 | RISEDRONATE ACC 75MG CPR 6\n",
      "  3400941701245 | LEFLUNOMIDE EG 10 MG CPR 30\n",
      "  3400941701306 | LEFLUNOMIDE EG 20 MG CPR 30\n",
      "  3400941701474 | LYRICA 20 MG/ML SOL BUV 1\n",
      "  3400941701825 | TYVERB 250MG CPR 140\n",
      "  3400941701993 | TYVERB 250MG CPR 84\n",
      "  3400941703546 | NICORANDIL ALM 20MG CPR 30\n",
      "  3400941703836 | RISEDRONATE BGA 75MG CPR 6\n",
      "  3400941704208 | IBUPROFENE CRT 400MG CPR PELL 30\n",
      "  3400941714313 | MILNACIPRAN ARW 50MG GELULE 56\n",
      "  3400941714603 | MILNACIPRAN ARW 25MG GELULE 56\n",
      "  3400941715143 | NICORANDIL BGA 10MG CPR 30\n",
      "  3400941715372 | NICORANDIL BGA 20MG CPR 30\n",
      "  3400941715433 | VALSARTAN EVO 40MG CPR 30\n",
      "  3400941715662 | VALSARTAN EVO 40MG CPR 90\n",
      "  3400941715723 | VALSARTAN EVO 80MG CPR 30\n",
      "  3400941715891 | VALSARTAN EVO 80MG CPR 90\n",
      "  3400941715952 | VALSARTAN EVO 160MG CPR 30\n",
      "  3400941716034 | VALSARTAN EVO 160MG CPR 90\n",
      "  3400941719165 | RISEDRONATE EG 75MG CPR 6\n",
      "  3400941719455 | RISEDRONATE ARW 75MG CPR 6\n",
      "  3400941720055 | ZOLMITRIPTAN ZEN 2,5MG CPR ORODISP 6\n",
      "  3400941720345 | ZOLMITRIPTAN ZEN 2,5MG CPR ORODISP 12\n",
      "  3400941720925 | ZOLMITRIPTAN ZEN 2,5MG CPR 6\n",
      "  3400941721175 | ZOLMITRIPTAN ZEN 2,5MG CPR 12\n",
      "  3400941724657 | ATORVASTATINE EVO 40MG CPR 90\n",
      "  3400941730221 | ATORVASTATINE ALT 40MG CPR 30\n",
      "  3400941730689 | ATORVASTATINE ALT 40MG CPR 90\n",
      "  3400941739095 | ATORVASTATINE ALT 10MG CPR 30\n",
      "  3400941739446 | ATORVASTATINE ALT 10MG CPR 90\n",
      "  3400941744297 | ATORVASTATINE ALT 20MG CPR 30\n",
      "  3400941744648 | ATORVASTATINE ALT 20MG CPR 90\n",
      "  3400941746888 | ATORVASTATINE EVO 20MG CPR 90\n",
      "  3400941750212 | BETAHISTINE ARW 8MG CPR 30\n",
      "  3400941750441 | BETAHISTINE ARW 8MG CPR 90\n",
      "  3400941751561 | BISOPROLOL TVS 1,25MG CPR 30\n",
      "  3400941751622 | BISOPROLOL TVS 1,25MG CPR 90\n",
      "  3400941751790 | BISOPROLOL TVS 2,5MG CPR 30\n",
      "  3400941751851 | BISOPROLOL TVS 2,5MG CPR 90\n",
      "  3400941751912 | BISOPROLOL TVS 3,75MG CPR 30\n",
      "  3400941752223 | BISOPROLOL TVS 5MG CPR 30\n",
      "  3400941752452 | BISOPROLOL TVS 7,5MG CPR 30\n",
      "  3400941752681 | BISOPROLOL TVS 10MG CPR 30\n",
      "  3400941758485 | MANIDIPINE ZEN 10MG CPR 30\n",
      "  3400941758607 | MANIDIPINE ZEN 10MG CPR 90\n",
      "  3400941758775 | MANIDIPINE ZEN 20MG CPR 30\n",
      "  3400941759086 | MANIDIPINE ZEN 20MG CPR 90\n",
      "  3400941765698 | PRAVASTATINE ALS 40MG CPR 84\n",
      "  3400941766589 | XEPLION LP 25 MG SUSP INJ SER 1\n",
      "  3400941766640 | XEPLION LP 50 MG SUSP INJ SER 1\n",
      "  3400941766701 | XEPLION LP 75 MG SUSP INJ SER 1\n",
      "  3400941766879 | XEPLION LP 100 MG SUSP INJ SER 1\n",
      "  3400941766930 | XEPLION LP 150 MG SUSP INJ SER 1\n",
      "  3400941771033 | TAMSULOSINE EG LP 0,4MG CPR 30\n",
      "  3400941771491 | ROPINIROLE EG 2MG CPR 21\n",
      "  3400941772153 | TAMSULOSINE VIATRIS LP 0,4MG CPR 30\n",
      "  3400941772733 | ROPINIROLE EG 1MG CPR 21\n",
      "  3400941774393 | TAMSULOSINE VIATRIS LP 0,4MG CPR 30\n",
      "  3400941775925 | TAMSULOSINE BGA LP 0,4MG CPR 30\n",
      "  3400941778766 | GILENYA 0,5MG GELULE 28\n",
      "  3400941779077 | SIMVASTATINE SUN 20MG CPR 90\n",
      "  3400941779138 | SIMVASTATINE SUN 40MG CPR 90\n",
      "  3400941780486 | BORAX/AC BORIQUE ZEN SOL OPH UNIDOSE 20\n",
      "  3400941783388 | LANSOPRAZOLE CRT 15 MG GELULE 30\n",
      "  3400941784279 | LANSOPRAZOLE CRT 15 MG GELULE 15\n",
      "  3400941784569 | LANSOPRAZOLE CRT 15 MG GELULE 30\n",
      "  3400941787751 | LANSOPRAZOLE CRT 30MG GELULE 28\n",
      "  3400941788413 | LANSOPRAZOLE CRT 30MG GELULE 14\n",
      "  3400941788642 | LANSOPRAZOLE CRT 30MG GELULE 28\n",
      "  3400941796746 | MILNACIPRAN ARW 25MG GELULE 56\n",
      "  3400941797637 | ATORVASTATINE ZTL 10MG CPR 30\n",
      "  3400941797927 | ATORVASTATINE ZTL 10MG CPR 90\n",
      "  3400941798818 | ATORVASTATINE ZTL 20MG CPR 30\n",
      "  3400941799068 | ATORVASTATINE ZTL 20MG CPR 90\n",
      "  3400941799877 | ATORVASTATINE ZTL 40MG CPR 30\n",
      "  3400941800160 | ATORVASTATINE ZTL 40MG CPR 90\n",
      "  3400941800801 | ATORVASTATINE ZTL 80MG CPR 30\n",
      "  3400941801051 | ATORVASTATINE ZTL 80MG CPR 90\n",
      "  3400941801341 | MILNACIPRAN ARW 50MG GELULE 56\n",
      "  3400941805073 | VALSARTAN/HCTZ KRK 80/12,5MG CPR 30\n",
      "  3400941805653 | VALSARTAN/HCTZ KRK 80/12,5MG CPR 90\n",
      "  3400941816130 | MANIDIPINE BGA 10MG CPR 30\n",
      "  3400941816369 | MANIDIPINE BGA 10MG CPR 90\n",
      "  3400941816420 | MANIDIPINE BGA 20MG CPR 30\n",
      "  3400941816598 | MANIDIPINE BGA 20MG CPR 90\n",
      "  3400941822391 | NARATRIPTAN MYL 2,5MG CPR 6\n",
      "  3400941822452 | NARATRIPTAN MYL 2,5MG CPR 12\n",
      "  3400941823404 | FENOFIBRATE ZYD 145MG CPR 30\n",
      "  3400941823862 | FENOFIBRATE ZYD 145MG CPR 90\n",
      "  3400941825583 | ACETYLLEUCINE BGA 500MG CPR 30\n",
      "  3400941825644 | ACETYLLEUCINE ZEN 500MG CPR 30\n",
      "  3400941859014 | MOPRAL 20 MG GELULE GASTRO-RESIS 30\n",
      "  3400941859533 | ZOLTUM 20 MG GELULE 30\n",
      "  3400941879173 | OLANZAPINE SDZ 5MG CPR ORODISP 28\n",
      "  3400941879753 | OLANZAPINE SDZ 10MG CPR ORODISP 28\n",
      "  3400941882135 | NARATRIPTAN ZYD 2,5MG CPR 6\n",
      "  3400941882364 | NARATRIPTAN ZYD 2,5MG CPR 12\n",
      "  3400941888229 | ESOMEPRAZOLE RBX 20MG CPR 14\n",
      "  3400941888458 | ESOMEPRAZOLE RBX 20MG CPR 28\n",
      "  3400941889578 | ESOMEPRAZOLE RBX 40MG CPR 28\n",
      "  3400941898563 | BETAHISTINE VTS 24MG CPR 60\n",
      "  3400941899973 | GLICLAZIDE BGR LM 30MG CPR 180\n",
      "  3400941900037 | PRAVASTATINE ACC 20MG CPR 84\n",
      "  3400941900266 | PRAVASTATINE ACC 40 MG CPR 84\n",
      "  3400941902048 | LANSOPRAZOLE BGR 30MG GELULE 30\n",
      "  3400941902109 | LANSOPRAZOLE BGR 15MG GELULE 30\n",
      "  3400941914164 | TELMISARTAN SDZ 40MG CPR 30\n",
      "  3400941914683 | TELMISARTAN SDZ 40MG CPR 90\n",
      "  3400941915406 | TELMISARTAN SDZ 80MG CPR 30\n",
      "  3400941916007 | TELMISARTAN SDZ 80MG CPR 90\n",
      "  3400941916755 | SIMVASTATINE EVO 20MG CPR 84\n",
      "  3400941916816 | SIMVASTATINE EVO 40MG CPR 84\n",
      "  3400941918308 | CLAREAL 75MCG CPR 28\n",
      "  3400941918476 | CLAREAL 75MCG CPR 84\n",
      "  3400941918766 | VALSARTAN ARG 80MG CPR 30\n",
      "  3400941919138 | VALSARTAN ARG 160MG CPR 30\n",
      "  3400941938818 | MILNACIPRAN BGA 25MG GELULE 56\n",
      "  3400941941429 | DESLORATADINE ARW 5 MG CPR 15\n",
      "  3400941941719 | DESLORATADINE ARW 5 MG CPR 30\n",
      "  3400941945380 | PRADAXA 150 MG GELULE 60\n",
      "  3400941945441 | ELIQUIS 2.5MG CPR 10\n",
      "  3400941945502 | ELIQUIS 2.5MG CPR 20\n",
      "  3400941945670 | ELIQUIS 2.5MG CPR 60\n",
      "  3400941945960 | LATANOPROST TVC 0,005% COLLYRE 1\n",
      "  3400941946042 | LATANOPROST TVC 0,005% COLLYRE 3\n",
      "  3400941946561 | CETIRIZINE ALM 10MG CPR 15\n",
      "  3400941948404 | ATORVASTATINE HCS 80MG CPR 30\n",
      "  3400941949005 | ATORVASTATINE HCS 80MG CPR 90\n",
      "  3400941950414 | EXEMESTANE PFZ 25MG CPR 30\n",
      "  3400941950933 | ZOFENOPRIL VTS 30MG CPR 30\n",
      "  3400941951183 | ZOFENOPRIL VTS 30MG CPR 90\n",
      "  3400941960697 | DORZOLAMIDE TIMOLOL VTS COLLYRE 5ML 1\n",
      "  3400941961700 | LOSARTAN HCTZ TVC 100/12,5MG CPR 30\n",
      "  3400941962011 | LOSARTAN HCTZ TVC 100/12,5MG CPR 90\n",
      "  3400941963940 | DESLORATADINE BGA 0,5MG/ML BUV 150ML 1\n",
      "  3400941964312 | LEVOFLOXACINE AHL 500MG CPR 5\n",
      "  3400941965722 | DESLORATADINE VTS 0,5MG/ML BUV 150ML 1\n",
      "  3400941966903 | DESLORATADINE CRT 5MG CPR 15\n",
      "  3400941967382 | IRBESARTAN HCTZ EG 150/12,5MG CPR 30\n",
      "  3400941967443 | DESLORATADINE CRT 5MG CPR 30\n",
      "  3400941967733 | IRBESARTAN HCTZ EG 150/12,5MG CPR 90\n",
      "  3400941971006 | IRBESARTAN HCTZ EG 300/25MG CPR 30\n",
      "  3400941971464 | IRBESARTAN HCTZ EG 300/25MG CPR 90\n",
      "  3400941971983 | IRBESARTAN HCTZ EG 300/12,5MG CPR 30\n",
      "  3400941972294 | IRBESARTAN HCTZ EG 300/12,5MG CPR 90\n",
      "  3400941976087 | TELMISARTAN BGA 40MG CPR 30\n",
      "  3400941976209 | TELMISARTAN BGA 40MG CPR 90\n",
      "  3400941977039 | TELMISARTAN BGA 80MG CPR 30\n",
      "  3400941977329 | TELMISARTAN BGA 80MG CPR 90\n",
      "  3400941978739 | TELMISARTAN CRT 40MG CPR 30\n",
      "  3400941979040 | TELMISARTAN CRT 40MG CPR 90\n",
      "  3400941979798 | TELMISARTAN CRT 80MG CPR 30\n",
      "  3400941979910 | TELMISARTAN CRT 80MG CPR 90\n",
      "  3400941987724 | TERBUTALINE BGA 5MG/2ML SOL INHAL 50\n",
      "  3400941987953 | ATORVASTATINE EG 10 MG CPR 30\n",
      "  3400941988035 | ATORVASTATINE EG 10 MG CPR 90\n",
      "  3400941988264 | ATORVASTATINE EG 20 MG CPR 30\n",
      "  3400941988325 | ATORVASTATINE EG 20 MG CPR 90\n",
      "  3400941988493 | ATORVASTATINE EG 40 MG CPR 30\n",
      "  3400941988554 | ATORVASTATINE EG 40 MG CPR 90\n",
      "  3400941988615 | ATORVASTATINE EG 80 MG CPR 30\n",
      "  3400941988783 | ATORVASTATINE EG 80 MG CPR 90\n",
      "  3400941989155 | MANIDIPINE EG 10MG CPR 30\n",
      "  3400941989216 | MANIDIPINE EG 10MG CPR 90\n",
      "  3400941989384 | MANIDIPINE EG 20MG CPR 30\n",
      "  3400941989445 | MANIDIPINE EG 20MG CPR 90\n",
      "  3400941992865 | ACETYLLEUCINE VTS 500MG CPR 30\n",
      "  3400941994296 | RALOXIFENE ZEN 60MG CPR 28\n",
      "  3400941994418 | RALOXIFENE ZEN 60MG CPR 84\n",
      "  3400941994708 | RALOXIFENE BGA 60MG CPR 28\n",
      "  3400941994937 | RALOXIFENE BGA 60MG CPR 84\n",
      "  3400941999031 | DESLORATADINE BGA 5MG CPR 15\n",
      "  3400941999499 | DESLORATADINE BGA 5MG CPR 30\n",
      "  3400949000128 | COVERAM 10MG/10MG CPR (AIP)(MWI)(PL) 30\n",
      "  3400949000135 | COVERAM 10MG/10MG CPR (AIP)(MWI)(PL) 90\n",
      "  3400949000166 | COVERAM 5MG/10MG CPR (AIP)(MWI) (PL) 30\n",
      "  3400949000289 | GRANOCYTE 34 MUI INJ SER (AIP)(MWI) 1\n",
      "  3400949000340 | SINGULAIR 10MG CPR (AIP) (MWI) 28\n",
      "  3400949000371 | NEURONTIN 600MG CPR (AIP) BBF 90\n",
      "  3400949000401 | FEMARA 2,5 MG CPR (AIP)(BBA) 30\n",
      "  3400949000425 | QVAR AUTOHALER 100MICROG (AIP) (MWI) 1\n",
      "  3400949000470 | GRANOCYTE 34 MUI PDR SOL INJ (AIP) 1\n",
      "  3400949000524 | MONURIL 3G GRANULES SACHET (AIP) MWI 1\n",
      "  3400949000531 | VOLTARENE LP 75MG CPR (AIP) (MWIES) 30\n",
      "  3400949000548 | TADENAN 50 MG 1 BOITE DE 60, CAPSULES MOLLES\n",
      "  3400949000579 | PERMIXON 160 MG GELULE (AIP MWI BG) 180\n",
      "  3400949000586 | PERMIXON 160 MG GELULE (AIP MWI BG) 60\n",
      "  3400949000593 | SEBIPROX 1,5% SHAMPOOING (AIP MED) 1\n",
      "  3400949000616 | DEPAKINE CHRONO 500MG CPR (AIP)(MWI) 30\n",
      "  3400949000654 | SEROPLEX 10 MG CPR (AIP MEDIWIN) 28\n",
      "  3400949000661 | GUTRON 2,5MG CPR (AIP)(BBA) 30\n",
      "  3400949000678 | GUTRON 2,5MG CPR (AIP)(BBA) 90\n",
      "  3400949000708 | CADUET 10 MG/10 MG CPR (AIP)(BBA) 30\n",
      "  3400949000722 | CADUET 5 MG/10 MG CPR (AIP) (BBA) 90\n",
      "  3400949000739 | CADUET 5 MG/10 MG CPR (AIP) (BBA) 30\n",
      "  3400949000746 | GRANOCYTE 34 MUI PDR INJ SER (AIP P) 1\n",
      "  3400949000760 | TAHOR 10 MG CPR (AIP) (MWI IT) 90\n",
      "  3400949000784 | AROMASINE 25MG CPR (AIP) (MED LTD) 30\n",
      "  3400949000791 | COVERAM 5MG/5MG CPR (AIP) (PLA PL) 90\n",
      "  3400949000821 | CORDARONE 200 MG CPR (AIP) (MDW LD) 30\n",
      "  3400949000852 | TAHOR 10 MG CPR (AIP) (BBA) 90\n",
      "  3400949000890 | PERMIXON 160MG GELULE (AIP BBF SRL) 60\n",
      "  3400949000906 | PERMIXON 160MG GELULE (AIP BBF SRL) 180\n",
      "  3400949000913 | GRANOCYTE 34 MUI INJ SER AIP BBF 2 1\n",
      "  3400949000937 | FEMARA 2,5MG CPR (AIP) (BBA CZ) 30\n",
      "  3400949000944 | FEMARA 2,5 MG CPR (AIP)(BBFARMA) 30\n",
      "  3400949000975 | BIPRETERAX 10MG/2,5MG CPR (AIP BB F) 30\n",
      "  3400949000982 | BIPRETERAX 10MG/2,5MG CPR (AIP BB F) 90\n",
      "  3400949000999 | BIPRETERAX 10MG/2,5MG CPR (AIP MWL) 30\n",
      "  3400949001095 | NEORAL 100MG CAPSULE (AIP) (BBF BE) 60\n",
      "  3400949001187 | RHINOCORT 64 MICROG SUSP (AIP) (MWI) 1\n",
      "  3400949001194 | KAYEXALATE 454G PDR ORAL/RECT (AIP) 1\n",
      "  3400949001248 | PERMIXON 160 MG GELULE (AIP BBA LT) 180\n",
      "  3400949001293 | CLOBEX 500 MICROG/G SH (AIP BBFARMA) 1\n",
      "  3400949001361 | TRIATEC 2,5 MG CPR (AIP BBA) 30\n",
      "  3400949001378 | PERMIXON 160MG GELULE (AIP) 60\n",
      "  3400949001408 | TRIATEC 5 MG CPR (AIP BBA) 30\n",
      "  3400949001453 | VENTOLINE 100MCG SUSP INH (AIP)(MWI) 1\n",
      "  3400949001460 | COVERAM 10MG/10MG CPR (AIP) (PLA) 30\n",
      "  3400949001484 | COVERAM 10MG/5MG CPR (AIP) (PLA) 30\n",
      "  3400949001507 | COVERAM 5MG/10MG CPR (AIP)(PLA) (EL) 30\n",
      "  3400949001521 | COVERAM 5MG/5MG CPR (AIP) (PLA) 30\n",
      "  3400949001675 | TEMERIT 5MG CPR (AIP) (MDW LD) 30\n",
      "  3400949001682 | TEMERIT 5MG CPR (AIP) (MDW LD) 90\n",
      "  3400949001699 | ZITHROMAX 250MG CPR(AIP) ( BBF) 6\n",
      "  3400949001705 | VOLTARENE LP 75MG CPR (AIP) (PLAES) 30\n",
      "  3400949001873 | INIPOMP 20 MG CPR (AIP) (MWI) PL 28\n",
      "  3400949001910 | CLOBEX 500 MICROG/G SH (AIP MWIES) 1\n",
      "  3400949001972 | AROMASINE 25MG CPR (AIP) (BBF)1 30\n",
      "  3400949002009 | VENTOLINE 100MCG SUSP INH (AIP)(PLA) 1\n",
      "  3400949002016 | CLOBEX 500 MICROG/G SH (AIP) (PLA) 1\n",
      "  3400949002139 | FEMARA 2,5 MG CPR (AIP)(DIF) 30\n",
      "  3400949002160 | KETODERM 2% CREME ( AIP ) 1\n",
      "  3400949002191 | SEBIPROX 1,5% SHAMPOOING (AIP PLA) 1\n",
      "  3400949002207 | PERMIXON 160MG GELULE (AIP BBF ) 60\n",
      "  3400949002214 | PERMIXON 160MG GELULE (AIP BBF ) 180\n",
      "  3400949002313 | COUMADINE 5MG CPR (MWI) (LT) 30\n",
      "  3400949002320 | FORTZAAR 100MG/25MG CPR (I) 28\n",
      "  3400949002351 | CORDARONE 200 MG CPR (AIP) (BBF) 30\n",
      "  3400949002368 | TEMERITDUO 5MG/25MG CPR (AIP) MDW 30\n",
      "  3400949002375 | TEMERITDUO 5MG/25MG CPR (AIP) MDW 90\n",
      "  3400949002382 | TEMERITDUO 5MG/12,5MG CPR (AIP) MWI 30\n",
      "  3400949002399 | TEMERITDUO 5MG/12,5MG CPR (AIP) MWI 90\n",
      "  3400949002405 | CHIBRO-PROSCAR 5MG CPR (AIP)(MWI) 28\n",
      "  3400949002412 | HYPERIUM 1MG CPR (AIP) (MWI) 30\n",
      "  3400949002429 | HYPERIUM 1MG CPR (AIP) (MWI) 90\n",
      "  3400949002498 | ZOXAN LP 4MG CPR (UK) 2 28\n",
      "  3400949002504 | PERMIXON 160MG GELULE (AIP PHL) 60\n",
      "  3400949002535 | XEROQUEL LP 50MG CPR (AIP) (BBFA) 30\n",
      "  3400949002559 | PERMIXON 160MG GELULE (ES) 1 60\n",
      "  3400949002573 | BIPRETERAX 10MG/2,5MG CPR (AIP PLA) 90\n",
      "  3400949002597 | AVODART 0,5MG CAPSULE (AIP) (MDW IT) 30\n",
      "  3400949002627 | GLUCOPHAGE 1000MG CPR AIP MWI 90\n",
      "  3400949002634 | DECAPEPTYL LP 11,25MG INJ (AIP BBF) 1\n",
      "  3400949002665 | VALACICLOVIR MYL 500MG CPR AIP BBF 112\n",
      "  3400949002689 | NEORAL 50MG CAPSULE AIP BBA 60\n",
      "  3400949002719 | NEORAL 100MG CAPSULE (AIP) (PHL) 60\n",
      "  3400949002757 | XEROQUEL LP 300MG CPR (AIP BBF) 30\n",
      "  3400949002771 | XEROQUEL LP 400MG CPR ( AIP BBF ) 30\n",
      "  3400949002818 | DECAPEPTYL LP 11,25MG INJ (AIP PLA) 1\n",
      "  3400949002825 | KETODERM 2% CREME ( AIP BBF ) 1\n",
      "  3400949002832 | VENTOLINE 100MCG SUSP INH AIP BBA UK 1\n",
      "  3400949002856 | CACIT VIT D3 1000MG/880UI GRN AIPMWI 30\n",
      "  3400949002863 | CACIT VIT D3 1000MG/880UI GRN AIPMWI 90\n",
      "  3400949002986 | NOZINAN 25MG CPR AIP MWI 20\n",
      "  3400949002993 | NOZINAN 100MG CPR AIP MWI 20\n",
      "  3400949003013 | AROMASINE 25MG CPR (AIP) (BBF)2 30\n",
      "  3400949003051 | KAYEXALATE 454G PDR ORAL/RECT AIP M 1\n",
      "  3400949003082 | EZETROL 10MG CPR AIP MWI IT 90\n",
      "  3400949003129 | VENTOLINE 100MCG SUSP INH AIP BBA BE 1\n",
      "  3400949003136 | EZETROL 10MG CPR (AIP)( BBF) 90\n",
      "  3400949003143 | COUMADINE 5MG CPR (AIP BBA IT) 30\n",
      "  3400949003167 | INEGY 10MG/20MG CPR (AIP)(BBF) 30\n",
      "  3400949003174 | INEGY 10MG/20MG CPR (AIP)(BBF) 90\n",
      "  3400949003181 | INEGY 10MG/40MG CPR (AIP)(BBF) 30\n",
      "  3400949003198 | INEGY 10MG/40MG CPR (AIP)(BBF) 90\n",
      "  3400949003204 | AVODART 0,5MG CAPS (AIP)(BBA) 30\n",
      "  3400949003228 | AVODART 0,5MG CAPS (AIP)(BBF) 30\n",
      "  3400949003235 | NOZINAN 25MG CPR AIP BBA BE 20\n",
      "  3400949003242 | NOZINAN 100MG CPR AIP BBA 20\n",
      "  3400949003266 | DECAPEPTYL 0,1 MG PDR ET SOL INJ AIP 7\n",
      "  3400949003273 | VENTOLINE 100MCG SUSP INH (AIP)(MDL) 1\n",
      "  3400949003297 | DALACINE 300 MG GELULE (AIP MWI) 16\n",
      "  3400949003327 | NOZINAN 25MG CPR AIP BBF 20\n",
      "  3400949003334 | UN ALFA 0,25MCG CAPS AIP MWI 30\n",
      "  3400949003341 | UN ALFA 1 MICROGRAMME CAPSULE (AIP) 30\n",
      "  3400949003365 | GELTIM LP 1MG/G GEL OPHT (AIP) 30\n",
      "  3400949003389 | PERMIXON 160MG GELULE (ES) 1 180\n",
      "  3400949003419 | MODIODAL 100MG CPR (AIP BBF) 30\n",
      "  3400949003426 | DECAPEPTYL 0,1 MG PDR SOL INJ AIPBBF 7\n",
      "  3400949003501 | MONURIL 3G GRANULES SACHET (AIP) PL 1\n",
      "  3400949003570 | IXPRIM 37,5MG/325MG CPR (AIP MDL) 20\n",
      "  3400949003587 | BECOTIDE 250 MICROG SOL INHA AIP MDL 1\n",
      "  3400949003594 | EZETROL 10MG CPR (AIP)( PHL) 90\n",
      "  3400949003624 | VENTOLINE 100MCG SUSP INH (AIP)(BBF) 1\n",
      "  3400949003679 | TADENAN 50 MG 1 BOITE DE 60, CAPSULES MOLLES\n",
      "  3400949003761 | CLOPIXOL AP 200 MG SOL INJ (AIP BBF) 1\n",
      "  3400949003792 | AVODART 0,5MG CAPSULE (AIP) (PHL) 30\n",
      "  3400949003815 | IMUREL 50 MG CPR PELLICULE (AIP BBF) 100\n",
      "  3400949003846 | DECAPEPTYL LP 11,25MG PDR SOL AIP 1\n",
      "  3400949003853 | DECAPEPTYL LP 11,25MG PDR SOL (AIP) 1\n",
      "  3400949003860 | TRIFLUCAN 40 MG/ML PDR ORALE (AIP) 1\n",
      "  3400949003938 | DECAPEPTYL LP11,25MG PDR INJ (AIP) 1\n",
      "  3400949003976 | TEMERIT 5MG CPR (AIP) (BBF) 30\n",
      "  3400949003983 | TEMERIT 5MG CPR (AIP) (BBF) 90\n",
      "  3400949004003 | ANASTROZOLE MYL 1MG CPR (AIP BBF) 30\n",
      "  3400949004010 | ANASTROZOLE MYL 1MG CPR (AIP BBF) 90\n",
      "  3400949004027 | TRIFLUCAN 100 MG, GELULE (AIP) 7\n",
      "  3400949004034 | IXPRIM 37,5MG/325MG CPR (AIP BBF) 1\n",
      "  3400949004041 | TRUSOPT 20 MG/ML COLLYRE (AIP) 1\n",
      "  3400949004058 | COVERAM 10MG/5MG CPR (AIP) 30\n",
      "  3400949004065 | COVERAM 10MG/5MG CPR (AIP) 90\n",
      "  3400949004089 | COVERAM 10MG/10MG CPR(AIP) 30\n",
      "  3400949004096 | COVERAM 10MG/10MG CPR(AIP) 90\n",
      "  3400949004140 | PERMIXON 160MG GELULE (AIP DFM) 60\n",
      "  3400949004188 | LETROZOLE SDZ 2.5MG CPR (AIP)(BBF) 30\n",
      "  3400949004195 | CARDENSIEL 2,5MG CPR (AIP) (DFM) 30\n",
      "  3400949004201 | CARDENSIEL 2,5MG CPR (AIP) (DFM) 90\n",
      "  3400949004225 | VENTOLINE 100MCG SUSP INH (AIP)(PHL) 1\n",
      "  3400949004256 | SERETIDE DISKUS 250/50MCG PDR 60 AIP 60\n",
      "  3400949004287 | PURINETHOL 50 MG CPR (AIP PHL2) 25\n",
      "  3400949004300 | TEMERITDUO 5MG/25MG CPR (AIP) BBF 90\n",
      "  3400949004324 | TEMERITDUO 5MG/12,5MG CPR (AIP) BBF 90\n",
      "  3400949004393 | LIPOROSA 10MG/10MG GELULE AIP DFD 30\n",
      "  3400949004409 | LIPOROSA 10MG/10MG GELULE AIP DFD 90\n",
      "  3400949004416 | LIPOROSA 20 MG/10 MG GELULE AIP DFD 30\n",
      "  3400949004423 | LIPOROSA 20 MG/10 MG GELULE AIP DFD 90\n",
      "  3400949004430 | NATRIXAM 1,5 MG/5 MG LM CPR 30\n",
      "  3400949004447 | NATRIXAM 1,5 MG/5 MG LM CPR 90\n",
      "  3400949004454 | NATRIXAM 1,5 MG/10 MG CPR LM (AIP) 30\n",
      "  3400949004461 | NATRIXAM 1,5 MG/10 MG CPR LM (AIP) 90\n",
      "  3400949004522 | NOZINAN 100 MG CPR PELL (AIP ) 20\n",
      "  3400949004553 | CLOPIXOL ACTION PROLONGEE 200MG INJ 1\n",
      "  3400949004560 | COVERSYL 10MG CPR (AIP) (UK) 30\n",
      "  3400949004577 | LIPTRUZET 10 MG/10 MG CPR (AIP) 30\n",
      "  3400949004584 | LIPTRUZET 10 MG/10 MG CPR (AIP) 90\n",
      "  3400949004591 | LIPOROSA 10MG/10MG GELULE AIP BBF 30\n",
      "  3400949004607 | LIPOROSA 10MG/10MG GELULE AIP BBF 90\n",
      "  3400949004614 | VENTOLINE 100MCG /DOSE SUSP INH FL 1\n",
      "  3400949004669 | LIPOROSA 20 MG/10 MG GELULE 30\n",
      "  3400949004676 | LIPOROSA 20 MG/10 MG GELULE 90\n",
      "  3400949004683 | LIPTRUZET 10 MG/20MG CPR (AIP)(BBF) 30\n",
      "  3400949004690 | LIPTRUZET 10 MG/20MG CPR (AIP)(BBF) 90\n",
      "  3400949004706 | LIPTRUZET 10 MG/40MG CPR (AIP)(BBF) 30\n",
      "  3400949004713 | LIPTRUZET 10 MG/40MG CPR (AIP)(BBF) 90\n",
      "  3400949004744 | DECAPEPTYL L.P. 11,25 MG PDR INJ 1\n",
      "  3400949004751 | VENTOLINE 100MCG /DOSE INH FL AIP 1\n",
      "  3400949004782 | KAYEXALATE PDR SUSP ORALE/RECTALE 1\n",
      "  3400949004812 | LIPOROSA 20/10MG GEL (AIP)(PHL) 30\n",
      "  3400949004829 | LIPOROSA 20/10MG GEL (AIP)(PHL) 90\n",
      "  3400949004843 | LIPOROSA 10MG/10MG GEL ( AIP)( PHL) 30\n",
      "  3400949004867 | LIPOROSA 10MG/10MG GEL ( AIP)( PHL) 90\n",
      "  3400949004904 | DECAPEPTYL L.P 11.25MG INJ (AIP PHL) 1\n",
      "  3400949004911 | FEMARA 2,5MG CPR (AIP) 30\n",
      "  3400949004935 | NATRIXAM 1,5MG/5MG CPR LM AIP BBF 30\n",
      "  3400949004942 | NATRIXAM 1,5MG/5MG CPR LM AIP BBF 90\n",
      "  3400949004973 | NATRIXAM 1,5/10MG CPR LM (AIP)(BBF) 30\n",
      "  3400949004980 | NATRIXAM 1,5/10MG CPR LM (AIP)(BBF) 90\n",
      "  3400949005161 | PERMIXON 160MG GELULE (ES) 2 60\n",
      "  3400949005390 | ZOXAN LP 4MG CPR (UK) 1 28\n",
      "  3400949005512 | ZOXAN LP 8MG CPR (UK) 28\n",
      "  3400949005802 | EZETROL 10MG CPR AIP (UK) 28\n",
      "  3400949006632 | QVAR AUTOHALER 100 MICROG (DE) 1\n",
      "  3400949007813 | PERMIXON 160MG GELULE (AIP) (BBF) 60\n",
      "  3400949008063 | QVAR AUTOHALER 100MCG INH (AIP) (GR) 1\n",
      "  3400949009244 | ZOXAN LP 8MG CPR (AIP) (UK) 28\n",
      "  3400949009534 | PERMIXON 160MG GELULE (ES) 2 180\n",
      "  3400949009763 | OGAST 30 MG (LANSOPRAZOLE) 1 BOITE DE 28, GELULES\n",
      "  3400949009992 | SYMBICORT TURB 400/12 MICROG AIP 1\n",
      "  3400949010134 | COVERAM 10MG/5MG CPR (AIP) (POL) 30\n",
      "  3400949012893 | XATRAL LP 10MG CPR (AIP) (MWI IT) 30\n",
      "  3400949013265 | PERMIXON 160MG GELULE (AIP) (BBF) 180\n",
      "  3400949013906 | NEURONTIN 400MG GELULE (AIP) (BB) 90\n",
      "  3400949014095 | NEURONTIN 300MG GELULE (AIP) (BB) 90\n",
      "  3400949015337 | COVERAM 5MG/5MG CPR (AIP) (PLA PL) 30\n",
      "  3400949015566 | COVERAM 10MG/10MG CPR (AIP) (PLAPL) 30\n",
      "  3400949016167 | FEMARA 2,5MG CPR (AIP)(PLA IT) 30\n",
      "  3400949016228 | DIAMICRON LM 60MG CPR (AIP) (BBABE) 30\n",
      "  3400949016396 | DIAMICRON LM 60MG CPR (AIP) (BBABE) 90\n",
      "  3400949021130 | TAHOR 10 MG CPR (AIP) (MWI ES) 28\n",
      "  3400949021888 | FORADIL 12 MICROG PDR INH (AIP) 60\n",
      "  3400949023202 | PERMIXON 160MG GELULE (AIP) (MWI LT) 60\n",
      "  3400949023370 | COVERAM 5MG/5MG CPR (AIP) (BBA CZ) 30\n",
      "  3400949023431 | COVERAM 5MG/5MG CPR (AIP) (BBA CZ) 90\n",
      "  3400949023660 | COVERAM 5MG/10MG CPR (AIP) (BBA CZ) 30\n",
      "  3400949023721 | COVERAM 5MG/10MG CPR (AIP) (BBA CZ) 90\n",
      "  3400949023899 | COVERAM 10MG/5MG CPR (AIP) (BBA CZ) 30\n",
      "  3400949023950 | COVERAM 10MG/5MG CPR (AIP) (BBA CZ) 90\n",
      "  3400949024032 | COVERAM 10MG/10MG CPR (AIP) (BBACZ) 30\n",
      "  3400949024261 | COVERAM 10MG/10MG CPR (AIP) (BBACZ) 90\n",
      "  3400949026043 | NEURONTIN 300MG GELULE (AIP) (PLA) 90\n",
      "  3400949027682 | VOLTARENE LP 75MG CPR (AIP) (BBAES) 30\n",
      "  3400949028344 | SINGULAIR 10MG CPR (AIP) (BBA) 28\n",
      "  3400949100644 | PERINDOPRIL INDAP KRK 2/0,625MG CPR 30\n",
      "  3400949101016 | PERINDOPRIL INDAP KRK 2/0,625MG CPR 90\n",
      "  3400949102426 | PERINDOPRIL INDAP KRK 4/1,25MG CPR 30\n",
      "  3400949102884 | PERINDOPRIL INDAP KRK 4/1,25MG CPR 90\n",
      "  3400949105496 | VALSARTAN EG 40MG CPR 30\n",
      "  3400949105786 | VALSARTAN EG 40MG CPR 90\n",
      "  3400949106097 | VALSARTAN EG 80MG CPR 30\n",
      "  3400949106387 | VALSARTAN EG 80MG CPR 90\n",
      "  3400949106677 | VALSARTAN EG 160MG CPR 30\n",
      "  3400949107049 | VALSARTAN EG 160MG CPR 90\n",
      "  3400949113422 | QIADE GE 150/30 MCG CPR 63\n",
      "  3400949115433 | PARACETAMOL ARW 500MG CPR EFF 16\n",
      "  3400949120406 | METFORMINE VIATRIS 500MG CPR 30\n",
      "  3400949121175 | METFORMINE VIATRIS 500MG CPR 90\n",
      "  3400949123018 | METFORMINE MYP 850MG CPR 30\n",
      "  3400949123766 | METFORMINE MYP 850MG CPR 90\n",
      "  3400949125777 | METFORMINE VIATRIS 1 000 MG CPR 30\n",
      "  3400949126439 | METFORMINE VIATRIS 1 000 MG CPR 90\n",
      "  3400949129102 | TRIMEBUTINE ZYD 200MG CPR 30\n",
      "  3400949131341 | VOTRIENT 200 MG CPR 30\n",
      "  3400949131570 | VOTRIENT 400 MG CPR 30\n",
      "  3400949131631 | VOTRIENT 400 MG CPR 60\n",
      "  3400949133932 | DICLOFENAC TVC 1% GEL FLACON 1\n",
      "  3400949134014 | DICLOFENAC EG 1% GEL FL100ML 1\n",
      "  3400949140855 | LETROZOLE ZEN 2,5MG CPR 30\n",
      "  3400949144587 | GLICLAZIDE ARW LM 30MG CPR 30\n",
      "  3400949144709 | GLICLAZIDE ARW LM 30MG CPR 60\n",
      "  3400949147489 | TAREG 3 MG/ML SOL BUV 1\n",
      "  3400949152162 | VALSARTAN/HCTZ SDZ 80/12,5MG CPR 30\n",
      "  3400949152803 | VALSARTAN/HCTZ SDZ 80/12,5MG CPR 90\n",
      "  3400949157365 | VALSARTAN/HCTZ SDZ 160/12,5MG CPR 30\n",
      "  3400949158027 | VALSARTAN/HCTZ SDZ 160/12,5MG CPR 90\n",
      "  3400949162567 | VALSARTAN/HCTZ SDZ 160/25MG CPR 30\n",
      "  3400949163458 | VALSARTAN/HCTZ SDZ 160/25MG CPR 90\n",
      "  3400949172214 | PICOPREP BUV PDR ORALE SACH 2\n",
      "  3400949172733 | IMIPENEM CIL VTS 500/500MG PDR INJ 1\n",
      "  3400949175345 | RISPERIDONE SDZ 4MG CPR DISP 28\n",
      "  3400949176007 | RISPERIDONE SDZ 3MG CPR DISP 28\n",
      "  3400949179596 | MYCOPHENOLATE BGA 250MG GELULE 100\n",
      "  3400949179886 | CITALOPRAM EVO 20MG CPR 28\n",
      "  3400949183739 | LERCANIDIPINE CRT 10MG CPR 30\n",
      "  3400949184101 | LERCANIDIPINE CRT 10MG CPR 90\n",
      "  3400949185399 | LERCANIDIPINE CRT 20MG CPR 30\n",
      "  3400949185689 | LERCANIDIPINE CRT 20MG CPR 90\n",
      "  3400949186280 | BISOPROLOL EG 3,75MG CPR 30\n",
      "  3400949187232 | BISOPROLOL EG 1,25MG CPR 30\n",
      "  3400949187751 | BISOPROLOL EG 1,25MG CPR 90\n",
      "  3400949188123 | LETROZOLE BGA 2,5 MG CPR 30\n",
      "  3400949188703 | BISOPROLOL EG 2,5MG CPR 30\n",
      "  3400949189182 | BISOPROLOL EG 2,5MG CPR 90\n",
      "  3400949190133 | EXEMESTANE SDZ 25MG CPR 30\n",
      "  3400949191482 | OXOMEMAZINE BGA 0,33MG/ML SOL BUV 1\n",
      "  3400949205592 | EXEMESTANE TVC 25MG CPR 30\n",
      "  3400949206254 | CANDESARTAN/HCTZ SDZ 8/12,5 CPR 30\n",
      "  3400949206773 | CANDESARTAN/HCTZ SDZ 8/12,5 CPR 90\n",
      "  3400949208494 | CANDESARTAN/HCTZ SDZ 16/12,5 CPR 30\n",
      "  3400949209095 | CANDESARTAN/HCTZ SDZ 16/12,5 CPR 90\n",
      "  3400949212118 | MYCOPHENOLATE SDZ 250MG GELULE 100\n",
      "  3400949214587 | TRAMADOL ACTAVIS 50 MG 1 BOITE DE 30, GELULES\n",
      "  3400949215188 | OXOMEMAZINE TVC 0,33MG/ML SOL BUV 1\n",
      "  3400949215300 | OXOMEMAZINE ARW 0,33 MG/ML SOL BUV 1\n",
      "  3400949215539 | OXOMEMAZINE VTS 0,33MG/ML SOL BUV 1\n",
      "  3400949215768 | CROMOGLICATE BGA 2% COLLYRE FL 5ML 1\n",
      "  3400949218899 | BISOPROLOL SUN 1,25MG CPR 30\n",
      "  3400949219780 | BISOPROLOL SUN 2,5MG CPR 30\n",
      "  3400949221271 | OXOMEMAZINE ZTV 0,33MG/ML SOL BUV 1\n",
      "  3400949221851 | PERINDOPRIL EG 8MG CPR 30\n",
      "  3400949222162 | PERINDOPRIL EG 8MG CPR 90\n",
      "  3400949242962 | ADAPALENE ZEN 0,1% CREME 1\n",
      "  3400949243273 | ADAPALENE TVC 0,1% CREME 1\n",
      "  3400949243624 | ADAPALENE ZEN 0,1% GEL 1\n",
      "  3400949244454 | OXOMEMAZINE EG 0,33MG/ML SOL BUV 1\n",
      "  3400949244515 | MYCOPHENOLATE SDZ 500MG CPR 50\n",
      "  3400949245406 | RISEDRONATE BGR 35MG CPR 4\n",
      "  3400949245635 | RISEDRONATE BGR 35MG CPR 12\n",
      "  3400949245925 | PRAMIPEXOLE TVC 0,18MG CPR 100\n",
      "  3400949246175 | PRAMIPEXOLE TVC 0,7MG CPR 100\n",
      "  3400949246236 | OXOMEMAZINE EG 0,33MG/ML SIROP 1\n",
      "  3400949246694 | OXOMEMAZINE VTS 0,33MG/ML SIROP 1\n",
      "  3400949246755 | OXOMEMAZINE ARW 0,33MG/ML SIROP 1\n",
      "  3400949246816 | OXOMEMAZINE ZTV 0,33MG/ML SIROP 1\n",
      "  3400949247127 | ZOLMITRIPTAN BGA 2,5MG CPR ORODISP 6\n",
      "  3400949247295 | ZOLMITRIPTAN BGA 2,5MG CPR ORODISP 12\n",
      "  3400949250196 | FRAGMINE 10 000UI AXA/0,4ML SOL INJ 5\n",
      "  3400949250318 | ZALERG 0,25MG/ML COLLYRE FL 5ML 1\n",
      "  3400949252619 | ANASTROZOLE ARW 1MG CPR 90\n",
      "  3400949253678 | IBUPROFENE ZYF 400MG CPR PELL 20\n",
      "  3400949253739 | IBUPROFENE ZYF 400MG CPR PELL 30\n",
      "  3400949255689 | MONTELUKAST SDZ 10MG CPR 28\n",
      "  3400949267408 | MODAFINIL BGA 100MG CPR 30\n",
      "  3400949269068 | SUMATRIPTAN SUN 6 MG SOL INJ 2\n",
      "  3400949269129 | OXOMEMAZINE TVC 0,33MG/ML SIROP 1\n",
      "  3400949269419 | MODAFINIL MYL 100MG CPR 30\n",
      "  3400949270187 | QUINAPRIL HCTZ ARL 20/12,5MG CPR 28\n",
      "  3400949275731 | ANASTROZOLE EVO 1MG CPR 30\n",
      "  3400949278404 | REPAGLINIDE SDZ 0,5MG CPR 90\n",
      "  3400949279173 | REPAGLINIDE SDZ 0,5MG CPR 270\n",
      "  3400949279524 | REPAGLINIDE SDZ 1MG CPR 90\n",
      "  3400949280124 | REPAGLINIDE SDZ 1MG CPR 270\n",
      "  3400949280414 | REPAGLINIDE SDZ 2MG CPR 90\n",
      "  3400949281015 | REPAGLINIDE SDZ 2MG CPR 270\n",
      "  3400949285785 | PROLIA 60 MG SOL INJ 1\n",
      "  3400949288168 | VALSARTAN BGA 40 MG CPR 30\n",
      "  3400949288229 | VALSARTAN BGA 40 MG CPR 90\n",
      "  3400949288809 | VALSARTAN BGA 80 MG CPR 30\n",
      "  3400949288977 | VALSARTAN BGA 80 MG CPR 90\n",
      "  3400949289349 | RISPERIDONE EG 0,5MG CPR DISP 28\n",
      "  3400949289578 | VALSARTAN BGA 160 MG CPR 30\n",
      "  3400949289639 | VALSARTAN BGA 160 MG CPR 90\n",
      "  3400949290468 | RISPERIDONE EG 1MG CPR DISP 28\n",
      "  3400949291069 | RISPERIDONE EG 2MG CPR DISP 28\n",
      "  3400949291588 | SPIRAM/METRO ALM 1,5 MUI/250 MG CPR 10\n",
      "  3400949292011 | SPIRAM/METRO CRT 1,5MUI/250MG CPR 10\n",
      "  3400949295371 | EXEMESTANE ACC 25MG CPR 30\n",
      "  3400949297153 | MYCOPHENOLATE BGA 500MG CPR 50\n",
      "  3400949297672 | PRAVASTATINE ACC 10MG CPR 28\n",
      "  3400949298563 | PRAVASTATINE ACC 20MG CPR 28\n",
      "  3400949304578 | RAPAMUNE 0,5MG CPR 30\n",
      "  3400949311262 | VALSARTAN ZEN 40MG CPR 30\n",
      "  3400949311491 | VALSARTAN ZEN 40MG CPR 90\n",
      "  3400949311781 | VALSARTAN ZEN 80MG CPR 30\n",
      "  3400949311903 | VALSARTAN ZEN 80MG CPR 90\n",
      "  3400949312214 | VALSARTAN ZEN 160MG CPR 30\n",
      "  3400949312443 | VALSARTAN ZEN 160MG CPR 90\n",
      "  3400949322039 | VALSARTAN SDZ 40MG CPR 30\n",
      "  3400949322787 | VALSARTAN SDZ 40MG CPR 90\n",
      "  3400949327461 | VALSARTAN SDZ 80MG CPR 30\n",
      "  3400949328062 | VALSARTAN SDZ 80MG CPR 90\n",
      "  3400949332373 | VALSARTAN SDZ 160MG CPR 30\n",
      "  3400949333035 | VALSARTAN SDZ 160MG CPR 90\n",
      "  3400949335046 | RALOXIFENE TVC 60MG CPR 28\n",
      "  3400949335107 | RALOXIFENE TVC 60MG CPR 84\n",
      "  3400949336456 | PANTOPRAZOLE TVS 20MG CPR 14\n",
      "  3400949336517 | PANTOPRAZOLE TVS 20MG CPR 28\n",
      "  3400949337118 | PANTOPRAZOLE TVS 40MG CPR 7\n",
      "  3400949337286 | PANTOPRAZOLE TVS 40MG CPR 14\n",
      "  3400949337347 | PANTOPRAZOLE TVS 40MG CPR 28\n",
      "  3400949350872 | PERINDOPRIL INDAP SDZ 2/0,625MG CPR 30\n",
      "  3400949351183 | PERINDOPRIL INDAP SDZ 2/0,625MG CPR 90\n",
      "  3400949352883 | PERINDOPRIL INDAP SDZ 4/1,25MG CPR 30\n",
      "  3400949353194 | PERINDOPRIL INDAP SDZ 4/1,25MG CPR 90\n",
      "  3400949362998 | NARATRIPTAN EG 2,5MG CPR 6\n",
      "  3400949363131 | NARATRIPTAN EG 2,5MG CPR 12\n",
      "  3400949363599 | TRAMADOL CRT LP 100MG CPR 30\n",
      "  3400949363940 | TRAMADOL CRT LP 150MG CPR 30\n",
      "  3400949375547 | TELMISARTAN TVS 40MG CPR 30\n",
      "  3400949376148 | TELMISARTAN TVS 40MG CPR 90\n",
      "  3400949378098 | TELMISARTAN TVS 80MG CPR 30\n",
      "  3400949378449 | TELMISARTAN TVS 80MG CPR 90\n",
      "  3400949378678 | TRAMADOL CRT LP 200MG CPR 30\n",
      "  3400949389735 | ATORVASTATINE SDZ 80MG CPR 30\n",
      "  3400949390915 | ATORVASTATINE SDZ 80MG CPR 90\n",
      "  3400949391974 | NARATRIPTAN BGA 2,5MG CPR 6\n",
      "  3400949392117 | NARATRIPTAN BGA 2,5MG CPR 12\n",
      "  3400949393237 | NARATRIPTAN ARW 2,5 MG CPR 6\n",
      "  3400949393527 | NARATRIPTAN ARW 2,5 MG CPR 12\n",
      "  3400949394708 | ATORVASTATINE ZYF 10MG CPR 30\n",
      "  3400949395019 | ATORVASTATINE ZYF 20MG CPR 30\n",
      "  3400949395309 | ATORVASTATINE ZYF 40MG CPR 30\n",
      "  3400949395767 | ATORVASTATINE ZYF 80MG CPR 30\n",
      "  3400949397198 | ATORVASTATINE ALM 10MG CPR 30\n",
      "  3400949397488 | ATORVASTATINE ALM 20MG CPR 30\n",
      "  3400949397778 | ATORVASTATINE ALM 40MG CPR 30\n",
      "  3400949398140 | ATORVASTATINE ALM 80MG CPR 30\n",
      "  3400949398379 | OLANZAPINE ARG 5MG CPR 28\n",
      "  3400949398959 | OLANZAPINE BGA 5MG CPR 28\n",
      "  3400949399031 | OLANZAPINE BGA 7,5MG CPR 28\n",
      "  3400949399260 | OLANZAPINE BGA 10 MG CPR 28\n",
      "  3400949399321 | OLANZAPINE ZTL 5MG CPR 28\n",
      "  3400949399499 | OLANZAPINE ZTL 7,5MG CPR 28\n",
      "  3400949399550 | OLANZAPINE ZTL 10MG CPR 28\n",
      "  3400949404674 | FLUOXETINE ACC 20MG GELULE 14\n",
      "  3400949407118 | OZURDEX 700MCG IMPL SACH 1\n",
      "  3400949408528 | CLARITHROMYCINE TVC LM 500MG CPR 5\n",
      "  3400949408986 | CLARITHROMYCINE TVC LM 500MG CPR 10\n",
      "  3400949409648 | KALETRA 200MG/50MG CPR 120\n",
      "  3400949413379 | NIVESTIM 12 MUI SOL INJ 1\n",
      "  3400949413669 | NIVESTIM 30 MUI SOL INJ 1\n",
      "  3400949413720 | NIVESTIM 30 MUI SOL INJ 5\n",
      "  3400949413898 | NIVESTIM 48 MUI SOL INJ 1\n",
      "  3400949413959 | NIVESTIM 48 MUI SOL INJ 5\n",
      "  3400949430178 | OLANZAPINE ZENTIVA 5MG CPR SEC 28\n",
      "  3400949430697 | OLANZAPINE ZENTIVA 7,5MG CPR 28\n",
      "  3400949431700 | OLANZAPINE ZENTIVA 10MG CPR 28\n",
      "  3400949433599 | OLANZAPINE ZEN 5MG CPR DISP 28\n",
      "  3400949434190 | OLANZAPINE ZEN 10MG CPR DISP 28\n",
      "  3400949440924 | ATORVASTATINE TVS 10MG CPR 28\n",
      "  3400949441693 | ATORVASTATINE TVS 10MG CPR 90\n",
      "  3400949442584 | ATORVASTATINE TVS 20MG CPR 28\n",
      "  3400949443246 | ATORVASTATINE TVS 20MG CPR 90\n",
      "  3400949444137 | ATORVASTATINE TVS 40MG CPR 28\n",
      "  3400949444946 | ATORVASTATINE TVS 40MG CPR 90\n",
      "  3400949445608 | ATORVASTATINE TVS 80MG CPR 28\n",
      "  3400949446438 | ATORVASTATINE TVS 80MG CPR 90\n",
      "  3400949452460 | LETROZOLE EG 2,5MG CPR 30\n",
      "  3400949457083 | RISEDRONATE SDZ 35MG CPR 4\n",
      "  3400949457205 | RISEDRONATE SDZ 35MG CPR 12\n",
      "  3400949458783 | TAHOR 10MG CPR CROQ 30\n",
      "  3400949458844 | TAHOR 20MG CPR CROQ 30\n",
      "  3400949460274 | VALACICLOVIR ZYD 500MG CPR 10\n",
      "  3400949460564 | VALACICLOVIR ZYD 500MG CPR 42\n",
      "  3400949460854 | VALACICLOVIR ZYD 500MG CPR 112\n",
      "  3400949461745 | SPRYCEL 140 MG CPR 30\n",
      "  3400949464708 | TWYNSTA 40MG/5MG CPR 30\n",
      "  3400949464937 | TWYNSTA 40MG/5MG CPR 90\n",
      "  3400949465248 | TWYNSTA 40MG/10MG CPR 30\n",
      "  3400949465309 | TWYNSTA 40MG/10MG CPR 90\n",
      "  3400949465477 | TWYNSTA 80MG/5MG CPR 30\n",
      "  3400949465538 | TWYNSTA 80MG/5MG CPR 90\n",
      "  3400949465767 | TWYNSTA 80MG/10MG CPR 30\n",
      "  3400949465828 | TWYNSTA 80MG/10MG CPR 90\n",
      "  3400949467020 | BICALUTAMIDE ACC 50MG CPR 30\n",
      "  3400949476534 | MOVICOL SS AROME PDR ORALE SACH 20\n",
      "  3400949476824 | MOVICOL CHOCOLAT PDR ORALE SACH 20\n",
      "  3400949478545 | MEDIKINET 5MG LM GELULE 28\n",
      "  3400949479207 | MONTELUKAST KRK 10MG CPR 28\n",
      "  3400949481385 | MEDIKINET 10MG LM GELULE 28\n",
      "  3400949481507 | MEDIKINET 20MG LM GELULE 28\n",
      "  3400949481736 | MEDIKINET 30MG LM GELULE 28\n",
      "  3400949482108 | MEDIKINET 40MG LM GELULE 28\n",
      "  3400949483518 | POLYGYNAX CAPSULE VAGINALE 6\n",
      "  3400949484928 | ATENOLOL AHL 50MG CPR 30\n",
      "  3400949485000 | ATENOLOL AHL 50MG CPR 90\n",
      "  3400949485529 | ATENOLOL AHL 100MG CPR 30\n",
      "  3400949485697 | ATENOLOL AHL 100MG CPR 90\n",
      "  3400949486298 | CLARITHROMYCINE EVO LM 500MG CPR 10\n",
      "  3400949487189 | PANTOPRAZOLE ARW 40 MG PDR INJ 1\n",
      "  3400949490899 | CICLETANINE VIATRIS 50MG GELULE 30\n",
      "  3400949491032 | CICLETANINE VIATRIS 50MG GELULE 90\n",
      "  3400949491322 | LEVOFLOXACINE ALM 500MG CPR 5\n",
      "  3400949494514 | RABEPRAZOLE KRK 20MG CPR 14\n",
      "  3400949494743 | RABEPRAZOLE KRK 20MG CPR 28\n",
      "  3400949495573 | RABEPRAZOLE KRK 10MG CPR 14\n",
      "  3400949495863 | RABEPRAZOLE KRK 10MG CPR 28\n",
      "  3400949497294 | ANASTROZOLE ACC 1MG CPR 30\n",
      "  3400949497706 | ANASTROZOLE ACC 1MG CPR 90\n",
      "  3400949498246 | LANSOPRAZOLE EVO 15MG GELULE 30\n",
      "  3400949498994 | LANSOPRAZOLE EVO 30MG GELULE 28\n",
      "  3400949499717 | BUDESONIDE PHR 0,5MG/2ML INH 20\n",
      "  3400949500062 | KEPPRA 250MG CPR (ADP) (MWI) 60\n",
      "  3400949500086 | LUMIGAN 0,3MG/ML COLLY 3ML (ADP) PLA 1\n",
      "  3400949500093 | AZARGA 10MG/5MG/ML COLLYRE ADP MWI 1\n",
      "  3400949500130 | AERIUS 5MG CPR ADP MWI 30\n",
      "  3400949500185 | CLOPIDOGREL TPH 75 MG CPR (ADP BBA) 30\n",
      "  3400949500192 | ABILIFY 5 MG CPR (ADP) (BBF) 28\n",
      "  3400949500222 | AERIUS 5MG CPR ADP BBF 30\n",
      "  3400949500239 | ZONEGRAN 25 MG GELULE 14\n",
      "  3400949500291 | HEPSERA 10MG CPR (AIP) 30\n",
      "  3400949500437 | UROREC 4MG GELULE (ADP) (PLA) 30\n",
      "  3400949500451 | LUMIGAN 0,1 MG/ML COLLYRE (ADP MWI ) 1\n",
      "  3400949500468 | FOSAVANCE 70MG/2800UI CPR (ADP) MEDW 4\n",
      "  3400949500505 | AZILECT 1MG CPR 30\n",
      "  3400949500536 | LYRICA 75 MG GELULE 56 DIFARMED 56\n",
      "  3400949500550 | NIVESTIM 30 MUI SOL INJ (ADP BBF) 1\n",
      "  3400949500567 | NIVESTIM 48 MUI SOL INJ (ADP BBF) 1\n",
      "  3400949500574 | ZARZIO 30 MUI SOL INJ SER 5\n",
      "  3400949500581 | ZARZIO 30 MUI SOL INJ SER 1\n",
      "  3400949500598 | ZARZIO 48 MUI SOL INJ SER ADP BB FAR 5\n",
      "  3400949500604 | ZARZIO 48 MUI SOL INJ SER ADP BB FAR 1\n",
      "  3400949500611 | LYRICA 75 MG GELULE 56 BB FARMA 56\n",
      "  3400949500765 | ADVAGRAF LP 3MG GELULE 30\n",
      "  3400949500819 | ZONEGRAN 50 MG GELULE 14\n",
      "  3400949500833 | EMEND 80 MG ET 125 MG GELULES 3\n",
      "  3400949500840 | LYRICA 50 MG GELULE (ADP)(BBF) 84\n",
      "  3400949500857 | LYRICA 100 MG GELULE 84\n",
      "  3400949500918 | ADVAGRAF LP 1MG GELULE 30\n",
      "  3400949500925 | PELGRAZ 6 MG SOL INJ SER (ADP)(PHL) 1\n",
      "  3400949500963 | ALDARA 5% CREME (ADP BBF) 12\n",
      "  3400949500970 | PELMEG 6 MG SER SOL INJ (ADP)(BBF) 1\n",
      "  3400949500987 | AZOPT 10MG/ML COLLYRE FL 5ML (ADP1) 1\n",
      "  3400949500994 | ENTECAVIR MYL 0,5 MG CPR 30\n",
      "  3400949501007 | ENVARSUS LP 1MG CPR 30\n",
      "  3400949501045 | ADVAGRAF LP 5MG GELULE 30\n",
      "  3400949501120 | FOSAVANCE 70MG/5600UI CPR (ADP) 4\n",
      "  3400949501410 | FOSAVANCE 70MG/2800UI CPR (ADP) MEDW 12\n",
      "  3400949501588 | FOSAVANCE 70MG/5600UI CPR (ADP) 12\n",
      "  3400949501649 | AZOPT 10MG/ML COLLYRE FL 5ML (ADP2) 1\n",
      "  3400949501878 | FOSAVANCE 70MG/2800UI CPR (ADP) PLAB 12\n",
      "  3400949501939 | FOSAVANCE 70MG/5600UI CPR (ADP) 4\n",
      "  3400949502011 | ALDARA 5% CREME (UK) ADP 12\n",
      "  3400949502301 | PLAVIX 75MG CPR (ADP) 30\n",
      "  3400949502820 | TRAVATAN 0,004% COLLYRE 2,5ML (ADP) 1\n",
      "  3400949502998 | PLAVIX 75MG CPR (ADP) 2 30\n",
      "  3400949503131 | GANFORT 0,3MG/ML + 5MG/ML COL UK ADP 1\n",
      "  3400949503940 | ZYPREXA 5MG CPR (ADP) 28\n",
      "  3400949504480 | CELLCEPT 250MG GELULE (ADP) MWI 100\n",
      "  3400949504541 | CELLCEPT 500MG CPR (ADP) 50\n",
      "  3400949504831 | KEPPRA 1000MG CPR ADP 60\n",
      "  3400949505081 | KEPPRA 500MG CPR (ADP) (MDW) 60\n",
      "  3400949505142 | ZYPREXA 5MG CPR (ADP) (BBA) 28\n",
      "  3400949505371 | ZYPREXA VELOTAB 5MG CPR (ADP) (BBA) 28\n",
      "  3400949506033 | ARAVA 20 MG CPR (ADP BBA) 30\n",
      "  3400949506262 | ARAVA 10 MG CPR (ADP BBA) 30\n",
      "  3400949506323 | UROREC 4 MG GELULE (ADP) (IR) MWI 30\n",
      "  3400949506491 | UROREC 8 MG GELULE (ADP) (IR) 30\n",
      "  3400949506781 | XARELTO 10 MG CPR ADP 30\n",
      "  3400949506842 | PLAVIX 75MG CPR (ADP) (MWI) 30\n",
      "  3400949507153 | ZYPREXA 5MG CPR (ADP) (PLA) 28\n",
      "  3400949507214 | PROCORALAN 5 MG CPR ADP PHL 56\n",
      "  3400949508914 | KEPPRA 500MG CPR (ADP) (BBA) 60\n",
      "  3400949510573 | KEPPRA 1000MG CPR (ADP) (ITT) 60\n",
      "  3400949510634 | KEPPRA 500MG CPR (ADP) (PLA) 60\n",
      "  3400949510863 | KEPPRA 1000MG CPR (ADP) (PLA) 60\n",
      "  3400949511006 | CELLCEPT 500MG CPR (ADP) BBA 50\n",
      "  3400949511235 | UROREC 4MG GELULE (ADP) (BBA) 30\n",
      "  3400949512065 | ARAVA 20 MG CPR (ADP) (PLA) 30\n",
      "  3400949512294 | KEPPRA 250MG CPR (ADP) (PLA) 60\n",
      "  3400949512355 | ARIXTRA 2,5MG/0,5ML INJ (AIP) (MWI) 7\n",
      "  3400949512645 | PLAVIX 75MG CPR (ADP) (ITT) 30\n",
      "  3400949600915 | BUDESONIDE PHR 1MG/2ML INH 20\n",
      "  3400949605538 | IZALGI 500 MG/25 MG GELULE 16\n",
      "  3400949606139 | DORZOLAMIDE VIATRIS 2% COLLYRE 5ML 1\n",
      "  3400949610969 | VENLAFAXINE KRK LP 37,5MG GELULE 30\n",
      "  3400949615353 | VENLAFAXINE KRK LP 75MG GELULE 30\n",
      "  3400949617135 | CANDESARTAN ZEN 4MG CPR 30\n",
      "  3400949617593 | CANDESARTAN ZEN 4MG CPR 90\n",
      "  3400949617944 | ALLOPURINOL TVC 100MG CPR 28\n",
      "  3400949618835 | RISEDRONATE ACC 35MG CPR 4\n",
      "  3400949619375 | RISEDRONATE ACC 35MG CPR 12\n",
      "  3400949620036 | ALLOPURINOL TVC 200MG CPR 28\n",
      "  3400949620906 | CANDESARTAN ZEN 8MG CPR 30\n",
      "  3400949621217 | CANDESARTAN ZEN 8MG CPR 90\n",
      "  3400949621736 | CANDESARTAN ZEN 16MG CPR 30\n",
      "  3400949622108 | CANDESARTAN ZEN 16MG CPR 90\n",
      "  3400949622795 | CANDESARTAN ZEN 32MG CPR 30\n",
      "  3400949623686 | ALLOPURINOL TVC 300MG CPR 28\n",
      "  3400949624348 | IRBESARTAN CRT 75MG CPR PELL 30\n",
      "  3400949624638 | IRBESARTAN CRT 75MG CPR PELL 90\n",
      "  3400949625178 | IRBESARTAN CRT 150MG CPR PELL 30\n",
      "  3400949625529 | IRBESARTAN CRT 150MG CPR PELL 90\n",
      "  3400949625987 | IRBESARTAN CRT 300MG CPR PELL 30\n",
      "  3400949626298 | IRBESARTAN CRT 300MG CPR PELL 90\n",
      "  3400949626359 | EXEMESTANE EG 25MG CPR 30\n",
      "  3400949636815 | PRAMIPEXOLE VIATRIS 0,18MG CPR 30\n",
      "  3400949637294 | PRAMIPEXOLE VIATRIS 0,18MG CPR 100\n",
      "  3400949639076 | PRAMIPEXOLE VIATRIS 0,7MG CPR 30\n",
      "  3400949639595 | PRAMIPEXOLE VIATRIS 0,7MG CPR 100\n",
      "  3400949642557 | OFLOXACINE BGA 1,5MG/0,5ML SOL AURIC 20\n",
      "  3400949644339 | RISEDRONATE ZTL 35MG CPR 4\n",
      "  3400949644568 | RISEDRONATE ZTL 35MG CPR 12\n",
      "  3400949656516 | ACIDE FUSIDIQUE BGR 2% CREME 1\n",
      "  3400949657117 | IRBESARTAN HCTZ ZYD 150/12,5MG CPR 30\n",
      "  3400949657407 | IRBESARTAN HCTZ ZYD 150/12,5MG CPR 90\n",
      "  3400949666331 | PECFENT 100 MCG/DOSE SOL NASAL 1,55 1\n",
      "  3400949666621 | PECFENT 400 MICROG/DOSE SOL NASAL 1\n",
      "  3400949666911 | IRBESARTAN HCTZ ZYD 300/12,5MG CPR 30\n",
      "  3400949667390 | IRBESARTAN HCTZ ZYD 300/12,5MG CPR 90\n",
      "  3400949668861 | ATOVAQ/PROGUAN AFS 250/100MG CPR 12\n",
      "  3400949669233 | MONTELUKAST VIATRIS 10MG CPR 28\n",
      "  3400949695256 | ALPRAZOLAM ZEN 0,25MG CPR 30\n",
      "  3400949695317 | ALPRAZOLAM ZEN 0,50MG CPR 30\n",
      "  3400949696086 | VENLAFAXINE TVS LP 37,5 MG GELULE 30\n",
      "  3400949697618 | VENLAFAXINE TVS LP 75 MG GELULE 30\n",
      "  3400949699858 | RABEPRAZOLE TEVA 10MG CPR 14\n",
      "  3400949700202 | RABEPRAZOLE TEVA 10MG CPR 28\n",
      "  3400949701612 | RABEPRAZOLE TVS 20MG CPR 14\n",
      "  3400949702091 | RABEPRAZOLE TVS 20MG CPR 28\n",
      "  3400949710027 | LOPERAMIDE ALM 2MG GELULE 20\n",
      "  3400949717699 | ESOMEPRAZOLE ZEN 20MG GELULE 7\n",
      "  3400949717750 | ESOMEPRAZOLE ZEN 20MG GELULE 14\n",
      "  3400949717811 | ESOMEPRAZOLE ZEN 20MG GELULE 28\n",
      "  3400949718061 | ESOMEPRAZOLE ZEN 40MG GELULE 14\n",
      "  3400949718122 | ESOMEPRAZOLE ZEN 40MG GELULE 28\n",
      "  3400949718351 | ESOMEPRAZOLE BGA 20 MG GELULE 7\n",
      "  3400949718412 | ESOMEPRAZOLE BGA 20 MG GELULE 14\n",
      "  3400949718580 | ESOMEPRAZOLE BGA 20 MG GELULE 28\n",
      "  3400949718702 | ESOMEPRAZOLE BGA 40MG GELULE 14\n",
      "  3400949718870 | ESOMEPRAZOLE BGA 40MG GELULE 28\n",
      "  3400949719013 | ESOMEPRAZOLE VTS 20 MG GELULE 7\n",
      "  3400949719181 | ESOMEPRAZOLE VTS 20 MG GELULE 14\n",
      "  3400949719242 | ESOMEPRAZOLE VTS 20 MG GELULE 28\n",
      "  3400949719471 | ESOMEPRAZOLE VTS 40 MG GELULE 14\n",
      "  3400949719532 | ESOMEPRAZOLE VTS 40 MG GELULE 28\n",
      "  3400949720651 | ESOMEPRAZOLE EG 20MG GELULE 7\n",
      "  3400949720712 | ESOMEPRAZOLE EG 20MG GELULE 14\n",
      "  3400949720880 | ESOMEPRAZOLE EG 20MG GELULE 28\n",
      "  3400949721023 | ESOMEPRAZOLE EG 40MG GELULE 14\n",
      "  3400949721191 | ESOMEPRAZOLE EG 40MG GELULE 28\n",
      "  3400949721313 | ESOMEPRAZOLE ARW 20MG GELULE 7\n",
      "  3400949721481 | ESOMEPRAZOLE ARW 20MG GELULE 14\n",
      "  3400949721542 | ESOMEPRAZOLE ARW 20MG GELULE 28\n",
      "  3400949721771 | ESOMEPRAZOLE ARW 40MG GELULE 14\n",
      "  3400949721832 | ESOMEPRAZOLE ARW 40MG GELULE 28\n",
      "  3400949722891 | GLICLAZIDE ZEN 30MG CPR LM 30\n",
      "  3400949723034 | GLICLAZIDE ZEN 30MG CPR LM 60\n",
      "  3400949723782 | GLICLAZIDE ZEN 30MG CPR LM 180\n",
      "  3400949725625 | CICLETANINE BGA 50MG GELULE 30\n",
      "  3400949725854 | CICLETANINE BGA 50MG GELULE 90\n",
      "  3400949726165 | QUASYM LP 10MG GELULE 28\n",
      "  3400949726226 | QUASYM LP 20MG GELULE 28\n",
      "  3400949726394 | CICLETANINE TVC 50MG GELULE 30\n",
      "  3400949726516 | CICLETANINE TVC 50MG GELULE 90\n",
      "  3400949726745 | QUASYM LP 30MG GELULE 28\n",
      "  3400949726806 | LEFLUNOMIDE ZEN 10MG CPR 30\n",
      "  3400949727056 | LEFLUNOMIDE WTP 20MG CPR 30\n",
      "  3400949728985 | RISEDRONATE EG 5MG CPR 28\n",
      "  3400949729586 | RISEDRONATE EG 35MG CPR 4\n",
      "  3400949729647 | RISEDRONATE EG 35MG CPR 12\n",
      "  3400949730827 | PERINDOPRIL INDAP EG 4/1,25MG CPR 30\n",
      "  3400949731077 | PERINDOPRIL INDAP EG 4/1,25MG CPR 90\n",
      "  3400949731718 | PERINDOPRIL INDAP EG 2/0,625MG CPR 30\n",
      "  3400949731947 | PERINDOPRIL INDAP EG 2/0,625MG CPR 90\n",
      "  3400949734610 | RISEDRONATE BGA 35 MG CPR 4\n",
      "  3400949734788 | RISEDRONATE BGA 35 MG CPR 12\n",
      "  3400949737161 | GLICLAZIDE ZYD LM 30MG CPR 30\n",
      "  3400949737390 | GLICLAZIDE ZYD LM 30MG CPR 60\n",
      "  3400949737970 | GLICLAZIDE ZYD LM 30MG CPR 180\n",
      "  3400949739523 | XEROQUEL LP 50MG CPR 10\n",
      "  3400949739691 | XEROQUEL LP 50MG CPR 30\n",
      "  3400949740291 | XEROQUEL LP 300MG CPR 30\n",
      "  3400949740352 | XEROQUEL LP 300MG CPR 60\n",
      "  3400949740413 | XEROQUEL LP 400MG CPR 30\n",
      "  3400949740581 | XEROQUEL LP 400MG CPR 60\n",
      "  3400949740642 | APOKINON 50 MG/10 ML SOL INJ AMP 10\n",
      "  3400949741823 | GENOTONORM 5,3 MG/1 ML PDR SOL INJ 1\n",
      "  3400949741991 | GENOTONORM 5,3 MG/1 ML PDR SOL INJ 5\n",
      "  3400949742073 | GENOTONORM 12 MG/1ML PDR SOL INJ 1\n",
      "  3400949742134 | GENOTONORM 12 MG/1ML PDR SOL INJ 5\n",
      "  3400949746156 | RISEDRONATE VTS 35MG CPR 4\n",
      "  3400949746385 | RISEDRONATE VTS 35MG CPR 12\n",
      "  3400949750467 | ZOLMITRIPTAN SUN 2,5MG CPR ORODISP 12\n",
      "  3400949750818 | ZOLMITRIPTAN BGA 2,5 MG CPR 6\n",
      "  3400949750986 | ZOLMITRIPTAN BGA 2,5 MG CPR 12\n",
      "  3400949751877 | ZOLMITRIPTAN ARG 2,5 MG CPR 6\n",
      "  3400949751938 | ZOLMITRIPTAN ARG 2,5 MG CPR 12\n",
      "  3400949752478 | ZOLMITRIPTAN TVS 2,5MG CPR 12\n",
      "  3400949752829 | ZOLMITRIPTAN TVS 2,5MG CPR ORODISP 6\n",
      "  3400949753079 | ZOLMITRIPTAN TVS 2,5MG CPR ORODISP 12\n",
      "  3400949753420 | ZOLMITRIPTAN ARG 2,5 MG CPR ORODISP 6\n",
      "  3400949753659 | ZOLMITRIPTAN ARG 2,5 MG CPR ORODISP 12\n",
      "  3400949754779 | OMEPRAZOLE CRP 10MG GELULE 30\n",
      "  3400949755370 | OMEPRAZOLE BIPHAR 20MG GELULE 28\n",
      "  3400949755950 | OMEPRAZOLE BIPHAR 20MG GELULE 15\n",
      "  3400949756032 | OMEPRAZOLE BIPHAR 20MG GELULE 28\n",
      "  3400949757152 | OMEPRAZOLE ACF 10MG GELULE 14\n",
      "  3400949757381 | OMEPRAZOLE ACF 10MG GELULE 28\n",
      "  3400949758333 | OMEPRAZOLE ACF 20MG GELULE 7\n",
      "  3400949758562 | OMEPRAZOLE ACF 20MG GELULE 14\n",
      "  3400949758791 | OMEPRAZOLE ACF 20MG GELULE 28\n",
      "  3400949759804 | OMEPRAZOLE TVS 10MG GELULE 14\n",
      "  3400949760053 | OMEPRAZOLE TVS 10MG GELULE 28\n",
      "  3400949761005 | OMEPRAZOLE TVS 20MG GELULE 7\n",
      "  3400949761173 | OMEPRAZOLE TVS 20MG GELULE 14\n",
      "  3400949761463 | OMEPRAZOLE TVS 20MG GELULE 28\n",
      "  3400949761982 | OMEPRAZOLE ALM 10MG GELULE 14\n",
      "  3400949762064 | OMEPRAZOLE ALM 10MG GELULE 28\n",
      "  3400949762415 | OMEPRAZOLE ALM 10MG GELULE 14\n",
      "  3400949762644 | OMEPRAZOLE ALM 10MG GELULE 28\n",
      "  3400949763016 | OMEPRAZOLE ALM 20MG GELULE 7\n",
      "  3400949763184 | OMEPRAZOLE ALM 20MG GELULE 14\n",
      "  3400949763245 | OMEPRAZOLE ALM 20MG GELULE 28\n",
      "  3400949763535 | OMEPRAZOLE ALM 20MG GELULE 7\n",
      "  3400949763764 | OMEPRAZOLE ALM 20MG GELULE 14\n",
      "  3400949763993 | OMEPRAZOLE ALM 20MG GELULE 28\n",
      "  3400949764594 | OMEPRAZOLE EGG 10MG GELULE 14\n",
      "  3400949764655 | OMEPRAZOLE EGG 10MG GELULE 28\n",
      "  3400949765027 | OMEPRAZOLE EGG 10MG GELULE 14\n",
      "  3400949765256 | OMEPRAZOLE EGG 10MG GELULE 28\n",
      "  3400949765607 | OMEPRAZOLE EGG 20MG GELULE 7\n",
      "  3400949765775 | OMEPRAZOLE EGG 20MG GELULE 14\n",
      "  3400949765836 | OMEPRAZOLE EGG 20MG GELULE 28\n",
      "  3400949766208 | OMEPRAZOLE EGG 20MG GELULE 7\n",
      "  3400949766376 | OMEPRAZOLE EGG 20MG GELULE 14\n",
      "  3400949766666 | OMEPRAZOLE EGG 20MG GELULE 28\n",
      "  3400949767786 | OMEPRAZOLE KRK 10MG GELULE 14\n",
      "  3400949767908 | OMEPRAZOLE KRK 10MG GELULE 28\n",
      "  3400949769278 | OMEPRAZOLE KRK 20MG GELULE 28\n",
      "  3400949793921 | MYCOPHENOLATE MOFETIL VTS 500MG CPR 50\n",
      "  3400949800308 | METFORMINE EG 500MG CPR 30\n",
      "  3400949814664 | AMOROLFINE TVC 5% VERNIS MED 1\n",
      "  3400949814893 | AMOROLFINE ARW 5% VERNIS MED 1\n",
      "  3400949814954 | AMOROLFINE VTS 5% VERNIS MED 1\n",
      "  3400949815036 | AMOROLFINE EG 5% VERNIS MED 1\n",
      "  3400949815845 | TASIGNA 150MG GELULE 28\n",
      "  3400949815906 | TASIGNA 150MG GELULE 112\n",
      "  3400949818396 | BINOCRIT 20 000UI SER INJ 1\n",
      "  3400949818518 | BINOCRIT 30 000UI SER INJ 1\n",
      "  3400949818747 | BINOCRIT 40 000UI SER INJ 1\n",
      "  3400949819348 | VALSARTAN/HCTZ EG 80/12,5MG CPR 30\n",
      "  3400949819638 | VALSARTAN/HCTZ EG 80/12,5MG CPR 90\n",
      "  3400949820528 | VALSARTAN/HCTZ EG 160/12,5MG CPR 30\n",
      "  3400949820818 | VALSARTAN/HCTZ EG 160/12,5MG CPR 90\n",
      "  3400949820986 | VALSARTAN/HCTZ EG 160/25MG CPR 30\n",
      "  3400949821297 | VALSARTAN/HCTZ EG 160/25MG CPR 90\n",
      "  3400949852345 | TADENAN 50MG CAPSULE 180\n",
      "  3400949854936 | JEXT 0,15 MG SOL INJ STYLO 1\n",
      "  3400949855018 | JEXT 300 MCG SOL INJ STYLO 1\n",
      "  3400949855827 | LETROZOLE SUN 2,5MG CPR 30\n",
      "  3400949858439 | PENTASA 1G CPR 60\n",
      "  3400949871445 | REPAGLINIDE CRT 0,5MG CPR 90\n",
      "  3400949874408 | REPAGLINIDE CRT 1MG CPR 90\n",
      "  3400949875986 | REPAGLINIDE CRT 2MG CPR 90\n",
      "  3400949877539 | DORZOLAMIDE EG 2% COLLYRE 5ML 1\n",
      "  3400949879250 | FOSFOPHARM AD 3G GRANULES SACHET 1\n",
      "  3400949879311 | FOSFOMYCINE EVO 3G GRANULES SACHET 1\n",
      "  3400949884452 | MONTELUKAST KRK 4MG CPR CROQ 28\n",
      "  3400949886234 | MONTELUKAST KRK 5MG CPR CROQ 28\n",
      "  3400949887415 | BRILIQUE 90 MG CPR 60\n",
      "  3400949890774 | TERBINAFINE SDZ 250 MG CPR 14\n",
      "  3400949890835 | TERBINAFINE SDZ 250 MG CPR 28\n",
      "  3400949896110 | BISOPROLOL ZYF 5MG CPR 30\n",
      "  3400949896349 | BISOPROLOL ZYF 5MG CPR 90\n",
      "  3400949896639 | BISOPROLOL ZYF 2,5MG CPR 30\n",
      "  3400949896929 | BISOPROLOL ZYF 2,5MG CPR 90\n",
      "  3400949898879 | BISOPROLOL ZYF 1,25MG CPR 30\n",
      "  3400949899012 | BISOPROLOL ZYF 1,25MG CPR 90\n",
      "  3400949911929 | PERINDOPRIL ZYD 2MG CPR 90\n",
      "  3400949912001 | PERINDOPRIL ZYD 4MG CPR 90\n",
      "  3400949912179 | PERINDOPRIL ZYD 8MG CPR 90\n",
      "  3400949912469 | RILUZOLE TVC 50MG CPR 56\n",
      "  3400949913299 | TOBI PODHALER 28MG PDR GELU 224\n",
      "  3400949913350 | RILUZOLE EG 50MG CPR 56\n",
      "  3400949913589 | BILASKA 20MG CPR 10\n",
      "  3400949913701 | BILASKA 20MG CPR 30\n",
      "  3400949913879 | INORIAL 20MG CPR 10\n",
      "  3400949914012 | INORIAL 20MG CPR 30\n",
      "  3400949914302 | FENTANYL LVH 25MICROG/H DISP TRANSD 5\n",
      "  3400949914531 | FENTANYL BGR 50MICROG/H DISP TRANSD 5\n",
      "  3400949914821 | FENTANYL BGR 75MICROG/H DISP TRANSD 5\n",
      "  3400949914999 | ONDANSETRON VTS 8MG CPR DISP 2\n",
      "  3400949915071 | ONDANSETRON VTS 8MG CPR DISP 4\n",
      "  3400949915590 | FENTANYL BGR 100MICROG/H DISP TRANSD 5\n",
      "  3400949916542 | LETROZOLE VIATRIS 2,5MG CPR 30\n",
      "  3400949921744 | GABAPENTINE ARG 100MG GELULE 90\n",
      "  3400949922574 | GABAPENTINE ARG 300MG GELULE 90\n",
      "  3400949924585 | GABAPENTINE ARG 400MG GELULE 90\n",
      "  3400949926138 | IBUPROFENE TVC 400MG CPR PELL 20\n",
      "  3400949926367 | IBUPROFENE TVC 400MG CPR PELL 30\n",
      "  3400949929559 | IBUPROFENE EVO 400 MG CPR PELL 20\n",
      "  3400949929610 | IBUPROFENE EVO 400 MG CPR PELL 30\n",
      "  3400949930968 | OLANZAPINE ALT 10MG CPR DISP 28\n",
      "  3400949931859 | EXEMESTANE VIATRIS 25MG CPR 30\n",
      "  3400949933631 | RILMENIDINE EVO 1MG CPR 30\n",
      "  3400949933921 | RILMENIDINE EVO 1MG CPR 90\n",
      "  3400949935871 | BUPRENORPHINE EG 2MG CPR 7\n",
      "  3400949937424 | BUPRENORPHINE EG 8MG CPR 7\n",
      "  3400949939206 | PROFENID 50MG GELULE 20\n",
      "  3400949939893 | RABEPRAZOLE BGR 10MG CPR 14\n",
      "  3400949940264 | RABEPRAZOLE BGR 10MG CPR 28\n",
      "  3400949941155 | RABEPRAZOLE BIOGARAN 20MG CPR 14\n",
      "  3400949941445 | RABEPRAZOLE BIOGARAN 20MG CPR 28\n",
      "  3400949943807 | CANDESARTAN CRP 8 MG CPR 30\n",
      "  3400949944118 | CANDESARTAN CRP 8 MG CPR 90\n",
      "  3400949945009 | CANDESARTAN CRP 16 MG CPR 30\n",
      "  3400949945528 | CANDESARTAN CRP 16 MG CPR 90\n",
      "  3400949946709 | ESOMEPRAZOLE TVC 20MG GELULE 14\n",
      "  3400949946877 | ESOMEPRAZOLE TVC 20MG GELULE 28\n",
      "  3400949947010 | ESOMEPRAZOLE TVC 40MG GELULE 28\n",
      "  3400949951321 | CEFIXIME EVO 200MG CPR 8\n",
      "  3400949952670 | QUINOFREE 1,5MG COLLYRE UNIDOS 20\n",
      "  3400949953622 | REPAGLINIDE BGA 2MG CPR 90\n",
      "  3400949953851 | REPAGLINIDE BGA 2MG CPR 270\n",
      "  3400949954391 | REPAGLINIDE BGA 1MG CPR 90\n",
      "  3400949954513 | REPAGLINIDE BGA 1MG CPR 270\n",
      "  3400949954971 | REPAGLINIDE BGA 0,5MG CPR 90\n",
      "  3400949955114 | REPAGLINIDE BGA 0,5MG CPR 270\n",
      "  3400949955572 | REPAGLINIDE ZYD 0,5MG CPR 90\n",
      "  3400949956234 | REPAGLINIDE ZYD 1MG CPR 90\n",
      "  3400949956982 | REPAGLINIDE ZYD 2MG CPR 90\n",
      "  3400949960194 | AMOROLFINE SDZ 5% VERNIS MED 1\n",
      "  3400949960255 | AMOROLFINE ZEN 5% VERNIS MED 1\n",
      "  3400949968411 | RABEPRAZOLE SDZ 10MG CPR 14\n",
      "  3400949968879 | RABEPRAZOLE SDZ 10MG CPR 28\n",
      "  3400949970421 | RABEPRAZOLE SDZ 20MG CPR 14\n",
      "  3400949970889 | RABEPRAZOLE SDZ 20MG CPR 28\n",
      "  3400949974153 | NAPROXENE SODIQUE EG 550MG CPR 16\n",
      "  3400949974214 | ACECLOFENAC ACC 100MG CPR 30\n",
      "  3400949978694 | MONTELUKAST ZYD 10MG CPR 28\n",
      "  3400949980246 | VALPROATE NA ARW 200 MG/ML BUV 40ML 1\n",
      "  3400949980994 | EXEMESTANE BGA 25MG CPR 30\n",
      "  3400949991822 | MONTELUKAST EG 5MG CPR CROQ 28\n",
      "  3400949998685 | MONTELUKAST EG 10MG CPR 28\n",
      "  9999999999999 | INCONNU\n",
      "  3400921661477 | DESOGESTREL VIATRIS SANTE 75MCG CPR 28\n",
      "  3400921661538 | DESOGESTREL VIATRIS SANTE 75MCG CPR 84\n",
      "  3400921845761 | PRAVASTATINE VTS 10MG CPR 28\n",
      "  3400921846652 | PRAVASTATINE VTS 40MG CPR 28\n",
      "  3400921846881 | PRAVASTATINE VTS 40MG CPR 84\n",
      "  3400921890945 | PERINDOPRIL VIATRIS 2,5 MG CPR 30\n",
      "  3400921891195 | PERINDOPRIL VIATRIS 2,5 MG CPR 90\n",
      "  3400921892086 | PERINDOPRIL VIATRIS 5MG CPR 30\n",
      "  3400921892208 | PERINDOPRIL VIATRIS 5MG CPR 90\n",
      "  3400921893038 | PERINDOPRIL VIATRIS 10MG CPR 30\n",
      "  3400921893328 | PERINDOPRIL VIATRIS 10MG CPR 90\n",
      "  3400922253701 | NIMENRIX PDR ET SOL INJ SER 1\n",
      "  3400922262406 | BISOPROLOL ZTL 5MG CPR 90\n",
      "  3400922491462 | RABEPRAZOLE RBX 10MG CPR 28\n",
      "  3400926629007 | KETOPROFENE CRISTERS LP 100MG CPR 20\n",
      "  3400926743697 | GABAPENTINE ARG 800MG CPR 90\n",
      "  3400926908362 | XENETIX 350 SOL INJ FLV 20ML 1\n",
      "  3400926943202 | FROVATRIPTAN VTS 2,5 MG CPR 2\n",
      "  3400926943370 | FROVATRIPTAN VTS 2,5 MG CPR 6\n",
      "  3400926943431 | FROVATRIPTAN VTS 2,5 MG CPR 12\n",
      "  3400926989507 | RIZATRIPTAN ARL 10MG CPR 12\n",
      "  3400927350078 | HEXYON SUSP INJ SER 1A 1\n",
      "  3400927357053 | ENTACAPONE ARROW 200MG CPR 100\n",
      "  3400927517914 | PRAVASTATINE ZEN 40MG CPR 56\n",
      "  3400927518164 | PRAVASTATINE ZEN 40MG CPR 504\n",
      "  3400927550041 | CANDESARTAN ARL 4MG CPR 30\n",
      "  3400927550560 | CANDESARTAN ARL 8MG CPR 30\n",
      "  3400927550911 | CANDESARTAN ARL 16MG CPR 30\n",
      "  3400927551451 | CANDESARTAN ARL 32MG CPR 30\n",
      "  3400927564987 | EPIPEN VTS 300 MCG SOL INJ STYLO 2\n",
      "  3400927565410 | XARELTO 2,5 MG CPR 56\n",
      "  3400927565939 | GIOTRIF 50MG CPR 28\n",
      "  3400927570322 | TROSPIPHARM 20 MG CPR 60\n",
      "  3400927672897 | INVOKANA 100 MG CPR PEL 30\n",
      "  3400927672958 | INVOKANA 300 MG CPR PEL 30\n",
      "  3400927703577 | EBASTINE BGA 10MG CPR ORODISP 30\n",
      "  3400927794766 | PERINDOPRIL CRT 10 MG CPR 30\n",
      "  3400927800481 | PANTOPRAZOLE VIATRIS 20MG CPR FILM 14\n",
      "  3400927800542 | PANTOPRAZOLE VIATRIS 20MG CPR FILM 28\n",
      "  3400927800832 | PANTOPRAZOLE VTS 40MG CPR 7\n",
      "  3400927801082 | PANTOPRAZOLE VTS 40MG CPR 14\n",
      "  3400927801143 | PANTOPRAZOLE VTS 40MG CPR 28\n",
      "  3400927889370 | OXYCODONE VTS LP 10MG CPR 28\n",
      "  3400927949326 | PLEGRIDY 125 MCG SOL INJ SER SC 2\n",
      "  3400927966064 | OMEPRAZOLE ALTER 20MG GELULE 28\n",
      "  3400928099655 | CORTIFOAM 10 %MOUSS RECT PRESS 20G 1\n",
      "  3400928099723 | TUBERSOL INJ FL10DOS 10\n",
      "  3400928099761 | VAXIGRIPTETRA HS SUSP INJ DOSE 1\n",
      "  3400930000946 | LEVOSOLO 1,5 MG CPR 1\n",
      "  3400930001790 | OMEPRAZOLE TVP 20MG GELULE 28\n",
      "  3400930002353 | CITALOPRAM VTS 20MG CPR 28\n",
      "  3400930002384 | SEVELAMER CARBONATE VTS 800MG CPR 180\n",
      "  3400930009666 | TIXTAR 550 MG CPR 56\n",
      "  3400930010662 | AMOXICILLINE VTS GEN 1G CPR DISP 6\n",
      "  3400930010716 | AMOXICILLINE VTS GEN 1G CPR DISP 14\n",
      "  3400930012093 | RETACRIT 1 000 UI SOL INJ SER + D 6\n",
      "  3400930017241 | ARIPIPRAZOLE TVC 10MG CPR 28\n",
      "  3400930017319 | ARIPIPRAZOLE TVC 5MG CPR 28\n",
      "  3400930017401 | ARIPIPRAZOLE TVC 15MG CPR 28\n",
      "  3400930018118 | PREGABALINE VTS 25MG GELULE 56\n",
      "  3400930018125 | PREGABALINE VTS 25MG GELULE 84\n",
      "  3400930018149 | PREGABALINE VTS 50MG GELULE 84\n",
      "  3400930018163 | PREGABALINE VTS 75MG GELULE 56\n",
      "  3400930018187 | PREGABALINE VTS 100MG GELULE 84\n",
      "  3400930018200 | PREGABALINE VTS 150MG GELULE 56\n",
      "  3400930018224 | PREGABALINE VTS 200MG GELULE 84\n",
      "  3400930018248 | PREGABALINE VTS 300MG GELULE 56\n",
      "  3400930018644 | BCG MEDAC PDR SOL INJ 1\n",
      "  3400930018972 | ABILIFY MAINTENA LP 400 MG INJ SRG 1\n",
      "  3400930023860 | SOMAVERT 25 MG PDR ET SOLV INJ 30\n",
      "  3400930023877 | SOMAVERT 30MG PDR ET SOL INJ 30\n",
      "  3400930024560 | RAXONE 150MG CPR 180\n",
      "  3400930030202 | ETORICOXIB VIATRIS 30 MG CPR 2\n",
      "  3400930035269 | ATORVASTATINE ARG 10 MG CPR 90\n",
      "  3400930039540 | NEFOPAM BIOCODEX 20 MG SOL INJ AMP 5\n",
      "  3400930044520 | VORICONAZOLE ACC 50MG CPR 28\n",
      "  3400930045749 | BISOPROLOL CRT 1,25 MG CPR 90\n",
      "  3400930046081 | BISOPROLOL CRT 5 MG CPR 90\n",
      "  3400930046272 | BISOPROLOL CRT 10 MG CPR 90\n",
      "  3400930056882 | PREGABALINE BGR 25 MG GELULE 56\n",
      "  3400930056899 | PREGABALINE BGR 25 MG GELULE 84\n",
      "  3400930057377 | CINACALCET VTS 30MG CPR 28\n",
      "  3400930057391 | CINACALCET VTS 60MG CPR 28\n",
      "  3400930057414 | CINACALCET VTS 90MG CPR 28\n",
      "  3400930058794 | ZONISAMIDE VTS 25 MG GELULE 14\n",
      "  3400930058824 | ZONISAMIDE VTS 50 MG GELULE 14\n",
      "  3400930058886 | ZONISAMIDE VTS 100 MG GELULE 56\n",
      "  3400930060025 | LOPINAVIR/RITONAVIR VTS 100/25MG CPR 60\n",
      "  3400930060049 | LOPINAVIR/RITONAVIR VTS 200/50MG CPR 120\n",
      "  3400930060063 | RASAGILINE VTS 1MG CPR 30\n",
      "  3400930060308 | PREGABALINE BGR 75 MG GELULE 56\n",
      "  3400930060346 | PREGABALINE BGR 150 MG GELULE 56\n",
      "  3400930060391 | PREGABALINE BGR 300 MG GELULE 56\n",
      "  3400930074954 | KISPLYX 4MG GELULE 30\n",
      "  3400930074961 | KISPLYX 10MG GELULE 30\n",
      "  3400930079041 | TENOFOVIR DISO VTS 245 MG CPR 30\n",
      "  3400930079782 | VAXELIS SUSP INJ SRG 1A 1\n",
      "  3400930079799 | VAXELIS SUSP INJ SRG 1\n",
      "  3400930082539 | ROPINIROLE VIATRIS LP 2MG CPR 28\n",
      "  3400930082621 | ROPINIROLE VIATRIS LP 4MG CPR 28\n",
      "  3400930082690 | ROPINIROLE VIATRIS LP 8MG CPR 28\n",
      "  3400930084939 | DARUNAVIR VIATRIS 400MG CPR 60\n",
      "  3400930084953 | DARUNAVIR VIATRIS 600MG CPR 60\n",
      "  3400930084977 | DARUNAVIR VIATRIS 800MG CPR 30\n",
      "  3400930091111 | INSTANYL 50 MICROG/DOSEGUARD SOL NAS 1\n",
      "  3400930091128 | INSTANYL 100 MICROG/DOSEGUARD NASALE 1\n",
      "  3400930091135 | INSTANYL 200 MICROG/DOSEGUARD NASALE 1\n",
      "  3400930091357 | VENLAFAXINE ARG LP 37,5MG GELULE 30\n",
      "  3400930091517 | VENLAFAXINE ARG LP 75MG GELULE 30\n",
      "  3400930095584 | CHOLECALCIFEROL LABO X.O 2.5MG BUV 1\n",
      "  3400930095591 | CHOLECALCIFEROL STP 2.5MG/2ML BUV 1\n",
      "  3400930096833 | IMATINIB CRT 100 MG CPR 60\n",
      "  3400930096888 | IMATINIB CRT 400 MG CPR 30\n",
      "  3400930097359 | ENOXAPARINE BECAT 4000UI/0.4ML SER 2\n",
      "  3400930097366 | ENOXAPARINE BECAT 4000UI/0.4ML SER 6\n",
      "  3400930098127 | ENOXAPARINE CRU 8000UI/0.8ML SER 2\n",
      "  3400930098219 | ENOXAPARINE CRU 6000UI/0.6ML SER 10\n",
      "  3400930103272 | BETAHISTINE ARG 24MG CPR 60\n",
      "  3400930105474 | ENTECAVIR ZYD 1 MG CPR 30\n",
      "  3400930115053 | REVESTIVE 1.25MG PDR ET SOL INJ 28\n",
      "  3400930115343 | FLECAINIDE VTS LP 50MG GELULE 30\n",
      "  3400930115350 | FLECAINIDE VIATRIS LP 100MG GELULE 30\n",
      "  3400930115367 | FLECAINIDE VTS LP 150MG GELULE 30\n",
      "  3400930115374 | FLECAINIDE VTS LP 200MG GELULE 30\n",
      "  3400930115572 | ENTECAVIR VTS 0,5 MG CPR 30\n",
      "  3400930115602 | ENTECAVIR VTS 1 MG CPR 30\n",
      "  3400930118771 | ENTECAVIR ACC 1 MG CPR 30\n",
      "  3400930118887 | EUTHYROX 150 MICROG CPR AIT 100\n",
      "  3400930119099 | LACOSAMIDE ACC 50MG CPR 14\n",
      "  3400930119105 | LACOSAMIDE ACC 50MG CPR 56\n",
      "  3400930119150 | LACOSAMIDE ACC 100MG CPR 56\n",
      "  3400930119204 | LACOSAMIDE ACC 150MG CPR 56\n",
      "  3400930119259 | LACOSAMIDE ACC 200MG CPR 56\n",
      "  3400930122372 | RITONAVIR VTS 100 MG CPR 30\n",
      "  3400930131961 | BLEOMYCINE BLN 15MG PDR INJ 1\n",
      "  3400930133064 | PANTOPRAZOLE VTS 2/1 40MG CPR 28\n",
      "  3400930133255 | PANTOPRAZOLE VIATRIS 20MG CPR FLC 28\n",
      "  3400930136164 | FILIOP 40MCG/5MG/ML COLLYRE 1\n",
      "  3400930136188 | KIVIZIDIALE 40MCG/5MG COLLYRE 1\n",
      "  3400930136522 | GLICLAZIDE VIATRIS 60MG CPR 30\n",
      "  3400930136546 | GLICLAZIDE VIATRIS 60MG CPR 90\n",
      "  3400930136997 | RIVAROXABAN SDZ 10 MG CPR 30\n",
      "  3400930137260 | AMOXICILLINE ARL 1G CPR DISP 6\n",
      "  3400930137284 | AMOXICILLINE ARL 1G CPR DISP 14\n",
      "  3400930137888 | DIAZEPAM ACC 5 MG CPR 40\n",
      "  3400930138540 | SUNITINIB TEVA 25 MG, GELULE 1\n",
      "  3400930139578 | EZETIMIBE ARW 10MG CPR 30\n",
      "  3400930140970 | BRIMONIDINE/TIM VTS 2/5MG/ML COLLYRE 1\n",
      "  3400930141724 | AMGEVITA 40 MG SOL INJ SER 0.8ML 1\n",
      "  3400930141731 | AMGEVITA 40 MG SOL INJ SER 0.8ML 2\n",
      "  3400930141755 | AMGEVITA 40 MG SOL INJ SER 0.8ML 6\n",
      "  3400930141762 | AMGEVITA 40 MG SOL INJ STY 0.8ML 1\n",
      "  3400930141779 | AMGEVITA 40 MG SOL INJ STY 0.8ML 2\n",
      "  3400930141809 | AMGEVITA 40 MG SOL INJ STY 0.8ML 6\n",
      "  3400930142288 | AMGEVITA 20 MG SOL INJ SER 0.4ML 1\n",
      "  3400930144213 | LYNPARZA 150 MG CPR 8\n",
      "  3400930145463 | ELFASETTE 75 MCG CPR 28\n",
      "  3400930145470 | ELFASETTE 75 MCG CPR 84\n",
      "  3400930145937 | DOMPERIDONE VIATRIS 10 MG CPR 20\n",
      "  3400930148891 | VALSARTAN/HCTZ ZYF 80/12,5MG CPR 90\n",
      "  3400930149911 | AMGLIDIA 0,6 MG/ML SUSP BUV30ML+S1ML 1\n",
      "  3400930152720 | ZOPICLONE ARL 7,5MG CPR 5\n",
      "  3400930153604 | BICAFRES 1000 MG CPR GASTRO 100\n",
      "  3400930156438 | FLUTICASO/SALM TEVA 125/25 MCG INH 1\n",
      "  3400930156452 | PROP FLUT/SALM TVA 250/25 MICROG INH 1\n",
      "  3400930160244 | PRASUGREL VTS 10 MG CPR 30\n",
      "  3400930161494 | ATAZANAVIR VIATRIS 150MG GELULE 60\n",
      "  3400930161517 | ATAZANAVIR VIATRIS 200MG GELULE 60\n",
      "  3400930161531 | ATAZANAVIR VIATRIS 300MG GELULE 30\n",
      "  3400930163108 | PROP FLUT TVA 125 MCG/DOSE SUSP INH 1\n",
      "  3400930163146 | PROP FLUT TVA 250 MCG/DOSE SUSP INH 1\n",
      "  3400930166246 | ZEULIDE 3.75MG PDR ET SOL INJ 1\n",
      "  3400930166253 | ZEULIDE 22,5MG PDR ET SOL INJ 1\n",
      "  3400930166321 | TIMOPTOL LP 0,25% COLLYRE FLBD 2,5ML 1\n",
      "  3400930167090 | GEFITINIB ZEN 250MG CPR 30\n",
      "  3400930167236 | FEBUXOSTAT VTS 80MG CPR 28\n",
      "  3400930167243 | FEBUXOSTAT VTS 120MG CPR 28\n",
      "  3400930168455 | SPIRIVA RESPIMAT 2,5MCG SOL PR INHI 1\n",
      "  3400930168547 | SPIOLTO RESPIMAT 2,5MCG SOL PR INH 1\n",
      "  3400930168875 | ATANTO 80MG+125MG GELULE 3\n",
      "  3400930168998 | SPIOLTO RESPIMAT 2,5MCG SOL PR INH 3\n",
      "  3400930169049 | DASATINIB TEVA 20 MG CPR 60\n",
      "  3400930169247 | DASATINIB TEVA 50 MG CPR 60\n",
      "  3400930169261 | DASATINIB TEVA 70 MG CPR 60\n",
      "  3400930169322 | DASATINIB TEVA 100 MG CPR 30\n",
      "  3400930169964 | SPIRIVA RESPIMAT 2,5MCG SOL PR INHI 3\n",
      "  3400930171301 | CITALOPRAM ARL 20MG CPR 30\n",
      "  3400930172049 | FLUTICASO/SALM SDZ 125/25 MICROG INH 1\n",
      "  3400930172087 | FLUTICASO/SALM SDZ 250/25 MICROG INH 1\n",
      "  3400930173398 | SILODOSINE VTS 4MG GELULE 30\n",
      "  3400930173442 | SILODOSINE VTS 8MG GELULE 30\n",
      "  3400930175767 | BUDESONIDE/ FOR SDZ 160/4,5 MCG INHA 120\n",
      "  3400930175798 | FLUTICASO/SALM ZEN 50/25 MICROG INH 1\n",
      "  3400930175804 | FLUTICASO/SALM ZEN 125/25 MICROG INH 1\n",
      "  3400930175811 | FLUTICASO/SALM ZEN 250/25 MICROG INH 1\n",
      "  3400930175972 | FLUOXETINE ARL 20MG GELULE 14\n",
      "  3400930176771 | SIMVASTATINE VTS 20MG CPR 28\n",
      "  3400930177648 | TENOFOVIR DISO QIL 245 MG CPR 30\n",
      "  3400930177693 | DUPIXENT 200 MG, SOLUTION INJECTABLE 1\n",
      "  3400930180006 | LATAZED 50MCG/ML COLL 2,5ML 1\n",
      "  3400930180013 | LATAZED 50MCG/ML COLL 2,5ML 3\n",
      "  3400930180822 | EBASTINE ARL 10 MG CPR ORODISP 30\n",
      "  3400930181133 | CANDESARTAN/HCTZ ARL 16/12,5 MG CPR 30\n",
      "  3400930181164 | CANDESARTAN/HCTZ ARL 16/12,5 MG CPR 90\n",
      "  3400930181966 | WAYLIVRA 285 MG SOL INJ SRG 1\n",
      "  3400930182215 | EMTRICITABIN TENOF ZYD 200/245MG CPR 30\n",
      "  3400930183434 | LOPERAMIDE ARL 2MG GELULE 20\n",
      "  3400930183649 | BISOPROLOL VIATRIS 1.25 MG CPR 30\n",
      "  3400930183816 | BISOPROLOL VIATRIS 2,5MG CPR 30\n",
      "  3400930184059 | BISOPROLOL VIATRIS 5 MG CPR 30\n",
      "  3400930184066 | BISOPROLOL VIATRIS 5 MG CPR 90\n",
      "  3400930184165 | BISOPROLOL VIATRIS 5 MG CPR 30\n",
      "  3400930184417 | BISOPROLOL VIATRIS 10MG CPR 30\n",
      "  3400930184424 | BISOPROLOL VIATRIS 10MG CPR 90\n",
      "  3400930185704 | KIVIZIDIALE 40MCG/5MG COLLYRE 3\n",
      "  3400930185742 | FILIOP 40MCG/5MG/ML COLLYRE 3\n",
      "  3400930186169 | ALLOPURINOL ARL 100MG CPR 28\n",
      "  3400930186176 | ALLOPURINOL ARL 100MG CPR 30\n",
      "  3400930186206 | ALLOPURINOL ARL 200MG CPR 28\n",
      "  3400930186251 | ALLOPURINOL ARL 300MG CPR 28\n",
      "  3400930187364 | CROMOPTIC 2% COLLYRE FL 10ML CG 1\n",
      "  3400930187661 | MOVYMIA 20 MICROG/80 MICROL INJ STYL 1\n",
      "  3400930187845 | OPTIJECT 300 SOL INJ SER + P 100ML O 1\n",
      "  3400930187869 | OPTIJECT 300 SOL INJ SER + P 125ML O 1\n",
      "  3400930187876 | OPTIJECT 350 SOL INJ SER + P 100ML O 1\n",
      "  3400930189764 | VENLAFAXINE VTS LP 75MG GELULE 30\n",
      "  3400930190807 | IBUPROFENE EVP 400 MG CPR PELL 30\n",
      "  3400930191040 | PARACETAMOL ARL 500MG GELULE 16\n",
      "  3400930194775 | CELESTENE CHRONODOSE 5,70 MG/ML INJ 1\n",
      "  3400930195352 | RACECADOTRIL ZEN 100MG GELULE 20\n",
      "  3400930195505 | DIVALCOTE 250MG CPR GASTRO R 30\n",
      "  3400930195574 | DIVALCOTE 500MG CPR GASTRO R 90\n",
      "  3400930195697 | CLOPIDOGREL/AC ACETYLSALIC VTS 75 MG 30\n",
      "  3400930198346 | ISTURISA 1 MG CPR 60\n",
      "  3400930198353 | ISTURISA 5 MG, COMPRIME PELLICULE 60\n",
      "  3400930198360 | ISTURISA 10 MG, COMPRIME PELLICULE 60\n",
      "  3400930198377 | BEOVU 120 MG/ML SOL INJ 1\n",
      "  3400930198384 | BEOVU 19.8MG SOL INJ SER 1\n",
      "  3400930198445 | RIVAROXABAN ZEN 2,5 MG CPR 56\n",
      "  3400930198483 | RIVAROXABAN ZEN 10 MG CPR 30\n",
      "  3400930198513 | RIVAROXABAN ZEN 15 MG CPR 28\n",
      "  3400930198575 | RIVAROXABAN ZEN 20 MG CPR 28\n",
      "  3400930199305 | BRINZOLAMIDE/TIM VTS 10/5MG/ML COLL 1\n",
      "  3400930199374 | GADOVISTA 1MMOL/ML INJ SER 7,5MLMRX 1\n",
      "  3400930199381 | GADOVISTA 1MMOL/ML INJ SER 10MLMRX 1\n",
      "  3400930199404 | GADOVISTA 1MMOL/ML INJ SER 15MLMRX 1\n",
      "  3400930200919 | BISOPROLOL HCTZ ARL 2,5/6,25MG CPR 30\n",
      "  3400930200926 | BISOPROLOL HCTZ ARL 2,5/6,25MG CPR 90\n",
      "  3400930200933 | BISOPROLOL HCTZ ARL 5/6,25MG CPR 30\n",
      "  3400930200940 | BISOPROLOL HCTZ ARL 5/6,25MG CPR 90\n",
      "  3400930201015 | NIFEXINE CREME RECTALE 1\n",
      "  3400930201343 | ENOXAPARINE ARW 10000UI/1ML INJ SER 10\n",
      "  3400930201862 | URAPIDIL ZENTIVA LP 30MG GELULE 30\n",
      "  3400930201909 | URAPIDIL ZENTIVA LP 60MG GELULE 30\n",
      "  3400930202647 | URAPIDIL BGA LP 60MG GELULE 30\n",
      "  3400930202784 | URAPIDIL TVC LP 60 MG GELULE LP 30\n",
      "  3400930202838 | URAPIDIL TEVA LP 30MG GELULE 30\n",
      "  3400930202975 | URAPIDIL VIATRIS LP 30MG GELULE 30\n",
      "  3400930203019 | URAPIDIL VIATRIS LP 60MG GELULE 30\n",
      "  3400930203132 | URAPIDIL ARW LP 60MG GELU 30\n",
      "  3400930203187 | URAPIDIL ARW LP 30MG GELU 30\n",
      "  3400930203538 | GRASUSTEK 6MG SOL INJ SER 1\n",
      "  3400930203736 | ACIDE URSODESOXYCH VTS 500MG CPR SEC 60\n",
      "  3400930204122 | URAPIDIL EG LP 30MG GELULE 30\n",
      "  3400930204160 | URAPIDIL EG LP 60MG GELULE 30\n",
      "  3400930204467 | FIXALATIM 50 MCG/5 MG/ML COLL 1\n",
      "  3400930204474 | FIXALATIM 50 MCG/5 MG/ML COLL 3\n",
      "  3400930206201 | ECBIRIO 0,3/5MG/ML COLLYRE 1\n",
      "  3400930207383 | AC ZOLEDRONIQUE ZTL 4MG INJ POCHE 1\n",
      "  3400930207642 | AMISULPRIDE OHP 100 MG/ML SOL BUV 1\n",
      "  3400930208465 | VILDAGLIPTINE ACCORD 50MG CPR 30\n",
      "  3400930208472 | VILDAGLIPTINE ACCORD 50MG CPR 60\n",
      "  3400930208908 | ENERZAIR BRZ 114/46/136MCG PDR CAPT 30\n",
      "  3400930209301 | CEFEPIME STRAGEN 2 G PDR INJ 1\n",
      "  3400930209417 | PERINDOPRIL CRT 10 MG CPR 90\n",
      "  3400930209936 | SORAFENIB EG 200MG CPR 112\n",
      "  3400930211441 | ACARBOSE ARW 50MG CPR 90\n",
      "  3400930211465 | ACARBOSE ARW 100MG CPR SEC 90\n",
      "  3400930212189 | FINGOLIMOD EVOLUGEN 0,5MG GELULE 28\n",
      "  3400930212325 | AMLODIPINE/VALSART ACC 5MG/80MG CP 30\n",
      "  3400930212332 | AMLODIPINE/VALSART ACC 5MG/80MG CP 90\n",
      "  3400930212356 | AMLODIPINE/VALSARTAN ACC 5/160MG CPR 90\n",
      "  3400930212608 | TAKHZYRO 300 MG SOL INJ SER 2 ML 1\n",
      "  3400930212929 | CALQUENCE 100 MG, GELULE 60\n",
      "  3400930213551 | FINGOLIMOD EG 0,5MG GELULE 28\n",
      "  3400930214756 | AYVAKYT 100 MG CPR 30\n",
      "  3400930214763 | AYVAKYT 200 MG CPR 30\n",
      "  3400930214770 | AYVAKYT 300MG CPR 1\n",
      "  3400930214879 | EMTRICITABIN TENOF ACC 200/245MG CPR 30\n",
      "  3400930215678 | ARIPIPRAZOLE MDP 10MG CPR ORODISP 28\n",
      "  3400930215708 | ARIPIPRAZOLE MDP 15MG CPR ORODISP 28\n",
      "  3400930217443 | OXLUMO 94,5 MG/0,5ML SOL INJ 1\n",
      "  3400930217849 | EZETIMIBE/SIMVAST ACC 10MG/20MG CPR 30\n",
      "  3400930217863 | EZETIMIBE/SIMVAST ACC 10MG/40MG CPR 30\n",
      "  3400930217900 | IMENOR 2,5 MG CPR 24\n",
      "  3400930218006 | RISPERIDONE TEVA LP 25 MG INJ 1\n",
      "  3400930218020 | RISPERIDONE TVC LP 37,5 MG/2 ML INJ 1\n",
      "  3400930218037 | RISPERIDONE TEVA LP 50 MG/2 ML INJ 1\n",
      "  3400930218600 | FIXAPOST 50 MCG/5 MG/ML COLL 6ML 1\n",
      "  3400930218730 | ANASTROZOLE ARL 1MG CPR PEL 30\n",
      "  3400930219232 | VEDFA 50MG/1000MG CPR 60\n",
      "  3400930219508 | CETRORELIX SUN 0,25 MG, SOL INJ SER 1\n",
      "  3400930219560 | PLEGRIDY 125 MCG SOL INJ SER IM 2\n",
      "  3400930220047 | RIVAROXABAN TVC 10 MG CPR 30\n",
      "  3400930220078 | RIVAROXABAN TVC 15 MG CPR 28\n",
      "  3400930220108 | RIVAROXABAN TVC 20 MG CPR 28\n",
      "  3400930220214 | TUKYSA 50 MG CPR PEL 88\n",
      "  3400930220221 | TUKYSA 150MG CPR 84\n",
      "  3400930220948 | SUNITINIB ACCORD 25 MG GELULE 28\n",
      "  3400930222195 | SITAGLIPTINE /MET SDZ 50/1000MG CPR 0\n",
      "  3400930222225 | FIVASA 1 G SUPPOSITOIRE 30\n",
      "  3400930222270 | GLIMEZIT 1000 MG, COMPRIME EFFERVESC 28\n",
      "  3400930222447 | AC GADOTERIQUE GEB 0,5MMOL/ML SER 10 1\n",
      "  3400930222454 | AC GADOTERIQUE GEB 0,5MMOL/ML SER 15 1\n",
      "  3400930222478 | AC GADOTERIQUE GEB 0,5MMOL/ML SER15A 1\n",
      "  3400930222485 | AC GADOTERIQUE GEB 0,5MMOL/ML SER20A 1\n",
      "  3400930222638 | SUNITINIB ZENTIVA 37,5 MG, GELULE 28\n",
      "  3400930223017 | TRIMBOW 172/5/9 MCG SOL INH FL120D 120\n",
      "  3400930223024 | BUDESONIDE/FOR SDZ 320/9MCG INH UNID 60\n",
      "  3400930224359 | FINTEPLA 2,2MG/ML F60ML+S3ML 1\n",
      "  3400930224366 | FINTEPLA 2,2MG/ML 120ML+S3ML 1\n",
      "  3400930224373 | FINTEPLA 2,2MG/ML 360ML+S6ML 1\n",
      "  3400930224700 | TRIMBOW 88/5/9 MCG PDR INH 120 D 360\n",
      "  3400930225004 | LAMICTAL 25MG CPR DISP +S 30\n",
      "  3400930225035 | LAMICTAL 100 MG CPR DISP +S 30\n",
      "  3400930225127 | LAMICTAL 50 MG CPR DISP SEC ENF 30\n",
      "  3400930225189 | LAMICTAL 200 MG CPR DISP SE 30\n",
      "  3400930225417 | BISOPROLOL ZENTIVA K.S 2,5 MG CPR 30\n",
      "  3400930225929 | FINGOLIMOD ACC 0,5MG GELULE 28\n",
      "  3400930226506 | HULIO 20 MG SOL INJ SRG + TAMP 2\n",
      "  3400930226766 | SIMVASTATINE VIATRIS 10 MG CPR 28\n",
      "  3400930226872 | SIMVASTATINE VTS 20 MG CPR 28\n",
      "  3400930226919 | SIMVASTATINE VTS 20 MG CPR 84\n",
      "  3400930226940 | SIMVASTATINE VTS 20 MG CPR 28\n",
      "  3400930227022 | SIMVASTATINE VTS 40 MG CPR 28\n",
      "  3400930227053 | SIMVASTATINE VTS 40 MG CPR 84\n",
      "  3400930229392 | GONADOTROPHINE CHORIO GEN 5000UI INJ 1\n",
      "  3400930230008 | ASPIRINE PROTECT 100MG CPR 30\n",
      "  3400930230176 | KOSELUGO 10 MG GELULE 60\n",
      "  3400930230183 | KOSELUGO 25 MG GELULE 60\n",
      "  3400930230640 | ASCOFER 33MG GELULE 90\n",
      "  3400930230688 | TRIXEO AEROSPHERE 5/7.2MCG INH 120 D 360\n",
      "  3400930231128 | TIGREAT 2,5MG CPR 6\n",
      "  3400930231135 | TIGREAT 2,5MG CPR 12\n",
      "  3400930231203 | NOXIBEN 3MG CPR 14\n",
      "  3400930231234 | NOXIBEN 2MG CPR 14\n",
      "  3400930231272 | NOXIBEN 1MG CPR 14\n",
      "  3400930231326 | OMEPRAZOLE TVP 10MG GELULE 14\n",
      "  3400930231333 | OMEPRAZOLE TVP 10MG GELULE 28\n",
      "  3400930231418 | OMEPRAZOLE TVP 20MG GELULE 7\n",
      "  3400930231425 | OMEPRAZOLE TVP 20MG GELULE 14\n",
      "  3400930232163 | DEFERASIROX ARW 90 MG CPR 30\n",
      "  3400930232187 | DEFERASIROX ARW 180 MG CPR 30\n",
      "  3400930232217 | DEFERASIROX ARW 360 MG CPR 30\n",
      "  3400930232859 | FLUDROCORTISONE ACC 0.1MG CPR 30\n",
      "  3400930233221 | ABIRATERONE SDZ 1000MG CPR 30\n",
      "  3400930233665 | EVRENZO 20MG CPR 12\n",
      "  3400930233672 | EVRENZO 50MG CPR 12\n",
      "  3400930233689 | EVRENZO 70MG CPR 12\n",
      "  3400930233696 | EVRENZO 100MG CPR 12\n",
      "  3400930233702 | EVRENZO 150MG CPR 12\n",
      "  3400930233726 | ENANTONE LP 1.88MG PDR INJ SER 1\n",
      "  3400930234075 | CEFIXIME PHC 100MG/5ML ENF PDR ORALE 1\n",
      "  3400930234433 | ENSPRYNG 120MG SOL INJ SER 1\n",
      "  3400930234600 | AMIRIOX 0,9 MG COLLYRE SOL 1\n",
      "  3400930234945 | UVECAPS 20 000 UI CAPSULE MOLLE 4\n",
      "  3400930235485 | ACCOFIL 12 MUI/0,2 ML SOL INJ SER 1\n",
      "  3400930235492 | ACCOFIL 70 MUI/0,73 ML SOL INJ SER 1\n",
      "  3400930235546 | ENALAPRIL ACC 5MG CPR 30\n",
      "  3400930235577 | ENALAPRIL ACC 20MG CPR 30\n",
      "  3400930235942 | MANTADIX 100MG CAPSULE 50\n",
      "  3400930236093 | METFORMINE ACC 500 MG CPR PEL SEC 30\n",
      "  3400930236109 | METFORMINE ACC 500 MG CPR PEL SEC 90\n",
      "  3400930236123 | METFORMINE ACC 850 MG CPR PEL SEC 30\n",
      "  3400930236130 | METFORMINE ACC 850 MG CPR PEL SEC 90\n",
      "  3400930236154 | METFORMINE ACC 1000 MG CPR PEL SEC 30\n",
      "  3400930236178 | METFORMINE ACC 1000 MG CPR PEL SEC 90\n",
      "  3400930236673 | VOXZOGO 0,4 MG PDR POUR SOL INJ 10\n",
      "  3400930236697 | VOXZOGO 0,56 MG, POUDRE ET SOLVANT P 1\n",
      "  3400930236703 | VOXZOGO 1,2 MG, POUDRE ET SOLVANT PO 1\n",
      "  3400930236796 | BILASTINE EG 20 MG CPR 10\n",
      "  3400930236833 | OFLOXACINE VTS 1,5MG/0,5ML SOL AURIC 20\n",
      "  3400930237045 | BYLVAY 200 MICROG GELULES 30\n",
      "  3400930237069 | BYLVAY 400 MICROG GELULES 30\n",
      "  3400930237083 | BYLVAY 1200 MICROG GELULES 30\n",
      "  3400930238059 | GABAPENTINE CRP 100 MG GELULE 90\n",
      "  3400930238097 | GABAPENTINE CRP 300 MG GEL 90\n",
      "  3400930238806 | EZETIMIBE ZEN 10MG CPR 30\n",
      "  3400930238851 | EZETIMIBE ZEN 10MG CPR 90\n",
      "  3400930239520 | SITAGLIPTINE /MET EG 50/1000MG CPR 60\n",
      "  3400930240069 | QUETIAPINE MEDIPHA LP 400MG CPR 60\n",
      "  3400930240595 | RYALTRIS 25 MCG/600MCG/DOSE SUSP NAS 1\n",
      "  3400930240953 | ENOXAPARINE TVC 2000UI/0,2ML INJ SER 2\n",
      "  3400930240960 | ENOXAPARINE TVC 2000UI/0,2ML INJ SER 6\n",
      "  3400930241172 | BEXAROTENE CIPLA 75MG CAPSULE 100\n",
      "  3400930241417 | MENOPUR 1200 UI SOL INJ STYLO 1\n",
      "  3400930241431 | MENOPUR 600 UI SOL INJ STYLO 1\n",
      "  3400930242391 | BRUKINSA 80MG GELU 120\n",
      "  3400930242414 | CHLORHEXIDINE BGA 0,12% SOL BDB 200 1\n",
      "  3400930242797 | KAFTRIO 37,5/25/50MG CPR 56\n",
      "  3400930242940 | CICLOPIROX OLAMINE ARW 1% CREME 1\n",
      "  3400930243213 | EMTRICIT/TENOF DIS KRK 200/245MG CPR 28\n",
      "  3400930243640 | QINLOCK 50 MG CPR 90\n",
      "  3400930243671 | ASPAVELI 1 080 MG SOL INJ 8\n",
      "  3400930243909 | IZIXATE 30 MG/0,60ML SOL INJ STYLO 1\n",
      "  3400930244043 | VILDAGLIPTINE TIEFENBACHER 50MG CPR 30\n",
      "  3400930244067 | VILDAGLIPTINE TIEFENBACHER 50MG CPR 60\n",
      "  3400930244371 | VAXNEUVANCE SUSP INJ SER AA 1\n",
      "  3400930244395 | VAXNEUVANCE SUSP INJ SER AA 1\n",
      "  3400930244425 | SITAGLIPTINE /MET TEVA 50/1000MG CPR 60\n",
      "  3400930244586 | ENOXAPARINE TVC 6000UI/0,6ML INJ SER 2\n",
      "  3400930245071 | ENOXAPARINE TVC 8000UI/0,8ML INJ SER 2\n",
      "  3400930245101 | ENOXAPARINE TVC 8000UI/0,8ML INJ SER 10\n",
      "  3400930245194 | ENOXAPARINE TVC 10000UI/1ML INJ SER 10\n",
      "  3400930245347 | FLUCORTAC 5MG SOL BUV FL 50ML 1\n",
      "  3400930245590 | VILDAGLIPTINE/MET ALT 50/1000 MG CPR 60\n",
      "  3400930245705 | PERINDOPRIL VIATRIS 2 MG CPR 30\n",
      "  3400930245712 | PERINDOPRIL VIATRIS 2 MG CPR 90\n",
      "  3400930245729 | PERINDOPRIL VIATRIS 4 MG CPR 30\n",
      "  3400930245743 | PERINDOPRIL VIATRIS 4 MG CPR 90\n",
      "  3400930245750 | PERINDOPRIL VIATRIS 8 MG CPR 30\n",
      "  3400930245767 | PERINDOPRIL VIATRIS 8 MG CPR 90\n",
      "  3400930245781 | PERINDOPRIL HCS 5MG CPR 30\n",
      "  3400930245798 | PERINDOPRIL HCS 5MG CPR 90\n",
      "  3400930245804 | PERINDOPRIL HCS 10MG CPR 30\n",
      "  3400930245811 | PERINDOPRIL HCS 10MG CPR 90\n",
      "  3400930246085 | LERCANIDIPINE ACC 10MG CPR 30\n",
      "  3400930246092 | LERCANIDIPINE ACC 10MG CPR 90\n",
      "  3400930246115 | LERCANIDIPINE ACC 20MG CPR 30\n",
      "  3400930246122 | LERCANIDIPINE ACC 20MG CPR 90\n",
      "  3400930246382 | GLYDO 221.10MG GEL EN SER DE 11ML 10\n",
      "  3400930246535 | TELMISARTAN ARW 40MG CPR 30\n",
      "  3400930246542 | TELMISARTAN ARW 40MG CPR 90\n",
      "  3400930246559 | TELMISARTAN ARW 80MG CPR 30\n",
      "  3400930246573 | TELMISARTAN ARW 80MG CPR 90\n",
      "  3400930246948 | TAVNEOS 10MG GELULES 180\n",
      "  3400930246962 | DUTASTE/TAMSU GNR 0,5MG/0,4MG GELULE 30\n",
      "  3400930247235 | NGENLA 24 MG SOL INJ STYLO 1\n",
      "  3400930247273 | NGENLA 60 MG SOL INJ STYLO 1\n",
      "  3400930247570 | CELIPROLOL EVO 200MG CPR 84\n",
      "  3400930247853 | PREVENAR 20 SUSP INJ SRG 1\n",
      "  3400930248249 | SITAGLIPTINE /MET ZEN 50/1000MG CPR 60\n",
      "  3400930248478 | METOPIMAZINE VEP 7,5 MG CPR ORODI SS 16\n",
      "  3400930248584 | SITAGLIP/METFORM LICONSA 50MG/1G CPR 60\n",
      "  3400930248591 | PARACETAMOL ZENTIVA LAB 500 MG CPR 16\n",
      "  3400930248645 | IBUPROFENE BILLEV 400 MG CPR 20\n",
      "  3400930248652 | IBUPROFENE BILLEV 400 MG CPR 30\n",
      "  3400930248775 | SITAGLIPT/METFORM GNR 50/1000MG CPR 56\n",
      "  3400930248836 | METFORMINE ZENTIVA K.S. 500 MG CPR 30\n",
      "  3400930248898 | METFORMINE ZENTIVA K.S. 500 MG CPR 90\n",
      "  3400930248904 | CABESOL 500 MICROG/G SHAMP 1\n",
      "  3400930248935 | AYVAKYT 25 MG CPR 30\n",
      "  3400930248942 | AYVAKYT 50 MG CPR 30\n",
      "  3400930249611 | BETAHISTINE ARW GENERIQUES 8 MG CPR 90\n",
      "  3400930249659 | GUIOX 80 000 UI SOL BUV AMP 1\n",
      "  3400930249666 | GUIOX 200 000 UI SOL BUV AMP 1\n",
      "  3400930249673 | CHOLECALCIFEROL SUBSTI 80 000 UI BUV 1\n",
      "  3400930249680 | CHOLECALCIFEROL SUBST 200 000 UI BUV 1\n",
      "  3400930249826 | PIRFENIDONE TVC 267 MG CPR 252\n",
      "  3400930249840 | PIRFENIDONE TVC 801 MG CPR 84\n",
      "  3400930249994 | LACOSAMIDE ZYD 50 MG CPR 14\n",
      "  3400930250136 | TRIMEBUTINE VIATRIS 200MG CPR 30\n",
      "  3400930250198 | AMIFAMPRIDINE AXUNIO 10 MG CPR 100\n",
      "  3400930250433 | NUCALA 40MG INJ SRG 0,4ML 1\n",
      "  3400930250495 | VILDAGLIP/MET ACC 50/1000 MG CPR 60\n",
      "  3400930250563 | NUCALA 100MG INJ STYL1ML 3\n",
      "  3400930250594 | ZONISAMIDE ARW 25 MG GELULE 14\n",
      "  3400930250600 | ZONISAMIDE ARW 50 MG GELULE 14\n",
      "  3400930250617 | ZONISAMIDE ARW 100 MG GELULE 56\n",
      "  3400930250808 | SITAGLIPTINE /MET MYL 50/1000MG CPR 60\n",
      "  3400930250822 | PIRFENIDONE SDZ 267 MG CPR 252\n",
      "  3400930250846 | PIRFENIDONE SDZ 801 MG CPR 84\n",
      "  3400930250853 | SITAGL/METF BGR 50MG/1000MG CPR 60\n",
      "  3400930250983 | MOMETASONE ALT 50 MICROG SUSP N 140 140\n",
      "  3400930251546 | GRUMABIX 500 MG CPR 60\n",
      "  3400930251553 | RISEDRONATE EVO 35MG CPR PEL 4\n",
      "  3400930251560 | RISEDRONATE EVO 35MG CPR PEL 12\n",
      "  3400930251584 | PANTOPRAZOLE ZEN 40 MG PDR INJ 1\n",
      "  3400930252512 | NEFOPAM PANPHARMA 30 MG, CPR PELL 30\n",
      "  3400930252604 | ENBREL 25 MG, SOLUTION INJECTABLE EN 4\n",
      "  3400930252611 | ENBREL 50MG INJ CARTCHE1ML 4\n",
      "  3400930252635 | FENOFIBRATE ARL 67MG GELULE 50\n",
      "  3400930252673 | FENOFIBRATE ARL 200MG GELULE 30\n",
      "  3400930252703 | FENOFIBRATE ARL 200MG GELULE 90\n",
      "  3400930252727 | RISEDRONATE EVO 75MG CPR PEL 2\n",
      "  3400930252734 | RISEDRONATE EVO 75MG CPR PEL 6\n",
      "  3400930252956 | PERINDOPRIL INDAP HCS 5/1,25MG CPR 30\n",
      "  3400930252963 | PERINDOPRIL INDAP HCS 5/1,25MG CPR 90\n",
      "  3400930252970 | PERINDOPRIL INDAP HCS 10/2,5MG CPR 30\n",
      "  3400930252987 | PERINDOPRIL INDAP HCS 10/2,5MG CPR 90\n",
      "  3400930253069 | VILDAGLIPTINE ARW 50MG CPR 30\n",
      "  3400930253120 | PIRFENIDONE ZENTIVA 267 MG CPR 252\n",
      "  3400930253243 | PIRFENIDONE ZENTIVA 801 MG CPR 84\n",
      "  3400930254004 | BETAHISTINE ARW GENERIQUES 8 MG CPR 30\n",
      "  3400930254035 | ZEJULA 100 MG CPR 56\n",
      "  3400930254042 | ZEJULA 100 MG CPR 84\n",
      "  3400930254172 | ILUMETRI 200MG SOL INJ SER 1\n",
      "  3400930254288 | EMTRICITABIN TENOF MYL 200/245MG CPR 30\n",
      "  3400930254479 | TIXOCORTOL EG1% SUSP NASALE FL 10ML 1\n",
      "  3400930254561 | LATAZED 50MCG/ML COLL 5ML 1\n",
      "  3400930254639 | BIMATOPROST TEVA SANTE 0,1 MG/ML COL 1\n",
      "  3400930254684 | GABAPENTINE CRP 600 MG CRP SEC 90\n",
      "  3400930254707 | GABAPENTINE CRP 800 MG CRP SEC 90\n",
      "  3400930254738 | RINVOQ 45MG CPR LP 28\n",
      "  3400930254882 | METOTAB 2,5 MG CPR 24\n",
      "  3400930254998 | METOTAB 10 MG CPR 10\n",
      "  3400930255117 | BUDESONIDE LICONSA 3 MG GELULE LM 45\n",
      "  3400930255131 | FESOTERODINE ARROW LP 4MG CPR 30\n",
      "  3400930255148 | FESOTERODINE ARROW LP 8MG CPR 30\n",
      "  3400930255278 | ENAL / LERCANID VTS 20/20 MG CPR 30\n",
      "  3400930255339 | ENAL / LERCANID VTS 20/20 MG CPR 90\n",
      "  3400930255834 | BRIMONIDIN/TIMOL BGR 2 + 5 MG/ML COL 1\n",
      "  3400930255933 | PIRFENIDONE EG 267 CPR MG 252\n",
      "  3400930256275 | PIRFENIDONE EG 801 MG CPR 84\n",
      "  3400930256633 | PERINDOPRIL/AMLO HCS 5/5MG CPR 30\n",
      "  3400930256640 | PERINDOPRIL/AMLO HCS 5/5MG CPR 90\n",
      "  3400930256657 | PERINDOPRIL/AMLO HCS 5/10MG CPR 30\n",
      "  3400930256664 | PERINDOPRIL/AMLO HCS 5/10MG CPR 90\n",
      "  3400930256688 | PERINDOPRIL/AMLO HCS 10/5MG CPR 30\n",
      "  3400930256695 | PERINDOPRIL/AMLO HCS 10/5MG CPR 90\n",
      "  3400930256701 | PERINDOPRIL/AMLO HCS 10/10MG CPR 30\n",
      "  3400930256718 | PERINDOPRIL/AMLO HCS 10/10MG CPR 90\n",
      "  3400930256749 | PIRFENIDONE BIOGARAN 801 MG CPR 84\n",
      "  3400930256756 | PIRFENIDONE BIOGARAN 267 MG CPR 252\n",
      "  3400930256848 | DIMETHYL FUM.PPA 240MG GELU 56\n",
      "  3400930256916 | ATORVASTATINE LABO ALTER 10 MG CPR 30\n",
      "  3400930257005 | ATORVASTATINE LABO ALTER 20 MG CPR 30\n",
      "  3400930257098 | ATORVASTATINE LABO ALTER 40 MG CPR 30\n",
      "  3400930257180 | ATORVASTATINE LABO ALTER 80 MG CPR 30\n",
      "  3400930257463 | BILASTINE ARROW 20 MG CPR 30\n",
      "  3400930257555 | PERINDOPRIL ARG ZEN 2,5MG CPR 30\n",
      "  3400930257579 | PERINDOPRIL ARG ZEN 2,5MG CPR 90\n",
      "  3400930257630 | PERINDOPRIL ARG ZEN 5MG CPR 30\n",
      "  3400930257647 | PERINDOPRIL ARG ZEN 5MG CPR 90\n",
      "  3400930257678 | PERINDOPRIL ARG ZEN 10MG CPR 30\n",
      "  3400930257685 | PERINDOPRIL ARG ZEN 10MG CPR 90\n",
      "  3400930258002 | NEXPOVIO 20MG CPR 12\n",
      "  3400930258019 | NEXPOVIO 20MG CPR 16\n",
      "  3400930258057 | SUNLENCA 300MG CPR 5\n",
      "  3400930258064 | SUNLENCA 464MG SOL INJ 2\n",
      "  3400930258071 | PHLOROGLUCINOL ZEN 160MG CPR ORODISP 5\n",
      "  3400930258101 | SCEMBLIX 20MG CPR 60\n",
      "  3400930258125 | SCEMBLIX 40MG CPR 60\n",
      "  3400930258200 | PERINDOPRIL ARG ZEK 2,5MG CPR 30\n",
      "  3400930258217 | PERINDOPRIL ARG ZEK 2,5MG CPR 90\n",
      "  3400930258279 | PERINDOPRIL ARGININE EG 5MG CPR 30\n",
      "  3400930258286 | PERINDOPRIL ARGININE EG 5MG CPR 90\n",
      "  3400930258316 | PERINDOPRIL ARGININE EG 10MG CPR 30\n",
      "  3400930258323 | PERINDOPRIL ARGININE EG 10MG CPR 90\n",
      "  3400930258330 | ORGOVYX 120 MG CPR 1\n",
      "  3400930258347 | CHOLECALCIFEROL SUBST 50 000 UI BUV 1\n",
      "  3400930258354 | CHOLECALCIFEROL SUBST 50 000 UI BUV 2\n",
      "  3400930258361 | CHOLECALCIFEROL SUBST 50 000 UI BUV 4\n",
      "  3400930258378 | VILDAGLIPTINE ARW 50MG CPR 60\n",
      "  3400930258415 | ZONISAMIDE NEURAXPHARM 25 MG CPR 14\n",
      "  3400930258460 | ZONISAMIDE NEURAXPHARM 50 MG CPR 14\n",
      "  3400930258538 | ZONISAMIDE NEURAXPHARM 100 MG CPR 56\n",
      "  3400930258569 | ZONISAMIDE NEURAXPHARM 200 MG CPR 28\n",
      "  3400930258590 | ZONISAMIDE NEURAXPHARM 300 MG CPR 28\n",
      "  3400930258675 | RANIVISIO 10 MG/ML SOL INJ 1\n",
      "  3400930259061 | SITAGLIPTINE HCS 50 MG CPR 30\n",
      "  3400930259078 | SITAGLIPTINE HCS 100 MG CPR PEL 30\n",
      "  3400930259108 | CYAMEMAZINE ARROW 25MG CPR 30\n",
      "  3400930259122 | CYAMEMAZINE ARROW 100MG CPR 25\n",
      "  3400930260197 | LERCANIDIPINE ALMUS 10MG CPR 30\n",
      "  3400930260203 | LERCANIDIPINE ALMUS 10MG CPR 90\n",
      "  3400930260210 | LERCANIDIPINE ALMUS 20MG CPR 30\n",
      "  3400930260227 | LERCANIDIPINE ALMUS 20MG CPR 90\n",
      "  3400930260302 | FESOTERODINE CRISTERS LP 4MG CPR 30\n",
      "  3400930260357 | FESOTERODINE CRISTERS LP 8MG CPR 30\n",
      "  3400930260388 | NIQUITIN 7MG/24H DISP TRANSD 28\n",
      "  3400930260401 | NIQUITIN 14MG/24H DISP TRANSD 28\n",
      "  3400930260432 | NIQUITIN 21MG/24H DISP TRANSDER 28\n",
      "  3400930260494 | AMVUTTRA 25 MG SOL INJ SRG 1\n",
      "  3400930261149 | GABAPENTINE ZYDUS FRANCE 600 MG CPR 90\n",
      "  3400930261156 | GABAPENTINE ZYDUS FRANCE 800 MG CPR 90\n",
      "  3400930261187 | SITAGLIPTINE /MET ALT 50/1000MG CPR 60\n",
      "  3400930261200 | DABIGATRAN ETEX GALENICUM 75MG GEL 30\n",
      "  3400930261231 | DABIGATRAN ETEX GALENICUM 110MG GEL 30\n",
      "  3400930261248 | DABIGATRAN ETEX GALENICUM 110MG GEL 60\n",
      "  3400930261279 | DABIGATRAN ETEX GALENICUM 150MG GEL 60\n",
      "  3400930261347 | RISEDRONATE CRISTERS PHARM 75MG CPR 2\n",
      "  3400930261378 | RISEDRONATE CRISTERS PHARM 75MG CPR 6\n",
      "  3400930261590 | TEZSPIRE 210 MG SOL INJ SRG 1\n",
      "  3400930261903 | SITAGLIPTINE/METF ZYD 50/1000MG CPR 60\n",
      "  3400930261941 | TRIENTINE WAYMADE 200 MG GELULE 100\n",
      "  3400930261958 | BECLOM/FORMOT VTS 100/6 MCG/DOSE INH 120\n",
      "  3400930262061 | ZOLPIDEM VIATRIS 10MG CPR 5\n",
      "  3400930262108 | ABIRATERONE LEON FARMA 500 MG CPR 60\n",
      "  3400930262115 | SITAGLIPTINE ALM 50MG CPR 30\n",
      "  3400930262122 | SITAGLIPTINE ALM 100MG CPR 30\n",
      "  3400930262238 | TERIFLUNOMIDE BIOGARAN 14 MG CPR 28\n",
      "  3400930262337 | PARACETAMOL COD BGA 500/30MG CPR 16\n",
      "  3400930262344 | TRAMADOL BGA 50MG GELULE 10\n",
      "  3400930262351 | TRAMADOL BGR LP 100MG CPR 10\n",
      "  3400930262368 | TRAMADOL BGR LP 150MG CPR 10\n",
      "  3400930262375 | TRAMADOL BGR LP 200MG CPR 10\n",
      "  3400930262405 | FENOFIBRATE ARROW 145MG CPR 30\n",
      "  3400930262412 | FENOFIBRATE ARROW 145MG CPR 90\n",
      "  3400930262511 | BIKTARVY 30/120/15MG CPR 30\n",
      "  3400930262597 | VABYSMO 120 MG/ML SOL INJ 1\n",
      "  3400930262788 | ELETRIPTAN PHC 20 MG CPR 6\n",
      "  3400930262931 | ELETRIPTAN PHC 40 MG CPR 6\n",
      "  3400930262948 | ELETRIPTAN PHC 40 MG CPR 10\n",
      "  3400930263082 | IBUPROFENE VTS 400MG CPR 30\n",
      "  3400930263143 | TERIFLUNOMIDE EG 14 MG CPR 28\n",
      "  3400930263778 | CETIRIZINE CRP 10MG CPR 15\n",
      "  3400930263822 | DABIGATRAN ETEX BGR 75 MG GELULE 30\n",
      "  3400930263853 | DABIGATRAN ETEX BGR 110MG GELULE 30\n",
      "  3400930263860 | DABIGATRAN ETEX BGR 110MG GELULE 60\n",
      "  3400930263907 | DABIGATRAN ETEX BGR 150MG GELULE 60\n",
      "  3400930263938 | TERIFLUNOMIDE VTS 14MG CPR 28\n",
      "  3400930264140 | LUZADEL 266 MCG CAPS 1\n",
      "  3400930264171 | METHYLPHENIDATE EG LP 18MG CPR 28\n",
      "  3400930264188 | METHYLPHENIDATE EG LP 36 MG CPR 28\n",
      "  3400930264201 | METHYLPHENIDATE EG LP 54 MG CPR 28\n",
      "  3400930264355 | EMYLIF 50 MG FILM ORODISPERSIBLE 56\n",
      "  3400930264362 | FINASTERIDE VTS 5MG CPR 28\n",
      "  3400930264713 | OSPERZO 1,5 G GRANULES LP 60\n",
      "  3400930264751 | OSPERZO 3 G GRANULES LP 30\n",
      "  3400930264805 | DIMETHYL FUMARATE BGR 240 MG GELULE 56\n",
      "  3400930264911 | TEREBYO 14 MG CPR 28\n",
      "  3400930264959 | LIVMARLI 9,5 MG/ML SOL BUV 1\n",
      "  3400930264997 | SITAGLIPTINE ZYDUS 50 MG CPR 28\n",
      "  3400930265000 | SITAGLIPTINE ZYDUS 50 MG CPR 30\n",
      "  3400930265031 | SITAGLIPTINE ZYDUS 100 MG CPR 28\n",
      "  3400930265048 | SITAGLIPTINE ZYDUS 100 MG CPR 30\n",
      "  3400930265116 | AMITRIPTYLINE SBST 40 MG/ML BUV GTE 1\n",
      "  3400930265123 | CLOSALIS 50 MCG / 0.5 MG/G POM 60G 1\n",
      "  3400930265154 | QUETIAPINE TVS LP 50 MG CPR 30\n",
      "  3400930265161 | QUETIAPINE TVS LP 300 MG CPR 30\n",
      "  3400930265178 | QUETIAPINE TVS LP 300 MG CPR 60\n",
      "  3400930265185 | QUETIAPINE TVS LP 400 MG CPR 30\n",
      "  3400930265192 | QUETIAPINE TVS LP 400 MG CPR 60\n",
      "  3400930265215 | CONTRAMAL 50MG GELULE 10\n",
      "  3400930265260 | SITAGLIPTIN/METFOR ARL 50/1000MG CPR 60\n",
      "  3400930265543 | ARTIREM 0,0025 MMOL/ML SOL INJECT 1\n",
      "  3400930265581 | RIVAROXABAN BIOGARAN 10 MG CPR 30\n",
      "  3400930265598 | RIVAROXABAN BIOGARAN 15 MG CPR 28\n",
      "  3400930265611 | RIVAROXABAN BIOGARAN 20 MG CPR 28\n",
      "  3400930265642 | RIVAROXABAN EG 10 MG CPR 30\n",
      "  3400930265659 | RIVAROXABAN EG 15 MG CPR 28\n",
      "  3400930265680 | RIVAROXABAN EG 20 MG CPR 28\n",
      "  3400930265703 | RIVAROXABAN EG 15 MG GELULE 28\n",
      "  3400930265734 | RIVAROXABAN EG 20 MG GELULE 28\n",
      "  3400930266083 | LOSARTAN EG LABO 50 MG CPR 90\n",
      "  3400930266151 | TRIMEBUTINE MSO 50 MG SOL INJ 5\n",
      "  3400930266168 | LONQUEX 6 MG/0,6ML SOL INJ 1\n",
      "  3400930266199 | ATORVASTATINE LABO ALTER 10 MG CPR 90\n",
      "  3400930266212 | ATORVASTATINE LABO ALTER 20 MG CPR 90\n",
      "  3400930266236 | ATORVASTATINE LABO ALTER 40 MG CPR 90\n",
      "  3400930266250 | ATORVASTATINE LABO ALTER 80 MG CPR 90\n",
      "  3400930266366 | AMOXICILLINE MLA 500MG BU100ML AIT 1\n",
      "  3400930266380 | EMTRICITABIN TENOF TVC 200/245MG CPR 1\n",
      "  3400930266410 | TRAMADOL TVC 50MG CPR 10\n",
      "  3400930266427 | TRAMADOL TVC LP 100MG CPR 10\n",
      "  3400930266434 | TRAMADOL TVC LP 150MG CPR 10\n",
      "  3400930266441 | TRAMADOL TVC LP 200MG CPR 10\n",
      "  3400930266489 | IVERMECTINE TEVA 3 MG CPR 4\n",
      "  3400930266533 | TRIUMEQ 5/60/30 MG CPR DISP 90\n",
      "  3400930266601 | JUNALIZA 10 MG/10 MG GELULE 30\n",
      "  3400930266625 | JUNALIZA 10 MG/10 MG GELULE 90\n",
      "  3400930266632 | JUNALIZA 20 MG/10 MG GELULE 30\n",
      "  3400930266649 | JUNALIZA 20 MG/10 MG GELULE 90\n",
      "  3400930266656 | JUNALIZA 40 MG/10 MG GELULE 30\n",
      "  3400930266663 | JUNALIZA 40 MG/10 MG GELULE 90\n",
      "  3400930266670 | IMENOR 10 MG CPR 10\n",
      "  3400930266717 | ESLICARBAZEPINE ARROW 800 MG CPR 30\n",
      "  3400930266731 | IMATINIB ACC 100 MG CPR 60\n",
      "  3400930266755 | IMATINIB ACC 400 MG CPR 30\n",
      "  3400930267271 | LOSARTAN HCTZ EGL 100/12,5 MG CPR 30\n",
      "  3400930267288 | LOSARTAN HCTZ EGL 100/12,5 MG CPR 90\n",
      "  3400930267295 | LOSARTAN HCTZ EGL 100/25 MG CPR 30\n",
      "  3400930267301 | LOSARTAN HCTZ EGL 100/25 MG CPR 90\n",
      "  3400930267431 | PIRFENIDONE VIATRIS 267 MG CPR 252\n",
      "  3400930267455 | PIRFENIDONE VIATRIS 801 MG CPR 84\n",
      "  3400930267479 | POSEXONA 50 000 UI, SOL BUV AMP 1\n",
      "  3400930267486 | POSEXONA 50 000 UI, SOL BUV AMP 2\n",
      "  3400930267493 | POSEXONA 50 000 UI, SOL BUV AMP 4\n",
      "  3400930267547 | TRAMADOL VIATRIS 50MG GELULE 10\n",
      "  3400930267554 | FERTISTARTKIT 900 UI PDR ET SOLV INJ 1\n",
      "  3400930267578 | METFORMINE ZYD 1000MG CPR 30\n",
      "  3400930267585 | METFORMINE ZYD 1000MG CPR 90\n",
      "  3400930267592 | METFORMINE ZYF 850MG CPR 30\n",
      "  3400930267615 | METFORMINE ZYF 850MG CPR 90\n",
      "  3400930267813 | CONTRAMAL LP 100MG CPR 10\n",
      "  3400930268056 | TRAMADOL CRT LP 100MG CPR 10\n",
      "  3400930268063 | TRAMADOL CRT LP 150MG CPR 10\n",
      "  3400930268070 | TRAMADOL CRT LP 200MG CPR 10\n",
      "  3400930268087 | MANIDIPINE ARROW 10MG CPR SEC 30\n",
      "  3400930268094 | MANIDIPINE ARROW 10MG CPR SEC 90\n",
      "  3400930268117 | MANIDIPINE ARROW 20MG CPR SEC 30\n",
      "  3400930268124 | MANIDIPINE ARROW 20MG CPR SEC 90\n",
      "  3400930268599 | BEYFORTUS 50 MG SOL INJ SRG 1\n",
      "  3400930268636 | BEYFORTUS 100 MG SOL INJ SRG 1\n",
      "  3400930268674 | ALPRAZOLAM EVOL PHARMA 0,25 MG CPR 30\n",
      "  3400930268681 | ALPRAZOLAM EVOL PHARMA 0,5 MG CPR 30\n",
      "  3400930268698 | TEZSPIRE 210 MG SOL INJ STYLO 1\n",
      "  3400930268742 | ALPRAZOLAM ZDF 0,25MG CPR 30\n",
      "  3400930268759 | ALPRAZOLAM ZDF 0,5MG CPR 30\n",
      "  3400930268780 | ZAMUDOL LP 100MG GELULE 10\n",
      "  3400930268803 | ZAMUDOL LP 150MG GELULE 10\n",
      "  3400930268827 | ZAMUDOL LP 50MG GELULE 10\n",
      "  3400930268988 | GANIRELIX EG 0,25 MG/0,5 ML SOL INJ 1\n",
      "  3400930268995 | GANIRELIX EG 0,25 MG/0,5 ML SOL INJ 5\n",
      "  3400930269107 | TRAMADOL SDZ 50MG CPR 10\n",
      "  3400930269114 | TRAMADOL SDZ LP 100MG CPR 10\n",
      "  3400930269121 | TRAMADOL SDZ LP 150MG CPR 10\n",
      "  3400930269138 | TRAMADOL SDZ LP 200MG CPR 10\n",
      "  3400930269145 | TERIFLUNOMIDE ZENTIVA 14 MG CPR 28\n",
      "  3400930269176 | ACIDE FOLIQUE BGA 0,4MG CPR 30\n",
      "  3400930269183 | ACIDE FOLIQUE BGA 0,4MG CPR 90\n",
      "  3400930269305 | SOTYKTU 6 MG CPR PELL 7\n",
      "  3400930269329 | RIVAROXABAN VTS 10 MG CPR 30\n",
      "  3400930269350 | RIVAROXABAN VTS 15 MG CPR 28\n",
      "  3400930269404 | RIVAROXABAN VTS 15 MG + 20 MG CPR 49\n",
      "  3400930270394 | EMTRICITABIN TENOF MYL 200/245MG CPR 90\n",
      "  3400930270479 | TRAMADOL EG 50MG CPR 10\n",
      "  3400930270486 | DIENOGEST LABO MAJORELLE 2 MG CPR 28\n",
      "  3400930270493 | DIENOGEST LABO MAJORELLE 2 MG CPR 84\n",
      "  3400930270530 | FIXICAL 500MG CPR 60\n",
      "  3400930270547 | FIXICAL VITAMINE D3 500 MG/400UI CPR 60\n",
      "  3400930270554 | FIXICAL VITAMINE D3 500 MG/400UI CPR 180\n",
      "  3400930270592 | MACROGOL 4000 ZYD 4G PDR ORALE SACH 20\n",
      "  3400930270608 | MACROGOL 4000 ZYD 10G PDR ORALE SACH 20\n",
      "  3400930270882 | CALQUENCE 100 MG CPR 60\n",
      "  3400930270899 | FULVESTRANT ARW 250 MG SOL INJ SER 1 1\n",
      "  3400930270981 | OPZELURA 15 MG/G CREME TA 1\n",
      "  3400930270998 | METHYLPHENIDATE BGR LP 18 MG CPR LP 28\n",
      "  3400930271018 | METHYLPHENIDATE BGR LP 36 MG CPR LP 28\n",
      "  3400930271025 | METHYLPHENIDATE BGR LP 54 MG CPR LP 28\n",
      "  3400930271162 | TERROSA 20 MCG/80MCL INJ STYLO 1\n",
      "  3400930271209 | DIPROSONE 0,05% LOTION FL 30ML 1\n",
      "  3400930271216 | DIPROSALIC LOTION FL 30 ML 1\n",
      "  3400930272459 | ILUMETRI 100 MG SOL INJ STYLO 1\n",
      "  3400930272572 | PREGABALINE EVP 200 MG GELULE 84\n",
      "  3400930272596 | PREGABALINE EVP 300 MG GELULE 56\n",
      "  3400930272725 | BUDESONIDE LICONSA 3 MG GELULE LM 90\n",
      "  3400930272787 | AMLODIPINE KRKA D.D 5MG CPR 30\n",
      "  3400930272794 | AMLODIPINE KRKA D.D 5MG CPR 90\n",
      "  3400930272800 | AMLODIPINE KRKA D.D 10MG CPR 30\n",
      "  3400930272817 | AMLODIPINE KRKA D.D 10MG CPR 90\n",
      "  3400930272978 | FRAGMINE 2 500UI AXA/0,2ML SOL INJ 5\n",
      "  3400930272985 | FRAGMINE 5 000UI AXA/0,2ML SOL INJ 5\n",
      "  3400930272992 | HYRIMOZ 20 MG SOL INJ SRG 2\n",
      "  3400930273005 | HYRIMOZ 40 MG SOL INJ SRG 0,4ML 1\n",
      "  3400930273029 | HYRIMOZ 40 MG SOL INJ SRG 0,4ML 2\n",
      "  3400930273036 | HYRIMOZ 40 MG SOL INJ STYLO 0,4ML 1\n",
      "  3400930273043 | HYRIMOZ 40 MG SOL INJ STYLO 0,4ML 2\n",
      "  3400930273050 | HYRIMOZ 80 MG SOL INJ SRG 1\n",
      "  3400930273067 | HYRIMOZ 80 MG SOL INJ SRG 2\n",
      "  3400930273074 | HYRIMOZ 80 MG SOL INJ STYLO 1\n",
      "  3400930273081 | HYRIMOZ 80 MG SOL INJ STYLO 2\n",
      "  3400930273357 | HYRIMOZ 40 MG SOL INJ STYLO 0,4ML 4\n",
      "  3400930273364 | HYRIMOZ 40 MG SOL INJ STYLO 0,4ML 6\n",
      "  3400930273876 | IBIRON 1000MG CPR 30\n",
      "  3400930274095 | METOPIMAZINE ARW 7,5 MG SS CPR DISP 16\n",
      "  3400930274101 | ORKAMBI 75/94 MG GRANULES SACH 56\n",
      "  3400930274224 | ESOMEPRAZOLE ARL 20MG GELULE GR 28\n",
      "  3400930274262 | ESOMEPRAZOLE ARL 40MG GELULE GR 14\n",
      "  3400930274279 | ESOMEPRAZOLE ARL 40MG GELULE GR 28\n",
      "  3400930274460 | RACECADOTRIL VIATRIS 100MG GELULE 20\n",
      "  3400930274583 | ANASTROZOLE ZEN 1MG CPR 30\n",
      "  3400930274613 | ANASTROZOLE ZEN 1MG CPR 90\n",
      "  3400930274927 | CHOLECALCIFEROL VTS 50000 UI BUV AMP 1\n",
      "  3400930274934 | CHOLECALCIFEROL VTS 50000 UI BUV AMP 2\n",
      "  3400930274958 | CHOLECALCIFEROL VTS 50000 UI BUV AMP 4\n",
      "  3400930275108 | OSPERZO 1 G SUPPOSITOIRE 30\n",
      "  3400930275115 | STELARA 45 MG INJ STYLO 1\n",
      "  3400930275122 | STELARA 90 MG INJ STYLO 1\n",
      "  3400930275429 | RIVAROXABAN SDZ 15 MG CPR 28\n",
      "  3400930275450 | RIVAROXABAN SDZ 20 MG CPR 28\n",
      "  3400930275474 | ERYNJA 2 MG CPR 28\n",
      "  3400930275498 | ERYNJA 2 MG CPR 84\n",
      "  3400930275573 | ABRYSVO PDR ET SOLVANT SOL INJ 1\n",
      "  3400930276013 | EUTHYROX 25 MICROG CPR 50\n",
      "  3400930276020 | EUTHYROX 50 MICROG CPR 50\n",
      "  3400930276037 | EUTHYROX 75 MICROG CPR 50\n",
      "  3400930276044 | EUTHYROX 100 MICROG CPR 50\n",
      "  3400930276051 | EUTHYROX 125 MICROG CPR SEC 50\n",
      "  3400930276068 | EUTHYROX 150 MICROG CPR AIT 50\n",
      "  3400930276099 | TRAMADOL ZYD LP 100MG CPR 10\n",
      "  3400930276112 | TRAMADOL ZYD LP 150MG CPR 10\n",
      "  3400930276129 | OPZELURA 15 MG/G CREME TL 1\n",
      "  3400930276136 | ADTRALZA 300 MG SOL INJ STYLO 2\n",
      "  3400930276211 | RIVAROXABAN VIATRIS 20 MG CPR 28\n",
      "  3400930276334 | CAMZYOS 2,5 MG GELULE 28\n",
      "  3400930276358 | CAMZYOS 5 MG, GELULE 28\n",
      "  3400930276389 | CAMZYOS 10 MG GELULE 28\n",
      "  3400930276402 | CAMZYOS 15 MG GELULE 28\n",
      "  3400930276501 | CHLORURE DE TROSPIUM VTS 20 MG CPR 30\n",
      "  3400930276556 | AZELASTINE PRO 137/50MCG PULV NAS 1\n",
      "  3400930276563 | ALPRAZOLAM TVC 0,50MG CPR 30\n",
      "  3400930276570 | ALPRAZOLAM TVC 0,25MG CPR 30\n",
      "  3400930276600 | LYTGOBI 4 MG CPR 35\n",
      "  3400930276853 | ALFUZOSINE ARROW LP 10MG CPR 30\n",
      "  3400930276877 | DESMOPRESSINE EG 60MCG CPR SUBLING 30\n",
      "  3400930276884 | DESMOPRESSINE EG 60MCG CPR SUBLING 100\n",
      "  3400930276907 | DESMOPRESSINE EG 120MCG CPR SUBLING 30\n",
      "  3400930276914 | DESMOPRESSINE EG 120MCG CPR SUBLING 100\n",
      "  3400930276921 | DESMOPRESSINE EG 240MCG CPR SUBLING 30\n",
      "  3400930276938 | DESMOPRESSINE BGA 60MCG CPR SUBLING 30\n",
      "  3400930276945 | DESMOPRESSINE BGA 60MCG CPR SUBLING 100\n",
      "  3400930276983 | DESMOPRESSINE BGA 120MCG CPR SUBLING 30\n",
      "  3400930276990 | DESMOPRESSINE BGA 120MCG CPR SUBLING 100\n",
      "  3400930277027 | DESMOPRESSINE BGA 240MCG CPR SUBLING 30\n",
      "  3400930277065 | DESMOPRESSINE ZEN 60MCG CPR SUBLING 30\n",
      "  3400930277072 | DESMOPRESSINE ZEN 60MCG CPR SUBLING 100\n",
      "  3400930277089 | DESMOPRESSINE ZEN 120MCG CPR SUBLING 30\n",
      "  3400930277096 | DESMOPRESSINE ZEN 120MCG CPR SUBLING 100\n",
      "  3400930277102 | DESMOPRESSINE ZEN 240MCG CPR SUBLING 30\n",
      "  3400930277126 | ENTRESTO 6MG/6MG GRANULES EN GELULES 60\n",
      "  3400930277133 | ENTRESTO 15MG/16MG GRANULES EN GELUL 60\n",
      "  3400930277362 | TERIFLUNOMIDE TEVA 14 MG CPR 28\n",
      "  3400930277652 | ERLEADA 240 MG CPR 30\n",
      "  3400930277720 | TOLVAPTAN BGA 15 MG / 45 MG CPR 56\n",
      "  3400930277751 | TOLVAPTAN BGA 30 MG / 60 MG CPR 56\n",
      "  3400930277799 | TOLVAPTAN BGA 30 MG / 90 MG CPR 56\n",
      "  3400930277867 | ASPIRINE ARROW 75 MG CPR GR 30\n",
      "  3400930278048 | BYOOVIZ 10 MG/ML SOL INJ 1\n",
      "  3400930278406 | RIZMOIC 200 MICROG CPR PEL 30\n",
      "  3400930278420 | TYENNE 162 MG SOL INJ SRG 4\n",
      "  3400930278437 | TYENNE 162 MG SOL INJ STYLO 4\n",
      "  3400930279083 | SCYOVA 240 MG/ML + 12 MG/ML SOL INJ 7\n",
      "  3400930279458 | HYRIMOZ 80 MG SOL INJ STYLO 3\n",
      "  3400930279717 | AMLODIPINE/VALSART EVP 5MG/80MG CP 90\n",
      "  3400930279724 | LITFULO 50 MG GELULE 30\n",
      "  3400930279823 | AMLODIPINE/VALSART EVP 5MG/160MG CPR 30\n",
      "  3400930279878 | AMLODIPINE/VALSART EVP 5MG/160MG CPR 90\n",
      "  3400930279946 | AMLODIPINE/VALSART EVP 10/160MG CPR 30\n",
      "  3400930279984 | AMLODIPINE/VALSART EVP 10/160MG CPR 90\n",
      "  3400930280287 | DOVATO 50MG/300MG CPR 30\n",
      "  3400930280294 | DOVATO 50MG/300MG CPR 90\n",
      "  3400930280416 | AMOXICILLINE VTS 500MG/5ML BUV 54ML 1\n",
      "  3400930280430 | DARAPRIM 25MG CPR 30\n",
      "  3400930280959 | UVEDOSE 50 000 UI SOL BUV 2\n",
      "  3400930280966 | UVEDOSE 50 000 UI SOL BUV 4\n",
      "  3400930280997 | PHENOXYMETH.UCP 250MG CPR AIT 28\n",
      "  3400930281109 | XOLAIR 75 MG SOL INJ SER 1\n",
      "  3400930281123 | XOLAIR 75 MG SOL INJ STYLO 1\n",
      "  3400930281130 | XOLAIR 150 MG SOL INJ SER 1\n",
      "  3400930281147 | XOLAIR 300 MG SOL INJ STYLO 1\n",
      "  3400930281154 | XOLAIR 300 MG SOL INJ SRG 1\n",
      "  3400930281161 | XOLAIR 150 MG SOL INJ STYLO 1\n",
      "  3400930281420 | CHINTAL 60MCG CPR SUBLING 30\n",
      "  3400930281437 | CHINTAL 60MCG CPR SUBLING 100\n",
      "  3400930281444 | CHINTAL 120MCG CPR SUBLING 30\n",
      "  3400930281451 | CHINTAL 120MCG CPR SUBLING 100\n",
      "  3400930281468 | SOLU-MEDROL 40 MG/1 ML, PDR SOLV INJ 1\n",
      "  3400930281475 | CHINTAL 240MCG CPR SUBLING 30\n",
      "  3400930281789 | BILASTINE ZYDUS 20MG CPR 10\n",
      "  3400930281802 | BILASTINE ZYDUS 20MG CPR 30\n",
      "  3400930281819 | TESTOSTERONE BES 1000 MG SOL INJ FL 1\n",
      "  3400930282403 | NEFOGJIX 20 MG/ 2ML INJ 5\n",
      "  3400930282717 | TERIPARATIDE TEVA 20MCG/80MCL INJ ST 1\n",
      "  3400930283158 | YUFLYMA 20 MG SOL INJ SRG 2\n",
      "  3400930283165 | CHOLECALCIFEROL EVO 100 000UI BUV 1\n",
      "  3400930283219 | LIBMYRIS 40 MG SOL INJ SRG 2\n",
      "  3400930283226 | LIBMYRIS 40 MG SOL INJ STYLO 2\n",
      "  3400930283554 | BRINZOLAM/TIM BGA 10/5 MG/ML COLLYRE 1\n",
      "  3400930284605 | EZETIMIBE/ ATOR ZEN 10 MG/10 MG CPR 30\n",
      "  3400930284612 | EZETIMIBE/ ATOR ZEN 10 MG/10 MG CPR 90\n",
      "  3400930284636 | EZETIMIBE/ ATOR ZEN 10 MG/20 MG CPR 30\n",
      "  3400930284643 | EZETIMIBE/ ATOR ZEN 10 MG/20 MG CPR 90\n",
      "  3400930284667 | EZETIMIBE/ ATOR ZEN 10 MG/40 MG CPR 30\n",
      "  3400930284674 | EZETIMIBE/ ATOR ZEN 10 MG/40 MG CPR 90\n",
      "  3400930284698 | EZETIMIBE/ ATOR ZEN 10 MG/80 MG CPR 30\n",
      "  3400930284704 | EZETIMIBE/ ATOR ZEN 10 MG/80 MG CPR 90\n",
      "  3400930284711 | BACLOFENE ZYD 10MG CPR 30\n",
      "  3400930284797 | AC ZOLEDRONIQUE BGA 5MG/100M SOL INJ 1\n",
      "  3400930284902 | CALCIFEDIOL DESMA 0,15MG/ML SOL BUV 1\n",
      "  3400930284957 | UZPRUVO 45 MG SOL INJ SRG 1\n",
      "  3400930284964 | UZPRUVO 90 MG SOL INJ SRG 1\n",
      "  3400930285008 | EZETIMIBE/ ATOR ZYD 10 MG/10 MG CPR 30\n",
      "  3400930285015 | EZETIMIBE/ ATOR ZYD 10 MG/10 MG CPR 90\n",
      "  3400930285039 | EZETIMIBE/ ATOR ZYD 10 MG/20 MG CPR 30\n",
      "  3400930285046 | EZETIMIBE/ ATOR ZYD 10 MG/20 MG CPR 90\n",
      "  3400930285060 | EZETIMIBE/ ATOR ZYD 10 MG/40 MG CPR 30\n",
      "  3400930285084 | EZETIMIBE/ ATOR ZYD 10 MG/40 MG CPR 90\n",
      "  3400930285121 | EZETIMIBE/ ATOR ZYD 10 MG/80 MG CPR 30\n",
      "  3400930285145 | EZETIMIBE/ ATOR ZYD 10 MG/80 MG CPR 90\n",
      "  3400930285374 | ARIPIPRAZOLE BGA 5 MG CPR 28\n",
      "  3400930285473 | ARIPIPRAZOLE BGA 10 MG CPR 28\n",
      "  3400930285558 | ARIPIPRAZOLE BGA 15 MG CPR 28\n",
      "  3400930285695 | NICORETTE 2MG CPR A SUCER 80\n",
      "  3400930285756 | EZETIMIBE/ ATOR EG 10 MG/10 MG CPR 30\n",
      "  3400930285787 | EZETIMIBE/ ATOR EG 10 MG/10 MG CPR 90\n",
      "  3400930285824 | NICORETTE FRUITS 2MG CPR A SUCER 80\n",
      "  3400930285862 | EZETIMIBE/ ATOR EG 10 MG/20 MG CPR 30\n",
      "  3400930285909 | EZETIMIBE/ ATOR EG 10 MG/20 MG CPR 90\n",
      "  3400930285930 | EZETIMIBE/ ATOR EG 10 MG/40 MG CPR 30\n",
      "  3400930285978 | EZETIMIBE/ ATOR EG 10 MG/40 MG CPR 90\n",
      "  3400930286005 | EZETIMIBE/ ATOR EG 10 MG/80 MG CPR 30\n",
      "  3400930286043 | EZETIMIBE/ ATOR EG 10 MG/80 MG CPR 90\n",
      "  3400930286241 | EZETIMIBE/ ATOR TEVA 10 MG/10 MG CPR 30\n",
      "  3400930286289 | EZETIMIBE/ ATOR TEVA 10 MG/10 MG CPR 90\n",
      "  3400930286326 | EZETIMIBE/ ATOR TEVA 10 MG/20 MG CPR 30\n",
      "  3400930286357 | EZETIMIBE/ ATOR TEVA 10 MG/20 MG CPR 90\n",
      "  3400930286388 | EZETIMIBE/ ATOR TEVA 10 MG/40 MG CPR 30\n",
      "  3400930286418 | EZETIMIBE/ ATOR TEVA 10 MG/40 MG CPR 90\n",
      "  3400930286456 | EZETIMIBE/ ATOR TEVA 10 MG/80 MG CPR 30\n",
      "  3400930286500 | EZETIMIBE/ ATOR TEVA 10 MG/80 MG CPR 90\n",
      "  3400930287231 | DABIGATRAN ETEXILATE VTS 75 MG GELU 30\n",
      "  3400930287255 | DABIGATRAN ETEXILATE VTS 110 MG GELU 30\n",
      "  3400930287279 | DABIGATRAN ETEXILATE VTS 110 MG GELU 60\n",
      "  3400930287293 | DABIGATRAN ETEXILATE VTS 150 MG GELU 60\n",
      "  3400930287330 | EZETIMIBE/ ATOR BGA 10 MG/10 MG CPR 30\n",
      "  3400930287347 | EZETIMIBE/ ATOR BGA 10 MG/10 MG CPR 90\n",
      "  3400930287354 | EZETIMIBE/ ATOR BGA 10 MG/20 MG CPR 30\n",
      "  3400930287361 | EZETIMIBE/ ATOR BGA 10 MG/20 MG CPR 90\n",
      "  3400930287385 | EZETIMIBE/ ATOR BGA 10 MG/40 MG CPR 30\n",
      "  3400930287392 | EZETIMIBE/ ATOR BGA 10 MG/40 MG CPR 90\n",
      "  3400930287408 | EZETIMIBE/ ATOR BGA 10 MG/80 MG CPR 30\n",
      "  3400930287880 | BOSUTINIB EG 100 MG CPR 28\n",
      "  3400930287903 | BOSUTINIB EG 400 MG CPR 28\n",
      "  3400930288146 | TRAMADOL ZTV LP 50MG CPR 30\n",
      "  3400930288306 | TRAMADOL ZTV LP 100MG CPR 30\n",
      "  3400930289112 | ACIDE ACETYLSALICYL BGA 75MG CPR 30\n",
      "  3400930289129 | ACIDE ACETYLSALICYL BGA 100MG CPR 30\n",
      "  3400930289204 | BOSUTINIB BGR 100 MG CPR 28\n",
      "  3400930289228 | BOSUTINIB BGR 400 MG CPR 28\n",
      "  3400930289235 | BOSUTINIB BGR 500 MG CPR 28\n",
      "  3400930289433 | ACIDE ACETYLSALICYL BGA 75MG CPR 90\n",
      "  3400930289532 | ASPIRINE ARROW 75 MG CPR GR 90\n",
      "  3400930289907 | XGEVA 120MG INJ SRG1ML 1\n",
      "  3400930289938 | EZETIMIBE/ ATOR BGA 10 MG/80 MG CPR 90\n",
      "  3400930290323 | IGNAYOL 10 MG GELULE GR 28\n",
      "  3400930290361 | IGNAYOL 20 MG GELULE GR 28\n",
      "  3400930290422 | FUROSEMIDE RTP 500MG CPR AIP 20\n",
      "  3400930290477 | BOSUTINIB ZEN 100 MG CPR 28\n",
      "  3400930290514 | BOSUTINIB ZEN 400 MG CPR 28\n",
      "  3400930291795 | FLUDROCORTISONE ACETLAB 50 MCG CPR 60\n",
      "  3400930291849 | EZETIMIBE/ ATOR VTS 10 MG/10 MG CPR 30\n",
      "  3400930291856 | EZETIMIBE/ ATOR VTS 10 MG/10 MG CPR 90\n",
      "  3400930291863 | EZETIMIBE/ ATOR VTS 10 MG/20 MG CPR 30\n",
      "  3400930291870 | EZETIMIBE/ ATOR VTS 10 MG/20 MG CPR 90\n",
      "  3400930291887 | EZETIMIBE/ ATOR VTS 10 MG/40 MG CPR 30\n",
      "  3400930291894 | EZETIMIBE/ ATOR VTS 10 MG/40 MG CPR 90\n",
      "  3400930291900 | EZETIMIBE/ ATOR VTS 10 MG/80 MG CPR 30\n",
      "  3400930291917 | EZETIMIBE/ ATOR VTS 10 MG/80 MG CPR 90\n",
      "  3400930291962 | PARACETAMOL EVP 500MG CPR 16\n",
      "  3400930291986 | PARACETAMOL EVP 1000MG CPR 8\n",
      "  3400930293331 | SOLUMEDROL SAB 125MG FL DBLE 1\n",
      "  3400930293379 | SAXAGLIPTINE BIOGARAN 5MG CPR 30\n",
      "  3400930293416 | PYZCHIVA 45 MG SOL INJ SRG 1\n",
      "  3400930293423 | PYZCHIVA 90 MG SOL INJ SRG 1\n",
      "  3400930293683 | DIMETHYL FUMARATE TVS 120MG GELULE 14\n",
      "  3400930293713 | DIMETHYL FUMARATE TVS 240 MG GELULE 56\n",
      "  3400930294178 | PARACETAMOL BENTA 500MG CPR 16\n",
      "  3400930294505 | AMGEVITA 40 MG SOL INJ STY 0.4ML 1\n",
      "  3400930294512 | AMGEVITA 40 MG SOL INJ STY 0.4ML 2\n",
      "  3400930294536 | AMGEVITA 80 MG SOL INJ SER 0.8ML 1\n",
      "  3400930294567 | AMGEVITA 80 MG SOL INJ STY 0.8ML 1\n",
      "  3400930294598 | AMGEVITA 80 MG SOL INJ STY 0.8ML 6\n",
      "  3400930295229 | CHOLECALCIFEROL VTS 80 00UI BUV AMP 1\n",
      "  3400930295496 | WEZENLA 45 MG SOL INJ SRG 1\n",
      "  3400930295502 | WEZENLA 90 MG SOL INJ SRG 1\n",
      "  3400930298916 | THIAMINE HCL STO 50MG/ML AMP AIT 10\n",
      "  3400930299937 | RITALINE LP 20MG GEL AIT 30\n",
      "  3400930299944 | RITALINE HDK 30MG GELULE LP 30\n",
      "  3400930299951 | RITALINE HDK 40MG GELULE LP 30\n",
      "  3400930515648 | HYDROCORTANCYL 2,5% SUSP INJ 1\n",
      "  3400931153184 | XYLOCAINE 10MG/ML INJ AB 5ML 1\n",
      "  3400931261445 | SODIUM BIC BSD 1,4% INJ FV 250ML 1\n",
      "  3400931844082 | SODIUM CHL AGT 0,9% INJ FV 500ML 1\n",
      "  3400931952572 | SODIUM BIC AGT 1,4% SOL 500ML 1\n",
      "  3400931994046 | COLPOTROPHINE 1% CREME VAGINALE 1\n",
      "  3400932387656 | FLUOGEL GEL DENTAIRE 1\n",
      "  3400932421756 | ACUPAN 20 MG/2 ML SOL INJ 5\n",
      "  3400932610204 | ACIDE ACETYLS PAN 1G PDR ET SOL INJ 6\n",
      "  3400932783168 | FRAXIPARINE 5700UI AXA/0,6ML SOL INJ 10\n",
      "  3400932783458 | FRAXIPARINE 9500UI AXA/1ML SOL INJ 10\n",
      "  3400932855759 | ALBEY VENIN ABEILLE 0,12MG INJ 1\n",
      "  3400932855988 | ALBEY VENIN GUEPE 0,12MG INJ 1\n",
      "  3400933143312 | SELOKEN 100MG CPR 28\n",
      "  3400933433154 | INNOHEP 2 500UI AXA/0,25ML SOL INJ 10\n",
      "  3400933433383 | INNOHEP 3 500UI AXA/0,35ML SOL INJ 10\n",
      "  3400933661090 | CROMEDIL 2% COLLYRE FL 5ML 1\n",
      "  3400933785321 | PROHANCE 0,5 MMOL/ML SOL INJ FL 15 1\n",
      "  3400933785499 | PROHANCE 0,5 MMOL/ML SOL INJ FL 20 1\n",
      "  3400933825973 | BROMAZEPAM RPG 6MG CPR 30\n",
      "  3400933830595 | ALLERGODIL VIATRIS 0,1% SOL NASALE 1\n",
      "  3400934045837 | SPIRONOLACTONE ALTIZIDE RPG CPR 30\n",
      "  3400934176579 | OXYBUTYNINE CRISTERS 5 MG CPR 0\n",
      "  3400934217135 | INNOHEP 4 500UI AXA/0,45ML SOL INJ 10\n",
      "  3400934250071 | EUROBIOL 25000U GELULE 90\n",
      "  3400934544927 | ALLERVI 120MG CPR 15\n",
      "  3400934545696 | FEXOFENADINE ZTV 120MG CPR 15\n",
      "  3400934546068 | FEXOFENADINE ZTV 180MG CPR 15\n",
      "  3400934600678 | OMNIPAQUE 300MG SOL INJ FP 10ML 1\n",
      "  3400934802591 | BUSPIRONE VIATRIS 10MG CPR 20\n",
      "  3400934802652 | BUSPIRONE VIATRIS 10MG CPR 20\n",
      "  3400935082886 | PROHANCE 0,5 MMOL/MLSOL INJ SER 15 1\n",
      "  3400935082947 | PROHANCE 0,5 MMOL/ML SOL INJ SER 17 1\n",
      "  3400935102911 | FLUOXETINE VTS 20MG GELULE 14\n",
      "  3400935200426 | VISIPAQUE 320MG/ML SOL INJ FP 1\n",
      "  3400935201836 | VISIPAQUE 320MG/ML SOL INJ BP 200ML 1\n",
      "  3400935202376 | VISIPAQUE 270MG/ML SOL INJ FP 1\n",
      "  3400935203908 | VISIPAQUE 270MG/ML SOL INJ BP 200ML 1\n",
      "  3400935284921 | ZOPICLONE ALT 7,5MG CPR 5\n",
      "  3400935312877 | CARDENSIEL 5MG CPR 90\n",
      "  3400935395672 | BCG MEDAC PDR+SOL INJ 1\n",
      "  3400935451316 | AZATHIOPRINE VTS 50MG CPR 100\n",
      "  3400935514103 | LEPONEX 100MG CPR 28\n",
      "  3400935567550 | CEFTRIAXONE VTS0,5G/5ML PDR INJ IV 1\n",
      "  3400935584069 | EUPANTOL 40 MG CPR 28\n",
      "  3400935589033 | ZOPICLONE ZYD 7,5MG CPR 5\n",
      "  3400935613028 | GLUCOSE 5% AGT SOL INJ POC 50ML 1\n",
      "  3400935613196 | GLUCOSE 5% AGT SOL INJ POC 100ML 1\n",
      "  3400935613318 | GLUCOSE 5% AGT SOL INJ POC 250ML 1\n",
      "  3400935613486 | GLUCOSE 5% AGT SOL INJ POC 500ML 1\n",
      "  3400935613547 | GLUCOSE 5% AGT SOL INJ POC 1L 1\n",
      "  3400935631466 | SODIUM CHL AGT 0,9% INJ POC 50ML 1\n",
      "  3400935631527 | SODIUM CHL AGT 0,9% INJ POC 100ML 1\n",
      "  3400935631756 | SODIUM CHL AGT 0,9% INJ POC 250ML 1\n",
      "  3400935631817 | SODIUM CHL AGT 0,9% INJ POC 500ML 1\n",
      "  3400935631985 | SODIUM CHL AGT 0,9% INJ POC 1L 1\n",
      "  3400935644183 | ATENOLOL BGA 50 MG CPR 28\n",
      "  3400935684455 | AMOXICILLINE MYL 1G CPR DISP 3\n",
      "  3400935829139 | LACTULOSE EG 10G/15ML SOL SAC 20\n",
      "  3400935833969 | LACTULOSE ZYD 10G SOL BUV SAC 20\n",
      "  3400935905451 | MEBEVERINE EG 200MG GELULE 30\n",
      "  3400936015272 | SOTALOL ARW 80MG CPR 30\n",
      "  3400936077546 | NEULASTA 6MG SOL INJ SER 1\n",
      "  3400936102712 | ZOLPIDEM BGA 10MG CPR 7\n",
      "  3400936114838 | ISOTRETINOINE ACN 20MG CAPSULE MOLLE 30\n",
      "  3400936141971 | ATENOLOL TVC 50MG CPR 28\n",
      "  3400936167766 | CITALOPRAM VTS 20MG CPR 28\n",
      "  3400936260948 | NORMAFIBE 62G/100G GRANULES SACH 1KG 1\n",
      "  3400936261020 | NORMAFIBE 62G/100G GRANULES SACH 10G 30\n",
      "  3400936284951 | AMOXICILLINE CRT 500MG GELULE 12\n",
      "  3400936285552 | TUSSIDANE 3MG/ML SOL BUV FL 1\n",
      "  3400936456549 | ZOLPIDEM ALM 10MG CPR 7\n",
      "  3400936485464 | EFFERALGAN 1000 MG CPR 8\n",
      "  3400936648586 | ENALAPRIL HCTZ ARW 20/12,5MG CP 30\n",
      "  3400936651258 | OROZAMUDOL 50MG CPR 10\n",
      "  3400936773295 | SODIUM CHL BLZ 0,9% SOL INJ PO 500ML 1\n",
      "  3400936773356 | SODIUM CHL BLZ 0,9% SOL INJ PO 500ML 1\n",
      "  3400936786592 | SIMVASTATINE VTS 20MG CPR 28\n",
      "  3400936855182 | PAROXETINE ARW 20MG CPR 14\n",
      "  3400936873742 | REPEVAX SUSP INJ SER AS 1\n",
      "  3400936874633 | TETRAVAC ACELLULAIRE INJ 1AIG 1\n",
      "  3400936876064 | REVAXIS SUSP INJ SER 0,5ML ATC 1\n",
      "  3400936934696 | VALPROATE NA ZEN LP 500MG CPR 30\n",
      "  3400936966116 | VALPROATE NA TVS LP 500MG CPR 30\n",
      "  3400937019095 | PRAVASTATINE BGA 40MG CPR 28\n",
      "  3400937019675 | PRAVASTATINE EVO 40MG CPR 28\n",
      "  3400937056236 | PINAVERIUM BGA 100MG CPR 30\n",
      "  3400937123563 | RAMIPRIL ZEN 1,25MG CPR 90\n",
      "  3400937198493 | SIMVASTATINE VTS 20MG CPR 84\n",
      "  3400937230582 | VOLTARENE EMULGEL 1% GEL TUBE 100G 1\n",
      "  3400937338554 | RAMIPRIL ARL 2,5MG CPR 90\n",
      "  3400937359207 | PRAVASTATINE BGA 20MG CPR 84\n",
      "  3400937391832 | METFORMINE EG 1000MG CPR 90\n",
      "  3400937428835 | AMOX/AC CLAV ZEN 500/62,5 CPR 24\n",
      "  3400937456289 | ALGINATE BICAR SODIUM EG BUV 1\n",
      "  3400937524629 | FINASTERIDE SDZ 5MG CPR 30\n",
      "  3400937667838 | TIMOLOL SDZ 0,50% COLLYRE 3ML 1\n",
      "  3400937714365 | GARDASIL SUSP INJ 1\n",
      "  3400937812160 | GABAPENTINE EG 400MG GELULE 90\n",
      "  3400937813570 | GABAPENTINE EG 100MG GELULE 90\n",
      "  3400937827300 | LANSOPRAZOLE ZYD 15MG GELULE 30\n",
      "  3400937827829 | LANSOPRAZOLE ZYD 30MG GELULE 28\n",
      "  3400937874663 | LISINOPRIL HCTZ ZEN 20/12,5MG CPR 30\n",
      "  3400937874892 | LISINOPRIL HCTZ ZEN 20/12,5MG CPR 90\n",
      "  3400937946384 | METFORMINE VTS 1000MG CPR DISP 90\n",
      "  3400937955959 | NIQUITIN 21MG/24H DISP TRANSDER S 28\n",
      "  3400937982863 | OXCARBAZEPINE VIATRIS 300MG CPR 50\n",
      "  3400938093346 | CIPROFLOXACINE CRP 250MG CPR 12\n",
      "  3400938095418 | CIPROFLOXACINE CRP 500MG CPR 12\n",
      "  3400938212754 | TRAMADOL VTS LP 100MG CPR 10\n",
      "  3400938222630 | TRAMADOL VIATRIS LP 150MG CPR 10\n",
      "  3400938222920 | TRAMADOL VIATRIS LP 150MG CPR 30\n",
      "  3400938225303 | TRAMADOL VIATRIS LP 200MG CPR 10\n",
      "  3400938225532 | TRAMADOL VIATRIS LP 200MG CPR 30\n",
      "  3400938226881 | TRAMADOL ZTV LP 50MG CPR 10\n",
      "  3400938228144 | TRAMADOL ZTV LP 100MG CPR 10\n",
      "  3400938229554 | TRAMADOL ZTV LP 150MG CPR 10\n",
      "  3400938230734 | TRAMADOL ZTV LP 200MG CPR 10\n",
      "  3400938285215 | VERSATIS 700MG EMPLATRE 5\n",
      "  3400938417340 | VALACICLOVIR SDZ 500MG CPR 42\n",
      "  3400938448795 | VENLAFAXINE VTS LP 150MG CPR 30\n",
      "  3400938471977 | TRANDOLAPRIL VIATRIS 0,5MG GELULE 28\n",
      "  3400938472868 | TRANDOLAPRIL VIATRIS 2MG GELULE 28\n",
      "  3400938473230 | TRANDOLAPRIL VIATRIS 2MG GELULE 84\n",
      "  3400938473759 | TRANDOLAPRIL VIATRIS 4MG GELULE 28\n",
      "  3400938474121 | TRANDOLAPRIL VIATRIS 4MG GELULE 84\n",
      "  3400938524598 | KETOPROFENE CRISTERS 50MG GELULE 24\n",
      "  3400938558609 | PREDNISONE CRT 1MG CPR 30\n",
      "  3400938598179 | INDAPAMIDE RCRT LP 1,5MG CPR 30\n",
      "  3400938598520 | INDAPAMIDE RCRT LP 1,5MG CPR 90\n",
      "  3400938649598 | TEVAGRASTIM 30 MUI/0,5 ML SRG INJ 5\n",
      "  3400938649710 | TEVAGRASTIM 48 MUI/0,8 ML SER INJ 5\n",
      "  3400939002767 | ALVESCO 80 MICROGRAMMES/DOSE (CICLESONIDE) SOLUTIO\n",
      "  3400939003078 | ALVESCO 160 MICROGRAMMES/DOSE (CICLESONIDE) SOLUTI\n",
      "  3400939060439 | FLUCORTAC 50MICROGRAMMES CPR 30\n",
      "  3400939109329 | PREDNISOLONE EVO 20MG CPR ORODISP 20\n",
      "  3400939145228 | PANTOPRAZOLE ZYD 20MG CPR 28\n",
      "  3400939145518 | ALENDRONIQUE ACIDE ZEN 70MG CPR 4\n",
      "  3400939145747 | ALENDRONIQUE ACIDE ZEN 70MG CPR 12\n",
      "  3400939146577 | PANTOPRAZOLE ZYD 40MG CPR 28\n",
      "  3400939251127 | METFORMINE BLF 500MG CPR 30\n",
      "  3400939252018 | METFORMINE BLF 500MG CPR 90\n",
      "  3400939252995 | METFORMINE BLF 850MG CPR 30\n",
      "  3400939253947 | METFORMINE BLF 850MG CPR 90\n",
      "  3400939254487 | METFORMINE RBX 1000MG CPR 30\n",
      "  3400939255149 | METFORMINE RBX 1000MG CPR 90\n",
      "  3400939323947 | VALACICLOVIR EG LABO 500MG CPR 10\n",
      "  3400939324197 | VALACICLOVIR EG LABO 500MG CPR 42\n",
      "  3400939324487 | VALACICLOVIR EG LABO 500MG CPR 112\n",
      "  3400939416199 | CEFPODOXIME SDZ 100MG CPR 10\n",
      "  3400939454221 | OLANZAPINE VTS 5MG CPR 28\n",
      "  3400939454399 | OLANZAPINE VTS 5MG CPR 28\n",
      "  3400939454689 | OLANZAPINE VTS 7,5MG CPR 28\n",
      "  3400939454979 | OLANZAPINE VTS 10MG CPR PEL 28\n",
      "  3400939455051 | OLANZAPINE VTS 10MG CPR PEL 28\n",
      "  3400939476681 | TRAMADOL ARW LP 200MG CPR 10\n",
      "  3400939478692 | TRAMADOL ACT LP 100MG CPR 10\n",
      "  3400939501048 | ONYTEC 8% VERNIS 1\n",
      "  3400939629698 | TRIMEBUTINE ACT 200MG CPR 30\n",
      "  3400939665887 | ANASTROZOLE CRT 1MG CPR 90\n",
      "  3400939792200 | CLOPIDOGREL SDZ 75MG CPR 30\n",
      "  3400939816074 | OMEPRAZOLE EVO 20MG GELULE 28\n",
      "  3400939826011 | TRAMADOL ACT LP 150MG CPR 10\n",
      "  3400939889115 | FOSFOMYCINE CRST 3G GRANULES SACHET 1\n",
      "  3400939917351 | VALSARTAN/HCTZ ZYD 80/12,5MG CPR 30\n",
      "  3400939917702 | VALSARTAN/HCTZ ZYD 80/12,5MG CPR 90\n",
      "  3400939918532 | VALSARTAN/HCTZ ZYD 160/25MG CPR 30\n",
      "  3400939919072 | VALSARTAN/HCTZ ZYD 160/25MG CPR 90\n",
      "  3400939932149 | CEFPODOXIME VTS 100MG CPR 10\n",
      "  3400939981635 | RATIOGRASTIM 30MUI/0,5ML INJ DSP SEC 1\n",
      "  3400939981864 | RATIOGRASTIM 30MUI/0,5ML INJ DSP SEC 5\n",
      "  3400939981925 | RATIOGRASTIM 48MUI/0,8ML INJ DSP SEC 1\n",
      "  3400939982007 | RATIOGRASTIM 48MUI/0,8ML INJ DSP SEC 5\n",
      "  3400941558634 | VALSARTAN/HCTZ ZYD 160/12,5MG CPR 30\n",
      "  3400941559174 | VALSARTAN/HCTZ ZYD 160/12,5MG CPR 90\n",
      "  3400941822391 | NARATRIPTAN VIATRIS 2,5MG CPR 6\n",
      "  3400941822452 | NARATRIPTAN VIATRIS 2,5MG CPR 12\n",
      "  3400941861604 | PERINDOPRIL INDA MYL 2,5/0,625MG CPR 30\n",
      "  3400941861833 | PERINDOPRIL INDA MYL 2,5/0,625MG CPR 90\n",
      "  3400941862373 | PERINDOPRIL INDA MYL 5MG/1.25MG CPR 30\n",
      "  3400941862663 | PERINDOPRIL INDA MYL 5MG/1.25MG CPR 90\n",
      "  3400949000067 | COVERAM 10MG/5MG CPR (AIP)(MWI)(PL) 30\n",
      "  3400949000074 | COVERAM 10MG/5MG CPR (AIP)(MWI)(PL) 90\n",
      "  3400949000159 | COVERAM 5MG/10MG CPR (AIP)(MWI) (PL) 90\n",
      "  3400949001224 | XEROQUEL LP 50MG CPR (AIP) (BBA) 30\n",
      "  3400949002535 | XEROQUEL LP 50MG CPR (AIP) (BBFA) 10\n",
      "  3400949004157 | PERMIXON 160MG GELULE (AIP DFM) 180\n",
      "  3400949004249 | SERETIDE DISKUS 100/50MICROG PDR AIP 60\n",
      "  3400949004263 | GABAPENTINE MYL 300MG GELULE AIP BBF 90\n",
      "  3400949004393 | LIPOROSA 10MG/10MG GELULE AIP (DFD) 30\n",
      "  3400949004409 | LIPOROSA 10MG/10MG GELULE AIP (DFD) 90\n",
      "  3400949004959 | LIPTRUZET 10 MG/20MG CPR (AIP)(DIF) 30\n",
      "  3400949004966 | LIPTRUZET 10 MG/20MG CPR (AIP)(DIF) 90\n",
      "  3400949005000 | LIPTRUZET 10 MG/40MG CPR (AIP)(DIF) 30\n",
      "  3400949005086 | DEPAKINE CHRONO 500 MG, COMPRIME PEL 1\n",
      "  3400949005093 | DECAPEPTYL 0,1 MG, POUDRE ET SOLVANT 7\n",
      "  3400949005130 | VENTOLINE 100MCG SUSP INH AIP DIFARM 1\n",
      "  3400949005178 | TWICOR 10MG/10MG CPR AIP (DFD)) 30\n",
      "  3400949005185 | TWICOR 10MG/10MG CPR AIP (DFD)) 90\n",
      "  3400949005215 | SERETIDE 125/25 MCG SUSP INHAL AIP 120\n",
      "  3400949005239 | DECAPEPTYL LP 22,5 MG, POUDRE ET SOL 1\n",
      "  3400949005246 | DECAPEPTYL LP 11,25MG INJ (AIP PHL) 1\n",
      "  3400949005260 | LIPTRUZET 10 MG/20MG CPR (AIP)(PHL) 30\n",
      "  3400949005277 | LIPTRUZET 10 MG/20MG CPR (AIP)(PHL) 90\n",
      "  3400949005352 | TWICOR 10MG/10MG CPR AIP (BBF)) 30\n",
      "  3400949005369 | TWICOR 10MG/10MG CPR AIP (BBF)) 90\n",
      "  3400949005376 | VENTOLINE 100 MCG SUSP INH AIP (DFD) 1\n",
      "  3400949005383 | LIPOROSA 10MG/10MG GELULE AIP DFD 30\n",
      "  3400949005406 | LIPOROSA 10MG/10MG GELULE AIP DFD 90\n",
      "  3400949005413 | LIPOROSA 20 MG/10 MG GELULE AIP DFD 30\n",
      "  3400949005420 | LIPOROSA 20 MG/10 MG GELULE AIP DFD 90\n",
      "  3400949005444 | TWICOR 20MG/10MG CPR AIP BBF 30\n",
      "  3400949005468 | TWICOR 20MG/10MG CPR AIP BBF 90\n",
      "  3400949005475 | DEPAKINE CHRONO 500 MG CPR AIP DFD 30\n",
      "  3400949005482 | TRIFLUCAN 40 MG/ML PDR ORALE AIP PHL 1\n",
      "  3400949005499 | ARIMIDEX 1MG CPR (AIP) (DFR) 30\n",
      "  3400949005505 | ARIMIDEX 1MG CPR (AIP) (DFR) 90\n",
      "  3400949005543 | LIPOROSA 20 MG/10 MG GELULE AIP BBF 30\n",
      "  3400949005550 | LIPOROSA 20 MG/10 MG GELULE AIP BBF 90\n",
      "  3400949005598 | SUVREZA 10MG/10MG CPR AIP DFD 30\n",
      "  3400949005604 | SUVREZA 10MG/10MG CPR AIP DFD 90\n",
      "  3400949005611 | SUVREZA 20MG/10MG CPR AIP DFD 30\n",
      "  3400949005628 | SUVREZA 20MG/10MG CPR AIP DFD 90\n",
      "  3400949009824 | MONURIL 3G GRANULES SACHET (AIP) 1\n",
      "  3400949028115 | SINGULAIR 5MG CPR (AIP) BBA) 28\n",
      "  3400949289110 | VALSARTAN BGA 80 MG CPR 90\n",
      "  3400949344550 | PANTOPRAZOLE SUN 40 MG PDR INJ 1\n",
      "  3400949500444 | ZARZIO 30 MUI SOL INJ SER ABACUS M 5\n",
      "  3400949500499 | MEKINIST 2 MG CPR ADP ABACUS 30\n",
      "  3400949500505 | AZILECT 1MG CPR BBPHARMA 30\n",
      "  3400949500529 | FOSAVANCE 70MG/2800UI CPR (ADP) PLAB 4\n",
      "  3400949500574 | ZARZIO 30 MUI SOL INJ SER BBFARMA 5\n",
      "  3400949500581 | ZARZIO 30 MUI SOL INJ SER BBFARMA 1\n",
      "  3400949500765 | ADVAGRAF LP 3MG GELULE BBFARMA 30\n",
      "  3400949500826 | PELMEG 6 MG SER SOL INJ (ADP)(MDW) 1\n",
      "  3400949500833 | EMEND 80 MG ET 125 MG GELULES 2 3\n",
      "  3400949500857 | LYRICA 100 MG GELULE ADP BB FARMA 84\n",
      "  3400949500918 | ADVAGRAF LP 1MG GELULE BBFARMA 30\n",
      "  3400949500932 | IMATINIB TVC 400MG CPR BBFARMA 30\n",
      "  3400949500994 | ENTECAVIR VTS 0,5 MG CPR ADP BBFARMA 30\n",
      "  3400949501007 | ENVARSUS LP 1MG CPR ADP BBFARMA 30\n",
      "  3400949501021 | PELGRAZ 6 MG SOL INJ SER (ADP)(BBF) 1\n",
      "  3400949501045 | ADVAGRAF LP 5MG GELULE ADP BBF 30\n",
      "  3400949501052 | PREZISTA 800MG CPR BBFARMA 30\n",
      "  3400949501076 | ADVAGRAF LP 0,5 MG GELULE DIFARMED 30\n",
      "  3400949501083 | ADVAGRAF LP 1MG GELULE DIFARMED 30\n",
      "  3400949501090 | ADVAGRAF LP 3MG GELULE DIFARMED 30\n",
      "  3400949501106 | ADVAGRAF LP 5MG GELULE ADP DIFARMED 30\n",
      "  3400949501113 | CELLCEPT 1 G/5 ML PDR ORALE AIP BB F 1\n",
      "  3400949501137 | ZARZIO 30 MUI SOL INJ SER PHARMALAB 1\n",
      "  3400949501144 | ZARZIO 30 MUI SOL INJ SER PHARMALAB 5\n",
      "  3400949501151 | NIVESTIM 30 MUI SOL INJ (ADP PHL) 1\n",
      "  3400949501168 | NIVESTIM 48 MUI SOL INJ (ADP PHL) 1\n",
      "  3400949501175 | BARACLUDE 0,5 MG CPR ADP BBF 30\n",
      "  3400949501182 | ZARZIO 48 MUI SOL INJ SER ADP PHARMA 1\n",
      "  3400949501199 | ZARZIO 48 MUI SOL INJ SER ADP PHARMA 5\n",
      "  3400949501205 | CELLCEPT 1 G/5 ML PDR ORALE AIP ABAC 1\n",
      "  3400949501212 | PELMEG 6 MG SER SOL INJ (ADP)(ABACUS 1\n",
      "  3400949501229 | ZARZIO 48 MUI SOL INJ SER ADP ABACUS 1\n",
      "  3400949501236 | ZARZIO 48 MUI SOL INJ SER ADP ABACUS 5\n",
      "  3400949501243 | BINOCRIT 40 000UI SER INJ DAP ABACUS 1\n",
      "  3400949501267 | ZIEXTENZO 6 MG SER SOL INJ ADP BBF 1\n",
      "  3400949501274 | ZARZIO 30 MUI SOL INJ SER ABACUS M 1\n",
      "  3400949501328 | BINOCRIT 30 000UI SER INJ ADP 1\n",
      "  3400949501335 | PELMEG 6 MG SER SOL INJ ADPPHARMALAB 1\n",
      "  3400949501465 | NIVESTIM 30 MUI SOL INJ (ADP ABACUS) 1\n",
      "  3400949501519 | NIVESTIM 30 MUI SOL INJ (ADP ABACUS) 5\n",
      "  3400949501533 | ZARZIO 48 MUI SOL INJ SER ADP DIF 1\n",
      "  3400949504190 | ZYPREXA VELOTAB 5MG CPR (ADP) 28\n",
      "  3400949510405 | KEPPRA 500MG CPR (ADP) (ITP) 60\n",
      "  3400949656806 | FUSIDATE NA SPIRIG 2% POMMADE 1\n",
      "  3400949766727 | OMEPRAZOLE EGG 20MG GELULE 30\n",
      "  3400949931279 | TETMODIS 25MG CPR 112\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : TOP_GEN\n",
      "================================================================================\n",
      "\n",
      "  à partir de 2022 |  | de 2014 à 2021 | \n",
      "  TOP_GEN | Libellé Top Générique | TOP_GEN | Libellé Top Générique\n",
      "  0 | pas dans une famille de générique | 0 | Sans Objet\n",
      "  1 | Générique | 9 | Inconnu\n",
      "  4 | Princep de la famille des génériques | G | Générique\n",
      "  9 |  inconnu | R | Référent\n",
      "   |  | S | Quasi-Générique\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : GEN_NUM\n",
      "================================================================================\n",
      "\n",
      "  GEN_NUM | Libellé Numéro Groupe Générique\n",
      "  1 | ACEBUTOLOL EQ 200MG CPR PELLIC\n",
      "  3 | ACICLOVIR 200MG CPR\n",
      "  5 | ACIDE TIAPROFENIQUE 100MG CPR SECAB\n",
      "  6 | ACIDE TRANEXAMIQUE 1G SOL BUV\n",
      "  7 | ACIDE TRANEXAMIQUE 500MG CPR PELLIC\n",
      "  8 | ALLOPURINOL 100MG CPR\n",
      "  9 | ALLOPURINOL 200MG CPR\n",
      "  10 | ALLOPURINOL 300MG CPR\n",
      "  11 | ALPRAZOLAM 0,25MG CPR SECAB\n",
      "  12 | ALPRAZOLAM 0,50MG CPR SECAB\n",
      "  16 | AMOXICILLINE 250MG/5ML PDR PR SIR - CLAMOXYL\n",
      "  17 | AMOXICILLINE 500MG/5ML PDR PR SIR - CLAMOXYL\n",
      "  18 | AMOXICILLINE 1G PDR PR SUSP BUV, SACH - CLAMOXYL\n",
      "  20 | AMOXICILLINE 1G CPR DISP - CLAMOXYL\n",
      "  22 | AMOXICILLINE 250MG/5ML PDR PR SIR - HICONCIL\n",
      "  23 | AMOXICILLINE 500MG/5ML PDR PR SIR - HICONCIL\n",
      "  26 | AMOXICILLINE SODIQUE EQ 1G PDR+SOL PR PREP INJ IM\n",
      "  31 | BETAHISTINE 8MG CPR\n",
      "  32 | BROMAZEPAM 6MG CPR 4-SECAB\n",
      "  33 | BROMOCRIPTINE MESILATE EQ 2,5MG CPR SEC INHI LACT\n",
      "  34 | BROMOCRIPTINE MESILATE EQ 2,5MG CPR SECAB\n",
      "  35 | BROMOCRIPTINE MESILATE EQ 5MG GELU\n",
      "  36 | BROMOCRIPTINE MESILATE EQ 10MG GELU\n",
      "  37 | BUSPIRONE 10MG CPR SECAB\n",
      "  39 | CALCITONINE SALMINE SYNTHETIQUE 80UI/0,8ML SOL INJ\n",
      "  44 | CEFADROXIL 500MG/5ML PDR PR SUSP BUV\n",
      "  45 | CEFADROXIL 500MG GELU\n",
      "  46 | CEFALEXINE 250MG GRANULô SACH - CEPOREXINE\n",
      "  51 | CEFALEXINE 1G CPR PELLIC\n",
      "  53 | CEFRADINE 500MG GELU\n",
      "  54 | CIMETIDINE 200MG CPR PELLIC\n",
      "  55 | CIMETIDINE 200MG CPR EFFV\n",
      "  56 | CIMETIDINE 400MG CPR PELLIC\n",
      "  57 | CIMETIDINE 800MG CPR PELLIC SECAB\n",
      "  59 | CLOMIPRAMINE 10MG CPR ENROB\n",
      "  60 | CLOMIPRAMINE 25MG CPR ENROB\n",
      "  63 | CYCLANDELATE 400MG GELU\n",
      "  65 | DIAZEPAM 2MG CPR SECAB\n",
      "  66 | DIAZEPAM 5MG CPR SECAB\n",
      "  67 | DIAZEPAM 10MG CPR SECAB\n",
      "  71 | DICLOFENAC SODIQUE 25MG SUPPO\n",
      "  72 | DICLOFENAC SODIQUE 100MG SUPPO\n",
      "  74 | DIHYDROERGOTAMINE MESILATE 2MG/ML SOL BUV GTT\n",
      "  78 | DILTIAZEM 60MG CPR - TILDIEM\n",
      "  81 | DILTIAZEM 300MG GELU LP - DILRENE\n",
      "  82 | DIOSMINE 300MG CPR PELLIC\n",
      "  83 | DIOSMINE 600MG CPR PELLIC\n",
      "  85 | DISOPYRAMIDE 100MG GELU\n",
      "  86 | DOXYCYCLINE 100MG CPR SECAB\n",
      "  87 | DOXYCYCLINE EQ 100MG GELU\n",
      "  88 | ECONAZOLE 1% CREME\n",
      "  90 | ECONAZOLE 1% PDR PR APPLIC LOC FL PDREUR\n",
      "  91 | ECONAZOLE 1% SOL PR APPLIC LOC FL PULV\n",
      "  92 | ERYTHROMYCINE ETHYLSUCCINATE EQ 250MG GRAN SACH\n",
      "  93 | ERYTHROMYCINE ETHYLSUCCINATE EQ 500MG GRAN SACH\n",
      "  95 | ERYTHROMYCINE PROPIONATE EQ 500MG CPR\n",
      "  96 | FENOFIBRATE 100MG GELU - FENOX\n",
      "  97 | FENOFIBRATE 300MG GELU - FENOX\n",
      "  102 | FUROSEMIDE 20MG/2ML SOL INJ AMP\n",
      "  105 | INDAPAMIDE 2,5MG CPR PELLIC\n",
      "  107 | INDOMETACINE 50MG SUPPO\n",
      "  108 | INDOMETACINE 100MG SUPPO\n",
      "  111 | ISOSORBIDE DINITRATE 20MG CPR LP - RISORDAN\n",
      "  112 | ISOSORBIDE DINITRATE 40MG CPR LP - RISORDAN\n",
      "  114 | ISOSORBIDE DINITRATE 20MG CPR LP - LANGORAN\n",
      "  116 | ISOSORBIDE DINITRATE 80MG CPR LP - LANGORAN\n",
      "  118 | KETOPROFENE 100MG CPR PELLIC\n",
      "  119 | KETOPROFENE 200MG CPR LP\n",
      "  120 | KETOPROFENE 200MG GELU LP\n",
      "  124 | LACTULOSE 66,5% SOL BUV FL\n",
      "  125 | LACTULOSE 10G SOL BUV SACH\n",
      "  127 | MEBEVERINE 100MG CPR ENROB\n",
      "  128 | MEBEVERINE 200MG GELU\n",
      "  129 | METFORMINE 500MG CPR PELLIC\n",
      "  130 | METFORMINE 850MG CPR PELLIC\n",
      "  133 | METOPROLOL 100MG CP\n",
      "  135 | MIANSERINE 30MG CPR PELLIC\n",
      "  136 | MIANSERINE 60MG CPR PELLIC SECAB\n",
      "  138 | MINOCYCLINE EQ 100MG GELU - MYNOCINE\n",
      "  140 | NAFTIDROFURYL OXALATE ACIDE 100MG GELU\n",
      "  142 | NIFEDIPINE 10MG CAPS MOL\n",
      "  143 | NIFEDIPINE 20MG CPR LP\n",
      "  146 | NIFUROXAZIDE 200MG GELU\n",
      "  147 | OXYBUTYNINE 5MG CPR SECAB\n",
      "  149 | PHLOROGLUCINOL 80MG LYOPH ORAL\n",
      "  150 | PIRACETAM 20G/100ML SOL BUV\n",
      "  151 | PIROXICAM 10MG GELU\n",
      "  152 | PIROXICAM 20MG GELU\n",
      "  153 | PIROXICAM 20MG SUPPO\n",
      "  154 | PIROXICAM 20MG SOL INJ IM\n",
      "  155 | PROPRANOLOL 40MG CPR SECAB\n",
      "  156 | PYRANTEL EMBONATE EQ 125MG CPR\n",
      "  157 | PYRANTEL EMBONATE EQ 125MG/2,5ML SUSP BUV\n",
      "  158 | SELEGILINE 5MG CPR SECAB\n",
      "  160 | SPIRONOLACTONE 75MG CPR PELLIC SECAB\n",
      "  161 | SPIRONOLACTONE 25MG + ALTIZIDE 15MG CPR PELLIC SEC\n",
      "  162 | SUCRALFATE 1G SUSP BUV SACH\n",
      "  163 | SUCRALFATE 1G CPR\n",
      "  165 | SULFAMETHOXAZOLE 800MG +TRIMETHOPRIME 160MG CPR\n",
      "  168 | SULPIRIDE 0,5MG/100ML SOL BUV\n",
      "  170 | TAMOXIFENE CITRATE EQ 10MG CPR PELLIC\n",
      "  171 | TAMOXIFENE CITRATE EQ 20MG CPR ENROB\n",
      "  173 | TETRAZEPAM 50MG CPR ENROB SECAB\n",
      "  174 | THIOCOLCHICOSIDE 4MG CPR\n",
      "  176 | TIAPRIDE EQ 100MG CPR SECAB\n",
      "  178 | TIMOLOL  EQ 0,5% COLLY\n",
      "  179 | TRAMADOL 50 MG GELU\n",
      "  180 | TRIMEBUTINE  100MG CPR PELLIC\n",
      "  181 | TRIMETAZIDINE 20MG/ML SOL BUV FL\n",
      "  182 | VALPROATE DE SODIUM 200MG/ML SOL BUV\n",
      "  183 | VALPROATE DE SODIUM 200MG CPR GASTRORES\n",
      "  184 | VALPROATE DE SODIUM 500MG CPR GASTRORES\n",
      "  186 | VERAPAMIL 240MG CPR PELLIC SECAB LP\n",
      "  187 | ZOPICLONE 7,5MG CPR SECAB\n",
      "  188 | ACICLOVIR 3% POM OPHT\n",
      "  189 | BUFLOMEDIL 150MG CPR PELLIC\n",
      "  190 | BUFLOMEDIL 300MG CPR PELLIC\n",
      "  191 | CAPTOPRIL 25MG CPR SECAB\n",
      "  192 | CAPTOPRIL 50MG CPR SECAB\n",
      "  193 | CEFADROXIL 1G CPR DISP\n",
      "  194 | FENOFIBRATE 67MG GELU - LIPANTHYL\n",
      "  196 | GLICLAZIDE 80MG CPR SECAB\n",
      "  197 | NICERGOLINE 5MG GELU\n",
      "  198 | NICERGOLINE 10MG GELU\n",
      "  200 | PIRACETAM 800MG CPR PELLIC\n",
      "  201 | PIROXICAM 20MG CP DISPERSIBLE SECAB\n",
      "  202 | RANITIDINE EQ 150MG CP PELLIC\n",
      "  203 | RANITIDINE EQ 300MG CP PELLIC\n",
      "  204 | AMBROXOL 0,6% SOL BUV\n",
      "  205 | CARBAMAZEPINE 200MG CPR PELLIC SECAB LP\n",
      "  206 | CARBAMAZEPINE 400MG CPR PELLIC SECAB LP\n",
      "  209 | CIMETIDINE 200MG/2ML SOL INJ IM IV\n",
      "  210 | CLOMIPRAMINE 75MG CPR PELLIC SECAB\n",
      "  211 | GLIPIZIDE 5MG CPR SECAB\n",
      "  212 | KETOTIFENE FUMARATE EQ 1MG GELU\n",
      "  213 | LORAZEPAM 1MG CPR SECAB\n",
      "  214 | LORAZEPAM 2,5MG CPR SECAB\n",
      "  215 | METOCLOPRAMIDE 10MG CPR SECAB\n",
      "  216 | MOLSIDOMINE 2MG CPR SECAB\n",
      "  217 | MOLSIDOMINE 4MG CPR\n",
      "  219 | NITRENDIPINE 20MG CPR\n",
      "  221 | SPIRAMYCINE 3MUI CPR PELLIC\n",
      "  225 | AMILORIDE 5MG + HCTZ 50 MG CPR SEC\n",
      "  227 | TROXERUTINE 3500MG PDR PR SOL BUV SACH\n",
      "  228 | CARBOCISTEINE 2% S/SUCRE ENF NOUR SIR\n",
      "  229 | CARBOCISTEINE 5% AD EXPECTORANT S/SUCRE SIR\n",
      "  230 | CEFACLOR 125MG /5ML PDR PR SUSP BUV\n",
      "  232 | DIPIVEFRINE 0,1G/100ML COLLY\n",
      "  233 | SOTALOL 80MG CPR SECAB\n",
      "  234 | SOTALOL 160MG CPR SECAB\n",
      "  236 | TROXERUTINE 3500MG/7ML SOL BUV AMP\n",
      "  237 | CEFTRIAXONE SODIQUE EQ 500MG PDR+SOLV P SOL INJ IM\n",
      "  238 | CEFTRIAXONE SODIQUE EQ 1G PDR+SOLV PR SOL INJ IM\n",
      "  239 | CEFTRIAXONE SODIQUE EQ 500MG PDR+SOLV P SOL INJ IV\n",
      "  241 | ENALAPRIL 5MG CPR SECAB\n",
      "  242 | ENALAPRIL 20MG CPR SECAB\n",
      "  243 | AZATHIOPRINE 50MG CPR SECAB\n",
      "  245 | FLUOXETINE EQ 20MG GELU\n",
      "  248 | PROGESTERONE 200MG CAPS MOL ORALE, VAG\n",
      "  249 | AMOXICILLINE+CLAVULANATE K NOUR PDR BUV FL\n",
      "  250 | AMOXICILLINE+CLAVULANATE K ENF PDR BUV FL\n",
      "  251 | AMOXICILLINE+CLAVULANATE K EQ 500/62,5 AD CPR PELL\n",
      "  252 | AMOXICILLINE+CLAVULANATE K EQ 1/125 AD PDR BUV SA\n",
      "  254 | CELIPROLOL 200MG CPR PELLIC\n",
      "  256 | PREDNISOLONE METASULFOBENZO SODIQ EQ 20MG CPR EFFV\n",
      "  257 | CLOZAPINE 25MG CPR SECAB\n",
      "  258 | CLOZAPINE 100MG CPR SECAB\n",
      "  259 | ISOTRETINOINE 5MG CAPS MOL\n",
      "  260 | ISOTRETINOINE 10MG CAPS MOL\n",
      "  261 | ISOTRETINOINE 20MG CAPS MOL\n",
      "  262 | TICLOPIDINE 250MG CPR PELLIC\n",
      "  263 | ACIDE FOLIQUE 5MG CPR\n",
      "  264 | FLUOXETINE EQ 20MG/5ML SOL BUV FL\n",
      "  265 | DIOSMINE 600MG PDR PR SUSP BUV SACH\n",
      "  266 | LEVO 0,05 0,075 0,125+ETHIN 0,03 0,04 0,03 CPR ENR\n",
      "  268 | FLUVOXAMINE  50MG CPR PELLIC\n",
      "  269 | FLUVOXAMINE  100MG CPR PELLIC\n",
      "  271 | POVIDONE IODEE 10% SOL PR APPLIC LOC\n",
      "  272 | RILMENIDINE DIHYDROGENOEQEQ 1MG CPR\n",
      "  273 | ETIDRONATE DE SODIUM 200MG CPR\n",
      "  275 | BISOPROLOL 10MG CPR P.SEC - DETENSIEL\n",
      "  276 | FLECAINIDE ACETATE 100MG CPR SECAB\n",
      "  277 | ROXITHROMYCINE 150MG CPR PELLIC\n",
      "  278 | DOMPERIDONE 10MG CPR PELLIC\n",
      "  279 | OFLOXACINE 200MG CPR PELLIC SECAB\n",
      "  281 | CIPROFIBRATE 100MG GELU\n",
      "  282 | CARBAMAZEPINE 200MG CPR SECAB\n",
      "  283 | NAPROXENE SODIQUE 275MG CPR PELLIC\n",
      "  285 | NAPROXENE 250MG CPR\n",
      "  286 | NAPROXENE 500MG CPR\n",
      "  293 | RANITIDINE EQ 150MG CP EFFV\n",
      "  294 | RANITIDINE EQ 300MG CP EFFV\n",
      "  296 | IBUPROFENE 20MG/ML SUSP BUV - NUREFLEX\n",
      "  297 | CYPROTERONE ACETATE 50MG CPR\n",
      "  298 | CIMETIDINE 800MG CPR EFFV\n",
      "  299 | AMISULPRIDE 200MG CPR\n",
      "  300 | BUDESONIDE 0,50MG/2ML SUSP INHAL UNIDOS\n",
      "  301 | BUDESONIDE 1MG/2ML SUSP INHAL UNIDOS\n",
      "  303 | CHLORMADINONE ACETATE 5MG CPR\n",
      "  304 | CITALOPRAM EQ 20MG CPR PELLIC SECAB\n",
      "  305 | ETIDRONATE DE SODIUM 400MG CPR\n",
      "  306 | FAMOTIDINE 20MG CPR PELLIC\n",
      "  307 | FAMOTIDINE 40MG CPR PELLIC\n",
      "  308 | FLUOXETINE EQ 20MG CPR DISP SECAB\n",
      "  309 | OMEPRAZOLE 20MG GELU GASTRO-RES\n",
      "  313 | CEFACLOR 250MG GELU\n",
      "  314 | CIPROFLOXACINE EQ 250MG CPR PELLIC\n",
      "  316 | DOMPERIDONE 1MG SUSP BUV\n",
      "  317 | METFORMINE 1000MG CPR PELLIC\n",
      "  318 | MOCLOBEMIDE 150MG CPR PELLIC SECAB\n",
      "  319 | RANITIDINE EQ 75MG CP EFFV\n",
      "  320 | SPIRAMYCINE 0,75MUI + METRONIDAZOLE 125MG CPR PELL\n",
      "  321 | NOMEGESTROL ACETATE 5MG CPR SECAB\n",
      "  322 | ALFUZOSINE 2,5MG CPR PELLIC\n",
      "  323 | DESOGESTREL 150Y+ETHINYLESTRADIOL 30Y-VARNOLINE CP\n",
      "  324 | DESOGESTREL 150Y+ETHINYLESTRADIOL 20Y-MERCILON CPR\n",
      "  325 | LISINOPRIL EQ 5MG CPR SECAB\n",
      "  326 | LISINOPRIL EQ 20MG CPR SECAB\n",
      "  328 | SALBUTAMOL EQ 2,5MG SOL INHAL UNIDOS\n",
      "  330 | SIMVASTATINE 20MG CPR ENROB SECAB\n",
      "  331 | SIMVASTATINE 40MG CPR PELLIC\n",
      "  332 | CIPROFLOXACINE EQ 750MG CPR PELLIC\n",
      "  333 | FOSFOMYCINE TROMETAMOL EQ 3G GLE PR SOL BUV SACH\n",
      "  334 | LORATADINE 10MG CPR\n",
      "  336 | CETIRIZINE 10MG CPR PELLIC SECAB\n",
      "  338 | CHLORMADINONE ACETATE 10MG CPR\n",
      "  340 | FLUCONAZOLE 150MG GELU - BEAGYNE\n",
      "  342 | FLUCONAZOLE 100MG GELU - TRIFLUCAN\n",
      "  343 | FLUCONAZOLE 200MG GELU - TRIFLUCAN\n",
      "  344 | IPRATROPIUM BROMURE 0,5MG/2ML SOL INHAL UNIDOS\n",
      "  345 | PREDNISOLONE METASULFOBENZO SODIQ EQ 5MG CPR EFFV\n",
      "  346 | PREDNISONE 5MG CPR\n",
      "  347 | PREDNISONE 20MG CPR SECAB\n",
      "  348 | CEFUROXIME AXETIL EQ 125MG CPR PELLIC\n",
      "  349 | CEFUROXIME AXETIL EQ 250MG CPR PELLIC\n",
      "  350 | CEFUROXIME AXETIL EQ 500MG CPR PELLIC\n",
      "  351 | TERBUTALINE 5MG/2ML SOL INHAL NEB UNIDOS\n",
      "  352 | CARVEDILOL 12,5MG CPR SECAB\n",
      "  353 | RAMIPRIL 1,25MG GELU\n",
      "  354 | RAMIPRIL 2,5MG GELU\n",
      "  357 | AMISULPRIDE 400MG CPR PELLIC SECAB\n",
      "  359 | AMOXICILLINE+CLAVULANATE K EQ 1/200 AD PDR INJ IV\n",
      "  362 | CARVEDILOL 25MG CPR SECAB\n",
      "  363 | OFLOXACINE 200MG CPR PELLIC - MONOFLOCET\n",
      "  364 | LEVOCETIRIZINE 5MG CPR PELLIC\n",
      "  367 | IBUPROFENE 400MG CPR ENROB - ADVIL\n",
      "  368 | ECONAZOLE 150MG OV LIB PROL\n",
      "  370 | CEFUROXIME AXETIL EQ 125MG GLE PR SUSP BUV FL\n",
      "  371 | CEFUROXIME AXETIL EQ 250MG GLE PR SUSP BUV SACH\n",
      "  372 | GABAPENTINE 400MG GELU\n",
      "  373 | IPRATROPIUM BROMURE 0,25MG/1ML SOL INHAL UNIDOS\n",
      "  374 | NALTREXONE 50MG CPR PELLIC SECAB\n",
      "  378 | ITRACONAZOLE 100MG GELU\n",
      "  381 | CLARITHROMYCINE 250MG CPR PELLIC\n",
      "  382 | PINAVERIUM BROMURE 50MG CPR PELLIC\n",
      "  383 | PINAVERIUM BROMURE 100MG CPR PELLIC\n",
      "  385 | PREDNISONE 1MG CPR\n",
      "  386 | RISPERIDONE 1MG CPR PELLIC SECAB\n",
      "  387 | RISPERIDONE 2MG CPR PELLIC SECAB\n",
      "  389 | SPIRAMYCINE 1,5MUI + METRONIDAZOLE 250MG CPR PELL\n",
      "  391 | SIMVASTATINE 10MG CPR ENROB\n",
      "  398 | METOCLOPRAMIDE EQ 0,1% SOL BUV\n",
      "  399 | DEXTROPROP.27MG+PARACETAMOL 400MG+CAFEINE 30MG CPR\n",
      "  400 | GABAPENTINE 100MG GELU\n",
      "  402 | GABAPENTINE 600MG CPR PELLIC\n",
      "  404 | LISINOPRIL EQ 20MG + HCTZ 12,5MG CPR SEC\n",
      "  408 | RAMIPRIL 1,25MG CPR\n",
      "  409 | RAMIPRIL 2,5MG CPR SECAB\n",
      "  410 | RAMIPRIL 5MG CPR SECAB\n",
      "  411 | SODIUM ALGIN.50MG/ML+SODIUM BICAR.26,7MG/ML BUV FL\n",
      "  412 | AMISULPRIDE 50MG CPR\n",
      "  415 | PRAVASTATINE SODIQUE 10MG CPR SECAB\n",
      "  417 | PRAVASTATINE SODIQUE 40MG CPR\n",
      "  418 | RAMIPRIL 10MG CPR SECAB\n",
      "  419 | XIPAMIDE 20MG CPR SECAB\n",
      "  420 | AMOXICILLINE+CLAVULANATE K EQ 2/200 AD PDR INJ IV\n",
      "  423 | CLARITHROMYCINE 500MG CPR PELLIC\n",
      "  424 | DEFEROXAMINE 100MG/ML PDR+SOLV PR SOL INJ\n",
      "  427 | LAMOTRIGINE 2MG CPR DISP\n",
      "  429 | LAMOTRIGINE 25MG CPR DISP CROQ\n",
      "  432 | LAMOTRIGINE 200MG CPR DISP CROQ\n",
      "  435 | TERBINAFINE 250MG CPR SECAB\n",
      "  438 | VALPROATE DE SODIUM 500MG CPR PELLIC SECAB LP\n",
      "  439 | LAMOTRIGINE 50MG CPR\n",
      "  440 | LIDOCAINE 2,5% + PRILOCAINE 2,5% CREME\n",
      "  443 | CYPROTERONE ACETATE 100MG CPR SECAB\n",
      "  444 | SERTRALINE EQ 50MG GELU\n",
      "  445 | FLUOROURACILE 250MG/5ML SOL INJ FL\n",
      "  448 | CEFTAZIDIME 500MG PDR PR SOL INJ (IM-IV)\n",
      "  449 | CEFTAZIDIME 1G PDR PR SOL INJ (IM-IV)\n",
      "  450 | CEFTAZIDIME 2G PDR PR SOL INJ (IV)\n",
      "  452 | GLIBENCLAMIDE 5MG CPR SECAB\n",
      "  455 | ALFUZOSINE 10MG CPR LIB PROL\n",
      "  456 | MELOXICAM 7,5MG CPR\n",
      "  457 | MELOXICAM 15MG CPR SECAB\n",
      "  461 | ACICLOVIR 250MG PDR PR SOL INJ (IV)\n",
      "  462 | ACICLOVIR 500MG PDR PR SOL INJ (IV)\n",
      "  463 | CEFTAZIDIME 250MG PDR PR SOL INJ (IM-IV)\n",
      "  466 | GLIMEPIRIDE 1MG CPR\n",
      "  471 | HYDROXYCARBAMIDE 500MG GELU\n",
      "  472 | IOHEXOL EQ 350MG I/ML SOL INJ\n",
      "  473 | METHOTREXATE 2,5MG/ML SOL INJ\n",
      "  476 | TAMSULOSINE EQ 0,4MG GELU LP\n",
      "  477 | BISOPROLOL 1,25MG CPR P.S.- CARDENSIEL\n",
      "  478 | BISOPROLOL 2,5MG CPR P.SEC- CARDENSIEL\n",
      "  479 | BISOPROLOL 3,75MG CPR P.S.- CARDENSIEL\n",
      "  480 | BISOPROLOL 5MG CPR P.SEC - CARDENSIEL (CARDIOCOR)\n",
      "  482 | BISOPROLOL 10MG CPR P.SEC - CARDENSIEL\n",
      "  483 | EBASTINE 10MG\n",
      "  485 | QUINAPRIL EQ 5MG CPR ENROB\n",
      "  487 | SERTRALINE EQ 25MG GELU\n",
      "  490 | BUPRENORPHINE 0,4 MG CPR SUBLING.\n",
      "  491 | BUPRENORPHINE 2 MG CPR SUBLING.\n",
      "  492 | BUPRENORPHINE 8 MG CPR SUBLING.\n",
      "  496 | TRIMEBUTINE  200MG CPR PELLIC\n",
      "  499 | AMLODIPINE BESILATE 10MG GELU\n",
      "  500 | ALENDRONATE MONOSODIQUE EQ 70MG CPR\n",
      "  503 | AZATHIOPRINE 50MG CPR PELLIC\n",
      "  504 | CIPROFLOXACINE EQ 200MG SOL INJ PR PERF IV\n",
      "  505 | CIPROFLOXACINE EQ 400MG SOL INJ PR PERF IV\n",
      "  508 | FOSINOPRIL 10MG CPR SECAB\n",
      "  509 | KETOPROFENE 100MG/2ML SOL INJ IM\n",
      "  510 | MOXONIDINE 0,2MG CPR PELLIC\n",
      "  511 | MOXONIDINE 0,4MG CPR PELLIC\n",
      "  512 | NICORANDIL 10MG CPR SECAB\n",
      "  514 | PERGOLIDE MESILATE 0,05MG CPR SECAB\n",
      "  519 | GESTODENE 0,075MG+ETHINYLESTRADIOL0,03MG CPR ENROB\n",
      "  522 | ATENOLOL 50MG + NIFEDIPINE 20MG GELU\n",
      "  523 | BICALUTAMIDE 50MG CPR ENROB\n",
      "  524 | IBUPROFENE 200MG CPR ENROB - ADVIL\n",
      "  525 | METHOTREXATE 2,5MG CPR\n",
      "  526 | MIRTAZAPINE 15MG CPR ORODISP\n",
      "  531 | ONDANSETRON EQ 8MG CPR PELL\n",
      "  532 | PERINDOPRIL T-B.2MG EQ-PERINDOPRIL ARG.2,5MG EQ CP\n",
      "  533 | PERINDOPRIL T-B.4MG EQ-PERINDOPRIL ARG.5MG EQ CPR\n",
      "  534 | TOPIRAMATE 50MG CPR PELLIC\n",
      "  535 | TOPIRAMATE 100MG CPR PELLIC\n",
      "  536 | TOPIRAMATE 200MG CPR PELLIC\n",
      "  537 | IBUPROFENE 5% GEL - ADVIL\n",
      "  539 | LAMOTRIGINE 50MG CPR (PREMIER MOIS DE TRAITEMENT)\n",
      "  540 | ONDANSETRON CHLORHYD.DIHYD.EQ2MG/ML SOL INJ AMP IV\n",
      "  541 | QUINAPRIL EQ20MG + HCTZ12,5MG CPR P.SEC\n",
      "  542 | RISPERIDONE 0,5MG CPR ORODISP\n",
      "  543 | RISPERIDONE 1MG CPR ORODISP\n",
      "  544 | RISPERIDONE 2MG CPR ORODISP\n",
      "  547 | PEROXYDE DE BENZOYLE HYDRATE 2,5% GEL APPLIC LOC\n",
      "  549 | PERINDOPRIL T-B.8MG EQ-PERINDOPRIL ARG.10MG EQ CPR\n",
      "  551 | CROMOGLICATE DE SODIUM 2% COLLY UNIDOS\n",
      "  553 | AZITHROMYCINE EQ 250MG CPR PELLIC\n",
      "  554 | AZITHROMYCINE EQ MONODOSE 250MG CPR PELL\n",
      "  555 | BENAZEPRIL 5MG CPR PELLIC SECAB\n",
      "  556 | BENAZEPRIL 10MG CPR PELLIC SECAB\n",
      "  558 | CARBIDOPA 25MG + LEVODOPA 100MG CPR LIB PROL\n",
      "  559 | CARBIDOPA 50MG + LEVODOPA 200MG CPR LIB PROL\n",
      "  561 | CEFPODOXIME PROXETIL 40MG/5ML GLE PR SUSP BUV\n",
      "  562 | DILTIAZEM 90MG CPR ENROB LP-BITILDIEM\n",
      "  563 | DILTIAZEM120MG CPR ENROB LP-BITILDIEM\n",
      "  568 | FINASTERIDE 5MG CPR PELLIC\n",
      "  577 | FEXOFENADINE 120MG CPR PELLIC\n",
      "  578 | FEXOFENADINE 180MG CPR PELLIC\n",
      "  579 | FLUCONAZOLE 50MG/5ML PDR PR SUSP BUV - TRIFLUCAN\n",
      "  583 | CYTARABINE 20MG/ML SOL INJ FL2ML\n",
      "  585 | FELODIPINE 5MG CPR ENROB LIB PROL\n",
      "  586 | LOSARTAN 50MG CPR ENROB SECAB\n",
      "  587 | LOSARTAN 100MG CPR PELLIC\n",
      "  589 | OCTREOTIDE ACETATE EQ 50MCG/1ML SOL INJ\n",
      "  590 | OCTREOTIDE ACETATE EQ 100MCG/1ML SOL INJ\n",
      "  591 | OCTREOTIDE ACETATE EQ 500MCG/1ML SOL INJ AMP SC\n",
      "  592 | ONDANSETRON 8MG LYOT ORAL\n",
      "  594 | PAMIDRONATE DE SODIUM 15MG/5ML PDR+SOLV P/SOL PERF\n",
      "  598 | CEFTAZIDIME 1G PDR+SOLV PR SOL INJ (IM,IV)\n",
      "  601 | OXYTOCINE 5UI/1ML SOL INJ AMP\n",
      "  603 | CEFIXIME 200MG CPR PELLIC\n",
      "  604 | FOSINOPRIL 20MG + HCTZ 12,5MG CPR SEC\n",
      "  605 | GRANISETRON EQ 2MG CPR PELLIC\n",
      "  606 | GRANISETRON EQ 3MG/3ML SOL INJ IV\n",
      "  607 | OXCARBAZEPINE 150MG CPR PELLIC\n",
      "  608 | OXCARBAZEPINE 300MG CPR PELLIC\n",
      "  610 | RANITIDINE EQ 50MG/2ML SOL INJ AMP\n",
      "  613 | AZITHROMYCINE EQ 40MG/ML PDR PR SUSP BUV\n",
      "  614 | BETAHISTINE 24MG CPR - BETASERC\n",
      "  618 | LANSOPRAZOLE 15MG CPR ORODISP\n",
      "  622 | GRANISETRON EQ 1MG CPR PELLIC\n",
      "  623 | NEBIVOLOL EQ 5MG CPR 4-SECAB\n",
      "  624 | ONDANSETRON 4MG LYOT ORAL\n",
      "  625 | PIPERACIL. EQ 2G+TAZOBACT. EQ 250MG PDR PERF\n",
      "  631 | BISOPROLOL 2,5MG + HCTZ 6,25MG CPR PELLIC\n",
      "  638 | DICLOFENAC DIETHYLAMINE EQ 1G/100G GEL\n",
      "  639 | DOMPERIDONE 10MG LYOT ORAL\n",
      "  640 | LOSARTAN 50MG + HCTZ 12,5MG CPR PELL\n",
      "  641 | LOSARTAN 100MG + HCTZ 25MG CPR PELL\n",
      "  642 | PANTOPRAZOLE 40MG CPR GASTRORES\n",
      "  646 | VENLAFAXINE EQ 37,5MG GELU LIB PROL\n",
      "  648 | DICLOFENAC DIETHYLAMINE EQ 1G/100G GEL FL PRESS\n",
      "  649 | FLUVASTATINE SODIQUE EQ 20MG GELU\n",
      "  650 | FLUVASTATINE SODIQUE EQ 40MG GELU\n",
      "  653 | LEVODOPA 50MG + BENSERAZIDE CHL.EQ 12,5MG GELU\n",
      "  654 | LEVODOPA 100MG + BENSERAZIDE CHL.EQ 25MG GELU\n",
      "  657 | PAMIDRONATE DE SODIUM 90MG/10ML PDR+SOL P/SOL PERF\n",
      "  662 | CALCIPOTRIOL MONOHYDRATE 0,05MG/G CR\n",
      "  663 | CALCIPOTRIOL MONOHYDRATE 0,05MG/G POM\n",
      "  666 | DONEPEZIL 5MG CPR PELLIC\n",
      "  667 | DONEPEZIL 10MG CPR PELLIC\n",
      "  668 | KETOCONAZOLE 2% GEL SACH DOS\n",
      "  669 | KETOCONAZOLE 2% GEL RECIPIENT UNIDOS\n",
      "  671 | VALACICLOVIR EQ 500MG CPR ENROB\n",
      "  672 | VENLAFAXINE EQ 25MG CPR\n",
      "  679 | LEVONORGESTREL 1,5MG CPR\n",
      "  680 | LEVONORGESTREL0,1+ETHINYLESTRADIOL 0,02 CPR ENROB\n",
      "  682 | PREDNISOLONE METASULFOBENZO SODIQ EQ 5MG CPR DISP\n",
      "  684 | TRANDOLAPRIL 0,5MG GELU\n",
      "  685 | TRANDOLAPRIL 2MG GELU\n",
      "  686 | TRANDOLAPRIL 4MG GELU\n",
      "  689 | ROPINIROLE 0,25MG CPR PELLIC - REQUIP\n",
      "  690 | ROPINIROLE 0,50MG CPR PELLIC - REQUIP\n",
      "  691 | ROPINIROLE 1MG CPR PELLIC - REQUIP\n",
      "  692 | ROPINIROLE 2MG CPR PELLIC - REQUIP\n",
      "  693 | ROPINIROLE 5MG CPR PELLIC - REQUIP\n",
      "  694 | BORAX 60MG+ACIDE BORIQUE 90MG SOL LAV OPHT UNIDOS\n",
      "  699 | CILAZAPRIL MONOHYDRATE 0,5MG CPR PELLIC SECAB\n",
      "  700 | CILAZAPRIL MONOHYDRATE 1MG CPR PELLIC SECAB\n",
      "  701 | CILAZAPRIL MONOHYDRATE 2,5MG CPR PELLIC SECAB\n",
      "  702 | EPIRUBICINE 10MG PDR PR SOL PERF (FL)\n",
      "  703 | EPIRUBICINE 50MG PDR PR SOL PERF (FL)\n",
      "  704 | GLICLAZIDE 30MG CPR LIB MODIF\n",
      "  705 | INDAPAMIDE 1,5MG CPR PELLIC LIB PROL\n",
      "  708 | NIMESULIDE 100MG CPR\n",
      "  712 | TRAMADOL 150MG CPR LIB PROL\n",
      "  713 | TRAMADOL 200MG CPR LIB PROL\n",
      "  715 | BENAZEPRIL 10MG + HCTZ 12,5MG CPR PELL S\n",
      "  720 | SODIUM FUSIDATE 2% POM\n",
      "  721 | TRAMADOL 50MG CPR LIB PROL\n",
      "  722 | FENTANYL 12 MICROGRAMMES/HEURE DISP TRANS\n",
      "  723 | FENTANYL 25 MICROGRAMMES/HEURE DISP TRANS\n",
      "  724 | FENTANYL 50 MICROGRAMMES/HEURE DISP TRANS\n",
      "  725 | FENTANYL 75 MICROGRAMMES/HEURE DISP TRANS\n",
      "  726 | FENTANYL 100 MICROGRAMMES/HEURE DISP TRANS\n",
      "  727 | BETAMETHASONE 2MG CPR DISP SECAB\n",
      "  728 | CICLOPIROX 8% SOL FILM PR APPLIC LOC FL\n",
      "  729 | DIACERHEINE 50MG GELU\n",
      "  730 | FLUVASTATINE SODIQUE EQ 80MG CPR PELLIC LIB PROL\n",
      "  731 | IBUPROFENE 20MG/ML S/SUCRE SUSP BUV - NUROFENPRO\n",
      "  733 | IMIPENEM+CILASTATINE SODIQ.EQ500/500 PDR PERF+SYST\n",
      "  735 | PERIND.T-B.4MG-PERIND.ARG.5MG+INDAPAM.1,25MG CPR\n",
      "  737 | ZIDOVUDINE 100MG GELU\n",
      "  738 | ZIDOVUDINE 250MG GELU\n",
      "  740 | BETAMETHASONE 0,05% SOL BUV GTT\n",
      "  743 | MACROGOL 4000 10G PDR PR SOL BUV SACH DOS\n",
      "  744 | TERBINAFINE 1% CR\n",
      "  745 | TROLAMINE 0,67% EMUL PR APPLIC CUTA\n",
      "  747 | BETAINE CITRATE ANHYDRE 2G CPR EFFV\n",
      "  748 | CARBOMERE 940 0,2% GEL OPHT UNIDOS\n",
      "  749 | CARBOMERE 980 0,2% GEL OPHT\n",
      "  750 | CEFEPIME DICHLOR.MONOHYDRATE EQ 0,5G PDR PR US PAR\n",
      "  752 | CEFEPIME DICHLOR.MONOHYDRATE EQ 2G PDR PR US PAR\n",
      "  753 | DIMEGLUMINE 0,5MMOL/ML SOL INJ IV\n",
      "  754 | DORZOLAMIDE EQ 20MG/ML COLLY SOL\n",
      "  756 | LEVOFLOXACINE EQ 500MG CPR PELL SECAB\n",
      "  757 | RISPERIDONE 3MG CPR ORODISP\n",
      "  758 | RISPERIDONE 4MG CPR ORODISP\n",
      "  759 | LETROZOLE 2,5MG CPR PELLIC\n",
      "  760 | LEVONORGESTREL0,15+ETHIN 0,03 CPR ENROB-ADEPAL\n",
      "  761 | MAGNESIUM 470MG+PYRIDOXINE 5MG CPR ENROB\n",
      "  762 | MYCOPHENOLATE MOFETIL 250MG - GELU\n",
      "  765 | LERCANIDIPINE 20MG CPR PELLIC\n",
      "  770 | SALBUTAMOL SULF.EQ 0,5MG/1ML INJ SC AMP-VENTOLINE\n",
      "  773 | TOPIRAMATE 25MG GELU\n",
      "  779 | ROPINIROLE 0,50MG CPR PELLIC - ADARTREL\n",
      "  780 | ROPINIROLE 1MG CPR PELLIC - ADARTREL\n",
      "  781 | ROPINIROLE 2MG CPR PELLIC - ADARTREL\n",
      "  784 | CHLORHEXID.0,05ML/ML+CHLOROBUT.0,05G/ML SOL B.BCHE\n",
      "  790 | FENOFIBRATE 145MG CPR PELLIC - LIPANTHYL\n",
      "  793 | IBUPROFENE 400MG CPR PELLIC\n",
      "  794 | LEVOCARNITINE 1G/10ML SOL BUV\n",
      "  795 | LEVOCARNITINE 1G/5ML SOL INJ AMP\n",
      "  799 | OLANZAPINE 7,5MG CPR ENROB\n",
      "  800 | OLANZAPINE 10MG CPR ENROB\n",
      "  802 | OLANZAPINE 5MG CPR ORODISP\n",
      "  803 | OLANZAPINE 10MG CPR ORODISP\n",
      "  806 | PRAMIPEXOLE EQ 0,18MG CPR\n",
      "  807 | PRAMIPEXOLE EQ 0,7MG CPR\n",
      "  809 | ZOLMITRIPTAN 2,5MG CPR PELLIC\n",
      "  810 | DOXAZOSINE EQ 4MG CPR LIB PROL\n",
      "  811 | FAMCICLOVIR 125MG CPR PELLIC\n",
      "  812 | FAMCICLOVIR 500MG CPR PELLIC\n",
      "  814 | IRBESARTAN 150MG CPR PELLIC\n",
      "  815 | IRBESARTAN 300MG CPR PELLIC\n",
      "  817 | MYCOPHENOLATE MOFETIL 500MG CPR\n",
      "  819 | ORNITHINE 5G PDR PR SOL BUV/ENTER SACH\n",
      "  822 | RIVASTIGMINE EQ 1,5MG GELU\n",
      "  823 | RIVASTIGMINE EQ 3MG GELU\n",
      "  824 | RIVASTIGMINE EQ 4,5MG GELU\n",
      "  825 | RIVASTIGMINE EQ 6MG GELU\n",
      "  828 | CLOPIDOGREL HYDROGENOSULFATE/BESILATE EQ 75MG CPR\n",
      "  829 | BLEOMYCINE EQ 15MG PDR PR SOL INJ\n",
      "  833 | PRAMIPEXOLE EQ 0,35MG CPR\n",
      "  835 | RIBAVIRINE 200MG GELU\n",
      "  836 | SPIRONOLACTONE 25MG CPR PELLIC SECAB\n",
      "  838 | TOBRAMYCINE 0,3% COLLY EN SOL\n",
      "  839 | TOPIRAMATE 50MG GELU\n",
      "  840 | AMOROLFINE EQ 5G/100ML VERN ONGL MED\n",
      "  841 | DORZOLAMIDE eq 20MG/ML+TIMOLOL eq 5MG/ML\n",
      "  842 | GLYCEROL 15%+VASELINE 8%+PARAFFINE LIQ.2% CR TB\n",
      "  843 | KETOPROFENE 150MG CPR SECAB - BIPROFENID\n",
      "  847 | LOSARTAN 100MG + HCTZ 12,5MG CPR PELL\n",
      "  849 | TIAPRIDE eq 0,13790G/1ML SOL BUV GTT\n",
      "  850 | VALSARTAN 40MG CPR PELLIC SECAB\n",
      "  851 | VALSARTAN 80MG CPR PELLIC\n",
      "  853 | VALSARTAN 80MG + HCTZ 12,5MG CPR PELLIC\n",
      "  854 | VALSARTAN 160MG + HCTZ 12,5MG CPR PELLIC\n",
      "  855 | VALSARTAN 160MG + HCTZ 25MG CPR PELLIC\n",
      "  857 | CANDESARTAN CILEXETIL 8MG CPR SECAB\n",
      "  858 | CANDESARTAN CILEXETIL 16MG CPR SECAB\n",
      "  859 | CANDESARTAN CILEXETIL 32MG CPR SECAB\n",
      "  860 | CHLORHEXIDINE 0,05% SOL APPL LOC UNIDOS\n",
      "  862 | FLUOROMETHOLONE 0,1G/100ML COLLY\n",
      "  863 | IMIPENEM+CILASTATINE EQ 250MG/250MG PDR PERF\n",
      "  867 | PRAZEPAM 10MG CPR\n",
      "  868 | PRAZEPAM 15MG/ML SOL BUV GTT\n",
      "  870 | TRIMEBUTINE 4,8MG/ML GLE PR SUSP BUV FL\n",
      "  873 | CLARITHROMYCINE 500MG CPR PELLIC LIB MODIF\n",
      "  877 | IBANDRONATE  EQ 150MG CPR PEL\n",
      "  878 | PANTOPRAZOLE EQ 40MG PDR INJ (IV)\n",
      "  882 | REPAGLINIDE 0,5MG CPR\n",
      "  883 | REPAGLINIDE 1MG CPR\n",
      "  884 | REPAGLINIDE 2MG CPR\n",
      "  889 | ACARBOSE 50MG CPR\n",
      "  890 | ACARBOSE 100MG CPR SECAB\n",
      "  891 | ACETYLCYSTEINE 200MG GLE PR SOL BUV\n",
      "  895 | LAMIVUDINE 150MG CPR PELLIC\n",
      "  896 | LAMIVUDINE 300MG CPR PELLIC\n",
      "  897 | NEVIRAPINE ANHYDRE 200MG CPR\n",
      "  898 | FLUTICASONE PROPIONATE 0,05% CR\n",
      "  900 | METFORMINE 500MG+GLIBENCLAMIDE 5MG CPR PELL\n",
      "  901 | NEFOPAM EQ 20MG/2ML SOL INJ\n",
      "  904 | RIZATRIPTAN EQ 10MG LYOT ORAL\n",
      "  905 | LEVOTHYROXINE 25MCG CPR SECAB\n",
      "  906 | LEVOTHYROXINE 50MCG CPR SECAB\n",
      "  907 | LEVOTHYROXINE 75MCG CPR SECAB\n",
      "  908 | LEVOTHYROXINE 100MCG CPR SECAB\n",
      "  909 | LEVOTHYROXINE 125MCG CPR SECAB\n",
      "  910 | LEVOTHYROXINE 150MCG CPR SECAB\n",
      "  911 | LEVOTHYROXINE 175MCG CPR SECAB\n",
      "  912 | LEVOTHYROXINE 200MCG CPR SECAB\n",
      "  913 | DIOSMECTITE 3G PDR PR SUSP BUV SACH\n",
      "  914 | OXOMEMAZINE 0,33MG/ML SIR\n",
      "  915 | ZOLMITRIPTAN 2,5MG CPR ORODISP\n",
      "  916 | ATORVASTATINE EQ 10MG CPR PELLIC\n",
      "  917 | ATORVASTATINE EQ 20MG CPR PELLIC\n",
      "  918 | ATORVASTATINE EQ 40MG CPR PELLIC\n",
      "  920 | CEFIXIME EQ100MG/5ML PDR PR SUSP BUV FL\n",
      "  922 | CLOBETASOL 0,05% CR\n",
      "  925 | EXEMESTANE 25MG CPR ENROB\n",
      "  927 | MANIDIPINE 10MG CPR\n",
      "  930 | MEROPENEM EQ 1G PDR PR SOL INJ\n",
      "  931 | MOXIFLOXACINE EQ 400MG CPR PELLIC\n",
      "  933 | PHOLCODINE 131MG/100ML SANS SUCRE SIR\n",
      "  934 | PHOLCODINE 131MG/100ML SIR\n",
      "  939 | TELMISARTAN 80MG CPR\n",
      "  947 | ADAPALENE 0,1% GEL\n",
      "  949 | CANDESARTAN CIL. 8MG + HCTZ 12,5MG CPR\n",
      "  953 | RIBAVIRINE 200MG CPR PELLIC\n",
      "  954 | RIBAVIRINE 400MG CPR PELLIC\n",
      "  960 | PRAMIPEXOLE EQ 0,18MG CP-MIRAPEXIN\n",
      "  961 | PRAMIPEXOLE EQ 0,7MG CPR-MIRAPEXIN\n",
      "  962 | RIVASTIGMINE EQ 2MG/ML SOL BUV\n",
      "  963 | CICLETANINE 50MG GELU\n",
      "  964 | DESMOPRESSINE 0,1MG CPR\n",
      "  967 | ESOMEPRAZOLE 40MG CPR GAST-RES\n",
      "  971 | RALOXIFENE 60MG CPR PELLIC - EVISTA\n",
      "  976 | DORZOLAMIDE CHL.EQ20MG/ML+TIM.M EQ5MG/ML CY UNIDOS\n",
      "  978 | IRBESARTAN 300MG+HYDROCHLOR.12,5MG CPR PELLIC\n",
      "  981 | RABEPRAZOLE SODIQUE 10MG CPR GASTRO-RES\n",
      "  982 | RABEPRAZOLE SODIQUE 20MG CPR GASTRO-RES\n",
      "  983 | RISEDRONATE 5MG CPR PEL\n",
      "  984 | RISEDRONATE 30MG CPR PEL\n",
      "  988 | VALSARTAN 40MG GELU\n",
      "  989 | VALSARTAN 80MG GELU\n",
      "  990 | VALSARTAN 160MG GELU\n",
      "  991 | MACROGOL 3350 13,125G PDR PR SOL BUV SACH\n",
      "  992 | ATOVAQUONE 250MG+PROGUANIL CHL.100MG CPR PELLIC\n",
      "  998 | TIANEPTINE SODIQUE 12,5MG CPR ENROB\n",
      "  1004 | HYDROXYZINE 100MG/2ML SOL INJ\n",
      "  1005 | KETOPROFENE 100MG CPR SECAB LIB PROL - BIPROFENID\n",
      "  1006 | LIDOCAINE 10MG SOL INJ\n",
      "  1007 | METOCLOPRAMIDE 10MG/2ML SOL INJ AMP\n",
      "  1010 | PETHIDINE 50MG/ML SOL INJ\n",
      "  1014 | CARBOMERE 980 2MG/G GEL OPHT - CIVIGEL\n",
      "  1018 | FUROSEMIDE 500MG CPR SECAB\n",
      "  1019 | GLICLAZIDE 60MG CPR SECAB LIB MODIF\n",
      "  1021 | LAMIVUDINE 150MG+ZIDOVUDINE 300MG CPR PELLIC\n",
      "  1022 | LEVETIRACETAM 250MG CPR PELLIC\n",
      "  1023 | LEVETIRACETAM 500MG CPR PELLIC\n",
      "  1028 | ROPINIROLE 2MG CPR LIB PROL - REQUIP\n",
      "  1029 | ROPINIROLE 4MG CPR LIB PROL - REQUIP\n",
      "  1030 | ROPINIROLE 8MG CPR LIB PROL - REQUIP\n",
      "  1031 | TETRABENAZINE 25MG CPR SECAB\n",
      "  1032 | DESLORATADINE 5MG CPR PELLIC\n",
      "  1033 | DESLORATADINE 0,5MG/ML SOL BUV\n",
      "  1034 | DESOGESTREL 0,075MG CPR PELLIC\n",
      "  1036 | GALANTAMINE LP 16MG GELU LIB PROL\n",
      "  1037 | GALANTAMINE LP 24MG GELU LIB PROL\n",
      "  1041 | RIZATRIPTAN 10MG CPR\n",
      "  1042 | PERINDOPRIL ARG.2,5MG + INDAPAMIDE 0,625MG CPR\n",
      "  1045 | DOXAZOSINE 8MG CPR LIB PROL\n",
      "  1046 | IMIPENEM+CILASTATINE 500/500 PDR IM+SOL\n",
      "  1048 | LEVETIRACETAM 100MG/ML SOL BUV\n",
      "  1051 | ACETYLLEUCINE 500MG CPR\n",
      "  1053 | AMLODIPINE 10MG+ATORVASTATINE 10MG CP\n",
      "  1055 | EBASTINE 10MG LYOT ORAL\n",
      "  1059 | LEFLUNOMIDE 20MG CPR PELLIC\n",
      "  1061 | ZOFENOPRIL 30MG CPR PELLIC\n",
      "  1063 | MONTELUKAST 4MG GLE\n",
      "  1068 | KETOTIFENE EQ 0,25MG/ML COLLY UNIDOS\n",
      "  1070 | LEFLUNOMIDE 100MG CPR PELLIC\n",
      "  1071 | RAMIPRIL 5MG + HYDROCHLOROTHIAZIDE 12,5MG CPR\n",
      "  1073 | TRAMADOL CHL.37,5MG+PARACETAMOL 325MG CPR EFFV\n",
      "  1074 | DOMPERIDONE 20MG CPR PELLIC SECAB\n",
      "  1075 | IRBESARTAN 150MG + HCTZ 12,5MG CPR\n",
      "  1076 | IRBESARTAN 300MG + HCTZ 12,5MG CPR\n",
      "  1077 | ACIDE URSODESOXYCHOLIQUE 250MG CPR PELLIC\n",
      "  1078 | ACIDE ZOLEDRONIQUE 4MG/5ML SOL PERF\n",
      "  1084 | CICLOPIROX OLAMINE 1% CR\n",
      "  1087 | ACIDE ZOLEDRONIQUE EQ  5MG SOL PR PERF\n",
      "  1089 | CAPECITABINE 150MG CPR PELLIC\n",
      "  1090 | CAPECITABINE 500MG CPR PELLIC\n",
      "  1092 | CELECOXIB 100MG GELU\n",
      "  1094 | DILTIAZEM 200MG GELU LP - MONOTILDIEM\n",
      "  1095 | DILTIAZEM 300MG GELU LP - MONOTILDIEM\n",
      "  1096 | ESCITALOPRAM 5MG CPR PELLIC\n",
      "  1097 | ESCITALOPRAM 10MG CPR PELLIC SECAB\n",
      "  1098 | ESCITALOPRAM 15MG CPR PELLIC SECAB\n",
      "  1099 | ESCITALOPRAM 20MG CPR PELLIC SECAB\n",
      "  1100 | IBANDRONATE 3MG SOL INJ\n",
      "  1107 | ACIDE ZOLEDRONIQUE EQ 4MG/100ML SOL PERF\n",
      "  1111 | LIDOCAINE EQ10MG/ML+ADRENALINE SOL INJ\n",
      "  1112 | LIDOCAINE EQ20MG/ML+ADRENALINE SOL INJ\n",
      "  1113 | MEMANTINE 10MG CPR PELLIC\n",
      "  1114 | MEMANTINE 20MG CPR PELLIC\n",
      "  1115 | PERINDOPRIL 10MG EQ + INDAPAMIDE 2,5MG C.PELL\n",
      "  1117 | TELMISARTAN 40MG + HYDROCHLOROTHIAZIDE 12,5MG CPR\n",
      "  1118 | TELMISARTAN 80MG + HYDROCHLOROTHIAZIDE 12,5MG CPR\n",
      "  1121 | EFAVIRENZ 600MG CPR PELLIC\n",
      "  1122 | SERTRALINE EQ 25MG CPR PELLIC\n",
      "  1123 | SERTRALINE EQ 50MG CPR PELLIC SECAB\n",
      "  1125 | CARBIDOPA 10MG + LEVODOPA 100MG CPR\n",
      "  1126 | CARBIDOPA 25MG + LEVODOPA 250MG CPR\n",
      "  1128 | DESOGESTREL 150Y+ETHINYL.30Y CP-VARNOLINE CONTINU\n",
      "  1131 | NICOTINE EQ 2MG GOM MACH MEDIC S/SUC\n",
      "  1133 | DOMPERIDONE 20MG CPR ORODISP\n",
      "  1136 | FLECAINIDE 100MG GELU LIB PROL\n",
      "  1137 | FLECAINIDE 150MG GELU LIB PROL\n",
      "  1138 | FLECAINIDE 200MG GELU LIB PROL\n",
      "  1139 | LEVONORGESTREL0,1+ETHIN 0,02 CPR ENROB-FEMOSIA\n",
      "  1140 | MUPIROCINE 2% POM\n",
      "  1141 | TROSPIUM 20MG CPR ENROB\n",
      "  1142 | ACAMPROSATE CALCIQUE 333MG CPR ENROB GASTRO-RES\n",
      "  1145 | LIDOCAINE 2,5% + PRILOCAINE 2,5% PANS ADH CUTA\n",
      "  1147 | LORMETAZEPAM 2MG CPR SECAB\n",
      "  1148 | NICOTINE 7MG/24H DISP TRANS\n",
      "  1149 | NICOTINE 14MG/24H DISP TRANS\n",
      "  1150 | NICOTINE 21MG/24H DISP TRANS\n",
      "  1151 | NICOTINE EQ 1,5MG PAST\n",
      "  1152 | NICOTINE EQ 2MG GOM MACH XYLITOL-ACESULF\n",
      "  1153 | NICOTINE EQ 4MG GOM MACH XYLITOL-ACESULF\n",
      "  1154 | NICOTINE EQ 1,5MG CPR SUCER\n",
      "  1155 | NICOTINE EQ 4MG CPR SUCER\n",
      "  1156 | CARBIMAZOLE 5MG CPR\n",
      "  1157 | CARBIMAZOLE 20MG CPR\n",
      "  1159 | NICOTINE EQ 2MG CPR SUCER\n",
      "  1160 | PRAMIPEXOLE EQ 0,26MG CPR LP\n",
      "  1162 | PRAMIPEXOLE EQ 1,05MG CPR LP\n",
      "  1163 | PRAMIPEXOLE EQ 2,1MG CPR LP\n",
      "  1166 | MOMETASONE EQ 50Y/DOS PULV NAS\n",
      "  1172 | LYMECYCLINE EQ 300MG GELU\n",
      "  1173 | MEMANTINE 5MG/PRESSION SOL BUV\n",
      "  1176 | OXYCODONE 5MG CPR PELLIC LIB PROL\n",
      "  1177 | OXYCODONE 10MG CPR PELLIC LIB PROL\n",
      "  1178 | OXYCODONE 15MG CPR PELLIC LIB PROL\n",
      "  1179 | OXYCODONE 20MG CPR PELLIC LIB PROL\n",
      "  1180 | OXYCODONE 30MG CPR PELLIC LIB PROL\n",
      "  1181 | OXYCODONE 40MG CPR PELLIC LIB PROL\n",
      "  1182 | OXYCODONE 60MG CPR PELLIC LIB PROL\n",
      "  1183 | OXYCODONE 80MG CPR PELLIC LIB PROL\n",
      "  1185 | HYDROXYZINE 25MG CPR PELLIC SECAB\n",
      "  1190 | LEVONORGESTREL 750MCG CPR\n",
      "  1192 | AMOXICILLINE 250MG GELU - CLAMOXYL\n",
      "  1197 | LEVOD.75MG+CARBID.18,75MG+ENTACAP.200MG CPR PELL\n",
      "  1198 | LEVOD.100MG+CARBID.25MG+ENTACAP.200MG CPR PELL\n",
      "  1199 | LEVOD.125MG+CARBID.31,25MG+ENTACAP.200MG CPR PELL\n",
      "  1200 | LEVOD.150MG+CARBID.37,5MG+ENTACAP.200MG CPR PELL\n",
      "  1201 | LEVOD.175MG+CARBID.43,75MG+ENTACAP.200MG CPR PELL\n",
      "  1202 | LEVOD.200MG+CARBID.50MG+ENTACAP.200MG CPR PELL\n",
      "  1203 | SEVELAMER 800MG CPR PELLIC\n",
      "  1204 | CHOLECALCIFEROL 100 000 UI SOL BUV AMP\n",
      "  1205 | ACEBUTOLOL EQ 500MG CPR PELLIC LP\n",
      "  1206 | ACIDE GADOTERIQUE 0,5MMOL/ML SOL INJ\n",
      "  1207 | ACIDE GADOTERIQUE 0,5MMOL/ML SOL INJ SRG PREREMPL\n",
      "  1210 | LOPRAZOLAM MONOHYDRATE EQ 1MG CPR SECAB\n",
      "  1211 | QUETIAPINE EQ 50MG CPR LIB PROL\n",
      "  1228 | EPLERENONE 25MG CPR PELLIC\n",
      "  1229 | EPLERENONE 50MG CPR PELLIC\n",
      "  1231 | ARIPIPRAZOLE 5MG CPR\n",
      "  1232 | ARIPIPRAZOLE 10MG CPR\n",
      "  1233 | ARIPIPRAZOLE 15MG CPR\n",
      "  1234 | OMEGA-3 1000MG CAPS MOL\n",
      "  1235 | PREGABALINE 25MG GELU\n",
      "  1236 | PREGABALINE 50MG GELU\n",
      "  1237 | PREGABALINE 75MG GELU\n",
      "  1238 | PREGABALINE 100MG GELU\n",
      "  1240 | PREGABALINE 200MG GELU\n",
      "  1242 | RASAGILINE EQ 1MG CPR\n",
      "  677 | DOXORUBICINE 2MG/ML LYOT INJ FL (FL10MG)\n",
      "  678 | DOXORUBICINE 2MG/ML LYOT INJ FL (FL50MG)\n",
      "  434 | MITOXANTRONE 20MG/10ML SOL PERF\n",
      "  852 | VALSARTAN 160MG CPR PELLIC\n",
      "  856 | CANDESARTAN CILEXETIL 4MG CPR SECAB\n",
      "  734 | PERIND.T-B.2MG-PERIND.ARG.2,5MG+INDAPAM.0,625MG CP\n",
      "  302 | CAPTOPRIL 50MG + HCTZ 25MG CPR SECAB\n",
      "  327 | QUINAPRIL EQ 20MG CPR ENROB\n",
      "  493 | FOSINOPRIL 20MG CPR\n",
      "  29 | ATENOLOL 100MG CPR PELLIC SECAB\n",
      "  1144 | IOPAMIDOL EQ 370MG SOL INJ\n",
      "  454 | ALFUZOSINE 5MG CPR PELLIC LIB PROL\n",
      "  247 | TERAZOSINE EQ 5MG CPR\n",
      "  311 | CLODRONATE DE SODIUM 400MG GELU\n",
      "  28 | ATENOLOL 50MG CPR PELLIC SECAB\n",
      "  141 | NAFTIDROFURYL OXALATE ACIDE 200MG CPR\n",
      "  1108 | BETAXOLOL 20MG CPR PELLIC SECAB\n",
      "  388 | RISPERIDONE 4MG CPR PELLIC SECAB\n",
      "  177 | TIMOLOL  EQ 0,25% COLLY\n",
      "  310 | PAROXETINE EQ 20MG CPR PELLIC SECAB\n",
      "  75 | DIHYDROERGOTAMINE MESILATE 3MG CPR\n",
      "  379 | LORATADINE 1MG/ML SIR\n",
      "  751 | CEFEPIME DICHLOR.MONOHYDRATE EQ 1G PDR PR US PAR\n",
      "  240 | CEFTRIAXONE SODIQUE EQ 1G PDR+SOLV PR SOL INJ IV\n",
      "  14 | AMIODARONE 200MG CPR SECAB\n",
      "  1069 | LATANOPROST+TIMOLOL MAL.EQ 50MCG/5MG/ML COLLY\n",
      "  950 | CANDESARTAN CIL. 16MG + HCTZ 12,5MG CPR\n",
      "  903 | RIZATRIPTAN EQ 5MG LYOT ORAL\n",
      "  430 | LAMOTRIGINE 50MG CPR DISP CROQ\n",
      "  783 | CALCIPOTRIOL MONOHYDRATE 50MCG/ML SOL CUIR CHEVELU\n",
      "  1040 | RIZATRIPTAN 5MG CPR\n",
      "  218 | NITRENDIPINE 10MG CPR\n",
      "  195 | FENOFIBRATE 200MG GELU - LIPANTHYL\n",
      "  403 | GABAPENTINE 800MG CPR PELLIC\n",
      "  632 | BISOPROLOL 5MG + HCTZ 6,25MG CPR PELLIC\n",
      "  764 | LERCANIDIPINE 10MG CPR PELLIC SECAB\n",
      "  280 | ROXITHROMYCINE 100MG CPR PELLIC\n",
      "  609 | OXCARBAZEPINE 600MG CPR PELLIC\n",
      "  99 | FLUTAMIDE 250MG CPR\n",
      "  253 | CEFATRIZINE PROPYLENEGLYCOL EQ 500MG GELU\n",
      "  776 | LATANOPROST 0,005% COLLY\n",
      "  222 | TRIMEBUTINE 0,7870G/100G GLE PR SUSP BUV FL\n",
      "  1027 | PHLOROGLUCINOL+TRIMETHYLPHLOR.40/0,04MG/4ML INJ A.\n",
      "  62 | CROMOGLICATE DE SODIUM 100MG/5ML SOL BUV AMP\n",
      "  144 | NIFUROXAZIDE 4% SUSP BUV\n",
      "  122 | KETOPROFENE 100MG LYOPH ET SOL PR US PAR IM\n",
      "  437 | NIFEDIPINE 30MG CPR PELLIC LP\n",
      "  80 | DILTIAZEM 120MG GELU LP - DIACOR\n",
      "  928 | MANIDIPINE 20MG CPR\n",
      "  1052 | AMLODIPINE 5MG+ATORVASTATINE 10MG CPR\n",
      "  792 | HEXAMIDINE 1MG/ML SOL PR APPLIC LOC\n",
      "  695 | CABERGOLINE 0,5MG CPR\n",
      "  946 | ADAPALENE 0,1% CR\n",
      "  977 | IRBESARTAN 150MG+HYDROCHLOR.12,5MG CPR PELLIC\n",
      "  1062 | TAMSULOSINE 0,4MG CPR PELLIC LP\n",
      "  683 | PREDNISOLONE METASULFOBENZO SODIQ EQ 20MG CPR DISP\n",
      "  38 | CALCITONINE SALMINE SYNTHETIQUE 50UI/1ML SOL INJ\n",
      "  315 | CIPROFLOXACINE EQ 500MG CPR PELLIC SECAB\n",
      "  919 | ATORVASTATINE EQ 80MG CPR PELLIC\n",
      "  166 | SULPIRIDE 50MG GELU\n",
      "  41 | CARBOCISTEINE 5% AD SIR\n",
      "  431 | LAMOTRIGINE 100MG CPR DISP CROQ\n",
      "  295 | ZOLPIDEM 10MG CPR PELLIC SECAB\n",
      "  115 | ISOSORBIDE DINITRATE 40MG CPR LP - LANGORAN\n",
      "  706 | LEVOFOLINATE DE CALCIUM EQ 25MG/2,5ML SOL INJ\n",
      "  846 | LEVOFOLINATE DE CALCIUM EQ 50MG/5ML SOL INJ\n",
      "  103 | IBUPROFENE 200MG CPR ENROB - NUREFLEX\n",
      "  446 | MIRTAZAPINE 15MG CPR PELLIC\n",
      "  139 | MINOCYCLINE CHLORH EQ 100MG CPR PELL SEC-MESTACINE\n",
      "  104 | IBUPROFENE 400MG CPR ENROB - BRUFEN\n",
      "  284 | NAPROXENE SODIQUE 550MG CPR PELLIC SECAB\n",
      "  1054 | DICLOFENAC 12,5MG CPR ENROB\n",
      "  70 | DICLOFENAC SODIQUE 100MG CPR ENROB LP\n",
      "  1057 | FLURBIPROFENE 100MG CPR PELLIC\n",
      "  223 | ACIDE TIAPROFENIQUE 200MG CPR SECAB\n",
      "  1024 | LEVETIRACETAM 1000MG CPR PELLIC\n",
      "  1241 | PREGABALINE 300MG GELU\n",
      "  711 | TRAMADOL 100MG CPR LIB PROL\n",
      "  175 | THIOCOLCHICOSIDE 4MG/2ML SOL INJ IM\n",
      "  30 | BACLOFENE 10MG CPR SECAB\n",
      "  1116 | LIDOCAINE 5MG/ML SOL INJ\n",
      "  224 | TRIMETAZIDINE 20MG CPR\n",
      "  1135 | FLECAINIDE 50MG GELU LIB PROL\n",
      "  84 | DIPYRIDAMOLE 75MG CPR ENROB\n",
      "  861 | FLUCONAZOLE 200MG/5ML PDR PR SUSP BUV - TRIFLUCAN\n",
      "  94 | ERYTHROMYCINE ETHYLSUCCINATE EQ 1000MG GRAN SACH\n",
      "  688 | CLARITHROMYCINE 50MG/ML GLE PR SUSP BUV\n",
      "  1025 | MILNACIPRAN 25MG GELU\n",
      "  1026 | MILNACIPRAN 50MG GELU\n",
      "  1127 | CLOXACILLINE EQ 500MG GELU\n",
      "  782 | AZITHROMYCINE EQ 600MG CPR PELLIC\n",
      "  19 | AMOXICILLINE 500MG GELU - CLAMOXYL\n",
      "  21 | AMOXICILLINE 125MG/5ML PDR PR SIR - HICONCIL\n",
      "  965 | DESMOPRESSINE 0,2MG CPR\n",
      "  24 | AMOXICILLINE 500MG GELU - HICONCIL\n",
      "  899 | METFORMINE 500MG+GLIBENCLAMIDE 2,5MG CPR P.\n",
      "  50 | CEFALEXINE 500MG CPR PELLIC\n",
      "  43 | CEFADROXIL 250MG/5ML PDR PR SUSP BUV\n",
      "  42 | CEFADROXIL 125MG/5ML PDR PR SUSP BUV\n",
      "  957 | ENTACAPONE 200MG CPR PELLIC\n",
      "  1161 | PRAMIPEXOLE EQ 0,52MG CPR LP\n",
      "  1120 | ALGIN.SODIUM 0,5G+BICAR.SODIUM 0,267G BUV SACH\n",
      "  952 | OXOMEMAZINE 0,33MG/ML SANS SUCRE SOL BUV\n",
      "  356 | CETIRIZINE 10MG/ML SOL BUV GTT\n",
      "  1146 | LORMETAZEPAM 1MG CPR SECAB\n",
      "  335 | ZOPICLONE 3,75MG CPR PELLIC\n",
      "  515 | PERGOLIDE MESILATE 0,25MG CPR SECAB\n",
      "  1196 | LEVOD.50MG+CARBID.12,5MG+ENTACAP.200MG CPR PELL\n",
      "  778 | ROPINIROLE 0,25MG CPR PELLIC - ADARTREL\n",
      "  1035 | GALANTAMINE LP 8MG GELU LIB PROL\n",
      "  13 | AMBROXOL 30MG CPR SECAB\n",
      "  796 | MONTELUKAST SODIQUE EQ 10MG CPR PELLIC\n",
      "  997 | MONTELUKAST SODIQUE EQ 4MG CPR CROQ\n",
      "  169 | SULPIRIDE 100MG/2ML SOL INJ IM\n",
      "  628 | TIAPRIDE EQ 100MG/2ML SOL INJ\n",
      "  619 | LANSOPRAZOLE 30MG CPR ORODISP\n",
      "  966 | ESOMEPRAZOLE 20MG CPR GAST-RES\n",
      "  384 | OMEPRAZOLE 10MG GELU GASTRO-RES\n",
      "  621 | LANSOPRAZOLE 30MG GELU GASTRO-RES\n",
      "  620 | LANSOPRAZOLE 15MG GELU GASTRO-RES\n",
      "  719 | PANTOPRAZOLE 20MG CPR GASTRORES\n",
      "  552 | VINCRISTINE 1MG/ML SOL INJ\n",
      "  433 | MITOXANTRONE 10MG/5ML SOL PERF\n",
      "  101 | FUROSEMIDE 40MG CPR SECAB\n",
      "  100 | FUROSEMIDE 20MG CPR\n",
      "  938 | TELMISARTAN 40MG CPR\n",
      "  813 | IRBESARTAN 75MG CPR PELLIC\n",
      "  159 | SPIRONOLACTONE 50MG CPR PELLIC SECAB\n",
      "  358 | ENALAPRIL 20MG + HCTZ 12,5MG CPR SEC\n",
      "  486 | QUINAPRIL EQ 10MG CPR ENROB\n",
      "  1043 | PERINDOPRIL ARG.5MG + INDAPAMIDE 1,25MG CPR\n",
      "  361 | CARVEDILOL 6,25MG CPR SECAB\n",
      "  1143 | IOPAMIDOL EQ 300MG SOL INJ\n",
      "  2 | ACEBUTOLOL EQ 400MG CPR PELLIC\n",
      "  148 | PENTOXIFYLLINE 400MG CPR ENROB LP\n",
      "  980 | OFLOXACINE 1,5MG/0,5ML SOL AURIC UNIDOS\n",
      "  1088 | AZELASTINE 0,05% COLLY\n",
      "  506 | CROMOGLICATE DE SODIUM 2G/100ML COLLY\n",
      "  627 | RISPERIDONE 0,5MG CPR PELLIC\n",
      "  401 | GABAPENTINE 300MG GELU\n",
      "  467 | GLIMEPIRIDE 2MG CPR\n",
      "  123 | KETOPROFENE 2,5% GEL - PROFENID\n",
      "  498 | AMLODIPINE BESILATE 5MG GELU\n",
      "  312 | AMISULPRIDE 100MG CPR SECAB\n",
      "  425 | FENOFIBRATE 160MG CPR PELLIC - LIPANTHYL\n",
      "  69 | DICLOFENAC SODIQUE 50MG CPR ENROB GASTRORES\n",
      "  469 | GLIMEPIRIDE 4MG CPR\n",
      "  468 | GLIMEPIRIDE 3MG CPR\n",
      "  520 | GESTODENE 0,075MG+ETHINYLESTRADIOL0,02MG CPR ENROB\n",
      "  451 | GLIBENCLAMIDE 2,5MG CPR SECAB\n",
      "  416 | PRAVASTATINE SODIQUE 20MG CPR SECAB\n",
      "  270 | KETOPROFENE 2,5% GEL - KETUM\n",
      "  674 | VENLAFAXINE EQ 50MG CPR\n",
      "  936 | RISEDRONATE EQ 35MG CPR PEL\n",
      "  530 | ONDANSETRON EQ 4MG CPR PELL\n",
      "  126 | LOPERAMIDE 2MG GELU\n",
      "  659 | ANASTROZOLE 1MG CPR PELLIC\n",
      "  501 | ACECLOFENAC 100MG CPR PELLIC\n",
      "  137 | MINOCYCLINE EQ 50MG GELU - MYNOCINE\n",
      "  732 | IMIPENEM+CILASTATINE SODIQ.EQ 500MG/500MG PDR PERF\n",
      "  626 | PIPERACIL. EQ 4G+TAZOBACT. EQ 500MG PDR PERF\n",
      "  633 | BISOPROLOL 10MG + HCTZ 6,25MG CPR PELLIC\n",
      "  643 | RISPERIDONE 1MG/ML SOL BUV\n",
      "  513 | NICORANDIL 20MG CPR\n",
      "  661 | BRIMONIDINE 0,2% (2MG/ML) COLLY SOL\n",
      "  1224 | RACECADOTRIL 100MG GELU\n",
      "  869 | TRIMEBUTINE 74,4MG GLE PR SUSP BUV SACH\n",
      "  926 | MACROGOL 3350 5,9G PDR PR SOL BUV SACH\n",
      "  235 | TIMOLOL  EQ 0,10% COLLY\n",
      "  1008 | METOCLOPRAMIDE 20MG/1ML SOL INJ\n",
      "  574 | METHOTREXATE 50MG SOL INJ\n",
      "  68 | DICLOFENAC SODIQUE 25MG CPR ENROB GASTRORES\n",
      "  79 | DILTIAZEM 90MG GELU LP - DIACOR\n",
      "  355 | RAMIPRIL 5MG GELU\n",
      "  481 | BISOPROLOL 7,5MG CPR P.SEC- CARDENSIEL\n",
      "  185 | VERAPAMIL 120MG GELU\n",
      "  89 | ECONAZOLE 1% EMUL FLUIDE PR APPLIC LOC\n",
      "  660 | BENFLUOREX 150MG CPR ENROB\n",
      "  255 | LEVONORGESTREL0,15+ETHINYLESTRADIOL 0,03 CPR ENROB\n",
      "  548 | PEROXYDE DE BENZOYLE HYDRATE 5% GEL APPLIC LOC\n",
      "  1119 | TELMISARTAN 80MG + HYDROCHLOROTHIAZIDE 25MG CPR\n",
      "  979 | IRBESARTAN 300MG+HYDROCHLOR.25MG CPR PELLIC\n",
      "  274 | NORFLOXACINE 400MG CPR ENROB\n",
      "  267 | ACICLOVIR 5% CREME\n",
      "  676 | ACIDE FUSIDIQUE 2% CR\n",
      "  647 | VENLAFAXINE EQ 75MG GELU LIB PROL\n",
      "  15 | AMOXICILLINE 125MG/5ML PDR PR SIR - CLAMOXYL\n",
      "  64 | DEXTROPROPOXYPHENE CHL 30MG+PARACETAMOL 400MG GELU\n",
      "  134 | MIANSERINE 10MG CPR PELLIC\n",
      "  390 | SUMATRIPTAN SUCCINATE EQ 50MG CPR PELLIC\n",
      "  4 | ACICLOVIR 800MG CPR\n",
      "  167 | SULPIRIDE 200MG CPR SECAB\n",
      "  40 | CARBOCISTEINE 2% ENF NOUR SIR\n",
      "  341 | FLUCONAZOLE 50MG GELU - TRIFLUCAN\n",
      "  73 | DICLOFENAC SODIQUE 75MG/3ML SOL INJ\n",
      "  1093 | CELECOXIB 200MG GELU\n",
      "  117 | KETOPROFENE 50MG GELU\n",
      "  1058 | LEFLUNOMIDE 10MG CPR PELLIC\n",
      "  502 | AZATHIOPRINE 25MG CPR PELLIC\n",
      "  1083 | OXCARBAZEPINE 60MG/ML SUSP BUV\n",
      "  707 | NARATRIPTAN EQ 2,5MG CPR PELLIC\n",
      "  1072 | TRAMADOL CHL.37,5MG+PARACETAMOL 325MG CPR PELLIC\n",
      "  516 | SUMATRIPTAN SUCCINATE EQ 6MG/0,5ML SOL INJ SRG\n",
      "  538 | LAMOTRIGINE 25MG CPR (PREMIER MOIS DE TRAITEMENT)\n",
      "  1191 | ALMOTRIPTAN EQ 12,5MG CPR PELLIC\n",
      "  428 | LAMOTRIGINE 5MG CPR DISP CROQ\n",
      "  1239 | PREGABALINE 150MG GELU\n",
      "  1011 | RISEDRONATE 75MG CPR PEL\n",
      "  656 | PAMIDRONATE DE SODIUM 60MG/10ML PDR+SOL P/SOL PERF\n",
      "  365 | ALENDRONATE MONOSODIQUE EQ 10MG CPR\n",
      "  1110 | IBANDRONATE EQ 6MG SOL PERF\n",
      "  644 | LIDOCAINE 2% SOL INJ\n",
      "  612 | TRIMETAZIDINE 35MG CPR PELL LIB MOD\n",
      "  1132 | NICOTINE EQ 4MG GOM MACH MEDIC S/SUC\n",
      "  580 | MODAFINIL 100MG CPR\n",
      "  1060 | METHYLPHENIDATE 10MG CPR\n",
      "  199 | PIRACETAM 400MG GELU\n",
      "  687 | CLARITHROMYCINE 25MG/ML GLE PR SUSP BUV\n",
      "  597 | CEFTAZIDIME 500MG PDR+SOLV PR SOL INJ (IM-IV)\n",
      "  560 | CEFPODOXIME PROXETIL 100MG CPR PELLIC\n",
      "  231 | CEFACLOR 250MG /5ML PDR PR SUSP BUV\n",
      "  441 | AMOXICILLINE+CLAVULANATE K EQ 500/50 BB/ENF PDR IV\n",
      "  369 | CEFUROXIME AXETIL EQ 125MG GLE PR SUSP BUV SACH\n",
      "  1230 | VALGANCICLOVIR EQ 450MG CPR PELLIC\n",
      "  220 | PROGESTERONE 100MG CAPS MOL ORALE, VAG\n",
      "  798 | OLANZAPINE 5MG CPR ENROB\n",
      "  337 | CHLORMADINONE ACETATE 2MG CPR\n",
      "  996 | MIZOLASTINE 10MG CPR LIB MODIF\n",
      "  655 | LEVODOPA 200MG + BENSERAZIDE CHL.EQ 50MG GELU\n",
      "  834 | PRAMIPEXOLE EQ 0,088MG CPR\n",
      "  1169 | ESCITALOPRAM EQ 20MG/ML SOL BUV GTT\n",
      "  329 | SALBUTAMOL EQ 5MG SOL INHAL UNIDOS\n",
      "  821 | RILUZOLE 50MG CPR PELLIC\n",
      "  777 | MONTELUKAST SODIQUE EQ 5MG CPR CROQ\n",
      "  1208 | PYRIDOSTIGMINE BROMURE 60MG CPR ENROB\n",
      "  426 | LAMOTRIGINE 25MG CPR\n",
      "  1044 | AMISULPRIDE 100MG/ML SOL BUV\n",
      "  1214 | QUETIAPINE EQ 300MG CPR LIB PROL\n",
      "  1215 | QUETIAPINE EQ 400MG CPR LIB PROL\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : AGE\n",
      "================================================================================\n",
      "\n",
      "  AGE | Libellé Tranche d'Age Bénéficiaire\n",
      "  0 | 0-19 ANS\n",
      "  20 | 20 - 59 ANS\n",
      "  60 | 60 ANS ET +\n",
      "  99 | AGE INCONNU\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : SEXE\n",
      "================================================================================\n",
      "\n",
      "  SEXE | Libellé Sexe du Bénéficiaire\n",
      "  1 | MASCULIN\n",
      "  2 | FEMININ\n",
      "  9 | VALEUR INCONNUE\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : BEN_REG\n",
      "================================================================================\n",
      "\n",
      "  BEN_REG | Libellé Région de Résidence du Bénéficiaire\n",
      "  5 | Régions et Départements d'outre-mer \n",
      "  11 | Ile-de-France\n",
      "  24 | Centre-Val de Loire\n",
      "  27 | Bourgogne-Franche-Comté\n",
      "  28 | Normandie\n",
      "  32 | Nord-Pas-de-Calais-Picardie\n",
      "  44 | Alsace-Champagne-Ardenne-Lorraine\n",
      "  52 | Pays de la Loire\n",
      "  53 | Bretagne\n",
      "  75 | Aquitaine-Limousin-Poitou-Charentes\n",
      "  76 | Languedoc-Roussillon-Midi-Pyrénées\n",
      "  84 | Auvergne-Rhône-Alpes\n",
      "  93 | Provence-Alpes-Côte d'Azur et Corse\n",
      "  0 et 99 | Inconnu\n",
      "\n",
      "================================================================================\n",
      "  FEUILLE : PSP_SPE\n",
      "================================================================================\n",
      "\n",
      "  PSP_SPE | Libellé Prescripteur | \n",
      "  1 | MEDECINE GENERALE LIBERALE | PRESCRIPTEURS DE VILLE\n",
      "(MEDECINS et DENTISTES)\n",
      "  2 | ANESTHESIOLOGIE - REANIMATION LIBERALE | \n",
      "  3 | PATHOLOGIE CARDIO-VASCULAIRE LIBERALE | \n",
      "  4 | CHIRURGIE LIBERALE | \n",
      "  5 | DERMATOLOGIE ET VENEROLOGIE LIBERALE | \n",
      "  6 | RADIOLOGIE LIBERALE | \n",
      "  7 | GYNECOLOGIE OBSTETRIQUE LIBERALE | \n",
      "  8 | GASTRO-ENTEROLOGIE ET HEPATOLOGIE LIBERALE | \n",
      "  9 | MEDECINE INTERNE LIBERALE | \n",
      "  11 | OTO RHINO-LARYNGOLOGIE LIBERALE | \n",
      "  12 | PEDIATRIE LIBERALE | \n",
      "  13 | PNEUMOLOGIE LIBERALE | \n",
      "  14 | RHUMATOLOGIE LIBERALE | \n",
      "  15 | OPHTALMOLOGIE LIBERALE | \n",
      "  17 | PSYCHIATRIE LIBERALE | \n",
      "  18 | STOMATOLOGIE LIBERALE | \n",
      "  19 | CHIRURGIE DENTAIRE | \n",
      "  31 | MEDECINE PHYSIQUE ET DE READAPTATION LIBERALE | \n",
      "  32 | NEUROLOGIE LIBERALE | \n",
      "  35 | NEPHROLOGIE LIBERALE | \n",
      "  36 | CHIRURGIE DENTAIRE (SPECIALISTE O.D.F.) | \n",
      "  37 | ANATOMIE-CYTOLOGIE-PATHOLOGIQUE LIBERALE | \n",
      "  38 | DIRECTEUR LABORATOIRE MEDECIN LIBERAL | \n",
      "  42 | ENDOCRINOLOGIE ET METABOLISMES LIBERAL | \n",
      "  90 | PRESCRIPTEURS SALARIES | Principalement hôpitaux publics\n",
      "  98 | PRESCRIPTEURS DE VILLE AUTRES QUE MEDECINS (Dentistes, Auxiliaires médicaux, Laboratoires, Sages-Femmes) | \n",
      "  99 | VALEUR INCONNUE | \n"
     ]
    }
   ],
   "source": [
    "XL_PATH = Path(\"../../data/raw/open_medic/2024_descriptif-variables_open-medic.xls\")\n",
    "\n",
    "try:\n",
    "    import xlrd  # noqa: F401\n",
    "except ImportError:\n",
    "    import subprocess, sys\n",
    "    subprocess.run([sys.executable, \"-m\", \"pip\", \"install\", \"xlrd\", \"-q\"], check=True)\n",
    "\n",
    "xl = pd.ExcelFile(XL_PATH, engine=\"xlrd\")\n",
    "print(f\"Fichier : {XL_PATH.name}\")\n",
    "print(f\"Feuilles ({len(xl.sheet_names)}) : {xl.sheet_names}\\n\")\n",
    "print(\"=\" * 80)\n",
    "\n",
    "for sheet in xl.sheet_names:\n",
    "    raw = pd.read_excel(xl, sheet_name=sheet, header=None, dtype=str).fillna(\"\")\n",
    "    # Drop completely empty rows and columns\n",
    "    raw = raw.loc[~(raw == \"\").all(axis=1), ~(raw == \"\").all(axis=0)].reset_index(drop=True)\n",
    "    if raw.empty:\n",
    "        continue\n",
    "    print(f\"\\n{'=' * 80}\")\n",
    "    print(f\"  FEUILLE : {sheet}\")\n",
    "    print(f\"{'=' * 80}\\n\")\n",
    "    # Print cell by cell, aligned as a table\n",
    "    for _, row in raw.iterrows():\n",
    "        cells = [str(v) for v in row]\n",
    "        if all(c.strip() == \"\" for c in cells):\n",
    "            continue\n",
    "        print(\"  \" + \" | \".join(cells))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "uelqust16z9",
   "metadata": {},
   "source": "---\n## Analyses\n\n| # | Question | Angle analytique | Colonnes utilisées |\n|---|---------|-----------------|-------------------|\n| Q1 | La prescription est-elle concentrée sur quelques médicaments ? | Courbe de Lorenz + Pareto par CIP13 | `CIP13`, `BOITES` |\n| Q2 | Comment les dépenses se répartissent-elles par classe thérapeutique ? | Volume vs coût — dissociation fondamentale | `l_ATC1`, `BOITES`, `REM` |\n| Q3 | La prescription révèle-t-elle des inégalités démographiques ? | Distribution âge/sexe, heatmap âge × ATC | `age`, `sexe`, `l_ATC1` |\n| Q4 | Pénétration des génériques et économies potentielles | Taux de substitution générique par classe ATC | `TOP_GEN`, `GEN_NUM`, `l_ATC1` |\n| Q5 | Profil prescripteur par spécialité médicale | Heatmap spécialité × ATC, coût unitaire | `PSP_SPE`, `l_ATC1` |\n| Q6 | Disparités régionales de prescription | Volume par région, % antibiotiques (J01) | `BEN_REG`, `ATC2` |\n| Q7 | Polymédication et budget des seniors (60+) | Coût unitaire et diversité thérapeutique | `age`, `l_ATC1`, `REM` |\n| Q8 | Volume et montants remboursés par molécule (ATC5) | Palmarès volume vs REM, dissociation prix | `l_ATC5`, `BOITES`, `REM` |"
  },
  {
   "cell_type": "markdown",
   "id": "bo5f9xejo8s",
   "metadata": {},
   "source": [
    "### Q1 — La prescription est-elle concentrée sur quelques médicaments ?\n",
    "\n",
    "La BDPM répertorie ~14 000 spécialités avec une AMM active, mais tous ne sont pas réellement\n",
    "prescrits. Open Medic révèle la hiérarchie *réelle* de la prescription : quels CIP13 concentrent\n",
    "la majorité du volume dispensé ? La courbe de Lorenz visualise cette concentration, et le\n",
    "coefficient de Gini la quantifie en un seul indicateur."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "0bm1uxyfojh",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Q1 — Concentration des prescriptions (2024) ===\n",
      "\n",
      "Médicaments distincts (CIP13) : 12,646\n",
      "Total boîtes dispensées       : 2368 millions\n",
      "Coefficient de Gini           : 0.869\n",
      "\n",
      "Concentration par palier :\n",
      "  Palier                         Nb CIP13   % boîtes\n",
      "  ----------------------------------------------------\n",
      "  Top  1% des CIP13                126      39.8%\n",
      "  Top  5% des CIP13                632      66.6%\n",
      "  Top 10% des CIP13              1,264      79.4%\n",
      "  Top 20% des CIP13              2,529      90.3%\n",
      "  Top 50% des CIP13              6,323      98.9%\n",
      "\n",
      "  50% du volume atteint par 249 CIP13 (2.0% des codes)\n",
      "  80% du volume atteint par 1310 CIP13 (10.4% des codes)\n",
      "\n",
      "Top 10 médicaments par volume :\n",
      "  CIP13                 Boîtes   % total\n",
      "  ----------------------------------------\n",
      "  3400935955838    166,162,738      7.0%\n",
      "  3400941533969     60,537,669      2.6%\n",
      "  3400936158832     32,850,384      1.4%\n",
      "  3400935294227     27,494,203      1.2%\n",
      "  3400934744198     20,930,394      0.9%\n",
      "  3400932679041     18,775,939      0.8%\n",
      "  3400935291783     18,307,084      0.8%\n",
      "  3400932320189     15,933,515      0.7%\n",
      "  3400935154958     13,409,505      0.6%\n",
      "  3400934615467     12,837,848      0.5%\n"
     ]
    }
   ],
   "source": [
    "top_cip_boxes = df.groupby(CIP_COL)[BOX_COL].sum().sort_values(ascending=False)\n",
    "\n",
    "n_total     = len(top_cip_boxes)\n",
    "boxes_total = top_cip_boxes.sum()\n",
    "\n",
    "# Courbe de Lorenz\n",
    "sorted_vals = top_cip_boxes.sort_values().values\n",
    "cumul_labs  = np.arange(1, n_total + 1) / n_total * 100\n",
    "cumul_boxes = np.cumsum(sorted_vals) / sorted_vals.sum() * 100\n",
    "\n",
    "# Coefficient de Gini\n",
    "n    = n_total\n",
    "gini = (2 * np.sum(np.arange(1, n + 1) * sorted_vals) / (n * sorted_vals.sum())) - (n + 1) / n\n",
    "\n",
    "fig, axes = plt.subplots(1, 2, figsize=(18, 6))\n",
    "\n",
    "# Top 20\n",
    "top20 = top_cip_boxes.head(20)\n",
    "top20.sort_values().plot.barh(ax=axes[0], color=\"steelblue\")\n",
    "axes[0].set_title(f\"Top 20 médicaments par volume\\n(boîtes dispensées — Open Medic {YEAR})\",\n",
    "                  fontsize=11, fontweight=\"bold\")\n",
    "axes[0].set_xlabel(\"Nombre de boîtes\")\n",
    "axes[0].xaxis.set_major_formatter(plt.FuncFormatter(lambda x, _: f\"{x/1e6:.0f}M\"))\n",
    "axes[0].set_yticklabels([str(l)[-13:] for l in top20.sort_values().index], fontsize=8)\n",
    "\n",
    "# Courbe de Lorenz\n",
    "axes[1].plot(cumul_labs, cumul_boxes, color=\"steelblue\", linewidth=2, label=\"Répartition réelle\")\n",
    "axes[1].plot([0, 100], [0, 100], color=\"gray\", linestyle=\"--\", linewidth=1, label=\"Égalité parfaite\")\n",
    "axes[1].fill_between(cumul_labs, cumul_boxes, cumul_labs, alpha=0.15, color=\"steelblue\")\n",
    "axes[1].set_xlabel(\"% cumulé des médicaments (CIP13, du moins au plus prescrit)\")\n",
    "axes[1].set_ylabel(\"% cumulé des boîtes dispensées\")\n",
    "axes[1].set_title(f\"Courbe de Lorenz — Concentration des prescriptions\\n(Gini = {gini:.3f})\",\n",
    "                  fontsize=11, fontweight=\"bold\")\n",
    "axes[1].legend()\n",
    "axes[1].grid(alpha=0.3)\n",
    "\n",
    "for pct_labs in [10, 1]:\n",
    "    n_labs  = max(1, int(pct_labs / 100 * n_total))\n",
    "    pct_vol = top_cip_boxes.head(n_labs).sum() / boxes_total * 100\n",
    "    x_pos = 100 - pct_labs\n",
    "    y_pos = 100 - pct_vol\n",
    "    axes[1].annotate(\n",
    "        f\"Top {pct_labs}% des CIP13\\n→ {pct_vol:.0f}% des boîtes\",\n",
    "        xy=(x_pos, y_pos), xytext=(x_pos - 20, y_pos - 12),\n",
    "        arrowprops={\"arrowstyle\": \"->\", \"color\": \"gray\"}, fontsize=8, color=\"darkblue\"\n",
    "    )\n",
    "\n",
    "plt.suptitle(\"Q1 — Concentration des prescriptions par médicament\", fontsize=13, fontweight=\"bold\", y=1.01)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# --- Résultats détaillés ---\n",
    "print(f\"=== Q1 — Concentration des prescriptions ({YEAR}) ===\")\n",
    "print(f\"\\nMédicaments distincts (CIP13) : {n_total:,}\")\n",
    "print(f\"Total boîtes dispensées       : {boxes_total/1e6:.0f} millions\")\n",
    "print(f\"Coefficient de Gini           : {gini:.3f}\")\n",
    "\n",
    "print(f\"\\nConcentration par palier :\")\n",
    "print(f\"  {'Palier':<30} {'Nb CIP13':>8}  {'% boîtes':>9}\")\n",
    "print(f\"  {'-'*52}\")\n",
    "for pct in [1, 5, 10, 20, 50]:\n",
    "    n_k   = max(1, int(pct / 100 * n_total))\n",
    "    share = top_cip_boxes.head(n_k).sum() / boxes_total * 100\n",
    "    print(f\"  Top {pct:>2}% des CIP13           {n_k:>8,}  {share:>8.1f}%\")\n",
    "\n",
    "cumul = top_cip_boxes.cumsum()\n",
    "n50 = int((cumul <= boxes_total * 0.50).sum()) + 1\n",
    "n80 = int((cumul <= boxes_total * 0.80).sum()) + 1\n",
    "print(f\"\\n  50% du volume atteint par {n50} CIP13 ({n50/n_total*100:.1f}% des codes)\")\n",
    "print(f\"  80% du volume atteint par {n80} CIP13 ({n80/n_total*100:.1f}% des codes)\")\n",
    "\n",
    "print(f\"\\nTop 10 médicaments par volume :\")\n",
    "print(f\"  {'CIP13':<15} {'Boîtes':>12}  {'% total':>8}\")\n",
    "print(f\"  {'-'*40}\")\n",
    "for cip, v in top_cip_boxes.head(10).items():\n",
    "    print(f\"  {str(cip):<15} {int(v):>12,}  {v/boxes_total*100:>7.1f}%\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "m9empvhi208",
   "source": "#### Top 20 — nom commercial vs molécule (double vue)\n\n**Par nom commercial** : `CIP13` est la clé de jointure vers la BDPM — `CIS_CIP_bdpm.txt` relie chaque CIP13 à un code CIS, puis `CIS_bdpm.txt` fournit la dénomination commerciale (ex. DOLIPRANE, GLUCOPHAGE).\n\n**Par molécule** : la colonne `L_ATC5_` du fichier Open Medic contient directement la substance chimique (ex. paracétamol, metformine). **Pas besoin de la BDPM pour cette vue** — la jointure n'est utile que pour retrouver le nom de marque.",
   "metadata": {}
  },
  {
   "cell_type": "code",
   "id": "714c1nkus4a",
   "source": "# ── BDPM : CIP13 → nom commercial ──────────────────────────────────────────\nBDPM_DIR = Path(\"../../data/raw/bdpm\")\n\ncip_ref = pd.read_csv(\n    BDPM_DIR / \"CIS_CIP_bdpm.txt\",\n    sep=\"\\t\", header=None, encoding=\"latin-1\", low_memory=False,\n    usecols=[0, 2, 6],\n    names=[\"code_cis\", \"libelle_presentation\", \"code_cip13\"],\n    dtype=str,\n)\ncis_ref = pd.read_csv(\n    BDPM_DIR / \"CIS_bdpm.txt\",\n    sep=\"\\t\", header=None, encoding=\"latin-1\", low_memory=False,\n    usecols=[0, 1, 2],\n    names=[\"code_cis\", \"denomination_specialite\", \"forme_pharmaceutique\"],\n    dtype=str,\n)\ndrug_ref = (\n    cip_ref\n    .merge(cis_ref, on=\"code_cis\", how=\"left\")\n    [[\"code_cip13\", \"denomination_specialite\", \"forme_pharmaceutique\"]]\n    .assign(code_cip13=lambda d: d[\"code_cip13\"].str.strip().str.zfill(13))\n    .drop_duplicates(\"code_cip13\")\n)\n\n# ── Vue 1 : top 20 par nom commercial (jointure BDPM) ──────────────────────\ntop20_cip = (\n    top_cip_boxes.head(20)\n    .reset_index()\n    .rename(columns={CIP_COL: \"code_cip13\", BOX_COL: \"boites\"})\n)\ntop20_cip[\"code_cip13\"] = top20_cip[\"code_cip13\"].astype(str).str.strip().str.zfill(13)\ntop20_cip = top20_cip.merge(drug_ref, on=\"code_cip13\", how=\"left\")\ntop20_cip[\"label\"] = top20_cip.apply(\n    lambda r: str(r[\"denomination_specialite\"])[:45]\n              if pd.notna(r[\"denomination_specialite\"]) else f\"CIP {r['code_cip13']}\",\n    axis=1,\n)\nn_matched = top20_cip[\"denomination_specialite\"].notna().sum()\nprint(f\"Couverture BDPM : {n_matched}/20 CIP13 résolus en noms commerciaux\\n\")\n\n# ── Vue 2 : top 20 par molécule (L_ATC5 — direct Open Medic, sans BDPM) ────\nATC5_COL_Q1 = find_col(df, [\"L_ATC5\", \"ATC5\", \"atc5\"])\nif ATC5_COL_Q1:\n    top20_mol = (\n        df[df[ATC5_COL_Q1].notna()]\n        .groupby(ATC5_COL_Q1)[BOX_COL]\n        .sum()\n        .sort_values(ascending=False)\n        .head(20)\n    )\n    print(f\"Top molécule : {str(top20_mol.index[0]).title()} — {top20_mol.iloc[0]/1e6:.0f}M boîtes\")\nelse:\n    top20_mol = None\n    print(\"⚠  L_ATC5 introuvable — vue molécule désactivée\")\n\n# ── Graphiques côte à côte ─────────────────────────────────────────────────\nncols = 2 if top20_mol is not None else 1\nfig, axes = plt.subplots(1, ncols, figsize=(18, 7))\nif ncols == 1:\n    axes = [axes]\n\n# Panneau gauche : noms commerciaux\ntop20_cip_s = top20_cip.sort_values(\"boites\")\naxes[0].barh(range(len(top20_cip_s)), top20_cip_s[\"boites\"] / 1e6,\n             color=\"#3498db\", alpha=0.85)\naxes[0].set_yticks(range(len(top20_cip_s)))\naxes[0].set_yticklabels([l[:48] for l in top20_cip_s[\"label\"].tolist()], fontsize=8)\naxes[0].set_xlabel(\"Boîtes dispensées (millions)\")\naxes[0].set_title(\n    f\"Par nom commercial (BDPM)\\nOpen Medic {YEAR}\",\n    fontsize=10, fontweight=\"bold\"\n)\n\n# Panneau droit : molécules (ATC5, sans BDPM)\nif top20_mol is not None:\n    mol_vals   = top20_mol.values / 1e6\n    mol_labels = [str(s).title()[:45] for s in top20_mol.index]\n    sorted_idx = np.argsort(mol_vals)\n    axes[1].barh(range(len(mol_vals)), mol_vals[sorted_idx],\n                 color=\"#e67e22\", alpha=0.85)\n    axes[1].set_yticks(range(len(mol_vals)))\n    axes[1].set_yticklabels([mol_labels[i] for i in sorted_idx], fontsize=8)\n    axes[1].set_xlabel(\"Boîtes dispensées (millions)\")\n    axes[1].set_title(\n        f\"Par molécule — substance chimique ATC5 (sans BDPM)\\nOpen Medic {YEAR}\",\n        fontsize=10, fontweight=\"bold\"\n    )\n\nplt.suptitle(\n    f\"Q1 — Top 20 médicaments par nom commercial vs par molécule — {YEAR}\",\n    fontsize=12, fontweight=\"bold\", y=1.02\n)\nplt.tight_layout()\nplt.show()\n\n# ── Tableau comparatif ─────────────────────────────────────────────────────\nif top20_mol is not None:\n    tbl = pd.DataFrame({\n        \"Nom commercial (BDPM)\":        top20_cip[\"label\"].values,\n        \"Boîtes/nom (M)\":               (top20_cip[\"boites\"].values / 1e6).round(1),\n        \"Molécule (ATC5 — sans BDPM)\":  [str(s).title() for s in top20_mol.index],\n        \"Boîtes/mol. (M)\":              (top20_mol.values / 1e6).round(1),\n    }, index=range(1, 21))\n    tbl.index.name = \"Rang\"\n    display(tbl)",
   "metadata": {},
   "execution_count": null,
   "outputs": []
  },
  {
   "cell_type": "markdown",
   "id": "pztrr0n0nef",
   "metadata": {},
   "source": [
    "### Q2 — Comment les dépenses de remboursement se répartissent-elles par classe thérapeutique ?\n",
    "\n",
    "La classification ATC est la valeur ajoutée principale d'Open Medic par rapport à la BDPM : elle permet\n",
    "de segmenter le marché par système anatomique et aire thérapeutique. L'analyse met en évidence une\n",
    "dissociation fondamentale entre **volumes** (les classes qui prescrivent le plus) et **coûts** (les\n",
    "classes qui consomment le plus de budget Assurance Maladie). Cette dissociation est au cœur des enjeux\n",
    "de régulation pharmaceutique."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "6bgh7gxsry9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2200x700 with 3 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1300x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Q2 — Paysage thérapeutique ATC (2024) ===\n",
      "\n",
      "Classe ATC                                         Boîtes (M)   % vol   Remb. (M€)   % coût    €/boîte\n",
      "  ----------------------------------------------------------------------------------------------------\n",
      "  SYSTEME NERVEUX                                          867   36.6%          71    21.3%      0.08€\n",
      "  SYSTEME DIGESTIF ET METABOLISME                          417   17.6%          49    14.6%      0.12€\n",
      "  SYSTEME CARDIO-VASCULAIRE                                241   10.2%          78    23.4%      0.32€\n",
      "  ANTI-INFECTIEUX (USAGE SYSTEMIQUE)                       158    6.7%          35    10.5%      0.22€\n",
      "  SYSTEME RESPIRATOIRE                                     155    6.6%          21     6.3%      0.14€\n",
      "  SANG ET ORGANES HEMATOPOIETQUES                          130    5.5%          12     3.7%      0.10€\n",
      "  SYSTEME MUSCULO-SQUELETTIQUE                              86    3.6%          13     4.0%      0.15€\n",
      "  ORGANES SENSORIELS                                        80    3.4%          11     3.2%      0.13€\n",
      "  DERMATOLOGIE                                              79    3.3%          13     4.0%      0.17€\n",
      "  SYSTEME GENITO-URINAIRE ET HORMONES SEXUELLES             61    2.6%          10     2.9%      0.16€\n",
      "  HORMONES SYSTEMIQUES, A L EXCLUSION DES HORMONES          61    2.6%          10     3.0%      0.16€\n",
      "  ANTINEOPLASIQUES ET AGENTS IMMUNOMODULANTS                21    0.9%           2     0.6%      0.09€\n",
      "\n",
      "Dissociation volume/coût — les extrêmes :\n",
      "\n",
      "  Classes les moins chères par boîte :\n",
      "    SYSTEME NERVEUX                               0.08 €/boîte\n",
      "    ANTINEOPLASIQUES ET AGENTS IMMUNOMODULANTS    0.09 €/boîte\n",
      "    SANG ET ORGANES HEMATOPOIETQUES               0.10 €/boîte\n",
      "\n",
      "  Classes les plus chères par boîte :\n",
      "    DIVERS                                        1.08 €/boîte\n",
      "    ANTIPARASITAIRES, INSECTICIDES ET REPULSIFS   0.34 €/boîte\n",
      "    SYSTEME CARDIO-VASCULAIRE                     0.32 €/boîte\n"
     ]
    }
   ],
   "source": [
    "assert ATC1_COL, f\"Colonne ATC niveau 1 introuvable — colonnes disponibles : {list(df.columns)}\"\n",
    "assert REM_COL,  f\"Colonne montant remboursé introuvable\"\n",
    "\n",
    "# Agrégation par classe ATC niveau 1\n",
    "atc1 = df.groupby(ATC1_COL).agg(\n",
    "    boites=       (BOX_COL, \"sum\"),\n",
    "    remboursement=(REM_COL, \"sum\"),\n",
    ").dropna()\n",
    "atc1[\"cout_par_boite\"] = atc1[\"remboursement\"] / atc1[\"boites\"]\n",
    "atc1[\"pct_volume\"]     = atc1[\"boites\"] / atc1[\"boites\"].sum() * 100\n",
    "atc1[\"pct_couts\"]      = atc1[\"remboursement\"] / atc1[\"remboursement\"].sum() * 100\n",
    "atc1 = atc1.sort_values(\"boites\", ascending=False)\n",
    "\n",
    "fig, axes = plt.subplots(1, 3, figsize=(22, 7))\n",
    "\n",
    "top_vol = atc1[\"boites\"].head(10).sort_values()\n",
    "top_vol.plot.barh(ax=axes[0], color=\"steelblue\")\n",
    "axes[0].set_title(\"Classes ATC niveau 1\\npar volume (boîtes)\", fontsize=11, fontweight=\"bold\")\n",
    "axes[0].set_xlabel(\"Boîtes dispensées\")\n",
    "axes[0].xaxis.set_major_formatter(plt.FuncFormatter(lambda x, _: f\"{x/1e6:.0f}M\"))\n",
    "axes[0].set_yticklabels([str(l)[:45] for l in top_vol.index], fontsize=8)\n",
    "\n",
    "top_rem = atc1[\"remboursement\"].sort_values().tail(10).sort_values()\n",
    "top_rem.plot.barh(ax=axes[1], color=\"darkorange\")\n",
    "axes[1].set_title(\"Classes ATC niveau 1\\npar montant remboursé (€)\", fontsize=11, fontweight=\"bold\")\n",
    "axes[1].set_xlabel(\"Montant remboursé\")\n",
    "axes[1].xaxis.set_major_formatter(plt.FuncFormatter(lambda x, _: f\"{x/1e9:.1f} Md€\"))\n",
    "axes[1].set_yticklabels([str(l)[:45] for l in top_rem.index], fontsize=8)\n",
    "\n",
    "top_cpb = atc1[\"cout_par_boite\"].sort_values().tail(10).sort_values()\n",
    "bars = axes[2].barh(range(len(top_cpb)), top_cpb.values, color=\"seagreen\")\n",
    "axes[2].set_yticks(range(len(top_cpb)))\n",
    "axes[2].set_yticklabels([str(l)[:45] for l in top_cpb.index], fontsize=8)\n",
    "axes[2].set_xlabel(\"Coût moyen par boîte (€)\")\n",
    "axes[2].set_title(\"Coût moyen par boîte (€)\\npar classe ATC (top 10)\", fontsize=11, fontweight=\"bold\")\n",
    "for bar, v in zip(bars, top_cpb.values):\n",
    "    axes[2].text(v + 0.3, bar.get_y() + bar.get_height() / 2,\n",
    "                 f\"{v:.1f}€\", va=\"center\", fontsize=7, fontweight=\"bold\")\n",
    "\n",
    "plt.suptitle(\"Q2 — Paysage thérapeutique ATC : volume vs coût\", fontsize=13, fontweight=\"bold\", y=1.01)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Bubble chart: volume vs remboursement\n",
    "fig, ax = plt.subplots(figsize=(13, 8))\n",
    "sc = ax.scatter(\n",
    "    atc1[\"boites\"] / 1e6,\n",
    "    atc1[\"remboursement\"] / 1e9,\n",
    "    s=atc1[\"cout_par_boite\"] * 4,\n",
    "    c=atc1[\"cout_par_boite\"],\n",
    "    cmap=\"RdYlGn_r\", alpha=0.8, edgecolors=\"white\", linewidth=0.5\n",
    ")\n",
    "for atc_name, row in atc1.iterrows():\n",
    "    ax.annotate(str(atc_name)[:35], (row[\"boites\"] / 1e6, row[\"remboursement\"] / 1e9),\n",
    "                fontsize=7, alpha=0.85, xytext=(4, 3), textcoords=\"offset points\")\n",
    "plt.colorbar(sc, ax=ax, label=\"Coût moyen / boîte (€)\")\n",
    "ax.set_xlabel(\"Volume (millions de boîtes)\")\n",
    "ax.set_ylabel(\"Montant remboursé (milliards €)\")\n",
    "ax.set_title(\"Volume vs Coût par classe ATC niveau 1\\n(taille et couleur des bulles = coût moyen par boîte)\",\n",
    "             fontsize=12, fontweight=\"bold\")\n",
    "ax.grid(alpha=0.3)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# --- Résultats détaillés ---\n",
    "print(f\"=== Q2 — Paysage thérapeutique ATC ({YEAR}) ===\")\n",
    "print(f\"\\n{'Classe ATC':<50} {'Boîtes (M)':>10}  {'% vol':>6}  {'Remb. (M€)':>11}  {'% coût':>7}  {'€/boîte':>9}\")\n",
    "print(f\"  {'-'*100}\")\n",
    "for atc_name, row in atc1.head(12).iterrows():\n",
    "    label = str(atc_name)[:48]\n",
    "    print(f\"  {label:<50} {row['boites']/1e6:>9.0f}  {row['pct_volume']:>5.1f}%  \"\n",
    "          f\"{row['remboursement']/1e6:>10.0f}  {row['pct_couts']:>6.1f}%  {row['cout_par_boite']:>8.2f}€\")\n",
    "\n",
    "print(f\"\\nDissociation volume/coût — les extrêmes :\")\n",
    "cheapest  = atc1.nsmallest(3,  \"cout_par_boite\")\n",
    "costliest = atc1.nlargest(3, \"cout_par_boite\")\n",
    "print(f\"\\n  Classes les moins chères par boîte :\")\n",
    "for a, r in cheapest.iterrows():\n",
    "    print(f\"    {str(a)[:45]:<45} {r['cout_par_boite']:.2f} €/boîte\")\n",
    "print(f\"\\n  Classes les plus chères par boîte :\")\n",
    "for a, r in costliest.iterrows():\n",
    "    print(f\"    {str(a)[:45]:<45} {r['cout_par_boite']:.2f} €/boîte\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3a1d1nlgkhh",
   "metadata": {},
   "source": [
    "### Q3 — La prescription révèle-t-elle des inégalités démographiques ?\n",
    "\n",
    "Open Medic ventile chaque ligne par tranche d'âge (trois classes : 0-19 ans, 20-59 ans, 60 ans et plus)\n",
    "et par sexe — une dimension absente de la BDPM. Cette granularité permet de répondre à une question\n",
    "clé : **qui** consomme réellement les médicaments ? La répartition observée est loin d'être uniforme :\n",
    "certaines classes thérapeutiques sont quasi-exclusivement consommées par des patients âgés, d'autres\n",
    "présentent un fort déséquilibre hommes/femmes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "oc2kub1dpw",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1400x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Q3 — Démographie des patients (2024) ===\n",
      "\n",
      "Répartition par âge (codes : 0=0-19 ans, 20=20-59 ans, 60=60 ans et plus, 99=inconnu) :\n",
      "  Tranche               Boîtes (M)   % total\n",
      "  --------------------------------------------\n",
      "    0                         183      7.7%\n",
      "    20                        856     36.2%\n",
      "  ★ 60                       1328     56.1%\n",
      "    99                          1      0.0%\n",
      "\n",
      "  → 60 ans et plus : 1328M boîtes (56.1% du total)\n",
      "\n",
      "Répartition par sexe :\n",
      "  Homme                 1013M boîtes  (42.8%)\n",
      "  Femme                 1355M boîtes  (57.2%)\n",
      "  Non précisé              0M boîtes  (0.0%)\n",
      "\n",
      "Top 8 classes ATC — index de féminité (% boîtes chez les femmes) :\n",
      "  Classe ATC                                           % Femme    % Homme\n",
      "  ------------------------------------------------------------------------\n",
      "  SYSTEME NERVEUX                                        59.4%      40.6%\n",
      "  ORGANES SENSORIELS                                     58.6%      41.4%\n",
      "  SYSTEME DIGESTIF ET METABOLISME                        58.4%      41.6%\n",
      "  ANTI-INFECTIEUX (USAGE SYSTEMIQUE)                     56.6%      43.4%\n",
      "  SYSTEME RESPIRATOIRE                                   56.1%      43.9%\n",
      "  SYSTEME MUSCULO-SQUELETTIQUE                           56.0%      44.0%\n",
      "  SANG ET ORGANES HEMATOPOIETQUES                        50.9%      49.1%\n",
      "  SYSTEME CARDIO-VASCULAIRE                              49.5%      50.5%\n"
     ]
    }
   ],
   "source": [
    "assert AGE_COL, f\"Colonne âge introuvable — colonnes dispo : {list(df.columns)}\"\n",
    "assert SEX_COL, f\"Colonne sexe introuvable — colonnes dispo : {list(df.columns)}\"\n",
    "\n",
    "# Codes AGE : 0=0-19 ans, 20=20-59 ans, 60=60 ans et plus, 99=inconnu\n",
    "age_boxes = df.groupby(AGE_COL)[BOX_COL].sum()\n",
    "\n",
    "def age_sort_key(label):\n",
    "    m = re.search(r'\\d+', str(label))\n",
    "    return int(m.group()) if m else 999\n",
    "\n",
    "age_boxes = age_boxes.reindex(sorted(age_boxes.index, key=age_sort_key))\n",
    "\n",
    "# --- Sexe ---\n",
    "sex_boxes = df.groupby(SEX_COL)[BOX_COL].sum()\n",
    "sex_labels = {1: \"Homme\", 2: \"Femme\", 9: \"Non précisé\"}\n",
    "sex_boxes.index = sex_boxes.index.map(lambda x: sex_labels.get(int(x) if str(x).isdigit() else x, str(x)))\n",
    "sex_hf = sex_boxes[[l for l in [\"Homme\", \"Femme\"] if l in sex_boxes.index]]\n",
    "\n",
    "# --- Graphiques ---\n",
    "fig, axes = plt.subplots(1, 2, figsize=(18, 6))\n",
    "\n",
    "age_boxes.plot.barh(ax=axes[0], color=\"steelblue\")\n",
    "axes[0].set_title(f\"Boîtes dispensées par tranche d'âge\\nOpen Medic {YEAR}\", fontsize=11, fontweight=\"bold\")\n",
    "axes[0].set_xlabel(\"Nombre de boîtes\")\n",
    "axes[0].xaxis.set_major_formatter(plt.FuncFormatter(lambda x, _: f\"{x/1e6:.0f}M\"))\n",
    "\n",
    "colors_sex = [\"#3498db\", \"#e74c3c\"]\n",
    "if len(sex_hf) >= 2:\n",
    "    axes[1].pie(\n",
    "        sex_hf.values, labels=sex_hf.index, autopct=\"%1.1f%%\",\n",
    "        colors=colors_sex[:len(sex_hf)], startangle=90,\n",
    "        wedgeprops={\"edgecolor\": \"white\", \"linewidth\": 1.5}\n",
    "    )\n",
    "axes[1].set_title(f\"Répartition des boîtes par sexe\\n(hors 'non précisé')\", fontsize=11, fontweight=\"bold\")\n",
    "axes[1].set_ylabel(\"\")\n",
    "\n",
    "plt.suptitle(\"Q3 — Démographie des patients : âge et sexe\", fontsize=13, fontweight=\"bold\", y=1.01)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# --- Heatmap âge × ATC ---\n",
    "if ATC1_COL:\n",
    "    age_atc = df.groupby([AGE_COL, ATC1_COL])[BOX_COL].sum().unstack(fill_value=0)\n",
    "    top_atc_cols = age_atc.sum().nlargest(8).index\n",
    "    age_atc_top  = age_atc[top_atc_cols]\n",
    "    age_atc_top  = age_atc_top.reindex(sorted(age_atc_top.index, key=age_sort_key))\n",
    "    age_atc_pct  = age_atc_top.div(age_atc_top.sum(axis=1), axis=0) * 100\n",
    "\n",
    "    fig, ax = plt.subplots(figsize=(14, 6))\n",
    "    im = ax.imshow(age_atc_pct.T.values, aspect=\"auto\", cmap=\"Blues\", vmin=0)\n",
    "    ax.set_xticks(range(len(age_atc_pct.index)))\n",
    "    ax.set_xticklabels(age_atc_pct.index, rotation=45, ha=\"right\", fontsize=8)\n",
    "    ax.set_yticks(range(len(age_atc_pct.columns)))\n",
    "    ax.set_yticklabels([str(c)[:50] for c in age_atc_pct.columns], fontsize=8)\n",
    "    plt.colorbar(im, ax=ax, label=\"Part des boîtes dans la tranche d'âge (%)\")\n",
    "    ax.set_title(\"Profil thérapeutique par tranche d'âge — part de chaque classe ATC (%)\",\n",
    "                 fontsize=11, fontweight=\"bold\")\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "# --- Résultats détaillés ---\n",
    "print(f\"=== Q3 — Démographie des patients ({YEAR}) ===\")\n",
    "\n",
    "total_b = age_boxes.sum()\n",
    "# Code AGE = 60 correspond à \"60 ans et plus\"\n",
    "age_60p_val = age_boxes[[a for a in age_boxes.index if age_sort_key(a) == 60]].sum()\n",
    "\n",
    "print(f\"\\nRépartition par âge (codes : 0=0-19 ans, 20=20-59 ans, 60=60 ans et plus, 99=inconnu) :\")\n",
    "print(f\"  {'Tranche':<20} {'Boîtes (M)':>11}  {'% total':>8}\")\n",
    "print(f\"  {'-'*44}\")\n",
    "for age_label, v in age_boxes.items():\n",
    "    is_senior = \"★\" if age_sort_key(age_label) == 60 else \" \"\n",
    "    print(f\"  {is_senior} {str(age_label):<18} {v/1e6:>10.0f}  {v/total_b*100:>7.1f}%\")\n",
    "print(f\"\\n  → 60 ans et plus : {age_60p_val/1e6:.0f}M boîtes ({age_60p_val/total_b*100:.1f}% du total)\")\n",
    "\n",
    "print(f\"\\nRépartition par sexe :\")\n",
    "for s, v in sex_boxes.items():\n",
    "    print(f\"  {str(s):<15} {v/1e6:>10.0f}M boîtes  ({v/sex_boxes.sum()*100:.1f}%)\")\n",
    "\n",
    "# Profil ATC par sexe\n",
    "if ATC1_COL:\n",
    "    print(f\"\\nTop 8 classes ATC — index de féminité (% boîtes chez les femmes) :\")\n",
    "    sex_atc = df[df[SEX_COL].astype(str).isin([\"1\", \"2\"])].copy()\n",
    "    sex_atc[\"sexe_label\"] = sex_atc[SEX_COL].astype(str).map({\"1\": \"Homme\", \"2\": \"Femme\"})\n",
    "    atc_sex = sex_atc.groupby([ATC1_COL, \"sexe_label\"])[BOX_COL].sum().unstack(fill_value=0)\n",
    "    if \"Femme\" in atc_sex.columns and \"Homme\" in atc_sex.columns:\n",
    "        atc_sex[\"total\"]     = atc_sex[\"Femme\"] + atc_sex[\"Homme\"]\n",
    "        atc_sex[\"pct_femme\"] = atc_sex[\"Femme\"] / atc_sex[\"total\"] * 100\n",
    "        top_atc_by_vol = atc_sex.nlargest(8, \"total\")\n",
    "        print(f\"  {'Classe ATC':<50} {'% Femme':>9}  {'% Homme':>9}\")\n",
    "        print(f\"  {'-'*72}\")\n",
    "        for atc_n, row in top_atc_by_vol.sort_values(\"pct_femme\", ascending=False).iterrows():\n",
    "            print(f\"  {str(atc_n)[:48]:<50} {row['pct_femme']:>8.1f}%  {100-row['pct_femme']:>8.1f}%\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b5cymulliju",
   "metadata": {},
   "source": [
    "---\n",
    "## Comparaison multi-années (optionnel — nécessite de télécharger d'autres millésimes)\n",
    "\n",
    "Open Medic couvre 2014-2024 : dix ans de prescription permettent d'analyser les tendances\n",
    "structurelles (montée des biologiques, baisse des antibiotiques, hausse des traitements\n",
    "du diabète de type 2...). Décommenter la cellule suivante pour télécharger tous les millésimes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "4js4a2yaxgk",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Cellule multi-années — décommenter pour exécuter.\n"
     ]
    }
   ],
   "source": [
    "# Décommenter pour télécharger et comparer tous les millésimes disponibles (2014-2024)\n",
    "# for year in range(2014, 2025):\n",
    "#     dest_y = RAW_DIR / f\"open_medic_{year}.csv\"\n",
    "#     if dest_y.exists():\n",
    "#         print(f\"  [skip] {year}\")\n",
    "#         continue\n",
    "#     print(f\"  Downloading {year}...\", end=\" \")\n",
    "#     with httpx.stream(\"GET\", open_medic_url(year), follow_redirects=True, timeout=600) as r:\n",
    "#         r.raise_for_status()\n",
    "#         with open(dest_y, \"wb\") as f:\n",
    "#             for chunk in r.iter_bytes(65536):\n",
    "#                 f.write(chunk)\n",
    "#     print(f\"{dest_y.stat().st_size/1e6:.0f} MB\")\n",
    "#\n",
    "# dfs = []\n",
    "# for year in range(2014, 2025):\n",
    "#     p = RAW_DIR / f\"open_medic_{year}.csv\"\n",
    "#     if not p.exists():\n",
    "#         continue\n",
    "#     d = pd.read_csv(p, sep=\";\", encoding=\"latin-1\", low_memory=False)\n",
    "#     d.columns = d.columns.str.strip()\n",
    "#     bc = find_col(d, ['boite', 'BOITES'])\n",
    "#     rc = find_col(d, ['REM'])\n",
    "#     if bc and rc:\n",
    "#         for col in [bc, rc]:\n",
    "#             d[col] = pd.to_numeric(d[col].astype(str).str.replace(',', '.'), errors='coerce')\n",
    "#         dfs.append({\"year\": year, \"boites\": d[bc].sum(), \"remboursement\": d[rc].sum()})\n",
    "#\n",
    "# if dfs:\n",
    "#     trend = pd.DataFrame(dfs).set_index(\"year\")\n",
    "#     fig, axes = plt.subplots(1, 2, figsize=(14, 5))\n",
    "#     trend[\"boites\"].div(1e9).plot.bar(ax=axes[0], color=\"steelblue\")\n",
    "#     axes[0].set_title(\"Total boîtes dispensées par année (Mds)\")\n",
    "#     axes[0].set_ylabel(\"Milliards de boîtes\")\n",
    "#     trend[\"remboursement\"].div(1e9).plot.bar(ax=axes[1], color=\"darkorange\")\n",
    "#     axes[1].set_title(\"Total remboursé par année (Mds €)\")\n",
    "#     axes[1].set_ylabel(\"Milliards €\")\n",
    "#     plt.tight_layout()\n",
    "#     plt.show()\n",
    "print(\"Cellule multi-années — décommenter pour exécuter.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "yd79nfbgtys",
   "metadata": {},
   "source": [
    "---\n",
    "## Q4 — Pénétration des génériques par classe thérapeutique\n",
    "\n",
    "Open Medic encode si chaque boîte dispensée était un générique (`TOP_GEN=1`) ou un original\n",
    "(`TOP_GEN=0`), et si la molécule appartient à un groupe de génériques (`GEN_NUM>0`).\n",
    "Ces deux indicateurs permettent de mesurer la substitution effective et d'estimer combien\n",
    "de boîtes originales auraient pu être substituées — proxy direct du potentiel d'économies\n",
    "pour l'Assurance Maladie."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "luqry0of6c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x700 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Q4 — Pénétration des génériques (2024) ===\n",
      "\n",
      "  Encodage TOP_GEN (depuis 2022) :\n",
      "    0 = pas dans une famille de générique (aucun générique existant)\n",
      "    1 = Générique\n",
      "    4 = Princep (original dont il existe un générique)\n",
      "    9 = Inconnu\n",
      "\n",
      "  Statut                         Boîtes (M)   % boîtes   Remb. (M€)   % coût\n",
      "  ---------------------------------------------------------------------------\n",
      "  Sans famille de générique           1094      46.2%          89    26.7%\n",
      "  Générique                           1062      44.8%         209    62.9%\n",
      "  Princep (original)                   212       9.0%          35    10.4%\n",
      "  Inconnu                                0       0.0%           0     0.0%\n",
      "\n",
      "  Taux de substitution (génériques / [génériques + princeps]) par classe ATC :\n",
      "  Classe ATC                                          Taux sub.   Marché générique (M boîtes)\n",
      "  --------------------------------------------------------------------------------------------\n",
      "  ANTI-INFECTIEUX (USAGE SYSTEMIQUE)                      95.0%                          111\n",
      "  SYSTEME MUSCULO-SQUELETTIQUE                            94.1%                           59\n",
      "  SYSTEME RESPIRATOIRE                                    90.3%                           79\n",
      "  SYSTEME GENITO-URINAIRE ET HORMONES SEXUELLES           90.1%                           38\n",
      "  SYSTEME CARDIO-VASCULAIRE                               89.4%                          220\n",
      "  ANTIPARASITAIRES, INSECTICIDES ET REPULSIFS             87.7%                            3\n",
      "  SYSTEME DIGESTIF ET METABOLISME                         84.7%                          281\n",
      "  DERMATOLOGIE                                            82.8%                           54\n",
      "  SYSTEME NERVEUX                                         79.3%                          312\n",
      "  ORGANES SENSORIELS                                      66.3%                           18\n",
      "  HORMONES SYSTEMIQUES, A L EXCLUSION DES HORMONES        58.7%                           47\n",
      "  ANTINEOPLASIQUES ET AGENTS IMMUNOMODULANTS              50.6%                            7\n",
      "  SANG ET ORGANES HEMATOPOIETQUES                         50.0%                           43\n",
      "  DIVERS                                                  42.1%                            1\n",
      "\n",
      "  Synthèse du marché générique :\n",
      "    Boîtes en famille générique (GEN_NUM > 0) : 813M (34.3% du total)\n",
      "    dont Génériques (TOP_GEN=1)               : 1062M\n",
      "    dont Princeps  (TOP_GEN=4)                : 212M (non substituées)\n",
      "    Taux de substitution effectif              : 83.3%\n"
     ]
    }
   ],
   "source": [
    "assert GEN_COL,    f\"TOP_GEN introuvable — colonnes : {list(df.columns)}\"\n",
    "assert GENNUM_COL, f\"GEN_NUM introuvable — colonnes : {list(df.columns)}\"\n",
    "\n",
    "# TOP_GEN (depuis 2022) :\n",
    "#   0 = pas dans une famille de générique (pas de générique disponible)\n",
    "#   1 = Générique\n",
    "#   4 = Princep (original dans une famille qui a des génériques)\n",
    "#   9 = Inconnu\n",
    "# NB : pour 2014-2021, l'encodage était différent (G/R/S/9/0)\n",
    "GEN_MAP = {0: \"Sans famille de générique\", 1: \"Générique\", 4: \"Princep (original)\", 9: \"Inconnu\"}\n",
    "df[\"_gen_label\"] = df[GEN_COL].map(GEN_MAP).fillna(\"Code \" + df[GEN_COL].astype(str))\n",
    "\n",
    "# ── Globalement ──\n",
    "g_stats = df.groupby(\"_gen_label\").agg(\n",
    "    boites        =(BOX_COL, \"sum\"),\n",
    "    remboursement =(REM_COL, \"sum\"),\n",
    ").dropna().reindex([GEN_MAP[k] for k in sorted(GEN_MAP) if GEN_MAP[k] in df[\"_gen_label\"].unique()])\n",
    "g_stats[\"pct_boites\"] = g_stats[\"boites\"] / g_stats[\"boites\"].sum() * 100\n",
    "g_stats[\"pct_rem\"]    = g_stats[\"remboursement\"] / g_stats[\"remboursement\"].sum() * 100\n",
    "\n",
    "# ── Taux de substitution par classe ATC niveau 1 ──\n",
    "# Générique + Princep = molécules avec famille générique (GEN_NUM > 0)\n",
    "# Taux de substitution = Générique / (Générique + Princep)\n",
    "gen_atc = df.groupby([ATC1_COL, GEN_COL])[BOX_COL].sum().unstack(fill_value=0)\n",
    "gen_atc.columns = [GEN_MAP.get(int(c) if str(c).isdigit() else c, str(c)) for c in gen_atc.columns]\n",
    "gen_atc[\"total\"] = gen_atc.sum(axis=1)\n",
    "gen_col = \"Générique\"\n",
    "pri_col = \"Princep (original)\"\n",
    "if gen_col in gen_atc.columns and pri_col in gen_atc.columns:\n",
    "    gen_atc[\"marche_generique\"] = gen_atc[gen_col] + gen_atc[pri_col]\n",
    "    gen_atc[\"taux_sub\"] = gen_atc[gen_col] / gen_atc[\"marche_generique\"].replace(0, float(\"nan\")) * 100\n",
    "    gen_atc = gen_atc.sort_values(\"taux_sub\", ascending=False)\n",
    "elif gen_col in gen_atc.columns:\n",
    "    gen_atc[\"taux_sub\"] = gen_atc[gen_col] / gen_atc[\"total\"] * 100\n",
    "    gen_atc = gen_atc.sort_values(\"taux_sub\", ascending=False)\n",
    "\n",
    "# ── Substitution potentielle : boîtes prescrites en Princep ──\n",
    "df[\"_gennum\"]       = pd.to_numeric(df[GENNUM_COL], errors=\"coerce\").fillna(0)\n",
    "df[\"_is_princep\"]   = df[GEN_COL] == 4   # original avec générique dispo\n",
    "df[\"_is_generic\"]   = df[GEN_COL] == 1\n",
    "n_with_gen_fam  = df[df[\"_gennum\"] > 0][BOX_COL].sum()\n",
    "n_princep       = df[df[\"_is_princep\"]][BOX_COL].sum()\n",
    "n_generic       = df[df[\"_is_generic\"]][BOX_COL].sum()\n",
    "n_total_boxes   = df[BOX_COL].sum()\n",
    "taux_sub_global = n_generic / (n_generic + n_princep) * 100 if (n_generic + n_princep) > 0 else 0\n",
    "\n",
    "# ── Graphiques ──\n",
    "fig, axes = plt.subplots(1, 2, figsize=(18, 7))\n",
    "\n",
    "if \"taux_sub\" in gen_atc.columns:\n",
    "    gen_atc[\"taux_sub\"].dropna().sort_values().plot.barh(ax=axes[0], color=\"seagreen\")\n",
    "    axes[0].axvline(gen_atc[\"taux_sub\"].dropna().mean(), color=\"red\", linestyle=\"--\", alpha=0.7,\n",
    "                    label=f\"Moyenne : {gen_atc['taux_sub'].dropna().mean():.1f}%\")\n",
    "    axes[0].set_title(\"Taux de substitution générique\\npar classe ATC niveau 1\",\n",
    "                      fontsize=11, fontweight=\"bold\")\n",
    "    axes[0].set_xlabel(\"% boîtes en générique (parmi les molécules génériquées)\")\n",
    "    axes[0].legend(fontsize=9)\n",
    "    axes[0].set_yticklabels(\n",
    "        [str(l)[:45] for l in gen_atc[\"taux_sub\"].dropna().sort_values().index], fontsize=8)\n",
    "\n",
    "# Camembert global\n",
    "pie_data = g_stats[\"boites\"].dropna()\n",
    "pie_data = pie_data[pie_data > 0]\n",
    "axes[1].pie(pie_data, labels=pie_data.index,\n",
    "            autopct=\"%1.1f%%\", startangle=90,\n",
    "            colors=[\"#27ae60\", \"#e67e22\", \"#95a5a6\", \"#c0392b\"][:len(pie_data)],\n",
    "            wedgeprops={\"edgecolor\": \"white\", \"linewidth\": 1.5})\n",
    "axes[1].set_title(\"Répartition des boîtes\\npar statut TOP_GEN\", fontsize=11, fontweight=\"bold\")\n",
    "\n",
    "plt.suptitle(\"Q4 — Pénétration des génériques par classe thérapeutique\",\n",
    "             fontsize=13, fontweight=\"bold\", y=1.01)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# ── Résultats ──\n",
    "print(f\"=== Q4 — Pénétration des génériques ({YEAR}) ===\\n\")\n",
    "print(f\"  Encodage TOP_GEN (depuis 2022) :\")\n",
    "print(f\"    0 = pas dans une famille de générique (aucun générique existant)\")\n",
    "print(f\"    1 = Générique\")\n",
    "print(f\"    4 = Princep (original dont il existe un générique)\")\n",
    "print(f\"    9 = Inconnu\\n\")\n",
    "print(f\"  {'Statut':<30} {'Boîtes (M)':>10}  {'% boîtes':>9}  {'Remb. (M€)':>11}  {'% coût':>7}\")\n",
    "print(f\"  {'-'*75}\")\n",
    "for label, row in g_stats.iterrows():\n",
    "    if pd.isna(row[\"boites\"]):\n",
    "        continue\n",
    "    print(f\"  {str(label):<30} {row['boites']/1e6:>9.0f}  {row['pct_boites']:>8.1f}%  \"\n",
    "          f\"{row['remboursement']/1e6:>10.0f}  {row['pct_rem']:>6.1f}%\")\n",
    "\n",
    "print(f\"\\n  Taux de substitution (génériques / [génériques + princeps]) par classe ATC :\")\n",
    "print(f\"  {'Classe ATC':<50} {'Taux sub.':>10}  {'Marché générique (M boîtes)':>28}\")\n",
    "print(f\"  {'-'*92}\")\n",
    "if \"taux_sub\" in gen_atc.columns:\n",
    "    for atc_n, row in gen_atc.dropna(subset=[\"taux_sub\"]).sort_values(\"taux_sub\", ascending=False).iterrows():\n",
    "        print(f\"  {str(atc_n)[:48]:<50} {row['taux_sub']:>9.1f}%  {row.get('marche_generique', row['total'])/1e6:>27.0f}\")\n",
    "\n",
    "print(f\"\\n  Synthèse du marché générique :\")\n",
    "print(f\"    Boîtes en famille générique (GEN_NUM > 0) : {n_with_gen_fam/1e6:.0f}M ({n_with_gen_fam/n_total_boxes*100:.1f}% du total)\")\n",
    "print(f\"    dont Génériques (TOP_GEN=1)               : {n_generic/1e6:.0f}M\")\n",
    "print(f\"    dont Princeps  (TOP_GEN=4)                : {n_princep/1e6:.0f}M (non substituées)\")\n",
    "print(f\"    Taux de substitution effectif              : {taux_sub_global:.1f}%\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "u4xtn34i5jb",
   "metadata": {},
   "source": [
    "---\n",
    "## Q5 — Profil prescripteur par spécialité médicale\n",
    "\n",
    "Open Medic ventile chaque ligne par code de spécialité du prescripteur (`PSP_SPE`).\n",
    "Cette dimension permet d'identifier qui prescrit quoi : le médecin généraliste domine-t-il\n",
    "par le volume, ou les spécialistes génèrent-ils l'essentiel de la dépense ?\n",
    "La heatmap spécialité × classe ATC révèle les \"signatures thérapeutiques\" propres\n",
    "à chaque spécialité — et permet de détecter les prescriptions atypiques (hors périmètre habituel)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "5knkhgrzjnp",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x700 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Q5 — Analyse par spécialité prescriptrice (2024) ===\n",
      "\n",
      "  Spécialité                             Boîtes (M)   % vol.   Remb. (M€)   % coût    €/boîte\n",
      "  ----------------------------------------------------------------------------------------\n",
      "  Médecine générale libérale                  1596    67.4%          68    20.6%      0.04€\n",
      "  Prescripteurs salariés (hôpitaux)            457    19.3%          73    21.9%      0.16€\n",
      "  Ophtalmologie                                 40     1.7%           6     1.9%      0.15€\n",
      "  Psychiatrie                                   33     1.4%          11     3.3%      0.33€\n",
      "  Chirurgie dentaire                            32     1.4%           6     1.9%      0.20€\n",
      "  Chirurgie                                     25     1.1%          12     3.6%      0.48€\n",
      "  Valeur inconnue                               21     0.9%          62    18.7%      2.92€\n",
      "  Autres prescripteurs de ville                 20     0.9%           8     2.3%      0.38€\n",
      "  Pédiatrie                                     20     0.8%           5     1.5%      0.26€\n",
      "  Gynécologie-obstétrique                       19     0.8%           6     1.9%      0.33€\n",
      "  Pathologie cardio-vasculaire                  18     0.8%          16     4.8%      0.88€\n",
      "  Rhumatologie                                  14     0.6%           6     1.7%      0.39€\n",
      "  Dermatologie et vénérologie                   12     0.5%           6     1.9%      0.51€\n",
      "  Pneumologie                                   10     0.4%           6     1.7%      0.57€\n",
      "  Endocrinologie et métabolismes                10     0.4%           8     2.3%      0.80€\n",
      "  Gastro-entérologie et hépatologie              8     0.3%           5     1.4%      0.58€\n",
      "  ORL                                            7     0.3%           6     1.8%      0.82€\n",
      "  Radiologie                                     6     0.3%           6     1.7%      0.92€\n",
      "  Neurologie                                     6     0.2%           5     1.4%      0.83€\n",
      "  Médecine interne                               4     0.2%           5     1.4%      1.06€\n",
      "\n",
      "  Spécialités libérales au coût unitaire le plus élevé (€ / boîte) :\n",
      "  Spécialité                               €/boîte  Boîtes (M)   Remb. (M€)\n",
      "  ------------------------------------------------------------------------\n",
      "  Anatomie-cytologie pathologique            2.21€          0           0\n",
      "  Directeur laboratoire médecin              1.43€          0           0\n",
      "  Médecine physique et réadaptation          1.11€          0           1\n",
      "  Anesthésiologie-réanimation                1.10€          2           2\n",
      "  Médecine interne                           1.06€          4           5\n",
      "  Radiologie                                 0.92€          6           6\n",
      "  Néphrologie                                0.91€          3           3\n",
      "  Pathologie cardio-vasculaire               0.88€         18          16\n"
     ]
    }
   ],
   "source": [
    "assert PSP_SPE_COL, f\"PSP_SPE introuvable — colonnes : {list(df.columns)}\"\n",
    "\n",
    "# Codes PSP_SPE — source : feuille PSP_SPE du fichier descriptif-variables CNAM\n",
    "# Prescripteurs de ville (médecins et dentistes libéraux)\n",
    "SPE_LABELS = {\n",
    "    1:  \"Médecine générale libérale\",\n",
    "    2:  \"Anesthésiologie-réanimation\",\n",
    "    3:  \"Pathologie cardio-vasculaire\",\n",
    "    4:  \"Chirurgie\",\n",
    "    5:  \"Dermatologie et vénérologie\",\n",
    "    6:  \"Radiologie\",\n",
    "    7:  \"Gynécologie-obstétrique\",\n",
    "    8:  \"Gastro-entérologie et hépatologie\",\n",
    "    9:  \"Médecine interne\",\n",
    "    11: \"ORL\",\n",
    "    12: \"Pédiatrie\",\n",
    "    13: \"Pneumologie\",\n",
    "    14: \"Rhumatologie\",\n",
    "    15: \"Ophtalmologie\",\n",
    "    17: \"Psychiatrie\",\n",
    "    18: \"Stomatologie\",\n",
    "    19: \"Chirurgie dentaire\",\n",
    "    31: \"Médecine physique et réadaptation\",\n",
    "    32: \"Neurologie\",\n",
    "    35: \"Néphrologie\",\n",
    "    36: \"Chirurgie dentaire (ODF)\",\n",
    "    37: \"Anatomie-cytologie pathologique\",\n",
    "    38: \"Directeur laboratoire médecin\",\n",
    "    42: \"Endocrinologie et métabolismes\",\n",
    "    # Autres\n",
    "    90: \"Prescripteurs salariés (hôpitaux)\",\n",
    "    98: \"Autres prescripteurs de ville\",\n",
    "    99: \"Valeur inconnue\",\n",
    "}\n",
    "df[\"_spe_label\"] = (pd.to_numeric(df[PSP_SPE_COL], errors=\"coerce\")\n",
    "                    .map(SPE_LABELS)\n",
    "                    .fillna(\"Code \" + df[PSP_SPE_COL].astype(str).str.strip()))\n",
    "\n",
    "spe_stats = df.groupby(\"_spe_label\").agg(\n",
    "    boites        =(BOX_COL, \"sum\"),\n",
    "    remboursement =(REM_COL, \"sum\"),\n",
    ").dropna().sort_values(\"boites\", ascending=False)\n",
    "spe_stats[\"cout_par_boite\"] = spe_stats[\"remboursement\"] / spe_stats[\"boites\"]\n",
    "spe_stats[\"pct_volume\"]     = spe_stats[\"boites\"] / spe_stats[\"boites\"].sum() * 100\n",
    "spe_stats[\"pct_couts\"]      = spe_stats[\"remboursement\"] / spe_stats[\"remboursement\"].sum() * 100\n",
    "\n",
    "EXCLUDE = [\"Valeur inconnue\", \"Prescripteurs salariés (hôpitaux)\", \"Autres prescripteurs de ville\"]\n",
    "\n",
    "# ── Graphiques barres ──\n",
    "fig, axes = plt.subplots(1, 2, figsize=(18, 7))\n",
    "\n",
    "top_vol = spe_stats[~spe_stats.index.isin(EXCLUDE)].head(12)\n",
    "top_vol[\"boites\"].sort_values().plot.barh(ax=axes[0], color=\"steelblue\")\n",
    "axes[0].set_title(f\"Top spécialités libérales\\npar volume de prescription — {YEAR}\",\n",
    "                  fontsize=11, fontweight=\"bold\")\n",
    "axes[0].set_xlabel(\"Boîtes dispensées\")\n",
    "axes[0].xaxis.set_major_formatter(plt.FuncFormatter(lambda x, _: f\"{x/1e6:.0f}M\"))\n",
    "axes[0].set_yticklabels([str(l)[:40] for l in top_vol[\"boites\"].sort_values().index], fontsize=8)\n",
    "\n",
    "top_cpb = spe_stats[~spe_stats.index.isin(EXCLUDE)].nlargest(12, \"cout_par_boite\")\n",
    "top_cpb[\"cout_par_boite\"].sort_values().plot.barh(ax=axes[1], color=\"darkorange\")\n",
    "axes[1].set_title(f\"Coût moyen par boîte\\npar spécialité prescriptrice — {YEAR}\",\n",
    "                  fontsize=11, fontweight=\"bold\")\n",
    "axes[1].set_xlabel(\"€ / boîte\")\n",
    "axes[1].set_yticklabels([str(l)[:40] for l in top_cpb[\"cout_par_boite\"].sort_values().index], fontsize=8)\n",
    "for bar, v in zip(axes[1].patches, top_cpb[\"cout_par_boite\"].sort_values()):\n",
    "    axes[1].text(v + 0.1, bar.get_y() + bar.get_height() / 2,\n",
    "                 f\"{v:.1f}€\", va=\"center\", fontsize=7)\n",
    "\n",
    "plt.suptitle(\"Q5 — Profil prescripteur par spécialité médicale\",\n",
    "             fontsize=13, fontweight=\"bold\", y=1.01)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# ── Heatmap spécialité × ATC ──\n",
    "top_spe_labels = spe_stats[~spe_stats.index.isin(EXCLUDE)].head(10).index.tolist()\n",
    "spe_atc = (df[df[\"_spe_label\"].isin(top_spe_labels)]\n",
    "           .groupby([\"_spe_label\", ATC1_COL])[BOX_COL].sum()\n",
    "           .unstack(fill_value=0))\n",
    "spe_atc_pct = spe_atc.div(spe_atc.sum(axis=1), axis=0) * 100\n",
    "\n",
    "fig, ax = plt.subplots(figsize=(16, 6))\n",
    "im = ax.imshow(spe_atc_pct.values, aspect=\"auto\", cmap=\"Blues\", vmin=0)\n",
    "ax.set_xticks(range(len(spe_atc_pct.columns)))\n",
    "ax.set_xticklabels([str(c)[:28] for c in spe_atc_pct.columns],\n",
    "                   rotation=45, ha=\"right\", fontsize=7)\n",
    "ax.set_yticks(range(len(spe_atc_pct.index)))\n",
    "ax.set_yticklabels([str(r)[:40] for r in spe_atc_pct.index], fontsize=8)\n",
    "for i in range(len(spe_atc_pct.index)):\n",
    "    for j in range(len(spe_atc_pct.columns)):\n",
    "        v = spe_atc_pct.values[i, j]\n",
    "        if v > 8:\n",
    "            ax.text(j, i, f\"{v:.0f}%\", ha=\"center\", va=\"center\",\n",
    "                    fontsize=6, color=\"white\" if v > 35 else \"black\")\n",
    "plt.colorbar(im, ax=ax, label=\"% des boîtes prescrites (dans la spécialité)\")\n",
    "ax.set_title(\"Signature thérapeutique par spécialité — part de chaque classe ATC (%)\",\n",
    "             fontsize=11, fontweight=\"bold\")\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# ── Résultats ──\n",
    "print(f\"=== Q5 — Analyse par spécialité prescriptrice ({YEAR}) ===\\n\")\n",
    "print(f\"  {'Spécialité':<38} {'Boîtes (M)':>10}  {'% vol.':>7}  {'Remb. (M€)':>11}  {'% coût':>7}  {'€/boîte':>9}\")\n",
    "print(f\"  {'-'*88}\")\n",
    "for spe, row in spe_stats.head(20).iterrows():\n",
    "    print(f\"  {str(spe)[:36]:<38} {row['boites']/1e6:>9.0f}  {row['pct_volume']:>6.1f}%  \"\n",
    "          f\"{row['remboursement']/1e6:>10.0f}  {row['pct_couts']:>6.1f}%  {row['cout_par_boite']:>8.2f}€\")\n",
    "\n",
    "print(f\"\\n  Spécialités libérales au coût unitaire le plus élevé (€ / boîte) :\")\n",
    "print(f\"  {'Spécialité':<38} {'€/boîte':>9}  {'Boîtes (M)':>10}  {'Remb. (M€)':>11}\")\n",
    "print(f\"  {'-'*72}\")\n",
    "for spe, row in spe_stats[~spe_stats.index.isin(EXCLUDE)].nlargest(8, \"cout_par_boite\").iterrows():\n",
    "    print(f\"  {str(spe)[:36]:<38} {row['cout_par_boite']:>8.2f}€  \"\n",
    "          f\"{row['boites']/1e6:>9.0f}  {row['remboursement']/1e6:>10.0f}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "23rox9mnrdi",
   "metadata": {},
   "source": [
    "---\n",
    "## Q6 — Disparités régionales de prescription\n",
    "\n",
    "Open Medic code la région du bénéficiaire (`BEN_REG`). L'agrégation par région révèle\n",
    "deux types de disparités : les disparités de **volume** (liées à la démographie et à la densité\n",
    "médicale) et les disparités de **composition thérapeutique** (liées aux pratiques locales).\n",
    "Le taux de prescription d'antibiotiques (ATC2 = J01), très variable selon les territoires,\n",
    "est un indicateur clé de santé publique directement mesurable ici."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "40mtdrdr2wq",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2100x800 with 3 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Q6 — Disparités régionales (2024) ===\n",
      "  (Codes BEN_REG = noms pré-réforme 2016, périmètres correspondant aux nouvelles régions)\n",
      "\n",
      "  Région                              Boîtes (M)   % vol.   Remb. (M€)    €/boîte   % Antibio.\n",
      "  ----------------------------------------------------------------------------------------\n",
      "  Île-de-France                             379    16.0%          42      0.11€        5.49%\n",
      "  Auvergne-Rhône-Alpes                      261    11.0%          28      0.11€        4.71%\n",
      "  Nord-Pas-de-Calais-Picardie               238    10.0%          24      0.10€        4.73%\n",
      "  Aquitaine-Limousin-Poitou-Ch.             227     9.6%          26      0.12€        4.81%\n",
      "  PACA et Corse                             222     9.4%          32      0.15€        4.90%\n",
      "  Languedoc-Roussillon-Midi-Pyr.            219     9.2%          30      0.14€        4.84%\n",
      "  Alsace-Champ.-Ardenne-Lorraine            206     8.7%          25      0.12€        4.67%\n",
      "  Normandie                                 127     5.3%          20      0.16€        4.51%\n",
      "  Pays de la Loire                          118     5.0%          20      0.17€        4.51%\n",
      "  Bretagne                                  116     4.9%          19      0.16€        4.43%\n",
      "  Bourgogne-Franche-Comté                   101     4.3%          20      0.19€        4.71%\n",
      "  Centre-Val de Loire                        90     3.8%          21      0.23€        4.41%\n",
      "  DOM-TOM                                    59     2.5%          15      0.25€        4.20%\n",
      "  Inconnu                                     5     0.2%          10      1.93€        6.43%\n",
      "\n",
      "  Région + forte prescription antibiotique : Île-de-France (5.49%)\n",
      "  Région + faible prescription antibiotique : Centre-Val de Loire (4.41%)\n",
      "  → Rapport max / min : 1.2x\n"
     ]
    }
   ],
   "source": [
    "assert REG_COL, f\"BEN_REG introuvable — colonnes : {list(df.columns)}\"\n",
    "\n",
    "# Codes BEN_REG — source : feuille BEN_REG du fichier descriptif-variables CNAM\n",
    "# Attention : noms pré-réforme régionale 2016 (anciens périmètres)\n",
    "REG_LABELS = {\n",
    "    \"5\":  \"DOM-TOM\",\n",
    "    \"11\": \"Île-de-France\",\n",
    "    \"24\": \"Centre-Val de Loire\",\n",
    "    \"27\": \"Bourgogne-Franche-Comté\",\n",
    "    \"28\": \"Normandie\",\n",
    "    \"32\": \"Nord-Pas-de-Calais-Picardie\",\n",
    "    \"44\": \"Alsace-Champ.-Ardenne-Lorraine\",\n",
    "    \"52\": \"Pays de la Loire\",\n",
    "    \"53\": \"Bretagne\",\n",
    "    \"75\": \"Aquitaine-Limousin-Poitou-Ch.\",\n",
    "    \"76\": \"Languedoc-Roussillon-Midi-Pyr.\",\n",
    "    \"84\": \"Auvergne-Rhône-Alpes\",\n",
    "    \"93\": \"PACA et Corse\",\n",
    "    \"0\":  \"Inconnu\",\n",
    "    \"99\": \"Inconnu\",\n",
    "}\n",
    "df[\"_reg_label\"] = (df[REG_COL].astype(str).str.strip()\n",
    "                    .map(REG_LABELS)\n",
    "                    .fillna(\"Code \" + df[REG_COL].astype(str).str.strip()))\n",
    "\n",
    "reg_stats = df.groupby(\"_reg_label\").agg(\n",
    "    boites        =(BOX_COL, \"sum\"),\n",
    "    remboursement =(REM_COL, \"sum\"),\n",
    ").dropna()\n",
    "reg_stats[\"cout_par_boite\"] = reg_stats[\"remboursement\"] / reg_stats[\"boites\"]\n",
    "reg_stats[\"pct_volume\"]     = reg_stats[\"boites\"] / reg_stats[\"boites\"].sum() * 100\n",
    "\n",
    "# Taux d'antibiotiques (ATC2 code = J01) par région\n",
    "if ATC2_CODE_COL:\n",
    "    ab_mask = df[ATC2_CODE_COL].astype(str).str.upper().str.strip() == \"J01\"\n",
    "    reg_stats[\"boites_antibio\"] = df[ab_mask].groupby(\"_reg_label\")[BOX_COL].sum()\n",
    "    reg_stats[\"pct_antibio\"]    = reg_stats[\"boites_antibio\"] / reg_stats[\"boites\"] * 100\n",
    "\n",
    "mask_fr = ~reg_stats.index.isin([\"Inconnu\", \"DOM-TOM\"])\n",
    "reg_fr  = reg_stats[mask_fr].copy()\n",
    "\n",
    "# ── Graphiques ──\n",
    "ncols = 3 if ATC2_CODE_COL else 2\n",
    "fig, axes = plt.subplots(1, ncols, figsize=(7 * ncols, 8))\n",
    "\n",
    "reg_fr.sort_values(\"boites\")[\"boites\"].plot.barh(ax=axes[0], color=\"steelblue\")\n",
    "axes[0].set_title(f\"Boîtes dispensées par région\\n({YEAR})\", fontsize=11, fontweight=\"bold\")\n",
    "axes[0].set_xlabel(\"Boîtes\")\n",
    "axes[0].xaxis.set_major_formatter(plt.FuncFormatter(lambda x, _: f\"{x/1e6:.0f}M\"))\n",
    "axes[0].set_yticklabels([str(l)[:38] for l in reg_fr.sort_values(\"boites\").index], fontsize=8)\n",
    "\n",
    "reg_fr.sort_values(\"cout_par_boite\")[\"cout_par_boite\"].plot.barh(ax=axes[1], color=\"darkorange\")\n",
    "axes[1].set_title(f\"Coût moyen par boîte\\npar région ({YEAR})\", fontsize=11, fontweight=\"bold\")\n",
    "axes[1].set_xlabel(\"€ / boîte\")\n",
    "axes[1].set_yticklabels([str(l)[:38] for l in reg_fr.sort_values(\"cout_par_boite\").index], fontsize=8)\n",
    "for bar, v in zip(axes[1].patches, reg_fr.sort_values(\"cout_par_boite\")[\"cout_par_boite\"]):\n",
    "    axes[1].text(v + 0.02, bar.get_y() + bar.get_height() / 2,\n",
    "                 f\"{v:.2f}€\", va=\"center\", fontsize=7)\n",
    "\n",
    "if ATC2_CODE_COL and \"pct_antibio\" in reg_fr.columns:\n",
    "    reg_ab = reg_fr.sort_values(\"pct_antibio\")\n",
    "    reg_ab[\"pct_antibio\"].plot.barh(ax=axes[2], color=\"crimson\")\n",
    "    mean_ab = reg_ab[\"pct_antibio\"].mean()\n",
    "    axes[2].axvline(mean_ab, color=\"black\", linestyle=\"--\", alpha=0.6,\n",
    "                    label=f\"Moyenne : {mean_ab:.2f}%\")\n",
    "    axes[2].set_title(f\"% de boîtes antibiotiques (J01)\\npar région ({YEAR})\",\n",
    "                      fontsize=11, fontweight=\"bold\")\n",
    "    axes[2].set_xlabel(\"% des boîtes dispensées\")\n",
    "    axes[2].legend(fontsize=8)\n",
    "    axes[2].set_yticklabels([str(l)[:38] for l in reg_ab.index], fontsize=8)\n",
    "\n",
    "plt.suptitle(\"Q6 — Disparités régionales de prescription\\n(noms de régions pré-réforme 2016)\",\n",
    "             fontsize=13, fontweight=\"bold\", y=1.01)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# ── Résultats ──\n",
    "print(f\"=== Q6 — Disparités régionales ({YEAR}) ===\")\n",
    "print(f\"  (Codes BEN_REG = noms pré-réforme 2016, périmètres correspondant aux nouvelles régions)\\n\")\n",
    "hdr = f\"  {'Région':<35} {'Boîtes (M)':>10}  {'% vol.':>7}  {'Remb. (M€)':>11}  {'€/boîte':>9}\"\n",
    "if \"pct_antibio\" in reg_stats.columns:\n",
    "    hdr += f\"  {'% Antibio.':>11}\"\n",
    "print(hdr)\n",
    "print(f\"  {'-'*88}\")\n",
    "for reg, row in reg_stats.sort_values(\"boites\", ascending=False).iterrows():\n",
    "    line = (f\"  {str(reg)[:33]:<35} {row['boites']/1e6:>9.0f}  {row['pct_volume']:>6.1f}%  \"\n",
    "            f\"{row['remboursement']/1e6:>10.0f}  {row['cout_par_boite']:>8.2f}€\")\n",
    "    if \"pct_antibio\" in reg_stats.columns:\n",
    "        line += f\"  {row.get('pct_antibio', float('nan')):>10.2f}%\"\n",
    "    print(line)\n",
    "\n",
    "if \"pct_antibio\" in reg_stats.columns:\n",
    "    top_ab    = reg_stats[mask_fr].nlargest(1, \"pct_antibio\")\n",
    "    bottom_ab = reg_stats[mask_fr].nsmallest(1, \"pct_antibio\")\n",
    "    ratio     = top_ab[\"pct_antibio\"].iloc[0] / bottom_ab[\"pct_antibio\"].iloc[0]\n",
    "    print(f\"\\n  Région + forte prescription antibiotique : {top_ab.index[0]} ({top_ab['pct_antibio'].iloc[0]:.2f}%)\")\n",
    "    print(f\"  Région + faible prescription antibiotique : {bottom_ab.index[0]} ({bottom_ab['pct_antibio'].iloc[0]:.2f}%)\")\n",
    "    print(f\"  → Rapport max / min : {ratio:.1f}x\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7v7s4jw79ie",
   "metadata": {},
   "source": [
    "---\n",
    "## Q7 — Polymédication et budget des seniors (60 ans et plus)\n",
    "\n",
    "La Q3 a montré que les 60 ans et plus (code AGE=60) concentrent la majorité des boîtes dispensées.\n",
    "Cette analyse va plus loin : elle quantifie le **coût unitaire** de la prescription senior\n",
    "(les seniors consomment-ils des médicaments plus chers ?) et mesure la **diversité\n",
    "thérapeutique** par tranche d'âge — proxy direct de la polymédication.\n",
    "Elle identifie également les classes ATC qui dominent le budget des 60 ans et plus."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "bnniwvm5m7v",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2200x700 with 3 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Q7 — Budget et polymédication seniors (2024) ===\n",
      "\n",
      "  Seniors (60 ans et plus) :\n",
      "    Boîtes dispensées  : 1328M (56.1% du total)\n",
      "    Montant remboursé  : 0.15 Md€ (45.6% du total)\n",
      "    Coût moyen / boîte : 0.11 €\n",
      "\n",
      "  Non-seniors (0-59 ans) :\n",
      "    Boîtes dispensées  : 1039M (43.9% du total)\n",
      "    Montant remboursé  : 0.18 Md€ (54.0% du total)\n",
      "    Coût moyen / boîte : 0.17 €\n",
      "\n",
      "  → Coût unitaire seniors / non-seniors : 0.66x plus élevé\n",
      "\n",
      "  Top 10 classes thérapeutiques chez les 60+ (triées par montant remboursé) :\n",
      "  Classe ATC                                         Boîtes (M)   Remb. (M€)    €/boîte\n",
      "  -----------------------------------------------------------------------------------\n",
      "  SYSTEME CARDIO-VASCULAIRE                                199          45      0.23€\n",
      "  SYSTEME NERVEUX                                          453          29      0.06€\n",
      "  SYSTEME DIGESTIF ET METABOLISME                          259          24      0.09€\n",
      "  ANTI-INFECTIEUX (USAGE SYSTEMIQUE)                        58          12      0.21€\n",
      "  SYSTEME RESPIRATOIRE                                      60           7      0.12€\n",
      "  SANG ET ORGANES HEMATOPOIETQUES                           95           6      0.06€\n",
      "  SYSTEME MUSCULO-SQUELETTIQUE                              40           6      0.15€\n",
      "  ORGANES SENSORIELS                                        53           5      0.09€\n",
      "  DERMATOLOGIE                                              33           5      0.14€\n",
      "  SYSTEME GENITO-URINAIRE ET HORMONES SEXUELLES             29           4      0.14€\n",
      "\n",
      "  Évolution du coût unitaire et de la diversité thérapeutique avec l'âge :\n",
      "  Tranche            Boîtes (M)   Remb. (M€)    €/boîte   Nb classes ATC\n",
      "  ----------------------------------------------------------------------\n",
      "    0                      183          44      0.24€               14\n",
      "    20                     856         136      0.16€               14\n",
      "  ★ 60                    1328         151      0.11€               14\n",
      "    99                       1           2      1.66€               14\n"
     ]
    }
   ],
   "source": [
    "def age_sort_key(label):\n",
    "    m = re.search(r'\\d+', str(label))\n",
    "    return int(m.group()) if m else 999\n",
    "\n",
    "# Budget et diversité thérapeutique par tranche d'âge\n",
    "# Codes AGE : 0=0-19 ans, 20=20-59 ans, 60=60 ans et plus, 99=inconnu\n",
    "age_budget = df.groupby(AGE_COL).agg(\n",
    "    boites        =(BOX_COL, \"sum\"),\n",
    "    remboursement =(REM_COL, \"sum\"),\n",
    "    n_classes_atc =(ATC1_COL, \"nunique\"),\n",
    ").dropna()\n",
    "age_budget = age_budget.reindex(sorted(age_budget.index, key=age_sort_key))\n",
    "age_budget[\"cout_par_boite\"] = age_budget[\"remboursement\"] / age_budget[\"boites\"]\n",
    "\n",
    "# Seuil seniors : code AGE = 60 (60 ans et plus)\n",
    "df[\"_age_num\"] = df[AGE_COL].apply(age_sort_key)\n",
    "df[\"_senior\"]  = df[\"_age_num\"] == 60   # code 60 = 60 ans et plus\n",
    "senior_boxes   = df[df[\"_senior\"]][BOX_COL].sum()\n",
    "senior_rem     = df[df[\"_senior\"]][REM_COL].sum()\n",
    "non_sen_boxes  = df[df[\"_age_num\"].isin([0, 20])][BOX_COL].sum()\n",
    "non_sen_rem    = df[df[\"_age_num\"].isin([0, 20])][REM_COL].sum()\n",
    "total_b        = df[BOX_COL].sum()\n",
    "total_r        = df[REM_COL].sum()\n",
    "\n",
    "# Top classes ATC chez les 60+\n",
    "senior_atc = (df[df[\"_senior\"]]\n",
    "              .groupby(ATC1_COL).agg(\n",
    "                  boites        =(BOX_COL, \"sum\"),\n",
    "                  remboursement =(REM_COL, \"sum\"),\n",
    "              ).dropna().sort_values(\"remboursement\", ascending=False))\n",
    "\n",
    "# ── Graphiques ──\n",
    "# Rouge = 60+ (senior), gris = inconnu (99), bleu = <60\n",
    "colors_age = [\"#c0392b\" if age_sort_key(a) == 60\n",
    "              else \"#95a5a6\" if age_sort_key(a) == 99\n",
    "              else \"#3498db\"\n",
    "              for a in age_budget.index]\n",
    "fig, axes  = plt.subplots(1, 3, figsize=(22, 7))\n",
    "\n",
    "age_budget[\"remboursement\"].plot.barh(ax=axes[0], color=colors_age)\n",
    "axes[0].set_title(f\"Montant remboursé par tranche d'âge\\n({YEAR}) — rouge = 60 ans et plus\",\n",
    "                  fontsize=11, fontweight=\"bold\")\n",
    "axes[0].set_xlabel(\"Montant remboursé (€)\")\n",
    "axes[0].xaxis.set_major_formatter(\n",
    "    plt.FuncFormatter(lambda x, _: f\"{x/1e9:.1f}Md€\" if x >= 1e9 else f\"{x/1e6:.0f}M€\"))\n",
    "axes[0].set_yticklabels([str(l) for l in age_budget.index], fontsize=8)\n",
    "\n",
    "age_budget[\"cout_par_boite\"].plot.barh(ax=axes[1], color=colors_age)\n",
    "axes[1].set_title(f\"Coût moyen par boîte par tranche d'âge\\n({YEAR})\",\n",
    "                  fontsize=11, fontweight=\"bold\")\n",
    "axes[1].set_xlabel(\"€ / boîte\")\n",
    "axes[1].set_yticklabels([str(l) for l in age_budget.index], fontsize=8)\n",
    "for bar, v in zip(axes[1].patches, age_budget[\"cout_par_boite\"]):\n",
    "    axes[1].text(v + 0.05, bar.get_y() + bar.get_height() / 2,\n",
    "                 f\"{v:.2f}€\", va=\"center\", fontsize=6)\n",
    "\n",
    "age_budget[\"n_classes_atc\"].plot.barh(ax=axes[2], color=colors_age)\n",
    "axes[2].set_title(f\"Classes ATC distinctes prescrites\\npar tranche d'âge ({YEAR})\",\n",
    "                  fontsize=11, fontweight=\"bold\")\n",
    "axes[2].set_xlabel(\"Nb de classes ATC (sur 14 max)\")\n",
    "axes[2].set_yticklabels([str(l) for l in age_budget.index], fontsize=8)\n",
    "for bar, v in zip(axes[2].patches, age_budget[\"n_classes_atc\"]):\n",
    "    axes[2].text(v + 0.05, bar.get_y() + bar.get_height() / 2,\n",
    "                 str(int(v)), va=\"center\", fontsize=7)\n",
    "\n",
    "plt.suptitle(\"Q7 — Polymédication et budget des seniors (60 ans et plus)\",\n",
    "             fontsize=13, fontweight=\"bold\", y=1.01)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# ── Résultats ──\n",
    "cpb_senior = senior_rem  / senior_boxes  if senior_boxes  > 0 else 0\n",
    "cpb_nonsen = non_sen_rem / non_sen_boxes if non_sen_boxes > 0 else 0\n",
    "\n",
    "print(f\"=== Q7 — Budget et polymédication seniors ({YEAR}) ===\\n\")\n",
    "print(f\"  Seniors (60 ans et plus) :\")\n",
    "print(f\"    Boîtes dispensées  : {senior_boxes/1e6:.0f}M ({senior_boxes/total_b*100:.1f}% du total)\")\n",
    "print(f\"    Montant remboursé  : {senior_rem/1e9:.2f} Md€ ({senior_rem/total_r*100:.1f}% du total)\")\n",
    "print(f\"    Coût moyen / boîte : {cpb_senior:.2f} €\")\n",
    "print(f\"\\n  Non-seniors (0-59 ans) :\")\n",
    "print(f\"    Boîtes dispensées  : {non_sen_boxes/1e6:.0f}M ({non_sen_boxes/total_b*100:.1f}% du total)\")\n",
    "print(f\"    Montant remboursé  : {non_sen_rem/1e9:.2f} Md€ ({non_sen_rem/total_r*100:.1f}% du total)\")\n",
    "print(f\"    Coût moyen / boîte : {cpb_nonsen:.2f} €\")\n",
    "if cpb_nonsen > 0:\n",
    "    print(f\"\\n  → Coût unitaire seniors / non-seniors : {cpb_senior/cpb_nonsen:.2f}x plus élevé\")\n",
    "\n",
    "print(f\"\\n  Top 10 classes thérapeutiques chez les 60+ (triées par montant remboursé) :\")\n",
    "print(f\"  {'Classe ATC':<50} {'Boîtes (M)':>10}  {'Remb. (M€)':>11}  {'€/boîte':>9}\")\n",
    "print(f\"  {'-'*83}\")\n",
    "for atc_n, row in senior_atc.head(10).iterrows():\n",
    "    cpb = row['remboursement'] / row['boites'] if row['boites'] > 0 else 0\n",
    "    print(f\"  {str(atc_n)[:48]:<50} {row['boites']/1e6:>9.0f}  {row['remboursement']/1e6:>10.0f}  {cpb:>8.2f}€\")\n",
    "\n",
    "print(f\"\\n  Évolution du coût unitaire et de la diversité thérapeutique avec l'âge :\")\n",
    "print(f\"  {'Tranche':<18} {'Boîtes (M)':>10}  {'Remb. (M€)':>11}  {'€/boîte':>9}  {'Nb classes ATC':>15}\")\n",
    "print(f\"  {'-'*70}\")\n",
    "for age_l, row in age_budget.iterrows():\n",
    "    marker = \"★\" if age_sort_key(age_l) == 60 else \" \"\n",
    "    print(f\"  {marker} {str(age_l):<16} {row['boites']/1e6:>9.0f}  {row['remboursement']/1e6:>10.0f}  \"\n",
    "          f\"{row['cout_par_boite']:>8.2f}€  {int(row['n_classes_atc']):>15}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e8l5maj0o1t",
   "source": "---\n## Q8 — Volume et montants remboursés par molécule (substance chimique ATC5)\n\nLa classification ATC au niveau 5 identifie la **substance chimique** — l'équivalent de la « molécule ». Agréger Open Medic à ce grain révèle deux palmarès souvent très différents : les molécules qui **dominent en volume** (médication de masse à prix unitaire bas) et celles qui **dominent en valeur** (traitements chroniques à coût unitaire élevé).\n\nLe ratio **REM/boîte** est le principal indicateur de la valeur unitaire : une molécule peut être prescrite massivement tout en ayant un coût unitaire très faible (paracétamol), ou générer des remboursements élevés avec peu de boîtes (anticoagulants oraux directs, statines premium).\n\n> **Limite :** la colonne `REM` est censurée pour ~35 % des lignes (effectifs insuffisants par combinaison analytique). Les molécules onéreuses prescrites à peu de patients par strate sont structurellement sous-estimées ; l'analyse volumétrique (`BOITES`) reste fiable et complète.",
   "metadata": {}
  },
  {
   "cell_type": "code",
   "id": "79dnwonq1nj",
   "source": "# ── Q8 : volume et montants remboursés par molécule (substance chimique ATC5) ──\nATC5_COL = find_col(df, [\"L_ATC5\", \"ATC5\", \"atc5\"])\n\nif ATC5_COL is None:\n    print(\"⚠  Colonne ATC5 introuvable — colonnes disponibles :\")\n    print(\"  \", [c for c in df.columns if \"atc\" in c.lower()])\nelse:\n    _m = df[df[ATC5_COL].notna()].copy()\n    _m[BOX_COL] = pd.to_numeric(_m[BOX_COL], errors=\"coerce\")\n    _m[REM_COL] = pd.to_numeric(_m[REM_COL], errors=\"coerce\")\n\n    mol = (\n        _m.groupby(ATC5_COL)\n        .agg(boites=(BOX_COL, \"sum\"), rem=(REM_COL, \"sum\"))\n        .query(\"boites > 0\")\n        .sort_values(\"boites\", ascending=False)\n    )\n\n    n_mol = len(mol)\n    top_vol = mol.head(20)\n    top_rem = mol.sort_values(\"rem\", ascending=False).head(20)\n\n    print(f\"=== Q8 — Volume et REM par molécule (ATC5) — {YEAR} ===\\n\")\n    print(f\"  Molécules distinctes (ATC5) : {n_mol:,}\")\n    print(f\"\\n  Top 5 par volume :\")\n    for m, r in top_vol.head(5).iterrows():\n        print(f\"    {str(m).title()[:45]:<47}  {r['boites']/1e6:>7.0f}M boîtes  {r['rem']/1e6:>7.1f}M€\")\n    print(f\"\\n  Top 5 par montant remboursé (REM observé) :\")\n    for m, r in top_rem.head(5).iterrows():\n        print(f\"    {str(m).title()[:45]:<47}  {r['boites']/1e6:>7.0f}M boîtes  {r['rem']/1e6:>7.1f}M€\")\n\n    # ── Fig 1 : top 20 par volume + overlay REM ──────────────────────────────\n    fig, ax1 = plt.subplots(figsize=(14, 6))\n    ax2 = ax1.twinx()\n\n    xs = range(len(top_vol))\n    ax1.bar(xs, top_vol[\"boites\"] / 1e6, color=\"#3498db\", alpha=0.75, label=\"Boîtes (M)\")\n    ax2.plot(xs, top_vol[\"rem\"] / 1e6, \"o-\", color=\"#e74c3c\", lw=1.8, ms=6,\n             label=\"REM observé (M€)\")\n\n    ax1.set_xticks(list(xs))\n    ax1.set_xticklabels(\n        [str(s).title()[:38] for s in top_vol.index],\n        rotation=45, ha=\"right\", fontsize=8\n    )\n    ax1.set_ylabel(\"Boîtes dispensées (millions)\", color=\"#3498db\")\n    ax2.set_ylabel(\"Montant remboursé observé (M€)\", color=\"#e74c3c\")\n    ax1.set_title(\n        f\"Q8 — Top 20 molécules (ATC5) par volume de prescription — {YEAR}\\n\"\n        f\"(REM partiel : ~65 % des lignes renseignées — molécules onéreuses sous-estimées)\"\n    )\n    h1, l1 = ax1.get_legend_handles_labels()\n    h2, l2 = ax2.get_legend_handles_labels()\n    ax1.legend(h1 + h2, l1 + l2, loc=\"upper right\", fontsize=8)\n    plt.tight_layout()\n    plt.show()\n\n    # ── Fig 2 : top 20 par montant remboursé ─────────────────────────────────\n    fig, ax = plt.subplots(figsize=(12, 6))\n    ys = range(len(top_rem))\n    ax.barh(list(ys), top_rem[\"rem\"] / 1e6, color=\"#e74c3c\", alpha=0.75)\n    for i, (idx, row) in enumerate(top_rem.iterrows()):\n        ax.text(\n            row[\"rem\"] / 1e6 * 1.01, i,\n            f'{row[\"boites\"]/1e6:.0f}M btes',\n            va=\"center\", fontsize=7, color=\"#2c3e50\"\n        )\n    ax.set_yticks(list(ys))\n    ax.set_yticklabels([str(s).title()[:45] for s in top_rem.index], fontsize=8)\n    ax.invert_yaxis()\n    ax.set_xlabel(\"Montant remboursé observé (M€) — estimation partielle (~65 % des lignes)\")\n    ax.set_title(f\"Q8 — Top 20 molécules (ATC5) par montant remboursé observé — {YEAR}\")\n    plt.tight_layout()\n    plt.show()\n\n    # ── Tableau récapitulatif ─────────────────────────────────────────────────\n    tbl = mol.head(20).copy()\n    tbl.index = [str(s).title() for s in tbl.index]\n    tbl[\"Boîtes (M)\"]       = (tbl[\"boites\"] / 1e6).round(1)\n    tbl[\"REM observé (M€)\"] = (tbl[\"rem\"] / 1e6).round(1)\n    tbl[\"REM/boîte (€)\"]    = (tbl[\"rem\"] / tbl[\"boites\"]).round(2)\n    display(tbl[[\"Boîtes (M)\", \"REM observé (M€)\", \"REM/boîte (€)\"]])",
   "metadata": {},
   "execution_count": null,
   "outputs": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9692b338",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "name": "python",
   "version": "3.11.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}